Winters Declaration — In re Vyaire Medical, Inc., Case No. 24-11217 (BLS) (Bankr. D. Del.), jointly administered

Full text

Exhibit A

Winters Declaration
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 1 of 914

IN THE UNITED STATES BANKRUPTCY COURT
FOR THE DISTRICT OF DELAWARE

)

In re:
)
Chapter 11

)

VYAIRE MEDICAL, INC., et al.,1
)
Case No. 24-11217 (BLS)

)

Debtors.
)
(Jointly Administered)

)

DECLARATION OF SPENCER A. WINTERS
IN SUPPORT OF THE INTERIM AND FINAL FEE
APPLICATION OF KIRKLAND & ELLIS LLP AND KIRKLAND & ELLIS
INTERNATIONAL LLP, ATTORNEYS FOR THE DEBTORS AND DEBTORS IN
POSSESSION FOR THE (I) INTERIM FEE PERIOD FROM SEPTEMBER 1, 2024
THROUGH AND INCLUDING NOVEMBER 14, 2024 AND THE (II) FINAL FEE
PERIOD FROM JUNE 9, 2024 THROUGH AND INCLUDING NOVEMBER 14, 2024
I, Spencer A. Winters, being duly sworn, state the following under penalty of perjury:
1.
I am the president of Spencer A. Winters, P.C., a partner in the law firm of
Kirkland & Ellis LLP, located at 333 West Wolf Point Plaza, Chicago, IL 60654, and a partner of
Kirkland & Ellis International, LLP (together with Kirkland & Ellis LLP, “K&E”).2  I am one of
the lead attorneys from K&E working on the above-captioned chapter 11 cases.  I am a member
in good standing of the Bar of the State of Illinois, and I have been admitted to practice in United
States District Court for the Northern District of Illinois.  There are no disciplinary proceedings
pending against me.

1  The last four digits of Debtor Vyaire Medical, Inc.‘s federal tax identification number are 6495.  A complete list
of each of the Debtors in these chapter 11 cases and each such Debtor’s federal tax identification number may be
obtained on the website of the Debtors’ claims and noticing agent at https://omniagentsolutions.com/Vyaire.  The
location of Debtor Vyaire Medical, Inc.‘s principal place of business and the Debtors’ service address in these
chapter 11 cases is 26125 North Riverwoods Boulevard, Mettawa, Illinois, USA 60045.
2
Capitalized terms used but not otherwise defined herein shall have the meaning as set forth in the Fee Application
(as defined herein).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 2 of 914

2
2.
I have read the foregoing interim fee application of K&E, attorneys for the Debtors,
for the Fee Period (the “Fee Application”).  To the best of my knowledge, information and belief,
the statements contained in the Fee Application are true and correct.  In addition, I believe that the
Fee Application complies with Local Bankruptcy Rule 2016-2.
3.
In connection therewith, I hereby certify that:
a)
to the best of my knowledge, information, and belief, formed after
reasonable inquiry, the fees and disbursements sought in the Fee
Application are permissible under the relevant rules, court orders, and
Bankruptcy Code provisions, except as specifically set forth herein;
b)
except to the extent disclosed in the Fee Application, the fees and
disbursements sought in the Fee Application are billed at rates customarily
employed by K&E and generally accepted by K&E’s clients.  In addition,
none of the professionals seeking compensation varied their hourly rate
based on the geographic location of the Debtors’ case;
c)
the fees sought exceed the fees budgeted for the same time period in the
Budget and Staffing Plan by more than 10% for the following reasons:
a. the sale of the Debtors’ businesses involved multiple complex,
international transactions requiring significant time and specialized
expertise;
b. the volume of activity in the sales processes significantly exceeded
expectations, including the number of active bidders and the extent,
duration, and complexity of negotiations with the bidders, the
lenders, and other stakeholders;
c. the Sale Transactions required significant complex, international tax
structuring analysis; and
d. the Budget and Staffing Plan projected only through September 7,
2024, while the Fee Period extends an extra 9 weeks and 5 days,
through November 14, 2024.
The reasons justifying the variance have been discussed at length with the
Debtors;
d) K&E is seeking compensation with respect to (i) the approximately 76 hours
and $81,824.00 in fees spent reviewing or revising time records and
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 3 of 914

3
preparing, reviewing, and revising invoices;3 and (ii) the approximately 158
hours and $180,869.00 in fees spent reviewing time records to redact
privileged or confidential information;
e) in providing a reimbursable expense, K&E does not make a profit on that
expense, whether the service is performed by K&E in-house or through a
third party;
f) in accordance with Rule 2016(a) of the Federal Rules of Bankruptcy
Procedure and 11 U.S.C. § 504, no agreement or understanding exists
between K&E and any other person for the sharing of compensation to be
received in connection with the above cases except as authorized pursuant
to the Bankruptcy Code, Bankruptcy Rules, and Local Bankruptcy Rules;
and
g) all services for which compensation is sought were professional services on
behalf of the Debtors and not on behalf of any other person.
[Remainder of Page Intentionally Blank]

3
This is limited to work involved in preparing and editing billing records that would not be compensable outside
of bankruptcy and does not include reasonable fees for preparing a fee application.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 4 of 914

Pursuant to 28 U.S.C. § 1746, I declare under penalty of perjury that the foregoing is true
and correct to the best of my knowledge and belief.
Dated:  December 23, 2024
Respectfully submitted,

/s/ Spencer A. Winters

Spencer A. Winters
as President of Spencer A. Winters, P.C., as
Partner of Kirkland & Ellis LLP; and as Partner
of Kirkland & Ellis International LLP
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 5 of 914

Exhibit B

Retention Order
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 6 of 914

IN THE UNITED STATES BANKRUPTCY COURT
FOR THE DISTRICT OF DELAWARE
)
In re:
)
Chapter 11
)
VYAIRE MEDICAL, INC., et al.,1
)
Case No. 24-11217 (BLS)
)
Debtors.
)
(Jointly Administered)
)
)
Re:  Docket No. 259
ORDER AUTHORIZING THE RETENTION
AND EMPLOYMENT OF KIRKLAND & ELLIS LLP AND
KIRKLAND & ELLIS INTERNATIONAL LLP AS ATTORNEYS FOR THE
DEBTORS AND DEBTORS IN POSSESSION EFFECTIVE AS OF JUNE 9, 2024
Upon the application (the “Application”)2 of the above-captioned debtors and debtors in
possession (collectively, the “Debtors”) for the entry of an order (the “Order”) authorizing the
Debtors to retain and employ Kirkland & Ellis LLP and Kirkland & Ellis International LLP
(collectively, “Kirkland”) as their attorneys effective as of the Petition Date, pursuant to
sections 327(a) and 330 of title 11 of the United States Code (the “Bankruptcy Code”),
rules 2014(a) and 2016 of the Federal Rules of Bankruptcy Procedure (the “Bankruptcy Rules”),
and rules 2014-1 and 2016-1 of the Local Bankruptcy Rules for the District of Delaware
(the “Local Rules”); and the Court having reviewed the Application, the declaration of Spencer A.
Winters, the president of Spencer A. Winters, P.C., a partner of Kirkland & Ellis LLP and a partner
of Kirkland & Ellis International LLP (the “Winters Declaration”), and the declaration of John
Bibb, the Group Chief Executive Officer of Vyaire Medical, Inc. (the “Bibb Declaration”); and the
1
The last four digits of Debtor Vyaire Medical, Inc.’s federal tax identification number are 6495.  A complete list
of each of the Debtors in these chapter 11 cases and each such Debtor’s federal tax identification number may be
obtained on the website of the Debtors’ claims and noticing agent at https://omniagentsolutions.com/Vyaire.  The
location of Debtor Vyaire Medical, Inc.’s principal place of business and the Debtors’ service address in these
chapter 11 cases is 26125 North Riverwoods Boulevard, Mettawa, Illinois, USA 60045.
2
Capitalized terms used but not otherwise defined herein shall have the meanings set forth in the Application.
Case 24-11217-BLS    Doc 350    Filed 08/05/24    Page 1 of 6
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 7 of 914

2
Court having found that the Court has jurisdiction over this matter pursuant to 28 U.S.C. §§ 157
and 1334; and the Court having found that the Application is a core proceeding pursuant to
28 U.S.C. § 157(b)(2); and the Court having found that venue of this proceeding and the
Application in this district is proper pursuant to 28 U.S.C. §§ 1408 and 1409; and the Court having
found based on the representations made in the Application and in the Winters Declaration that (a)
Kirkland does not hold or represent an interest adverse to the Debtors’ estates and (b) Kirkland is
a “disinterested person” as defined in section 101(14) of the Bankruptcy Code and as required by
section 327(a) of the Bankruptcy Code; and the Court having found that the relief requested in the
Application is in the best interests of the Debtors’ estates, their creditors, and other parties in
interest; and the Court having found that the Debtors provided adequate and appropriate notice of
the Application under the circumstances and that no other or further notice is required; and the
Court having reviewed the Application and having heard statements in support of the Application
at a hearing held before the Court (the “Hearing”); and the Court having determined that the legal
and factual bases set forth in the Application and at the Hearing establish just cause for the relief
granted herein; and any objections to the relief requested herein having been withdrawn or
overruled on the merits; and after due deliberation and sufficient cause appearing therefor, IT IS
HEREBY ORDERED THAT:
1.
The Application is granted to the extent set forth herein.
2.
The Debtors are authorized to retain and employ Kirkland as their attorneys
effective as of the Petition Date in accordance with the terms and conditions set forth in the
Application and in the Engagement Letter attached hereto as Exhibit 1.
Case 24-11217-BLS    Doc 350    Filed 08/05/24    Page 2 of 6
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 8 of 914

3
3.
Kirkland is authorized to provide the Debtors with the professional services as
described in the Application and the Engagement Letter.  Specifically, but without limitation,
Kirkland will render the following legal services:
a.
advising the Debtors with respect to their powers and duties as debtors in
possession in the continued management and operation of their businesses
and properties;
b.
advising and consulting on their conduct during these chapter 11 cases,
including all of the legal and administrative requirements of operating in
chapter 11;
c.
attending meetings and negotiating with representatives of creditors and
other parties in interest;
d.
taking all necessary actions to protect and preserve the Debtors’ estates,
including prosecuting actions on the Debtors’ behalf, defending any action
commenced against the Debtors, and representing the Debtors in
negotiations concerning litigation in which the Debtors are involved,
including objections to claims filed against the Debtors’ estates;
e.
preparing pleadings in connection with these chapter 11 cases, including
motions, applications, answers, orders, reports, and papers necessary or
otherwise beneficial to the administration of the Debtors’ estates;
f.
representing the Debtors in connection with obtaining authority to continue
using cash collateral and postpetition financing;
g.
advising the Debtors in connection with any potential sale of assets;
h.
appearing before the Court and any appellate courts to represent the interests
of the Debtors’ estates;
i.
advising the Debtors regarding tax matters;
j.
taking any necessary action on behalf of the Debtors to negotiate, prepare,
and obtain approval of a disclosure statement and confirmation of a
chapter 11 plan and all documents related thereto; and
k.
performing all other necessary legal services for the Debtors in connection
with the prosecution of these chapter 11 cases, including:  (i) analyzing the
Debtors’ leases and contracts and the assumption and assignment or
rejection thereof; (ii) analyzing the validity of liens against the Debtors’
assets; and (iii) advising the Debtors on corporate and litigation matters.
Case 24-11217-BLS    Doc 350    Filed 08/05/24    Page 3 of 6
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 9 of 914

4
4.
Kirkland shall apply for compensation for professional services rendered and
reimbursement of expenses incurred in connection with the Debtors’ chapter 11 cases in
compliance with sections 330 and 331 of the Bankruptcy Code and applicable provisions of the
Bankruptcy Rules, Local Rules, and any other applicable procedures and orders of the Court.
Kirkland also intends to make a reasonable effort to comply with the U.S. Trustee’s requests for
information and additional disclosures as set forth in the Guidelines for Reviewing Applications
for Compensation and Reimbursement of Expenses Filed under 11 U.S.C. § 330 by Attorneys in
Larger Chapter 11 Cases Effective as of November 1, 2013, both in connection with the
Application and the interim and final fee applications to be filed by Kirkland in these chapter 11
cases.
5.
Notwithstanding anything in the Engagement Letter to the contrary, Kirkland shall
apply any remaining amounts of its prepetition special purpose retainer as a credit toward
postpetition fees and expenses, after such postpetition fees and expenses are approved pursuant to
an order of the Court awarding fees and expenses to Kirkland.  Kirkland is authorized without
further order of the Court to reserve and apply amounts from the prepetition special purpose
retainer that would otherwise be applied toward payment of postpetition fees and expenses as are
necessary and appropriate to compensate and reimburse Kirkland for fees or expenses incurred on
or prior to the Petition Date consistent with its ordinary course billing practices.
6.
Notwithstanding anything to the contrary in the Application, the Engagement
Letter, or the Declarations attached to the Application, the reimbursement provisions allowing the
reimbursement of fees and expenses incurred in connection with participating in, preparing for, or
responding to any action, claim, suit, or proceeding brought by or against any party that relates to
the legal services provided under the Engagement Letter and fees for defending any objection to
Case 24-11217-BLS    Doc 350    Filed 08/05/24    Page 4 of 6
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 10 of 914

5
Kirkland’s fee applications under the Bankruptcy Code are not approved pending further order of
the Court.
7.
Notwithstanding anything contained in the Application, its exhibits, and/or any
supporting filings, including the Engagement Letter, the Debtors’ rights to object to interim and/or
final allowance of Kirkland’s fees are fully reserved under the applicable bankruptcy law and the
procedures set forth in the Interim Compensation Procedures Order.
8.
Kirkland shall not charge a markup to the Debtors with respect to fees billed by
contract attorneys who are hired by Kirkland to provide services to the Debtors and shall ensure
that any such contract attorneys are subject to conflict checks and disclosures in accordance with
the requirements of the Bankruptcy Code and Bankruptcy Rules.
9.
Kirkland shall provide ten-business-days’ notice to the Debtors, the U.S. Trustee,
and the Committee before any increases in the rates set forth in the Application or the Engagement
Letter are implemented and shall file such notice with the Court.  The U.S. Trustee retains all rights
to object to any rate increase on all grounds, including the reasonableness standard set forth in
section 330 of the Bankruptcy Code, and the Court retains the right to review any rate increase
pursuant to section 330 of the Bankruptcy Code.
10.
The Debtors and Kirkland are authorized to take all actions necessary to effectuate
the relief granted pursuant to this Order in accordance with the Application.
11.
Notice of the Application as provided therein is deemed to be good and sufficient
notice of such Application, and the requirements of the Local Rules are satisfied by the contents
of the Application.
12.
To the extent the Application, the Winters Declaration, the Bibb Declaration, or the
Engagement Letter is inconsistent with this Order, the terms of this Order shall govern.
Case 24-11217-BLS    Doc 350    Filed 08/05/24    Page 5 of 6
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 11 of 914

6

13.
The terms and conditions of this Order shall be immediately effective and
enforceable upon its entry.
14.
The Court retains jurisdiction with respect to all matters arising from or related to
the implementation of this Order.
BRENDAN L. SHANNON
UNITED STATES BANKRUPTCY JUDGE
Dated: August 5th, 2024
Wilmington, Delaware
Case 24-11217-BLS    Doc 350    Filed 08/05/24    Page 6 of 6
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 12 of 914

1
EXHIBIT 1
Engagement Letter
Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 1 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 13 of 914

Josh Sussberg, P.C.
To Call Writer Directly:
+1 212 446 4829
joshua.sussberg@kirkland.com
601 Lexington Avenue
New York, NY  10022
United States
+1 212 446 4800
www.kirkland.com
Facsimile:
+1 212 446 4900
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
March 28, 2024
Via E-mail
CONFIDENTIAL
Mr. Vikram Bajaj
Chief Financial Officer
26125 North Riverwoods Boulevard
Mettawa, Illinois 60045
Re:
Retention to Provide Legal Services
Dear Mr. Vikram Bajaj:
We are very pleased that you have asked us to represent Vyaire Holding Company and its
affiliates and direct and indirect subsidiaries listed on Addendum A to this letter (collectively,
and as may be updated from time to time, “you” or “Client”) in connection with a potential
restructuring.  Please note, the Firm’s representation is only of Client; the Firm does not and will
not represent any direct or indirect shareholder, director, officer, partner, employee, affiliate, or
joint venturer of Client or of any other entity.
General Terms.  This retention letter (this “Agreement”) sets forth the terms of Client’s
retention of Kirkland & Ellis LLP and its affiliates (collectively, the “Firm,” “we,” “our” or “us”)
to provide legal services and constitutes an agreement between the Firm and Client (the
“Parties”).  This Agreement (notwithstanding any guidelines for outside counsel that Client may
provide to the Firm) sets forth the Parties’ entire agreement for rendering professional services
for the current matter, as well as for all other existing or future matters (collectively, the
“Engagement”), except where the Parties otherwise agree in writing.
Fees.  The Firm will bill Client for fees incurred at its regular hourly rates and in
quarterly increments of an hour (or in smaller time increments as otherwise required by a court).
The Firm reserves the right to adjust the Firm’s billing rates from time to time in the ordinary
course of the Firm’s representation of Client.
Although the Firm will attempt to estimate fees to assist Client in Client’s planning if
requested, such estimates are subject to change and are not binding unless otherwise expressly
and unequivocally stated in writing.
Execution Version
Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 2 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 14 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 2
CONFIDENTIAL
Expenses.  Expenses related to providing services shall be included in the Firm’s
statements as disbursements advanced by the Firm on Client’s behalf.  Such expenses include
photocopying, printing, scanning, witness fees, travel expenses, filing and recording fees, certain
secretarial overtime, and other overtime expenses, postage, express mail, and messenger charges,
deposition costs, computerized legal research charges, and other computer services, and
miscellaneous other charges.  Client shall pay directly (and is solely responsible for) certain
larger costs, such as consultant or expert witness fees and expenses, and outside suppliers’ or
contractors’ charges, unless otherwise agreed by the Parties.  By executing this Agreement
below, Client agrees to pay for all charges in accordance with the Firm’s schedule of charges, a
copy of which is attached hereto as Schedule I, as revised from time to time.
Billing Procedures.  The Firm’s statements of fees and expenses are typically delivered
monthly, but the Firm reserves the right to alter the timing of delivering its statements
depending on circumstances.  Client may have the statement in any reasonable format it chooses,
but the Firm will select an initial format for the statement unless Client otherwise requests in
writing.  Depending on the circumstances, however, estimated or summary statements may be
provided, with time and expense details to follow thereafter.
Retainer.  Client agrees to provide to the Firm a “special purpose retainer” (also known
as an “advance payment retainer”) as defined in Rule 1.5(d) of the Illinois Rules of Professional
Conduct, Dowling v. Chicago Options Assoc., Inc., 875 N.E.2d 1012, 1018 (Ill. 2007), and In re
Caesars Entm’t Operating Co., Inc., No. 15-01145 (ABG) (Bankr. N.D. Ill. May 28, 2015) (and
cases cited therein), in the amount of $2,500,000.  In addition, Client agrees to provide one or
more additional special purpose retainer upon request by the Firm so that the amount of any
special purpose retainer remains at or above the Firm’s estimated fees and expenses.  The Firm
may apply the special purpose retainer to any outstanding fees as services are rendered and to
expenses as they are incurred.  Client understands and acknowledges that any special purpose
retainer is earned by the Firm upon receipt, any special purpose retainer becomes the property of
the Firm upon receipt, Client no longer has a property interest in any special purpose retainer
upon the Firm’s receipt, any special purpose retainer will be placed in the Firm’s general account
and will not be held in a client trust account, and Client will not earn any interest on any special
purpose retainer; provided, however, that solely to the extent required under applicable law, at
the conclusion of the Engagement, if the amount of any special purpose retainer held by the Firm
is in excess of the amount of the Firm’s outstanding and estimated fees, expenses, and costs, the
Firm will pay to Client the amount by which any special purpose retainer exceeds such fees,
expenses, and costs.  Client further understands and acknowledges that the use of a special
purpose retainer is an integral condition of the Engagement, and is necessary to ensure that:
Client continues to have access to the Firm’s services; the Firm is compensated for its
representation of Client; the Firm is not a pre-petition creditor in the event of a Restructuring
Case (as defined below); and that in light of the foregoing, the provision of the special purpose
Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 3 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 15 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 3
CONFIDENTIAL
retainer is in Client’s best interests.  The fact that Client has provided the Firm with a special
purpose retainer does not affect Client’s right to terminate the client-lawyer relationship.
Please be advised that there is another type of retainer known as a “security retainer,” as
defined in Dowling v. Chicago Options Assoc., 875 N.E.2d at 1018, and In re Caesars Entm’t
Operating Co., Inc., No. 15-01145 (ABG) (Bankr. N.D. Ill. May 28, 2015) (and cases cited
therein).  A security retainer remains the property of the client until the lawyer applies it to
charges for services that are actually rendered and expenses that are incurred.  Any unearned
funds are then returned to the client.  In other circumstances not present here, the Firm would
consider a security retainer and Client’s funds would be held in the Firm’s segregated client trust
account until applied to pay fees and expenses.  Funds in a security retainer, however, can be
subject to claims of Client’s creditors and, if taken by creditors, may leave Client unable to pay
for ongoing legal services, which may result in the Firm being unable to continue the
Engagement.  Moreover, a security retainer creates clawback risks for the Firm in the event of an
insolvency proceeding.  The choice of the type of retainer to be used is Client’s choice alone, but
for the Engagement and for the reasons set forth above, the Firm is unwilling to represent Client
in the Engagement without using the special purpose retainer.
Termination.  The Engagement may be terminated by either Party at any time by written
notice by or to Client.  The Engagement will end at the earliest of (a) Client’s termination of the
Engagement, (b) the Firm’s withdrawal, and (c) the substantial completion of the Firm’s
substantive work.  If permission for withdrawal is required by a court, the Firm shall apply
promptly for such permission, and termination shall coincide with the court order for withdrawal.
If this Agreement or the Firm’s services are terminated for any reason, such termination shall be
effective only to terminate the Firm’s services prospectively and all the other terms of this
Agreement shall survive any such termination.
Upon cessation of the Firm’s active involvement in a particular matter (even if the Firm
continues active involvement in other matters on Client’s behalf), the Firm will have no further
duty to inform Client of future developments or changes in law as may be relevant to such
matter.  Further, unless the Parties mutually agree in writing to the contrary, the Firm will have
no obligation to monitor renewal or notice dates or similar deadlines that may arise from the
matters for which the Firm had been retained.
Cell Phone and E-Mail Communication.  The Firm hereby informs Client and Client
hereby acknowledges that the Firm’s attorneys sometimes communicate with their clients and
their clients’ professionals and agents by cell telephone, that such communications are capable of
being intercepted by others and therefore may be deemed no longer protected by the attorney-
client privilege, and that Client must inform the Firm if Client does not wish the Firm to discuss
privileged matters on cell telephones with Client or Client’s professionals or agents.
Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 4 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 16 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 4
CONFIDENTIAL
The Firm hereby informs Client and Client hereby acknowledges that the Firm’s
attorneys sometimes communicate with their clients and their clients’ professionals and agents
by unencrypted e-mail, that such communications are capable of being intercepted by others and
therefore may be deemed no longer protected by the attorney-client privilege, and that Client
must inform the Firm if Client wishes to institute a system to encode all e-mail between the Firm
and Client or Client’s professionals or agents.
File Retention.  All records and files will be retained and disposed of in compliance with
the Firm’s policy in effect from time to time.  Subject to future changes, it is the Firm’s current
policy generally not to retain records relating to a matter for more than five years.  Upon Client’s
prior written request, the Firm will return client records that are Client’s property to Client prior
to their destruction.  Although we will return your records (i.e., your client file) to you at any
time upon your written request, you agree that your client file will not include our Firm’s internal
files including administrative materials, internal communications, and drafts.  It is not
administratively feasible for the Firm to advise Client of the closing of a matter or the disposal of
records.  The Firm recommends, therefore, that Client maintain Client’s own files for reference
or submit a written request for Client’s client files promptly upon conclusion of a
matter.  Notwithstanding anything to the contrary herein, Client acknowledges and agrees that
any applicable privilege of Client (including any attorney-client and work product privilege or
any duty of confidentiality) (collectively, the “Privileges”) belongs to Client alone and not to any
successor entity (including without limitation the Client after a change in control or other similar
restructuring or non-restructuring transaction (including without limitation a reorganized Client
after the effective date of a plan of reorganization), whether through merger, asset or equity sale,
business combination, or otherwise, irrespective of whether such transaction occurs in a
Restructuring Case or on an out-of-court basis (in each case, a “Transaction”)).  Client hereby
waives any right, title, and interest of such successor entity to all information, data, documents,
or communications in any format covered by the Privileges that is in the possession of the Firm
(“Firm Materials”), to the extent that such successor entity had any right, title, and interest to
such Firm Materials.  For the avoidance of doubt, Client agrees and acknowledges that after a
Transaction, such successor entity shall have no right to claim or waive the Privileges or request
the return of any such Firm Materials; instead, such Firm Materials shall remain in the Firm’s
sole possession and control for its exclusive use, and the Firm will (a) not waive any Privileges
or disclose the Firm Materials, (b) take all reasonable steps to ensure that the Privileges survive
and remain in full force and effect, and (c) assert the Privileges to prevent disclosure of any Firm
Materials.
Data Protection.  You further agree that, if you provide us with personal data, you have
complied with applicable data protection legislation and that we may process such personal data
in accordance with our Data Transfer and Privacy Policy at www.kirkland.com.  We process
your personal data in order to (i) carry out work for you; (ii) share the data with third parties such
Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 5 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 17 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 5
CONFIDENTIAL
as expert witnesses and other professional advisers if our work requires; (iii) comply with
applicable laws and regulations and (iv) provide you with information relating to our Firm and
its services.
Conflicts of Interest.  As is customary for a law firm of the Firm’s size, there are
numerous business entities, with which Client currently has relationships, that the Firm has
represented or currently represents in matters unrelated to Client.  The Firm notes that the Firm
currently represents or has represented Apax Partners, L.P. and/or its affiliates (collectively, the
“Interested Parties”) in a variety of matters and will continue to do so in such unrelated matters.
Because Client is engaged in activities (and may in the future engage in additional activities) in
which Client’s interests may diverge from those of the Interested Parties or the Firm’s other
clients, the possibility exists that the Interested Parties or one of the Firm’s clients may take
positions adverse to Client.
Further, in undertaking the representation of Client, the Firm wants to be fair not only to
Client’s interests but also to those of the Firm’s other clients.  Because Client is engaged in
activities (and may in the future engage in additional activities) in which its interests may
diverge from those of the Firm’s other clients, the possibility exists that one of the Firm’s current
or future clients may take positions adverse to Client (including litigation or other dispute
resolution mechanisms) in a matter in which such other client may have retained the Firm or one
of Client’s adversaries may retain the Firm in a matter adverse to another entity or person.
In the event a present conflict of interest exists between Client and the Firm’s other
clients or in the event one arises in the future, Client agrees to waive any such conflict of interest
or other objection that would preclude the Firm’s representation of another client (a) in other
current or future matters substantially unrelated to the Engagement or (b) other than during a
Restructuring Case (as defined below), in other matters related to Client (such representation, an
“Allowed Adverse Representation”).  By way of example, such Allowed Adverse
Representations might take the form of, among other contexts: litigation (including arbitration,
mediation and other forms of dispute resolution); transactional work (including consensual and
non-consensual merger, acquisition, and takeover situations, financings, and commercial
agreements); counseling (including advising direct adversaries and competitors); and
restructuring (including bankruptcy, insolvency, financial distress, recapitalization, equity and
debt workouts, and other transactions or adversarial adjudicative proceedings related to any of
the foregoing and similar matters).
Client also agrees that it will not, for itself or any other entity or person, assert that either
(i) the Firm’s representation of Client or any of Client’s affiliates in any past, present, or future
matter or (ii) the Firm’s actual or possible possession of confidential information belonging to
Client or any of Client’s affiliates is a basis to disqualify the Firm from representing another
Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 6 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 18 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 6
CONFIDENTIAL
entity or person in any Allowed Adverse Representation.  Client further agrees that any Allowed
Adverse Representation does not breach any duty that the Firm owes to Client or any of Client’s
affiliates.  Client also agrees that the Firm’s representation in the Engagement is solely of Client
and that no member or other entity or person related to it (such as a shareholder, parent,
subsidiary, affiliate, director, officer, partner, employee, or joint venturer) has the status of a
client for conflict of interest purposes.
In addition, if a waiver of a conflict of interest necessary to allow the Firm to represent
another client in a matter that is not substantially related to the Engagement is not effective for
any reason, Client agrees that the Firm may withdraw from the Engagement.  Should that occur,
Client will not, for itself or any other entity or person, seek to preclude such termination of
services or assert that either (a) the Firm’s representation of Client or any of Client’s affiliates in
any past, present, or future matter or (b) the Firm’s actual or possible possession of confidential
information belonging to Client or any of Client’s affiliates is a basis to disqualify the Firm from
representing such other client or acting on such adverse matter.
It is important that you review this letter carefully and consider all of the advantages and
disadvantages of waiving certain conflicts of interests that would otherwise bar the Firm from
representing parties with interests adverse to you during the time in which the Firm is
representing you.  You also understand that because this waiver includes future issues and future
clients that are unknown and unknowable at this time, it is impossible to provide you with any
more details about those prospective clients and matters.  Thus, in choosing to execute this
waiver, you have recognized the inherent uncertainty about the array of potential matters and
clients the Firm might take on in matters that are adverse to you but have nonetheless decided it
is in your interest to waive conflicts of interest regarding the Allowed Adverse Representations
and waive rights to prohibit the Firm’s potential withdrawal should a conflict waiver prove
ineffectual.
The Firm informs Client that certain entities owned by current or former Firm attorneys
and senior staff (“attorney investment entities”) have investments in funds or companies that
may, directly or indirectly, be affiliated with Client, hold investments in Client’s debt or equity
securities, may be adverse to Client, or conduct commercial transactions with Client (each, a
“Passive Holding”).  The attorney investment entities are passive and have no management or
other control rights in such funds or companies.  The Firm notes that other persons may in the
future assert that a Passive Holding creates, in certain circumstances, a conflict between the
Firm’s exercise of its independent professional judgment in rendering advice to Client and the
financial interest of Firm attorneys participating in the attorney investment entities, and such
other persons might seek to limit Client’s ability to use the Firm to advise Client on a particular
matter.  While the Firm cannot control what a person might assert or seek, the Firm believes that
the Firm’s judgment will not be compromised by virtue of any Passive Holding.  Please let us
Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 7 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 19 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 7
CONFIDENTIAL
know if Client has any questions or concerns regarding the Passive Holdings.  By executing this
letter, Client acknowledges the Firm’s disclosure of the foregoing.
Restructuring Cases.  If it becomes necessary for Client to commence restructuring
cases under chapter 11 of the U.S. Bankruptcy Code (a “Restructuring Case”), the Firm’s
ongoing employment by Client will be subject to the approval of the court with jurisdiction over
the petitions.  If necessary, the Firm will take steps necessary to prepare the disclosure materials
required in connection with the Firm’s retention as lead restructuring counsel.  In the near term,
the Firm will begin conflicts checks on potentially interested parties as provided by Client.
If necessary, the Firm will prepare a preliminary draft of a schedule describing the Firm’s
relationships with certain interested parties (the “Disclosure Schedule”).  The Firm will give
Client a draft of the Disclosure Schedule once it is available.  Although the Firm believes that
these relationships do not constitute actual conflicts of interest, these relationships must be
described and disclosed in Client’s application to the court to retain the Firm.
If in the Firm’s determination a conflict of interest arises in Client’s Restructuring Case
requiring separate conflicts counsel, then Client will be required to use separate conflicts counsel
in those matters.
No Guarantee of Success.  It is impossible to provide any promise or guarantee about
the outcome of Client’s matters.  Nothing in this Agreement or any statement by Firm staff or
attorneys constitutes a promise or guarantee.  Any comments about the outcome of Client’s
matter are simply expressions of judgment and are not binding on the Firm.
Consent to Use of Information.  In connection with future materials that, for marketing
purposes, describe facets of the Firm’s law practice and recite examples of matters the Firm
handles on behalf of clients, Client agrees that, if those materials avoid disclosing Client’s
confidences and secrets as defined by applicable ethical rules, they may identify Client as a
client, may contain factual synopses of Client’s matters, and may indicate generally the results
achieved.
Reimbursement of Fees and Expenses.  Client agrees to promptly reimburse the Firm
for all internal or external fees and expenses, including the amount of the Firm’s attorney and
paralegal time at normal billing rates, as incurred by the Firm in connection with participating in,
preparing for, or responding to any action, claim, objection, suit, or proceeding brought by or
against any third-party that relates to the legal services provided by the Firm under this
Agreement.  Without limiting the scope of the foregoing, and by way of example only, this
paragraph extends to all such fees and expenses incurred by the Firm in responding to document
subpoenas, and preparing for and testifying at depositions and trials; and with respect to the
Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 8 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 20 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 8
CONFIDENTIAL
filing, preparation, prosecution or defense of any applications by the Firm for approval of fees
and expenses in a judicial, arbitral, or similar proceeding.  Further, Client understands,
acknowledges, and agrees that in connection with a Restructuring Case, if Client has not objected
to the payment of a Firm invoice or to a Firm fee and expense application, has in fact paid such
invoice, or has approved such fee and expense application, then Client waives its right (and the
right of any successor entity as a result of a Transaction or otherwise) to subsequently object to
the payment of fees and expenses covered by such invoice or fee application.
LLP.  Kirkland & Ellis LLP is a limited liability partnership organized under the laws of
Illinois, and Kirkland & Ellis International LLP is a limited liability partnership organized under
the laws of Delaware.  Pursuant to those statutory provisions, an obligation incurred by a limited
liability partnership, whether arising in tort, contract or otherwise, is solely the obligation of the
limited liability partnership, and partners are not personally liable, directly or indirectly, by way
of indemnification, contribution, assessment or otherwise, for such obligation solely by reason of
being or so acting as a partner.
Governing Law.  This Agreement shall be governed by, and construed in accordance
with, the laws of the State of Illinois, without giving effect to the conflicts of law principles
thereof.
Miscellaneous.  This Agreement sets forth the Parties’ entire agreement for rendering
professional services.  It can be amended or modified only in writing and not orally or by course
of conduct.  Each Party signing below is jointly and severally responsible for all obligations due
to the Firm and represents that each has full authority to execute this Agreement so that it is
binding.  This Agreement may be signed in one or more counterparts and binds each Party
countersigning below, whether or not any other proposed signatory ever executes it.  If any
provision of this Agreement or the application thereof is held invalid or unenforceable, the
invalidity or unenforceability shall not affect other provisions or applications of this Agreement
which can be given effect without such provisions or application, and to this end the provisions
of this Agreement are declared to be severable.  Any agreement or waiver contained herein by
Client extends to any assignee or successor in interest to Client, including without limitation the
reorganized Client upon and after the effective date of a plan of reorganization in a Restructuring
Case.
This Agreement is the product of arm’s-length negotiations between sophisticated parties,
and Client acknowledges that it is experienced with respect to the retention of legal counsel.
Therefore, the Parties acknowledge and agree that any otherwise applicable rule of contract
construction or interpretation which provides that ambiguities shall be construed against the
drafter (and all similar rules of contract construction or interpretation) shall not apply to this
Agreement.  The Parties further acknowledge that the Firm is not advising Client with respect to
Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 9 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 21 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 9
CONFIDENTIAL
this Agreement because the Firm would have a conflict of interest in doing so, and that Client
has consulted (or had the opportunity to consult) with legal counsel of its own choosing.  Client
further acknowledges that Client has entered into this Agreement and agreed to all of its terms
and conditions voluntarily and fully-informed, based on adequate information and Client’s own
independent judgment.  The Parties further acknowledge that they intend for this Agreement to
be effective and fully enforceable upon its execution and to be relied upon by the Parties.
***
Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 10 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 22 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 10
CONFIDENTIAL
Please confirm your agreement with the arrangements described in this letter by signing
the enclosed copy of this letter in the space provided below and returning it to us.  Please
understand that, if we do not receive a signed copy of this letter within twenty-one days, we will
withdraw from representing you in this Engagement.
Very truly yours,
KIRKLAND & ELLIS LLP
By:
Printed Name:  Joshua A. Sussberg, P.C.
Title:  Partner
Agreed and accepted this 3rd day of April, 2024
VYAIRE HOLDING COMPANY
By:
Name: Vikram Bajaj
Title: Chief Financial Officer
Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 11 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 23 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 10
CONFIDENTIAL
Please confirm your agreement with the arrangements described in this letter by signing
the enclosed copy of this letter in the space provided below and returning it to us.  Please
understand that, if we do not receive a signed copy of this letter within twenty-one days, we will
withdraw from representing you in this Engagement.
Very truly yours,
KIRKLAND & ELLIS LLP
By:
Printed Name:  Joshua A. Sussberg, P.C.
Title:  Partner
Agreed and accepted this 4th day of April, 2024
VYAIRE HOLDING COMPANY
By:
Name: Vikram Bajaj
Title: Chief Financial Officer

Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 12 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 24 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 11
CONFIDENTIAL
Addendum A:  List of Client Subsidiaries
1.
Vyaire Company
2.
Vyaire Finance B.V.
3.
Vyaire Medical, Inc.
4.
Bird Products Corporation
5.
Breathe US Holdco Inc.
6.
Breathe US Holdings LP
7.
EME Medical, Inc.
8.
Revolutionary Medical Devices, Inc.
9.
SensorMedics Corporation
10. VIASYS Holdings Inc.
11. Vyaire Medical 202, Inc.
12. Vyaire Medical 203, Inc.
13. Vyaire Medical 205, Inc.
14. Vyaire Medical 206, Inc.
15. Vyaire Medical 211, Inc.
16. Vyaire Medical BR LLC
17. Vyaire Medical Capital LLC
18. Vyaire Medical Consumables LLC
19. Vyaire Medical International LLC
20. Vyaire Medical LLC
21. Vyaire Medical Payroll LLC
22. Vyaire Respiratory Diagnostics LLC
23. Vyaire Financial Holdings LLC
24. VM Finance Sub LLC
25. Vyaire Receivables LLC
26. Vyaire TSR Sub, LLC
27. Vyaire TSR Midco, LLC
28. Vyaire Medical Pty Ltd
29. Intermed Equipamento Medico Hospitalar
LTDA
30. Servicos De Assistencia Tecnica A
Equipmaneto Medico Hospitalar LTDA
31. Vyaire Medical Products ULC
32. Beijing Branch of Vyaire Medical Products
(Shanghai) Co., Ltd.
33. Vyaire Medical Products (Shanghai) Co.,
Ltd.
34. Vyaire Medical Denmark Branch, Filial of
Vyaire Medical AB
35. MIM Medizinische Instrumente und
Monitoring GmbH
36. Vyaire GmbH
37. Vyaire Medical GmbH
38. Vyaire Medical Private Limited
39. Vyaire S.r.l.
40. Vyaire Medical S.r.l.
41. Vyaire Medical SDN BHD
42. Vyaire Medical Cooperatief U.A.
43. Vyaire Medical International B.V.
44. Vyaire Medical Holdings B.V.
45. Vyaire B.V.
46. Vyaire Medical B.V.
47. Vyaire Medical Products Limited (Spółka z
ograniczoną odpowiedzialnością) - Poland
Branch
48. Vyaire Limited Liability Company
49. imtmedical Pte. Ltd.
50. Vyaire Medical Pte. Ltd.
51. Vyaire Medical Korea Ltd.
52. Vyaire Medical AB
53. Acutronic Medical Systems AG
54. Advanced Respiratory Care AG
55. imtmedical ag
56. Vyaire Medical Sarl
57. Vyaire Turkey Tibbi Cihazlar Ticaret
Anonim Sirketi
58. Vyaire DMCC
59. Carefusion U.K. 235 Limited
60. CareFusion U.K. 232 Limited
61. Vyaire UK 236 Limited
62. Vyaire Medical Products Limited
Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 13 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 25 of 914

1
KIRKLAND & ELLIS LLP
SCHEDULE I:  CLIENT-REIMBURSABLE EXPENSES AND OTHER CHARGES
Effective 01/01/2024
The following outlines Kirkland & Ellis LLP’s (“K&E LLP”) policies and standard charges for
various services performed by K&E LLP and/or by other third parties on behalf of the client
which are often ancillary to our legal services.  Services provided by in-house K&E LLP
personnel are for the convenience of our clients.  Given that these services are often ancillary to
our legal services, in certain instances it may be appropriate and/or more cost efficient for these
services to be outsourced to a third-party vendor.  If services are provided beyond those outlined
below, pricing will be based on K&E LLP’s approximate cost and/or comparable market pricing.

Duplicating, Reprographics and Printing:  The following list details K&E LLP’s
charges for duplicating, reprographics and printing services:

Black and White Copy or Print (all sizes of paper):

$0.16 per impression for all U.S. offices

€0.10 per impression in Munich

£0.15 per impression in London

HK$1.50 per impression in Hong Kong

CNY1.00 per impression in Beijing and Shanghai

Color Copy or Print (all sizes of paper):

$0.55 per impression

Scanned Images:

$0.16 per page for black and white or color scans

Other Services:

CD/DVD Duplicating or Mastering - $7/$10 per CD/DVD

Binding - $0.70 per binding

Large or specialized binders - $13/$27

Tabs - $0.13 per item

OCR/File Conversion - $0.03 per page

Large Format Printing - $1.00 per sq. ft.

Secretarial and Word Processing:  Clients are not charged for secretarial and word
processing activities incurred on their matters during standard business hours.

Overtime Charges:  Clients will be charged for overtime costs for secretarial and
document services work if either (i) the client has specifically requested the after-hours
work or (ii) the nature of the work being done for the client necessitates out-of-hours
overtime and such work could not have been done during normal working hours.  If these
conditions are satisfied, costs for related overtime meals and transportation also will be
charged.
Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 14 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 26 of 914

2

Travel Expenses:  We charge clients our out-of-pocket costs for travel expenses
including associated travel agency fees.  We charge coach fares (business class for
international flights) unless the client has approved business-class, first-class or an
upgrade.  K&E LLP personnel are instructed to incur only reasonable airfare, hotel and
meal expenses.  K&E LLP negotiates, uses, and passes along volume discount hotel and
air rates whenever practicable.  However, certain retrospective rebates may not be passed
along.

Catering Charges:  Clients will be charged for any in-house catering service provided in
connection with client matters.

Communication Expenses:  We do not charge clients for telephone calls, conference
calls, videoconferences or faxes made from K&E LLP’s offices.
Charges incurred for conference calls, videoconferences, cellular telephones, and calls
made from other third-party locations will be charged to the client at the actual cost
incurred.  Further, other telecommunication expenses incurred at third-party locations
(e.g., phone lines at trial sites, Internet access, etc.) will be charged to the client at the
actual cost incurred.

Overnight Delivery/Postage:  We charge clients for the actual cost of overnight and
special delivery (e.g., Express Mail, FedEx, and DHL), and U.S. postage for materials
mailed on the client’s behalf.  K&E LLP negotiates, uses, and passes along volume
discount rates whenever practicable.

Messengers:  We charge clients for the actual cost of a third-party vendor messenger.

Library Research Services: Library Research staff provides research and document
retrieval services at the request of attorneys, and clients are charged per hour for these
services.  Any expenses incurred in connection with the request, such as outside retrieval
service or online research charges, are passed on to the client at cost, including any
applicable discounts.

Online Research Charges:  K&E LLP charges for costs incurred in using third-party
online research services in connection with a client matter.  K&E LLP negotiates and
uses discounts or special rates for online research services whenever possible and
practicable and passes through the full benefit of any savings to the client based on actual
usage.

Inter-Library Loan Services: Our standard client charge for inter-library loan services
when a K&E LLP library employee borrows a book from an outside source is $25 per
title.  There is no client charge for borrowing books from K&E LLP libraries in other
cities or from outside collections when the title is part of the K&E LLP collection but
unavailable.

Off-Site Legal Files Storage:  Clients are not charged for off-site storage of files unless
the storage charge is approved in advance.
Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 15 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 27 of 914

3

Electronic Data Storage:  K&E LLP will not charge clients for costs to store electronic
data and files on K&E LLP’s systems if the data stored does not exceed 100 gigabytes
(GB).  If the data stored for a specific client exceeds 100GB, K&E LLP will charge
clients $6.00 per month/per GB for all network data stored until the data is either returned
to the client or properly disposed of.  For e-discovery data on the Relativity platform,
K&E LLP will also charge clients $6.00 per month/per GB until the data is either
returned to the client or properly disposed of.

Tax Filings:  Clients will be charged a fixed fee for certain tax filings.  Our standard
charge is $400 per Form 8832 election; $250 per Form 83(b) election for the first 20
forms, $100 per form for any additional forms; $1,000 each for Form SS-4 (Foreign);
$100 each for Form SS-4 (Domestic); and $75 for each FIRPTA certificate.

Calendar Court Services:  Our standard charge is $25 for a court filing and other court
services or transactions.

Supplies:  There is no client charge for standard office supplies.  Clients are charged for
special items (e.g., a minute book, exhibit tabs/indexes/dividers, binding, etc.) and then at
K&E LLP’s actual cost.

Contract Attorneys and Contract Non-Attorney Billers:  If there is a need to utilize a
contract attorney or contract non-attorney on a client engagement, clients will be charged
a standard hourly rate for these billers unless other specific billing arrangements are
agreed between K&E LLP and client.

Expert Witnesses, Experts of Other Types, and Other Third Party Consultants:  If
there is a need to utilize an expert witness, expert of other type, or other third party
consultant such as accountants, investment bankers, academicians, other attorneys, etc.
on a client engagement, clients will be requested to retain or pay these individuals
directly unless specific billing arrangements are agreed between K&E LLP and client.

Third Party Expenditures: Third party expenditures (e.g., corporate document and lien
searches, lease of office space at Trial location, IT equipment rental, SEC and regulatory
filings, etc.) incurred on behalf of a client, will be passed through to the client at actual
cost.  If the invoice exceeds $50,000, it is K&E LLP’s policy that wherever possible such
charges will be directly billed to the client.  In those circumstances where this is not
possible, K&E LLP will seek reimbursement from our client prior to paying the vendor.
Unless otherwise noted, charges billed in foreign currencies are based on current U.S. charges at
an appropriate exchange rate.
Case 24-11217-BLS    Doc 350-1    Filed 08/05/24    Page 16 of 16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 28 of 914

Exhibit C

Engagement Letter
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 29 of 914

Josh Sussberg, P.C.
To Call Writer Directly:
+1 212 446 4829
joshua.sussberg@kirkland.com
601 Lexington Avenue
New York, NY  10022
United States
+1 212 446 4800
www.kirkland.com
Facsimile:
+1 212 446 4900
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
March 28, 2024
Via E-mail
CONFIDENTIAL
Mr. Vikram Bajaj
Chief Financial Officer
26125 North Riverwoods Boulevard
Mettawa, Illinois 60045
Re:
Retention to Provide Legal Services
Dear Mr. Vikram Bajaj:
We are very pleased that you have asked us to represent Vyaire Holding Company and its
affiliates and direct and indirect subsidiaries listed on Addendum A to this letter (collectively,
and as may be updated from time to time, “you” or “Client”) in connection with a potential
restructuring.  Please note, the Firm’s representation is only of Client; the Firm does not and will
not represent any direct or indirect shareholder, director, officer, partner, employee, affiliate, or
joint venturer of Client or of any other entity.
General Terms.  This retention letter (this “Agreement”) sets forth the terms of Client’s
retention of Kirkland & Ellis LLP and its affiliates (collectively, the “Firm,” “we,” “our” or “us”)
to provide legal services and constitutes an agreement between the Firm and Client (the
“Parties”).  This Agreement (notwithstanding any guidelines for outside counsel that Client may
provide to the Firm) sets forth the Parties’ entire agreement for rendering professional services
for the current matter, as well as for all other existing or future matters (collectively, the
“Engagement”), except where the Parties otherwise agree in writing.
Fees.  The Firm will bill Client for fees incurred at its regular hourly rates and in
quarterly increments of an hour (or in smaller time increments as otherwise required by a court).
The Firm reserves the right to adjust the Firm’s billing rates from time to time in the ordinary
course of the Firm’s representation of Client.
Although the Firm will attempt to estimate fees to assist Client in Client’s planning if
requested, such estimates are subject to change and are not binding unless otherwise expressly
and unequivocally stated in writing.
Execution Version
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 30 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 2
CONFIDENTIAL
Expenses.  Expenses related to providing services shall be included in the Firm’s
statements as disbursements advanced by the Firm on Client’s behalf.  Such expenses include
photocopying, printing, scanning, witness fees, travel expenses, filing and recording fees, certain
secretarial overtime, and other overtime expenses, postage, express mail, and messenger charges,
deposition costs, computerized legal research charges, and other computer services, and
miscellaneous other charges.  Client shall pay directly (and is solely responsible for) certain
larger costs, such as consultant or expert witness fees and expenses, and outside suppliers’ or
contractors’ charges, unless otherwise agreed by the Parties.  By executing this Agreement
below, Client agrees to pay for all charges in accordance with the Firm’s schedule of charges, a
copy of which is attached hereto as Schedule I, as revised from time to time.
Billing Procedures.  The Firm’s statements of fees and expenses are typically delivered
monthly, but the Firm reserves the right to alter the timing of delivering its statements
depending on circumstances.  Client may have the statement in any reasonable format it chooses,
but the Firm will select an initial format for the statement unless Client otherwise requests in
writing.  Depending on the circumstances, however, estimated or summary statements may be
provided, with time and expense details to follow thereafter.
Retainer.  Client agrees to provide to the Firm a “special purpose retainer” (also known
as an “advance payment retainer”) as defined in Rule 1.5(d) of the Illinois Rules of Professional
Conduct, Dowling v. Chicago Options Assoc., Inc., 875 N.E.2d 1012, 1018 (Ill. 2007), and In re
Caesars Entm’t Operating Co., Inc., No. 15-01145 (ABG) (Bankr. N.D. Ill. May 28, 2015) (and
cases cited therein), in the amount of $2,500,000.  In addition, Client agrees to provide one or
more additional special purpose retainer upon request by the Firm so that the amount of any
special purpose retainer remains at or above the Firm’s estimated fees and expenses.  The Firm
may apply the special purpose retainer to any outstanding fees as services are rendered and to
expenses as they are incurred.  Client understands and acknowledges that any special purpose
retainer is earned by the Firm upon receipt, any special purpose retainer becomes the property of
the Firm upon receipt, Client no longer has a property interest in any special purpose retainer
upon the Firm’s receipt, any special purpose retainer will be placed in the Firm’s general account
and will not be held in a client trust account, and Client will not earn any interest on any special
purpose retainer; provided, however, that solely to the extent required under applicable law, at
the conclusion of the Engagement, if the amount of any special purpose retainer held by the Firm
is in excess of the amount of the Firm’s outstanding and estimated fees, expenses, and costs, the
Firm will pay to Client the amount by which any special purpose retainer exceeds such fees,
expenses, and costs.  Client further understands and acknowledges that the use of a special
purpose retainer is an integral condition of the Engagement, and is necessary to ensure that:
Client continues to have access to the Firm’s services; the Firm is compensated for its
representation of Client; the Firm is not a pre-petition creditor in the event of a Restructuring
Case (as defined below); and that in light of the foregoing, the provision of the special purpose
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 31 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 3
CONFIDENTIAL
retainer is in Client’s best interests.  The fact that Client has provided the Firm with a special
purpose retainer does not affect Client’s right to terminate the client-lawyer relationship.
Please be advised that there is another type of retainer known as a “security retainer,” as
defined in Dowling v. Chicago Options Assoc., 875 N.E.2d at 1018, and In re Caesars Entm’t
Operating Co., Inc., No. 15-01145 (ABG) (Bankr. N.D. Ill. May 28, 2015) (and cases cited
therein).  A security retainer remains the property of the client until the lawyer applies it to
charges for services that are actually rendered and expenses that are incurred.  Any unearned
funds are then returned to the client.  In other circumstances not present here, the Firm would
consider a security retainer and Client’s funds would be held in the Firm’s segregated client trust
account until applied to pay fees and expenses.  Funds in a security retainer, however, can be
subject to claims of Client’s creditors and, if taken by creditors, may leave Client unable to pay
for ongoing legal services, which may result in the Firm being unable to continue the
Engagement.  Moreover, a security retainer creates clawback risks for the Firm in the event of an
insolvency proceeding.  The choice of the type of retainer to be used is Client’s choice alone, but
for the Engagement and for the reasons set forth above, the Firm is unwilling to represent Client
in the Engagement without using the special purpose retainer.
Termination.  The Engagement may be terminated by either Party at any time by written
notice by or to Client.  The Engagement will end at the earliest of (a) Client’s termination of the
Engagement, (b) the Firm’s withdrawal, and (c) the substantial completion of the Firm’s
substantive work.  If permission for withdrawal is required by a court, the Firm shall apply
promptly for such permission, and termination shall coincide with the court order for withdrawal.
If this Agreement or the Firm’s services are terminated for any reason, such termination shall be
effective only to terminate the Firm’s services prospectively and all the other terms of this
Agreement shall survive any such termination.
Upon cessation of the Firm’s active involvement in a particular matter (even if the Firm
continues active involvement in other matters on Client’s behalf), the Firm will have no further
duty to inform Client of future developments or changes in law as may be relevant to such
matter.  Further, unless the Parties mutually agree in writing to the contrary, the Firm will have
no obligation to monitor renewal or notice dates or similar deadlines that may arise from the
matters for which the Firm had been retained.
Cell Phone and E-Mail Communication.  The Firm hereby informs Client and Client
hereby acknowledges that the Firm’s attorneys sometimes communicate with their clients and
their clients’ professionals and agents by cell telephone, that such communications are capable of
being intercepted by others and therefore may be deemed no longer protected by the attorney-
client privilege, and that Client must inform the Firm if Client does not wish the Firm to discuss
privileged matters on cell telephones with Client or Client’s professionals or agents.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 32 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 4
CONFIDENTIAL
The Firm hereby informs Client and Client hereby acknowledges that the Firm’s
attorneys sometimes communicate with their clients and their clients’ professionals and agents
by unencrypted e-mail, that such communications are capable of being intercepted by others and
therefore may be deemed no longer protected by the attorney-client privilege, and that Client
must inform the Firm if Client wishes to institute a system to encode all e-mail between the Firm
and Client or Client’s professionals or agents.
File Retention.  All records and files will be retained and disposed of in compliance with
the Firm’s policy in effect from time to time.  Subject to future changes, it is the Firm’s current
policy generally not to retain records relating to a matter for more than five years.  Upon Client’s
prior written request, the Firm will return client records that are Client’s property to Client prior
to their destruction.  Although we will return your records (i.e., your client file) to you at any
time upon your written request, you agree that your client file will not include our Firm’s internal
files including administrative materials, internal communications, and drafts.  It is not
administratively feasible for the Firm to advise Client of the closing of a matter or the disposal of
records.  The Firm recommends, therefore, that Client maintain Client’s own files for reference
or submit a written request for Client’s client files promptly upon conclusion of a
matter.  Notwithstanding anything to the contrary herein, Client acknowledges and agrees that
any applicable privilege of Client (including any attorney-client and work product privilege or
any duty of confidentiality) (collectively, the “Privileges”) belongs to Client alone and not to any
successor entity (including without limitation the Client after a change in control or other similar
restructuring or non-restructuring transaction (including without limitation a reorganized Client
after the effective date of a plan of reorganization), whether through merger, asset or equity sale,
business combination, or otherwise, irrespective of whether such transaction occurs in a
Restructuring Case or on an out-of-court basis (in each case, a “Transaction”)).  Client hereby
waives any right, title, and interest of such successor entity to all information, data, documents,
or communications in any format covered by the Privileges that is in the possession of the Firm
(“Firm Materials”), to the extent that such successor entity had any right, title, and interest to
such Firm Materials.  For the avoidance of doubt, Client agrees and acknowledges that after a
Transaction, such successor entity shall have no right to claim or waive the Privileges or request
the return of any such Firm Materials; instead, such Firm Materials shall remain in the Firm’s
sole possession and control for its exclusive use, and the Firm will (a) not waive any Privileges
or disclose the Firm Materials, (b) take all reasonable steps to ensure that the Privileges survive
and remain in full force and effect, and (c) assert the Privileges to prevent disclosure of any Firm
Materials.
Data Protection.  You further agree that, if you provide us with personal data, you have
complied with applicable data protection legislation and that we may process such personal data
in accordance with our Data Transfer and Privacy Policy at www.kirkland.com.  We process
your personal data in order to (i) carry out work for you; (ii) share the data with third parties such
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 33 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 5
CONFIDENTIAL
as expert witnesses and other professional advisers if our work requires; (iii) comply with
applicable laws and regulations and (iv) provide you with information relating to our Firm and
its services.
Conflicts of Interest.  As is customary for a law firm of the Firm’s size, there are
numerous business entities, with which Client currently has relationships, that the Firm has
represented or currently represents in matters unrelated to Client.  The Firm notes that the Firm
currently represents or has represented Apax Partners, L.P. and/or its affiliates (collectively, the
“Interested Parties”) in a variety of matters and will continue to do so in such unrelated matters.
Because Client is engaged in activities (and may in the future engage in additional activities) in
which Client’s interests may diverge from those of the Interested Parties or the Firm’s other
clients, the possibility exists that the Interested Parties or one of the Firm’s clients may take
positions adverse to Client.
Further, in undertaking the representation of Client, the Firm wants to be fair not only to
Client’s interests but also to those of the Firm’s other clients.  Because Client is engaged in
activities (and may in the future engage in additional activities) in which its interests may
diverge from those of the Firm’s other clients, the possibility exists that one of the Firm’s current
or future clients may take positions adverse to Client (including litigation or other dispute
resolution mechanisms) in a matter in which such other client may have retained the Firm or one
of Client’s adversaries may retain the Firm in a matter adverse to another entity or person.
In the event a present conflict of interest exists between Client and the Firm’s other
clients or in the event one arises in the future, Client agrees to waive any such conflict of interest
or other objection that would preclude the Firm’s representation of another client (a) in other
current or future matters substantially unrelated to the Engagement or (b) other than during a
Restructuring Case (as defined below), in other matters related to Client (such representation, an
“Allowed Adverse Representation”).  By way of example, such Allowed Adverse
Representations might take the form of, among other contexts: litigation (including arbitration,
mediation and other forms of dispute resolution); transactional work (including consensual and
non-consensual merger, acquisition, and takeover situations, financings, and commercial
agreements); counseling (including advising direct adversaries and competitors); and
restructuring (including bankruptcy, insolvency, financial distress, recapitalization, equity and
debt workouts, and other transactions or adversarial adjudicative proceedings related to any of
the foregoing and similar matters).
Client also agrees that it will not, for itself or any other entity or person, assert that either
(i) the Firm’s representation of Client or any of Client’s affiliates in any past, present, or future
matter or (ii) the Firm’s actual or possible possession of confidential information belonging to
Client or any of Client’s affiliates is a basis to disqualify the Firm from representing another
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 34 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 6
CONFIDENTIAL
entity or person in any Allowed Adverse Representation.  Client further agrees that any Allowed
Adverse Representation does not breach any duty that the Firm owes to Client or any of Client’s
affiliates.  Client also agrees that the Firm’s representation in the Engagement is solely of Client
and that no member or other entity or person related to it (such as a shareholder, parent,
subsidiary, affiliate, director, officer, partner, employee, or joint venturer) has the status of a
client for conflict of interest purposes.
In addition, if a waiver of a conflict of interest necessary to allow the Firm to represent
another client in a matter that is not substantially related to the Engagement is not effective for
any reason, Client agrees that the Firm may withdraw from the Engagement.  Should that occur,
Client will not, for itself or any other entity or person, seek to preclude such termination of
services or assert that either (a) the Firm’s representation of Client or any of Client’s affiliates in
any past, present, or future matter or (b) the Firm’s actual or possible possession of confidential
information belonging to Client or any of Client’s affiliates is a basis to disqualify the Firm from
representing such other client or acting on such adverse matter.
It is important that you review this letter carefully and consider all of the advantages and
disadvantages of waiving certain conflicts of interests that would otherwise bar the Firm from
representing parties with interests adverse to you during the time in which the Firm is
representing you.  You also understand that because this waiver includes future issues and future
clients that are unknown and unknowable at this time, it is impossible to provide you with any
more details about those prospective clients and matters.  Thus, in choosing to execute this
waiver, you have recognized the inherent uncertainty about the array of potential matters and
clients the Firm might take on in matters that are adverse to you but have nonetheless decided it
is in your interest to waive conflicts of interest regarding the Allowed Adverse Representations
and waive rights to prohibit the Firm’s potential withdrawal should a conflict waiver prove
ineffectual.
The Firm informs Client that certain entities owned by current or former Firm attorneys
and senior staff (“attorney investment entities”) have investments in funds or companies that
may, directly or indirectly, be affiliated with Client, hold investments in Client’s debt or equity
securities, may be adverse to Client, or conduct commercial transactions with Client (each, a
“Passive Holding”).  The attorney investment entities are passive and have no management or
other control rights in such funds or companies.  The Firm notes that other persons may in the
future assert that a Passive Holding creates, in certain circumstances, a conflict between the
Firm’s exercise of its independent professional judgment in rendering advice to Client and the
financial interest of Firm attorneys participating in the attorney investment entities, and such
other persons might seek to limit Client’s ability to use the Firm to advise Client on a particular
matter.  While the Firm cannot control what a person might assert or seek, the Firm believes that
the Firm’s judgment will not be compromised by virtue of any Passive Holding.  Please let us
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 35 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 7
CONFIDENTIAL
know if Client has any questions or concerns regarding the Passive Holdings.  By executing this
letter, Client acknowledges the Firm’s disclosure of the foregoing.
Restructuring Cases.  If it becomes necessary for Client to commence restructuring
cases under chapter 11 of the U.S. Bankruptcy Code (a “Restructuring Case”), the Firm’s
ongoing employment by Client will be subject to the approval of the court with jurisdiction over
the petitions.  If necessary, the Firm will take steps necessary to prepare the disclosure materials
required in connection with the Firm’s retention as lead restructuring counsel.  In the near term,
the Firm will begin conflicts checks on potentially interested parties as provided by Client.
If necessary, the Firm will prepare a preliminary draft of a schedule describing the Firm’s
relationships with certain interested parties (the “Disclosure Schedule”).  The Firm will give
Client a draft of the Disclosure Schedule once it is available.  Although the Firm believes that
these relationships do not constitute actual conflicts of interest, these relationships must be
described and disclosed in Client’s application to the court to retain the Firm.
If in the Firm’s determination a conflict of interest arises in Client’s Restructuring Case
requiring separate conflicts counsel, then Client will be required to use separate conflicts counsel
in those matters.
No Guarantee of Success.  It is impossible to provide any promise or guarantee about
the outcome of Client’s matters.  Nothing in this Agreement or any statement by Firm staff or
attorneys constitutes a promise or guarantee.  Any comments about the outcome of Client’s
matter are simply expressions of judgment and are not binding on the Firm.
Consent to Use of Information.  In connection with future materials that, for marketing
purposes, describe facets of the Firm’s law practice and recite examples of matters the Firm
handles on behalf of clients, Client agrees that, if those materials avoid disclosing Client’s
confidences and secrets as defined by applicable ethical rules, they may identify Client as a
client, may contain factual synopses of Client’s matters, and may indicate generally the results
achieved.
Reimbursement of Fees and Expenses.  Client agrees to promptly reimburse the Firm
for all internal or external fees and expenses, including the amount of the Firm’s attorney and
paralegal time at normal billing rates, as incurred by the Firm in connection with participating in,
preparing for, or responding to any action, claim, objection, suit, or proceeding brought by or
against any third-party that relates to the legal services provided by the Firm under this
Agreement.  Without limiting the scope of the foregoing, and by way of example only, this
paragraph extends to all such fees and expenses incurred by the Firm in responding to document
subpoenas, and preparing for and testifying at depositions and trials; and with respect to the
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 36 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 8
CONFIDENTIAL
filing, preparation, prosecution or defense of any applications by the Firm for approval of fees
and expenses in a judicial, arbitral, or similar proceeding.  Further, Client understands,
acknowledges, and agrees that in connection with a Restructuring Case, if Client has not objected
to the payment of a Firm invoice or to a Firm fee and expense application, has in fact paid such
invoice, or has approved such fee and expense application, then Client waives its right (and the
right of any successor entity as a result of a Transaction or otherwise) to subsequently object to
the payment of fees and expenses covered by such invoice or fee application.
LLP.  Kirkland & Ellis LLP is a limited liability partnership organized under the laws of
Illinois, and Kirkland & Ellis International LLP is a limited liability partnership organized under
the laws of Delaware.  Pursuant to those statutory provisions, an obligation incurred by a limited
liability partnership, whether arising in tort, contract or otherwise, is solely the obligation of the
limited liability partnership, and partners are not personally liable, directly or indirectly, by way
of indemnification, contribution, assessment or otherwise, for such obligation solely by reason of
being or so acting as a partner.
Governing Law.  This Agreement shall be governed by, and construed in accordance
with, the laws of the State of Illinois, without giving effect to the conflicts of law principles
thereof.
Miscellaneous.  This Agreement sets forth the Parties’ entire agreement for rendering
professional services.  It can be amended or modified only in writing and not orally or by course
of conduct.  Each Party signing below is jointly and severally responsible for all obligations due
to the Firm and represents that each has full authority to execute this Agreement so that it is
binding.  This Agreement may be signed in one or more counterparts and binds each Party
countersigning below, whether or not any other proposed signatory ever executes it.  If any
provision of this Agreement or the application thereof is held invalid or unenforceable, the
invalidity or unenforceability shall not affect other provisions or applications of this Agreement
which can be given effect without such provisions or application, and to this end the provisions
of this Agreement are declared to be severable.  Any agreement or waiver contained herein by
Client extends to any assignee or successor in interest to Client, including without limitation the
reorganized Client upon and after the effective date of a plan of reorganization in a Restructuring
Case.
This Agreement is the product of arm’s-length negotiations between sophisticated parties,
and Client acknowledges that it is experienced with respect to the retention of legal counsel.
Therefore, the Parties acknowledge and agree that any otherwise applicable rule of contract
construction or interpretation which provides that ambiguities shall be construed against the
drafter (and all similar rules of contract construction or interpretation) shall not apply to this
Agreement.  The Parties further acknowledge that the Firm is not advising Client with respect to
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 37 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 9
CONFIDENTIAL
this Agreement because the Firm would have a conflict of interest in doing so, and that Client
has consulted (or had the opportunity to consult) with legal counsel of its own choosing.  Client
further acknowledges that Client has entered into this Agreement and agreed to all of its terms
and conditions voluntarily and fully-informed, based on adequate information and Client’s own
independent judgment.  The Parties further acknowledge that they intend for this Agreement to
be effective and fully enforceable upon its execution and to be relied upon by the Parties.
***
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 38 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 10
CONFIDENTIAL
Please confirm your agreement with the arrangements described in this letter by signing
the enclosed copy of this letter in the space provided below and returning it to us.  Please
understand that, if we do not receive a signed copy of this letter within twenty-one days, we will
withdraw from representing you in this Engagement.
Very truly yours,
KIRKLAND & ELLIS LLP
By:
Printed Name:  Joshua A. Sussberg, P.C.
Title:  Partner
Agreed and accepted this 3rd day of April, 2024
VYAIRE HOLDING COMPANY
By:
Name: Vikram Bajaj
Title: Chief Financial Officer
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 39 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 10
CONFIDENTIAL
Please confirm your agreement with the arrangements described in this letter by signing
the enclosed copy of this letter in the space provided below and returning it to us.  Please
understand that, if we do not receive a signed copy of this letter within twenty-one days, we will
withdraw from representing you in this Engagement.
Very truly yours,
KIRKLAND & ELLIS LLP
By:
Printed Name:  Joshua A. Sussberg, P.C.
Title:  Partner
Agreed and accepted this 4th day of April, 2024
VYAIRE HOLDING COMPANY
By:
Name: Vikram Bajaj
Title: Chief Financial Officer

Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 40 of 914

Mr. Vikram Bajaj
March 28, 2024
Page 11
CONFIDENTIAL
Addendum A:  List of Client Subsidiaries
1.
Vyaire Company
2.
Vyaire Finance B.V.
3.
Vyaire Medical, Inc.
4.
Bird Products Corporation
5.
Breathe US Holdco Inc.
6.
Breathe US Holdings LP
7.
EME Medical, Inc.
8.
Revolutionary Medical Devices, Inc.
9.
SensorMedics Corporation
10. VIASYS Holdings Inc.
11. Vyaire Medical 202, Inc.
12. Vyaire Medical 203, Inc.
13. Vyaire Medical 205, Inc.
14. Vyaire Medical 206, Inc.
15. Vyaire Medical 211, Inc.
16. Vyaire Medical BR LLC
17. Vyaire Medical Capital LLC
18. Vyaire Medical Consumables LLC
19. Vyaire Medical International LLC
20. Vyaire Medical LLC
21. Vyaire Medical Payroll LLC
22. Vyaire Respiratory Diagnostics LLC
23. Vyaire Financial Holdings LLC
24. VM Finance Sub LLC
25. Vyaire Receivables LLC
26. Vyaire TSR Sub, LLC
27. Vyaire TSR Midco, LLC
28. Vyaire Medical Pty Ltd
29. Intermed Equipamento Medico Hospitalar
LTDA
30. Servicos De Assistencia Tecnica A
Equipmaneto Medico Hospitalar LTDA
31. Vyaire Medical Products ULC
32. Beijing Branch of Vyaire Medical Products
(Shanghai) Co., Ltd.
33. Vyaire Medical Products (Shanghai) Co.,
Ltd.
34. Vyaire Medical Denmark Branch, Filial of
Vyaire Medical AB
35. MIM Medizinische Instrumente und
Monitoring GmbH
36. Vyaire GmbH
37. Vyaire Medical GmbH
38. Vyaire Medical Private Limited
39. Vyaire S.r.l.
40. Vyaire Medical S.r.l.
41. Vyaire Medical SDN BHD
42. Vyaire Medical Cooperatief U.A.
43. Vyaire Medical International B.V.
44. Vyaire Medical Holdings B.V.
45. Vyaire B.V.
46. Vyaire Medical B.V.
47. Vyaire Medical Products Limited (Spółka z
ograniczoną odpowiedzialnością) - Poland
Branch
48. Vyaire Limited Liability Company
49. imtmedical Pte. Ltd.
50. Vyaire Medical Pte. Ltd.
51. Vyaire Medical Korea Ltd.
52. Vyaire Medical AB
53. Acutronic Medical Systems AG
54. Advanced Respiratory Care AG
55. imtmedical ag
56. Vyaire Medical Sarl
57. Vyaire Turkey Tibbi Cihazlar Ticaret
Anonim Sirketi
58. Vyaire DMCC
59. Carefusion U.K. 235 Limited
60. CareFusion U.K. 232 Limited
61. Vyaire UK 236 Limited
62. Vyaire Medical Products Limited
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 41 of 914

1
KIRKLAND & ELLIS LLP
SCHEDULE I:  CLIENT-REIMBURSABLE EXPENSES AND OTHER CHARGES
Effective 01/01/2024
The following outlines Kirkland & Ellis LLP’s (“K&E LLP”) policies and standard charges for
various services performed by K&E LLP and/or by other third parties on behalf of the client
which are often ancillary to our legal services.  Services provided by in-house K&E LLP
personnel are for the convenience of our clients.  Given that these services are often ancillary to
our legal services, in certain instances it may be appropriate and/or more cost efficient for these
services to be outsourced to a third-party vendor.  If services are provided beyond those outlined
below, pricing will be based on K&E LLP’s approximate cost and/or comparable market pricing.

Duplicating, Reprographics and Printing:  The following list details K&E LLP’s
charges for duplicating, reprographics and printing services:

Black and White Copy or Print (all sizes of paper):

$0.16 per impression for all U.S. offices

€0.10 per impression in Munich

£0.15 per impression in London

HK$1.50 per impression in Hong Kong

CNY1.00 per impression in Beijing and Shanghai

Color Copy or Print (all sizes of paper):

$0.55 per impression

Scanned Images:

$0.16 per page for black and white or color scans

Other Services:

CD/DVD Duplicating or Mastering - $7/$10 per CD/DVD

Binding - $0.70 per binding

Large or specialized binders - $13/$27

Tabs - $0.13 per item

OCR/File Conversion - $0.03 per page

Large Format Printing - $1.00 per sq. ft.

Secretarial and Word Processing:  Clients are not charged for secretarial and word
processing activities incurred on their matters during standard business hours.

Overtime Charges:  Clients will be charged for overtime costs for secretarial and
document services work if either (i) the client has specifically requested the after-hours
work or (ii) the nature of the work being done for the client necessitates out-of-hours
overtime and such work could not have been done during normal working hours.  If these
conditions are satisfied, costs for related overtime meals and transportation also will be
charged.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 42 of 914

2

Travel Expenses:  We charge clients our out-of-pocket costs for travel expenses
including associated travel agency fees.  We charge coach fares (business class for
international flights) unless the client has approved business-class, first-class or an
upgrade.  K&E LLP personnel are instructed to incur only reasonable airfare, hotel and
meal expenses.  K&E LLP negotiates, uses, and passes along volume discount hotel and
air rates whenever practicable.  However, certain retrospective rebates may not be passed
along.

Catering Charges:  Clients will be charged for any in-house catering service provided in
connection with client matters.

Communication Expenses:  We do not charge clients for telephone calls, conference
calls, videoconferences or faxes made from K&E LLP’s offices.
Charges incurred for conference calls, videoconferences, cellular telephones, and calls
made from other third-party locations will be charged to the client at the actual cost
incurred.  Further, other telecommunication expenses incurred at third-party locations
(e.g., phone lines at trial sites, Internet access, etc.) will be charged to the client at the
actual cost incurred.

Overnight Delivery/Postage:  We charge clients for the actual cost of overnight and
special delivery (e.g., Express Mail, FedEx, and DHL), and U.S. postage for materials
mailed on the client’s behalf.  K&E LLP negotiates, uses, and passes along volume
discount rates whenever practicable.

Messengers:  We charge clients for the actual cost of a third-party vendor messenger.

Library Research Services: Library Research staff provides research and document
retrieval services at the request of attorneys, and clients are charged per hour for these
services.  Any expenses incurred in connection with the request, such as outside retrieval
service or online research charges, are passed on to the client at cost, including any
applicable discounts.

Online Research Charges:  K&E LLP charges for costs incurred in using third-party
online research services in connection with a client matter.  K&E LLP negotiates and
uses discounts or special rates for online research services whenever possible and
practicable and passes through the full benefit of any savings to the client based on actual
usage.

Inter-Library Loan Services: Our standard client charge for inter-library loan services
when a K&E LLP library employee borrows a book from an outside source is $25 per
title.  There is no client charge for borrowing books from K&E LLP libraries in other
cities or from outside collections when the title is part of the K&E LLP collection but
unavailable.

Off-Site Legal Files Storage:  Clients are not charged for off-site storage of files unless
the storage charge is approved in advance.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 43 of 914

3

Electronic Data Storage:  K&E LLP will not charge clients for costs to store electronic
data and files on K&E LLP’s systems if the data stored does not exceed 100 gigabytes
(GB).  If the data stored for a specific client exceeds 100GB, K&E LLP will charge
clients $6.00 per month/per GB for all network data stored until the data is either returned
to the client or properly disposed of.  For e-discovery data on the Relativity platform,
K&E LLP will also charge clients $6.00 per month/per GB until the data is either
returned to the client or properly disposed of.

Tax Filings:  Clients will be charged a fixed fee for certain tax filings.  Our standard
charge is $400 per Form 8832 election; $250 per Form 83(b) election for the first 20
forms, $100 per form for any additional forms; $1,000 each for Form SS-4 (Foreign);
$100 each for Form SS-4 (Domestic); and $75 for each FIRPTA certificate.

Calendar Court Services:  Our standard charge is $25 for a court filing and other court
services or transactions.

Supplies:  There is no client charge for standard office supplies.  Clients are charged for
special items (e.g., a minute book, exhibit tabs/indexes/dividers, binding, etc.) and then at
K&E LLP’s actual cost.

Contract Attorneys and Contract Non-Attorney Billers:  If there is a need to utilize a
contract attorney or contract non-attorney on a client engagement, clients will be charged
a standard hourly rate for these billers unless other specific billing arrangements are
agreed between K&E LLP and client.

Expert Witnesses, Experts of Other Types, and Other Third Party Consultants:  If
there is a need to utilize an expert witness, expert of other type, or other third party
consultant such as accountants, investment bankers, academicians, other attorneys, etc.
on a client engagement, clients will be requested to retain or pay these individuals
directly unless specific billing arrangements are agreed between K&E LLP and client.

Third Party Expenditures: Third party expenditures (e.g., corporate document and lien
searches, lease of office space at Trial location, IT equipment rental, SEC and regulatory
filings, etc.) incurred on behalf of a client, will be passed through to the client at actual
cost.  If the invoice exceeds $50,000, it is K&E LLP’s policy that wherever possible such
charges will be directly billed to the client.  In those circumstances where this is not
possible, K&E LLP will seek reimbursement from our client prior to paying the vendor.
Unless otherwise noted, charges billed in foreign currencies are based on current U.S. charges at
an appropriate exchange rate.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 44 of 914

Exhibit D

Budget and Staffing Plan
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 45 of 914

Budget and Staffing Plan

(For Matter Categories for the Period Beginning on June 9, 2024 and Ending on
September 7, 2024)

Budget

Matter
Number
Matter Category
Description
Hours Budgeted
Total Compensation Budgeted
4
Chapter 11 Bankruptcy Filing
and First Day Preparation
160 - 248
$180,000 - $280,000
5
Corporate and Governance
Matters
60 - 93
$90,000 - $140,000
6
Disclosure Statement, Plan,
and Confirmation
257 - 400
$270,000 - $420,000
7
DIP Financing and Cash
Collateral
153 - 237
$180,000 - $280,000
8
Cash Management
79 - 122
$90,000 - $140,000
9
Automatic Stay Issues
68 - 106
$67,500 - $105,000
10
Asset Sales/Section 363
Issues
1,080 - 1,680
$1,575,000 - $2,450,000
11
Executory Contracts and
Unexpired Leases
88 - 136
$90,000 - $140,000
12
Business Operations
95 - 147
$139,500 - $217,000
13
Claims Administration
66 - 102
$74,250 - $115,500
14
Schedules and Statements
(SOFAs)
61 - 95
$68,850 - $107,100
15
Creditor and Stakeholder
Communications
46 - 71
$58,050 - $90,300
16
U.S. Trustee Matters and
Communication
53 - 82
$73,800 - $114,800
17
Hearings
61 - 94
$76,500 - $119,000
18
Insurance and Surety Matters
59 - 91
$67,500 - $105,000
19
Utilities
59 - 91
$67,500 - $105,000
20
Tax Matters
107 - 166
$135,000 - $210,000
21
Case Administration
188 - 292
$225,000 - $350,000
22
K&E Fee Applications
266 - 414
$405,000 - $630,000
23
Non-K&E Fee / Employment
Applications
99 - 154
$132,750 - $206,500
24
Vendor Matters
96 - 149
$126,000 - $196,000
25
Litigation
101 - 156
$135,000 - $210,000
27
Non-Working Travel Time
12 - 17
$11,250 - $17,500
28
Creditors’ Committee Issues
34 - 53
$45,000 - $70,000
29
Employee and Labor Matters
73 - 114
$88,650 - $137,900
Totals
3,421 – 5,310
$4,472,100 - $6,956,600

Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 46 of 914

4
Staffing Plan

Category of Timekeeper
Number of Timekeepers
Expected to Work on
the Matter Categories
During the Budget Period
Average
Hourly Rate1
Partner
31
$1,789
Associate
49
$1,122
Legal Assistant
12
$502
Total
92
$1,244

1
The Average Hourly Rate is a weighted average based on the individual hourly rate of, and projected number of
hours worked by, each timekeeper over the course of these chapter 11 cases.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 47 of 914

Exhibit E

Voluntary Rate Disclosures
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 48 of 914

• The blended hourly rate for all K&E timekeepers (including both professionals and
paraprofessionals) who billed to non-bankruptcy matters (collectively, the “Non-Bankruptcy
Matters”)1 during the 12-month period beginning on December 1, 2023, and ending on
November 30, 2024 (the “Comparable Period”) was, in the aggregate, approximately
$1,315.38 per hour (the “Non-Bankruptcy Blended Hourly Rate”).2
• The blended hourly rate for all K&E timekeepers (including both professionals and
paraprofessionals)
who
billed
to
the
Debtors
during
the
Fee
Period
was
approximately $1,291.28 per hour (the “Debtor Blended Hourly Rate”).3
• A detailed comparison of these rates is as follows:
Position at K&E
Debtor Blended Hourly
Rate for This Fee
Application
Non-Bankruptcy Blended
Hourly Rate
Partner
$1,769.43
$1,798.92
Of Counsel
-
$1,451.76
Retired Partner
-
$2,213.07
Associate
$1,149.53
$1,062.38
Visiting Attorney
-
$792.45
Law Clerk
-
$491.75
Paralegal
$567.20
$530.52
Junior Paralegal
$355.00
$323.71
Support Staff
$364.59
$575.06
Attorneys & Paraprofessionals
$1,291.28
$1,315.38

1
It is the nature of K&E’s practice that certain non-bankruptcy engagements require the advice and counsel of
professionals and paraprofessionals who work primarily within K&E’s Restructuring Group.  Accordingly,
“Non-Bankruptcy Matters” consist of matters for which K&E domestic timekeepers represented a client in a
matter other than an in-court bankruptcy proceeding.  Moreover, the Non-Bankruptcy Matters include time billed
by K&E domestic timekeepers who work primarily within K&E’s Restructuring Group.
2
K&E calculated the blended rate for Non-Bankruptcy Matters by dividing the total dollar amount billed by K&E
domestic timekeepers to the Non-Bankruptcy Matters during the Comparable Period by the total number of hours
billed by K&E domestic timekeepers to the Non-Bankruptcy Matters during the Comparable Period.
3
K&E calculated the blended rate for timekeepers who billed to the Debtors by dividing the total dollar amount
billed by such timekeepers during the Fee Period by the total number of hours billed by such timekeepers during
the Fee Period.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 49 of 914

Exhibit F
Summary of Total Fees Incurred and Hours Billed During the Fee Period
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 50 of 914

Attorney Name
Position
Department
Date of
Admission
Fees Billed
In this Application
Hours
Billed
In this
Application
Number
of Rate
Increases
Hourly Rate Billed
Fees Billed
In this Application
at First Interim
Application Billing
Rate
In this
Application
In the First
Interim
Application
Kon Asimacopoulos
Partner
Restructuring
2000
$103,725.00
45.00
N/A
$2,305.00
$2,305.00
$103,725.00
Adam Thomas
Clifford, P.C.
Partner
Corporate -
M&A/Private Equity
2013
$20,748.00
10.40
N/A
$1,995.00
$1,995.00
$20,748.00
Michael Ehret
Partner
Taxation
2001
$547,276.00
288.80
N/A
$1,895.00
$1,895.00
$547,276.00
Emma L. Flett
Partner
Technology & IP
Transactions
2009
$11,421.00
5.40
N/A
$2,115.00
$2,115.00
$11,421.00
Andrew Idrizovic,
P.C.
Partner
Corporate - Debt
Finance
2009
$5,985.00
3.00
N/A
$1,995.00
$1,995.00
$5,985.00
Partha Kar
Partner
Restructuring
2002
$45,178.00
19.60
N/A
$2,305.00
$2,305.00
$45,178.00
Daniel Lewis, P.C.
Partner
Technology & IP
Transactions
2008
$60,547.00
31.70
N/A
$1,910.00
$1,910.00
$60,547.00
Mario Mancuso, P.C.
Partner
International Trade
1997
$480.00
0.20
N/A
$2,400.00
$2,400.00
$480.00
Mark McKane, P.C.
Partner
Litigation - General
1999
$12,390.00
6.00
N/A
$2,065.00
$2,065.00
$12,390.00
James Morgan
Partner
Taxation
2004
$7,090.50
2.90
N/A
$2,445.00
$2,445.00
$7,090.50
Mavnick Nerwal
Partner
Taxation
2008
$1,132.50
0.50
N/A
$2,265.00
$2,265.00
$1,132.50
Scott D. Price, P.C.
Partner
ECEB - Executive
Compensation
1998
$7,633.00
3.40
N/A
$2,245.00
$2,245.00
$7,633.00
Jay M. Ptashek, P.C.
Partner
Corporate - Debt
Finance
1993
$6,735.00
3.00
N/A
$2,245.00
$2,245.00
$6,735.00
Josh Sussberg, P.C.
Partner
Restructuring
2004
$16,826.50
7.30
N/A
$2,305.00
$2,305.00
$16,826.50
Paul D. Tanaka, P.C.
Partner
Environment -
Transactional
2003
$35,743.50
16.90
N/A
$2,115.00
$2,115.00
$35,743.50
Cristina Weidner
Partner
Restructuring
2005
$79,254.00
47.60
N/A
$1,665.00
$1,665.00
$79,254.00
Dennis Williams
Partner
Corporate -
Healthcare
2008
$3,037.50
1.50
N/A
$2,025.00
$2,025.00
$3,037.50
Spencer A. Winters,
P.C.
Partner
Restructuring
2013
$524,877.50
311.50
N/A
$1,685.00
$1,685.00
$524,877.50
Sara B. Zablotney,
P.C.
Partner
Taxation
2003
$223,717.50
91.50
N/A
$2,445.00
$2,445.00
$223,717.50
Marin Boney
Partner
Antitrust/Competition
2008
$4,712.50
2.50
N/A
$1,885.00
$1,885.00
$4,712.50
Hendrik Braun
Partner
Corporate -
M&A/Private Equity
2010
(Germany)
$11,335.50
9.90
N/A
$1,145.00
$1,145.00
$11,335.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 51 of 914

2
Attorney Name
Position
Department
Date of
Admission
Fees Billed
In this Application
Hours
Billed
In this
Application
Number
of Rate
Increases
Hourly Rate Billed
Fees Billed
In this Application
at First Interim
Application Billing
Rate
In this
Application
In the First
Interim
Application
John G. Caruso
Partner
Real Estate
1992
$18,189.00
8.60
N/A
$2,115.00
$2,115.00
$18,189.00
Bernadette Coppola
Partner
Technology & IP
Transactions
2013
$148,680.00
94.40
N/A
$1,575.00
$1,575.00
$148,680.00
Hannah Crawford
Partner
Restructuring
2015
$43,384.00
27.20
N/A
$1,595.00
$1,595.00
$43,384.00
Sion Davies
Partner
Antitrust/Competition
2016
$8,977.50
5.70
N/A
$1,575.00
$1,575.00
$8,977.50
Tabitha J. De Paulo
Partner
Litigation - General
2015
$153,114.50
106.70
N/A
$1,435.00
$1,435.00
$153,114.50
Anthony M. Del Rio
Partner
Corporate -
Healthcare
2014
$126,483.50
79.30
N/A
$1,595.00
$1,595.00
$126,483.50
Susan D. Golden
Partner
Restructuring
1988
$19,840.00
12.40
N/A
$1,600.00
$1,600.00
$19,840.00
Luci Hague
Partner
International Trade
2015
$630.00
0.40
N/A
$1,575.00
$1,575.00
$630.00
Kate Hardey
Partner
Corporate -
Healthcare
2003
$156,607.50
78.50
N/A
$1,995.00
$1,995.00
$156,607.50
Erik Hepler
Partner
Corporate - Debt
Finance
1990
$423.00
0.20
N/A
$2,115.00
$2,115.00
$423.00
Sarah Kimmer
Partner
Litigation - General
2015
$2,730.00
2.00
N/A
$1,365.00
$1,365.00
$2,730.00
Maximilian Liegl
Partner
Corporate -
M&A/Private Equity
2017
(Germany)
$1,070.00
1.00
N/A
$1,070.00
$1,070.00
$1,070.00
Sean McClay
Partner
Corporate - Debt
Finance
2018
$18,427.50
11.70
N/A
$1,575.00
$1,575.00
$18,427.50
Alisa Melekhina
Partner
Litigation - General
2015
$85,492.00
53.60
N/A
$1,595.00
$1,595.00
$85,492.00
Maureen D. O’Brien
Partner
ECEB - Employee
Benefits
1998
$54,778.50
25.90
N/A
$2,115.00
$2,115.00
$54,778.50
Rakesh Patel
Partner
Taxation
2000
$4,162.50
2.50
N/A
$1,665.00
$1,665.00
$4,162.50
Evangelia Podaras
Partner
ECEB -
Labor/Employment
2016
$41,107.50
26.10
N/A
$1,575.00
$1,575.00
$41,107.50
William T. Pruitt
Partner
Litigation - General
2004
$5,932.50
3.50
N/A
$1,695.00
$1,695.00
$5,932.50
Risa Salins
Partner
ECEB -
Labor/Employment
2002
$72,121.50
34.10
N/A
$2,115.00
$2,115.00
$72,121.50
Yusuf Salloum
Partner
Restructuring
2018
$514,228.00
322.40
N/A
$1,595.00
$1,595.00
$514,228.00
Anna Schwander
Partner
Corporate - Capital
Markets
2002
$35,505.00
27.00
N/A
$1,315.00
$1,315.00
$35,505.00
Scottie Shermetaro
Partner
Technology & IP
Transactions
2018
$32,602.50
20.70
N/A
$1,575.00
$1,395.00
$28,876.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 52 of 914

3
Attorney Name
Position
Department
Date of
Admission
Fees Billed
In this Application
Hours
Billed
In this
Application
Number
of Rate
Increases
Hourly Rate Billed
Fees Billed
In this Application
at First Interim
Application Billing
Rate
In this
Application
In the First
Interim
Application
Noah Shier
Partner
Technology & IP
Transactions
2017
$14,962.50
9.50
N/A
$1,575.00
$1,575.00
$14,962.50
Jessica H. Sicsu
Partner
Corporate -
M&A/Private Equity
2002
$1,221.50
0.70
N/A
$1,745.00
$1,745.00
$1,221.50
Michael D. Thorpe
Partner
Antitrust/Competition
2010
$1,017.00
0.60
N/A
$1,695.00
$1,695.00
$1,017.00
Steve Toth
Partner
Corporate -
M&A/Private Equity
2005
$1,069,796.00
587.80
N/A
$1,820.00
$1,820.00
$1,069,796.00
Sarah Ullathorne
Partner
Restructuring
2004
$11,182.50
7.10
N/A
$1,575.00
$1,575.00
$11,182.50
Nicholas Warther
Partner
Taxation
2017
$329,503.50
197.90
N/A
$1,665.00
$1,665.00
$329,503.50
Ann-Kathrin Ziegler
Partner
Restructuring
2018
$3,424.00
3.20
N/A
$1,070.00
$1,050.00
$3,360.00
Rebecca H. Arnall
Associate
ECEB - Executive
Compensation
2017
$9,307.50
8.50
N/A
$1,095.00
$1,095.00
$9,307.50
$19,101.50
15.10
N/A
$1,265.00
$1,095.00
$16,534.50
Cooper Barghols
Associate
Corporate - General
2023
$5,623.50
6.90
1
$815.00
$815.00
$5,623.50
$5,362.50
5.50
$975.00
$815.00
$4,482.50
Wes Benter
Associate
ECEB -
Labor/Employment
2019
$787.50
0.50
N/A
$1,575.00
$1,575.00
$787.50
Samantha Bradley
Associate
Technology & IP
Transactions
2019
$9,415.00
7.00
N/A
$1,345.00
$1,345.00
$9,415.00
Chris Ceresa
Associate
Restructuring
2020
$161,669.00
120.20
1
$1,345.00
$1,345.00
$161,669.00
$692,478.00
496.40
$1,395.00
$1,345.00
$667,658.00
Tiffani Chanroo
Associate
Restructuring
2021
$133,837.00
105.80
1
$1,265.00
$1,265.00
$133,837.00
$475,457.50
353.50
$1,345.00
$1,265.00
$447,177.50
Kenny Chiaghana
Associate
Restructuring
2023
$51,426.50
63.10
1
$815.00
$815.00
$51,426.50
$84,727.50
86.90
$975.00
$815.00
$70,823.50
Erica D. Clark
Associate
Restructuring
2019
$168,272.50
105.50
N/A
$1,595.00
$1,595.00
$168,272.50
Dominique Collins
Associate
ECEB - Executive
Compensation
2020
$1,861.50
1.70
1
$1,095.00
$1,095.00
$1,861.50
$506.00
0.40
$1,265.00
$1,095.00
$438.00
Georgia Cooper-
Dervan
Associate
Litigation - General
2021
$1,066.50
0.90
N/A
$1,185.00
$1,185.00
$1,066.50
Joseph A. D’Antonio
Associate
Litigation - General
2021
$7,110.00
6.00
1
$1,185.00
$1,185.00
$7,110.00
$7,533.50
6.10
$1,235.00
$1,185.00
$7,228.50
Erin Davey
Associate
ECEB -
Labor/Employment
2023
$5,655.00
5.80
N/A
$975.00
$975.00
$5,655.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 53 of 914

4
Attorney Name
Position
Department
Date of
Admission
Fees Billed
In this Application
Hours
Billed
In this
Application
Number
of Rate
Increases
Hourly Rate Billed
Fees Billed
In this Application
at First Interim
Application Billing
Rate
In this
Application
In the First
Interim
Application
Jaina Desai
Associate
Restructuring
2023
$98,289.00
120.60
1
$815.00
$815.00
$98,289.00
$418,762.50
429.50
$975.00
$815.00
$350,042.50
Shareen Dhillon
Associate
Technology & IP
Transactions
2018
$2,530.00
2.00
N/A
$1,265.00
$1,265.00
$2,530.00
Luke Finn
Associate
Corporate -
M&A/Private Equity
2021
$625,963.00
465.40
N/A
$1,345.00
$1,345.00
$625,963.00
Justin M. Garfinkle
Associate
Technology & IP
Transactions
2022
$10,042.50
10.30
1
$975.00
$975.00
$10,042.50
$105,229.50
96.10
$1,095.00
$975.00
$93,697.50
Emanuel Goetz
Associate
Taxation
2024
$2,170.00
3.50
1
$620.00
$620.00
$2,170.00
$108,000.00
144.00
$750.00
$620.00
$89,280.00
Palmer Gunderson
Associate
Taxation
2023
$28,645.50
33.90
1
$845.00
$845.00
$28,645.50
$230,342.50
231.50
$995.00
$845.00
$195,617.50
David Hackel
Associate
Restructuring
2023
$108,907.50
111.70
1
$975.00
$975.00
$108,907.50
$58,692.00
53.60
$1,095.00
$975.00
$52,260.00
Yoonie Han
Associate
Corporate - Debt
Finance
2019
$25,528.50
18.30
1
$1,395.00
$1,395.00
$25,528.50
$14,805.00
9.40
$1,575.00
$1,395.00
$13,113.00
Liz Ji
Associate
Taxation
2021
$18,330.00
15.60
1
$1,175.00
$1,175.00
$18,330.00
$16,833.50
13.10
$1,285.00
$1,175.00
$15,392.50
Olivia Kaufmann
Associate
Corporate -
Healthcare
2023
$19,890.00
20.40
1
$975.00
$975.00
$19,890.00
$39,420.00
36.00
$1,095.00
$975.00
$35,100.00
Sooah Kim
Associate
ECEB - Employee
Benefits
2022
$4,485.00
4.60
1
$975.00
$975.00
$4,485.00
$18,286.50
16.70
$1,095.00
$975.00
$16,282.50
Brian King
Associate
Corporate -
Healthcare
2017
$4,842.00
3.60
N/A
$1,345.00
$1,345.00
$4,842.00
Maggie Kate King
Associate
Technology & IP
Transactions
2021
$15,877.50
14.50
1
$1,095.00
$1,095.00
$15,877.50
$70,587.00
55.80
$1,265.00
$1,095.00
$61,101.00
Sabrina Lieberman
Associate
Restructuring
2023
$112,388.50
137.90
1
$815.00
$815.00
$112,388.50
$278,947.50
286.10
$975.00
$815.00
$233,171.50
Savannah Malnar-
Cole
Associate
Antitrust/Competition
2023
$9,964.50
9.10
1
$1,095.00
$1,095.00
$9,964.50
$4,933.50
3.90
$1,265.00
$1,095.00
$4,270.50
Jennifer Mancini
Associate
Litigation - General
2022
$1,387.50
1.50
1
$925.00
$925.00
$1,387.50
$4,837.50
4.50
$1,075.00
$925.00
$4,162.50
Rebecca J. Marston
Associate
Restructuring
2021
$162,679.00
128.60
1
$1,265.00
$1,265.00
$162,679.00
$214,796.50
159.70
$1,345.00
$1,265.00
$202,020.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 54 of 914

5
Attorney Name
Position
Department
Date of
Admission
Fees Billed
In this Application
Hours
Billed
In this
Application
Number
of Rate
Increases
Hourly Rate Billed
Fees Billed
In this Application
at First Interim
Application Billing
Rate
In this
Application
In the First
Interim
Application
Brandan Matthews
Associate
Corporate -
M&A/Private Equity
2021
$159,113.50
118.30
N/A
$1,345.00
$1,345.00
$159,113.50
Grant McClernon
Associate
Corporate -
Healthcare
2023
$1,630.00
2.00
N/A
$815.00
$815.00
$1,630.00
Ruan J. Meintjes
Associate
Corporate -
Healthcare
2022
$27,885.00
28.60
1
$975.00
$975.00
$27,885.00
$87,490.50
79.90
$1,095.00
$975.00
$77,902.50
Julienne Miranda
Associate
Corporate - General
2023
$12,958.50
15.90
1
$815.00
$815.00
$12,958.50
$780.00
0.80
$975.00
$815.00
$652.00
Jake Moeller
Associate
Corporate - General
2022
$6,132.00
5.60
N/A
$1,095.00
$1,095.00
$6,132.00
Michael William
Morgan
Associate
Corporate - General
2022
$9,457.50
9.70
1
$975.00
$975.00
$9,457.50
$328.50
0.30
$1,095.00
$975.00
$292.50
Jai Mudhar
Associate
Restructuring
2020
$8,855.00
7.00
1
$1,265.00
$1,265.00
$8,855.00
$45,326.50
33.70
$1,345.00
$1,265.00
$42,630.50
Trent Nachbar
Associate
Corporate -
M&A/Private Equity
2022
$35,916.00
32.80
1
$1,095.00
$1,095.00
$35,916.00
$169,889.50
134.30
$1,265.00
$1,095.00
$147,058.50
Dan O’Connor
Associate
Corporate -
M&A/Private Equity
2021
$79,062.50
62.50
1
$1,265.00
$1,265.00
$79,062.50
$353,735.00
263.00
$1,345.00
$1,265.00
$332,695.00
Sarah Osborne
Associate
Restructuring
2023
$85,004.50
104.30
1
$815.00
$815.00
$85,004.50
$148,297.50
152.10
$975.00
$815.00
$123,961.50
Carolin Paus
Associate
Restructuring
2023
$21,762.00
35.10
1
$620.00
$620.00
$21,762.00
$101,325.00
135.10
$750.00
$620.00
$83,762.00
D. Taylor Petersen
Associate
Corporate - General
2023
$28,567.50
29.30
N/A
$975.00
$975.00
$28,567.50
Joseph Cermak
Profancik
Associate
Corporate - Debt
Finance
2022
$17,842.50
18.30
1
$975.00
$975.00
$17,842.50
$8,760.00
8.00
$1,095.00
$975.00
$7,800.00
Joshua Raphael
Associate
Restructuring
2023
$16,380.00
16.80
1
$975.00
$975.00
$16,380.00
$167,316.00
152.80
$1,095.00
$975.00
$148,980.00
Adrian Salmen
Associate
Restructuring
2021
$32,521.50
29.70
1
$1,095.00
$1,095.00
$32,521.50
$74,129.00
58.60
$1,265.00
$1,095.00
$64,167.00
Seth Sanders
Associate
Restructuring
2021
$92,637.00
84.60
1
$1,095.00
$1,095.00
$92,637.00
$86,020.00
68.00
$1,265.00
$1,095.00
$74,460.00
Florian Schuette
Associate
Taxation
2023
$1,125.00
1.50
N/A
$750.00
$750.00
$1,125.00
Scottie Shermetaro
Associate
Technology & IP
Transactions
2018
$30,969.00
22.20
1
$1,395.00
$1,395.00
$30,969.00
$267,592.50
169.90
$1,575.00
$1,395.00
$237,010.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 55 of 914

6
Attorney Name
Position
Department
Date of
Admission
Fees Billed
In this Application
Hours
Billed
In this
Application
Number
of Rate
Increases
Hourly Rate Billed
Fees Billed
In this Application
at First Interim
Application Billing
Rate
In this
Application
In the First
Interim
Application
Daniel Shin
Associate
Technology & IP
Transactions
2023
$36,660.00
37.60
N/A
$975.00
$975.00
$36,660.00
Noah Spector
Associate
Litigation - General
2021
$537.50
0.50
1
$1,075.00
$1,075.00
$537.50
$91,126.50
76.90
$1,185.00
$1,075.00
$82,667.50
Alex Stephenson
Associate
Taxation
2022
$3,055.00
2.60
N/A
$1,175.00
$1,175.00
$3,055.00
Matt Swanson
Associate
Environment -
Transactional
2021
$885.50
0.70
1
$1,265.00
$1,265.00
$885.50
$3,766.00
2.80
$1,345.00
$1,265.00
$3,542.00
Kyle Nolan Trevett
Associate
Restructuring
2020
$78,292.50
71.50
1
$1,095.00
$1,095.00
$78,292.50
$48,955.50
38.70
$1,265.00
$1,095.00
$42,376.50
Josh Valletta
Associate
Restructuring
2023
$292.50
0.30
N/A
$975.00
$975.00
$292.50
Paul Vasiloff
Associate
ECEB -
Labor/Employment
2021
$7,337.00
5.80
1
$1,265.00
$1,265.00
$7,337.00
$21,520.00
16.00
$1,345.00
$1,265.00
$20,240.00
Donatus Wang
Associate
Restructuring
2022
$32,761.00
36.20
1
$905.00
$905.00
$32,761.00
$54,048.00
56.30
$960.00
$905.00
$50,951.50
Quin Wetzel
Associate
Restructuring
2023
$44,580.50
54.70
1
$815.00
$815.00
$44,580.50
$61,620.00
63.20
$975.00
$815.00
$51,508.00
Ali Mohammad
Zarrabi
Associate
Corporate -
M&A/Private Equity
2022
$34,164.00
31.20
N/A
$1,095.00
$1,095.00
$34,164.00
Ann-Kathrin Ziegler
Associate
Restructuring
2018
$12,600.00
12.00
1
$1,050.00
$1,050.00
$12,600.00
$40,446.00
37.80
$1,070.00
$1,050.00
$39,690.00
Attorney Total
$12,134,487.00
9,122.00

$11,640,786.50

Paraprofessional
Name
Position
Department
Date of
Admission
Fees Billed
In this Application
Hours
Billed
In this
Application
Number of
Rate
Increases
Hourly Rate Billed
Fees Billed
In this Application
at First Interim
Application Billing
Rate
In this
Application
In the First
Interim
Application
Lauren Austgen
Paralegal
Technology & IP
Transactions
N/A
$652.50
1.50
N/A
$435.00
$435.00
$652.50
Amy Donahue
Paralegal
Restructuring
N/A
$21,367.50
40.70
N/A
$525.00
$525.00
$21,367.50
Julia R. Foster
Paralegal
Restructuring
N/A
$35,280.00
67.20
N/A
$525.00
$525.00
$35,280.00
Angela Leonard
Paralegal
Litigation - General
N/A
$16,812.50
26.90
N/A
$625.00
$625.00
$16,812.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 56 of 914

7
Paraprofessional
Name
Position
Department
Date of
Admission
Fees Billed
In this Application
Hours
Billed
In this
Application
Number of
Rate
Increases
Hourly Rate Billed
Fees Billed
In this Application
at First Interim
Application Billing
Rate
In this
Application
In the First
Interim
Application
Michelle L.
Nowicki
Paralegal
Technology & IP
Transactions
N/A
$31,875.00
51.00
N/A
$625.00
$625.00
$31,875.00
Robert Orren
Paralegal
Restructuring
N/A
$312.50
0.50
N/A
$625.00
$625.00
$312.50
Henry Rosas
Paralegal
Corporate - Debt
Finance
N/A
$312.50
0.50
N/A
$625.00
$625.00
$312.50
Barbara M.
Siepka
Paralegal
Technology & IP
Transactions
N/A
$1,653.00
3.80
N/A
$435.00
$435.00
$1,653.00
Hayley Smith
Paralegal
Technology & IP
Transactions
N/A
$1,250.00
2.00
N/A
$625.00
$625.00
$1,250.00
Rob Soneson
Paralegal
Technology & IP
Transactions
N/A
$6,250.00
10.00
N/A
$625.00
$625.00
$6,250.00
Stephanie Choi
Junior
Paralegal
Litigation - General
N/A
$21,229.00
59.80
N/A
$355.00
$355.00
$21,229.00
Georgia Meadow
Junior
Paralegal
Restructuring
N/A
$177.50
0.50
N/A
$355.00
$355.00
$177.50
Ashley Brittanie
Miller
Junior
Paralegal
Technology & IP
Transactions
N/A
$248.50
0.70
N/A
$355.00
$355.00
$248.50
Tanzila Zomo
Junior
Paralegal
Restructuring
N/A
$28,684.00
80.80
N/A
$355.00
$355.00
$28,684.00
Michael Y. Chan
Conflicts
Specialist
Conflicts Analysis
N/A
$9,480.00
24.00
N/A
$395.00
$395.00
$9,480.00
Matthew Cooper
Conflicts
Analyst II
Conflicts Analysis
N/A
$1,700.00
5.00
N/A
$340.00
$340.00
$1,700.00
Marta Dudyan
Conflicts
Analyst II
Conflicts Analysis
N/A
$8,500.00
25.00
N/A
$340.00
$340.00
$8,500.00
Shaun Patrick
Kelly
Senior
Firmwide
Presentation
Designer
Presentation Design
N/A
$2,128.50
4.30
N/A
$495.00
$495.00
$2,128.50
Eric Nyberg
Conflicts
Analyst II
Conflicts Analysis
N/A
$7,650.00
22.50
N/A
$340.00
$340.00
$7,650.00
Paraprofessional Total
$195,563.00
426.70

$195,563.00
Attorney & Paraprofessional Total
$12,330,050.00
9,548.70

$11,836,349.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 57 of 914

Exhibit G

Summary of Actual and Necessary Expenses for the Fee Period

Expense
Vendor (if any)
Unit Cost
(if applicable)
Amount
Standard Copies or Prints
Kirkland & Ellis LLP
$0.10
$544.10
Color Copies or Prints
Kirkland & Ellis LLP

$1,572.45
Local Transportation
VITAL TRANSPORTATION
SERVICES INC

$1,322.22
Travel Expense

$4,322.74
Airfare

$7,457.53
Transportation to/from airport
Boston Coach Corporation;
Uber; SUNNY’S
WORLDWIDE

$3,469.17
Travel Meals

$547.65
Court Reporter Fee/Deposition
RELIABLE WILMINGTON

$72.90
Other Court Costs and Fees
Miller Advertising Agency Inc.

$32,208.66
Outside Printing Services

$1,771.48
Working Meals/K&E Only

$1,046.19
Outside Retrieval Service
CSC; Clarivate Analytics
(Compumark) Inc.;
BUNDESANZEIGER
VERLAG

$2,359.39
Computer Database Research
Restructuring Concepts LLC;
RELX Inc DBA LexisNexis -
Courtlink

$3,430.38
Westlaw Research
Thomson Reuters - West
Publishing Corp - Westlaw

$6,545.56
LexisNexis Research
RELX Inc DBA LexisNexis

$2,163.95
Overtime Transportation

$1,749.56
Overtime Meals - Attorney
GRUBHUB HOLDINGS INC

$1,265.75
Rental Expenses
Aquipt Holdings LLC

$5,142.16
Overnight Delivery - Hard
Federal Express

$242.67
Computer Database Research - Soft
PACER

$120.80
Totals
$77,355.31
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 58 of 914

Exhibit H

Summary of Fees and Expenses by Matter for the Fee Period
Matter
Number
Matter Category
Description
Hours
Total Compensation
Budgeted
Billed
Budgeted
Billed
4
Chapter 11 Bankruptcy
Filing and First Day
Preparation
160 - 248
429.70
$180,000 - $280,000
$468,189.00
5
Corporate and Governance
Matters
60 - 93
215.00
$90,000 - $140,000
$250,128.00
6
Disclosure Statement, Plan,
and Confirmation
257 - 400
633.60
$270,000 - $420,000
$751,623.00
7
DIP Financing and Cash
Collateral
153 - 237
292.40
$180,000 - $280,000
$373,322.00
8
Cash Management
79 - 122
5.80
$90,000 - $140,000
$6,718.00
9
Automatic Stay Issues
68 - 106
3.10
$67,500 - $105,000
$3,069.50
10
Asset Sales/Section 363
Issues
1,080 - 1,680
4,979.20
$1,575,000 - $2,450,000
$6,790,549.50
11
Executory Contracts and
Unexpired Leases
88 - 136
81.20
$90,000 - $140,000
$93,377.50
12
Business Operations
95 - 147
149.40
$139,500 - $217,000
$190,457.00
13
Claims Administration
66 - 102
55.70
$74,250 - $115,500
$58,921.50
14
Schedules and Statements
(SOFAs)
61 - 95
86.60
$68,850 - $107,100
$104,485.00
15
Creditor and Stakeholder
Communications
46 - 71
32.30
$58,050 - $90,300
$32,215.50
16
U.S. Trustee Matters and
Communication
53 - 82
31.90
$73,800 - $114,800
$38,906.50
17
Hearings
61 - 94
33.70
$76,500 - $119,000
$47,865.50
18
Insurance and Surety
Matters
59 - 91
71.70
$67,500 - $105,000
$111,872.50
19
Utilities
59 - 91
17.10
$67,500 - $105,000
$18,139.50
20
Tax Matters
107 - 166
864.70
$135,000 - $210,000
$1,268,802.50
21
Case Administration
188 - 292
368.10
$225,000 - $350,000
$379,526.50
22
K&E Fee Applications
266 - 414
497.00
$405,000 - $630,000
$506,272.00
23
Non-K&E Fee /
Employment Applications
99 - 154
145.20
$132,750 - $206,500
$155,886.50
24
Vendor Matters
96 - 149
58.80
$126,000 - $196,000
$66,390.50
25
Litigation
101 - 156
241.50
$135,000 - $210,000
$263,115.50
27
Non-Working Travel Time
12 - 17
33.30
$11,250 - $17,500
$46,201.50
28
Creditors’ Committee Issues
34 - 53
108.00
$45,000 - $70,000
$123,574.00
29
Employee and Labor
Matters
73 - 114
113.70
$88,650 - $137,900
$180,441.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 59 of 914

Exhibit I

Detailed Description of Services Provided
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 60 of 914

June 9, 2024 – June 30, 2024
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 61 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102691
Client Matter: 48520-4
In the Matter of Chapter 11 Filing & First Day Pleadings
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 468,189.00
Total legal services rendered
$ 468,189.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 62 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Chapter 11 Filing & First Day Pleadings
Invoice Number:
Matter Number:
1050102691
48520-4
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Kon Asimacopoulos
23.30
2,305.00
53,706.50
Chris Ceresa
34.70
1,345.00
46,671.50
Tiffani Chanroo
29.80
1,265.00
37,697.00
Kenny Chiaghana
19.20
815.00
15,648.00
Hannah Crawford
0.20
1,595.00
319.00
Joseph A. D'Antonio
5.30
1,185.00
6,280.50
Tabitha J. De Paulo
1.60
1,435.00
2,296.00
Anthony M. Del Rio
0.40
1,595.00
638.00
Jaina Desai
28.90
815.00
23,553.50
Amy Donahue
23.90
525.00
12,547.50
Julia R. Foster
30.20
525.00
15,855.00
Susan D. Golden
1.00
1,600.00
1,600.00
David Hackel
58.40
975.00
56,940.00
Kate Hardey
0.50
1,995.00
997.50
Sabrina Lieberman
20.60
815.00
16,789.00
Rebecca J. Marston
16.60
1,265.00
20,999.00
Mark McKane, P.C.
0.80
2,065.00
1,652.00
Jai Mudhar
0.70
1,265.00
885.50
Sarah Osborne
28.20
815.00
22,983.00
Carolin Paus
3.50
620.00
2,170.00
Joseph Cermak Profancik
5.50
975.00
5,362.50
Yusuf Salloum
23.50
1,595.00
37,482.50
Seth Sanders
0.60
1,095.00
657.00
Josh Sussberg, P.C.
0.30
2,305.00
691.50
Kyle Nolan Trevett
25.90
1,095.00
28,360.50
Quin Wetzel
25.60
815.00
20,864.00
Spencer A. Winters, P.C.
20.50
1,685.00
34,542.50
TOTALS
429.70
$ 468,189.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 63 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Chapter 11 Filing & First Day Pleadings
Invoice Number:
Matter Number:
1050102691
48520-4
3
Description of Legal Services
Date
Name
Hours Description
06/09/24 Chris Ceresa
16.00 Review, revise first day motions (3.9);
telephone conferences with Y. Salloum,
Company re filing (2.9); review, analyze legal
issues re same (3.9); conferences with CS
team re first day motions (1.6); conferences
with T. Chanroo, K&E team re filing (3.7).
06/09/24 Tiffani Chanroo
16.00 Review, revise first day motions (3.9);
telephone conferences with Alix team re first
day diligence (3.9); review, analyze legal
issues re same and pleadings (3.4);
conferences with CS team re first day motions
(1.1); conferences with C. Ceresa, K&E team
re filing (3.7).
06/09/24 Kenny Chiaghana
11.50 Attend to first day preparations.
06/09/24 Tabitha J. De Paulo
1.60 Review, analyze first day motions and bid
procedures motion.
06/09/24 Jaina Desai
12.00 Revise bidding procedures motion (4.2);
conference with R. Marston, C. Ceresa re
same (.4); revise bidding procedures order
(1.1); conference with R. Marston, C. Ceresa
re same (.6); revise NOL motion (3.2);
correspond with T. Chanroo re same (.2);
conference with T. Chanroo re same (.3);
draft sale process org chart (.5); revise first
day declaration (.3); correspond with D.
Hackel re same (.2); conference with S.
Lieberman re 156(c) retention application
(.4); revise customer programs motion (.2);
conference with T. Chanroo re same (.1);
correspond with T. Chanroo re same (.1);
revise bidding procedures notices (.2).
06/09/24 Amy Donahue
14.00 Prepare for Chapter 11 filing (3.5);
conference with K&E team re work in process
(1.0); review and revise first day motions
(3.5); correspond with K&E team re case
filing logistics (1.5); download filed voluntary
petitions and organize on DMS (2.0);
download filed motions and organize on DMS
(2.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 64 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Chapter 11 Filing & First Day Pleadings
Invoice Number:
Matter Number:
1050102691
48520-4
4
Date
Name
Hours Description
06/09/24 Julia R. Foster
11.20 Prepare voluntary petitions for filing (3.9);
review, revise first day motions (3.9);
conference with K&E team re work in process
(.5); correspond with C. Ceresa re filing
logistics (.9); review, revise resolutions and
consents re petitions (2.0).
06/09/24 Julia R. Foster
7.00 Assist with Chapter 11 filing (3.9);
conference with K. Chiaghana, K&E team re
same (.5); continue to assist with Chapter 11
filing (2.6).
06/09/24 Susan D. Golden
1.00 Review, revise creditor matrix redaction
motion (.8); correspond with K&E team re
same (.2).
06/09/24 David Hackel
16.00 Review, analyze issues re first day
declaration, first day presentation, case status,
chapter 11 filing (4.5); correspond with Y.
Salloum, K&E team, external parties,
Company re same (1.3); conferences with Y.
Salloum, K&E team, external parties,
Company re same (.4); revise first day
declaration and exhibits (2.3); review, analyze
Company materials, DIP documents, sale
documents, RSA, bidding procedures (3);
analyze issues re deal status, sale process
(1.4); review, revise various first day motions
(1.2); research re same (1.0); revise first day
presentation (.9).
06/09/24 Sabrina Lieberman
12.00 Review and revise motion to seal retention
applications (1.9); review and revise motion
to retain claims agent (2.4); review and revise
tax motion (1.9); review and revise critical
vendors motion (2.3); conference with Omni
re service (.5); conference with Cole Schotz
re filing timeline (1.2); conference with C.
Ceresa and K&E team re filing timeline (1.1);
conference with AlixPartners re tax motion
and critical vendors motion (.7).
06/09/24 Sabrina Lieberman
2.00 Correspond with Company re NDAs (.2);
review and revise summary re same (1.3);
correspond with C. Ceresa and K&E team
(.1); review and revise motion to seal
retention applications (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 65 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Chapter 11 Filing & First Day Pleadings
Invoice Number:
Matter Number:
1050102691
48520-4
5
Date
Name
Hours Description
06/09/24 Rebecca J. Marston
16.00 Review and revise bidding procedures
pleadings (6.4); conference with C. Ceresa,
K&E team re first day hearing preparations
(.7); correspond with NDA counterparties,
PJT team (.4); review and revise first day
pleadings (7.6); correspond with C. Ceresa,
K&E team re same (.3); conference with Cole
Schotz team re sealing motions (.6).
06/09/24 Sarah Osborne
15.50 Review, revise joint administration motion
(1.2); review, revise RSA term sheet (4.5);
review, revise RSA (3.9); review, revise
wages motion (2.1); review, revise first day
presentation (3.0); compile signature pages
and filing checklist (.8).
06/09/24 Carolin Paus
3.50 Compile signature pages for standstill
agreement (1.2); draft, revise standstill
agreement (1.0); correspond with Finkenhof
on execution of standstill agreement (.5); draft
accession notices for Brazilian entities (.8).
06/09/24 Joseph Cermak Profancik
5.50 Coordinate with local Dutch counsel re Dutch
deliverables (.5); draft and revise K&E
opinion (2.0); coordinate responses to KYC
requests (.3); draft and revise closing
checklist (1.5); draft and revise credit
agreement schedules (1.0); review and
analyze Vyaire receivables LLCA (.1); draft
and revise borrowing notice (.1).
06/09/24 Yusuf Salloum
16.00 Review, revise documentation in connection
with preparing for chapter 11 filing (3.8);
research re same (3.5); conferences with
lenders' counsel, company-side advisors re
same (2.5); finalize filing documentation
(3.5); commence filing process (2.7).
06/09/24 Kyle Nolan Trevett
14.20 Office conference re chapter 11 filing (3.9);
research re same (3.1); participate in office
conference re chapter 11 filing (3.8); continue
research re same (3.4).
06/09/24 Quin Wetzel
16.00 Review, revise filing consents (2.9); review,
revise creditor matrix motion (1.3); review,
revise DIP declarations (2.1); review, revise
DIP roll-up summary (4.7); review, revise
insurance motion (2.2); compile and
proofread documents for filing (2.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 66 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Chapter 11 Filing & First Day Pleadings
Invoice Number:
Matter Number:
1050102691
48520-4
6
Date
Name
Hours Description
06/09/24 Spencer A. Winters, P.C.
8.90 Review, revise first day declaration (1.8);
review, analyze RSA issues (2.3); prepare for
and attend board meeting (.5); review,
analyze filing issues (2.5); correspond and
telephone conferences with multiple parties re
same (1.8).
06/10/24 Kon Asimacopoulos
1.50 Review, analyze international entity filing
issues.
06/10/24 Chris Ceresa
6.00 Conference with T. Chanroo, K&E team re
first day hearing (3.9); research re same (2.1).
06/10/24 Tiffani Chanroo
13.80 Conference with C. Ceresa, K&E team re
filing of chapter 11 cases (2.4); review, revise
first day motions (2.6); review, analyze issues
re same (1.4); conference with C. Ceresa,
K&E team re filing (.9); prepare for first day
hearing (1.6); review, revise talking points
(3.9); conference with N. Warther and K&E
team re first day motion (.5); conference with
U.S. Trustee re first day open diligence (.5).
06/10/24 Kenny Chiaghana
2.30 Conference with T. Chanroo, K&E team re
case filing.
06/10/24 Kenny Chiaghana
4.10 Analyze, revise first day motion talking points
(3.1); research re same (1.0).
06/10/24 Joseph A. D'Antonio
5.30 Conference with advisors re first day hearing
preparation (1.0); conference with
AlixPartners re same (.5); conference with
Company re same (.5); draft hearing outline
documents re same (3.3).
06/10/24 Anthony M. Del Rio
0.40 Review draft motions.
06/10/24 Jaina Desai
5.00 Revise customer programs motion (.9);
conference with T. Chanroo re same (.1);
revise bidding procedures motion (.6);
conference with C. Ceresa re same (.4); revise
bidding procedures motion (.6); conference
with C. Ceresa re same (.4); revise net
operating loss motion (.7); conference with T.
Chanroo re same (.3); revise bidding
procedures notices (.9); conference with C.
Ceresa re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 67 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Chapter 11 Filing & First Day Pleadings
Invoice Number:
Matter Number:
1050102691
48520-4
7
Date
Name
Hours Description
06/10/24 Jaina Desai
1.30 Correspond with T. Chanroo re customer
programs (.1); revise talking points re NOL
motion (.2); revise talking points re 156(c)
retention application (.3). correspond with
AlixPartners, T. Chanroo re customer
programs motion (.3); review, analyze
customer programs precedent (.2); revise
customer programs order (.1); correspond
with T. Chanroo, D. Hackel re same (.1).
06/10/24 Jaina Desai
1.50 Revise customer programs motion (.5);
correspond with T. Chanroo re same (.2);
revise NOL motion (.6); correspond with T.
Chanroo re same (.2).
06/10/24 Jaina Desai
4.30 Draft talking points for first day hearing (3.0);
review, analyze first day transcripts re NOL
motion (.4); review, analyze first day
transcripts re customer programs motion (.3);
review, analyze NOL motion (.4); correspond
with T. Chanroo re same (.1); correspond with
Y. Salloum re same (.1).
06/10/24 Jaina Desai
1.00 Revise talking points (.7); correspond with S.
Lieberman re same (.3).
06/10/24 Amy Donahue
3.70 Assist with Chapter 11 filing.
06/10/24 Amy Donahue
6.00 Assist with preparations for first day hearing
(3.5); prepare hearing binders for K&E
presenters (2.5).
06/10/24 Julia R. Foster
0.60 Draft notice of revised proposed orders re
interim NOL and interim customer programs.
06/10/24 Julia R. Foster
4.90 Prepare materials for June 11, 2024 hearing
(3.9); correspond with Y. Salloum re June 11,
2024 hearing logistics (.3); continue to
prepare materials for June 11, 2024 hearing
(.7).
06/10/24 Julia R. Foster
1.00 Research precedent re Judge Shannon hearing
transcripts.
06/10/24 David Hackel
10.50 Revise first day presentation (2.3); revise
talking points re first day hearing (2.1);
research re first day presentation, talking
points (1.5); correspond with S. Winters,
K&E team, Cole Schotz, Company re first
day hearing matters (1.4); conferences with S.
Winters, K&E team, Cole Schotz, Company
re same (.6); coordinate issues re first day
hearing (2.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 68 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Chapter 11 Filing & First Day Pleadings
Invoice Number:
Matter Number:
1050102691
48520-4
8
Date
Name
Hours Description
06/10/24 Sabrina Lieberman
6.60 Revise talking points re first-day motions
(3.4); correspond with T. Chanroo and K&E
team re same (1.0); review, analyze
transcripts re first-day hearings (1.5);
conference with T. Chanroo re first-day
hearing (.3); correspond with T. Chanroo re
same (.2); conference with D. Hackel re first
day declaration (.2).
06/10/24 Sarah Osborne
5.70 Prepare for chapter 11 filing (3.9); draft
notice of revised order (.5); further review,
revise same (.4); compile updated first day
motions for U.S. Trustee (.6); correspond with
T. Chanroo re same (.3).
06/10/24 Sarah Osborne
0.50 Review, revise first day hearing talking
points.
06/10/24 Sarah Osborne
3.00 Review, revise first day motion talking points
(1.5); review, analyze first day hearing
transcripts (1.5).
06/10/24 Yusuf Salloum
3.00 Research re filing, first day hearing.
06/10/24 Seth Sanders
0.60 Revise first-day presentation.
06/10/24 Josh Sussberg, P.C.
0.30 Review, analyze issues re first day hearing.
06/10/24 Kyle Nolan Trevett
11.70 Conference with C. Ceresa, K&E team re
chapter 11 filing (3.9); further conference
with C. Ceresa, K&E team re chapter 11
filing (1.5); review, revise interim DIP order,
motion, related pleadings (3.9); further
review, revise interim DIP order, motion, and
related pleadings (2.4).
06/10/24 Quin Wetzel
4.40 Review, revise first day motions (3.8);
correspond with local counsel re same (.6).
06/10/24 Quin Wetzel
4.20 Conference with C. Ceresa and T. Chanroo re
first day hearing (.4); review, analyze hearing
transcripts (2.6); draft talking points re first
day hearing (1.2).
06/10/24 Spencer A. Winters, P.C.
8.40 Draft first day hearing talking points (3.3);
review, revise first day presentation (1.3);
prepare for first day hearing (2.5); correspond
and telephone conferences with multiple
parties re same (1.3).
06/11/24 Kon Asimacopoulos
2.20 Review, analyze international entity filing
issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 69 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Chapter 11 Filing & First Day Pleadings
Invoice Number:
Matter Number:
1050102691
48520-4
9
Date
Name
Hours Description
06/11/24 Chris Ceresa
0.80 Review, analyze legal issues re filing (.6);
correspond and conference with Y. Salloum,
K&E team, advisors re same (.2).
06/11/24 Kenny Chiaghana
1.30 Annotate first day hearing remarks re cash
management and utilities motions.
06/11/24 Jaina Desai
2.00 Prepare for first day hearing (.6); attend first
day hearing (1.0); conference with S.
Lieberman re same (.1); draft correspondence
re same (.3).
06/11/24 Amy Donahue
0.20 Correspond with T. Chanroo, K&E team,
Cole Schotz re revised interim orders.
06/11/24 Julia R. Foster
5.20 Prepare first day orders for court submission
(2.7); review and revise same (2.5).
06/11/24 Rebecca J. Marston
0.60 Correspond with K. Chiaghana, J. Desai,
K&E team re first day hearing, first day
pleading issues.
06/11/24 Mark McKane, P.C.
0.80 Correspond with T. De Paulo re first day
hearing issues.
06/11/24 Sarah Osborne
1.50 Prepare for first day hearing (.5); attend first
day hearing (1.0).
06/11/24 Spencer A. Winters, P.C.
2.80 Review, revise talking points (.8); review,
analyze first day presentation (.7); review,
analyze issues re first day motions (.6);
prepare for first day hearing (.7).
06/12/24 Kon Asimacopoulos
2.20 Review, analyze international entity filing
issues.
06/12/24 Chris Ceresa
3.50 Review, analyze legal issues re filing (2.5);
correspond and conference with T. Chanroo,
K&E team, advisors re same (1.0).
06/12/24 Jaina Desai
1.50 Review, analyze NOL order (.5); correspond
with J. Foster re same (.3); correspond with T.
Chanroo re same (.2); revise NOL order (.3);
correspond with T. Chanroo, S. Golden re
same (.2).
06/12/24 Julia R. Foster
0.30 Correspond with J. Desai re NOL interim
order notice.
06/13/24 Kon Asimacopoulos
1.50 Review, analyze international entity filing
issues.
06/13/24 Chris Ceresa
2.30 Review, analyze legal issues re filing (1.3);
correspond and conference with K.
Chiaghana, K&E team, advisors re same
(1.0).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 70 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Chapter 11 Filing & First Day Pleadings
Invoice Number:
Matter Number:
1050102691
48520-4
10
Date
Name
Hours Description
06/13/24 David Hackel
1.00 Research re chapter 11 filing deck (.8);
correspond with J. Foster, K&E team re same
(.1); conference with T. Chanroo re same (.1).
06/14/24 Kon Asimacopoulos
2.20 Review, analyze international entity filing
issues.
06/14/24 David Hackel
1.80 Research re chapter 11 filing deck (.8);
review, analyze precedent materials re same
(.4); review, revise postpetition chapter 11
management presentation (.6).
06/14/24 Sarah Osborne
0.30 Review, analyze first day pleadings for
deadlines and reporting obligations (.2);
correspond with K. Chiaghana re same (.1).
06/15/24 Jaina Desai
0.30 Review, analyze NOL motion (.1); review,
analyze customer programs motion, 156(c)
retention application (.1); correspond with K.
Chiaghana re same (.1).
06/17/24 Kon Asimacopoulos
1.20 Review, analyze international entity legal
issues.
06/17/24 David Hackel
5.80 Research re chapter 11 management deck
(1.7); review, analyze precedent materials,
first day pleadings, RSA and declarations re
same (2.6); review, revise chapter 11
management deck (1.5).
06/17/24 Kate Hardey
0.50 Review, analyze first day filing information.
06/18/24 Kon Asimacopoulos
2.20 Review, analyze international entity filing
issues.
06/18/24 Chris Ceresa
2.20 Review, analyze service, noticing issues re
FDMs (1.2); correspond and conference with
S. Lieberman, K&E team, advisors re same
(1.0).
06/18/24 David Hackel
7.10 Research re chapter 11 management deck (.4);
review, analyze precedent materials, first day
pleadings, DIP credit agreement and other
DIP documents, RSA and declarations re
same (3.9); further analyze same (.3); review,
revise chapter 11 management deck (1.9);
correspond with T. Chanroo, K&E team re
same (.6).
06/19/24 Kon Asimacopoulos
2.20 Review, analyze international entity filing
issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 71 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Chapter 11 Filing & First Day Pleadings
Invoice Number:
Matter Number:
1050102691
48520-4
11
Date
Name
Hours Description
06/19/24 David Hackel
6.20 Review, revise chapter 11 post-petition deck
(3.2); review, analyze pleadings, DIP
materials, RSA, Company documents re same
(2.6); correspond with K. Chiaghana re same
(.4).
06/20/24 Chris Ceresa
1.00 Conference with T. Chanroo re first day
motions and next steps.
06/20/24 David Hackel
1.20 Review, revise chapter 11 post-petition deck
(.7); research re same (.3); correspond with K.
Chiaghana re same (.2).
06/21/24 David Hackel
3.60 Review, revise chapter 11 post-petition deck
(3.1); review, analyze pleadings, DIP
materials, RSA, Company documents re same
(.2); correspond with K. Chiaghana, K&E
team re same (.3).
06/24/24 David Hackel
0.40 Review, analyze issues re chapter 11 post-
petition deck.
06/25/24 Kon Asimacopoulos
2.20 Review, analyze international entity filing
issues.
06/25/24 Chris Ceresa
2.60 Review, analyze first day motions for second
day (1.6); review, analyze other second day
hearing motions (1.0).
06/25/24 David Hackel
1.50 Review, analyze issues re chapter 11 post-
petition deck (.7); correspond with K.
Chiaghana re same (.1); review, analyze
correspondence from C. Ceresa, K&E team re
second day pleadings (.5); review, analyze
summary of case (.1); correspond with J.
Sussberg, K&E team re same (.1).
06/25/24 Jai Mudhar
0.70 Telephone conference with P. Kar re
advisor services (.5); correspond with P. Kar,
Company re same (.2).
06/25/24 Yusuf Salloum
2.50 Review, revise second day pleadings.
06/25/24 Spencer A. Winters, P.C.
0.40 Review, analyze second day motions.
06/26/24 Kon Asimacopoulos
2.20 Review, analyze international entity filing
issues.
06/26/24 David Hackel
0.30 Review, analyze issues re chapter 11 post-
petition deck.
06/26/24 Quin Wetzel
1.00 Review, revise final insurance order re
insurance carrier comments.
06/27/24 Kon Asimacopoulos
1.50 Review, analyze international entity filing
issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 72 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Chapter 11 Filing & First Day Pleadings
Invoice Number:
Matter Number:
1050102691
48520-4
12
Date
Name
Hours Description
06/27/24 Hannah Crawford
0.20 Review, analyze correspondence re
international filing analysis.
06/27/24 David Hackel
1.20 Review, analyze issues re chapter 11 post-
petition deck (.3); review, revise same (.6);
review, analyze case status, first and second
day pleadings and orders re same (.3).
06/27/24 Sarah Osborne
1.10 Review, revise proposed final wages and
interim compensation orders for second day
hearing (.9); correspond with C. Ceresa, K&E
team re same (.2).
06/27/24 Yusuf Salloum
2.00 Review, revise second day pleadings.
06/28/24 Kon Asimacopoulos
2.20 Review, analyze international entity filing
issues.
06/28/24 Chris Ceresa
0.30 Review, analyze first day motions for second
day (.2); review, analyze other second day
hearing motions (.1).
06/28/24 David Hackel
0.30 Review, analyze issues re chapter 11 post-
petition deck (.1); review, analyze issues re
second day hearing and related
correspondence from C. Ceresa, K&E team
(.2).
06/28/24 Sarah Osborne
0.60 Review, revise proposed final first day
hearing orders (.4); correspond with C.
Ceresa, K&E team re same (.2).
06/29/24 David Hackel
1.50 Draft, revise summary of case, chapter 11
filing (.5); research re same (.2); review,
analyze case materials re same (.2);
correspond with C. Ceresa re same (.2);
review, analyze issues re chapter 11 deck (.2);
correspond with K. Chiaghana re same (.2).
Total
429.70
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 73 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102692
Client Matter: 48520-5
In the Matter of Corporate & Governance Matters
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 75,642.50
Total legal services rendered
$ 75,642.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 74 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050102692
48520-5
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Kon Asimacopoulos
1.50
2,305.00
3,457.50
Chris Ceresa
1.90
1,345.00
2,555.50
Kenny Chiaghana
7.00
815.00
5,705.00
Hannah Crawford
0.20
1,595.00
319.00
Tabitha J. De Paulo
0.30
1,435.00
430.50
Luci Hague
0.20
1,575.00
315.00
Partha Kar
2.60
2,305.00
5,993.00
Sabrina Lieberman
1.70
815.00
1,385.50
Sean McClay
4.00
1,575.00
6,300.00
Mark McKane, P.C.
0.60
2,065.00
1,239.00
Julienne Miranda
0.20
815.00
163.00
Jai Mudhar
1.40
1,265.00
1,771.00
Sarah Osborne
7.00
815.00
5,705.00
Carolin Paus
10.60
620.00
6,572.00
Seth Sanders
1.10
1,095.00
1,204.50
Donatus Wang
22.00
905.00
19,910.00
Cristina Weidner
2.70
1,665.00
4,495.50
Quin Wetzel
6.10
815.00
4,971.50
Ann-Kathrin Ziegler
3.00
1,050.00
3,150.00
TOTALS
74.10
$ 75,642.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 75 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050102692
48520-5
3
Description of Legal Services
Date
Name
Hours Description
06/10/24 Sean McClay
4.00 Review, analyze revisions to DIP credit
agreement (1.9); review, analyze DIP order
(2.1).
06/10/24 Julienne Miranda
0.20 Correspond with J. Profancik and Q. Wetzel
re omnibus consent.
06/11/24 Donatus Wang
3.50 Review and analyze correspondence from
Swiss auditor on solvency status of Swiss
entities and Swiss audit (.2); telephone
conference with client re same (.4); analyze
implications of solvency concerns re Swiss
entities for German entities (1.0); review,
analyze material contract review prepared by
C. Paus (.4); correspond with Finkenhof re
DIP budget and cash flow forecast (.2);
telephone conference with Finkenhof re
potential options for legal and operational
structuring (1.1); coordinate telephone
conference with Company and Finkenhof (.2).
06/12/24 Sabrina Lieberman
0.20 Correspond with Cole Schotz and Company
re special committee investigation.
06/12/24 Jai Mudhar
1.00 Review, analyze Swiss letter (.3); correspond
and conferences with Swiss counsel,
Company re same (.7).
06/12/24 Carolin Paus
1.20 Telephone conference with Company and
Finkenhof re cashflow forecast of Vyaire
Medical GmbH and post filing shipping (.7);
summarize call and next steps (.5).
06/12/24 Seth Sanders
1.10 Draft special committee update (.8);
correspond with C. Ceresa, K&E team re
same (.3).
06/12/24 Donatus Wang
4.80 Telephone conference with Company and
Finkenhof re German cash flow forecast and
shipping of products from Germany to US
entities and summarize takeaways (2.7);
correspond with Company re cash flow
forecasts (.3); correspond with AlixPartners re
allocation of payments (.2); telephone
conference with client account payables team
re open issues (.7); correspond with Company
re standstill agreement (.5); correspond with
Y. Salloum, K&E team re US law
considerations (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 76 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050102692
48520-5
4
Date
Name
Hours Description
06/13/24 Tabitha J. De Paulo
0.30 Conference with Company re status of
investigation.
06/13/24 Sabrina Lieberman
0.60 Conference with M. McKane and K&E team
re special committee investigation.
06/13/24 Mark McKane, P.C.
0.60 Conference with T. De Paulo, K&E team re
ongoing investigation, second day hearing
and next steps.
06/13/24 Donatus Wang
0.40 Correspond with AlixPartners re allocation of
payments by US entities (.1); review and
consider updated issues and workstreams list,
next steps (.2); correspond with C. Paus re
same (.1).
06/13/24 Quin Wetzel
0.70 Correspond with C. Ceresa, Company re
corporate governance documents and chapter
11 requirements.
06/14/24 Partha Kar
0.50 Conference with J. Mudhar, K&E team re
standstill, international liquidity
considerations.
06/14/24 Jai Mudhar
0.20 Conference with P. Kar, K&E team re
standstill, European liquidity (.1); correspond
with Company, P. Kar, K&E team re same
(.1).
06/14/24 Donatus Wang
1.10 Correspond with Company re standstill
agreement (.5); conference with J. Mudhar,
K&E team re same (.2); correspond with
Company re German cash flow forecasts and
allocation of payments by US entities to
German entities, discuss related next steps
with J. Mudhar, K&E team (.4).
06/15/24 Jai Mudhar
0.20 Correspond with Company re Switzerland.
06/17/24 Hannah Crawford
0.20 Correspond with various parties re standstill
agreement.
06/17/24 Partha Kar
1.50 Correspond with Company re auditor issues
in Switzerland (.6); telephone conference with
Swiss counsel re same, standstill document
(.9).
06/17/24 Quin Wetzel
0.60 Review, analyze governance consents (.4);
correspond with C. Ceresa re same (.2).
06/17/24 Ann-Kathrin Ziegler
0.20 Telephone conference with Company, J.
Mudhar and K&E team re scope of global
standstill agreement.
06/18/24 Sabrina Lieberman
0.10 Correspond with Cole Schotz re special
committee investigation.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 77 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050102692
48520-5
5
Date
Name
Hours Description
06/18/24 Sarah Osborne
2.10 Review, analyze RSA and RSA term sheet re
Company specific obligations (.9); correspond
with D. Hackel, K&E team re same (.2);
review, analyze wages motion for Company
specific obligations (.8); correspond with K.
Chiaghana re same (.2).
06/18/24 Donatus Wang
0.20 Conference and correspond with Finkenhof re
cash flow forecasts and other documents
requests for German entities.
06/19/24 Kenny Chiaghana
2.60 Analyze, revise company obligations
presentation.
06/19/24 Ann-Kathrin Ziegler
0.50 Conference with D. Wang, K&E team re
German and Swiss workstreams.
06/20/24 Kon Asimacopoulos
1.50 Review, analyze international entity filing
issues.
06/20/24 Chris Ceresa
0.70 Conference with special committee re open
issues (.5); draft minutes re same (.2).
06/20/24 Kenny Chiaghana
3.10 Analyze, revise company obligations
presentation.
06/20/24 Donatus Wang
3.00 Research re aspects of German capital
maintenance and claw-back in insolvency
(1.0); review, analyze correspondence
between Company and Baker McKenzie on
documentation required for audit of Swiss
entities (.2); review and comment on draft
going-concern assessment by board of
directors (1.3); correspond with Baker
McKenzie re same (.1); correspond with
Finkenhof re standstill agreement (.4).
06/20/24 Cristina Weidner
1.50 Telephone conference with Finkenhof re
updates (.5); correspond with Finkenhof re
same (1.0).
06/20/24 Ann-Kathrin Ziegler
1.70 Telephone conference with Company, FH re
Vyaire Medical GmbH workstreams (.8);
prepare for same (.2); review and revise draft
letter to Swiss auditor (.7).
06/21/24 Kenny Chiaghana
1.30 Analyze, revise company obligations
presentation.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 78 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050102692
48520-5
6
Date
Name
Hours Description
06/21/24 Donatus Wang
1.80 Review, analyze revised draft going-concern
assessment letter by board of directors,
correspond with Baker McKenzie re same
(.4); correspond with Company and Baker
McKenzie re documentation required for
audit (1.0); telephone conference with Baker
McKenzie re same, debrief with A. Ziegler,
K&E team (.4).
06/21/24 Quin Wetzel
0.90 Draft special committee board minutes (.8);
correspond with C. Ceresa re same (.1).
06/21/24 Ann-Kathrin Ziegler
0.60 Draft correspondence to C. Weidner, K&E
team re Swiss auditor comfort letter (.3);
review, analyze revised Swiss letter to auditor
(.3).
06/22/24 Donatus Wang
0.50 Review, analyze draft soft commitment letter
of US entities re funding of Swiss entities
(.3); correspond with Y. Salloum, K&E team
and Baker McKenzie re same (.2).
06/24/24 Sabrina Lieberman
0.10 Correspond with Company re outstanding
special committee investigation diligence.
06/24/24 Donatus Wang
1.50 Finalize draft soft commitment letter by US
entities for funding of Swiss entities (.8);
correspond with Baker McKenzie on same
(.3); correspond with S. Lieberman re signing
of same (.4).
06/24/24 Cristina Weidner
1.20 Correspond with various parties re Swiss
auditor.
06/24/24 Quin Wetzel
1.20 Correspond with S. Osborne re board minutes
(.2); review, revise special committee minutes
(1.0).
06/25/24 Chris Ceresa
0.60 Review, revise corporate minutes (.4);
correspond with S. Osborne, K&E team re
same (.2).
06/25/24 Sarah Osborne
0.80 Review, revise meeting minutes (.4);
correspond with C. Ceresa, K&E team re
same (.2); correspond with Company re same
(.2).
06/25/24 Sarah Osborne
0.80 Review, analyze board meeting minutes for
approval.
06/25/24 Carolin Paus
6.40 Draft presentation re German RDx business
(3.5); research re same (2.9).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 79 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050102692
48520-5
7
Date
Name
Hours Description
06/25/24 Donatus Wang
2.60 Correspond with S. Lieberman re signing of
draft soft commitment letter by US entities for
funding of Swiss entities (.8); correspond with
Baker McKenzie re same and audit process
(.3); review, analyze cash flow forecast for
Company and overview of underlying
assumptions (.8); correspond with A. Ziegler
and K&E team re same (.3); correspond with
Company and Finkenhof re same (.4).
06/26/24 Chris Ceresa
0.60 Review, revise corporate minutes (.4);
correspond with Q. Wetzel, K&E team re
same (.2).
06/26/24 Sabrina Lieberman
0.10 Correspond with Cole Schotz, S. Sanders and
K&E team re virtual data room.
06/26/24 Sarah Osborne
2.50 Draft special committee meeting minutes (.7);
correspond with C. Ceresa, K&E team re
same (.2); review, revise same (.4);
correspond with Company re same (.2); draft
full board minutes (.8); correspond with C.
Ceresa re same (.2).
06/26/24 Quin Wetzel
1.30 Draft notes for special committee meeting
(.5); correspond with C. Ceresa re same (.2);
draft minutes re same (.4); correspond with S.
Osborne re special committee minutes (.2).
06/27/24 Luci Hague
0.20 Correspond with W. Phalen re CFIUS
assessment.
06/27/24 Partha Kar
0.60 Correspond with J. Mudhar, K&E team re
SPA and foreign law input.
06/27/24 Sabrina Lieberman
0.60 Correspond with Y. Salloum and K&E re
board resolutions.
06/27/24 Sarah Osborne
0.80 Review, analyze prior minutes.
06/27/24 Carolin Paus
3.00 Research re treatment of intercompany
claims.
06/27/24 Donatus Wang
2.60 Review and consider shipment issues and
conference with Company re same (.4);
correspond with Finkenhof and Company re
same (.2); review and consider update from
Baker McKenzie Switzerland re feedback
from Swiss auditor, discuss next steps with
K&E team (.3); correspond with Company,
Finkenhof re cash flow forecast (.2); review,
analyze draft material contracts review (1.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 80 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050102692
48520-5
8
Date
Name
Hours Description
06/27/24 Quin Wetzel
1.40 Review, analyze responsible officer positions
(.7); analyze corporate governance structure
(.4); correspond with C. Ceresa, J. Raphael re
same (.3).
Total
74.10
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 81 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102693
Client Matter: 48520-6
In the Matter of Disclosure Statement/Plan/Confirmation
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 198,253.50
Total legal services rendered
$ 198,253.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 82 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050102693
48520-6
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Kon Asimacopoulos
3.40
2,305.00
7,837.00
Chris Ceresa
12.70
1,345.00
17,081.50
Jaina Desai
22.90
815.00
18,663.50
Julia R. Foster
2.80
525.00
1,470.00
Palmer Gunderson
0.10
845.00
84.50
David Hackel
4.10
975.00
3,997.50
Liz Ji
4.00
1,175.00
4,700.00
Sarah Osborne
26.30
815.00
21,434.50
Joshua Raphael
4.70
975.00
4,582.50
Yusuf Salloum
4.00
1,595.00
6,380.00
Seth Sanders
50.00
1,095.00
54,750.00
Kyle Nolan Trevett
35.60
1,095.00
38,982.00
Donatus Wang
3.10
905.00
2,805.50
Quin Wetzel
19.00
815.00
15,485.00
TOTALS
192.70
$ 198,253.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 83 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050102693
48520-6
3
Description of Legal Services
Date
Name
Hours Description
06/13/24 Jaina Desai
1.40 Telephone conference with K. Trevett re
disclosure statement motion (.3); review,
analyze correspondence re same (.1);
correspond with Q. Wetzel re same (.1);
research re Delaware disclosure statement
precedent (.8); draft correspondence re same
(.1).
06/13/24 Sarah Osborne
0.30 Correspond with K. Trevett re disclosure
statement.
06/13/24 Joshua Raphael
4.00 Draft, revise plan (3.5); research re same (.5).
06/13/24 Seth Sanders
2.30 Draft plan.
06/13/24 Kyle Nolan Trevett
1.20 Research re plan, disclosure statement issues.
06/14/24 Chris Ceresa
0.30 Correspond with S. Sanders, K&E team re
plan issues (.2); analyze same (.1).
06/14/24 Jaina Desai
2.30 Research re release rights re disclosure
statement motion (1.2); correspond with K.
Trevett re same (.2); research re solicitation
periods (.7); draft correspondence re same
(.2).
06/14/24 Sarah Osborne
2.20 Draft disclosure statement (1.0); research
precedent re same (1.2).
06/14/24 Joshua Raphael
0.70 Review, revise plan.
06/14/24 Seth Sanders
4.80 Draft plan (2.8); research precedent re same
(2.0).
06/14/24 Kyle Nolan Trevett
3.50 Research re plan, disclosure statement issues
(2.5); telephone conference with C. Ceresa re
same (.5); telephone conference with Cole
Schotz re same (.5).
06/15/24 Sarah Osborne
4.00 Draft disclosure statement (3.5); research
precedent re same (.5).
06/15/24 Seth Sanders
4.70 Draft liquidating plan (3.7); research re same
(1.0).
06/15/24 Kyle Nolan Trevett
2.00 Review, analyze plan and disclosure
statement issues (1.2); correspond with C.
Ceresa re same (.8).
06/16/24 Seth Sanders
3.80 Draft liquidating plan (2.9); analyze precedent
re same (.9).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 84 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050102693
48520-6
4
Date
Name
Hours Description
06/16/24 Kyle Nolan Trevett
1.00 Review, revise correspondence re plan and
disclosure statement research (.4); research re
same (.6).
06/17/24 Jaina Desai
0.80 Correspond with K. Trevett re disclosure
statement motion (.1); correspond with Q.
Wetzel re same (.1); telephone conference
with K. Trevett re disclosure statement
motion (.5); correspond with Q. Wetzel re
same (.1).
06/17/24 Jaina Desai
0.40 Review, analyze disclosure statement motion
precedent (.2); review, analyze disclosure
statement motion exhibits (.2).
06/17/24 Julia R. Foster
2.80 Draft disclosure statement motion (1.2); draft
disclosure statement motion schedules (1.6).
06/17/24 Kyle Nolan Trevett
0.40 Telephone conference with J. Desai and Q.
Wetzel re disclosure statement motion.
06/17/24 Quin Wetzel
2.60 Conference with K. Trevett, J. Desai re
disclosure statement motion and exhibits (.5);
review, analyze precedent re same (2.1).
06/18/24 Jaina Desai
1.10 Review, analyze DS motion exhibits (.6);
correspond with Q. Wetzel re same (.1);
review, analyze plan (.4).
06/18/24 Kyle Nolan Trevett
1.60 Review, revise case timeline (1.5); correspond
with C. Ceresa, T. Chanroo, Cole Schotz team
re same (.1).
06/18/24 Quin Wetzel
3.40 Research disclosure statement precedent (.9);
draft disclosure statement (2.2); correspond
with K. Trevett re same (.3).
06/19/24 Jaina Desai
2.00 Draft disclosure statement motion exhibits
(1.3); review, analyze plan (.3); review,
analyze disclosure statement motion (.2);
review, analyze case timeline (.1); correspond
with Q. Wetzel re same (.1).
06/19/24 Jaina Desai
1.20 Revise disclosure statement motion exhibits.
06/19/24 Sarah Osborne
0.30 Review, analyze RSA for key dates and
deadlines (.2); correspond with C. Ceresa re
same (.1).
06/19/24 Seth Sanders
7.80 Draft plan (3.9); research re same (3.9).
06/20/24 Jaina Desai
3.70 Revise disclosure statement motion exhibits
(2.5); review, analyze disclosure statement
motion exhibits (1.1); review, analyze
comments re disclosure statement exhibits
(.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 85 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050102693
48520-6
5
Date
Name
Hours Description
06/20/24 Sarah Osborne
3.90 Review, revise disclosure statement (3.8);
correspond with K. Trevett re same (.1).
06/20/24 Seth Sanders
3.60 Draft plan (3.3); correspond with C. Ceresa re
same (.3).
06/20/24 Kyle Nolan Trevett
4.40 Review, revise disclosure statement,
disclosure statement motion (3.9); correspond
with S. Osborne, J. Desai, Q. Wetzel re same
(.3); continue to review, revise disclosure
statement, disclosure statement motion (.2).
06/20/24 Quin Wetzel
3.80 Review, revise disclosure statement motion
(2.1); research precedent re combined
hearings (1.4); correspond with K. Trevett re
same (.3).
06/21/24 Kon Asimacopoulos
2.20 Review, analyze international entity filing
issues.
06/21/24 Jaina Desai
4.50 Review, analyze disclosure statement exhibits
(1.1); review, analyze comments to disclosure
statement exhibits (.1); revise disclosure
statement exhibits (2.7); correspond with K.
Trevett re same (.1); further revise disclosure
statement exhibits (.2); correspond with K.
Trevett re same (.1); correspond with Q.
Wetzel re same (.2).
06/21/24 Sarah Osborne
2.70 Review, revise disclosure statement (2.3);
correspond with K. Trevett re same (.1);
further review, revise same (.3).
06/21/24 Yusuf Salloum
2.00 Review, revise plan, disclosure statement.
06/21/24 Seth Sanders
3.20 Revise plan (2.9); correspond with Y.
Salloum re same (.3).
06/21/24 Kyle Nolan Trevett
2.10 Review, revise disclosure statement,
disclosure statement motion (1.9); correspond
with C. Ceresa, K&E team re same (.1);
correspond with AlixPartners team re same
(.1).
06/21/24 Quin Wetzel
3.90 Review, revise disclosure statement motion
(2.9); review, analyze plan (.7); correspond
with J. Desai, K. Trevett re same (.3).
06/22/24 Sarah Osborne
2.00 Review, revise disclosure statement for plan
updates.
06/22/24 Yusuf Salloum
2.00 Review, revise chapter 11 plan.
06/22/24 Seth Sanders
2.80 Revise plan (2.4); correspond with Y.
Salloum, K&E team re DS, plan (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 86 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050102693
48520-6
6
Date
Name
Hours Description
06/22/24 Kyle Nolan Trevett
0.90 Review, revise disclosure statement (.8);
correspond with S. Osborne, K&E team re
same (.1).
06/23/24 Sarah Osborne
2.40 Review, revise disclosure statement (2.3);
correspond with K. Trevett re same (.1).
06/23/24 Seth Sanders
3.90 Revise, draft plan (2.1); analyze, research
precedent re same (1.6); correspond with K.
Trevett, K&E team re same (.2).
06/23/24 Kyle Nolan Trevett
2.70 Review, revise disclosure statement (2.6);
correspond with Y. Salloum, K&E team re
same (.1).
06/24/24 Kon Asimacopoulos
1.20 Review, analyze international entity filing
issues.
06/24/24 Chris Ceresa
2.30 Review, revise plan (2.0); correspond with S.
Sanders, K&E team re same (.3).
06/24/24 David Hackel
4.10 Review, revise disclosure statement (3.6);
review, analyze first day declaration, first day
pleadings, Company documents, related
materials re same (.4); correspond with T.
Chanroo, K&E team re discharge research
(.1).
06/24/24 Sarah Osborne
0.50 Review, revise disclosure statement.
06/24/24 Seth Sanders
1.90 Analyze 363 plan precedent (1.1); analyze
DIP commitment signatories (.6); correspond
with Y. Salloum re same (.2).
06/24/24 Kyle Nolan Trevett
1.60 Review, revise disclosure statement, motion
(1.5); correspond with C. Ceresa, K&E team
re same (.1).
06/24/24 Quin Wetzel
2.00 Review, revise disclosure statement motion re
updated case timeline (1.8); correspond with
K. Trevett re same (.2).
06/25/24 Chris Ceresa
5.10 Review, revise plan (3.9); correspond with S.
Sanders, K&E team re same (1.0); research re
same (.2).
06/25/24 Jaina Desai
5.00 Review, analyze plan (1.4); review, analyze
disclosure statement (.5); correspond with Q.
Wetzel re case timeline (.1); revise disclosure
statement exhibits (3.0).
06/25/24 Jaina Desai
0.20 Review, analyze comments re disclosure
statement exhibits (.1); revise disclosure
statement exhibits (.1).
06/25/24 Palmer Gunderson
0.10 Telephone conference with L. Ji re disclosure
statement.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 87 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050102693
48520-6
7
Date
Name
Hours Description
06/25/24 Liz Ji
0.50 Correspond with N. Warther, K&E team re
disclosure statement.
06/25/24 Sarah Osborne
1.90 Review, revise disclosure statement (1.6);
correspond with D. Hackel, K&E team re
same (.3).
06/25/24 Seth Sanders
1.70 Revise plan.
06/25/24 Kyle Nolan Trevett
3.40 Review, revise case timeline (.5); review,
revise disclosure statement, motion (2.5);
correspond with Y. Salloum, K&E team re
same (.2); correspond with AlixPartners team
re liquidation analysis (.2).
06/26/24 Chris Ceresa
4.40 Review, revise, analyze, comment on draft
disclosure statement (3.9); correspond with S.
Osborne, K&E team re same (.5).
06/26/24 Sarah Osborne
4.40 Research re winddown disclosure statements
and data destruction (2.1); review, revise
disclosure statement (2.3).
06/26/24 Seth Sanders
5.10 Revise plan (3.1); correspond with C. Ceresa,
K&E team re same (.2); further revise plan
(1.1); analyze plan re tax considerations (.5);
correspond with C. Ceresa, K&E team re
same (.2).
06/26/24 Kyle Nolan Trevett
6.30 Review, revise disclosure statement (3.9);
further review, revise same (2.1); correspond
with S. Osborne, C. Ceresa re same (.3).
06/27/24 Chris Ceresa
0.40 Review, revise plan (.2); correspond with S.
Sanders, K&E team re same (.2).
06/27/24 Jaina Desai
0.30 Correspond with K. Trevett and Q. Wetzel re
disclosure statement exhibits.
06/27/24 Liz Ji
3.50 Review disclosure statement and chapter 11
plan.
06/27/24 Sarah Osborne
1.70 Review, revise disclosure statement (1.6);
correspond with K. Trevett re same (.1).
06/27/24 Seth Sanders
3.30 Revise plan (3.1); correspond with Y.
Salloum, K&E team, Gibson Dunn re same
(.2).
06/27/24 Kyle Nolan Trevett
2.40 Review, revise disclosure statement, motion
(2.3); correspond with Q. Wetzel re same (.1).
06/27/24 Quin Wetzel
2.80 Review, revise disclosure statement motion re
updated plan (1.2); revise disclosure
statement exhibits re updated (1.3);
correspond with J. Desai, K. Trevett re same
(.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 88 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050102693
48520-6
8
Date
Name
Hours Description
06/28/24 Chris Ceresa
0.20 Review, revise, analyze, comment on draft
disclosure statement (.1); correspond with K.
Trevett, K&E team re same (.1).
06/28/24 Seth Sanders
1.10 Analyze issues re classification of sponsor
commitments (.7); correspond with C. Ceresa,
K&E team re same (.4).
06/28/24 Kyle Nolan Trevett
2.10 Research re setoff issues (1.9); correspond
with C. Ceresa re same (.2).
06/28/24 Donatus Wang
3.10 Review, analyze draft overview of structuring
options for sale of German RDx business
(share deal vs. asset deal) (1.3); revise same
and prepare mark-up (.7); research re related
aspects under German law, consider related
input from K&E team (1.1).
06/29/24 Quin Wetzel
0.50 Review, analyze disclosure statement motion
(.3); correspond with S. Osborne, K. Trevett
re same (.2).
Total
192.70
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 89 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102694
Client Matter: 48520-7
In the Matter of DIP Financing and Cash Collateral
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 158,836.50
Total legal services rendered
$ 158,836.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 90 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050102694
48520-7
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
7.30
1,345.00
9,818.50
Tabitha J. De Paulo
1.60
1,435.00
2,296.00
Amy Donahue
0.80
525.00
420.00
David Hackel
2.10
975.00
2,047.50
Yoonie Han
18.00
1,395.00
25,110.00
Erik Hepler
0.20
2,115.00
423.00
Andrew Idrizovic, P.C.
3.00
1,995.00
5,985.00
Sean McClay
3.50
1,575.00
5,512.50
Julienne Miranda
15.70
815.00
12,795.50
Joseph Cermak Profancik
12.60
975.00
12,285.00
Joshua Raphael
2.70
975.00
2,632.50
Henry Rosas
0.50
625.00
312.50
Yusuf Salloum
15.40
1,595.00
24,563.00
Adrian Salmen
18.60
1,095.00
20,367.00
Seth Sanders
25.70
1,095.00
28,141.50
Kyle Nolan Trevett
5.00
1,095.00
5,475.00
Quin Wetzel
0.80
815.00
652.00
TOTALS
133.50
$ 158,836.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 91 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050102694
48520-7
3
Description of Legal Services
Date
Name
Hours Description
06/09/24 Tabitha J. De Paulo
0.40 Review and comment on redactions to fee
letter.
06/09/24 Yoonie Han
4.70 Review, revise various closing deliverables,
including but not limited to guaranty
agreement, CA exhibits, fee letters, escrow
agreement and ancillaries (3.5); supervise
overall process (1.2).
06/09/24 Andrew Idrizovic, P.C.
2.50 Attend board meeting (.5); analyze issues re
same (2).
06/09/24 Sean McClay
3.50 Review, analyze revisions to DIP credit
agreement and related DIP orders.
06/09/24 Seth Sanders
15.00 Revise DIP declarations (1.7); correspond
with S. Winters, K&E team, declarants re
same (1.3); draft, revise DIP credit agreement
(5.4); correspond with C. Ceresa, K&E team
re same (.3); correspond with GDC re same
(.4); analyze, revise research re roll-up
precedent (2.1); telephone conferences with
PJT re same (.3); revise evidentiary exhibit
(1.4); correspond with Y. Han, K&E team re
DIP credit agreement ancillaries (.5); revise
escrow agreement (1.6).
06/10/24 Tabitha J. De Paulo
1.20 Conference with PJT team re declaration in
support of DIP financing (.5); review, analyze
declarations and prepare for conference with
PJT (.7).
06/10/24 Yoonie Han
5.40 Revise credit agreement exhibits (1.6);
correspond with S. McClay, K&E team,
lenders' counsel and financial advisors re
same (.8); revise escrow agreement (.9);
correspond with S. McClay, K&E team,
lenders' counsel and financial advisors re
escrow arrangement (.7); finalize legal
opinion (.3); revise credit agreement
schedules (.4); correspond with Company re
know-your-customer items (.3); review and
revise final compiled debtor‑in‑possession
financing documents (.4).
06/10/24 Erik Hepler
0.20 Review, analyze comments to DIP financing
opinion.
06/10/24 Andrew Idrizovic, P.C.
0.50 Participate in discussions re DIP financing.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 92 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050102694
48520-7
4
Date
Name
Hours Description
06/10/24 Julienne Miranda
1.20 Revise signature pages for DIP documents.
06/10/24 Julienne Miranda
3.50 Revise ancillary documents.
06/10/24 Julienne Miranda
0.50 Correspond with Y. Han, K&E team and
Gibson Dunn team re Company’s signature
pages and compiled ancillaries in escrow.
06/10/24 Julienne Miranda
1.20 Draft support certificate.
06/10/24 Julienne Miranda
0.50 Correspond with J. Profancik and H. Rosas re
bringdown good standings.
06/10/24 Julienne Miranda
0.50 Correspond with C. Ceresa re K&E opinion
exhibits.
06/10/24 Joseph Cermak Profancik
2.50 Coordinate closing details re DIP credit
agreement (.2); review and analyze compiled
DIP documents (.3); draft and revise credit
agreement schedules (1.2); coordinate
responses to know‑your‑customer requests
(.6); correspond with Company re same (.2).
06/10/24 Henry Rosas
0.50 Conferences with J. Profancik and J. Miranda
re DIP closing, status (.1); review, revise
credit closing documents (.2); correspond
with J. Welch re bring down good standings
(.2).
06/10/24 Yusuf Salloum
7.30 Review, revise DIP documents (3.8); prepare
for hearing on DIP facility (3.5).
06/10/24 Seth Sanders
6.50 Telephone conferences with PJT re DIP
declaration (.7); revise PJT declaration re
same (.9); correspond with PJT team re same
(.3); telephone conference with AlixPartners
re DIP declaration (.4); correspond with
Gibson Dunn, Y. Salloum, K&E team re
finalizing DIP documents (.4); revise same
(1.1); coordinate re filing of same (.5);
correspond with Cole Schotz re filed DIP
documents (.4); revise escrow agreement (.3);
correspond with Y. Han re same (.1);
correspond Y. Han, K&E team, Gibson Dunn
re DIP funding (.4); telephone conference
with AlixPartners re funds flow (.3);
conference with Y. Salloum re same (.2);
correspond with Y. Han, K&E team re
partially pledged entities (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 93 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050102694
48520-7
5
Date
Name
Hours Description
06/11/24 Yoonie Han
2.20 Review and analyze credit agreement (.2);
correspond with K&E team re same (.2);
revise form of withdrawal notice (.5);
correspond with S. Sanders, K&E team,
lenders' counsel and financial advisors re
credit agreement exhibits (.4); revise escrow
agreement (.4); correspond with Y. Han, K&E
team, lenders' counsel, escrow agent's counsel
and financial advisors re escrow arrangement
(.3); correspond with Company re know‑your-
customer items (.2).
06/11/24 Julienne Miranda
0.50 Correspond with Y. Han, K&E team and
Gibson Dunn team re Company’s signature
pages and compiled ancillaries in escrow.
06/11/24 Julienne Miranda
1.50 Revise ancillary documents.
06/11/24 Julienne Miranda
0.30 Review and revise compiled guaranty and fee
letter.
06/11/24 Joseph Cermak Profancik
1.80 Correspond with Company re responses to
know‑your‑customer requests (.7); coordinate
execution of DIP documents (.5); correspond
with various parties re same (.3); review and
analyze same (.3).
06/11/24 Yusuf Salloum
6.80 Finalize DIP credit documentation (3.8);
finalize DIP order (1.5); research precedent re
same (1.5).
06/11/24 Seth Sanders
2.60 Correspond with GDC re unredacted fee
letters (.2); telephone conferences with Y.
Salloum, GDC re DIP funding (.9);
correspond with GDC re same (.3);
correspond with J. Profancik, K&E team re
DIP funding timing (.2); telephone
conferences with AlixPartners re same (.2);
coordinate re filing of revised compiled
interim DIP order (.8).
06/11/24 Kyle Nolan Trevett
5.00 Review, revise interim DIP order (3.9);
continue to review, revise interim DIP order
(1.1).
06/11/24 Quin Wetzel
0.80 Review, revise interim DIP order (.6);
correspond with Cole Schotz re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 94 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050102694
48520-7
6
Date
Name
Hours Description
06/12/24 Yoonie Han
1.20 Revise legal opinion (.2); correspond with S.
Sanders re debtor-in-possession order (.3);
review and analyze final credit agreement
(.2); correspond with financial advisors re
debtor-in-possession budget (.3); organize
closing of debtor-in-possession facility (.2).
06/12/24 Joseph Cermak Profancik
2.50 Coordinate closing deliverables with lender's
counsel (1.9); review and analyze DIP budget
(.2); correspond with company advisors re
same (.1); correspond with Y. Han and K&E
team re K&E opinion (.3).
06/12/24 Seth Sanders
0.50 Correspond with Y. Han, K&E team re DIP
funding timing (.2); correspond with Cole
Schotz re same (.3).
06/13/24 Yoonie Han
0.90 Correspond with Company's Dutch counsel re
closing (.4); prepare closing set re debtor-in-
possession facility (.5).
06/13/24 Julienne Miranda
5.00 Draft and compile closing set (3.9); research
re same (1.1).
06/13/24 Joseph Cermak Profancik
0.70 Coordinate and prepare closing set for
Company records.
06/14/24 Yoonie Han
0.30 Review and analyze closing set of debtor-in-
possession documents.
06/14/24 Julienne Miranda
0.50 Correspond with Y. Han and J. Profancik re
closing set.
06/14/24 Joseph Cermak Profancik
0.50 Prepare closing set of existing 1L, 2L and
note purchase agreement documents.
06/17/24 Yoonie Han
0.20 Correspond with J. Profancik, K&E team re
DIP.
06/17/24 Julienne Miranda
0.50 Correspond with J. Profancik, K&E team and
Company re closing set.
06/17/24 Joseph Cermak Profancik
0.50 Prepare and coordinate delivery of closing set
documents.
06/17/24 Yusuf Salloum
0.80 Analyze issues re escrow funding (.6);
correspond with AlixPartners re same (.2).
06/18/24 Chris Ceresa
2.20 Correspond with advisors, Y. Salloum, K&E
team re DIP professional fees weekly
statement items (1.7); conference with Y.
Salloum, K&E team re same (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 95 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050102694
48520-7
7
Date
Name
Hours Description
06/18/24 Yoonie Han
0.70 Correspond with D. Hackel re preparation of
the summary deck of company obligations
under DIP credit facility (.3); correspond with
J. Provancik re preparation of such summary
of DIP obligations (.2); analyze sample
summaries of DIP obligations (.2).
06/18/24 Joseph Cermak Profancik
0.50 Draft and revise compliance guide for DIP
credit agreement.
06/18/24 Seth Sanders
0.50 Analyze issues re DIP reporting obligations
(.3); correspond with C. Ceresa re same (.2).
06/19/24 Chris Ceresa
0.70 Correspond and telephone conference with
advisors, Y. Salloum, K&E team re DIP
professional fees weekly statement items (.2);
conference with Y. Salloum, K&E team re
same (.5).
06/19/24 Joseph Cermak Profancik
2.90 Draft and revise compliance guide re DIP
credit agreement (2.0); review and analyze
DIP credit agreement (.9).
06/19/24 Joshua Raphael
0.50 Draft correspondence re DIP professional fee
reporting (.4); correspond with C. Ceresa re
same (.1).
06/20/24 Chris Ceresa
0.40 Correspond and telephone conference with
advisors, K&E team re DIP pro fees weekly
statement items.
06/20/24 Joseph Cermak Profancik
0.50 Draft and revise compliance certificate (.4);
correspond with Y. Han re same (.1).
06/20/24 Joshua Raphael
0.30 Conference with A. Salemen, K&E team re
DIP coordination (.2); correspond with
professionals, C. Ceresa re DIP professional
fees (.1).
06/20/24 Adrian Salmen
2.30 Conference with J. Raphael, K&E team re
DIP workstreams (.5); correspond with C.
Ceresa, K&E team re same (.8); draft final
DIP order (1.0).
06/20/24 Seth Sanders
0.20 Telephone conference with A. Salmen re DIP.
06/21/24 Chris Ceresa
0.20 Correspond with advisors, Y. Salloum, K&E
team re DIP professional fees weekly
statement items (.1); conference with Y.
Salloum, K&E team re same (.1).
06/21/24 Adrian Salmen
2.20 Correspond with J. Raphael, K&E team re
DIP matters (.2); draft final DIP order (2.0).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 96 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050102694
48520-7
8
Date
Name
Hours Description
06/23/24 Yoonie Han
1.40 Analyze debtor-in-possession credit
agreement (.6); revise summary chart of
obligations under debtor-in-possession credit
agreement (.8).
06/24/24 Chris Ceresa
0.20 Review, analyze DIP reporting requirements.
06/24/24 David Hackel
2.10 Review, revise DIP credit agreement
compliance guide re same (.9); review,
analyze DIP credit agreement and related
materials re same (1.0); correspond with A.
Salmen, K&E team re same (.2).
06/24/24 Joseph Cermak Profancik
0.20 Correspond with C. Ceresa, K&E team re
credit agreement signatories (.1); review and
analyze credit agreement (.1).
06/24/24 Adrian Salmen
1.70 Review, analyze correspondence re
professional fees budget (.4); review, analyze
DIP CA re compliance terms (.9); correspond
with D. Hackel, J. Raphael re same (.4).
06/25/24 Adrian Salmen
0.50 Review, analyze correspondence from various
parties re professional fees (.4); correspond
with C. Ceresa re same (.1).
06/25/24 Seth Sanders
0.40 Correspond with J. Profancik, K&E team re
DIP signatories.
06/26/24 Chris Ceresa
0.30 Review, analyze DIP reporting requirements
(.1); review, revise officer cert re same (.1);
correspond with A. Salmen, K&E team,
advisors re draft reporting (.1).
06/26/24 Adrian Salmen
2.30 Correspond with C. Ceresa, K&E team,
lender advisors re professional fees (2.0);
review, analyze correspondence re same (.3).
06/27/24 Chris Ceresa
2.80 Review, analyze DIP reporting requirements
(1.2); review, revise officer certificate re same
(.3); review, revise draft reporting (.3);
correspond with A. Salmen, K&E team,
advisors re same (1.0).
06/27/24 Amy Donahue
0.80 Draft and revise DIP reply shell in support of
DIP motion.
06/27/24 Yoonie Han
0.70 Analyze officer's certificate delivery
requirement under DIP credit agreement (.4);
analyze final DIP order (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 97 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050102694
48520-7
9
Date
Name
Hours Description
06/27/24 Joshua Raphael
0.40 Correspond with various parties re variance
reporting (.1); review, analyze DIP CA,
responsible officer requirements (.1);
correspond with responsible officer (.1);
correspond with Q. Wetzel, K&E team re
same (.1).
06/27/24 Adrian Salmen
6.90 Review, analyze variance report (.9); review,
analyze precedent re same (1.8); correspond
with C. Ceresa, AlixPartners re same (.3);
review, analyze precedent DIP replies (.7);
correspond with lender advisors, creditor
counsel re DIP reply (.4); review, analyze
final DIP order (2.8).
06/28/24 Chris Ceresa
0.50 Review, analyze DIP reporting requirements
(.2); review, revise officer certificate re same
(.1); review, revise draft reporting (.1);
correspond with A. Salmen, K&E team,
advisors re same (.1).
06/28/24 Yoonie Han
0.30 Advise various parties re variance report
officer's certificate requirement.
06/28/24 Joshua Raphael
1.50 Draft variance reporting officer certificate and
draft correspondence re same (.9); review,
revise same (.3); correspond with C. Ceresa,
K&E team re same (.3).
06/28/24 Yusuf Salloum
0.50 Review, analyze final DIP order.
06/28/24 Adrian Salmen
2.70 Correspond with R. Raphael, K&E team,
lenders re DIP order (.3); review, analyze
same (2.4).
Total
133.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 98 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050103251
Client Matter: 48520-8
In the Matter of Cash Management
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 3,668.50
Total legal services rendered
$ 3,668.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 99 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Cash Management
Invoice Number:
Matter Number:
1050103251
48520-8
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Rebecca J. Marston
2.90
1,265.00
3,668.50
TOTALS
2.90
$ 3,668.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 100 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Cash Management
Invoice Number:
Matter Number:
1050103251
48520-8
3
Description of Legal Services
Date
Name
Hours Description
06/10/24 Rebecca J. Marston
2.90 Review, revise cash management talking
points (2.7); correspond with K. Chiaghana,
K&E team re same (.2).
Total
2.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 101 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102695
Client Matter: 48520-9
In the Matter of Automatic Stay Issues
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 2,651.00
Total legal services rendered
$ 2,651.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 102 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Automatic Stay Issues
Invoice Number:
Matter Number:
1050102695
48520-9
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Tiffani Chanroo
0.50
1,265.00
632.50
Sarah Osborne
1.40
815.00
1,141.00
Joshua Raphael
0.90
975.00
877.50
TOTALS
2.80
$ 2,651.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 103 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Automatic Stay Issues
Invoice Number:
Matter Number:
1050102695
48520-9
3
Description of Legal Services
Date
Name
Hours Description
06/20/24 Tiffani Chanroo
0.50 Conference with C. Ceresa, local counsel re
application of automatic stay.
06/20/24 Sarah Osborne
1.40 Research re automatic stay for proceedings
initiated by debtor (1.3); correspond with C.
Ceresa re same (.1).
06/20/24 Joshua Raphael
0.90 Research re automatic stay and tolling (.6);
correspond with C. Ceresa re same (.3).
Total
2.80
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 104 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102696
Client Matter: 48520-10
In the Matter of Asset Sales/Section 363 Issues: Use, Sale & Disposition of Property
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 706,449.50
Total legal services rendered
$ 706,449.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 105 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Rebecca H. Arnall
6.50
1,095.00
7,117.50
Cooper Barghols
2.50
815.00
2,037.50
Marin Boney
1.60
1,885.00
3,016.00
John G. Caruso
2.70
2,115.00
5,710.50
Chris Ceresa
35.10
1,345.00
47,209.50
Kenny Chiaghana
5.00
815.00
4,075.00
Adam Thomas Clifford, P.C.
6.40
1,995.00
12,768.00
Dominique Collins
1.70
1,095.00
1,861.50
Bernadette Coppola
18.10
1,575.00
28,507.50
Tabitha J. De Paulo
0.50
1,435.00
717.50
Anthony M. Del Rio
17.90
1,595.00
28,550.50
Jaina Desai
65.80
815.00
53,627.00
Amy Donahue
1.30
525.00
682.50
Michael Ehret
3.40
1,895.00
6,443.00
Julia R. Foster
0.50
525.00
262.50
Justin M. Garfinkle
10.30
975.00
10,042.50
Emanuel Goetz
0.50
620.00
310.00
David Hackel
2.60
975.00
2,535.00
Yoonie Han
0.30
1,395.00
418.50
Kate Hardey
11.00
1,995.00
21,945.00
Liz Ji
9.90
1,175.00
11,632.50
Olivia Kaufmann
14.80
975.00
14,430.00
Sooah Kim
4.60
975.00
4,485.00
Brian King
1.20
1,345.00
1,614.00
Maggie Kate King
14.50
1,095.00
15,877.50
Daniel Lewis, P.C.
7.50
1,910.00
14,325.00
Sabrina Lieberman
12.50
815.00
10,187.50
Savannah Malnar-Cole
9.10
1,095.00
9,964.50
Rebecca J. Marston
35.00
1,265.00
44,275.00
Sean McClay
1.00
1,575.00
1,575.00
Grant McClernon
2.00
815.00
1,630.00
Ruan J. Meintjes
23.20
975.00
22,620.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 106 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
3
Name
Hours
Rate
Amount
Michael William Morgan
9.60
975.00
9,360.00
Jai Mudhar
1.00
1,265.00
1,265.00
Trent Nachbar
32.80
1,095.00
35,916.00
Michelle L. Nowicki
8.70
625.00
5,437.50
Maureen D. O'Brien
3.00
2,115.00
6,345.00
Dan O'Connor
60.30
1,265.00
76,279.50
Sarah Osborne
11.50
815.00
9,372.50
Carolin Paus
5.50
620.00
3,410.00
Scott D. Price, P.C.
0.70
2,245.00
1,571.50
Joshua Raphael
5.40
975.00
5,265.00
Risa Salins
0.50
2,115.00
1,057.50
Yusuf Salloum
11.60
1,595.00
18,502.00
Adrian Salmen
9.30
1,095.00
10,183.50
Seth Sanders
0.50
1,095.00
547.50
Florian Schuette
0.50
750.00
375.00
Scottie Shermetaro
22.20
1,395.00
30,969.00
Matt Swanson
0.70
1,265.00
885.50
Paul D. Tanaka, P.C.
3.10
2,115.00
6,556.50
Steve Toth
22.50
1,820.00
40,950.00
Kyle Nolan Trevett
1.00
1,095.00
1,095.00
Sarah Ullathorne
1.20
1,575.00
1,890.00
Paul Vasiloff
4.30
1,265.00
5,439.50
Donatus Wang
4.70
905.00
4,253.50
Nicholas Warther
1.10
1,665.00
1,831.50
Spencer A. Winters, P.C.
22.10
1,685.00
37,238.50
TOTALS
572.80
$ 706,449.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 107 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
4
Description of Legal Services
Date
Name
Hours Description
06/10/24 Adam Thomas Clifford, P.C.
1.50 Analyze bidding procedures (.7); prepare for
and participate in telephone conference with
Company re sale process (.8).
06/10/24 Jaina Desai
0.10 Correspond with R. Marston re sale org chart.
06/10/24 Rebecca J. Marston
0.50 Correspond with J. Desai re bidding
procedures talking points (.2); review, analyze
same (.3).
06/10/24 Carolin Paus
0.70 Telephone conference with S. Zablotney,
K&E team re potential tax implications for
German entities in connection with previous
and envisaged sales processes.
06/10/24 Steve Toth
1.50 Participate in telephone conference with
Company, S. Zablotney, K&E team, BDO
and PwC (.8); discuss sale process matters
with Company, Y. Salloum, K&E team (.4);
prepare correspondence re sale process
timeline (.3).
06/10/24 Donatus Wang
0.50 Correspond with C. Ceresa, K&E team re DIP
funding, cash flow forecasts and correspond
with Company re German cash flow forecasts.
06/10/24 Nicholas Warther
0.40 Telephone conference with Company, S.
Zablotney, K&E team re sale process.
06/11/24 Adam Thomas Clifford, P.C.
0.80 Review, analyze 363 sale process materials
and status.
06/11/24 Anthony M. Del Rio
1.30 Review, analyze EU regulatory notice
obligations (.5); review, analyze change of
ownership notice requirements (.8).
06/11/24 Kate Hardey
0.50 Review, analyze correspondence re
pre‑market authorization products (.3);
conference with R. Meintjes re state license
review (.2).
06/11/24 Sabrina Lieberman
0.20 Correspond with NDA counterparty re NDA.
06/11/24 Rebecca J. Marston
5.10 Review and revise NDAs (1.9); correspond
with C. Ceresa, K&E team, counterparties re
same (.2); correspond with C. Ceresa re
sublease issues (.2); conference with C.
Ceresa re sublease issues (.4); review and
revise process letter (2.2); correspond with C.
Ceresa, K&E team re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 108 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
5
Date
Name
Hours Description
06/11/24 Ruan J. Meintjes
0.50 Review and analyze US state licenses and
permits (.4); conference with A. Del Rio,
K&E team re same (.1).
06/11/24 Steve Toth
1.40 Telephone conference with D. O’Connor re
transaction structure and bankruptcy
considerations (.3); analyze, revise process
letter (1.1).
06/11/24 Spencer A. Winters, P.C.
1.70 Review and analyze sale process issues (.8);
telephone conference with Y. Salloum, K&E
team re same (.5); review process letter (.4).
06/12/24 Chris Ceresa
1.30 Analyze legal issues re sale and contract
designation process (.5); correspond with R.
Marston, K&E team, advisors re same (.4);
telephone conference with R. Marston, K&E
team, advisors re same (.4).
06/12/24 Tabitha J. De Paulo
0.20 Review and comment on bidding procedures
motion.
06/12/24 Anthony M. Del Rio
0.30 Review, analyze EU regulatory notice
obligations.
06/12/24 Jaina Desai
0.40 Review, analyze correspondence re sale
stream (.3); correspond with R. Marston re
same (.1).
06/12/24 Kate Hardey
0.50 Review, analyze correspondence re
pre‑market authorization products (.3);
conference with R. Meintjes re state license
review (.2).
06/12/24 Sabrina Lieberman
0.70 Execute NDA (.3); correspond with PJT and
C. Ceresa re same (.2); revise summary re
same (.2).
06/12/24 Rebecca J. Marston
3.10 Correspond with Cole Schotz team, C.
Ceresa, K&E team re bidding procedures
noticing parties (.8); review, analyze
precedent re sale process (1.8); correspond
with C. Ceresa re same (.2); correspond with
Cole Schotz team re bidding procedures
declarations (.3).
06/12/24 Ruan J. Meintjes
0.70 Review and analyze state licensure,
permitting re change of ownership
considerations (.5); correspond with K.
Hardey, K&E team re same (.2).
06/12/24 Ruan J. Meintjes
0.50 Review, analyze change of ownership
analysis.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 109 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
6
Date
Name
Hours Description
06/12/24 Ruan J. Meintjes
0.50 Research pre-market notification change of
ownership requirements (.3); analyze and
draft summary of same (.2).
06/12/24 Yusuf Salloum
2.70 Analyze issues re sale processes (2.0);
conference with C. Ceresa, K&E team re
same (.7).
06/12/24 Spencer A. Winters, P.C.
1.70 Review and analyze sale process, strategy
issues (.8); correspond with Y. Salloum, K&E
team re same (.5); telephone conference with
Y. Salloum, K&E team re same (.4).
06/13/24 Anthony M. Del Rio
0.50 Review, analyze license and registration.
06/13/24 Jaina Desai
4.30 Draft bidding procedure declaration (2.2);
telephone conference with R. Marston re
same (.3); correspond with R. Marston re
same (.1); draft correspondence re bidding
procedures (.3); review, analyze work in
process chart (.1); revise bidding procedures
declaration (.2); correspond with T. De Paulo
re same (.1); revise bidding procedures
declaration (1.0).
06/13/24 Kate Hardey
0.20 Conference with R. Meintjes re pre‑market
authorization re sales process.
06/13/24 Sooah Kim
1.20 Telephone conference with Company re
employee benefits transaction considerations
(.6); review, analyze correspondence from
Company (.2); draft employee benefits issues
list (.4).
06/13/24 Sabrina Lieberman
0.80 Correspond with PJT, C. Ceresa, K&E team
re NDAs (.3); review and revise NDA
summary (.3); correspond with Omni, Cole
Schotz, T. Chanroo, K&E team re service of
M&A parties (.2).
06/13/24 Rebecca J. Marston
3.60 Correspond with PJT team re bidding
procedures declaration (.3); review and revise
same (2.1); correspond with J. Desai re same
(.4); correspond with S. Lieberman, K&E
team re NDAs (.5); correspond with C. Ceresa
re sale workstreams (.3).
06/13/24 Sean McClay
1.00 Telephone conference with Company and
advisor teams re status of potential bidders for
sale.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 110 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
7
Date
Name
Hours Description
06/13/24 Ruan J. Meintjes
1.20 Review and analyze pre‑market authorization
approvals re sales process (.5); draft analysis
re same (.5); conference with K. Hardey re
pre‑market authorization (.2).
06/13/24 Dan O'Connor
0.80 Telephone conference with Company, PJT, Y.
Salloum, K&E team re sale process (.7);
conference with Company re permits and
license matters (.1).
06/13/24 Joshua Raphael
0.10 Review, revise sale NDA.
06/13/24 Yusuf Salloum
2.00 Review, analyze sale transaction structuring
and diligence.
06/13/24 Seth Sanders
0.50 Telephone conference with PJT, S. Winters,
K&E team re sale process.
06/13/24 Steve Toth
0.50 Discuss sale process with Company, PJT,
AlixPartners, Y. Salloum, K&E team.
06/13/24 Spencer A. Winters, P.C.
3.00 Review and analyze issues re sale process,
case strategy (.8); prepare for telephone
conference re non-insider retention (.1);
telephone conference re non-insider retention
(.4); prepare for telephone conference with
AlixPartners, PJT re waterfall analysis (.2);
 telephone conference with AlixPartners, PJT
re same (.3); prepare for telephone conference
with Company re sale process update (.2);
telephone conference with Company re same
(.3); telephone conferences with Y. Salloum,
K&E team, PJT re same (.7).
06/14/24 Chris Ceresa
0.60 Analyze legal issues re sale and contract
designation process (.3); correspond with R.
Marston re same (.1); telephone conference
with R. Marston, K&E team, advisors re same
(.2).
06/14/24 Chris Ceresa
0.50 Correspond with R. Marston, K&E team re
sale NDA issues.
06/14/24 Adam Thomas Clifford, P.C.
0.50 Analyze legal issues re 363 transaction
structure.
06/14/24 Anthony M. Del Rio
2.30 Review, analyze pre‑market authorization
considerations and draft questions (.8);
review, analyze transaction structure (1.0);
conference with A. Clifford, K&E team re
regulatory analysis considerations implicated
by transaction (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 111 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
8
Date
Name
Hours Description
06/14/24 Kate Hardey
0.50 Conference with R. Meintjes, K&E team re
state-level license change of ownership
review.
06/14/24 Rebecca J. Marston
0.80 Correspond with J. Raphael, K&E team re
NDAs (.2); review and revise same (.3);
correspond with J. Desai re sale work streams
(.3).
06/14/24 Ruan J. Meintjes
1.70 Research, analyze change of ownership
notification requirements re state licenses
(1.2); conference with K. Hardey, K&E team
re same (.5).
06/14/24 Joshua Raphael
0.50 Review, revise sale process NDA (.3);
correspond with R. Marston re same (.2).
06/14/24 Yusuf Salloum
0.50 Review, analyze legal issues re sale
transactions.
06/14/24 Kyle Nolan Trevett
1.00 Telephone conference with Company re
privacy issues (.5); telephone conference with
Frejka re same (.3); telephone conference
with C. Ceresa re same (.2).
06/14/24 Spencer A. Winters, P.C.
1.40 Review and analyze issues re sale process,
case strategy (.7); correspond with A.
Clifford, K&E team re same (.3); telephone
conference with A. Clifford, K&E team re
same (.4).
06/15/24 Chris Ceresa
0.30 Correspond with S. Winters, K&E team re
sale NDA issues.
06/15/24 Rebecca J. Marston
0.70 Review and revise NDAs (.5); correspond
with J. Raphael re same (.1); correspond with
S. Lieberman re bidding procedures notice
parties (.1).
06/15/24 Joshua Raphael
0.30 Review, revise NDA (.2); correspond with C.
Ceresa re same (.1).
06/16/24 Anthony M. Del Rio
1.10 Review, research licensure filings (.8); review
and analyze wind-down considerations (.3).
06/17/24 Chris Ceresa
1.30 Review, analyze, comment on bidding
procedures declaration (.7); review, analyze,
comment on sale motion (.6).
06/17/24 Adam Thomas Clifford, P.C.
0.50 Review, analyze bidder diligence.
06/17/24 Tabitha J. De Paulo
0.30 Review, revise Schlappig declaration in
support of bid procedures motion.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 112 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
9
Date
Name
Hours Description
06/17/24 Jaina Desai
2.30 Review, analyze comments re AlixPartners
declaration (.4); revise AlixPartners
declaration (1.6); correspond with R. Marston
re same (.2); correspond with Omni re escrow
account (.1).
06/17/24 Jaina Desai
1.20 Review, analyze litigation comments re
bidding procedures declaration (.2); revise
PJT declaration (.4); correspond with R.
Marston re same (.1); review, analyze
comments re AlixPartners declaration (.1);
revise AlixPartners declaration (.2);
correspond with C. Ceresa re same (.2).
06/17/24 Jaina Desai
1.00 Correspond with R. Marston, K&E team
re bidding procedures (.5); review, analyze
bidding procedures talking points (.3); revise
bidding procedures talking points (.2).
06/17/24 Jaina Desai
1.70 Review, analyze declaration precedent (.2);
review, analyze PJT declaration (.2);
correspond with R. Marston re same (.1);
review, analyze sale NDA (.4); review,
analyze bidding procedures order (.1); draft
sale NDA (.6); correspond with J. Raphael re
same (.1).
06/17/24 Sabrina Lieberman
0.80 Revise NDA progress summary (.2);
correspond with C. Ceresa and K&E team re
same (.2); correspond with PJT and NDA
counterparties re NDAs (.2); review and
analyze NDAs (.2).
06/17/24 Rebecca J. Marston
2.90 Review and revise Braley declaration in
support of bidding procedures (1.0);
correspond with J. Desai re same (.1); review
and revise NDA (1.6); correspond with NDA
parties re same (.2).
06/17/24 Ruan J. Meintjes
1.40 Research and analyze change of ownership
regulatory considerations (1.1); telephone
conference with S. Winters, K&E team re
same (.3).
06/17/24 Joshua Raphael
1.30 Review, revise sale NDAs.
06/17/24 Yusuf Salloum
0.80 Review, analyze matters re sale transactions.
06/17/24 Florian Schuette
0.50 Review, analyze transaction structure (.3);
conference with E. Goetz re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 113 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
10
Date
Name
Hours Description
06/17/24 Spencer A. Winters, P.C.
1.10 Review and analyze issues re sale process,
case strategy (.6); telephone conferences with
Y. Salloum, K&E team re same (.5).
06/18/24 Marin Boney
0.50 Telephone conference with A. Clifford, K&E
team re deal status (.4); correspond with S.
Malnar-Cole re antitrust analysis (.1).
06/18/24 Chris Ceresa
0.40 Conference with T. Chanroo, K&E team,
Company, advisors re sale issues.
06/18/24 Kenny Chiaghana
1.50 Research re bidding procedures notice.
06/18/24 Adam Thomas Clifford, P.C.
0.30 Review, analyze 363 transaction structuring
issues.
06/18/24 Anthony M. Del Rio
2.30 Correspond with A. Clifford, K&E team re
review of licenses and impact of winddown
considerations (1.5); telephone conference
with AlixPartners re regulatory transactional
considerations (.8).
06/18/24 Jaina Desai
4.20 Review, analyze precedent re stalking horse
purchase agreements (1.1); correspond with
R. Marston, C. Ceresa re same (.1); review,
analyze escrow agreement (.6); draft escrow
agreement (.4); correspond with R. Marston
re same (.1); analyze, research escrow
agreement precedent (1.3); revise
AlixPartners declaration (.4); correspond with
R. Marston, C. Ceresa re same (.2).
06/18/24 Jaina Desai
2.40 Research noticing addresses (2.3); correspond
with R. Marston, S. Lieberman re same (.1).
06/18/24 Jaina Desai
1.10 Draft sale organization chart (1.0); correspond
with R. Marston re same (.1).
06/18/24 Jaina Desai
0.50 Revise sale organization chart (.4);
correspond with R. Marston re same (.1).
06/18/24 David Hackel
1.30 Research legal issues re bidding procedures.
06/18/24 Kate Hardey
3.50 Conference with G. McClernon, K&E team re
product transitions and FDA regulatory
matters (.5); review, analyze transition
services agreement terms re same (1.7);
prepare list of device wholesale and
manufacturer licenses for filing (1.3).
06/18/24 Brian King
1.20 Review, analyze change of ownership re
licensing requirements.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 114 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
11
Date
Name
Hours Description
06/18/24 Sabrina Lieberman
0.60 Correspond with PJT, NDA counterparties,
and C. Ceresa re NDAs (.4); revise summary
re same (.2).
06/18/24 Rebecca J. Marston
4.90 Review and revise NDAs (1.6); correspond
with counterparties, C. Ceresa, K&E team re
same (.4); review and revise bidding
procedures declarations (1.9); correspond
with J. Desai re same (.3); correspond with J.
Desai re sale escrow account (.3); review and
revise sale organizational chart (.2);
correspond with J. Desai re same (.2).
06/18/24 Grant McClernon
0.50 Telephone conference with A. Del Rio and K.
Hardey, Company re diligence questions.
06/18/24 Ruan J. Meintjes
1.00 Research and analyze state licensure change
of ownership filings (.8); correspond with K.
Hardey, K&E team re same (.2).
06/18/24 Dan O'Connor
0.50 Telephone conference with S. Toth, K&E
team re antitrust matters.
06/18/24 Steve Toth
0.20 Discuss antitrust matters with A. Clifford,
K&E team.
06/19/24 Marin Boney
0.30 Correspond with S. Malnar-Cole re risk
assessment.
06/19/24 Chris Ceresa
0.60 Review, analyze draft NDA markups (.4);
correspond with S. Lieberman, K&E team re
same (.2).
06/19/24 Chris Ceresa
1.80 Telephone conference with R. Marston, K&E
team re open sale items (.6); correspond with
R. Marston re same (.1); analyze open items
re sale and contract designation process (1.1).
06/19/24 Kenny Chiaghana
0.20 Research re sale escrow account.
06/19/24 Adam Thomas Clifford, P.C.
0.80 Telephone conference with advisors re 363
documentation process.
06/19/24 Jaina Desai
0.50 Draft correspondence re bidding procedures
milestones (.2); correspond with R. Marston,
C. Ceresa re same (.1); review, analyze
bidding procedures motion re same (.1);
correspond with Gibson Dunn re same (.1).
06/19/24 Jaina Desai
0.40 Review, analyze correspondence re contract
noticing (.3); correspond with C. Ceresa,
AlixPartners re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 115 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
12
Date
Name
Hours Description
06/19/24 Jaina Desai
0.60 Review, analyze PJT declaration (.1); review,
analyze correspondence re same (.1); revise
PJT declaration (.3); correspond with R.
Marston, Gibson Dunn re same (.1).
06/19/24 Jaina Desai
0.50 Revise sale NDA (.4); correspond with
counterparty, PJT Partners re same (.1).
06/19/24 Sabrina Lieberman
0.60 Revise summary re NDA status (.2);
correspond with C. Ceresa and K&E team re
same (.2); correspond with NDA parties re
same (.2).
06/19/24 Savannah Malnar-Cole
7.60 Research and analyze re antitrust risk for
potential bidders (3.9); draft analysis of same
(1.7); continue to research and analyze re
antitrust risk for potential bidders (2.0).
06/19/24 Rebecca J. Marston
1.90 Correspond with K. Chiaghana, Y. Salloum,
K&E team re escrow account, funding
estimates (.6); correspond with J. Desai, K&E
team re RSA milestones (.3); correspond with
DIP lenders’ counsel re same (.2); review and
revise PJT declaration in support of bidding
procedures (.5); correspond with J. Desai re
same (.3).
06/19/24 Grant McClernon
1.50 Research into change of ownership
requirements for medical device manufacturer
and wholesaler licenses.
06/19/24 Ruan J. Meintjes
1.60 Research and analyze change of ownership
notification requirements (1.0);
correspond with K. Hardey, K&E team re
same (.6).
06/19/24 Ruan J. Meintjes
0.50 Correspond with ex-US counsel re
notification requirements in connection with
potential Section 363 transaction.
06/19/24 Michael William Morgan
1.50 Review and summarize documents uploaded
to data room (1.4); correspond with D.
O'Connor re same (.1).
06/19/24 Dan O'Connor
2.70 Telephone conference and correspond with
AlixPartners, PJT, Y. Salloum, S. Toth re
transaction considerations (.6); correspond
with AlixPartners, PJT, Y. Salloum, S. Toth
re same (.2); review, analyze material
contracts (.5); review, revise summary re
same (.4); prepare disclosure schedules (.6);
review, analyze materials re same (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 116 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
13
Date
Name
Hours Description
06/19/24 Joshua Raphael
0.80 Analyze, research re 9019 precedent.
06/19/24 Joshua Raphael
1.00 Review, revise NDA (.5); correspond with
counterparty, R. Marston, K&E team re same
(.5).
06/19/24 Steve Toth
0.70 Participate in telephone conference re process
update with AlixPartners, Y. Salloum, K&E
team and advisors.
06/19/24 Donatus Wang
1.00 Review, analyze correspondence from N.
Warther, K&E team re tax structuring of
potential asset sale transactions (.2);
conference with E. Goetz, K&E team re
Germany status, workstreams (.4); correspond
with C. Ceresa, K&E team re sale process,
Swiss entity workstreams (.4).
06/19/24 Nicholas Warther
0.70 Telephone conference with S. Zablotney,
K&E team, AlixPartners re sale process.
06/19/24 Spencer A. Winters, P.C.
0.90 Review and analyze issues re sale process,
case strategy (.4); telephone conferences with
Y. Salloum, K&E team re same (.5).
06/20/24 Marin Boney
0.80 Analyze antitrust issues.
06/20/24 Chris Ceresa
1.20 Telephone conference with Y. Salloum, K&E
team, Company, advisors re sale issues.
06/20/24 Kenny Chiaghana
1.40 Analyze, revise de minimis asset procedures
motion.
06/20/24 Jaina Desai
1.20 Draft sale organizational chart (.4);
correspond with AlixPartners re notice
drafting (.1); correspond with R. Marston re
same (.1); revise sale organizational chart (.6).
06/20/24 Amy Donahue
1.00 Draft and revise de minimis asset sale motion
and order.
06/20/24 Sabrina Lieberman
0.60 Review and analyze NDA (.3); correspond
with C. Ceresa and K&E team re same (.3).
06/20/24 Savannah Malnar-Cole
1.20 Correspond with D. O’Connor re antitrust
analysis and questions for Company re same.
06/20/24 Rebecca J. Marston
3.70 Correspond with J. Desai, K&E team re sale
summary (.5); review and revise sale
organizational chart (.3); correspond with J.
Desai, K&E team re same (.2); correspond
with J. Desai, K&E team re NDAs (.1);
review and revise same (2.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 117 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
14
Date
Name
Hours Description
06/20/24 Ruan J. Meintjes
1.10 Review and analyze change of ownership
considerations for state licensure issues (.5);
prepare summary re same (.6).
06/20/24 Carolin Paus
0.60 Telephone conference with S. Zablotney,
K&E team re tax implications re sale process.
06/20/24 Joshua Raphael
0.40 Conference with potential transaction party re
NDA (.2); review, revise, NDA (.2).
06/20/24 Joshua Raphael
0.50 Research, analyze implications re 9019 (.2);
review, analyze precedent re same (.2);
correspond with C. Ceresa re same (.1).
06/20/24 Yusuf Salloum
1.20 Analyze issues re sale transactions.
06/20/24 Donatus Wang
1.30 Prepare for telephone conference with
Finkenhof re workstreams related to German
entities (.3); attend same (.5); correspond with
Munich tax team re structuring of potential
asset sale transaction (.5).
06/20/24 Spencer A. Winters, P.C.
2.10 Review and analyze issues re sale process,
case strategy (.3); telephone conference with
Y. Salloum, K&E team re same (.3); prepare
for and attend special committee call (.5);
prepare for and attend weekly telephone
conference with Company (.5); prepare for
and attend weekly telephone conference with
lender advisors (.5).
06/21/24 Chris Ceresa
0.30 Review, analyze draft NDA markups (.2);
correspond with S. Lieberman, K&E team re
same (.1).
06/21/24 Chris Ceresa
1.50 Analyze, comment on bidding procedures
declarations, sale motion.
06/21/24 Kenny Chiaghana
1.90 Analyze, revise de minimis asset procedures
motion.
06/21/24 Jaina Desai
2.20 Revise sale organizational chart (1.4);
correspond with R. Marston re same (.2);
correspond with C. Ceresa re same (.1);
review, analyze sales diligence (.2);
correspond with R. Marston, S. Lieberman re
same (.1); correspond with AlixPartners re
contract noticing (.1); revise sale organizer
(.1).
06/21/24 Amy Donahue
0.30 Research re de minimis asset sale exhibit
precedent.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 118 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
15
Date
Name
Hours Description
06/21/24 Julia R. Foster
0.50 Draft exhibits B and C re de minimis asset
motion.
06/21/24 Sabrina Lieberman
1.90 Review and revise NDA summary (.4);
correspond with C. Ceresa and K&E team re
same (1.0); review and analyze NDA (.2);
correspond with NDA counterparties re same
(.3).
06/21/24 Savannah Malnar-Cole
0.30 Advise D. O’Connor re redaction practices for
customer contracts.
06/21/24 Rebecca J. Marston
1.90 Correspond with J. Desai, K&E team re sale
organizational chart, sale work streams (1.4);
correspond with Omni team re noticing of
sale-related filings (.1); review and revise
NDAs (.2); correspond with S. Lieberman,
K&E team re same (.2).
06/21/24 Dan O'Connor
5.00 Prepare disclosure schedules (2.5); review,
analyze document files re same (2.0);
correspond with AlixPartners, Company re
same (.5).
06/21/24 Spencer A. Winters, P.C.
0.90 Review and analyze issues re sale process,
case strategy (.6); telephone conferences with
interested parties re same (.3).
06/22/24 Anthony M. Del Rio
0.60 Review, analyze regulatory filing research.
06/22/24 Sabrina Lieberman
0.30 Review and revise NDA (.2); revise summary
re same (.1).
06/22/24 Rebecca J. Marston
0.30 Review and revise NDA (.2); correspond with
S. Lieberman, K&E team re same (.1).
06/22/24 Michael William Morgan
2.50 Analyze, summarize diligence documents.
06/22/24 Dan O'Connor
1.80 Correspond with Company re contract review
(.5); correspond with Company, AlixPartners,
PJT re disclosure schedules (.3); review and
revise material contract chart (1.0).
06/23/24 Jaina Desai
0.30 Revise sale process organizational chart (.1);
review, analyze correspondence re same (.1);
correspond with R. Marston re same (.1).
06/23/24 Sabrina Lieberman
0.20 Review, analyze NDAs (.1); correspond with
NDA counterparties re same (.1).
06/23/24 Rebecca J. Marston
0.50 Review, analyze sale organizational chart (.4);
correspond with J. Desai re same (.1).
06/23/24 Michael William Morgan
0.50 Review and summarize diligence documents
(.3); correspond with Dan O’Connor re
summary (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 119 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
16
Date
Name
Hours Description
06/24/24 Chris Ceresa
1.10 Review, analyze sale legal issues, including
sale NDA issues (.4); correspond with Y.
Salloum, K&E team re same (.2); conference
with Company, Y. Salloum, K&E team re
same (.5).
06/24/24 Chris Ceresa
0.50 Review, analyze sale, plan terms re RSA.
06/24/24 Adam Thomas Clifford, P.C.
1.00 Prepare for telephone conference with
Company re disclosure schedules (.4);
telephone conference with Company re same
(.6).
06/24/24 Anthony M. Del Rio
0.40 Review and analyze structural considerations.
06/24/24 Jaina Desai
2.80 Correspond with counterparty re NDA (.1);
review, analyze correspondence re sale
organization chart (.2); correspond with R.
Marston re same (.1); revise sale
organizational chart (.3) draft correspondence
re sale organizational chart (.2); correspond
with R. Marston re sale organizational chart
(.1); correspond with K. Chiaghana re sale
milestones (.1); research, analyze documents
re same (.1); revise bidding procedures PJT
declaration (.3); correspond with R. Marston
re same (.1); correspond with C. Ceresa re
same (.1); telephone conference with
AlixPartners, C. Ceresa, K&E team re
contract noticing (.3); prepare for call re same
(.1); correspond with R. Marston re same (.1);
correspond with C. Ceresa re same (.1).
review, analyze AlixPartners declaration (.1);
correspond with R. Marston, C. Ceresa re
same (.1); research, review contract noticing
precedent (.3).
06/24/24 Jaina Desai
0.60 Correspond with C. Ceresa, AlixPartners re
contract noticing precedent (.1); review,
analyze PJT comments to declaration (.2);
correspond with R. Marston, C. Ceresa re
same (.1); revise sale organizer (.2).
06/24/24 Sabrina Lieberman
1.00 Revise NDA (.2); correspond with
counterparties re same (.4); correspond with
PJT, C. Ceresa and K&E team re same (.1);
correspond with C. Ceresa and K&E team re
NDA summary (.1); revise same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 120 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
17
Date
Name
Hours Description
06/24/24 Rebecca J. Marston
0.50 Prepare for and participate in conference with
Alix team, K&E team re contract noticing
(.3); correspond with J. Desai re sale-related
workstreams (.2).
06/24/24 Ruan J. Meintjes
3.60 Research and analyze state licensure change
of ownership considerations (3.0); prepare
summary of same (.5); correspond with K.
Hardey, K&E team re same (.1).
06/24/24 Michael William Morgan
1.20 Telephone conference with Company re
schedules (.8); prepare for same (.3); research
precedent re same (.1).
06/24/24 Trent Nachbar
6.00 Analyze asset purchase agreements and
schedules (3.9); research, analyze specialist
questions (1.0); continue to analyze asset
purchase agreements and schedules (1.1).
06/24/24 Dan O'Connor
5.90 Telephone conference with Company,
AlixPartners, PJT Partners, S. Toth, K&E
team re disclosure schedules (1.1); correspond
with AlixPartners, PJT, S. Toth, K&E team re
same (.4); review and revise material contract
summary chart (.6); correspond with
Company re same (.2); review, analyze VDR
materials (1.6); prepare disclosure schedules
(2.0).
06/24/24 Yusuf Salloum
2.40 Analyze issues re sale transactions (2.1);
conference with S. Toth, K&E team,
Company, AlixPartners team re asset
purchase agreements (.3).
06/24/24 Steve Toth
1.30 Telephone conference with Y. Salloum, K&E
team, AlixPartners, Company re asset
purchase agreements and disclosure schedules
(1.0); analyze tax structure memorandum (.3).
06/24/24 Spencer A. Winters, P.C.
1.20 Review and analyze issues re sale process,
case strategy (.4); telephone conference with
Y. Salloum re same (.3); prepare for and
attend standing update telephone conference
with Company and advisors re same (.5).
06/25/24 Chris Ceresa
1.40 Review, analyze sale legal issues, including
sale NDA issues (.8); correspond with Y.
Salloum, K&E team re same (.2); telephone
conference with Company, S. Lieberman,
K&E team re same (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 121 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
18
Date
Name
Hours Description
06/25/24 Adam Thomas Clifford, P.C.
0.50 Research, analyze carve-out and separation
matters.
06/25/24 Anthony M. Del Rio
1.80 Review and analyze regulatory filing
requirements.
06/25/24 Jaina Desai
1.70 Correspond with AlixPartners re contract
drafting (.1); review, analyze correspondence
re sale process materials (.1); review,
revise presentation re same (.1); correspond
with R. Marston re same (.1); revise 363 sale
process overview (.1); correspond with R.
Marston, Company re same (.1); review,
analyze asset sale diligence spreadsheet (.1);
correspond with C. Ceresa, R. Marston re
same (.1); review, analyze correspondence re
363 sale overview presentation (.1); review,
analyze 363 sale overview presentation (.1);
revise same (.1); correspond with R. Marston,
Company re same (.1); review, analyze PJT
comments re declaration (.5).
06/25/24 Emanuel Goetz
0.50 Conference with D. Wang, K&E team re
structuring considerations re potential sale.
06/25/24 Kate Hardey
0.30 Review, analyze correspondence re FDA
transfer considerations re German entities.
06/25/24 Olivia Kaufmann
4.20 Research and analyze state wind-down,
change of ownership and change of control
requirements for specific licenses (3.7);
conference with R. Meintjes re same (.5).
06/25/24 Sabrina Lieberman
0.70 Conference with NDA counterparty re NDA
(.1); correspond with PJT re NDA (.1); review
and revise NDA (.2); review and revise NDA
summary (.2); conference with C. Ceresa re
NDA (.1).
06/25/24 Rebecca J. Marston
4.60 Review and revise company slide deck re 363
sales (2.6); correspond with J. Desai, C.
Ceresa, K&E team re same (1.3); conference
with Company re same (.5); correspond with
PJT team re same (.2).
06/25/24 Ruan J. Meintjes
0.70 Research and analyze change of ownership
requirements for state licensure.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 122 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
19
Date
Name
Hours Description
06/25/24 Dan O'Connor
5.40 Telephone conference with Company,
AlixPartners, Y. Salloum, S. Toth, K&E team
re transition services agreement matters (.4);
review, analyze VDR materials (3.0); prepare
disclosure schedules and punch list (1.0);
correspond with Company re same (.5);
correspond with Y. Salloum, D. Lewis, B.
Coppola, K&E team re transition services
agreement and transaction matters (.5).
06/25/24 Carolin Paus
1.00 Telephone conference with S. Zablotney,
K&E team re tax implications in asset vs
share deal of German RDX entity.
06/25/24 Yusuf Salloum
1.50 Review, analyze issues re sale transaction, tax
structuring, transition services agreement.
06/25/24 Scottie Shermetaro
0.20 Review due diligence re asset sale.
06/25/24 Steve Toth
0.80 Telephone conference re transition services
agreement with Company, AlixPartners and
K&E team (.5); analyze correspondence re
transition services agreement matters and
presentation (.3).
06/25/24 Donatus Wang
1.10 Review, analyze PJT update on sales process
(.2); draft options analysis for German asset
sale or share sale structures for RDx business,
correspond with A. Ziegler, K&E team re
same (.9).
06/25/24 Spencer A. Winters, P.C.
1.10 Telephone conference with PWC Germany re
tax issues (.5); review and analyze issues re
sale process, case strategy (.3); telephone
conference with Y. Salloum, K&E team re
same (.3).
06/26/24 Cooper Barghols
2.50 Research and summarize state licensure
change of ownership requirements (2.1);
correspond with R. Meintjes re edits to
auction draft asset purchase agreement (.4).
06/26/24 John G. Caruso
1.20 Review and revise asset purchase agreement.
06/26/24 Chris Ceresa
2.10 Telephone conference with Company,
advisors, Y. Salloum, K&E team re health
regulatory issues re potential sale scenarios
(1.1); conference with health regulatory
advisors re issues re same (1.0).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 123 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
20
Date
Name
Hours Description
06/26/24 Chris Ceresa
7.10 Review, analyze sale legal issues, including
sale NDA issues (3.9); correspond with Y.
Salloum, K&E team re same (1.1); telephone
conference with Company, Y. Salloum K&E
team re same (.9); continue to review, analyze
sale legal issues, including sale NDA issues
(1.2).
06/26/24 Adam Thomas Clifford, P.C.
0.50 Review, analyze separation and carve-out
matters.
06/26/24 Bernadette Coppola
5.40 Conference with S. Shermetaro re purchase
agreement and transition services agreement
(.4); draft revisions to purchase agreement
(1.4); correspond with D. Lewis and K&E
team, Company and advisors re transition
services agreement (.3); correspond with A.
Del Rio, K&E team re transition services
agreement (.2); conference with D. Lewis,
K&E team re transaction structure and
strategy (.9); correspond with D. Lewis, K&E
team re same (.4); telephone conference with
Company, S. Shermetaro and K&E team re
intellectual property matters (.4); correspond
with Company re same (.4); analyze
disclosures (1.0).
06/26/24 Anthony M. Del Rio
2.10 Review and analyze regulatory filing
requirements (1.0); review and comment on
purchase agreement (1.1).
06/26/24 Jaina Desai
10.70 Review, analyze correspondence re sale
stream (.7); review, analyze asset purchase
agreement (3.0); correspond with R. Marston
re same (.3); review, analyze precedent re
same (2.0); revise asset purchase agreement
(2.0); conference with R. Marston re same
(.3); correspond with C. Ceresa, Y. Salloum
re same (.2); revise sale organizer (.3);
analyze, compile precedent re asset purchase
agreement (.3); correspond with K. Trevett re
bidding procedures order, case timeline (.1);
telephone conference with S. Toth, K&E
team, counterparty re asset purchase
agreement (1.0); telephone conference with B.
Coppola, K&E team re same (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 124 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
21
Date
Name
Hours Description
06/26/24 Michael Ehret
1.70 Correspond with E. Goetz, K&E team re
German tax structuring, transaction issues,
related considerations (.5); conferences with
E. Goetz, AlixPartners, PJT, Company, K&E
team re transaction considerations (.5);
review, analyze issues re same (.7).
06/26/24 Justin M. Garfinkle
2.70 Telephone conference with S. Toth, K&E
team re asset purchase agreement (.5); draft
comments to asset purchase agreement (2.2).
06/26/24 David Hackel
0.50 Review, analyze confidential party asset
purchase agreement.
06/26/24 Yoonie Han
0.30 Analyze asset purchase agreement.
06/26/24 Kate Hardey
1.50 Review, analyze revisions to merger
agreement (.7); conference with R. Meintjes,
K&E team team re same (.4); review, analyze
German entity filings and 510k listings re
asset transfer (.4).
06/26/24 Liz Ji
1.30 Revise asset purchase agreement.
06/26/24 Olivia Kaufmann
5.50 Research and analyze state wind-down,
change of ownership and change of control
requirements for specific licenses (3.9);
conference with R. Meintjes, C. Barghol re
same (.5); continue to research and analyze
state wind-down, change of ownership and
change of control requirements for specific
licenses (1.1)
06/26/24 Sooah Kim
1.00 Review and revise asset purchase agreement.
06/26/24 Daniel Lewis, P.C.
3.00 Analyze transition services agreement and
separation matters (1.0); telephone conference
with B. Coppola, K&E team re same (.5);
correspond with B. Coppola, K&E team re
same (.5); telephone conference with S. Toth,
K&E team re same (.5); analyze IP matters
(.5).
06/26/24 Sabrina Lieberman
1.50 Review and analyze bidding procedures
affidavit of service (.5); review and revise
NDA (.2); correspond with C. Ceresa, K&E
team re same (.2); review and revise NDA
summary and ancillary documents (.6).
06/26/24 Michael William Morgan
2.00 Draft and circulate the intellectual property
assignment agreement form (1.0); draft and
circulate bill of sale form (.5); revise working
group list (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 125 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
22
Date
Name
Hours Description
06/26/24 Trent Nachbar
8.20 Review and revise asset purchase agreements
and disclosure schedules (3.9); review and
research specialist questions and coordinate
markups (2.0); continue to review and revise
asset purchase agreements and disclosure
schedules (2.3).
06/26/24 Maureen D. O'Brien
1.00 Review and revise asset purchase agreement.
06/26/24 Dan O'Connor
9.20 Telephone conference with S. Toth, Y.
Salloum, K&E team, various parties re
confidential party bid (.6); telephone
conference with Company, PJT, Y. Salloum,
S. Toth, K&E team re transition services
agreement matters (.4); telephone conference
with bidder counsel, confidential party, PJT
Partners, Company re diligence matters (.7);
telephone conference with S. Toth, K&E team
re asset purchase agreement (1.0); telephone
conference with S. Toth, K&E team re
transaction matters (.5); review, analyze bid
asset purchase agreement and draft issues list
re same (3.4); correspond with S. Toth re
same (.2); correspond with B. Coppola and J.
Garfinkle re transaction matters (.5);
correspond with T. Nachbar and M. Morgan
re disclosure schedules and diligence matters
(.5); correspond with Company re disclosure
schedules (.8); prepare disclosure schedules
(.6).
06/26/24 Carolin Paus
1.80 Draft German sale presentation.
06/26/24 Risa Salins
0.50 Review M&A counterparty markup of auction
draft asset purchase agreement.
06/26/24 Adrian Salmen
3.10 Correspond with AlixPartners, C. Ceresa,
K&E team re asset purchase agreement draft
(.5); review, analyze creditor revisions to sale
order (.5); review, analyze precedent sale
order language (1.9); correspond with J.
Desai, R. Marston re sale workstream (.2).
06/26/24 Scottie Shermetaro
4.10 Review, revise asset purchase agreement
(2.1); conference with B. Coppola re deal
timeline and deliverables (.5); telephone
conference with B. Coppola and client re
approach to IP diligence (.6); conduct due
diligence (.5); correspond with B. Coppola re
IP searches (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 126 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
23
Date
Name
Hours Description
06/26/24 Matt Swanson
0.50 Review, analyze issues re purchase
agreement, related items.
06/26/24 Paul D. Tanaka, P.C.
1.90 Review and comment on asset purchase
agreement bid markup (1.6); correspond with
C. Ceresa, K&E team re same (.3).
06/26/24 Steve Toth
4.20 Telephone conference re transition services
agreement with Company, AlixPartners, PJT,
C. Ceresa, K&E team, bidder and bidder
advisors (.6); telephone conference re
structure chart with Company, S. Winters,
K&E team, bidder and bidder counsel (.4);
telephone conference with S. Winters, K&E
team re transition services agreement and
asset purchase agreement (.9); analyze asset
purchase agreement and prepare comments
and attorney notes (2.0); discuss IP matters
with Company, S. Winters, K&E team (.3).
06/26/24 Paul Vasiloff
2.00 Provide comments to asset purchase
agreement.
06/26/24 Donatus Wang
0.80 Review and revise draft German sale
presentation.
06/26/24 Spencer A. Winters, P.C.
2.20 Review and analyze issues re sale process,
case strategy (.4); telephone conferences with
Y. Salloum, K&E team re same (.3); prepare
for and attend standing special committee
meeting re same (.5); prepare for and attend
telephone conference with bidder counsel re
sale process (1.0).
06/27/24 John G. Caruso
1.50 Review and revise asset purchase agreement
(.6); review and revise asset purchase
agreement (.9).
06/27/24 Chris Ceresa
7.20 Review, analyze sale legal issues, including
sale NDA issues (3.9); correspond with Y.
Salloum, K&E team re same (.5); telephone
conference with Company, Y. Salloum, K&E
team re same (.5); continue to review, analyze
sale legal issues, including sale NDA issues
(2.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 127 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
24
Date
Name
Hours Description
06/27/24 Bernadette Coppola
4.30 Telephone conference with Company and
AlixPartners re technology separation
planning (1.0); telephone conference with
buyer, AlixPartners, Company, S. Toth, K&E
team re transition services agreement due
diligence (.5); attend conference with buyer,
Company, S. Toth, K&E team re intellectual
property due diligence (.5); conference with
S. Shermetaro, K&E team re drafting strategy
and intellectual property-related matters (.9);
correspond with S. Toth, K&E team re same
(.3); correspond with advisors re intellectual
property disclosures (.3); analyze comments
to asset purchase agreement (.4); telephone
conference with advisor (.4).
06/27/24 Anthony M. Del Rio
2.40 Review and analyze regulatory filing
requirements (.8); prepare for and participate
in telephone conference with Company re
international considerations (.7); telephone
conference with EU counsel re transaction
considerations (.5); review and comment on
disclosure schedules (.4).
06/27/24 Jaina Desai
4.20 Revise asset purchase agreement (3.0);
correspond with S. Osborne, C. Ceresa re
same (.2); review, analyze bidding procedures
order (.3); revise bidding procedures order
(.2); correspond with A. Salmen re same (.1);
correspond with D. O'Connor, K&E team re
asset purchase agreement (.1); review,
analyze correspondence re asset purchase
agreement, sale (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 128 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
25
Date
Name
Hours Description
06/27/24 Jaina Desai
3.70 Review, analyze correspondence re sale
workstream (.4); correspond with A. Salmen,
C. Ceresa re same (.1); review, analyze sale
NDA (.2); correspond with C. Ceresa re same
(.3); conference with A. Salmen re bidding
procedures workstream (.3); review, analyze
precedent re sale orders (.3); correspond with
A. Salmen re same (.1); review, analyze
correspondence re escrow accounts (.1);
review, analyze precedent re same (.3);
correspond with Omni re same (.1); revise
PJT declaration (.3); correspond with C.
Ceresa re same (.1); research, analyze
precedent re bidding procedures order (.1);
revise bidding procedures order (.1); analyze,
compile bidding procedures declarations (.1);
draft correspondence re same (.1); telephone
conference with AlixPartners, Y. Salloum,
K&E team (.6); correspond with A. Salmen re
same (.1).
06/27/24 Jaina Desai
3.30 Review, analyze bidding procedures notices
(.5); revise sale organizer (.2); revise asset
purchase agreement (2.4); telephone
conference with S. Osborne re same (.2).
06/27/24 Michael Ehret
1.70 Telephone conference with Company re
regulatory implications, share deal vs asset
deal, requirement of transition services
agreement (1.2); correspond with PwC re
structuring considerations (.5).
06/27/24 Justin M. Garfinkle
4.00 Draft transition services agreement (3.3);
discuss matter with M. Ehret, K&E team (.7).
06/27/24 David Hackel
0.50 Review, analyze confidential party APA.
06/27/24 Kate Hardey
1.20 Conferences with Company, C. Weidner,
K&E team re German entities and related
device transfers.
06/27/24 Olivia Kaufmann
0.20 Conference with A. Del Rio, K&E team
re state wind-down, change of ownership and
change of control requirements.
06/27/24 Sooah Kim
1.60 Conference with M. O'Brien re employee
benefits issues (.2); review and revise asset
purchase agreement (1.4).
06/27/24 Maggie Kate King
1.00 Conference with D. Lewis, K&E team re sale
workstreams.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 129 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
26
Date
Name
Hours Description
06/27/24 Maggie Kate King
2.00 Telephone conference with D. Lewis, K&E
team re transition services diligence call (.5);
telephone conference with D. Lewis, K&E
team re IP diligence (1.0); telephone
conference with Morgan Lewis re IP
diligence (.5).
06/27/24 Maggie Kate King
3.00 Revise transition services agreement.
06/27/24 Daniel Lewis, P.C.
1.50 Analyze transition services agreement and IP
matters (1.0); analyze asset purchase
agreements (.5).
06/27/24 Sabrina Lieberman
1.30 Correspond with NDA counterparties re NDA
(.2); review and revise same (.3); correspond
with C. Ceresa and K&E team re same (.3);
revise and revise summary re same (.3);
correspond with C. Ceresa and PJT re
interested parties (.2).
06/27/24 Ruan J. Meintjes
1.90 Review, revise bid asset purchase agreements
(1.8); correspond with A. Del Rio, K&E team
team re same (.1).
06/27/24 Ruan J. Meintjes
1.60 Review, revise regulatory components of
asset purchase agreement from bidders (1.2);
correspond with Y. Salloum, K&E team re
same (.4).
06/27/24 Michael William Morgan
0.70 Review, analyze purchase agreement and
amendment precedent to confirm accuracy of
schedules.
06/27/24 Jai Mudhar
1.00 Correspond with H. Crawford, K&E team
re sales process (.7); review, analyze issues
update from Swiss counsel (.2); conference
with D. Wang re same (.1).
06/27/24 Trent Nachbar
7.80 Review and revise asset purchase agreements
and disclosure schedules (3.9); analyze,
research, respond to and coordinate specialist
comments (1.8); continue to review and revise
asset purchase agreements and disclosure
schedules (2.1).
06/27/24 Michelle L. Nowicki
1.00 Coordinate with M. Morgan, K&E team re IP
due diligence.
06/27/24 Maureen D. O'Brien
1.00 Review and revise asset purchase agreement.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 130 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
27
Date
Name
Hours Description
06/27/24 Dan O'Connor
9.80 Telephone conference with Company,
confidential potential buyer, PJT,
AlixPartners, S. Toth, K&E team re IP
diligence matters (1.0); telephone conference
with buyer counsel, S. Toth and Y. Salloum re
transaction matters (.5); telephone conference
with AlixPartners, S. Toth, Y. Salloum, K&E
team re transaction matters (.6); review and
revise issues list (.6); correspond with
Company, S. Toth, K&E team re same (.2);
correspond with S. Toth, K&E team re special
transaction matters (.6); review and revise
asset purchase agreements (3.5); review,
analyze contracts in VDR and prepare
disclosure schedules (2.8).
06/27/24 Sarah Osborne
6.60 Review, revise markup to asset purchase
agreement (2.4); correspond with C. Ceresa re
same (.1); further review, revise markup to
asset purchase agreement (3.4); correspond
with C. Ceresa, K&E team re same (.3);
compile issues list re same (.4).
06/27/24 Joshua Raphael
0.50 Review, revise NDA and correspond with
counterparty re same.
06/27/24 Adrian Salmen
4.30 Review, analyze precedent bidding
procedures language (1.7); correspond with J.
Desai, K&E team re same (.3); conference
with J. Desai re same (.3); revise addition to
bidding procedures order (.5); telephone
conference with Y. Salloum, K&E team re
asset purchase agreement proposal (.5);
review, revise sale related notices (.3);
review, analyze asset purchase agreement
issues (.7).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 131 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
28
Date
Name
Hours Description
06/27/24 Scottie Shermetaro
5.70 Telephone conference with B. Coppola and
Company re RDx IT separation and transition
services agreement (1.0); telephone
conference with B. Coppola, M. King re
transition services agreement follow-up (.5);
conference with B. Coppola and PJT partners
re IP diligence (1.0); coordinate IP Searches
or all seller entities and separate by relevant
business unit (.3); review, revise transition
services agreement (1.5); conduct due
diligence and discuss findings with B.
Coppola, M. King and J. Garfinkel (1.0);
telephone conference with B. Coppola and
client's external IP counsel re IP issues (.4).
06/27/24 Matt Swanson
0.20 Review, analyze asset purchase agreement
related considerations.
06/27/24 Paul D. Tanaka, P.C.
1.20 Review and analyze multiple bid draft
purchase agreement markups (.9); correspond
with Y. Salloum, K&E team re same (.3).
06/27/24 Steve Toth
4.00 Telephone conference re transition services
agreement with Company, AlixPartners, Y.
Salloum, K&E team (1.0); analyze issues list
(.4); discuss transaction with bidder counsel,
Y. Salloum, K&E team (.3); revise asset
purchase agreement issues list (1.1); discuss
asset purchase agreement issues with
AlixPartners, Y. Salloum, K&E team (.6);
analyze correspondence re asset purchase
agreements (.2); revise issues list (.4).
06/27/24 Paul Vasiloff
1.30 Provide comments to asset purchase
agreement.
06/27/24 Spencer A. Winters, P.C.
2.90 Review and analyze sale process issues (.7);
correspond with Y. Salloum, K&E team re
same (.7); prepare for and attend standing
telephone conference with company advisors
re same (.5); prepare for and attend standing
telephone conference with lender advisors re
same (.5); prepare for and attend telephone
conference with bidder counsel re sale
process (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 132 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
29
Date
Name
Hours Description
06/28/24 Chris Ceresa
5.30 Review, analyze sale legal issues, including
sale NDA issues (3.3); correspond with Y.
Salloum, K&E team re same (1.0); telephone
conference with Company, K&E team re
same (1.0).
06/28/24 Bernadette Coppola
4.50 Telephone with D. Lewis re transition
services agreement and process (.3);
correspond with S. Shermetaro, K&E team re
intellectual property disclosures (.5); draft
revisions to purchase agreement (.5); draft
revisions to asset purchase agreement (1.7);
draft revisions to transition services
agreement (1.5).
06/28/24 Anthony M. Del Rio
1.90 Review and analyze regulatory filing
requirements (.5); review and
analyze structural considerations (.3); review
and comment on asset purchase agreements
(1.1).
06/28/24 Jaina Desai
1.60 Review, revise asset purchase agreement.
06/28/24 Jaina Desai
2.60 Revise asset purchase agreement.
06/28/24 Jaina Desai
3.20 Review, analyze correspondence re sale
workstream (.3); correspond with S. Osborne
re asset purchase agreements (.1); correspond
with AlixPartners re contract designation
process (.1); correspond with C. Ceresa re
same (.1); review, analyze escrow agreement
(.3); correspond with A. Salmen re same (.2);
review, analyze precedent re escrow
agreements (.8); review, research precedent re
U.S. Trustee comments re bidding procedures
(.8); revise escrow agreement (.4); correspond
with C. Ceresa re same (.1).
06/28/24 Jaina Desai
0.60 Correspond with C. Ceresa re asset purchase
agreements (.3); review, analyze escrow
agreement (.1); correspond with C. Ceresa re
same (.1); correspond with Omni re same (.1).
06/28/24 Jaina Desai
0.90 Revise asset purchase agreement.
06/28/24 Justin M. Garfinkle
3.20 Draft updates to asset purchase agreement
(.8); review, analyze comments from outside
counsel re disclosure schedules (1.2); draft
comments to asset purchase agreement (.8);
analyze transition services agreement (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 133 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
30
Date
Name
Hours Description
06/28/24 David Hackel
0.30 Review, analyze confidential party asset
purchase agreement.
06/28/24 Kate Hardey
0.80 Review, analyze Company clinical trials re
asset purchase agreement revisions.
06/28/24 Kate Hardey
1.50 Review, analyze asset purchase agreement
(1.0); conference with R. Meintjes re same
(.5).
06/28/24 Liz Ji
5.10 Review, analyze asset purchase agreement for
confidential parties (3.9); telephone
conference with N. Warther, K&E team re
intercompany debt (1.0); continue to Review,
analyze asset purchase agreement for
confidential parties (.2).
06/28/24 Olivia Kaufmann
4.70 Research and analyze state wind-down,
change of ownership and change of control
requirements re regulatory licenses (3.5);
correspond with state regulators re same (1.2).
06/28/24 Sooah Kim
0.80 Review, revise asset purchase agreement.
06/28/24 Maggie Kate King
1.50 Telephone conference re IP with Fox
Rothschild (.5); telephone conference re IP
with advisor (.5); coordinate with D. Lewis,
K&E team re intellectual property disclosures
(.5).
06/28/24 Maggie Kate King
1.00 Revise transition services agreement.
06/28/24 Daniel Lewis, P.C.
2.50 Analyze asset purchase agreements (.5);
analyze transition services agreement matters
(1.0); telephone conference with B. Coppola,
K&E team re transition services agreement
matters (1.0).
06/28/24 Sabrina Lieberman
0.80 Review and revise NDAs (.2); correspond
with NDA counterparties re same (.2); review
and revise NDA summary (.2); correspond
with C. Ceresa and K&E team re same (.2).
06/28/24 Ruan J. Meintjes
1.70 Research and analyze change of ownership
requirements (1.5); prepare summary of same
(.1); coordinate with Y. Salloum, K&E team
re same (.1).
06/28/24 Ruan J. Meintjes
1.80 Review and revise bid asset purchase
agreements (1.6); correspond with A. Del Rio
and K. Hardey re same (.2).
06/28/24 Michael William Morgan
1.20 Revise asset purchase agreement.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 134 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
31
Date
Name
Hours Description
06/28/24 Trent Nachbar
10.00 Review and revise asset purchase agreements
and disclosure schedules (3.9); analyze and
respond to specialist comments (1.0);
continue to review and revise asset purchase
agreements and disclosure schedules (3.8);
further review and revise asset purchase
agreements and disclosure schedules (1.3)
06/28/24 Michelle L. Nowicki
2.50 Review, analyze IP disclosures and prior
K&E IP schedules, deal correspondence, and
corporate entity list (1.0); commence IP
ownership searches (.3); telephone conference
with H. Horter re IP searches (1.0);
correspond with D. Lewis, K&E team re IP
due diligence (.2).
06/28/24 Maureen D. O'Brien
1.00 Review, revise asset purchase agreement.
06/28/24 Dan O'Connor
9.90 Correspond with Company, S. Toth, K&E
team, PJT Partners, AlixPartners teams re
issues list (1.0); prepare issues lists and bid
comparisons (3.9); review and revise asset
purchase agreement (1.5); review, analyze
contracts in VDR and prepare disclosure
schedules (2.8); continue to prepare issues
lists and bid comparisons (.7)
06/28/24 Sarah Osborne
4.90 Review, revise asset purchase agreement
markup (3.9); correspond with C. Ceresa,
K&E team re same (.4); continue to review,
revise asset purchase agreement markup (.6).
06/28/24 Carolin Paus
1.40 Research re clawback risks (1.0); finalize
presentation on asset vs share deal (.4).
06/28/24 Yusuf Salloum
0.50 Analyze asset purchase agreements.
06/28/24 Adrian Salmen
1.90 Review, revise bidding procedures
language(1.4); correspond with C. Ceresa,
K&E team, contract counterparty re same
(.3); correspond with J. Desai, K&E team re
sale workstream issues (.2).
06/28/24 Scottie Shermetaro
3.80 Telephone conference with M. King and
external trademark counsel re trademark
portfolio disclosures (.5); telephone
conference with M. King and external patent
counsel re patent portfolio disclosures (.5);
review, revise transition services agreement
(1.5); review, revise asset purchase agreement
(1.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 135 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
32
Date
Name
Hours Description
06/28/24 Steve Toth
6.30 Discuss asset purchase agreement issues with
Company, PJT, AlixPartners, S. Winters,
K&E team (1.3); analyze bidder asset
purchase agreement (1.6); analyze bidder
asset purchase agreement and prepare issues
list (2.3); revise issues lists and distribute
(1.1).
06/28/24 Sarah Ullathorne
1.20 Telephone conference with Y. Salloum, K&E
team re asset purchase agreement (.4); review,
analyze same (.4); correspond with
Y. Salloum, K&E team re antitrust and
foreign direct investment analysis (.4).
06/28/24 Paul Vasiloff
1.00 Provide comments to asset purchase
agreement.
06/28/24 Spencer A. Winters, P.C.
1.90 Prepare for and attend telephone conference
with Company re bidder asset purchase
agreement (1.5); review and analyze issues re
sale process, case status (.4).
06/29/24 Rebecca H. Arnall
6.50 Review, analyze asset purchase agreements
(3.9); correspond with S. Price re same (.5);
continue to review, analyze asset purchase
agreements (2.1).
06/29/24 Chris Ceresa
0.60 Review, analyze sale legal issues, including
sale NDA issues (.2); correspond with R.
Marston, K&E team re same (.1); telephone
conference with Company, Y. Salloum, K&E
team re same (.3).
06/29/24 Dominique Collins
0.20 Review, analyze deal summary and
correspondence re deliverables.
06/29/24 Dominique Collins
0.50 Review, revise asset purchase agreements.
06/29/24 Dominique Collins
1.00 Review, analyze precedent asset purchase
agreement.
06/29/24 Bernadette Coppola
2.00 Draft revisions to transition services
agreement (1.0); correspond with M. King,
K&E team re same (.2); correspond with J.
Garfinkle, K&E team re revisions to asset
purchase agreement (.2); review, analyze
revised draft of transition services agreement
(.3); correspond with M. King, K&E team re
same (.3).
06/29/24 Anthony M. Del Rio
0.90 Analyze structural considerations (.4); review
and comment on asset purchase agreements
(.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 136 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
33
Date
Name
Hours Description
06/29/24 Jaina Desai
3.60 Review, analyze correspondence, documents
re bidding procedures order (1.8); research,
analyze precedent re U. S. Trustee comments
(1.6); draft correspondence re same (.2).
06/29/24 Justin M. Garfinkle
0.40 Draft comments to asset purchase agreement.
06/29/24 Kate Hardey
0.50 Conference with R. Meintjes re EU and other
country device lists and related coordination
with EU counsel.
06/29/24 Maggie Kate King
4.00 Revise transition services agreement bid draft
(3.0); research re same (1.0).
06/29/24 Daniel Lewis, P.C.
0.50 Analyze transition services agreement matters
(.4); correspond with B. Coppola, K&E team
re same (.1).
06/29/24 Sabrina Lieberman
0.20 Review, revise NDA (.1); revise summary re
same (.1).
06/29/24 Ruan J. Meintjes
1.20 Review, revise bid asset purchase agreements
(1.0); correspond with A. Del Rio and K.
Hardey re same (.2).
06/29/24 Dan O'Connor
4.30 Telephone conference with bidder counsel, S.
Toth re asset purchase agreement (.4); review,
analyze contracts in VDR and prepare
disclosure schedules (1.9); review and revise
asset purchase agreements (2.0).
06/29/24 Scott D. Price, P.C.
0.70 Review, analyze asset purchase agreements.
06/29/24 Scottie Shermetaro
2.10 Review, revise markup of auction draft asset
purchase agreement (.7); review, revise
transition services agreement (1.4).
06/29/24 Steve Toth
0.50 Discuss asset purchase agreement issues with
bidder counsel, S. Winters, K&E team (.4);
analyze related attorney notes (.1).
06/30/24 Bernadette Coppola
1.90 Draft revisions to transition services
agreement (1.0); correspond with S.
Shermetaro, K&E team re same (.4);
correspond with M. King, K&E team re
revisions to Company correspondence (.5).
06/30/24 Jaina Desai
1.40 Revise bidding procedures order (.3); revise
bidding procedures notices (.9); draft
correspondence re same (.1); correspond with
A. Salmen re same (.1).
06/30/24 Liz Ji
3.50 Revise asset purchase agreements for
numerous bidders.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 137 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050102696
48520-10
34
Date
Name
Hours Description
06/30/24 Olivia Kaufmann
0.20 Research, analyze wind-down, change of
ownership, change of control requirements re
state license.
06/30/24 Maggie Kate King
2.00 Revise transition services agreement.
06/30/24 Sabrina Lieberman
0.30 Correspond with M&A counterparty re NDA
(.1); correspond with C. Ceresa re NDA
summary (.2).
06/30/24 Trent Nachbar
0.80 Review, revise asset purchase agreements and
disclosure schedules.
06/30/24 Michelle L. Nowicki
5.20 Correspond with D. Lewis, K&E team re IP
due diligence (.7); compare two sets of
trademark disclosures, prior K&E U.S.
trademark schedule and new trademark search
results (2.0); review, analyze related IP office
and Corsearch records (2.0); prepare
trademark schedule (.5).
06/30/24 Dan O'Connor
5.00 Review and revise asset purchase agreements
(3.9); correspond with S. Toth re same (.2);
correspond with S. Toth, K&E team re asset
purchase agreements (.8); continue to review
and revise asset purchase agreements (.1).
06/30/24 Scottie Shermetaro
6.30 Review, revise transition services agreement
(3.9); draft transition services agreement
issues list for Company (.6); review, analyze
IP-related diligence disclosures from client's
outside counsel (1.0); continue to review,
revise transition services agreement (.8).
06/30/24 Steve Toth
1.10 Analyze correspondence re transition services
agreement and diligence (.3); analyze asset
purchase agreement issues list (.8).
Total
572.80
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 138 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102697
Client Matter: 48520-11
In the Matter of Executory Contracts & Unexpired Leases
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 28,606.00
Total legal services rendered
$ 28,606.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 139 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Executory Contracts & Unexpired Leases
Invoice Number:
Matter Number:
1050102697
48520-11
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Tiffani Chanroo
0.90
1,265.00
1,138.50
David Hackel
22.00
975.00
21,450.00
Brian King
1.00
1,345.00
1,345.00
Sabrina Lieberman
0.50
815.00
407.50
Sarah Osborne
1.60
815.00
1,304.00
Joshua Raphael
0.60
975.00
585.00
Yusuf Salloum
1.00
1,595.00
1,595.00
Tanzila Zomo
2.20
355.00
781.00
TOTALS
29.80
$ 28,606.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 140 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Executory Contracts & Unexpired Leases
Invoice Number:
Matter Number:
1050102697
48520-11
3
Description of Legal Services
Date
Name
Hours Description
06/13/24 Yusuf Salloum
1.00 Analyze issues re sale transactions and
rejection.
06/14/24 Sabrina Lieberman
0.20 Correspond with T. Chanroo, parties in
interest and AlixPartners re executory
contract.
06/14/24 Joshua Raphael
0.60 Review, revise NDA (.5); review, analyze
master services agreement and correspond
with Y. Salloum re same (.1).
06/17/24 Sabrina Lieberman
0.30 Correspond with T. Chanroo and K&E team
re executory contract strategy.
06/17/24 Sarah Osborne
1.10 Review, analyze contracts with staffing
agency re executory status (.9); correspond
with J. Raphael re same (.2).
06/18/24 Tiffani Chanroo
0.90 Review, analyze executory contract (.7);
correspond with Company, C. Ceresa, K&E
team re same (.2).
06/18/24 David Hackel
0.70 Research contract rejection procedures (.3);
correspond with T. Chanroo, K&E team re
same (.1); review, analyze precedent re same
(.3).
06/18/24 Brian King
1.00 Prepare for and participate in conference with
K. Hardey, K&E team re regulatory
considerations to support lease rejections.
06/18/24 Tanzila Zomo
0.50 Research re contract rejection precedent (.3);
correspond with D. Hackel re same (.2).
06/19/24 David Hackel
4.10 Review, analyze precedent re contract
rejection procedures (.7); correspond with T.
Chanroo, K&E team re same (.1); draft, revise
contract rejection procedures pleadings (2.2);
research re same (1.1).
06/19/24 Tanzila Zomo
1.70 Research re contract rejection precedent.
06/20/24 David Hackel
4.60 Research re contract rejection procedures (.8);
correspond with T. Chanroo, K&E team re
same (.1); revise contract rejection procedures
pleadings (2.8); further research re same (.9).
06/21/24 David Hackel
3.80 Review, analyze precedent re contract
rejection procedures (.4); correspond with T.
Chanroo re same (.2); draft, revise contract
rejection procedures pleadings (2.9); research
re same (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 141 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Executory Contracts & Unexpired Leases
Invoice Number:
Matter Number:
1050102697
48520-11
4
Date
Name
Hours Description
06/22/24 David Hackel
0.60 Review, analyze contract rejection
procedures, related issues (.4); correspond
with Y. Salloum, K&E team re same (.2).
06/24/24 David Hackel
4.60 Review, analyze precedent re contract
rejection procedures (.7); correspond with T.
Chanroo, K&E team re same (.4); draft, revise
contract rejection procedures pleadings (2.8);
research re same (.7).
06/25/24 David Hackel
1.60 Review, revise contract rejection procedures
pleadings (.9); review, analyze issues re filing
same (.3); correspond with T. Chanroo, K&E
team re same (.2); review, revise notice re
same (.2).
06/25/24 Sarah Osborne
0.50 Prepare bar date, contract rejection motions
for filing (.3); review, revise notices for same
(.2).
06/26/24 David Hackel
1.30 Review, revise rejection procedures order
(.7); review, analyze precedent, research re
same (.4); correspond with T. Chanroo, K&E
team re same (.2).
06/27/24 David Hackel
0.20 Review, analyze issues re contract rejection
procedures.
06/28/24 David Hackel
0.50 Review, analyze contract rejection procedures
order (.3); review, analyze correspondence
from C. Ceresa re same (.1); correspond with
S. Lieberman re same (.1).
Total
29.80
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 142 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102698
Client Matter: 48520-12
In the Matter of Business Operations
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 48,045.50
Total legal services rendered
$ 48,045.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 143 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050102698
48520-12
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Cooper Barghols
4.40
815.00
3,586.00
Chris Ceresa
2.50
1,345.00
3,362.50
Anthony M. Del Rio
0.40
1,595.00
638.00
Kate Hardey
0.50
1,995.00
997.50
Partha Kar
1.50
2,305.00
3,457.50
Olivia Kaufmann
5.60
975.00
5,460.00
Brian King
1.40
1,345.00
1,883.00
Sabrina Lieberman
4.10
815.00
3,341.50
Ruan J. Meintjes
5.40
975.00
5,265.00
Sarah Osborne
0.20
815.00
163.00
Carolin Paus
14.90
620.00
9,238.00
Kyle Nolan Trevett
2.30
1,095.00
2,518.50
Donatus Wang
4.00
905.00
3,620.00
Ann-Kathrin Ziegler
4.30
1,050.00
4,515.00
TOTALS
51.50
$ 48,045.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 144 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050102698
48520-12
3
Description of Legal Services
Date
Name
Hours Description
06/10/24 Anthony M. Del Rio
0.40 Review, analyze regulatory notice
obligations.
06/10/24 Donatus Wang
3.50 Analyze German operations, shipping
considerations.
06/11/24 Sabrina Lieberman
0.70 Conference with P. Kar, K&E team, Baker
McKenzie and Company re Swiss audit (.5);
correspond with Y. Salloum and C. Ceresa re
same (.2).
06/11/24 Carolin Paus
1.10 Translate correspondence of Swiss auditor re
reporting obligations under Swiss Bankruptcy
law (.4); draft overview of intercompany
claims between Swiss and German entities
(.7).
06/11/24 Carolin Paus
1.40 Review and analyze new supply agreement
(1.2); revise contract review summary (.2).
06/11/24 Ann-Kathrin Ziegler
1.20 Conference with J. Mudhar re German
workstreams (.5); conference with German
counsel re restructuring considerations (.7).
06/12/24 Partha Kar
0.50 Telephone conference re Europe liquidity
forecasting with Company, AlixPartners.
06/12/24 Carolin Paus
1.80 Draft issues list with open questions re
standstill agreement, liquidity planning,
offsetting and settlement of inter-company
claims (1.0); review and revise clarification
correspondence re content and purpose of
standstill agreement (.8).
06/12/24 Ann-Kathrin Ziegler
2.00 Attend conference with Company, D. Wang
re German liquidity planning and future intra-
group shipping (1.0); prepare for same (.5);
review and revise draft correspondence to
Company re scope of standstill agreement
(.2); conference with D. Wang and J. Mudhar
re same (.3).
06/17/24 Kate Hardey
0.50 Conference with R. Meintjes re
manufacturing and FDA 510k transfers.
06/17/24 Sarah Osborne
0.20 Correspond with T. Chanroo re board
presentation for operations while in
bankruptcy.
06/17/24 Donatus Wang
0.20 Conference with Company re intercompany
payments and prepare for same.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 145 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050102698
48520-12
4
Date
Name
Hours Description
06/18/24 Brian King
1.10 Prepare summary of regulatory notices and
filings addresses.
06/18/24 Ruan J. Meintjes
1.30 Review and analyze FDA device approval
issues (1.0); conference with AlixPartners re
same (.3).
06/19/24 Chris Ceresa
0.40 Correspond with Y. Salloum, K&E team,
Company re international operational issues.
06/19/24 Brian King
0.30 Review and analyze correspondence to
international regulatory counsel.
06/19/24 Carolin Paus
0.50 Telephone conference with Y. Salloum, K&E
team re liquidity planning of German entities.
06/20/24 Carolin Paus
0.50 Review and revise AMS restructuring letter to
CORDIS audit AG.
06/20/24 Carolin Paus
0.80 Telephone conference with Company and
Finkenhof re cashflow forecast and director
duties.
06/21/24 Cooper Barghols
0.50 Coordinate with R. Meintjes and O.
Kaufmann re licensure change of ownership
rules and regulations.
06/21/24 Chris Ceresa
1.00 Correspond with Y. Salloum, K&E team,
Company re international operational issues.
06/21/24 Olivia Kaufmann
0.40 Analyze and discuss change of control,
change of ownership research assignment
with R. Meintjes and C. Barghols (.3);
correspond with R. Meintjes, K&E team re
same (.1).
06/21/24 Sabrina Lieberman
2.50 Draft letter to Swiss auditor re stay of Swiss
proceedings (1.5); correspond with
AlixPartners, Y. Salloum and K&E team re
same (1.0).
06/21/24 Ruan J. Meintjes
0.90 Analyze state licensure change of license
ownership strategy (.8); coordinate with Y.
Salloum, K&E team re same (.1).
06/22/24 Ruan J. Meintjes
1.20 Research and analyze change of ownership
requirement for state licenses (1.0);
coordinate with Y. Salloum, K&E team re
same (.2).
06/24/24 Cooper Barghols
2.30 Research and summarize state licensure
change of ownership requirements.
06/24/24 Olivia Kaufmann
5.20 Research and analyze state wind-down,
change of ownership and change of control
requirements for specific licenses (3.7); draft
summary re same (1.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 146 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050102698
48520-12
5
Date
Name
Hours Description
06/24/24 Sabrina Lieberman
0.90 Correspond with Company, AlixPartners, C.
Ceresa and K&E team re correspondence with
Swiss entities.
06/24/24 Carolin Paus
1.00 Review and revise comfort letter provided by
U.S. entities to Swiss entities (.7); draft
execution version of comfort letter (.3).
06/25/24 Cooper Barghols
0.80 Research and summarize state licensure
change of ownership requirements.
06/25/24 Donatus Wang
0.30 Conference with Y. Salloum, K&E team re
advisor engagement.
06/26/24 Chris Ceresa
0.50 Telephone conference with Y. Salloum, K&E
team, advisors re international business
operation issues.
06/26/24 Partha Kar
1.00 Correspond with Company re advisor
services.
06/26/24 Ruan J. Meintjes
2.00 Review and analyze state licensure change of
ownership requirements (1.8); coordinate with
C. Ceresa, K&E team re same (.2).
06/26/24 Carolin Paus
3.40 Review, summarize supplier agreements.
06/26/24 Ann-Kathrin Ziegler
0.30 Review, analyze correspondence re advisor
engagement, late filings of accounts.
06/27/24 Cooper Barghols
0.30 Conference with A. Del Rio and R. Meintjes
re state licensure change of ownership
investigation.
06/27/24 Chris Ceresa
0.60 Telephone conference with Y. Salloum, K&E
team, advisors re international business
operation issues.
06/27/24 Carolin Paus
4.40 Review and summarize supplier agreements
(3.0); research re same (1.4).
06/27/24 Kyle Nolan Trevett
0.50 Telephone conference with Company re
communications matters (.4); telephone
conference with C. Ceresa re same (.1).
06/27/24 Ann-Kathrin Ziegler
0.80 Review, analyze correspondence re shipping
of good from German to US entities and
alignment with D. Wang re next steps (.3);
review, analyze correspondence re Swiss
auditor and alignment with D. Wang re next
steps (.3); review, analyze correspondence re
German material contracts (.2).
06/28/24 Cooper Barghols
0.50 Review and revise due diligence investigation
re state licensure change of ownership rules.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 147 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050102698
48520-12
6
Date
Name
Hours Description
06/28/24 Kyle Nolan Trevett
1.80 Review, revise communications materials
(1.7); correspond with C. Ceresa, Company re
same (.1).
Total
51.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 148 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102699
Client Matter: 48520-13
In the Matter of Claims Administration
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 17,351.50
Total legal services rendered
$ 17,351.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 149 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Claims Administration
Invoice Number:
Matter Number:
1050102699
48520-13
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
3.10
1,345.00
4,169.50
Tiffani Chanroo
3.00
1,265.00
3,795.00
Kenny Chiaghana
7.30
815.00
5,949.50
David Hackel
0.60
975.00
585.00
Sarah Osborne
3.50
815.00
2,852.50
TOTALS
17.50
$ 17,351.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 150 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Claims Administration
Invoice Number:
Matter Number:
1050102699
48520-13
3
Description of Legal Services
Date
Name
Hours Description
06/14/24 Kenny Chiaghana
1.00 Analyze, revise bar date motion.
06/18/24 Kenny Chiaghana
0.80 Research re bar date motion.
06/19/24 Sarah Osborne
2.30 Research re noticing parties (2.1); correspond
with C. Ceresa re same (.2).
06/20/24 Kenny Chiaghana
0.20 Draft bar date motion.
06/24/24 Chris Ceresa
0.30 Review, revise, analyze legal issues re bar
date motion, order, and notices (.2);
correspond with K&E team re same (.1).
06/24/24 Tiffani Chanroo
1.20 Review, revise bar date motion (.7);
correspond with K. Chiaghana re same (.2);
review, analyze issues re same (.3).
06/24/24 Kenny Chiaghana
3.50 Analyze and revise bar date motion (3.1);
research re same (.4).
06/24/24 Sarah Osborne
1.00 Correspond with D. Hackel re Omni claims
inquiries (.3); telephone conference with C.
Ceresa, K&E team re same (.3); correspond
with AlixPartners, D. Hackel, K&E team re
same (.4).
06/25/24 Chris Ceresa
2.80 Review, revise, analyze legal issues re bar
date motion, order, and notices (2.1);
correspond with T. Chanroo, K&E team re
same (.7).
06/25/24 Tiffani Chanroo
1.40 Review, analyze bar date motion (.8);
correspond with Gibson Dunn, Omni, Y.
Salloum, K&E team re same (.6).
06/25/24 Kenny Chiaghana
0.90 Analyze and revise bar date motion.
06/25/24 Sarah Osborne
0.20 Correspond with AlixPartners re vendor
inquiry.
06/26/24 Tiffani Chanroo
0.40 Conference with D. Hackel, K&E team re
general motion bar date research.
06/26/24 Kenny Chiaghana
0.40 Analyze and revise bar date order.
06/29/24 David Hackel
0.60 Research re administrative claims, setoff
rights (.5); correspond with K. Chiaghana,
K&E team re same (.1).
06/30/24 Kenny Chiaghana
0.50 Research re claims setoff.
Total
17.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 151 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102700
Client Matter: 48520-14
In the Matter of Schedules and Statements (SOFAs)
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 34,467.50
Total legal services rendered
$ 34,467.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 152 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Schedules and Statements (SOFAs)
Invoice Number:
Matter Number:
1050102700
48520-14
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Tiffani Chanroo
17.90
1,265.00
22,643.50
Kenny Chiaghana
1.10
815.00
896.50
Julia R. Foster
0.40
525.00
210.00
David Hackel
10.00
975.00
9,750.00
Sarah Osborne
1.10
815.00
896.50
Tanzila Zomo
0.20
355.00
71.00
TOTALS
30.70
$ 34,467.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 153 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Schedules and Statements (SOFAs)
Invoice Number:
Matter Number:
1050102700
48520-14
3
Description of Legal Services
Date
Name
Hours Description
06/17/24 Tiffani Chanroo
4.50 Conference with AlixPartners team re
statements of financial affairs and schedules
(.7); correspond with Y. Salloum re same (.8);
correspond with U.S. Trustee re reporting
obligations (.4); review, analyze materials re
same (2.6).
06/18/24 Tiffani Chanroo
5.70 Conference with AlixPartners team re SoFA,
SOLA status (.6); review, analyze materials re
same (.6); correspond with AlixPartners re
initial debtor interview materials (.8); review,
analyze materials re same (1.1); review,
analyze issues re same (2.2); coordinate initial
debtor interview preparation (.4).
06/20/24 Tiffani Chanroo
4.40 Review, analyze materials re statement of
financial affairs and schedules (2.8);
correspond with AlixPartners team, Y.
Salloum, K&E team re same (1.6).
06/20/24 Kenny Chiaghana
0.60 Analyze, revise, SoFA extension motion.
06/21/24 Tiffani Chanroo
0.40 Correspond with AlixPartners, U.S. Trustee re
341 meeting scheduling (.2); correspond with
AlixPartners team re status of SoFA, SOLA
(.2).
06/24/24 Tiffani Chanroo
2.00 Attend initial debtor interview (.6);
correspond with Y. Salloum re same (.3);
correspond with AlixPartners team re
statements of financial affairs (.5); review,
analyze issues re same (.6).
06/25/24 Tiffani Chanroo
0.60 Review, analyze issues re statements of
financial affairs.
06/25/24 David Hackel
0.80 Correspond with T. Chanroo, PJT re funded
debt numbers (.2); research re same,
statements of financial affairs and
schedules(.3); review, analyze precedent re
same (.3).
06/26/24 David Hackel
2.40 Correspond with T. Chanroo, K&E team, PJT
re funded debt numbers (.3); research re same,
statements of financial affairs and schedules
(.8); review, analyze precedent re same (1.3).
06/27/24 Tiffani Chanroo
0.30 Correspond with D. Hackel re statements of
financial affairs global notes.
06/27/24 Kenny Chiaghana
0.50 Research re SoFA extension motion.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 154 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Schedules and Statements (SOFAs)
Invoice Number:
Matter Number:
1050102700
48520-14
4
Date
Name
Hours Description
06/27/24 David Hackel
1.40 Correspond with T. Chanroo, K&E team,
AlixPartners re funded debt numbers,
statements of financial affairs and schedules
(.3); research re same (.4); review, analyze
precedent re same (.1); review, analyze issues
re global notes for statements and schedules
(.6).
06/28/24 Julia R. Foster
0.40 Research precedent re global notes for
statements and schedules.
06/28/24 David Hackel
5.40 Correspond with T. Chanroo, K&E team re
funded debt numbers, statements of financial
affairs, schedules, global notes (.3); research
re same (1.2); review, analyze precedent re
same (2.0); review, revise re global notes for
statements and schedules (1.9).
06/28/24 Sarah Osborne
1.10 Research precedent re statements and
schedules purposes (.9); correspond with T.
Chanroo, K&E team re same (.2).
06/28/24 Tanzila Zomo
0.20 Research re global notes for statements and
schedules.
Total
30.70
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 155 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102701
Client Matter: 48520-15
In the Matter of Creditor and Stakeholder Communications
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 8,472.00
Total legal services rendered
$ 8,472.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 156 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Creditor and Stakeholder Communications
Invoice Number:
Matter Number:
1050102701
48520-15
2
Summary of Hours Billed
Name
Hours
Rate
Amount
David Hackel
6.00
975.00
5,850.00
Sabrina Lieberman
0.50
815.00
407.50
Eric Nyberg
1.00
340.00
340.00
Quin Wetzel
2.30
815.00
1,874.50
TOTALS
9.80
$ 8,472.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 157 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Creditor and Stakeholder Communications
Invoice Number:
Matter Number:
1050102701
48520-15
3
Description of Legal Services
Date
Name
Hours Description
06/10/24 Sabrina Lieberman
0.50 Conference with T. Chanroo, Omni and Cole
Schotz re service plan.
06/20/24 David Hackel
0.50 Review, analyze issues re service log (.3);
correspond with S. Osborne, T. Chanroo,
Omni re same (.2).
06/21/24 David Hackel
0.90 Review, analyze issues re service log (.5);
correspond with S. Osborne, T. Chanroo,
Omni re same (.3); telephone conference with
Omni re same (.1).
06/22/24 David Hackel
0.50 Review, analyze issues re service log (.4);
correspond with S. Osborne, T. Chanroo,
Omni re same (.1).
06/24/24 David Hackel
1.40 Review, analyze issues re service log (.6);
correspond with S. Osborne, K&E team,
Omni re same (.2); conference with C.
Ceresa, K&E team re same (.4); telephone
conference with Omni re same (.1); prepare
for same (.1).
06/24/24 Eric Nyberg
1.00 Organize and review disclosures relating to
creditors/entities.
06/24/24 Quin Wetzel
1.20 Review, revise notice of commencement (.7);
correspond with T. Chanroo re same (.1);
telephone conference with Omni re service of
notice of commencement (.2); correspond
with Omni, Cole Schotz re same (.2).
06/25/24 David Hackel
1.60 Review, analyze issues re service log (1.2);
correspond with S. Osborne, K&E team,
Omni, advisors, Company re same (.4).
06/25/24 Quin Wetzel
1.10 Review, analyze service requirements (.6);
correspond with T. Chanroo re notice of
commencement (.3); correspond with Omni re
service to creditors (.2).
06/26/24 David Hackel
0.10 Review, analyze issues re service log,
stakeholder issues.
06/27/24 David Hackel
0.30 Review, analyze issues re service log,
stakeholder issues (.2); correspond with
Omni, S. Osborne, K&E team re same (.1).
06/28/24 David Hackel
0.30 Review, analyze issues re service log,
stakeholder issues (.2); correspond with S.
Osborne re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 158 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Creditor and Stakeholder Communications
Invoice Number:
Matter Number:
1050102701
48520-15
4
Date
Name
Hours Description
06/29/24 David Hackel
0.40 Review, analyze issues re service log,
stakeholder issues (.2); revise summary re
same (.2).
Total
9.80
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 159 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102702
Client Matter: 48520-16
In the Matter of U.S. Trustee Matters and Communications
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 1,726.00
Total legal services rendered
$ 1,726.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 160 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
U.S. Trustee Matters and Communications
Invoice Number:
Matter Number:
1050102702
48520-16
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Tiffani Chanroo
1.30
1,265.00
1,644.50
Sabrina Lieberman
0.10
815.00
81.50
TOTALS
1.40
$ 1,726.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 161 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
U.S. Trustee Matters and Communications
Invoice Number:
Matter Number:
1050102702
48520-16
3
Description of Legal Services
Date
Name
Hours Description
06/15/24 Sabrina Lieberman
0.10 Correspond with C. Ceresa and T. Chanroo re
monthly operating reports.
06/20/24 Tiffani Chanroo
0.80 Correspond with U.S. Trustee, AlixPartners re
initial debtor interview material.
06/21/24 Tiffani Chanroo
0.50 Conference with Company, AlixPartners,
Cole Schotz team re initial debtor interview
preparation.
Total
1.40
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 162 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102703
Client Matter: 48520-17
In the Matter of Hearings
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 30,967.00
Total legal services rendered
$ 30,967.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 163 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Hearings
Invoice Number:
Matter Number:
1050102703
48520-17
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Tiffani Chanroo
12.20
1,265.00
15,433.00
Sabrina Lieberman
3.30
815.00
2,689.50
Yusuf Salloum
3.00
1,595.00
4,785.00
Josh Sussberg, P.C.
2.40
2,305.00
5,532.00
Spencer A. Winters, P.C.
1.50
1,685.00
2,527.50
TOTALS
22.40
$ 30,967.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 164 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Hearings
Invoice Number:
Matter Number:
1050102703
48520-17
3
Description of Legal Services
Date
Name
Hours Description
06/11/24 Tiffani Chanroo
3.70 Review, analyze issues re first day hearing
(2.2); participate in and present at first day
hearing (1.1); assist with filing of first day
orders (.4).
06/11/24 Sabrina Lieberman
3.30 Revise talking points for first day hearing
(1.5); correspond with S. Osborne and K&E
team re same (1.8).
06/11/24 Yusuf Salloum
3.00 Attend and participate in first day hearing
(1.5); prepare for same (1.5).
06/11/24 Josh Sussberg, P.C.
2.40 Attend and participate in first day hearing
(1.5); prepare for same (.9).
06/11/24 Spencer A. Winters, P.C.
1.50 Attend and participate in first day hearing.
06/21/24 Tiffani Chanroo
4.00 Review, revise second day hearing motions
(1.2); correspond with Y. Salloum, K&E team
re same (.6); review, analyze issues re same
(2.2).
06/24/24 Tiffani Chanroo
4.50 Review, revise second day hearing motions
(2.4); review, analyze same (.8); correspond
with D. Hackel, K&E team re same (.6);
correspond with Q. Wetzel re notice of
commencement (.7).
Total
22.40
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 165 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102704
Client Matter: 48520-18
In the Matter of Insurance and Surety Matters
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 1,026.00
Total legal services rendered
$ 1,026.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 166 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050102704
48520-18
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Joshua Raphael
0.30
975.00
292.50
Quin Wetzel
0.90
815.00
733.50
TOTALS
1.20
$ 1,026.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 167 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050102704
48520-18
3
Description of Legal Services
Date
Name
Hours Description
06/20/24 Joshua Raphael
0.20 Review, analyze party in interest’s comments
to orders and correspond with C. Ceresa,
K&E team re same.
06/21/24 Joshua Raphael
0.10 Correspond with A. Salmen, K&E team,
Gibson Dunn re Chubb comments to first day
orders.
06/27/24 Quin Wetzel
0.90 Review, revise insurance order (.8);
correspond with T. Chanroo re same (.1).
Total
1.20
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 168 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102705
Client Matter: 48520-19
In the Matter of Utilities
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 13,824.00
Total legal services rendered
$ 13,824.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 169 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Utilities
Invoice Number:
Matter Number:
1050102705
48520-19
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
0.50
1,345.00
672.50
Tiffani Chanroo
5.50
1,265.00
6,957.50
Kenny Chiaghana
7.60
815.00
6,194.00
TOTALS
13.60
$ 13,824.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 170 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Utilities
Invoice Number:
Matter Number:
1050102705
48520-19
3
Description of Legal Services
Date
Name
Hours Description
06/21/24 Chris Ceresa
0.30 Correspond with T. Chanroo, K&E team re
utilities objection.
06/24/24 Chris Ceresa
0.20 Conference with T. Chanroo re utilities
objection.
06/25/24 Kenny Chiaghana
1.80 Research re objection to utilities motion.
06/26/24 Tiffani Chanroo
0.80 Correspond with K. Chiaghana re utilities
objection (.3); review, analyze issues re same
(.5).
06/26/24 Kenny Chiaghana
1.90 Research re utilities objection.
06/27/24 Tiffani Chanroo
3.10 Correspond with K. Chiaghana, K&E team,
counterparty re utilities objection (1.2);
analyze issues re same (1.9).
06/27/24 Kenny Chiaghana
2.00 Research re utilities objection.
06/28/24 Tiffani Chanroo
1.60 Review, analyze issues re utilities objection
(.9); conference with counterparty re same
(.3); correspond with C. Ceresa, K&E team re
same (.4).
06/28/24 Kenny Chiaghana
1.90 Analyze and revise settlement re utilities
objection (1.0); research re same (.9).
Total
13.60
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 171 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102706
Client Matter: 48520-20
In the Matter of Tax Matters
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 142,679.50
Total legal services rendered
$ 142,679.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 172 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050102706
48520-20
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Hannah Crawford
0.50
1,595.00
797.50
Michael Ehret
12.30
1,895.00
23,308.50
Emanuel Goetz
3.00
620.00
1,860.00
Palmer Gunderson
33.80
845.00
28,561.00
Liz Ji
1.70
1,175.00
1,997.50
Partha Kar
7.80
2,305.00
17,979.00
Sabrina Lieberman
2.30
815.00
1,874.50
Jai Mudhar
3.90
1,265.00
4,933.50
Dan O'Connor
1.50
1,265.00
1,897.50
Florian Schuette
1.00
750.00
750.00
Donatus Wang
1.20
905.00
1,086.00
Nicholas Warther
20.20
1,665.00
33,633.00
Cristina Weidner
2.20
1,665.00
3,663.00
Sara B. Zablotney, P.C.
6.30
2,445.00
15,403.50
Ann-Kathrin Ziegler
4.70
1,050.00
4,935.00
TOTALS
102.40
$ 142,679.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 173 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050102706
48520-20
3
Description of Legal Services
Date
Name
Hours Description
06/09/24 Jai Mudhar
1.00 Correspond with N. Warther, K&E team re
final points pre-filing.
06/09/24 Nicholas Warther
0.20 Telephone conference with PJT, M. Ehret and
K&E team re taxes motion.
06/09/24 Sara B. Zablotney, P.C.
0.70 Correspond with N. Warther, K&E team
structures and first day motions (.2); review,
discuss Swiss agreements (.5).
06/10/24 Michael Ehret
1.70 Telephone conference with BDO, PwC, S.
Zablotney re tax considerations (1.0);
conference with A. Ziegler, K&E team re
Germany, structuring considerations (.2);
review, analyze issues and comment on
documents re same (.5).
06/10/24 Palmer Gunderson
1.50 Telephone conference with BDO, PwC,
Company re tax planning re sale (1.0);
telephone conference with T. Chanroo re
NOL motion (.3); correspond with S.
Zablotney, K&E team re first day tax motions
(.2).
06/10/24 Liz Ji
1.00 Telephone conference with N. Warther, K&E
team, Company re tax planning.
06/10/24 Partha Kar
2.50 Correspond with Company re Switzerland
auditor issues (.8); review, analyze relevant
documents re same (1.2); telephone
conference with Swiss counsel re local audit
issues (.5).
06/10/24 Sabrina Lieberman
1.80 Review, revise tax motion (1.5); conference
with T. Chanroo re same (.3).
06/10/24 Jai Mudhar
0.20 Correspond with P. Kar re Swiss
subordination issue (.1); conference with D.
Wang re next steps (.1).
06/10/24 Dan O'Connor
1.50 Correspond with Y. Salloum, K&E team re
transaction matters, tax considerations (.5);
telephone conference with S. Zablotney, K&E
team, PwC, BDO, Company re tax matters
(1.0).
06/10/24 Donatus Wang
0.50 Conference with M. Ehret, K&E team re tax
workstreams.
06/10/24 Nicholas Warther
0.80 Telephone conference with BDO, PwC, S.
Zablotney, K&E team re tax analysis.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 174 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050102706
48520-20
4
Date
Name
Hours Description
06/10/24 Cristina Weidner
2.20 Telephone conference with Company, P. Kar,
K&E team re Swiss issues.
06/10/24 Sara B. Zablotney, P.C.
1.40 Telephone conference with BDO, PwC re tax
structure and modeling (1.0); telephone
conference with Company re same (.4).
06/10/24 Ann-Kathrin Ziegler
1.00 Correspond with D. Wang re German
workstreams (.8); conference with M. Ehret,
K&E team re German tax workstream (.2).
06/11/24 Hannah Crawford
0.50 Prepare for conference with Company, local
counsel re Switzerland entity issues.
06/11/24 Partha Kar
2.00 Correspond with Company re auditor issues
in Switzerland (.8); telephone conference with
Swiss counsel and Company re local audit
issues (.5); telephone conference and
correspond with J. Mudhar, K&E team re
same (.7).
06/11/24 Jai Mudhar
2.00 Conference with Company, Swiss counsel re
Switzerland auditor issues (.5); correspond
with Company, Swiss counsel re same (.8);
telephone conference with P. Kar re follow up
re same (.7).
06/11/24 Ann-Kathrin Ziegler
0.80 Conferences with J. Mudhar, Company, Swiss
counsel re auditor issues.
06/12/24 Palmer Gunderson
1.20 Review, analyze company structure re
structure presentation for sale process.
06/13/24 Palmer Gunderson
5.20 Draft presentation re tax structuring for
potential sale transactions (4.0); research re
same (1.2).
06/14/24 Palmer Gunderson
0.30 Correspond with N. Warther re structuring
and tax planning considerations.
06/15/24 Sabrina Lieberman
0.20 Correspond with C. Ceresa re corporate
structure, tax issue.
06/17/24 Michael Ehret
1.50 Conferences with E. Goetz, K&E team,
Company, PwC re German tax matters,
structuring, related considerations (1.2);
correspond with Company, PwC re same (.3).
06/17/24 Palmer Gunderson
0.50 Correspond with Company re company tax
planning and structuring issues.
06/17/24 Sabrina Lieberman
0.20 Correspond with Company, P. Gunderson and
K&E team re corporate financing tax
implications.
06/17/24 Nicholas Warther
0.20 Correspond with S. Zablotney, K&E team re
tax modeling.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 175 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050102706
48520-20
5
Date
Name
Hours Description
06/18/24 Michael Ehret
0.70 Conference with S. Zablotney, K&E team,
BDO re tax, structuring considerations (.6);
correspond with N. Warther, K&E team and
follow up re same (.1).
06/18/24 Palmer Gunderson
1.30 Telephone conference with Company
representative re tax planning and diligence
considerations (.6); telephone conference with
N. Warther and S. Zablotney re tax planning
considerations (.2); telephone conference with
M. Ehret and N. Warther re German tax
considerations (.5).
06/18/24 Liz Ji
0.70 Telephone conference with N. Warther, K&E
team, BDO re tax considerations.
06/18/24 Nicholas Warther
2.20 Telephone conference with BDO, S.
Zablotney, K&E team, Company re tax
modeling (.9); review and analyze tax
structuring (.5); correspond with S.
Zablotney, K&E team re German tax
structuring (.8).
06/18/24 Sara B. Zablotney, P.C.
0.50 Telephone conference with N. Warther, P.
Gunderson re tax planning considerations.
06/19/24 Emanuel Goetz
2.00 Review, analyze German tax implications
(.8); draft summary re analysis re same (1.2).
06/19/24 Partha Kar
0.70 Correspond with Company re Swiss auditor
requests and issues (.2); telephone conference
re liquidity issues for Europe with Company,
AlixPartners (.5).
06/19/24 Florian Schuette
1.00 Review, analyze structuring, German tax
considerations (.5); conference with E. Goetz
re same (.5).
06/20/24 Emanuel Goetz
1.00 Review, analyze German tax implications and
summary of relevant fact pattern in relation to
German entities.
06/20/24 Nicholas Warther
1.50 Correspond with S. Zablotney, K&E team re
German tax structuring (.8); review, revise
summary of same (.7).
06/20/24 Sara B. Zablotney, P.C.
0.30 Research re tax analysis.
06/20/24 Ann-Kathrin Ziegler
0.80 Review and comment on tax structuring
issues correspondence.
06/21/24 Ann-Kathrin Ziegler
0.40 Conference with M. Ehret re German tax
workstreams.
06/23/24 Nicholas Warther
0.70 Review, analyze tax structuring.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 176 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050102706
48520-20
6
Date
Name
Hours Description
06/24/24 Michael Ehret
1.70 Review, analyze amendment draft write-up in
relation to German tax implications
re elimination of intergroup receivables,
payables (.9); conference with E. Goetz re
same (.3); correspond with N. Warther, K&E
team re tax, structuring, related considerations
(.2); conference with N. Warther, K&E team
re same, next steps (.3).
06/24/24 Palmer Gunderson
0.10 Correspond with S. Zablotney, K&E team re
draft disclosure schedule and plan of
reorganization re tax considerations.
06/24/24 Partha Kar
1.20 Correspond with Company re auditor issues,
cash flows and comfort letter in Switzerland.
06/24/24 Nicholas Warther
1.20 Correspond with M. Ehret, K&E team re
German tax analysis (.8); review, analyze
plan and disclosures re tax considerations (.4).
06/25/24 Michael Ehret
2.70 Conference with D. Wang, K&E team re
structuring considerations, German
workstreams (1.1); conference with Company
re structuring considerations (.5); conference
with PwC, N. Warther, K&E team re advisor
engagement (.5); correspond with Company,
N. Warther, K&E team re same (.6).
06/25/24 Palmer Gunderson
5.80 Correspond with N. Warther, K&E team re
structure of tax disclosure (.4); review,
comment on disclosure statement re tax (3.9);
review, comment on plan re tax
considerations (.6); continue to review,
comment on disclosure statement re tax (.9).
06/25/24 Partha Kar
1.00 Correspond with Company re advisor services
(.5); telephone conference J. Mudhar re
advisor services (.5).
06/25/24 Donatus Wang
0.70 Conference with M. Ehret, K&E team on
potential tax structuring options for asset deal
and share deal.
06/25/24 Nicholas Warther
1.00 Telephone conference with PwC re German
tax analysis (.6); review, analyze structuring
re tax considerations (.4).
06/25/24 Sara B. Zablotney, P.C.
1.00 Telephone conference re non-US analysis
(.5); coordinate modeling and analysis (.3);
follow up re regulatory issues (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 177 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050102706
48520-20
7
Date
Name
Hours Description
06/25/24 Ann-Kathrin Ziegler
1.70 Conference with M. Ehret, C. Weidner and D.
Wang re tax issues (.5); prepare for same (.4);
correspond with D. Wang, K&E team re
presentation outline re same (.6); conference
with N. Warther, K&E team re advisor
engagement (partial) (.2).
06/26/24 Palmer Gunderson
1.90 Review, prepare tax comments on bid asset
purchase agreement.
06/26/24 Jai Mudhar
0.70 Correspond with Company re EY services.
06/26/24 Nicholas Warther
1.20 Review, analyze structuring, tax
considerations (.6); correspond with S.
Zablotney, K&E team re same (.6).
06/26/24 Sara B. Zablotney, P.C.
0.20 Correspond with N. Warther, K&E team re
PwC analysis.
06/27/24 Palmer Gunderson
3.70 Correspond with N. Warther re tax
considerations re asset purchase agreements,
plan, disclosure statement (.8); review,
comment on tax considerations re asset
purchase agreement (2.9).
06/27/24 Partha Kar
0.40 Correspond with Company re advisor
services.
06/27/24 Sabrina Lieberman
0.10 Correspond with AlixPartners and C. Ceresa
re Hawai'i tax matter.
06/27/24 Nicholas Warther
4.00 Review, revise tax portions of asset purchase
agreement (.8); review, analyze questions re
tax modeling (1.6); review, revise tax portions
of plan (.3); correspond with BDO, Company
re tax modeling (.8); correspond with S.
Zablotney, K&E team re structuring (.5).
06/27/24 Sara B. Zablotney, P.C.
0.20 Correspond with N. Warther, K&E team re
tax structuring considerations.
06/28/24 Michael Ehret
2.50 Review, analyze asset purchase agreement,
documents re tax considerations (1.1);
conference with PwC re structuring, tax
considerations (1.0); correspond with PwC,
K&E team re same (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 178 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050102706
48520-20
8
Date
Name
Hours Description
06/28/24 Palmer Gunderson
8.80 Correspond with N. Warther, K&E team re
potential sale transactions, related structuring
considerations (1.8); revise tax comments re
potential asset purchase agreement for
respiratory diagnostics business (3.1),
telephone conference with S. Zablotney, K&E
team, Company re intercompany debt, asset
basis, tax structure (.4); review, comment on
asset purchase agreement for re tax matters,
related considerations (3.5).
06/28/24 Nicholas Warther
3.50 Telephone conference with BDO re tax
modeling (1.0); review, revise tax portions of
asset purchase agreement (1.4); correspond
with S. Zablotney, K&E team re tax
structuring (.7); review, revise tax portions of
plan (.4).
06/28/24 Sara B. Zablotney, P.C.
2.00 Telephone conference with P. Gunderson,
Company re tax structure, related
considerations (.9); review, comment on asset
purchase agreement re tax considerations (.5);
analyze deposit (.6).
06/29/24 Palmer Gunderson
0.60 Correspond with S. Zablotney, K&E team re
asset purchase agreements and transaction
structure (.4); review, analyze asset purchase
agreement re tax matters (.2).
06/29/24 Nicholas Warther
1.70 Review, revise tax portions of plan and
disclosure statement (.8); correspond with M.
Ehret, K&E team re same (.6); correspond
with M. Ehret, K&E team re German tax
issues (.3).
06/30/24 Michael Ehret
1.50 Review, analyze correspondence from P.
Gunderson, N. Warther re draft asset purchase
agreement re tax considerations (.4); review,
analyze draft asset purchase agreement (.8);
correspond with N. Warther, K&E team re
same (.3).
06/30/24 Palmer Gunderson
2.90 Revise tax comments re asset purchase
agreements (2.1); correspond with N.
Warther, K&E team re asset purchase
agreements and transaction structure (.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 179 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050102706
48520-20
9
Date
Name
Hours Description
06/30/24 Nicholas Warther
2.00 Review, revise tax portions of asset purchase
agreements (1.6); review, revise tax
disclosures (.4).
Total
102.40
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 180 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102707
Client Matter: 48520-21
In the Matter of Case Administration
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 101,014.50
Total legal services rendered
$ 101,014.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 181 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050102707
48520-21
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
4.60
1,345.00
6,187.00
Tiffani Chanroo
23.80
1,265.00
30,107.00
Kenny Chiaghana
15.90
815.00
12,958.50
Hannah Crawford
0.90
1,595.00
1,435.50
Tabitha J. De Paulo
1.60
1,435.00
2,296.00
Jaina Desai
3.00
815.00
2,445.00
Amy Donahue
3.30
525.00
1,732.50
Julia R. Foster
7.20
525.00
3,780.00
David Hackel
5.90
975.00
5,752.50
Sabrina Lieberman
15.80
815.00
12,877.00
Rebecca J. Marston
3.70
1,265.00
4,680.50
Sarah Osborne
2.50
815.00
2,037.50
Carolin Paus
0.60
620.00
372.00
Joshua Raphael
1.20
975.00
1,170.00
Yusuf Salloum
2.00
1,595.00
3,190.00
Adrian Salmen
1.10
1,095.00
1,204.50
Seth Sanders
2.80
1,095.00
3,066.00
Josh Sussberg, P.C.
0.20
2,305.00
461.00
Donatus Wang
1.20
905.00
1,086.00
Cristina Weidner
1.00
1,665.00
1,665.00
Spencer A. Winters, P.C.
0.50
1,685.00
842.50
Tanzila Zomo
4.70
355.00
1,668.50
TOTALS
103.50
$ 101,014.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 182 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050102707
48520-21
3
Description of Legal Services
Date
Name
Hours Description
06/09/24 Hannah Crawford
0.20 Correspond with P. Kar and J. Madhur re
matter status.
06/09/24 Donatus Wang
1.20 Correspond with Company re execution of
standstill agreement.
06/10/24 Amy Donahue
1.00 Download filed motion and documents and
organize.
06/10/24 Carolin Paus
0.60 Update workstream summary (.3); summarize
open topics (.3).
06/11/24 Tiffani Chanroo
4.00 Correspond with S. Lieberman, K&E team re
case status (2.1); review, analyze correspond
re work in process (1.9).
06/11/24 Tabitha J. De Paulo
1.60 Conference with PJT for first‑day hearing
(.2); correspond with PJT re same (.2);
conference with AlixPartners and Company re
same (1.2).
06/11/24 Jaina Desai
0.50 Review, revise case timeline (.4); correspond
with K. Trevett re same (.1).
06/11/24 Amy Donahue
0.60 Create and revise calendar invites for
upcoming hearings and distribute to C.
Ceresa, K&E team (.3); coordinate technical
logistics re hearing listen-only line (.3).
06/11/24 Seth Sanders
1.00 Correspond with declarants re hearing prep
(.4); telephone conference with PJT re same
(.6).
06/11/24 Tanzila Zomo
0.50 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.4);
correspond with C. Ceresa, K&E team re
same (.1).
06/11/24 Tanzila Zomo
0.50 Coordinate, monitor first day hearing line.
06/12/24 Tiffani Chanroo
4.40 Telephone conference with C. Ceresa re case
status (.8); correspond with C. Ceresa, K&E
team, AlixPartners team re work in process
(2.4); review, analyze materials re same (1.2).
06/12/24 Kenny Chiaghana
0.30 Draft summary of upcoming key dates and
deadlines re first day orders.
06/12/24 Jaina Desai
0.10 Correspond with T. Chanroo re post-petition
workstreams.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 183 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050102707
48520-21
4
Date
Name
Hours Description
06/12/24 David Hackel
3.30 Review, analyze issues re first day pleadings
(.9); draft, revise summary re same (1.4);
correspond with R. Meintjes, K&E team re
same (.3); research re same, precedent re first
day pleading, hearing issues (.7).
06/12/24 Rebecca J. Marston
0.10 Correspond with D. Hackel re case
description.
06/12/24 Tanzila Zomo
0.50 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.4);
correspond with C. Ceresa, K&E team re
same (.1).
06/13/24 Tiffani Chanroo
2.60 Conference with C. Ceresa, K&E team re
work in process (.5); conference with C.
Ceresa re case timeline (.6); review, analyze
issues re same (1.1); review, analyze
correspondence re case status (.4).
06/13/24 Kenny Chiaghana
1.90 Review, revise work in process summary
(1.4); conference with C. Ceresa, K&E team
re work in process (.5).
06/13/24 Jaina Desai
0.60 Telephone conference with C. Ceresa, K&E
team re case status, next steps (.5); correspond
with T. Chanroo re same (.1).
06/13/24 Amy Donahue
0.50 Telephone conference with C. Ceresa, K&E
team re work in process.
06/13/24 Julia R. Foster
1.30 Conference with C. Ceresa, K&E team re
work in process (.5); correspond with S.
Lieberman and K. Chiaghana re case
deadlines (.4); review, revise pleading
template (.4).
06/13/24 David Hackel
1.60 Review, analyze legal issues re first day
pleadings (.3); revise summary re same (.5);
correspond with C. Ceresa, K&E team re
same (.5); research re same, precedent re first
day pleading items (.3).
06/13/24 Sabrina Lieberman
0.30 Conference with C. Ceresa and K&E team re
work in process (partial).
06/13/24 Sarah Osborne
0.50 Telephone conference with C. Ceresa, K&E
team re case updates.
06/13/24 Joshua Raphael
0.40 Telephone conference with C. Ceresa, K&E
team re work in process (partial).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 184 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050102707
48520-21
5
Date
Name
Hours Description
06/13/24 Seth Sanders
0.90 Review, revise work in process summary (.3);
correspond with K. Chiaghana re same (.1);
telephone conference with C. Ceresa, K&E
team re work in process (.5).
06/13/24 Tanzila Zomo
0.70 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.1);
correspond with C. Ceresa, K&E team re
same (.1); K&E team re case status updates
(.5).
06/14/24 Tiffani Chanroo
2.10 Review, analyze correspondence re case
status (1.8); correspond with C. Ceresa, K&E
team re same (.3).
06/14/24 Kenny Chiaghana
0.80 Review, revise summary re upcoming key
case dates and deadlines re first day notions
and orders.
06/14/24 Sabrina Lieberman
0.20 Correspond with Cole Schotz and Omni re
master service list.
06/14/24 Rebecca J. Marston
0.20 Draft and submit weekly case report.
06/14/24 Tanzila Zomo
0.20 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.1);
correspond with C. Ceresa, K&E team re
same (.1).
06/15/24 Sabrina Lieberman
0.10 Correspond with C. Ceresa and K&E team re
service list.
06/16/24 Sabrina Lieberman
0.30 Review and analyze correspondence from C.
Ceresa and K&E team re work in process.
06/17/24 Chris Ceresa
1.00 Review, analyze case materials (.7);
correspond with T. Chanroo, K&E team,
advisors re same (.3).
06/17/24 Kenny Chiaghana
1.20 Review, revise summary re key dates and
deadlines (.9); review, revise work in process
summary (.3).
06/17/24 Amy Donahue
0.20 Create and revise calendar invites for
upcoming hearings.
06/17/24 Julia R. Foster
0.30 Review, analyze pleading template.
06/17/24 Sabrina Lieberman
1.00 Conference with T. Chanroo and AlixPartners
re reporting obligations (.5); conference with
T. Chanroo, K&E team re work in process
(.4); correspond with C. Ceresa and T.
Chanroo re same (.1).
06/17/24 Spencer A. Winters, P.C.
0.50 Prepare for and attend weekly telephone
conference with Company and advisors.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 185 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050102707
48520-21
6
Date
Name
Hours Description
06/17/24 Tanzila Zomo
0.20 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.1);
correspond with C. Ceresa, K&E team re
same (.1).
06/18/24 Chris Ceresa
0.50 Review, analyze case materials (.3);
correspond with Y. Salloum, K&E team,
advisors re same (.2).
06/18/24 Tiffani Chanroo
1.10 Conference with Y. Salloum, K&E team,
Company re various case issues (.5);
conference with C. Ceresa re same (.6).
06/18/24 Tiffani Chanroo
2.10 Conference with Cole Schotz team, C. Ceresa
re second day hearing (.5); review, analyze
issues re same (.6); conference with C. Ceresa
re second day motions (.4); correspond with
Y. Salloum, K&E team re second day motions
(.6).
06/18/24 Kenny Chiaghana
0.90 Review, revise summary re case deadlines.
06/18/24 Jaina Desai
0.20 Review, revise work in process summary
chart (.1); correspond with K. Chiaghana, R.
Marston re same (.1).
06/18/24 Jaina Desai
0.30 Review, revise case timeline.
06/18/24 Julia R. Foster
0.70 Correspond with D. Hackel re first day orders
(.4); compile first day entered orders (.3).
06/18/24 Sabrina Lieberman
4.30 Conference with AlixPartners re noticing and
service (.5); conference with Omni re same
(.5); conference with C. Ceresa re same (.3);
conference with R. Meintjes and K&E team
re same (.2); correspond with PJT, Omni, C.
Ceresa and K&E team re same (1.9); research
noticing parties (.9).
06/18/24 Rebecca J. Marston
2.20 Research noticing parties (1.9); correspond
with S. Lieberman, K&E team re same (.3).
06/18/24 Tanzila Zomo
0.30 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.2);
correspond with C. Ceresa, K&E team re
same (.1).
06/19/24 Tiffani Chanroo
0.80 Review, analyze materials re second day
hearing (.6); correspond with Y. Salloum,
K&E team re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 186 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050102707
48520-21
7
Date
Name
Hours Description
06/19/24 Sabrina Lieberman
1.00 Correspond with M. Boney and R. Marston re
anti-trust billing (.2); conference with Omni
re supplemental noticing (.1); correspond with
C. Ceresa re same (.2); review and analyze
correspondence from C. Ceresa and K&E
team re work in process. (.1); conference with
Omni (.1); review and analyze
correspondence re same (.3).
06/19/24 Cristina Weidner
1.00 Conference with A. Ziegler, K&E team re
work in process.
06/20/24 Chris Ceresa
0.30 Review, analyze case materials (.2);
correspond with T. Chanroo, K&E team,
advisors re same (.1).
06/20/24 Tiffani Chanroo
1.10 Conference with R. Marston, K&E team re
work in process (.5); conference with C.
Ceresa re case status (.6).
06/20/24 Tiffani Chanroo
1.60 Review, revise second day pleadings (1.2);
correspond with D. Hackel, K&E team re
same (.4).
06/20/24 Kenny Chiaghana
2.60 Review, revise summary re key dates and
deadlines (1.4); participate in conference with
K&E team, C. Ceresa re work in process (.2);
analyze, revise, work in process summary (1).
06/20/24 Jaina Desai
0.50 Telephone conference with T. Chanroo re
case status, next steps.
06/20/24 Amy Donahue
0.30 Telephone conference with T. Chanroo, K&E
team re work in process (partial).
06/20/24 Julia R. Foster
0.70 Telephone conference with T. Chanroo, K&E
team re work in process (.5); review, revise
post-petition pleading template (.2).
06/20/24 David Hackel
0.30 Conference with C. Ceresa, K&E team re case
status, next steps (partial).
06/20/24 Sabrina Lieberman
0.40 Conference with T. Chanroo and K&E team
re work in process (partial).
06/20/24 Rebecca J. Marston
0.50 Conference with C. Ceresa, K&E team re
work in process.
06/20/24 Sarah Osborne
0.50 Telephone conference with C. Ceresa, K&E
team re case updates.
06/20/24 Joshua Raphael
0.20 Telephone conference with C. Ceresa, K&E
team re work in process (partial).
06/20/24 Adrian Salmen
0.50 Conference with T. Chanroo, K&E team re
work in process.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 187 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050102707
48520-21
8
Date
Name
Hours Description
06/20/24 Seth Sanders
0.40 Telephone conference with C. Ceresa, K&E
team re work in process (partial).
06/20/24 Tanzila Zomo
0.30 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.2);
correspond with C. Ceresa, K&E team re
same (.1).
06/20/24 Tanzila Zomo
0.50 Telephone conference with J. Foster, K&E
team re case status updates.
06/21/24 Chris Ceresa
0.80 Review, analyze case materials (.4);
correspond with Y. Salloum, K&E team,
advisors re same (.4).
06/21/24 Hannah Crawford
0.20 Correspond with A. Chan and J. Mudhar re
list of local counsel.
06/21/24 Julia R. Foster
0.50 Compile filed first day motions and orders.
06/21/24 Sabrina Lieberman
0.50 Correspond with Omni re notice (.2); review
and analyze correspondence from Y. Salloum
and K&E team (.3).
06/21/24 Rebecca J. Marston
0.10 Draft weekly case report.
06/21/24 Yusuf Salloum
1.30 Review, revise second day pleadings.
06/22/24 Chris Ceresa
0.30 Review, analyze case materials (.2);
correspond with T. Chanroo, K&E team,
advisors re same (.1).
06/22/24 Tiffani Chanroo
0.30 Correspond with Y. Salloum, K&E team re
second day motions.
06/23/24 Tiffani Chanroo
0.30 Correspond with Gibson, Y. Salloum, K&E
team re second day motions.
06/24/24 Chris Ceresa
0.20 Conference with Y. Salloum re work in
process.
06/24/24 Kenny Chiaghana
2.50 Analyze and revise summary of upcoming
court dates and deadlines (1.7); analyze and
revise work in process summary (.8).
06/24/24 Jaina Desai
0.20 Review, revise work in process summary.
06/24/24 Sabrina Lieberman
0.10 Revise work in process summary.
06/24/24 Sabrina Lieberman
0.50 Correspond with C. Ceresa and R. Marston re
work in process.
06/25/24 Chris Ceresa
0.80 Conference with T. Chanroo K&E team re
work in process (.6); prepare for same (.2).
06/25/24 Tiffani Chanroo
0.80 Conference with C. Ceresa, K&E team re
work in process (.6); prepare for same (.2).
06/25/24 Tiffani Chanroo
1.70 Review, revise second day hearing motions
(1.3); correspond with C. Ceresa re same (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 188 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050102707
48520-21
9
Date
Name
Hours Description
06/25/24 Kenny Chiaghana
1.80 Analyze and revise work in process summary
(1.2); conference with K&E team and C.
Ceresa re work in process (.6).
06/25/24 Hannah Crawford
0.30 Correspond with Y. Salloum, K&E team re
case status.
06/25/24 Jaina Desai
0.60 Telephone conference with C. Ceresa, K&E
team re case status, next steps.
06/25/24 Amy Donahue
0.70 Telephone conference with C. Ceresa, K&E
team re work in process (.6); prepare for same
(.1).
06/25/24 Julia R. Foster
1.10 Conference with C. Ceresa, K&E team re
work in process (.6); review and revise orders
re July 9, 2024 hearing (.5).
06/25/24 Julia R. Foster
0.30 Coordinate calendar invites re July 17, 2024
341 meeting.
06/25/24 David Hackel
0.70 Conference with C. Ceresa, K&E team re case
status, next steps (.6); revise work in process
chart re same (.1).
06/25/24 Sabrina Lieberman
1.10 Conference with Y. Salloum and K&E team
re work in process (.6); review and analyze
correspondence from C. Ceresa and K&E
team re same (.5).
06/25/24 Rebecca J. Marston
0.60 Conference with C. Ceresa, K&E team re
work in process.
06/25/24 Sarah Osborne
0.50 Telephone conference with C. Ceresa, K&E
team re case updates (partial).
06/25/24 Joshua Raphael
0.60 Conference with C. Ceresa, K&E team re
work in process.
06/25/24 Yusuf Salloum
0.70 Conference with C. Ceresa, K&E team re
work in process (.6); prepare for same (.1).
06/25/24 Adrian Salmen
0.60 Conference with C. Ceresa, K&E team re
work in process.
06/25/24 Seth Sanders
0.50 Conference with C. Ceresa, K&E team re case
status (partial).
06/25/24 Josh Sussberg, P.C.
0.20 Review, analyze miscellaneous
correspondence.
06/25/24 Tanzila Zomo
0.20 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.1);
correspond with C. Ceresa, K&E team re
same (.1).
06/25/24 Tanzila Zomo
0.50 Telephone conference with J. Foster, K&E
team re case status updates (partial).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 189 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050102707
48520-21
10
Date
Name
Hours Description
06/26/24 Chris Ceresa
0.70 Review, analyze first day motions for second
day (.4); review, analyze other second day
hearing motions (.3).
06/26/24 Tiffani Chanroo
0.90 Review, analyze issues re second day hearing.
06/26/24 Kenny Chiaghana
2.10 Review, revise summary re key dates and
deadlines (1.1); analyze and revise work in
process summary (1).
06/26/24 Julia R. Foster
0.90 Review and revise pleading template (.7);
correspond with C. Ceresa re July 9, 2024
hearing (.2).
06/26/24 Sabrina Lieberman
0.60 Review and analyze correspondence from C.
Ceresa and K&E team re work in process.
06/27/24 Kenny Chiaghana
1.10 Review, revise summary of key dates and
deadlines (.7); review, revise work in process
summary (.4).
06/27/24 Hannah Crawford
0.20 Review, analyze correspondence re case
status.
06/27/24 Sabrina Lieberman
3.10 Conference with Omni re noticing plan (.3);
correspond with C. Ceresa and S. Osborne re
same (.2); review and analyze correspondence
from C. Ceresa and K&E team re work in
process. (2.6).
06/27/24 Sarah Osborne
1.00 Research re notice and master service list (.8);
correspond with Omni, C. Ceresa, K&E team
re same (.2).
06/27/24 Tanzila Zomo
0.30 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.2);
correspond with C. Ceresa, K&E team re
same (.1).
06/28/24 Kenny Chiaghana
0.70 Review, revise summary re work in process.
06/28/24 Julia R. Foster
1.40 Review and revise pleading template (.5);
review and revise first day orders (.9).
06/28/24 Sabrina Lieberman
2.30 Correspond with C. Ceresa and K&E team re
work in process (1.3); research re same (1.0).
Total
103.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 190 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102708
Client Matter: 48520-22
In the Matter of Retention - K&E
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 139,606.00
Total legal services rendered
$ 139,606.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 191 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050102708
48520-22
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
6.60
1,345.00
8,877.00
Michael Y. Chan
16.50
395.00
6,517.50
Matthew Cooper
5.00
340.00
1,700.00
Marta Dudyan
9.00
340.00
3,060.00
Julia R. Foster
0.90
525.00
472.50
Susan D. Golden
1.80
1,600.00
2,880.00
Sabrina Lieberman
42.60
815.00
34,719.00
Rebecca J. Marston
48.60
1,265.00
61,479.00
Eric Nyberg
4.00
340.00
1,360.00
Sarah Osborne
6.20
815.00
5,053.00
Yusuf Salloum
7.40
1,595.00
11,803.00
Spencer A. Winters, P.C.
1.00
1,685.00
1,685.00
TOTALS
149.60
$ 139,606.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 192 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050102708
48520-22
3
Description of Legal Services
Date
Name
Hours Description
06/10/24 Rebecca J. Marston
0.40 Correspond with Y. Salloum, K&E team re
billing memorandum, post-filing matter
categories.
06/11/24 Sabrina Lieberman
0.10 Draft correspondence to R. Marston and K&E
team re postpetition billing procedures.
06/11/24 Rebecca J. Marston
1.70 Correspond with C. Ceresa re billing
memorandum, matter categories (.4);
correspond with S. Lieberman re timekeeper
list (.4); correspond with S. Lieberman, K&E
team re matter categories (.9).
06/12/24 Marta Dudyan
4.00 Draft conflict disclosures for schedules (3.5);
research re same (.5).
06/12/24 Julia R. Foster
0.40 Correspond with S. Lieberman re K&E
retention application.
06/12/24 Sabrina Lieberman
4.20 Revise K&E retention application (2.5);
correspond with R. Marston and K&E team re
same (.7); correspond with R. Marston re
conflicts reports and retention application
(.5); correspond with C. Ceresa and R.
Marston re postpetition billing (.3);
correspond with S. Osborne re conflicts
reports (.2).
06/12/24 Rebecca J. Marston
3.40 Correspond with C. Ceresa, K&E team re new
matter categories (.9); correspond with C.
Ceresa, K&E team re K&E retention
application, Pillowtex chart (1.3); review,
revise same (.6); correspond with C. Ceresa re
retention declaration (.2); correspond with S.
Lieberman re specific disclosures (.4).
06/12/24 Sarah Osborne
0.50 Review, revise parties in interest list re
potential conflicts.
06/13/24 Marta Dudyan
2.00 Analyze update for supplemental disclosure
of creditors/entities.
06/13/24 Sabrina Lieberman
1.90 Review, revise K&E retention application
(1.6); correspond with R. Marston and S.
Osborne re same (.3).
06/13/24 Rebecca J. Marston
5.40 Correspond with D. Wang, K&E team re
billing categories (.2); review, revise retention
application (3.9); correspond with C. Ceresa,
K&E team re same (.8); continue to review,
revise retention application (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 193 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050102708
48520-22
4
Date
Name
Hours Description
06/13/24 Sarah Osborne
3.00 Review, revise parties in interest list.
06/14/24 Chris Ceresa
4.90 Review, revise K&E retention application,
declaration in support, and related disclosures
(3.9); telephone conferences with R. Marston,
K&E team re same (.6); continue to review,
revise K&E retention application, declaration
in support, and related disclosures (.4).
06/14/24 Michael Y. Chan
4.00 Organize and prepare parties for conflicts
searching for creditors/entities (1.5); research
creditors/entities (1.5); analyze disclosure of
creditors/entities (1.0).
06/14/24 Matthew Cooper
2.00 Analyze disclosure of creditors/entities
submitted as tax authorities.
06/14/24 Marta Dudyan
2.50 Organize and review supplemental
disclosures relating to creditors/entities.
06/14/24 Julia R. Foster
0.50 Research precedent re K&E retention
applications.
06/14/24 Sabrina Lieberman
5.50 Conference with C. Ceresa re K&E retention
application (.9); conference with R. Marston
re same (.2); conference with K. Chiaghana re
same (.1); conference with D. O'Connor re
same (.1); correspond with D. O'Connor and
K&E team re same (.7); review, revise same
(3.5).
06/14/24 Rebecca J. Marston
5.40 Review, revise K&E retention application
(3.9); correspond and telephone conference
with S. Lieberman, K&E team re same (.6);
continue to review, revise K&E retention
application (.9).
06/15/24 Chris Ceresa
0.30 Review, revise K&E retention application,
declaration, disclosures re same (.2);
correspond with S. Lieberman, K&E team re
same (.1).
06/15/24 Sabrina Lieberman
4.00 Review, revise K&E retention application
(3.8); research re same (.2).
06/15/24 Rebecca J. Marston
5.50 Correspond with Y. Salloum, K&E team re
retention application (.4); review, revise same
(3.9); correspond with S. Lieberman re same
(1.2).
06/15/24 Yusuf Salloum
3.00 Review, revise retention application.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 194 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050102708
48520-22
5
Date
Name
Hours Description
06/16/24 Sabrina Lieberman
2.60 Revise K&E retention application (1.5);
correspond with Y. Salloum and K&E team re
same (.1); review, analyze conflicts reports
(1.0).
06/16/24 Rebecca J. Marston
0.40 Correspond with Y. Salloum re retention
application, parties in interest list.
06/17/24 Michael Y. Chan
4.50 Organize and prepare parties for conflicts
searching for creditors/entities (.5); research
creditors/entities (.5); draft schedule 2 for
declaration (3.5).
06/17/24 Matthew Cooper
3.00 Organize and review disclosures relating to
all original creditors/entities (2.0); analyze
disclosure of creditors/entities submitted as
lenders and agents (1.0).
06/17/24 Sabrina Lieberman
1.80 Revise K&E retention application (1.6);
correspond with Y. Salloum and K&E team re
same (.2).
06/17/24 Rebecca J. Marston
1.40 Review, revise K&E retention application
(1.2); correspond with S. Lieberman re same
(.2).
06/17/24 Sarah Osborne
1.30 Review, analyze conflict reports re potential
conflict issues.
06/17/24 Yusuf Salloum
1.00 Review, revise K&E retention application.
06/18/24 Michael Y. Chan
2.50 Organize and prepare parties for conflicts
searching for creditors/entities (1.0); analyze
disclosure of creditors/entities (1.0); draft
schedule 2 for declaration (.5).
06/18/24 Sabrina Lieberman
1.60 Revise K&E retention application (.2);
correspond with Y. Salloum and K&E team re
same (.7); correspond with C. Ceresa and
K&E team re conflicts reports and surveys
(.7).
06/18/24 Rebecca J. Marston
0.40 Correspond with S. Lieberman re retention
work streams (.2); correspond with S. Golden
re K&E retention application (.2).
06/19/24 Sabrina Lieberman
1.00 Conference with C. Ceresa and R. Marston re
retention work in process.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 195 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050102708
48520-22
6
Date
Name
Hours Description
06/19/24 Rebecca J. Marston
4.90 Correspond with S. Lieberman re
parties‑in‑interest survey results (.2); review,
analyze same (.4); correspond with K&E
billing team re fee estimates (.3); conferences
and correspond with C. Ceresa, S. Lieberman
re retention work streams (.8); review, revise
K&E retention application (3.0); correspond
and conference with S. Lieberman re same
(.2).
06/19/24 Spencer A. Winters, P.C.
1.00 Review, revise K&E retention application.
06/20/24 Michael Y. Chan
3.00 Organize, prepare parties for conflicts
searching for creditors/entities (.7); research
creditors/entities (.3); analyze disclosure of
creditors/entities (.6); draft schedules 2 for
declaration in support of retention (1.4).
06/20/24 Marta Dudyan
0.50 Review, analyze correspondence re conflicts
reports.
06/20/24 Susan D. Golden
1.20 Review, revise K&E retention application.
06/20/24 Sabrina Lieberman
1.50 Revise K&E retention application (.8);
correspond with Y. Salloum and K&E team re
conflicts reports (.7).
06/20/24 Rebecca J. Marston
0.40 Correspond with S. Lieberman re
parties‑in‑interest list survey results, K&E
retention application.
06/20/24 Yusuf Salloum
1.00 Review, revise retention application, budget.
06/21/24 Chris Ceresa
0.60 Review, comment on draft K&E retention
application materials.
06/21/24 Michael Y. Chan
2.50 Organize and prepare parties for conflicts
searching for creditors/entities (1.0); analyze
disclosure of creditors/entities (1.0); draft
schedules 1 & 2 for declaration (.5).
06/21/24 Sabrina Lieberman
1.00 Review, revise K&E retention application
(.5); correspond with R. Marston and K&E
team re conflicts reports (.1); review, analyze
same (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 196 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050102708
48520-22
7
Date
Name
Hours Description
06/21/24 Rebecca J. Marston
5.10 Correspond with S. Lieberman re disclosure
schedules (.3); correspond with C. Ceresa,
K&E team re ordinary course professional
and interim compensation motions (1.3);
correspond with U.S. Trustee re same (.2);
review, revise same (1.9); correspond with S.
Lieberman, K&E team re OCPs (1.1);
correspond with Omni team re noticing of
same (.3).
06/21/24 Sarah Osborne
1.40 Review, analyze conflicts reports re Schedule
2 disclosures (1.3); correspond with S.
Lieberman re same (.1).
06/22/24 Sabrina Lieberman
1.20 Review, analyze conflicts reports (.7); review,
revise K&E retention application (.2); review,
analyze K&E invoice re privilege and
confidentiality (.3).
06/23/24 Sabrina Lieberman
6.20 Revise K&E invoice re privilege and
confidentiality (3.9); correspond with Y.
Salloum re K&E retention application (.2);
review, revise same (.3); review, continue to
revise K&E invoice re privilege and
confidentiality (1.8).
06/23/24 Rebecca J. Marston
0.30 Correspond with Gibson Dunn team re
ordinary course professional, interim
compensation motions.
06/24/24 Susan D. Golden
0.60 Telephone conference with Y. Salloum re
K&E retention application (.2); review,
analyze precedent re same (.2); correspond
with Y. Salloum re same (.2).
06/24/24 Sabrina Lieberman
0.80 Revise K&E retention application (.2);
correspond with Y. Salloum and K&E team re
same (.6).
06/24/24 Rebecca J. Marston
8.50 Review, revise invoice (1.6); review, revise
ordinary course professional motion (3.1);
correspond with S. Lieberman re ordinary
course professionals (.8); correspond with C.
Ceresa re ordinary course professional
motion, interim compensation motion (.3);
review, revise interim compensation motion
(2.2); correspond with S. Lieberman re same
(.5).
06/24/24 Yusuf Salloum
1.60 Review, revise K&E retention application.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 197 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050102708
48520-22
8
Date
Name
Hours Description
06/25/24 Sabrina Lieberman
4.20 Review, revise K&E retention application
(2.5); correspond with C. Ceresa and K&E
team re same (1.7).
06/25/24 Rebecca J. Marston
5.40 Review, revise ordinary course professional
motion (1.4); correspond with S. Lieberman,
K&E team re same (2.1); correspond with
Gibson Dunn re same (.2); correspond with S.
Winters, S. Golden, K&E team re interim
compensation motion (.4); review, revise
same (1.3).
06/25/24 Eric Nyberg
1.00 Organize, review disclosures relating to
creditors/entities.
06/25/24 Yusuf Salloum
0.80 Review, revise K&E retention application.
06/26/24 Sabrina Lieberman
2.90 Review, revise K&E retention application
(2.6); correspond with Y. Salloum and K&E
team re same (.1); conference with Y.
Salloum re same (.2).
06/26/24 Eric Nyberg
0.50 Review, analyze update for disclosure of
creditors/entities.
06/27/24 Sabrina Lieberman
0.30 Correspond with Y. Salloum and K&E team
re K&E retention application.
06/27/24 Eric Nyberg
2.00 Prepare list of parties for conflicts review
(1.0); review, analyze potential disclosures re
retention application (1.0).
06/28/24 Chris Ceresa
0.50 Review, comment on budget and staffing
memo re K&E retention (.3); correspond with
R. Marston, K&E team re same (.2).
06/28/24 Sabrina Lieberman
0.90 Correspond with Y. Salloum and K&E team
re K&E retention application and ancillary
documents.
06/28/24 Eric Nyberg
0.50 Review, analyze disclosure of
creditors/entities.
06/29/24 Chris Ceresa
0.30 Review, comment on budget and staffing
memo re K&E retention (.2); correspond with
R. Marston, K&E team re same (.1).
06/29/24 Sabrina Lieberman
0.90 Review, revise budget and staffing
memorandum.
Total
149.60
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 198 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102709
Client Matter: 48520-23
In the Matter of Retention - Non K&E
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 64,777.50
Total legal services rendered
$ 64,777.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 199 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050102709
48520-23
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
4.30
1,345.00
5,783.50
Amy Donahue
1.00
525.00
525.00
Susan D. Golden
0.40
1,600.00
640.00
Sabrina Lieberman
27.20
815.00
22,168.00
Rebecca J. Marston
21.80
1,265.00
27,577.00
Robert Orren
0.50
625.00
312.50
Sarah Osborne
9.10
815.00
7,416.50
Tanzila Zomo
1.00
355.00
355.00
TOTALS
65.30
$ 64,777.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 200 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050102709
48520-23
3
Description of Legal Services
Date
Name
Hours Description
06/10/24 Sabrina Lieberman
2.50 Review, revise motion to retain claims agent
(.5); revise motion to seal applications to
retain professionals (2.0).
06/10/24 Robert Orren
0.50 Retrieve Chief Restructuring Officer
engagement letter precedent (.3); correspond
with D. Hackel re same (.2).
06/11/24 Amy Donahue
1.00 Review, revise interim compensation motion.
06/11/24 Tanzila Zomo
1.00 Draft form application re professional
retentions.
06/12/24 Sabrina Lieberman
1.40 Revise PJT retention application.
06/12/24 Rebecca J. Marston
0.20 Correspond with AlixPartners re retention
applications.
06/13/24 Sabrina Lieberman
1.10 Review, revise PJT retention application (.2);
correspond with R. Marston re same (.1);
correspond with PJT, Omni, Cole Schotz,
BDO, AlixPartners, R. Marston re parties-
in‑interest list (.8).
06/13/24 Rebecca J. Marston
0.20 Correspond with S. Lieberman re PwC
retention.
06/14/24 Sabrina Lieberman
0.10 Correspond with R. Marston re PwC
retention.
06/14/24 Rebecca J. Marston
0.20 Correspond with S. Lieberman re PwC
retention.
06/17/24 Rebecca J. Marston
6.50 Correspond with S. Lieberman, K&E team re
PwC retention, service list parties, parties‑in
interest‑list, PJT, AlixPartners retention
applications (3.4); review, revise PJT
retention application (2.1); continue to
correspond with S. Lieberman, K&E team re
PwC retention, service list parties, parties‑in
interest‑list, PJT, AlixPartners retention
applications (1.0).
06/18/24 Sabrina Lieberman
1.90 Review, revise PJT retention application (.4);
correspond with C. Ceresa and R. Marston re
professional retention applications (.5);
correspond with AlixPartners, Omni and
BDO re same (.3); research precedent re
administrative advisor application (.7).
06/18/24 Rebecca J. Marston
0.20 Correspond with PwC, S. Lieberman, K&E
team re retention.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 201 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050102709
48520-23
4
Date
Name
Hours Description
06/18/24 Rebecca J. Marston
1.40 Correspond with C. Ceresa, K&E team re
ordinary course professional motion, interim
compensation motion (1.1); correspond with
K&E team re ordinary course professional list
(.3).
06/19/24 Chris Ceresa
2.70 Telephone conference with R. Marston and
K&E team re professional retention matters
(.6); review, revise draft PJT application
(1.1); review, revise draft interim
compensation procedures motion (1.0).
06/19/24 Sabrina Lieberman
1.50 Conference with Omni re administrative agent
application (.1); correspond with Omni, Cole
Schotz, R. Marston, K&E team re same (.3);
review, revise PJT retention application (.9);
correspond with R. Marston and K&E team re
PwC retention application (.2).
06/19/24 Rebecca J. Marston
1.20 Correspond with BDO re fee estimates (.3);
correspond with S. Lieberman re Omni
retention application (.2); correspond with S.
Lieberman re retention of non-U.S. regulatory
counsel (.7).
06/19/24 Rebecca J. Marston
5.50 Draft ordinary course professional motion
(3.9); review, revise interim compensation
motion (1.2); correspond with S. Osborne re
same (.4).
06/19/24 Sarah Osborne
4.00 Draft interim compensation order (1.6);
research precedent re same (.3); correspond
with R. Marston re same (.2); review, revise
same (1.9).
06/20/24 Chris Ceresa
0.50 Review, comment on draft interim
compensation and ordinary course
professional motions.
06/20/24 Sabrina Lieberman
1.10 Correspond with AlixPartners, BDO, C.
Ceresa and K&E team re ordinary course
professionals.
06/20/24 Rebecca J. Marston
3.80 Review, revise ordinary course professional
motion, interim compensation motion (2.3);
correspond with Cole Schotz team re same
(.2); correspond with C. Ceresa, K&E team re
same (.6); correspond with AlixPartners team,
K&E team re ordinary course professionals
(.7).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 202 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050102709
48520-23
5
Date
Name
Hours Description
06/20/24 Sarah Osborne
0.30 Review, revise interim compensation motion
(.1); correspond with C. Ceresa, K&E team re
same (.2).
06/21/24 Chris Ceresa
0.20 Review, comment on draft interim
compensation and ordinary course
professional motions.
06/21/24 Sabrina Lieberman
0.80 Correspond with AlixPartners, C. Ceresa and
K&E team re ordinary course professional
designations (.6); correspond with Y. Salloum
and C. Ceresa re non-K&E professional
retention applications (.2).
06/21/24 Rebecca J. Marston
0.20 Correspond with C. Ceresa, S. Lieberman re
ordinary course professional list.
06/21/24 Sarah Osborne
0.40 Review, revise interim compensation motion
(.3); correspond with R. Marston re same (.1).
06/22/24 Sabrina Lieberman
2.90 Revise PJT retention application (.4); revise
Omni retention application (1.8); correspond
with AlixPartners, BDO, Omni, PJT, PwC,
Cole Schotz, Y. Salloum and K&E team re
retention applications (.2); revise Cole Schotz
retention application (.5).
06/22/24 Rebecca J. Marston
0.50 Correspond with S. Lieberman re retention
applications (.1); review, revise PJT retention
application (.4).
06/23/24 Sabrina Lieberman
2.00 Review, revise PJT retention application (.3);
review, revise Cole Schotz retention
application (1.0); review, revise Omni
administrative agent application (.7).
06/23/24 Rebecca J. Marston
0.30 Correspond with S. Lieberman re PJT
retention application.
06/24/24 Chris Ceresa
0.60 Correspond with advisors, S. Lieberman,
K&E team re issues re retention.
06/24/24 Sabrina Lieberman
1.70 Review, revise PJT retention application (.1);
correspond with C. Ceresa, PJT re same (.1);
review, revise BDO retention application (.7);
correspond with AlixPartners, C. Ceresa and
K&E team re ordinary course professional
motion (.2); review, revise same (.6).
06/24/24 Rebecca J. Marston
0.40 Review, revise Cole Schotz retention
application (.3); correspond with S.
Lieberman re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 203 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050102709
48520-23
6
Date
Name
Hours Description
06/24/24 Sarah Osborne
1.70 Review, revise interim compensation motion
(.9); correspond with R. Marston re same (.2);
research re same (.6).
06/25/24 Chris Ceresa
0.30 Correspond with advisors, S. Lieberman,
K&E team re retention issues.
06/25/24 Susan D. Golden
0.40 Review, analyze interim compensation
motion (.3); correspond with R. Marston re
same (.1).
06/25/24 Sabrina Lieberman
3.90 Review, revise ordinary course professional
motion (1.0); correspond with AlixPartners,
C. Ceresa and K&E team re same (2.9).
06/25/24 Rebecca J. Marston
1.20 Conference with PwC team, K&E team re
retention (.5); prepare for and participate in
conference with K&E restructuring, corporate
teams re EY retention (.7).
06/25/24 Sarah Osborne
2.30 Review, revise interim compensation motion
(.3); correspond with C. Ceresa re same (.1);
compile proposed filing versions of ordinary
course professional and interim compensation
motions (.2); correspond with C. Ceresa,
K&E team re same (.1); review, revise ICP
motion (.3); correspond with S. Golden, K&E
team re same (.2); compile interim
compensation, ordinary course professional
motions for filing (.3); review, revise notices
re same (.2); correspond with Cole Schotz
team re filings (.6).
06/26/24 Sabrina Lieberman
2.20 Correspond with AlixPartners, C. Ceresa and
advisors re ordinary course professional
applications (1.3); review, revise BDO
retention application (.9).
06/26/24 Sarah Osborne
0.40 Review, analyze key dates and deadlines for
interim compensation motion (.3); correspond
with K. Chiaghana re same (.1).
06/27/24 Sabrina Lieberman
1.50 Correspond with AlixPartners, Cole Schotz
and C. Ceresa re sealing (.3); review, revise
PJT retention application (.3); correspond
with C. Ceresa re non-K&E retention
applications (.5); review, revise parties-
in‑interest lists (.2); correspond with C.
Ceresa, Reed Smith and AlixPartners re
Ordinary Course Professional designations
(.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 204 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050102709
48520-23
7
Date
Name
Hours Description
06/29/24 Sabrina Lieberman
2.60 Review, revise AlixPartners retention
application.
Total
65.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 205 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102710
Client Matter: 48520-24
In the Matter of Vendor Matters
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 21,509.50
Total legal services rendered
$ 21,509.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 206 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Vendor Matters
Invoice Number:
Matter Number:
1050102710
48520-24
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
2.50
1,345.00
3,362.50
Tiffani Chanroo
9.90
1,265.00
12,523.50
Sabrina Lieberman
6.50
815.00
5,297.50
Sarah Osborne
0.40
815.00
326.00
TOTALS
19.30
$ 21,509.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 207 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Vendor Matters
Invoice Number:
Matter Number:
1050102710
48520-24
3
Description of Legal Services
Date
Name
Hours Description
06/10/24 Sabrina Lieberman
1.20 Review, revise critical vendors motion (1.0);
conference with T. Chanroo re same (.2).
06/13/24 Sabrina Lieberman
0.50 Correspond with C. Ceresa and T. Chanroo re
vendor issue (.2); correspond with vendor
counsel re same (.1); review, analyze vendor
contract (.2).
06/14/24 Chris Ceresa
0.30 Correspond with Company, T. Chanroo, K&E
team re vendor issues.
06/18/24 Chris Ceresa
0.50 Correspond with T. Chanroo, K&E team,
advisors re vendor matter (.2); telephone
conference with T. Chanroo, K&E team,
advisors re vendor issue (.3).
06/18/24 Tiffani Chanroo
0.60 Review, analyze issues re vendors (.3);
correspond with S. Lieberman, K&E team,
AlixPartners team re same (.3).
06/18/24 Sabrina Lieberman
0.20 Correspond with vendor and AlixPartners re
business-only call.
06/19/24 Tiffani Chanroo
1.30 Review, revise trade agreement (1.1);
correspond with C. Ceresa re same (.2).
06/23/24 Sarah Osborne
0.40 Research, analyze issues re vendor inquiries.
06/24/24 Tiffani Chanroo
0.80 Review, revise vendor trade agreement (.6);
correspond with AlixPartners re same (.2).
06/25/24 Chris Ceresa
0.20 Correspond with advisors, counsel re vendor
inquiries and matters (.1); conference with
advisors, counsel re same (.1).
06/25/24 Sabrina Lieberman
0.40 Correspond with C. Ceresa, T. Chanroo and
AlixPartners team re vendor inquiry (.2);
research 509(b)(3) and 546(c)(1) re same (.2).
06/26/24 Tiffani Chanroo
1.40 Review, analyze vendor communication (.8);
correspond with S. Lieberman re same (.6).
06/26/24 Sabrina Lieberman
0.70 Conference with T. Chanroo re vendor work
in process (.2); correspond with AlixPartners,
T. Chanroo, party in interest re vendor matter
(.1); correspond with AlixPartners, vendor
counsel, T. Chanroo re vendor matter (.1);
research re same (.3).
06/27/24 Chris Ceresa
0.60 Correspond with advisors, counsel re vendor
inquiries and matters (.2); conference with
advisors, counsel re same (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 208 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Vendor Matters
Invoice Number:
Matter Number:
1050102710
48520-24
4
Date
Name
Hours Description
06/27/24 Tiffani Chanroo
3.50 Review, analyze vendor issues (2.8);
correspond with S. Lieberman re same (.4);
conference with AlixPartners, S. Lieberman
re same (.3).
06/27/24 Sabrina Lieberman
1.50 Conference with AlixPartners, C. Ceresa and
T. Chanroo re various vendor issues (.5);
conference with C. Ceresa, T. Chanroo and
vendor party re same (.3); correspond with
AlixPartners, C. Ceresa, T. Chanroo and
vendor counterparties and counsel re same
(.7).
06/28/24 Chris Ceresa
0.50 Correspond with advisors, counsel re vendor
inquiries and matters (.2); conference with
advisors, counsel re same (.3).
06/28/24 Tiffani Chanroo
2.10 Review, analyze vendor issues (1.3);
correspond with S. Lieberman, K&E team,
Alix team re same (.8).
06/28/24 Sabrina Lieberman
1.40 Conference with AlixPartners, vendor
counsel, Company, T. Chanroo and K&E
team re vendor matter (.4); correspond with
AlixPartners, T. Chanroo and K&E team re
same (.8); review, revise summary re same
(.2).
06/29/24 Chris Ceresa
0.40 Correspond with advisors, counsel re vendor
inquiries and matters (.2); conference with
advisors, counsel re same (.2).
06/29/24 Sabrina Lieberman
0.60 Review, analyze vendor matters (.4);
correspond with T. Chanroo re same (.2).
06/30/24 Tiffani Chanroo
0.20 Correspond with S. Osborne re 503(b)(9)
research.
Total
19.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 209 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102711
Client Matter: 48520-25
In the Matter of Litigation
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 23,939.50
Total legal services rendered
$ 23,939.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 210 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050102711
48520-25
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
2.30
1,345.00
3,093.50
Joseph A. D'Antonio
0.70
1,185.00
829.50
Tabitha J. De Paulo
11.20
1,435.00
16,072.00
Sabrina Lieberman
0.20
815.00
163.00
Jennifer Mancini
1.50
925.00
1,387.50
Michael William Morgan
0.10
975.00
97.50
Sarah Osborne
0.50
815.00
407.50
Joshua Raphael
0.60
975.00
585.00
Adrian Salmen
0.70
1,095.00
766.50
Noah Spector
0.50
1,075.00
537.50
TOTALS
18.30
$ 23,939.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 211 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050102711
48520-25
3
Description of Legal Services
Date
Name
Hours Description
06/10/24 Tabitha J. De Paulo
8.50 Conference with PJT re witness preparation
(1.0); conference with AlixPartners re witness
preparation (.9); prepare for same (3.4);
prepare for and attend hearing preparation
session with Company (2.4); draft direct
examination outlines in preparation for
hearing (.8).
06/10/24 Joshua Raphael
0.60 Conference with PJT, T. De Paulo, K&E team
re witness preparations.
06/13/24 Sabrina Lieberman
0.20 Correspond with M. McKane, Y. Salloum and
Cole Schotz re litigation call.
06/13/24 Sarah Osborne
0.50 Review, revise notice of suggestion of
bankruptcy (.3); correspond with Company re
same (.2).
06/14/24 Chris Ceresa
0.30 Correspond with Company re suggestions of
bankruptcy process.
06/19/24 Adrian Salmen
0.70 Research re settlement motion precedent.
06/20/24 Chris Ceresa
2.00 Telephone conference with Company re
prepetition litigation matters and suggestions
of bankruptcy (.5); conference with PJT,
AlixPartners teams re same (.6); correspond
with Y. Salloum, K&E team, Company re
same (.9).
06/23/24 Joseph A. D'Antonio
0.70 Draft, revise stipulated confidentiality
agreement and protective order.
06/24/24 Tabitha J. De Paulo
1.50 Review, revise draft protective order (.3);
correspond with Cole Schotz team re same
(.2); review, revise Frejka declaration (1.0).
06/24/24 Jennifer Mancini
1.30 Draft, revise protection order.
06/25/24 Michael William Morgan
0.10 Review and analyze litigation materials.
06/27/24 Tabitha J. De Paulo
0.70 Review, analyze board meeting minutes and
address discovery issues re same.
06/28/24 Tabitha J. De Paulo
0.50 Conference with N. Specter and J. Mancini re
privileged document redactions (.3);
correspond with C. Ceresa and K&E team re
same (.2).
06/28/24 Jennifer Mancini
0.20 Conference with T. De Paulo and K&E team
re redacting privileged documents.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 212 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050102711
48520-25
4
Date
Name
Hours Description
06/28/24 Noah Spector
0.50 Conference with T. De Paulo, J. Mancini re
redaction of privileged materials (.2); review,
analyze documents of interest for privileged
information (.3).
Total
18.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 213 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102713
Client Matter: 48520-27
In the Matter of Non-Working Travel
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 16,073.50
Total legal services rendered
$ 16,073.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 214 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Non-Working Travel
Invoice Number:
Matter Number:
1050102713
48520-27
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Julia R. Foster
5.90
525.00
3,097.50
Yusuf Salloum
3.50
1,595.00
5,582.50
Josh Sussberg, P.C.
2.40
2,305.00
5,532.00
Kyle Nolan Trevett
1.70
1,095.00
1,861.50
TOTALS
13.50
$ 16,073.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 215 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Non-Working Travel
Invoice Number:
Matter Number:
1050102713
48520-27
3
Description of Legal Services
Date
Name
Hours Description
06/09/24 Kyle Nolan Trevett
1.70 Travel from Chicago, IL to New York, NY re
chapter 11 filing (billed at half time).
06/10/24 Julia R. Foster
2.80 Travel from Chicago, IL to Wilmington, DE
to attend hearing (billed at half time).
06/10/24 Yusuf Salloum
1.50 Travel from Chicago, IL to Wilmington, DE
re hearing (billed at half time).
06/11/24 Julia R. Foster
3.10 Travel from Wilmington, DE to Chicago, IL
return from hearing (billed at half time).
06/11/24 Yusuf Salloum
2.00 Travel from Wilmington, DE to Chicago, IL
return from hearing (billed at half time).
06/11/24 Josh Sussberg, P.C.
1.20 Travel from New York, NY to Wilmington,
DE for hearing (billed at half time).
06/11/24 Josh Sussberg, P.C.
1.20 Travel from Wilmington, DE to New York,
NY (billed at half time).
Total
13.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 216 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102714
Client Matter: 48520-28
In the Matter of Creditors’ Committee Matters
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 9,859.00
Total legal services rendered
$ 9,859.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 217 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Creditors’ Committee Matters
Invoice Number:
Matter Number:
1050102714
48520-28
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
0.30
1,345.00
403.50
Sarah Osborne
3.60
815.00
2,934.00
Joseph Cermak Profancik
0.20
975.00
195.00
Yusuf Salloum
1.00
1,595.00
1,595.00
Seth Sanders
3.90
1,095.00
4,270.50
Josh Sussberg, P.C.
0.20
2,305.00
461.00
TOTALS
9.20
$ 9,859.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 218 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Creditors’ Committee Matters
Invoice Number:
Matter Number:
1050102714
48520-28
3
Description of Legal Services
Date
Name
Hours Description
06/17/24 Seth Sanders
0.30 Correspond with C. Ceresa re committee
matters.
06/24/24 Sarah Osborne
0.90 Review, analyze board minutes for UCC due
diligence (.8); correspond with C. Ceresa,
K&E team re same (.1).
06/26/24 Chris Ceresa
0.30 Conference with S. Osborne, K&E team re
preparation for UCC due diligence items.
06/26/24 Seth Sanders
1.40 Review, analyze re UCC diligence requests.
06/27/24 Sarah Osborne
0.20 Correspond with AlixPartners re creditor
inquiry.
06/28/24 Sarah Osborne
1.60 Research re creditor committee engagement
letters, organizational documents (1.4);
correspond with S. Sanders re same (.2).
06/28/24 Yusuf Salloum
0.50 Prepare materials for creditors' committee.
06/28/24 Seth Sanders
2.20 Correspond with C. Ceresa, K&E team, PJT
re UCC diligence (.9); correspond with
McDermott Will & Emery re diligence
requests (.4); research re committee fees (.7);
correspond with S. Osborne re same (.2).
06/28/24 Josh Sussberg, P.C.
0.20 Correspond with UCC re matters.
06/29/24 Sarah Osborne
0.90 Research re committee engagement letters
(.7); correspond with S. Sanders re same (.2).
06/29/24 Joseph Cermak Profancik
0.20 Prepare existing loan documents for
distribution to UCC counsel.
06/29/24 Yusuf Salloum
0.50 Review, analyze creditor committee data
requests.
Total
9.20
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 219 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102715
Client Matter: 48520-29
In the Matter of Employee and Labor Matters
For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail)
$ 27,170.00
Total legal services rendered
$ 27,170.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 220 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Employee and Labor Matters
Invoice Number:
Matter Number:
1050102715
48520-29
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Rebecca H. Arnall
2.00
1,095.00
2,190.00
Chris Ceresa
1.80
1,345.00
2,421.00
Tiffani Chanroo
1.00
1,265.00
1,265.00
Maureen D. O'Brien
3.00
2,115.00
6,345.00
Dan O'Connor
0.70
1,265.00
885.50
Sarah Osborne
1.20
815.00
978.00
Evangelia Podaras
0.90
1,575.00
1,417.50
Scott D. Price, P.C.
2.20
2,245.00
4,939.00
Joshua Raphael
0.40
975.00
390.00
Risa Salins
2.10
2,115.00
4,441.50
Paul Vasiloff
1.50
1,265.00
1,897.50
TOTALS
16.80
$ 27,170.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 221 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Employee and Labor Matters
Invoice Number:
Matter Number:
1050102715
48520-29
3
Description of Legal Services
Date
Name
Hours Description
06/11/24 Maureen D. O'Brien
0.50 Draft correspondence pension issues.
06/12/24 Scott D. Price, P.C.
0.20 Review, analyze form of bonus plan.
06/13/24 Maureen D. O'Brien
1.50 Conference with D. O’Connor, K&E team re
employee benefits (.8); review, revise
summary of employee benefits plan (.7).
06/13/24 Dan O'Connor
0.70 Telephone conference with Company, M.
O’Brien, K&E team re employee benefits.
06/13/24 Sarah Osborne
0.50 Draft key employee agreement (.4);
correspond with C. Ceresa re same (.1).
06/13/24 Scott D. Price, P.C.
0.70 Reviewempolyee plan (.4); correspond and
conference re same (.3).
06/14/24 Sarah Osborne
0.70 Correspond with S. Price, K&E team re
employee agreement (.2); review, revise same
(.4); correspond with Company re same (.1).
06/14/24 Scott D. Price, P.C.
0.50 Review, revise empolyee plan.
06/16/24 Maureen D. O'Brien
0.50 Draft correspondence re pension benefits.
06/18/24 Joshua Raphael
0.40 Review, analyze staffing agreement and
correspond with C. Ceresa, K&E team re
same.
06/20/24 Chris Ceresa
1.30 Correspond with T. Chanroo, K&E team,
Company, advisors re potential contingency
items (.8); conference with T. Chanroo, K&E
team re same (.5).
06/20/24 Tiffani Chanroo
0.50 Conference with C. Ceresa, K&E team re
contingency planning.
06/20/24 Maureen D. O'Brien
0.50 Correspond with S. Price re contingency
employment matters.
06/20/24 Evangelia Podaras
0.40 Conference with C. Ceresa and K&E team re
contingency planning.
06/20/24 Risa Salins
0.30 Telephone conference with C. Ceresa, E.
Podaras and P. Vasiloff re employee matters
(.2); correspond with Company re employee
data (.1).
06/20/24 Paul Vasiloff
0.50 Telephone conference with S. Winters, K&E
team re employment contingency issues.
06/21/24 Risa Salins
0.30 Review, revise updated employee data
provided by Company.
06/25/24 Scott D. Price, P.C.
0.80 Review, analyze compensation brief (.3);
revise compensation brief (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 222 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Employee and Labor Matters
Invoice Number:
Matter Number:
1050102715
48520-29
4
Date
Name
Hours Description
06/26/24 Chris Ceresa
0.30 Correspond with K&E team re employment
related updates.
06/26/24 Tiffani Chanroo
0.50 Conference with C. Ceresa, K&E team re
contingency planning.
06/26/24 Evangelia Podaras
0.50 Telephone conferences with K&E team, R.
Salins, P. Vasiloff re current status and
notices.
06/26/24 Risa Salins
0.50 Telephone conference with C. Ceresa, E.
Podaras and P. Vasiloff re employee matters
(.3); telephone conference with E. Podaras
and P. Vasiloff re contingency planning (.2).
06/26/24 Paul Vasiloff
1.00 Telephone conference with Y. Salloum, K&E
team re contingency planning (.5); update
draft notices (.5).
06/27/24 Rebecca H. Arnall
2.00 Conference with D. O'Connor, Company re
employment matters (.4); correspond with S.
Price re same (.2); review, analyze diligence,
purchase agreements re employment matters
(1.4).
06/28/24 Risa Salins
1.00 Review, revise notices.
06/29/24 Chris Ceresa
0.20 Correspond with T. Chanroo, K&E team re
employment related updates.
Total
16.80
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 223 of 914

July 2024
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 224 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104432
Client Matter: 48520-5
In the Matter of Corporate & Governance Matters
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 37,905.50
Total legal services rendered
$ 37,905.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 225 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050104432
48520-5
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
2.50
1,395.00
3,487.50
Hannah Crawford
1.30
1,595.00
2,073.50
David Hackel
0.60
1,095.00
657.00
Partha Kar
2.70
2,305.00
6,223.50
Sabrina Lieberman
0.50
975.00
487.50
Jai Mudhar
5.50
1,345.00
7,397.50
Sarah Osborne
10.60
975.00
10,335.00
Carolin Paus
4.60
750.00
3,450.00
William T. Pruitt
0.30
1,695.00
508.50
Josh Sussberg, P.C.
0.10
2,305.00
230.50
Steve Toth
0.50
1,820.00
910.00
Quin Wetzel
2.20
975.00
2,145.00
TOTALS
31.40
$ 37,905.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 226 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050104432
48520-5
3
Description of Legal Services
Date
Name
Hours Description
07/02/24 William T. Pruitt
0.30 Review, analyze indemnification and D&O
insurance issues (.2); correspond with C.
Ceresa re same (.1).
07/03/24 Sabrina Lieberman
0.10 Correspond with S. Osborne re governance
documents.
07/03/24 Sarah Osborne
0.40 Telephone conference with C. Ceresa, K&E
team, PJT, AlixPartners, special committee re
conference (.3); correspond with C. Ceresa re
same (.1).
07/08/24 Sarah Osborne
0.70 Draft special committee minutes (.6);
correspond with C. Ceresa re same (.1).
07/11/24 Chris Ceresa
0.60 Conference with S. Winters and special
committee re governance matters (.5); draft
minutes re same (.1).
07/11/24 Sabrina Lieberman
0.20 Correspond with Cole Schotz and Company
re special committee investigation diligence.
07/11/24 Sarah Osborne
3.40 Draft, review, revise resolutions re entry into
stalking horse agreement (2.7); research and
analyze precedent re same (.4); correspond
with C. Ceresa re same (.3).
07/16/24 Sarah Osborne
4.10 Review, analyze resolutions re formation of
special committee (.4); draft summary re
same (.8); correspond with C. Ceresa re same
(.2); draft omnibus consent re appointment of
D&O slate (1.9); research re same (.6);
correspond with C. Ceresa re same (.2).
07/16/24 Josh Sussberg, P.C.
0.10 Correspond with S. Winters re Company
officer legal issue.
07/17/24 David Hackel
0.60 Draft minutes re special committee meeting.
07/18/24 Chris Ceresa
0.60 Review, revise draft minutes re Special
Committee meeting.
07/18/24 Jai Mudhar
1.00 Conference with H. Crawford, K&E team re
Swiss entities and corporate governance
issues.
07/18/24 Quin Wetzel
0.60 Draft minutes for Special Committee meeting.
07/18/24 Quin Wetzel
0.60 Draft minutes re Special Committee meeting
(.5); correspond with C. Ceresa re same (.1).
07/23/24 Sabrina Lieberman
0.10 Correspond with R. Marston, K&E team re
special committee investigation diligence.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 227 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050104432
48520-5
4
Date
Name
Hours Description
07/24/24 Partha Kar
0.70 Conference with local counsel re international
corporate law issues.
07/25/24 Chris Ceresa
0.60 Conference with S. Winters and special
committee re corporate matters (.4);
correspond with S. Osborne, K&E team re
same (.2).
07/25/24 Hannah Crawford
0.80 Conference with J. Mudhar, K&E team re
international entities re corporate issues (.3);
correspond with Company and J. Mudhar,
K&E team re intercompany issues (.2);
correspond with J. Mudhar re Swiss and
German entities (.3).
07/25/24 Partha Kar
1.50 Review, analyze intercompany amendment
request (.5); telephone conference with
Company re intercompany amendment
request (1.0).
07/25/24 Sarah Osborne
0.50 Draft, revise special committee minutes.
07/25/24 Steve Toth
0.50 Participate in special committee telephone
conference with Company, PJT, AlixPartners,
C. Ceresa and K&E team.
07/25/24 Quin Wetzel
1.00 Review, analyze meeting notes (.3); draft
special committee minutes re same (.7).
07/26/24 Partha Kar
0.50 Correspond with local counsel re
intercompany amendment request from
clients.
07/28/24 Hannah Crawford
0.20 Correspond with P. Kar re intercompany
corporate structure matters.
07/28/24 Jai Mudhar
0.50 Correspond with H. Crawford, K&E team re
intercompany governance considerations.
07/28/24 Carolin Paus
4.60 Research re intercompany claims and
dividend payments (3.4); prepare summary re
same (1.2).
07/29/24 Hannah Crawford
0.30 Correspond with A. Chan K&E team re
capital structure.
07/29/24 Sabrina Lieberman
0.10 Correspond with S. Sanders and K&E team re
board resolutions and presentation re
compensation.
07/29/24 Jai Mudhar
4.00 Review, analyze issues re intercompany
approach (3.5); correspond with H. Crawford,
K&E team regarding the same (.5).
07/29/24 Sarah Osborne
0.60 Draft special committee meeting minutes.
07/30/24 Sarah Osborne
0.90 Draft special committee meeting minutes.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 228 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050104432
48520-5
5
Date
Name
Hours Description
07/31/24 Chris Ceresa
0.70 Conference with S. Winters and special
committee re corporate matters (.5); review,
analyze draft minutes re same (.2).
Total
31.40
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 229 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104433
Client Matter: 48520-6
In the Matter of Disclosure Statement/Plan/Confirmation
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 30,285.50
Total legal services rendered
$ 30,285.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 230 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050104433
48520-6
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
0.70
1,395.00
976.50
Amy Donahue
2.50
525.00
1,312.50
Julia R. Foster
1.70
525.00
892.50
David Hackel
6.80
1,095.00
7,446.00
Liz Ji
0.30
1,285.00
385.50
Sabrina Lieberman
3.80
975.00
3,705.00
Sarah Osborne
2.90
975.00
2,827.50
Joshua Raphael
1.50
1,095.00
1,642.50
Seth Sanders
3.60
1,265.00
4,554.00
Kyle Nolan Trevett
3.40
1,265.00
4,301.00
Quin Wetzel
2.30
975.00
2,242.50
TOTALS
29.50
$ 30,285.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 231 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050104433
48520-6
3
Description of Legal Services
Date
Name
Hours Description
07/02/24 Liz Ji
0.30 Correspond with P. Gunderson and K&E
team re chapter 11 plan.
07/02/24 Sabrina Lieberman
0.50 Research re assumption or rejection of
executory contracts, unexpired leases re plan
effective date.
07/02/24 Seth Sanders
1.00 Analyze issues re plan rejections (.5);
correspond with C. Ceresa re same (.2);
conference with S. Lieberman re same (.3).
07/03/24 Sabrina Lieberman
3.30 Research re assumption and rejection of
executory contracts under plan.
07/03/24 Seth Sanders
1.00 Analyze research re assumption and rejection
issues re plan (.8); correspond with S.
Lieberman re same (.2).
07/08/24 Sarah Osborne
1.20 Review, revise disclosure statement re tax
considerations (1.1); correspond with K.
Trevett re same (.1).
07/08/24 Joshua Raphael
0.30 Review, analyze plan question re tax and
correspond with P. Gunderson, K&E team re
same.
07/08/24 Seth Sanders
0.90 Telephone conference with J. Raphael re plan
revisions (.3); analyze issues re same (.6).
07/08/24 Quin Wetzel
0.90 Review, analyze disclosure statement motion
re updated sale timeline (.7); correspond with
K. Trevett, J. Desai re same (.2).
07/10/24 Quin Wetzel
1.40 Review, analyze chapter 11 plan, bid
procedures order (.5); review, revise
disclosure statement motion re same (.9).
07/11/24 Sarah Osborne
0.20 Review, revise disclosure statement.
07/11/24 Kyle Nolan Trevett
3.00 Review, revise disclosure statement (1.2);
review, revise case timeline (1.7); correspond
with S. Osborne, C. Ceresa re same (.1).
07/16/24 Chris Ceresa
0.70 Review, analyze issues re plan and disclosure
statement.
07/16/24 Sarah Osborne
0.90 Review, revise disclosure statement for
addition of credit bid option (.6); research
precedent re same (.2); correspond with K.
Trevett re same (.1).
07/16/24 Joshua Raphael
0.30 Review, analyze, and revise plan.
07/16/24 Seth Sanders
0.40 Revise plan.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 232 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050104433
48520-6
4
Date
Name
Hours Description
07/16/24 Kyle Nolan Trevett
0.40 Review, analyze plan, disclosure statement re
legal issues (.3); correspond with C. Ceresa,
S. Osborne re same (.1).
07/17/24 Joshua Raphael
0.90 Review, revise plan (.8); correspond with S.
Sanders re same (.1).
07/18/24 Seth Sanders
0.30 Correspond with C. Ceresa re plan matters.
07/23/24 Julia R. Foster
0.50 Research precedent re confirmation briefs and
declarations in support thereof.
07/23/24 David Hackel
5.10 Correspond with S. Sanders, K&E team re
confirmation issues and workstreams (.3);
review, analyze precedent re confirmation
brief (2.2); research re same (2.6).
07/24/24 Amy Donahue
1.00 Prepare and revise draft shell confirmation
order.
07/24/24 Julia R. Foster
1.20 Prepare draft shell of confirmation brief.
07/24/24 David Hackel
1.10 Review, analyze precedent re confirmation
brief (.6); review, revise confirmation brief
(.5).
07/25/24 Amy Donahue
1.50 Prepare draft shell of confirmation order.
07/25/24 David Hackel
0.40 Review, analyze precedent re confirmation
brief (.2); review, analyze confirmation brief
(.2).
07/26/24 David Hackel
0.20 Review, analyze issues, precedent re
confirmation brief.
07/26/24 Sarah Osborne
0.60 Review, revise disclosure statement.
Total
29.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 233 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104434
Client Matter: 48520-7
In the Matter of DIP Financing and Cash Collateral
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 110,306.00
Total legal services rendered
$ 110,306.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 234 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050104434
48520-7
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
12.40
1,395.00
17,298.00
David Hackel
0.50
1,095.00
547.50
Yoonie Han
9.40
1,575.00
14,805.00
Rebecca J. Marston
0.50
1,345.00
672.50
Mark McKane, P.C.
0.40
2,065.00
826.00
Julienne Miranda
0.80
975.00
780.00
Joseph Cermak Profancik
4.90
1,095.00
5,365.50
Joshua Raphael
14.10
1,095.00
15,439.50
Yusuf Salloum
7.00
1,595.00
11,165.00
Adrian Salmen
33.20
1,265.00
41,998.00
Noah Spector
0.80
1,185.00
948.00
Josh Sussberg, P.C.
0.20
2,305.00
461.00
TOTALS
84.20
$ 110,306.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 235 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050104434
48520-7
3
Description of Legal Services
Date
Name
Hours Description
07/01/24 Chris Ceresa
0.80 Review, analyze DIP issues.
07/01/24 David Hackel
0.50 Research re DIP issue (.2); review, analyze
CRO appointment materials re same (.2);
correspond with J. Raphael, K&E team re
same (.1).
07/01/24 Yoonie Han
0.50 Revise the DIP order (.5).
07/01/24 Mark McKane, P.C.
0.40 Conference with T. De Paulo re DIP and other
second day hearing issues.
07/01/24 Adrian Salmen
2.40 Correspond with C. Ceresa, K&E team,
lenders, parties in interest re DIP revisions
(1.7); review, analyze DIP order re reporting
requirements (.7).
07/02/24 Chris Ceresa
0.20 Review, analyze correspondence from A.
Salmen, K&E team re DIP issues.
07/02/24 Yoonie Han
0.20 Revise DIP order.
07/02/24 Joshua Raphael
0.10 Review, analyze GDC markup of final DIP
order and correspond with Y. Han, K&E team
re same.
07/02/24 Adrian Salmen
6.80 Correspond with C. Ceresa, K&E team,
lender counsel, insurer counsel re DIP
language (.9); review revised final DIP order
(1.1); correspond with C. Ceresa, K&E team
re DIP workstream (.8); review, analyze
committee issues list re DIP (2.1); prepare
final sealing order for filing (.4); review DIP
order precedent (.4); review, revise DIP reply
(1.1).
07/02/24 Noah Spector
0.80 Analyze DIP motion and related materials.
07/03/24 Chris Ceresa
3.30 Review, analyze correspondence from J.
Raphael, K&E team DIP issues
07/03/24 Yoonie Han
0.20 Correspond with S. Sanders re DIP credit
facility guarantors and lien searches and UCC
lien searches.
07/03/24 Julienne Miranda
0.80 Correspond with S. Osborne, Y. Han and S.
Sanders re guarantors list.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 236 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050104434
48520-7
4
Date
Name
Hours Description
07/03/24 Joshua Raphael
2.90 Review, analyze UCC issues list, GDC
responses and research re same (2.4);
correspond with A. Salmen, C. Ceresa re DIP,
related matters (.1); review, revise officer
certificate and correspond re same (.1);
review, analyze issue re same, signatory (.3).
07/03/24 Yusuf Salloum
1.50 Analyze comments to DIP documents.
07/03/24 Adrian Salmen
7.70 Review, analyze DIP precedent (2.7);
annotate UCC DIP issues list (2.4);
correspond with J. Raphael, K&E team re
same (.9); correspond with C. Ceresa, K&E
team, AlixPartners team, UCC, lenders re
professional fees issues (1.7).
07/04/24 Chris Ceresa
1.00 Review, analyze correspondence from Y.
Salloum, K&E team re DIP issues
07/04/24 Yusuf Salloum
1.00 Analyze issues re DIP financing documents.
07/04/24 Adrian Salmen
0.30 Correspond with interested parties re DIP
objection.
07/05/24 Chris Ceresa
0.50 Review, analyze DIP issues
07/05/24 Joshua Raphael
0.50 Correspond with C. Ceresa, K&E team,
advisors, AlixPartners re variance reporting,
professional fees (.2); review, analyze
variance reporting; correspond with C. Ceresa
re DIP (.3).
07/05/24 Adrian Salmen
1.60 Review, analyze DIP credit agreement re DIP
revisions (.9); correspond with J. Raphael,
K&E team, interested parties re DIP
objections, DIP issues (.7).
07/06/24 Chris Ceresa
0.20 Review, analyze correspondence from A.
Salmen, K&E team re DIP issues
07/06/24 Joshua Raphael
2.00 Review, analyze UCC comments to DIP order
(.2); draft talking points re final DIP order
(1.8).
07/06/24 Yusuf Salloum
1.00 Review, revise DIP order.
07/06/24 Adrian Salmen
3.90 Correspond with C. Ceresa, K&E team re DIP
workstream (.6); review, analyze DIP credit
agreement re DIP revisions (1.3); review,
analyze committee revisions to DIP order
(1.1); correspond with C. Ceresa, K&E team
re same (.4); review, revise DIP talking points
(.3); correspond with J. Raphael re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 237 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050104434
48520-7
5
Date
Name
Hours Description
07/07/24 Joshua Raphael
0.40 Review, revise DIP talking points (.3);
correspond with Y. Salmen, K&E team re
same (.1).
07/07/24 Adrian Salmen
0.90 Correspond with Y. Salloum, K&E team,
Gibson Dunn re DIP revisions (.4); review,
analyze precedent re same (.5).
07/08/24 Chris Ceresa
0.30 Correspond with A. Salmen, K&E team re
DIP reporting items.
07/08/24 Yoonie Han
0.40 Correspond with S. Sanders re DIP collateral
package (.2); analyze DIP order (.2).
07/08/24 Yusuf Salloum
1.50 Review, analyze DIP order.
07/08/24 Adrian Salmen
2.30 Review, analyze DIP order revisions, issues
(1.8); correspond with AlixPartners, C.
Ceresa re same (.2); correspond with C.
Ceresa, AlixPartners re professional fee
disbursements (.3).
07/09/24 Chris Ceresa
1.20 Correspond with A. Salmen, K&E team re
DIP reporting items.
07/09/24 Yoonie Han
0.70 Analyze DIP credit agreement re excluded
property (.3); analyze DIP order re DIP
collateral package (.4).
07/09/24 Rebecca J. Marston
0.50 Conference with GDC team, UCC counsel,
Haynes & Boone, C. Ceresa, K&E team re
DIP issues.
07/09/24 Joseph Cermak Profancik
0.50 Review and analyze DIP credit agreement
schedules for backstop parties (.3);
correspond with lender’s counsel re same (.2).
07/09/24 Joshua Raphael
1.30 Review, analyze, revise final DIP order (.4);
conference with S. Winters, K&E team,
advisors re same (.3); correspond with ad hoc
group, UCC counsel, C. Ceresa, A. Salmen,
K&E team re same (.4); finalize same (.2).
07/09/24 Yusuf Salloum
1.00 Review, analyze revisions to DIP order.
07/09/24 Adrian Salmen
3.10 Correspond with interested parties re DIP
order (1.2); review, revise final DIP order
(1.5); conference with interested parties re
final DIP issues (.4).
07/10/24 Chris Ceresa
0.30 Correspond with A. Salmen, K&E team re
DIP reporting items.
07/10/24 Yoonie Han
0.50 Correspond with S. Sanders re DIP collateral
package issues.
07/10/24 Yusuf Salloum
1.00 Review and analyze revisions to DIP order.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 238 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050104434
48520-7
6
Date
Name
Hours Description
07/10/24 Adrian Salmen
2.20 Correspond with J. Raphael, K&E team,
AlixPartners, lenders re DIP issues (1.1);
review, analyze payment history re same
(1.1).
07/11/24 Adrian Salmen
0.30 Correspond with C. Ceresa, AlixPartners re
DIP issues.
07/12/24 Chris Ceresa
0.20 Correspond with J. Raphael, K&E team re
DIP reporting items.
07/12/24 Joshua Raphael
0.80 Draft certificate re variance reporting (.3);
review, revise, variance testing (.2);
correspond with AlixPartners, C. Ceresa, re
same (.2); correspond with advisors re same
(.1).
07/15/24 Yoonie Han
2.10 Analyze DIP credit agreement re interest
payment mechanism (.6); analyze DIP order
re obligations re prepetition debt (.6); analyze
restructuring support agreement re existing
debt roll‑up mechanism (.7); correspond with
A. Idrizovic re interest payment mechanism
(.2).
07/15/24 Joseph Cermak Profancik
0.50 Review and analyze DIP credit agreement
(.3); correspond with Company re reporting
requirements (.2).
07/16/24 Chris Ceresa
1.10 Review, analyze DIP reporting (.9);
correspond with A. Salmen, K&E team re
same (.2).
07/16/24 Yoonie Han
1.50 Conference with Y. Salloum re reporting
obligations under prepetition credit facilities
pursuant to DIP orders (.7); analyze roll‑up
mechanism under DIP credit agreement (.4);
analyze DIP credit agreement notice
requirements re employment notices (.4).
07/16/24 Joseph Cermak Profancik
1.00 Conference with Company re DIP compliance
and reporting requirements (.8); correspond
with Company re organizational documents
(.2).
07/17/24 Chris Ceresa
0.30 Review, analyze DIP reporting (.2);
correspond with J. Profancik, K&E team re
same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 239 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050104434
48520-7
7
Date
Name
Hours Description
07/17/24 Yoonie Han
0.90 Analyze DIP credit agreement and
restructuring support agreement re roll‑up
mechanism and reporting obligations (.4);
conference with Y. Salloum re same (.4);
correspond with Company re roll‑up
mechanism and reporting obligations (.1).
07/17/24 Joseph Cermak Profancik
0.50 Correspond with Company re DIP reporting
requirements; review and analyze credit
agreement.
07/17/24 Adrian Salmen
1.10 Correspond with C. Ceresa, K&E team,
AlixPartners, lender advisors re professional
fee issues re DIP (.6); review, analyze
correspondence re same (.5).
07/19/24 Chris Ceresa
0.20 Review, analyze DIP reporting (.1);
correspond with A. Salmen, K&E team re
same (.1).
07/19/24 Joshua Raphael
0.10 Draft officer certificate, variance report and
correspond re same.
07/20/24 Chris Ceresa
0.30 Review, analyze DIP reporting (.2);
correspond with J. Raphael, K&E team re
same (.1).
07/22/24 Chris Ceresa
0.40 Review, analyze legal issues re DIP draws
(.2); correspond with Company, advisors re
same (.2).
07/22/24 Joseph Cermak Profancik
0.30 Review and analyze credit agreement exhibits
(.2); correspond with C. Ceresa, K&E team re
withdrawal notice (.1).
07/22/24 Joshua Raphael
0.40 Draft declaration ISO reporting requirements
under DIP orders and credit agreement.
07/22/24 Joshua Raphael
0.80 Review, analyze form of withdrawals notice
(.2); correspond with C. Ceresa re DIP request
(.1); conferences and correspond with C.
Ceresa, AlixPartners re withdrawal notices
(.4); correspond with DIP agent re same (.1).
07/22/24 Joshua Raphael
0.10 Correspond with AlixPartners re wire info re
DIP withdrawal notice.
07/23/24 Joshua Raphael
0.10 Correspond with AlixPartners, AFS re wire
info re DIP withdrawal notice.
07/24/24 Chris Ceresa
0.50 Review, analyze legal issues re DIP draws
(.3); correspond with Company, advisors re
same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 240 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050104434
48520-7
8
Date
Name
Hours Description
07/24/24 Yoonie Han
0.80 Conference with Company and AlixPartners
re interest payment mechanism under DIP
credit agreement (.5); correspond with C.
Ceresa and S. Toth re obligations under DIP
credit facility, 1L and 2L (.3).
07/24/24 Joseph Cermak Profancik
0.50 Review and analyze existing credit facility
collateral package (.3); correspond with C.
Ceresa, K&E team re same (.2).
07/24/24 Joshua Raphael
1.60 Correspond with AlixPartners, C. Ceresa re
fee reporting for DIP, DIP funding (.2);
review, analyze fee estimate and correspond
with C. Ceresa re same (.3); correspond with
C. Ceresa re lenders, agent re reporting and
funding (.1); review, analyze perfection
memorandum and correspond with C. Ceresa,
Y. Han re same (.5); review, analyze DIP
order, credit agreement re collateral packages
(.4); correspond with C. Ceresa re foreign
equity pledges (.1).
07/24/24 Adrian Salmen
0.30 Correspond with J. Raphael, K&E team,
AlixPartners team re professional fees
reporting under DIP.
07/25/24 Joshua Raphael
0.60 Research precedent pleadings, transcripts re
motion to compel DIP funding draw.
07/25/24 Josh Sussberg, P.C.
0.20 Correspond with S. Winters re status with
DIP lenders.
07/26/24 Joshua Raphael
2.20 Research precedent re emergency DIP
funding requests (.9); review, analyze
pleadings (.5); correspond with C. Ceresa re
summaries of same (.4); draft responsible
officer certificate and correspond with C.
Ceresa, K&E team, AlixPartners re same (.2);
revise notice of funding request and
correspond with agent re same (.1); review,
analyze 1L credit agreement and correspond
with S. Toth, K&E team re same (.1).
07/29/24 Yoonie Han
1.30 Conference with Company re interest
payment under DIP credit agreement (.5);
correspond with agent’s counsel re DIP
interest notices (.5); correspond with A.
Idrizovic re updating DIP credit agreement
(.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 241 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050104434
48520-7
9
Date
Name
Hours Description
07/29/24 Joseph Cermak Profancik
1.20 Conference with Company and advisors re
DIP interest rate (.7); review and analyze
credit agreement re same (.3); correspond
with lenders’ counsel re same (.2).
07/30/24 Chris Ceresa
0.80 Review, analyze legal issues re financing (.5);
correspond with Y. Salloum and K&E team re
issues re same (.3).
07/30/24 Yoonie Han
0.30 Correspond with J. Profancik re DIP interest
mechanism.
07/30/24 Joseph Cermak Profancik
0.40 Correspond with lenders’ counsel and
company advisors re interest rate language.
07/30/24 Joshua Raphael
0.10 Prepare DIP withdrawal request.
07/31/24 Chris Ceresa
0.80 Review, analyze legal issues re DIP financing
(.5); correspond with Y. Salloum and K&E
team re issues re same (.3).
07/31/24 Joshua Raphael
0.10 Correspond and conference with A. Salmen re
professional fee budget.
07/31/24 Adrian Salmen
0.30 Correspond with J. Raphael, K&E team,
AlixPartners team re professional fees.
Total
84.20
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 242 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104435
Client Matter: 48520-8
In the Matter of Cash Management
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 1,879.50
Total legal services rendered
$ 1,879.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 243 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Cash Management
Invoice Number:
Matter Number:
1050104435
48520-8
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Tiffani Chanroo
0.60
1,345.00
807.00
Kenny Chiaghana
1.10
975.00
1,072.50
TOTALS
1.70
$ 1,879.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 244 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Cash Management
Invoice Number:
Matter Number:
1050104435
48520-8
3
Description of Legal Services
Date
Name
Hours Description
07/02/24 Tiffani Chanroo
0.60 Correspond with Y. Salloum, K&E team re
cash management cap (.2); review, analyze
issues re same (.4).
07/07/24 Kenny Chiaghana
1.10 Analyze, revise cash management order.
Total
1.70
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 245 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104436
Client Matter: 48520-9
In the Matter of Automatic Stay Issues
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 418.50
Total legal services rendered
$ 418.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 246 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Automatic Stay Issues
Invoice Number:
Matter Number:
1050104436
48520-9
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
0.30
1,395.00
418.50
TOTALS
0.30
$ 418.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 247 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Automatic Stay Issues
Invoice Number:
Matter Number:
1050104436
48520-9
3
Description of Legal Services
Date
Name
Hours Description
07/16/24 Chris Ceresa
0.30 Review, analyze issues re automatic stay.
Total
0.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 248 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104437
Client Matter: 48520-10
In the Matter of Asset Sales/Section 363 Issues: Use, Sale & Disposition of Property
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 2,024,504.50
Total legal services rendered
$ 2,024,504.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 249 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Rebecca H. Arnall
5.40
1,265.00
6,831.00
Kon Asimacopoulos
4.50
2,305.00
10,372.50
Lauren Austgen
1.50
435.00
652.50
Cooper Barghols
4.30
975.00
4,192.50
Marin Boney
0.90
1,885.00
1,696.50
John G. Caruso
1.00
2,115.00
2,115.00
Chris Ceresa
86.70
1,395.00
120,946.50
Tiffani Chanroo
1.20
1,345.00
1,614.00
Adam Thomas Clifford, P.C.
4.00
1,995.00
7,980.00
Dominique Collins
0.40
1,265.00
506.00
Bernadette Coppola
43.10
1,575.00
67,882.50
Hannah Crawford
1.10
1,595.00
1,754.50
Sion Davies
0.70
1,575.00
1,102.50
Tabitha J. De Paulo
2.50
1,435.00
3,587.50
Anthony M. Del Rio
37.80
1,595.00
60,291.00
Jaina Desai
165.70
975.00
161,557.50
Amy Donahue
0.50
525.00
262.50
Michael Ehret
13.00
1,895.00
24,635.00
Luke Finn
74.30
1,345.00
99,933.50
Julia R. Foster
1.00
525.00
525.00
Justin M. Garfinkle
44.20
1,095.00
48,399.00
Luci Hague
0.20
1,575.00
315.00
Kate Hardey
22.70
1,995.00
45,286.50
Liz Ji
9.80
1,285.00
12,593.00
Partha Kar
2.00
2,305.00
4,610.00
Olivia Kaufmann
26.30
1,095.00
28,798.50
Sooah Kim
5.30
1,095.00
5,803.50
Maggie Kate King
33.10
1,265.00
41,871.50
Daniel Lewis, P.C.
8.80
1,910.00
16,808.00
Sabrina Lieberman
7.60
975.00
7,410.00
Savannah Malnar-Cole
3.90
1,265.00
4,933.50
Mario Mancuso, P.C.
0.20
2,400.00
480.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 250 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
3
Name
Hours
Rate
Amount
Rebecca J. Marston
44.90
1,345.00
60,390.50
Brandan Matthews
56.30
1,345.00
75,723.50
Ruan J. Meintjes
44.20
1,095.00
48,399.00
Ashley Brittanie Miller
0.70
355.00
248.50
Jake Moeller
5.60
1,095.00
6,132.00
Michael William Morgan
0.30
1,095.00
328.50
Jai Mudhar
5.40
1,345.00
7,263.00
Trent Nachbar
88.50
1,265.00
111,952.50
Michelle L. Nowicki
39.60
625.00
24,750.00
Maureen D. O'Brien
5.00
2,115.00
10,575.00
Dan O'Connor
101.90
1,345.00
137,055.50
Sarah Osborne
8.60
975.00
8,385.00
Carolin Paus
8.70
750.00
6,525.00
D. Taylor Petersen
28.60
975.00
27,885.00
Evangelia Podaras
8.80
1,575.00
13,860.00
Joshua Raphael
0.10
1,095.00
109.50
Risa Salins
0.70
2,115.00
1,480.50
Yusuf Salloum
40.70
1,595.00
64,916.50
Adrian Salmen
1.90
1,265.00
2,403.50
Anna Schwander
1.80
1,315.00
2,367.00
Scottie Shermetaro
65.40
1,575.00
103,005.00
Noah Shier
8.50
1,575.00
13,387.50
Daniel Shin
37.60
975.00
36,660.00
Hayley Smith
2.00
625.00
1,250.00
Noah Spector
1.30
1,185.00
1,540.50
Matt Swanson
1.20
1,345.00
1,614.00
Paul D. Tanaka, P.C.
8.20
2,115.00
17,343.00
Michael D. Thorpe
0.60
1,695.00
1,017.00
Steve Toth
129.20
1,820.00
235,144.00
Sarah Ullathorne
3.60
1,575.00
5,670.00
Paul Vasiloff
4.00
1,345.00
5,380.00
Donatus Wang
10.80
960.00
10,368.00
Nicholas Warther
9.60
1,665.00
15,984.00
Cristina Weidner
11.60
1,665.00
19,314.00
Dennis Williams
1.50
2,025.00
3,037.50
Spencer A. Winters, P.C.
69.20
1,685.00
116,602.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 251 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
4
Name
Hours
Rate
Amount
Sara B. Zablotney, P.C.
1.60
2,445.00
3,912.00
Ann-Kathrin Ziegler
23.80
1,070.00
25,466.00
Tanzila Zomo
3.70
355.00
1,313.50
TOTALS
1,499.40
$ 2,024,504.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 252 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
5
Description of Legal Services
Date
Name
Hours Description
07/01/24 Chris Ceresa
3.80 Review, analyze issues re sale structuring
(2.3); correspond with R. Marston and J.
Desai re bidding procedures issues (1.1);
review NDA markups (.4).
07/01/24 Adam Thomas Clifford, P.C.
0.50 Discuss sale separation matters with
Company and advisors.
07/01/24 Bernadette Coppola
2.90 Correspond with AlixPartners and team re
transition services agreement (.1); conference
with Company, AlixPartners, C. Ceresa, K&E
team re transition services agreement (1.5);
conference with bidder, AlixPartners, C.
Ceresa, K&E team re due diligence, transition
services agreement and separation matters
(.5); correspond with Y. Salloum re transition
services agreement (.1); correspond with PJT
Partners, Y. Salloum, K&E team re transition
services agreement due diligence calls (.1);
correspond with M. Nowicki and K&E team
re intellectual property schedules (.3);
correspond with R. Meintjes and K&E team
re healthcare regulatory matter (.1);
correspond with Company and AlixPartners
re same (.2).
07/01/24 Tabitha J. De Paulo
1.20 Review and comment on bid procedures
declarations.
07/01/24 Anthony M. Del Rio
1.00 Review and analyze regulatory filing
requirements triggered by transaction (.5);
review and comment on transition services
considerations (.5).
07/01/24 Jaina Desai
1.20 Telephone conference with R. Marston re
bidding procedures status, next steps (.4);
correspond with S. Golden re publication
timeline (.1); review, analyze correspondence
re same (.2); review, analyze bidding
procedures order (.3); correspond with R.
Marston re bidding procedures notices (.2).
07/01/24 Jaina Desai
0.60 Telephone conference with Omni re escrow
agreement (.3); correspond with R. Marston
re same (.1); correspond with C. Ceresa re
same (.1); review, analyze escrow agreement
(.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 253 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
6
Date
Name
Hours Description
07/01/24 Jaina Desai
1.40 Review, analyze correspondence re sale
stream (.4); correspond with R. Marston re
same (.1); correspond with C. Ceresa re sale
declarations (.1); review, analyze local rules
re procedures (.5); correspond with R.
Marston re same (.1); correspond with T. De
Paulo re declarations (.1); correspond with A.
Salmen re bidding procedures order (.1).
07/01/24 Jaina Desai
1.20 Review, analyze correspondence re escrow
account (.5); correspond with Omni re same
(.1); telephone conference with Omni re same
(.1); correspond with R. Marston re same (.1);
draft correspondence re second day hearing
witness preparation (.2); correspond with
AlixPartners, PJT re same (.1); correspond
with R. Marston re same (.1).
07/01/24 Jaina Desai
3.80 Revise bidding procedures declarations (2.6);
correspond with R. Marston, K&E team re
same (.4); correspond with PJT, AlixPartners
re same (.1); correspond with PJT,
AlixPartners re witness preparation (.2);
review, analyze comments re sale NDA (.3);
correspond with S. Lieberman re same (.1);
draft correspondence re declarations (.1).
07/01/24 Jaina Desai
0.60 Revise sale NDA (.5); correspond with R.
Marston, S. Lieberman re same (.1).
07/01/24 Jaina Desai
0.30 Correspond with AlixPartners, PJT, T. De
Paulo, K&E team re bid pros witness prep
coordination.
07/01/24 Justin M. Garfinkle
0.20 Review, analyze issues re ventilation
purchase agreement for M&A counterparty.
07/01/24 Kate Hardey
0.70 Review and revise APA re legal issues.
07/01/24 Liz Ji
3.20 Review, analyze asset purchase agreement for
numerous bidders (2.9); revise purchase price
allocation re same (.3).
07/01/24 Partha Kar
0.50 Correspond with Company re asset purchase
agreement legal issues.
07/01/24 Olivia Kaufmann
1.70 Correspond with NY regulator re change of
ownership and control (.6); revise analysis re
same (1.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 254 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
7
Date
Name
Hours Description
07/01/24 Maggie Kate King
2.00 Conference with AlixPartners and client re
M&A counterparty TSA (1.0); telephone
conference with bidders for respiratory
diagnostics business (.5); summarize notes re
same (.2); correspond with D. Lewis, K&E
team re same (.3).
07/01/24 Daniel Lewis, P.C.
1.00 Review, analyze issues related to TSA matters
(.5); review, analyze matters related to IP
diligence (.5).
07/01/24 Sabrina Lieberman
0.30 Review and revise NDA summary (.2);
correspond with C. Ceresa and K&E team re
same (.1).
07/01/24 Ruan J. Meintjes
0.70 Review and revise bid asset purchase
agreement (.5); coordinate with K. Hardey re
same (.2).
07/01/24 Ruan J. Meintjes
0.50 Review and revise transition services
agreement.
07/01/24 Trent Nachbar
7.20 Review, analyze issues re asset purchase
agreement and schedules (3.9); further
review, analyze same (2.6); research specialist
questions re same (.5); summarize specialist
comments re same (.2).
07/01/24 Michelle L. Nowicki
12.00 Review, analyze issues re trademark
disclosures, prior K&E US trademark
schedule,  new trademark search results (3.4);
analyze and review related intellectual
property  office records re trademarks (2.1);
draft trademark schedule (2.9); review,
analyze issues re  patent disclosures (2.1);
analyze and review related intellectual
property office records (.4); draft patent
schedule (.6); correspond with B. Coppola,
K&E team re intellectual property due
diligence (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 255 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
8
Date
Name
Hours Description
07/01/24 Dan O'Connor
8.30 Telephone conference with PJT team,
AlixPartners team, Y. Salloum, S. Toth, K&E
team members re work in process (.5);
telephone conference re legal diligence with
M&E Counterparty, AlixPartners team, A.
Cunha, B. Coppola and K&E team (.5);
telephone conference with S. Toth re
transaction matters (.3); telephone conference
with Company, S. Toth, K&E team re
transition services (.5); review and revise
M&A counterparty asset purchase agreement
(3.9); further review and revise same (.1);
correspond with S. Toth, T. Nachbar and
K&E team re same (.5); review and revise
disclosure schedules (.4); review, analyze IT
agreements in connection with disclosure
schedules (.8); correspond with Company,
K&E team re antitrust matters (.4); draft open
items summary for disclosure schedules (.3);
correspond with Company re same (.1).
07/01/24 D. Taylor Petersen
3.00 Draft disclosure schedules (1.2); review due
diligence (1.8).
07/01/24 Joshua Raphael
0.10 Review, execute sale NDA and correspond re
same.
07/01/24 Risa Salins
0.70 Review, revise purchase agreement.
07/01/24 Yusuf Salloum
2.00 Analyze, review issues re sale transactions.
07/01/24 Anna Schwander
1.50 Analyze German foreign direct investment
filing requirements in connection with
potential sale (1.0); draft RFI questionnaire
(.5).
07/01/24 Scottie Shermetaro
3.10 Review and revise asset purchase agreement
(1.9); review due diligence re same (.5);
review and revise TSA (.7).
07/01/24 Matt Swanson
1.00 Review, revise purchase agreement.
07/01/24 Paul D. Tanaka, P.C.
3.60 Review, revise auction draft markups of
purchase agreements (3.2); correspond with S.
Toth, K&E team re same (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 256 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
9
Date
Name
Hours Description
07/01/24 Steve Toth
6.30 Telephone conference with McDermott, Y.
Salloum, K&E team re introductions, case
status (.5); telephone conference with PJT,
AlixPartners, Y. Salloum, K&E team and
Company re case updates (.7); correspond
with AlixPartners, Company, Y. Salloum,
K&E team re TSA matters (.3); telephone
conference  with bidder, bidder counsel, C.
Ceresa, K&E team and AlixPartners re
diligence and TSA matters (.4); draft issues
list re bidder asset purchase agreement (.9);
analyze and revise bidder asset purchase
agreement (2.9); correspond with
AlixPartners re TSA matters (.4); correspond
with D. O’Connor re schedules and asset
purchase agreement (.2).
07/01/24 Spencer A. Winters, P.C.
1.50 Review and analyze issues re sale, case
strategy (.8); correspond and telephone
conferences with multiple parties re same (.7).
07/02/24 Lauren Austgen
1.50 Correspond with H. Smith re copyrights (.2);
review and analyze research re copyrights
(.9); review and compare copyright schedules
(.4).
07/02/24 Chris Ceresa
7.30 Review, analyze sale related issues (3.6);
correspond with Company, advisors, Y.
Salloum, K&E team re same (1.9); review and
analyze NDA markups (.3); review and
comment on bidding procedures declaration,
notices, and key dates (1.5).
07/02/24 Adam Thomas Clifford, P.C.
2.00 Review, analyze stalking horse bid process
matters and related documentation.
07/02/24 Bernadette Coppola
2.90 Correspond with S. Toth and K&E team re
transaction perimeter and intellectual property
matters (.3); conference with S. Toth, K&E
team, client re purchase agreements and
associated workstreams (1.1); correspond
with M. Nowicki and K&E team re analysis
of intellectual property search results (.4);
conference with S. Shermetaro and K&E team
re checklist (.8); conference with M. King re
matter updates (.3).
07/02/24 Tabitha J. De Paulo
0.30 Review and revise draft declaration of M.
Schlappig in support of bid procedures.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 257 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
10
Date
Name
Hours Description
07/02/24 Anthony M. Del Rio
3.20 Review and revise purchase agreement (1.5);
review, analyze research on regulatory filing
requirements and strategize on filing approach
(1.7).
07/02/24 Jaina Desai
1.30 Telephone conference with Company, S.
Toth, K&E team re asset purchase agreements
(1.2); correspond with R. Marston re same
(.1).
07/02/24 Jaina Desai
8.00 Revise bidding procedures declarations (2.6);
correspond with R. Marston re same (.4);
correspond with C. Ceresa, Y. Salloum re
same (.2); revise bidding procedures notices
(1.2); correspond with C. Ceresa re same (.2);
correspond with S. Golden re publication
notice (.1); revise bidding procedures order
(1.4); correspond with C. Ceresa re same (.1);
correspond with AlixPartners re bidding
procedures declaration (.2); telephone
conference with AlixPartners re same (.2);
correspond with PJT re budding procedures
declaration (.1); telephone conference with
PJT, R. Marston re bidding procedures
declaration (.2); further revise PJT bidding
procedures declaration (.3); review, analyze
precedent re notice requirement (.3);
correspond with G. Reardon re same (.1);
correspond with R. Marston re key dates (.2);
correspond with C. Ceresa re same (.2).
07/02/24 Luke Finn
8.10 Telephone conference with A. Clifford re case
introduction (.3); review, analyze bankruptcy
code 363 structure and precedent (.7);
telephone conference with client, S. Toth,
K&E team (1.4); telephone conference with
S. Toth, K&E team re allocation of bidders,
workstreams (.9); review, analyze deal
documents, asset purchase agreement (1.0);
review, revise updated M&A Counterparty
asset purchase agreement to include specialist
comments (3.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 258 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
11
Date
Name
Hours Description
07/02/24 Justin M. Garfinkle
4.50 Review, analyze issues re registered
intellectual property schedules, chain of title
issues, schedules of international owners (.9);
review, analyze issues re respiratory
diagnostics disclosure schedules (2.5);
correspond with B. Coppola, K&E team re
case updates and workstreams (1.1).
07/02/24 Kate Hardey
1.80 Revise APA (1.3); review, analyze TSA and
confer with R. Meintjes re HIPAA (.5).
07/02/24 Liz Ji
0.70 Review, analyze transition services agreement
re tax matters.
07/02/24 Olivia Kaufmann
1.00 Conference with R. Meintjes re change of
ownership (.4); conference with A. Del Rio,
R. Meintjes re next steps (.3); review and
revise summary (.2); correspond with
regulator (.1).
07/02/24 Sooah Kim
0.30 Review, revise transition services agreement
re employment matters.
07/02/24 Maggie Kate King
1.30 Conference with J. Garfinkle, K&E team re
project workstreams and status updates (1.0);
conference with B. Coppola re matter updates
(.3).
07/02/24 Daniel Lewis, P.C.
1.30 Review, analyze TSA and separation matters
(.8); correspond with B. Coppola and K&E
team re same (.5).
07/02/24 Sabrina Lieberman
2.00 Conference with Y. Salloum, K&E team, PJT,
AlixPartners, Company re sale work in
process (1.7); review, analyze NDA (.1);
review, revise NDA summary (.2).
07/02/24 Rebecca J. Marston
4.20 Conferences with C. Ceresa, K&E team,
confidential sale parties re asset purchase
agreement drafts, sale matters (.5); correspond
with J. Desai, K&E team re same (3.2);
conference with C. Ceresa, K&E team re U.S.
Trustee comments to bidding procedures
order (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 259 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
12
Date
Name
Hours Description
07/02/24 Brandan Matthews
3.00 Conference with M&A Counterparty re
purchase agreement markup (.5); correspond
with client re vents and respiratory business
unit purchase agreements (1.5); correspond
with S. Toth, K&E team re administrative
matters (.5); review M&A counterparty asset
purchase agreement (.3); review, analyze
client request re same (.2).
07/02/24 Ruan J. Meintjes
1.80 Conference with O. Kaufman and A. Del Rio
re next steps on change of ownership
notifications (.2); research re change of
ownership (1.6).
07/02/24 Ruan J. Meintjes
0.80 Review and revise bid revisions to asset
purchase agreement.
07/02/24 Ashley Brittanie Miller
0.70 Revise domain disclosures based on search
results (.5); correspond with M. Nowicki and
H. Smith re same (.2).
07/02/24 Trent Nachbar
7.20 Review, analyze issues re asset purchase
agreement and schedules (3.9); further
review, analyze same (2.1); telephone
conference with B. Matthews, K&E team re
transaction updates (.5); review, analyze
specialist comments for asset purchase
agreement (.5); summarize same (.2).
07/02/24 Michelle L. Nowicki
10.40 Correspond with B. Coppola, K&E team re
intellectual property due diligence (.8);
review, revise patent schedule to include PPR
patents and industrial designs (3.4); review
and analyze related online intellectual
property office records (1.1); review and
revise domain schedule (1.9); summarize
Domain Tools database searches (.6); review,
analyze records re same (.6); review and
revise copyright schedule (.5); review and
revise patent schedule (.7); correspond with
B. Coppola, K&E team re copyright, domain
name and patent schedules (.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 260 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
13
Date
Name
Hours Description
07/02/24 Dan O'Connor
10.50 Telephone conference with Cooley team, S.
Toth, K&E team re asset purchase agreement
(.5); review and revise purchase agreement
(1.5); telephone conference with A. Clifford,
S. Toth, B. Matthews, L. Finn, T. Nachbar
and T. Petersen re transaction matters (.7);
correspond with B. Matthews and L. Finn re
transaction matters (.5); telephone conference
with Company, PJT team, AlixPartners team,
S. Toth, Y. Salloum and K&E team re
transaction matters (1.4); review, analyze
VDR materials and prepare disclosure
schedules and open items punch list for M&A
counterparty (2.0); review, analyze VDR
(1.0); draft, summarize disclosure schedules
and open items punch list for M&A
Counterparty asset purchase agreement (1.5)
correspond with B. Coppola, K&E team re
transaction matters (.5); telephone conference
with T. Petersen re IT agreement review (.4);
correspond with AlixPartners team re
disclosure schedules and transaction matters
(.5).
07/02/24 Carolin Paus
0.70 Telephone conference with Company,
AlixPartners re cash flow forecast in prep for
sales.
07/02/24 D. Taylor Petersen
6.10 Summarize intellectual property due diligence
(2.4); draft summary re IT agreement terms
for ventilation and respiratory diagnostics
assets (3.7).
07/02/24 Yusuf Salloum
3.60 Analyze, review issues re sale transaction.
07/02/24 Scottie Shermetaro
4.50 Telephone conference with B. Coppola and
client re APAs (1.3); telephone conference
with S. Toth, K&E team re revisions to
purchase agreements (.8); review and revise
disclosure schedules (1.1); review and revise
intellectual property schedules (1.3).
07/02/24 Hayley Smith
2.00 Compile intellectual property due diligence
(.5); review, analyze schedules (1.1);
correspond with D. Peterson, K&E team re
same (.4).
07/02/24 Noah Spector
0.70 Analyze bid procedures motion and related
materials.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 261 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
14
Date
Name
Hours Description
07/02/24 Steve Toth
7.20 Analyze correspondence re asset purchase
agreement schedules (.3) analyze, review
correspondence re non‑debtor matters (.3);
correspond with A. Clifford re asset purchase
agreement and schedule matters (.2);
telephone conference with bidder, bidder
counsel, Company, PJT, AlixPartners, A.
Clifford, K&E team re asset purchase
agreement issues (.5); analyze and prepare
correspondence re asset purchase agreement
issues (.5); telephone conference with
Company, PJT, AlixPartners, S. Winters,
K&E team re bidder asset purchase agreement
issues (1.3); correspond with S. Winters,
K&E team re APAs and schedules (.6);
analyze and revise bidder asset purchase
agreement (3.5).
07/02/24 Donatus Wang
0.90 Prepare for conference with Company on cash
flow forecast for German entities re sales (.3);
conference with Company, AlixPartners re
same (.6).
07/02/24 Spencer A. Winters, P.C.
1.50 Review and analyze issues re sale process and
case strategy (.7); correspond and telephone
conferences with multiple parties re same (.8).
07/02/24 Ann-Kathrin Ziegler
1.00 Prepare for conference with Company and
German management counsel re cashflow
forecast in prep for sales (.2); conference with
Company and German management counsel
re same (.8).
07/03/24 Marin Boney
0.30 Correspond with Y. Salloum, K&E team re
HSR filing.
07/03/24 Chris Ceresa
4.90 Review, analyze sale related issues (3.9);
further review, analyze same (.5) correspond
with Company, advisors, Y. Salloum, K&E
team re same (.5).
07/03/24 Adam Thomas Clifford, P.C.
1.00 Review, analyze stalking horse bidder
markups and diligence matters.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 262 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
15
Date
Name
Hours Description
07/03/24 Bernadette Coppola
5.60 Conference with client, AlixPartners, bankers,
buyer, Y. Salloum, K&E team re transition
services agreement due diligence (1.0);
conference with Company, R. Meintjes and
K&E team re healthcare regulatory matters
and transition services agreement (.2);
correspond with S. Shermetaro and K&E
team re intellectual property matters (.4);
conference with S. Toth, Company and K&E
team re transaction strategy (.7); review draft
disclosure schedules (.2); revise same (.2);
conference with J. Garfinkle and K&E team
re same (.5); draft revisions to asset purchase
agreement (1.7); correspond with T. Nachbar
and K&E team re same (.1); analyze
Company materials re separation of
intellectual property assets (.2); correspond
with Company and K&E team re same (.1);
correspond with D. Lewis and K&E team re
matter updates (.2); correspond with M.
Nowicki and K&E team re intellectual
property schedules (.1).
07/03/24 Anthony M. Del Rio
2.10 Review and revise TSA and related regulatory
considerations (1.8); telephone conference
with Company and advisors re transition
services (.3).
07/03/24 Jaina Desai
1.00 Revise bidding procedures declarations (.2);
revise second day orders (.8).
07/03/24 Jaina Desai
1.80 Review, analyze comments re PJT bidding
procedure declaration (.2); revise same (.1);
correspond with R. Marston, PJT re same (.1);
revise AlixPartners bidding procedures
declaration (.2); correspond with R. Marston
re same (.1); correspond with AlixPartners re
same (.1); correspond with C. Ceresa re
bidding procedures (.1); correspond with T.
De Paulo, AlixPartners re witness preparation
meeting (.2); review, analyze correspondence
re second day orders (.2); revise second day
orders (.3); correspond with T. Chanroo re
same (.1); correspond with C. Ceresa re sale
NDA (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 263 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
16
Date
Name
Hours Description
07/03/24 Jaina Desai
5.10 Correspond with C. Ceresa re sale NDA (.1);
revise same (.7); correspond with PJT re same
(.1); revise bidding procedures declarations
(3.8); correspond with Y. Salloum, C. Ceresa
re same (.4).
07/03/24 Jaina Desai
1.10 Correspond with S. Golden re publication
notice (.1); revise publication notice (.1);
correspond with C. Ceresa re bidding
procedures order (.1); correspond with
AlixPartners re sale escrow account (.1);
summarize, analyze documents re same (.2);
revise sale summary (.3); review, analyze
correspondence re sale stream (.2).
07/03/24 Luke Finn
8.30 Telephone conference with client re
respiratory diagnostics representations and
warranties (.8); telephone conference with
client re M&A Counterparty representations
and warranties (1.5); review and revise M&A
Counterparty purchase representations and
warranties (1.0); review, analyze interim
operating covenants and ex‑US entity
structure (1.1); review, analyze revisions to
asset purchase agreement (1.0); correspond
with S. Toth re same (.2); review and revise
asset purchase agreement to include
intellectual property concerns (1.8);
summarize asset purchase agreement for
distribution to opposing counsel (.9).
07/03/24 Justin M. Garfinkle
5.00 Review, analyze issues re registered
intellectual property schedules and chain of
title issues (2.1); revise respiratory
diagnostics disclosure schedules (2.0);
correspond with outside intellectual property
counsel re same (.9).
07/03/24 Luci Hague
0.20 Review, analyze CFIUS due diligence
questions.
07/03/24 Kate Hardey
1.20 Review, analyze TSA provisions (.7); discuss
same with R. Meintjes, K&E team (.5).
07/03/24 Maggie Kate King
2.00 Conference with buyer re transition services
schedules (1.0); conference with D. Shin re
matter updates (.5); conference with client re
personal health information for transition
services agreement matters (.2); review IT
license summaries for assignability (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 264 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
17
Date
Name
Hours Description
07/03/24 Daniel Lewis, P.C.
0.50 Telephone conferences with B. Coppola,
K&E team re TSA matters.
07/03/24 Sabrina Lieberman
0.20 Review, revise NDA (.1); review, revise
summary re same (.1).
07/03/24 Savannah Malnar-Cole
0.70 Correspond with S. Winters, K&E team re
Hart Scott Rodino filing.
07/03/24 Mario Mancuso, P.C.
0.20 Review, revise CFIUS due diligence question.
07/03/24 Brandan Matthews
4.00 Review and revise ventilation business
stalking horse purchase agreement.
07/03/24 Ruan J. Meintjes
1.00 Review and revise transition services
agreement (.5); conference with Company re
protected health information diligence (.5).
07/03/24 Ruan J. Meintjes
0.80 Review and revise bid draft asset purchase
agreement comments from foreign counsel
(.5); coordinate with K. Hardey, K&E team re
the same (.3).
07/03/24 Jake Moeller
5.60 Review, analyze vendor and seller master
agreements, purchase orders and statements
of work (3.9); further review and analyze
same (.6); summarize results of same (1.0);
correspond with S. Toth, K&E team re results
(.1).
07/03/24 Trent Nachbar
7.10 Review, analyze issues re asset purchase
agreement and schedules (3.9); further
review, analyze same (2.7); review, analyze
issues re asset purchase agreement specialist
comments (.3); summarize same (.2).
07/03/24 Michelle L. Nowicki
0.50 Correspond with B. Coppola, K&E team re
intellectual property due diligence (.3); revise
patent schedule (.1); correspond with B.
Coppola, K&E team re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 265 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
18
Date
Name
Hours Description
07/03/24 Dan O'Connor
4.10 Telephone conference with Company re
respiratory diagnostics disclosure schedules
(.6); telephone conference with AlixPartners
team re bid comparisons (.8); telephone
conference with Company re transaction
matters (.4); telephone conference with
Company re interim operating covenants (.5);
correspond with S. Toth re same (.3);
correspond with Foley team re transaction
matters (.5); telephone conference with
Company, PJT team, AlixPartners team, S.
Toth, S. Winters, K&E team re transaction
strategy call (.5); correspond with M. Boney
and S. Malnar‑Cole re antitrust matters (.3);
correspond with T. Martin and T. Nachbar re
escrow matters (.2).
07/03/24 Dan O'Connor
3.60 Correspond with Goodwin, Cooley and PJT
teams re legal diligence matters (.4); review
and revise respiratory diagnostics disclosure
schedules (1.2); correspond with Crowell
team re same (.5); review and revise M&A
counterparty disclosure schedules (1.2);
correspond with Foley team re same (.3).
07/03/24 D. Taylor Petersen
4.60 Conduct due diligence (2.1); draft summary
sheet of comingled IT agreements (2.5).
07/03/24 Yusuf Salloum
1.20 Review, revise evidentiary support for bid
procedures.
07/03/24 Scottie Shermetaro
6.90 Telephone conference with B. Coppola and
client re TSA matters (1.0); review and revise
TSA (.3); telephone conference with J.
Garfinkle re intellectual property disclosure
schedules (.2); telephone conference with B.
Coppola and client re asset purchase
agreement markups (.7); review and revise
registered intellectual property portfolio (1.5);
review and revise disclosure schedules; (.4);
telephone conference with B. Coppola and J.
Garfinkle re disclosure schedule revisions
(.7); review, analyze intellectual property
disclosures (1.2); draft and revise intellectual
property mapping diligence questions (.9).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 266 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
19
Date
Name
Hours Description
07/03/24 Daniel Shin
6.30 Correspond with M. King re diligence and
agreement status (.5); review, analyze IT
licenses for intellectual property license
assignment provisions (3.9); further review,
analyze same (.3); telephone conference with
client re Ventilation strategy (.4); correspond
with B. Coppola, K&E team re same (.3);
draft intellectual property assignment
agreement (.9).
07/03/24 Michael D. Thorpe
0.30 Analyze HSR reportability of the transaction.
07/03/24 Steve Toth
7.80 Telephone conference with Company,
AlixPartners, bidder, bidder advisors, S.
Winters, K&E team re TSA matters (1.0);
analyze correspondence re schedules and
asset purchase agreement (.3); correspond
with S. Winters re sale updates(.1); analyze
bidder asset purchase agreement (.8); analyze
and revise bidder asset purchase agreement
(2.9); telephone conferences with bidder,
bidder advisor, Company, Y. Salloum, K&E
team re sale issue (.6); correspond with D.
O’Connor and AlixPartners re asset purchase
agreement comparison (.3); analyze and
revise asset purchase agreement (.8);
telephone conference with PJT, AlixPartners,
Company, Y. Salloum, K&E team re sale
strategy (.6); correspond with Y. Salloum,
K&E team re APAs (.4).
07/03/24 Donatus Wang
0.20 Review, analyze summary of German license
agreements.
07/03/24 Spencer A. Winters, P.C.
3.50 Review and analyze issues re marketing
process (1.4); prepare for and participate in
standing special committee telephone
conference with Company (.5); prepare for
and participate in telephone conference with
bidder principals (1.0); correspond and
telephone conferences with multiple parties re
same (.6).
07/04/24 Chris Ceresa
0.50 Review, analyze sale related issues (.2);
correspond with Company, advisors, Y.
Salloum, K&E team re same (.3).
07/04/24 Bernadette Coppola
0.20 Correspond with D. O’Connor and K&E team
re disclosure schedules.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 267 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
20
Date
Name
Hours Description
07/04/24 Jaina Desai
0.90 Review, analyze UCC comments to bidding
procedures order (.4); draft correspondence re
same (.2); review, analyze bidding procedures
order (.3).
07/04/24 Daniel Lewis, P.C.
0.50 Correspond with B. Coppola, K&E team re
asset purchase agreement and TSA matters.
07/04/24 Dan O'Connor
2.50 Correspond with Cooley team re foreign
subsidiaries (.4); review and revise respiratory
diagnostics disclosure schedules (1.0);
correspond with S. Toth, Company and
Crowell team re same (.5); draft open items
list for disclosure schedules (.4); correspond
with Company re same (.2).
07/04/24 Steve Toth
2.60 Correspond with AlixPartners re lease matters
(.4); draft correspondence re same (.5);
analyze correspondence re schedules
questions (.7); draft responses to same (.4);
analyze correspondence re transaction issues
(.6).
07/05/24 Chris Ceresa
3.90 Review, analyze sale related issues (3.4);
correspond with Company, advisors, Y.
Salloum, K&E team re same (.5).
07/05/24 Bernadette Coppola
1.40 Conference with S. Toth, K&E team, advisors
re sale strategy (.6); correspond with J.
Garfinkle and K&E team re disclosure
schedules (.4); correspond with S. Toth and
K&E team re transaction steps (.1);
conference with S. Mangal re transition
services agreement schedules (.2); correspond
with AlixPartners re same (.1).
07/05/24 Anthony M. Del Rio
1.10 Review and analyze filing requirements (.5);
review and revise purchase agreements (.6).
07/05/24 Jaina Desai
5.70 Revise bidding procedures order (3.3);
review, analyze re same (.6); correspond with
R. Marston re same (.4); correspond with C.
Ceresa, Y. Salloum re same (.8); review,
analyze precedent re same (.6).
07/05/24 Luke Finn
3.90 Review, analyze revisions to asset purchase
agreement re labor considerations (.6);
revise asset purchase agreement re same (.6);
review, analyze diligence materials in relation
to asset purchase agreement (2.0); correspond
with S. Toth, K&E team re sale updates (.7).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 268 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
21
Date
Name
Hours Description
07/05/24 Justin M. Garfinkle
4.70 Review, analyze issues re registered
intellectual property schedules and related
chain of title issues (2.2); review, analyze
issues re disclosure schedules for ventilation
business (1.0); review, analyze disclosed
agreements re same (1.5).
07/05/24 Kate Hardey
0.50 Review, analyze APA (.3); conference with
R. Meintjes re same (.2).
07/05/24 Olivia Kaufmann
0.20 Correspond with A. Del Rio re change of
control and ownership to licenses.
07/05/24 Daniel Lewis, P.C.
0.50 Correspond with B. Coppola, K&E team re
TSA matters.
07/05/24 Sabrina Lieberman
0.10 Revise NDA summary.
07/05/24 Brandan Matthews
2.70 Correspond with client re tax representations t
(.7); revise M&A counterparty purchase
agreement (2.0).
07/05/24 Ruan J. Meintjes
1.10 Review and revise M&A counterparty asset
purchase agreement.
07/05/24 Trent Nachbar
2.90 Review, analyze issues re asset purchase
agreement and schedules (2.5); review,
analyze specialist comments to asset purchase
agreement (.2); summarize same (.2).
07/05/24 Dan O'Connor
4.10 Telephone conference with Company re tax
matters (.6); correspond with Company re
same (.3); telephone conference with PJT
team re transaction matters (.4); telephone
conference with S. Toth re transaction matters
(.2); telephone conference with M&A
counterparty, Company, AlixPartners, PJT
team, S. Toth, K&E team re respiratory
diagnostics transaction matters (.6); telephone
conference with M&A counterparty, Foley
team, PJT team, Company, S. Toth, Y.
Salloum, K&E team re asset purchase
agreement (1.0); correspond with Company re
representations and warranties (.2);
correspond with B. Matthews and L. Finn re
transaction matters (.3); correspond with PJT
team re VDR matters (.2); review, analyze
VDR files re same (.3).
07/05/24 D. Taylor Petersen
2.20 Draft disclosure schedules (1.8); review,
revise disclosure schedules (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 269 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
22
Date
Name
Hours Description
07/05/24 Evangelia Podaras
2.50 Review, revise bid APAs (2.2); correspond
with S. Toth, K&E team re same (.3).
07/05/24 Yusuf Salloum
2.30 Conferences with M&A counterparty,
Company, PJT, S. Toth, K&E team re sale
transaction, structuring (1.5); review, revise
bid procedures (.8).
07/05/24 Scottie Shermetaro
1.60 Review and revise TSA (.9); review and
revise intellectual property disclosure
schedules (.7).
07/05/24 Daniel Shin
5.00 Revise and review intellectual property
assignment agreement (.2); review and
analyze respiratory diagnostics respiratory
diagnostics IT agreements (1.9); review and
analyze ventilation IT agreements (2.9).
07/05/24 Steve Toth
4.60 Telephone conference with Company,
AlixPartners, PJT Y. Salloum, K&E team re
bidder updates and strategy (.6); analyze
correspondence re APAs and transaction
issues and status (.4); telephone
conference with bidder, bidder advisor,
Company, PJT, AlixPartners, D.
O’Connor, K&E team re sale transaction
updates (.6); correspond with D. O’Connor re
sale issues (.6); review, analyze
correspondence re sale issues (.3); telephone
conference with bidder, bidder advisors,
Company, AlixPartners, PJT, D. O’Connor,
K&E team re diligence, transaction
documents and schedules (.6); correspond
with AlixPartners re bidders, APAs, structure
(.3); telephone conference with bidder, bidder
advisors, Company, AlixPartners, PJT, D.
O’Connor, K&E team re diligence matters
(1.2).
07/05/24 Sarah Ullathorne
0.20 Review, analyze issues re antitrust.
07/05/24 Spencer A. Winters, P.C.
1.00 Review and analyze sale process issues (.6);
correspond and telephone conferences with
working group re same (.4).
07/06/24 Chris Ceresa
1.00 Review, analyze sale related issues (.8);
correspond with Company, advisors, Y.
Salloum, K&E team re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 270 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
23
Date
Name
Hours Description
07/06/24 Bernadette Coppola
0.90 Correspond with J. Garfinkle and team re
revisions to disclosure schedules (.3);
correspond with M. King and K&E team re
revisions to transition services agreement (.2);
correspond with AlixPartners and client re
transition services agreement schedules (.2);
correspond with Company re separation of
assets (.2).
07/06/24 Jaina Desai
1.00 Revise bidding procedures talking points (.6);
correspond with R. Marston re same (.2);
review, analyze cure schedule (.1); review,
analyze precedent re bidding procedures
talking points (.1).
07/06/24 Jaina Desai
5.00 Draft bidding procedures talking points (1.0);
review precedent re same (.3); analyze,
summarize transcripts (.6); correspond with
R. Marston re same (.2); correspond with R.
Marston re bidding procedures talking points
(.1); revise bidding procedures talking points
(.3); revise bidding procedures declarations
(.2); correspond with Y. Salloum, C. Ceresa
re same (.1); revise bidding procedures
notices (1.5); correspond with R. Marston re
same (.6); correspond with C. Ceresa re same
(.1).
07/06/24 Luke Finn
1.30 Review, analyze issues re M&A counterparty
bid (1.0); correspond with B. Matthews, K&E
team re sale status (.3).
07/06/24 Justin M. Garfinkle
1.00 Review, analyze issues re ventilation
disclosure schedules.
07/06/24 Maggie Kate King
1.50 Review and revise transition services
schedules (1.1); review and revise intellectual
property assignment agreement (.4).
07/06/24 Daniel Lewis, P.C.
0.50 Correspond with B. Coppola, K&E team re
TSA matters.
07/06/24 Scottie Shermetaro
1.30 Review and revise TSA.
07/06/24 Daniel Shin
7.50 Review and revise transition services
agreement schedules (3.9); review and
analyze supply agreements for ventilation
disclosure schedules (2.8); review and revise
intellectual property assignment agreement
(.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 271 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
24
Date
Name
Hours Description
07/06/24 Steve Toth
1.20 Telephone conference with Company, PJT,
AlixPartners, D. O’Connor, K&E team re
transactions update (.9); analyze
correspondence re transaction matters and
status (.3).
07/07/24 Chris Ceresa
4.20 Review, analyze sale related issues (3.4);
correspond with Company, advisors, Y.
Salloum, K&E team re same (.8).
07/07/24 Adam Thomas Clifford, P.C.
0.50 Review, analyze issues re 363 sale process
matters.
07/07/24 Bernadette Coppola
2.50 Conference with S. Toth, K&E team, client,
advisors re transition services agreement
schedules (1.0); conference with S.
Shermetaro and M. King re revisions to
transition services agreement schedules (.8);
correspond with S. Toth and K&E team re
same (.2); correspond with D. Lewis and
K&E team re matter updates (.1); draft
revisions to transition services agreement
schedules (.2); correspond with M. King and
K&E team re same (.2).
07/07/24 Tabitha J. De Paulo
0.30 Review and comment on declarations in
support of bid procedures.
07/07/24 Jaina Desai
5.00 Revise bidding procedures declarations (.5);
correspond with R. Marston, K&E team re
same (.2); revise asset purchase agreement
(3.4); review, analyze asset purchase
agreement precedent (.4); correspond with Y.
Salloum, C. Ceresa re same (.2); revise sale
summary (.2); correspond with R. Marston re
same (.1).
07/07/24 Jaina Desai
1.90 Revise bidding procedures order (.9);
correspond with R. Marston re same (.2);
revise successful bidder notice (.3); review,
analyze correspondence re assumption and
assignment noticing exhibit (.3); correspond
with R. Marston re same (.2).
07/07/24 Luke Finn
1.50 Review, analyze issues re M&A counterparty
bid (.9); review disclosure schedules for
M&A Counterparty bid (.4); review, analyze
correspondence re same (.2).
07/07/24 Justin M. Garfinkle
0.60 Review, analyze issues re ventilation
disclosure schedules.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 272 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
25
Date
Name
Hours Description
07/07/24 Maggie Kate King
3.20 Conference with AlixPartners and Company
re transition services schedules (1.1); revise
transition services schedules (2.1).
07/07/24 Daniel Lewis, P.C.
0.50 Correspond with B. Coppola, K&E team re
asset purchase agreement matters.
07/07/24 Savannah Malnar-Cole
0.50 Review and analyze client responses re
ventilation business and competition.
07/07/24 Brandan Matthews
4.90 Telephone conference with stalking horse
bidder re asset purchase agreement (.7);
review, analyze purchase agreement markup
(2.6); review, revise issues list matters (1.6).
07/07/24 Maureen D. O'Brien
0.50 Correspond with S. Toth, K&E team
re purchase agreement.
07/07/24 Dan O'Connor
1.70 Telephone conference with M&A
counterparty, PJT Partners, Company, S.
Toth, K&E team re transaction matters (.6);
telephone conference with AlixPartners,
Company, S. Toth and Y. Salloum re cure
costs (.7); correspond with B. Matthews re
asset purchase agreement (.4).
07/07/24 Yusuf Salloum
4.00 Conferences with PJT, Company,
AlixPartners, C. Ceresa, K&E team re sale
negotiations (1.8); review, analyze transaction
documents re legal issues re same (2.2).
07/07/24 Scottie Shermetaro
4.50 Telephone conference with B. Coppola, M.
King and Company re TSA (1.0); telephone
conference with M. King and B. Coppola re
TSA revisions (.5); review and revise TSA
schedules (1.9); review and revise intellectual
property schedules (1.1).
07/07/24 Noah Spector
0.60 Review and analyze declaration and bidding
procedures motion.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 273 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
26
Date
Name
Hours Description
07/07/24 Steve Toth
7.10 Telephone conference with bidder, bidder
advisors, Company, PJT, Y. Salloum, K&E
team and AlixPartners re diligence and
transaction updates (.6); analyze
correspondence re transaction matters (.3);
analyze revised asset purchase agreement
(1.4); telephone conference with Company,
AlixPartners, D. O’Connor, K&E team re
cure costs (.9); revise attorney notes re APAs
and related issues and considerations (.6);
analyze and revise asset purchase agreement
issues list (.3); analyze correspondence re
deposits and TSA (.3); analyze
correspondence re asset purchase agreement
and TSA (.5); analyze correspondence re
schedules, IOCs and diligence (.5); telephone
conference with Company, AlixPartners, Y.
Salloum, K&E team re TSA matters (1.0);
analyze correspondence re asset purchase
agreement issues (.7).
07/08/24 Chris Ceresa
5.80 Review, analyze sale related legal issues
(1.8); review and comment on asset purchase
agreements re legal issues (2.4); correspond
with Company, PJT, AlixPartners, Y.
Salloum, K&E team re same (1.6).
07/08/24 Bernadette Coppola
2.90 Correspond with D. Lewis and K&E team re
transaction updates (.2); correspond with J.
Garfinkle and K&E team re intellectual
property schedules (.2); correspond with Alix
Partners, M. King and K&E team re transition
services agreement schedules (.4); conference
with S. Shermetaro and K&E team re
revisions to documents and matter updates
(.5); correspond with S. Shermetaro re same
(.2); draft revisions to purchase agreement
(.3); correspond with B. Matthews and K&E
team re same (.1); correspond with J.
Garfinkle re updates to intellectual property
schedules (.1); conference with S. Shermetaro
re revisions to purchase agreement and
transition services agreement schedules (.4);
correspond with M. King and K&E team re
revisions to transition services agreement
schedules (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 274 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
27
Date
Name
Hours Description
07/08/24 Anthony M. Del Rio
3.70 Review and revise purchase agreements (1.7);
review and analyze structure considerations
(1.4); telephone conference with UCC
counsel re transaction status (.4); prepare for
same (.2).
07/08/24 Jaina Desai
2.20 Telephone conference with PJT, Y. Salloum,
K&E team re second day hearing witness
preparation (.8); prepare for same (.3);
correspond with R. Marston re bidding
procedures declarations (.2); review, analyze
correspondence re sale stream (.1);
correspond with AlixPartners re second day
hearing (.1); draft correspondence re bidding
procedures hearing (.2); correspond with K.
Rasti, K&E team re same (.1); correspond
with R. Marston re bidding procedures order
(.2); correspond with K. Trevett, C. Ceresa re
bidding procedures talking points (.2).
07/08/24 Jaina Desai
0.90 Review, analyze bidding procedures order
(.2); revise bidding procedures order (.2);
correspond with C. Ceresa re same (.1); revise
bidding procedures talking points (.1);
correspond with K. Trevett, Y. Salloum re
same (.1); correspond with C. Ceresa re sale
notice, bidding procedures declarations (.1);
correspond with AlixPartners re escrow
account (.1).
07/08/24 Jaina Desai
1.10 Review, analyze UCC comments to bidding
procedures order (.1); correspond with R.
Marston re same (.2); revise bidding
procedures order (.6); correspond with R.
Marston re same (.2).
07/08/24 Jaina Desai
2.00 Telephone conference with AlixPartners, C.
Ceresa, K&E team re declarant witness
preparation (.3); correspond with R. Marston
re same (.1); review, analyze UCC comments
re bidding procedures (.1); revise bidding
procedures (.2); revise bidding procedures
order (1.0); correspond with R. Marston re
same (.1); revise bidding procedures
declarations (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 275 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
28
Date
Name
Hours Description
07/08/24 Jaina Desai
2.80 Correspond with C. Ceresa re status re sale
stream, next steps (.1); revise bidding
procedures order (.4); correspond with R.
Marston, C. Ceresa re same (.1); revise
bidding procedures declaration (.1); revise
bidding procedures order (1.8); correspond
with C. Ceresa re same (.2); telephone
conference with C. Ceresa re same (.1).
07/08/24 Jaina Desai
0.50 Revise bidding procedures order (.3);
correspond with C. Ceresa re same (.2).
07/08/24 Jaina Desai
0.20 Review, analyze correspondence re bidding
procedures order (.1); correspond with R.
Marston re same (.1).
07/08/24 Luke Finn
1.20 Telephone conference with Company re legal
issues re asset purchase agreement (.6);
review, analyze updated dataroom documents
(.6).
07/08/24 Justin M. Garfinkle
7.00 Review, revise ventilation purchase
agreement (1.2); review, analyze registered
intellectual property schedules, chain of title
questions, other missing information (3.9);
further review, analyze same (1.1) correspond
with L. Finn, K&E team re sale matters (.8).
07/08/24 Kate Hardey
3.10 Conference with R. Meintjes, K&E team re
state license change of ownership review (.5);
review and conference with R. Meintjes,
K&E team re comments to APA (1.5);
conference with R. Meintjes, K&E team re
transfer of products (1.1).
07/08/24 Liz Ji
2.30 Review, analyze tax legal issues re asset
purchase agreement.
07/08/24 Olivia Kaufmann
1.50 Review, revise asset purchase agreement re
health regulatory legal issues (.8); review,
analyze healthcare issues (.7).
07/08/24 Sooah Kim
0.60 Review and revise purchase agreement re
employment legal issues.
07/08/24 Maggie Kate King
2.60 Conference with B. Coppola, K&E team re
intellectual property and transition services
schedules (.5); review, analyze license
summary document (.5); revise transition
services agreement schedules (1.6).
07/08/24 Daniel Lewis, P.C.
0.30 Review, analyze issues re TSA matters.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 276 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
29
Date
Name
Hours Description
07/08/24 Rebecca J. Marston
9.50 Correspond with J. Desai, K&E team re sale
related documents (2.3); telephone
conferences with PJT team, C. Ceresa, K&E
team, AlixPartners team re witness
preparation (1.0); correspond with J. Desai,
K&E team re bidding procedures order,
talking points (3.9); review and revise same
(2.3).
07/08/24 Brandan Matthews
8.00 Correspond with Company re purchase
agreement issues list (.5); correspond with
Company re representations and warranty
changes (.5); review, analyze issues re
purchase agreement matters (3.9); further
review, analyze same (3.1).
07/08/24 Ruan J. Meintjes
4.20 Review and revise M&A counterparty asset
purchase agreement (3.8); correspond with M.
O’Brien, K&E team re the same (.4).
07/08/24 Ruan J. Meintjes
0.40 Telephone conference with UCC regulatory
counsel re sale updates.
07/08/24 Ruan J. Meintjes
1.00 Review and analyze change of ownership
regulations (.5); review and analyze foreign
regulatory considerations (.4); correspond
with A. Del Rio, K&E team re same (.1).
07/08/24 Michael William Morgan
0.30 Review, analyze correspondence re sale
updates (.2); correspond with T. Nachbar re
same (.1).
07/08/24 Trent Nachbar
11.20 Review, analyze issues re asset purchase
agreement and schedules (3.9); further review
and revise same (2.6); correspond with M.
Morgan, K&E team re same (1.5); review,
analyze, incorporate specialist comments to
the same (3.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 277 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
30
Date
Name
Hours Description
07/08/24 Michelle L. Nowicki
10.50 Correspond with B. Coppola, K&E team re
intellectual property due diligence (1.2);
review intellectual property counsel
comments re trademark portfolio (3.2);
review and revise trademark schedule (2.4);
review, analyze trademark issues (1.0);
correspond with B. Coppola, K&E team re
trademark schedule and issues list (.9);
review, analyze patent schedule, related
online intellectual property office records and
intellectual property counsel comments (1.0);
revise patent schedule (.5); correspond with
B. Coppola, K&E team reupdated patent
schedule (.3).
07/08/24 Maureen D. O'Brien
1.00 Review and revise purchase agreement re
employment matters.
07/08/24 Dan O'Connor
3.20 Telephone conference with Company, PJT
Partners, AlixPartners, S. Toth, K&E team re
M&A Counterparty asset purchase agreement
(.4); telephone conference with B. Coppola re
transaction matters (.2); telephone conference
with PJT team re weekly advisors check‑in
(.3); telephone conference with M&A
counterparty, Foley team, Company, S Toth,
K&E team re transaction matters (.2);
telephone conference with Company and B.
Matthews re representations and warranties
(.4); telephone conference with S. Toth re
transaction matters (.3); telephone conference
with B. Matthews re transaction matters (.4);
telephone conference with T. Nachbar re
transaction matters (.5); review and revise
escrow agreement (.2); correspond with M&A
counterparty re same (.3).
07/08/24 Dan O'Connor
4.40 Review and revise M&A counterparty asset
purchase agreement (.8); correspond with S.
Toth and B. Matthews re same (.2); review,
analyze contracts and other diligence
materials in VDR (1.0); draft M&A
counterparty disclosure schedules (1.0);
correspond with Company, S. Toth and T.
Nachbar re same (.8); correspond with R.
Meintjes, K&E team re transaction matters
(.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 278 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
31
Date
Name
Hours Description
07/08/24 Sarah Osborne
2.40 Research re section 363 sale and COBRA
liabilities (2.2); correspond with A. Salmen,
K&E team re same (.2).
07/08/24 D. Taylor Petersen
1.40 Summarize issues list from M&A
Counterparty’s draft of disclosure schedules
(.4); review and revise disclosure schedules
(1.0).
07/08/24 Evangelia Podaras
1.20 Review, revise asset purchase agreement re
employment related matters.
07/08/24 Adrian Salmen
1.90 Research re COBRA liabilities in 363 sale
(1.3); correspond with S. Osborne re same
(.3); review, revise summary re same (.3).
07/08/24 Anna Schwander
0.30 Correspond with Y. Salloum, K&E team re
German foreign direct investment re sale
issues.
07/08/24 Scottie Shermetaro
8.50 Telephone conference with B. Coppola re
TSA (1.0); review and revise TSA (2.7); draft
and revise TSA issues list (1.2); review and
revise asset purchase agreement (1.1);
telephone conference with B. Coppola, K&E
team re sale status update (.2); telephone
conference with B. Coppola re TSA schedules
(.3); review due diligence re IP schedules
(2.0).
07/08/24 Daniel Shin
5.50 Review and revise intellectual property
schedules (.4); review and revise disclosure
schedules (.8); review M&A counterparty
contracts for IP ownership (.7); correspond
with M. King re diligence items and IT
contracts (.5); review and draft intellectual
property assignment agreement (2.3);
correspond with client re ownership of IP
under M&A counterparty contracts (.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 279 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
32
Date
Name
Hours Description
07/08/24 Steve Toth
6.60 Analyze correspondence re asset purchase
agreement (.2); revise attorney notes re same
(.1); correspond with Company, PJT, Moelis,
D. O’Connor, K&E team re asset purchase
agreement issues list (.9); telephone
conference with Company, PJT, AlixPartners,
D. O’Connor, K&E team re sale status update
(.5); telephone conference with bidder, bidder
counsel, Company, PJT, Alix, Y. Salloum,
K&E team re asset purchase agreement and
TSA and diligence update (.4); analyze
correspondence re asset purchase agreement
(.4); analyze legal issues re asset purchase
agreement (1.0); revise same (.3); correspond
with MWE, Y. Salloum, K&E team re
transactions and regulatory matters (.5);
analyze asset purchase agreement (.5); revise
same (.5); correspond with D. O’Connor re
asset purchase agreement and schedules (.3);
further analyze, revise asset purchase
agreement (.6); analyze correspondence re
diligence matters (.4).
07/08/24 Steve Toth
1.10 Correspond with Company, AlixPartners, D.
O’Connor, K&E team re cure cost issues (.5);
analyze correspondence re APAs and bidder
updates (.6).
07/08/24 Sarah Ullathorne
1.20 Review, analyze responses to antitrust
questions.
07/08/24 Paul Vasiloff
1.00 Revise purchase agreement re employment
issues.
07/08/24 Spencer A. Winters, P.C.
1.50 Review and analyze sale process issues (.4);
correspond and telephone conferences with
working group re same (.3); draft talking
points for second day hearing re update re
same, case status (.8).
07/09/24 Chris Ceresa
5.20 Review, analyze sale related issues (2.4);
review, analyze legal issues re bidding
procedures and notices (.9); review and
comment on NDAs (.8); correspond with
Company, AlixPartners, PJT, Y. Salloum,
K&E team re issues re sale process (1.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 280 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
33
Date
Name
Hours Description
07/09/24 Bernadette Coppola
4.30 Correspond with M. King and K&E team re
revisions to transition services agreement
services (.2); correspond with AlixPartners re
transition services agreement schedules (.1);
conference with S. Toth, client and advisors
re transition services agreement and
transaction updates (.9); conference with S.
Toth and K&E team re regulatory matters
(.2); correspond with J. Garfinkle and K&E
team re revisions to intellectual property
schedules (1.3); analyze comments from
client re intellectual property schedules (.2);
conference with D. O’Connor re asset transfer
process (.2); correspond with M. King and
K&E team re same (.1); conference with
client, S. Toth and K&E team re regulatory
matters re transition services agreement
services (.7); follow‑up re same (.1);
conference with S. Toth re revisions to
transition services agreement schedules (.3).
07/09/24 Bernadette Coppola
1.00 Correspond with Company, S. Shermetaro
and K&E team re intellectual property
questions (.5); correspond with Company,
AlixPartners, S. Toth and K&E team re
separation matters (.5).
07/09/24 Anthony M. Del Rio
3.50 Review and revise purchase agreements re
health regulatory issues (.6); review and
revise TSA re same (.9); review, analyze
proposed transaction structure (1.2); review
and analyze regulatory filing requirements
(.8).
07/09/24 Jaina Desai
3.50 Revise bidding procedures order (.5); revise
bidding procedures notices (1.5); summarize,
analyze same (1.0); correspond with R.
Marston, C. Ceresa re same (.5).
07/09/24 Jaina Desai
0.80 Telephone conference with S. Winters, K&E
team, MWE re bidding procedures (.3); revise
bidding procedures notices (.2); summarize,
analyze same (.2); correspond with R.
Marston, C. Ceresa re same (.1).
07/09/24 Jaina Desai
0.50 Review, analyze NDA (.2); review, revise
NDA (.2); correspond with S. Lieberman re
same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 281 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
34
Date
Name
Hours Description
07/09/24 Jaina Desai
0.70 Correspond with R. Marston, AlixPartners re
disclosure schedule (.1); draft correspondence
re same (.2); analyze bidding procedures
notices (.3); correspond with Cole Schotz, C.
Ceresa re same (.1).
07/09/24 Luke Finn
0.60 Telephone conference with Cooley team re
M&A Counterparty bid (.2); correspond with
S. Toth, K&E team re Cooley call (.1);
review, analyze correspondence and team
communication re M&A counterparty bid
(.3).
07/09/24 Justin M. Garfinkle
6.00 Analyze issues re registered IP schedules
(3.9); further analyze same (1.1); review,
analyze issues re ventilation disclosure
schedules (1.0).
07/09/24 Kate Hardey
2.80 Conference with C. Ceresa, K&E team re
TSA (.6); conference with Company re
licenses, permits and TSA transfer services
(1.0); review, analyze legal entity lists related
to TSA (1.2).
07/09/24 Olivia Kaufmann
5.00 Conference with M&A counterparty re sale
(1.5); correspond with regulator re filings (.3);
review, analyze IP licenses (1.0); draft UCC
licenses summary (1.2); review and revise
UCC summary (.2); review, analyze UCC
licenses organization chart (.3); correspond
with K. Hardey, K&E team re same (.5).
07/09/24 Maggie Kate King
2.50 Revise transition services agreement
schedules (.8); correspond with buyer teams
re same (.2); conference with client re
revisions to same (1.0); revise IP assignment
agreement (.5).
07/09/24 Rebecca J. Marston
4.80 Correspond with J. Desai, K&E team, Cole
Schotz re bidding procedures order (1.3);
correspond with C. Ceresa re potentially
assumed and assigned contracts notice (.6);
correspond with S. Golden re sale notice
publication (.1); conference with C. Ceresa,
K&E team, counsel to potential sale
counterparty re sale issues (.5); review and
revise sale related notices (2.2); correspond
with J. Desai re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 282 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
35
Date
Name
Hours Description
07/09/24 Brandan Matthews
4.10 Review, analyze corporate issues re purchase
agreement matters (3.2); correspond with S.
Toth, K&E team re transition services
agreement matters (.5); conference with
M&A counterparty’s legal counsel re asset
purchase agreement issues (.2); review,
analyze correspondence re same (.2).
07/09/24 Ruan J. Meintjes
0.10 Review and analyze filing requirements under
US state permits.
07/09/24 Ruan J. Meintjes
3.30 Research and analyze change of ownership
considerations for state medical device and
drug distributor permits/licenses (3.0); draft,
revise summary re same (.3).
07/09/24 Trent Nachbar
6.70 Review, analyze issues re asset purchase
agreement and schedules (3.9); further
review, analyze same (2.1); revise same for
incorporation of specialist comments (.7).
07/09/24 Michelle L. Nowicki
0.20 Correspond with B. Coppola, K&E team re IP
due diligence.
07/09/24 Dan O'Connor
3.70 Correspond with T. Petersen re transaction
matters (.5); review and revise disclosure
schedules (.9); correspond with PJT team and
T. Petersen re same (.3); review and revise
M&A counterparty disclosure schedules (1.0);
review, analyze VDR contracts re same (.8);
correspond with Foley team re same (.2).
07/09/24 Dan O'Connor
3.60 Review and revise M&A counterparty
disclosure schedules (.9); correspond with
Company re same (.2); telephone conference
with S. Ullathorne and S. Davies re antitrust
matters (.3); correspond with S. Ullathorne,
K&E team re same (.2); telephone conference
with B. Coppola re transaction matters (.2);
telephone conference with Company re
license matters (.4); correspond with MWE
team re disclosure schedules (.2); review and
revise open items list for disclosure schedules
(.4); correspond with Company re same (.8).
07/09/24 D. Taylor Petersen
2.60 Revise disclosure schedules (1.4); draft
diligence responses to same (.4); draft tables
for disclosure schedules (.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 283 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
36
Date
Name
Hours Description
07/09/24 Yusuf Salloum
3.00 Analyze legal issues re sale processes (2.3);
correspond with C. Ceresa and K&E team re
same (.7).
07/09/24 Scottie Shermetaro
8.20 Review and revise TSA and TSA schedules
(3.8); review due diligence (2.4); revise IP
disclosure schedules for same (1.3); review
and revise asset purchase agreement (.7).
07/09/24 Daniel Shin
7.00 Draft correspondence re deleted transition
services agreement items on schedules (.9);
telephone conference with client re TSA
schedules (.8); review and draft transition
services agreement schedules (3.9); further
review, draft same (1.0); review and analyze
legal issues re IT agreements (.4).
07/09/24 Steve Toth
1.30 Analyze correspondence re TSA and
diligence (.3); correspond with B. Coppola re
TSA and related matters (.3); analyze TSA
cost estimates (.2); draft correspondence re
same (.1); draft correspondence re asset
purchase agreement and transaction open
issues (.4).
07/09/24 Steve Toth
5.80 Analyze and respond to correspondence re
asset purchase agreement and TSA schedules
(.6); telephone conference with Company,
Alix, D. O’Connor, K&E team re TSA
matters (.9); correspond with D. O’Connor,
K&E team re TSA regulatory matters (.3);
analyze TSA schedules and related
correspondence (.4); analyze revised asset
purchase agreement (1.1); analyze
correspondence re TSA (.2); correspond with
Y. Salloum re asset purchase agreement and
open issues (.5); telephone conference with
AlixPartners, Company, D. O’Connor, K&E
team re regulatory TSA services (.8); analyze
correspondence re TSA (.4); correspond with
bidder, bidder counsel, D. O’Connor, K&E
team re asset purchase agreement and status
(.6).
07/09/24 Sarah Ullathorne
1.50 Review, analyze issues re antitrust.
07/09/24 Spencer A. Winters, P.C.
0.90 Review and analyze issues re sale process,
case status (.6); correspond and telephone
conferences with multiple parties re same (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 284 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
37
Date
Name
Hours Description
07/10/24 Cooper Barghols
1.20 Research and summarize applicability of state
transaction notice requirements on proposed
transaction.
07/10/24 Chris Ceresa
9.20 Review, analyze sale related legal issues
(3.9); review, comment on draft stalking
horse order, declaration and bid procedures
notices (3.1); review, comment on purchase
agreement markup re legal issues (1.3);
correspond with Company, PJT, AlixPartners,
Y. Salloum, K&E team re same (.9).
07/10/24 Bernadette Coppola
5.10 Correspond with Company re responses to
allocation of intellectual property rights (.2);
conference with S. Toth, K&E team, client
and local counsel re regulatory considerations
for transition services agreement services (.5);
follow‑up re same (.1); conference with S.
Toth, K&E team, client and bidder team re
all‑hands discussion of open issues (1.3);
follow‑up re same (.5); conference with S.
Toth, Y. Salloum and K&E team re regulatory
matters (.5); correspond with M. King and
K&E team re revisions to transition services
agreement (.2); conference with S. Toth, K&E
team, client and bidder team re all‑hands
discussion of open sale issues (1.0);
correspond with D. Shin, bidder and K&E
team re analysis in response to bidder
question (.4); correspond with M. King and
K&E team re revisions to disclosure
schedules (.4).
07/10/24 Bernadette Coppola
0.90 Correspond with D. O'Connor and K&E team
re transaction updates (.2); conference with S.
Shermetaro and J. Garfinkle re revisions to
intellectual property schedules (.3); follow up
re same (.2); draft revisions to disclosure
schedules (.2).
07/10/24 Anthony M. Del Rio
3.80 Review and revise purchase agreements (1.5);
review and revise TSA considerations (.7);
review, analyze proposed transaction structure
(1.1); review, analyze regulatory filing
requirements (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 285 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
38
Date
Name
Hours Description
07/10/24 Jaina Desai
1.10 Revise stalking horse order (.9); correspond
with R Marston re same (.1); correspond with
C. Ceresa re declaration in support of stalking
horse bidder (.1).
07/10/24 Jaina Desai
1.20 Revise stalking horse notices (1.0);
correspond with R. Marston re same (.2).
07/10/24 Jaina Desai
3.70 Analyze, review precedent re stalking horse
notices, declarations and orders (1.9);
correspond with C. Ceresa, R. Marston re
same (.4); telephone conference with Cole
Schotz re stalking horse designation extension
notice (.4); correspond with S. Osborne, C.
Ceresa re asset purchase agreement (.5);
review, analyze asset purchase agreement
(.1); review, analyze bidding procedures order
(.3); correspond with R. Marston re same (.1).
07/10/24 Jaina Desai
1.00 Correspond with C. Ceresa, R. Marston re
sale stream (.3); telephone conference with C.
Ceresa re same (.1); correspond with J.
Foster, K&E team re sale order, stalking horse
order (.1); review, analyze precedent re same
(.2); review, analyze asset purchase
agreement (.3).
07/10/24 Jaina Desai
0.30 Review, analyze precedent re stalking horse
selection notices (.2); correspond with C.
Ceresa, R. Marston re same (.1).
07/10/24 Jaina Desai
3.60 Revise stalking horse orders, notices (2.5);
correspond with R. Marston re same (.5);
review, analyze comments re same (.6).
07/10/24 Amy Donahue
0.50 Draft shell order to approve stalking horse
bidder (.3); correspond with J. Desai re same
(.2).
07/10/24 Luke Finn
4.50 Telephone conference with Foley and M&A
counterparty re sale (1.4); telephone
conference with M&A counterparty re sale
(1.0); telephone conference with M&A
counterparty re sale (1.4); review, analyze
M&A counterparty disclosure schedules and
diligence findings (.7).
07/10/24 Julia R. Foster
1.00 Draft shell notice of selection of stalking
horse bidder (.5); correspond with J. Desai re
bidding procedures (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 286 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
39
Date
Name
Hours Description
07/10/24 Justin M. Garfinkle
3.90 Review, analyze issues re ventilation
disclosure schedules (1.0); review, analyze
issues re registered IP schedules, including
foreign entity schedules (2.4); review, analyze
issues re respiratory diagnostics disclosure
schedules (.5).
07/10/24 Kate Hardey
5.10 Review and comment on buyer APA
revisions and disclosure schedules (3.9);
multiple telephone conferences re structure
and TSA considerations (1.0); continue to
review and comment on buyer APA revisions
and disclosure schedules (.2).
07/10/24 Olivia Kaufmann
1.80 Telephone conference with M&A
counterparty re asset purchase agreement
(1.0); review, analyze change of ownership
analysis (.8).
07/10/24 Olivia Kaufmann
4.50 Telephone conference with S. Toth, K&E
team re asset purchase considerations (.8);
correspond with M&A counterparty re next
steps re same (.3); revise change of control
analysis (.5); correspond with state regulators
re change of control (.2); telephone
conference with K&E team and M&A
counterparty re change of control (.4);
correspond with R. Meintjes re same (.5);
review, analyze asset purchase agreement
schedules (.4); review, analyze issues re
change of ownership analysis (.9); correspond
with R. Meintjes, K&E team re same (.5).
07/10/24 Maggie Kate King
5.00 Conference with S. Toth, K&E team re
transition services agreement schedules
revisions (1.0); revise transition services
agreement schedules (3.0); telephone
conference with M&A counterparty re sale
(1.0).
07/10/24 Daniel Lewis, P.C.
1.00 Review, analyze legal issues re TSA matters.
07/10/24 Sabrina Lieberman
1.50 Conference with Company, Y. Salloum and
K&E team re German entities and sale issues
(.7); conference with O. Kaufmann re same
(.1); correspond with O. Kaufmann re same
(.2); correspond with Y. Salloum, K&E team
and PJT re NDA (.2); review, revise NDA
summary (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 287 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
40
Date
Name
Hours Description
07/10/24 Savannah Malnar-Cole
1.90 Review and analyze issues re ventilation
business (1.0); correspond with client re same
(.2); draft summary for M. Boney re same
(.7).
07/10/24 Rebecca J. Marston
9.20 Correspond with J. Desai, C. Ceresa re sale
work streams (3.9); correspond with A&M
team re schedule of potentially assumed and
assigned contracts (.3); correspond with C.
Ceresa, K&E team re same (.5); correspond
with K&E team, stakeholders re potential
claims, sale process (.4); review and revise
stalking horse bidder designation notice (1.2);
review and revise deadline extension notice
(.4); review and revise stalking horse order
(.7); review and revise declaration in support
of stalking horse (1.3); correspond with S.
Toth, K&E team re possible sale escrow
account (.3); correspond with T. De Paulo,
K&E team re declaration (.2).
07/10/24 Brandan Matthews
7.80 Telephone conference with S. Toth, K&E
team re sale updates (1.3); telephone
conference with client re ventilation business
open items (1.3); telephone conference with
S. Toth, K&E team re same (1.2); review,
analyze issues re signing matters (3.9); further
review, analyze same (.1).
07/10/24 Ruan J. Meintjes
2.50 Telephone conference with client and EU
counsel re transaction structure and regulatory
considerations in ex‑US territories (.8);
research and analyze further structure
considerations for US regulatory
considerations (1.0); correspond with S. Toth,
K&E team re same (.7).
07/10/24 Ruan J. Meintjes
3.20 Review and revise M&A counterparty asset
purchase agreement and schedules (2.5);
conference with S. Toth, K&E team re same
(.7).
07/10/24 Trent Nachbar
9.20 Review, analyze issues re asset purchase
agreement and schedules (3.9); further
review, analyze same (1.8); revise asset
purchase agreement to incorporate specialist
comments (2.4); revise asset purchase
agreement schedules to incorporate specialist
comments (1.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 288 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
41
Date
Name
Hours Description
07/10/24 Michelle L. Nowicki
2.00 Review, analyze correspondence with
Company re IP due diligence (.8); correspond
with B. Coppola, K&E team re same (.2);
revise IP schedules (.8); correspond with B.
Coppola, K&E team re IP schedules (.2).
07/10/24 Dan O'Connor
6.70 Telephone conference with PJT Partners,
Company, AlixPartners team, M&A
counterparty, S. Toth, S. Winters and Y.
Salloum re asset purchase agreement (1.4);
telephone conference with M&A
counterparty, Cooley team, Company, S.
Toth, L. Finn re legal diligence matters (1.0);
telephone conference with AlixPartners re
transaction matters (.5); telephone conference
with PJT team, Company, AlixPartners team,
S. Toth and K&E team re M&A counterparty
transaction matters (1.5); review and revise
lease and lease term sheet (.7); correspond
with Company and J. Caruso re same (.3);
telephone conference with M&A
counterparty, Foley team, PJT Partners team,
AlixPartners team, S. Toth and K&E team re
transaction matters (.7); review and revise
counterparty markup to disclosure schedules
(.3); correspond with counterparty re same
(.3).
07/10/24 Dan O'Connor
3.00 Correspond with counterparty counsel re
antitrust matters (.4); correspond with S. Toth,
K&E Team re transaction matters (.3);
correspond with M&A counterparty, counsel
re KYC matters (.2); correspond with B.
Coppola, K&E team re disclosure schedules
(.5); correspond with Company re same (.3);
correspond with Y. Salloum, K&E team re
escrow matters (.3); correspond with B.
Matthews, T. Nachbar and T. Petersen re
signing matters (1.0).
07/10/24 Sarah Osborne
1.10 Review, revise markup to asset purchase
agreement (.9); correspond with J. Desai,
K&E team re same (.2).
07/10/24 Carolin Paus
0.60 Telephone conference, with D. Wang, K&E
team re sale structuring.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 289 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
42
Date
Name
Hours Description
07/10/24 D. Taylor Petersen
3.60 Telephone conference with S. Toth, K&E
team re sale status (.4); revise disclosure
schedules (.4); draft signature pages (.2);
revise disclosure schedules (2.6).
07/10/24 Yusuf Salloum
5.00 Analyze issues re sale transaction (3.4);
conferences with PJT, AlixPartners,
Company, S. Toth, K&E team re same (1.6).
07/10/24 Scottie Shermetaro
9.60 Telephone conference with S. Toth, K&E
team re sale updates (1.4); review and revise
TSA and TSA schedules (1.8); telephone
conference with B. Coppola and K&E team re
asset purchase considerations (.5); telephone
conference with S. Toth, K&E team re sale
status (1.0); review and revise disclosure
schedules (1.7); telephone conference with J.
Garfinkle and M. Nowicki re IP diligence and
schedules (.5); review and revise disclosure
schedules (2.7).
07/10/24 Daniel Shin
4.00 Review and analyze IP license agreement and
disclosure schedules (.3); review and revise IP
assignment agreements (.2); correspond with
J. Garfinkle re same (.1); review and revise
TSA schedules (.7); correspond with M. King
re same (.2); draft IP license list from IT
agreements (2.5).
07/10/24 Michael D. Thorpe
0.30 Analyze HSR reportability of sale transaction.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 290 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
43
Date
Name
Hours Description
07/10/24 Steve Toth
5.40 Analyze and revise attorney notes re asset
purchase agreement and transaction issues
(.5); correspond with EU counsel, D.
O’Connor, K&E team and Company re
regulatory and transaction matters (.7);
analyze correspondence re TSA and
disclosure schedules (.2); telephone
conference with D. O’Connor, K&E team re
transaction issues (1.5); correspond with S.
Winters re transaction issues (.1); telephone
conference with bidder, bidder advisors,
Company, Alix, PJT, D. O’Connor, K&E
team re transaction perimeter and related
matters (.9); telephone conference with
bidder, bidder advisors, Company, Alix, D.
O’Connor, K&E team re TSA services (.8);
correspond with PJT and Y. Salloum re asset
purchase agreement status (.3); analyze and
revise attorney notes re transaction issues (.4).
07/10/24 Steve Toth
7.20 Telephone conference with Company, PJT,
AlixPartners, D. O’Connor, K&E team re
transaction update (1.6); correspond with N.
Warther re tax allocation (.1); analyze
correspondence re tax allocation and lease
amendment (.2); correspond with D.
O’Connor, K&E team re TSA needs (.5);
analyze correspondence re asset purchase
agreement and TSA (.5); telephone
conference with Y. Salloum, K&E team,
advisors re transaction issues (1.2);
correspond with B. Matthews re same (.1);
analyze correspondence and attorney notes re
asset purchase agreement issues (1.0); draft
issues list re same for lenders (.4); analyze
correspondence re TSA and schedules and
diligence updates (.3); analyze
correspondence re escrow matters, asset
purchase agreement exhibits and other signing
documents (1.3).
07/10/24 Donatus Wang
4.50 Conferences with A. Ziegler, K&E team and
Company re sale matters (1.6); review,
analyze legal issues re sale (1.9); conference
with A. Ziegler, K&E team re same debrief
(.6); summarize key considerations re same
(.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 291 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
44
Date
Name
Hours Description
07/10/24 Cristina Weidner
1.00 Correspond with A. Ziegler, K&E team re
sale legal issues.
07/10/24 Spencer A. Winters, P.C.
2.50 Review and analyze issues re sale process,
case status (.6); correspond and telephone
conferences with multiple parties re same (.6);
prepare for and participate in telephone
conference with Vents bidder (1.3).
07/10/24 Ann-Kathrin Ziegler
4.00 Analyze legal issues re sale (2.0); conference
with D. Wang, K&E team re same (1.0);
telephone conference with Company, Y.
Salloum, K&E team re same (.5); review and
revise summary correspondence re same (.5).
07/10/24 Tanzila Zomo
1.70 Prepare draft stalking horse notice (.5); draft
declaration re same (.7); review, revise online
document folders (.5).
07/11/24 Marin Boney
0.30 Review, analyze issues re risk assessment
(.1); correspond with D. O’Conner, S.
Malnar‑Cole and M. Thorpe re HSR analysis
(.2).
07/11/24 Chris Ceresa
8.70 Review, analyze sale related legal issues
(3.9); review, comment on sale related court
draft filings (2.2); correspond with Company,
PJT, AlixPartners, Y. Salloum, K&E team re
sale process issues (2.6).
07/11/24 Tiffani Chanroo
1.20 Draft stalking horse notice (.5); draft
declaration re same (.7).
07/11/24 Dominique Collins
0.20 Review and analyze draft asset purchase
agreement.
07/11/24 Dominique Collins
0.20 Review and analyze opposing counsel’s
updated asset purchase agreement.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 292 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
45
Date
Name
Hours Description
07/11/24 Bernadette Coppola
4.90 Conference with S. Shermetaro and J.
Garfinkle re revisions to intellectual property
schedules (.3); conference with Company, S.
Toth and K&E team re intercompany matters
and transaction steps (.8); conference with S.
Shermetaro re revisions to agreements (.1);
conference with D. Lewis re transition
services agreement (.1); draft revisions to
transition services agreement issues list (.3);
draft revisions to purchase agreement (.3);
correspond with client, D. O’Connor and
K&E team re same (.2); conference with S.
Toth, AlixPartners and K&E team re revisions
to transition services agreement (1.0);
follow‑up re same (.3); conference with S.
Shermetaro re revisions to transition services
agreement (.3); draft revisions to transition
services agreement (.9); correspond with S.
Toth and K&E team re same (.3).
07/11/24 Sion Davies
0.50 Conference and correspond with P. Kar, K&E
team re foreign filing analysis.
07/11/24 Tabitha J. De Paulo
0.70 Review and comment on declarations in
support of bid procedures.
07/11/24 Anthony M. Del Rio
2.80 Review and revise transaction documents
(2.2); review and analyze regulatory filings
triggered by transaction (.6).
07/11/24 Jaina Desai
1.00 Review, analyze comments re stalking horse
bidder (.2); correspond with C. Ceresa re
same (.1); review, analyze comments re
stalking horse declaration (.2); revise stalking
horse declaration (.4); correspond with R.
Marston re same (.1).
07/11/24 Jaina Desai
4.90 Revise stalking horse declaration (1.5);
correspond with R. Marston, C. Ceresa re
same (.3); review, analyze comments re same
(.3); further revise same (1.8); correspond
with R. Marston re same (.2); review, analyze
emails re same (.2); correspond with
AlixPartners re same (.2); telephone
conference with C. Ceresa re compiling
signatures re asset purchase agreement (.2);
correspond with C. Ceresa re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 293 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
46
Date
Name
Hours Description
07/11/24 Jaina Desai
5.00 Review, revise stalking horse notices (1.0);
review, revise bidding procedures notices
(1.6); correspond with R. Marston re same
(.4); revise, analyze signature pages (1.5);
correspond with Company, C. Ceresa re same
(.5).
07/11/24 Jaina Desai
0.30 Correspond with Cole Schotz re sale notices
(.2); correspond with S. Golden, C. Ceresa re
same (.1).
07/11/24 Michael Ehret
2.70 Correspond with C. Weidner re structuring
considerations, transfer of IP (.8); review,
revise draft TSA, asset purchase agreement
(1.2); correspond with P. Gunderson re same
(.7).
07/11/24 Luke Finn
4.30 Telephone conference with S. Toth, K&E
team re  intercompany agreements, tax and
accounting (1.0); review, analyze updated
M&A Counterparty bid disclosure schedules
received from Cooley (.8); revise M&A
Counterparty  bid disclosure schedules (1.5);
correspond with B. Matthews, K&E team re
M&A counterparty bid disclosure schedules
(.5); review, revise same (.5).
07/11/24 Justin M. Garfinkle
0.70 Draft revisions to ventilation purchase
agreement.
07/11/24 Kate Hardey
1.80 Review, revise draft APA re health regulatory
issues (1.3); conference with Company re
same (.5).
07/11/24 Liz Ji
2.40 Review, analyze asset purchase agreement
and transition service agreement re tax
considerations.
07/11/24 Olivia Kaufmann
0.20 Review, analyze asset purchase agreement.
07/11/24 Sooah Kim
0.50 Review and revise purchase agreement re
employment issues.
07/11/24 Maggie Kate King
7.70 Draft, revise transition services agreement
issues list (3.2); review, analyze, revise
transition services agreement from M&A
counterparty (3.9); conference with
AlixPartners re issues re same (.6).
07/11/24 Daniel Lewis, P.C.
0.70 Review, analyze legal issues re TSA.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 294 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
47
Date
Name
Hours Description
07/11/24 Sabrina Lieberman
0.20 Correspond with C. Ceresa and K&E team re
NDAs (.1); conference with Omni re service
of bidding procedures filings (.1).
07/11/24 Brandan Matthews
10.20 Review, analyze issues re purchase agreement
matters (3.9); further review, analyze same
(3.9); further review, analyze same (1.0);
telephone conference with S. Toth, K&E team
re cure schedule (.2); revise transaction
documents (1.2).
07/11/24 Ruan J. Meintjes
3.00 Review and revise M&A counterparty
purchase agreements and associated
transaction schedules (2.8); analyze and
revise transition services agreement (.2).
07/11/24 Trent Nachbar
7.70 Review, analyze issues re asset purchase
agreement and schedules (3.9); further
review, analyze same (3.0); revise same to
implement specialist comments (.8).
07/11/24 Maureen D. O'Brien
1.00 Review, analyze issues re asset purchase
agreement and TSA.
07/11/24 Dan O'Connor
2.30 Review and revise lease term sheet (.2);
correspond with Company, AlixPartners re
same (.3); telephone conference with PJT
team, Company, S. Toth, Y. Salloum, B.
Coppola, K&E team re intercompany
amounts and transaction matters (.4);
telephone conference with PJT team,
AlixPartners team, Y. Salloum, K&E team re
advisors check‑in call for sale updates (.2);
telephone conference with PJT team,
AlixPartners team, Gibson Dunn team,
Rothschild team, Y. Salloum, K&E team re
transaction matters (.2); telephone conference
with Company and S. Toth re employment
matters (.2); telephone conference with Foley
team, S. Toth, N. Warther, K&E team re
transaction matters (.4); telephone conference
with B. Coppola, K&E team and AlixPartners
re TSA matters (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 295 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
48
Date
Name
Hours Description
07/11/24 Dan O'Connor
5.90 Correspond with R. Meintjes, K&E team re
transaction matters (.3); telephone conference
with Company, R. Meintjes and K&E team re
purchase agreement matters (.4); telephone
conference with B. Matthews re transaction
matters (.4); review and revise asset purchase
agreement (.5); correspond with S. Toth and
B. Matthews re same (1.3); review and revise
M&A counterparty markup to disclosure
schedules (.8); correspond with C. Ceresa re
purchase agreement matters (.4); review and
revise disclosure schedules (1.3); telephone
conference with AlixPartners and PJT teams
re cure costs (.5).
07/11/24 Sarah Osborne
5.10 Review, revise asset purchase agreement (.8);
correspond with C. Ceresa, K&E team re
same (.3); draft stalking horse order (1.1);
correspond with C. Ceresa re same (.1);
review, revise same (.6); draft stalking horse
designation notice (.9); correspond with C.
Ceresa re same (.2); review, revise same (.8);
research precedent re stalking horse
designation notice (.3).
07/11/24 D. Taylor Petersen
1.50 Review, analyze signatures for closing (.1);
revise documents for same (.6); revise TSA
documents for closing (.8).
07/11/24 Evangelia Podaras
2.40 Telephone conferences with R. Salins, K&E
team re purchase agreement (.5); review,
revise purchase agreement (1.5); correspond
with S. Toth, K&E team re same (.4).
07/11/24 Yusuf Salloum
3.80 Analyze sale transaction issues re potential
stalking horse bidders (3.4); correspond with
C. Ceresa and K&E team re issues re same
(.4).
07/11/24 Scottie Shermetaro
12.10 Review and revise disclosure schedules to
APA (3.9); further review, revise same (.9);
review and revise asset purchase agreement
(2.9); review and revise transition services
agreement (3.9); telephone conference with B.
Coppola re transition services agreement
revisions (.5).
07/11/24 Daniel Shin
2.30 Telephone conference with AlixPartners re
transition services agreement issues (.5);
review and analyze same (1.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 296 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
49
Date
Name
Hours Description
07/11/24 Steve Toth
5.00 Correspond with Company, PJT,
AlixPartners, D. O’Connor, K&E team re
intercompany balances, taxes and settlement
(1.0); telephone conference with Company,
PJT, AlixPartners, D. O’Connor, K&E team
re sale status updates (.5); telephone
conference with PJT, AlixPartners, D.
O’Connor, K&E team and lender advisors re
sale updates (.3); analyze revised asset
purchase agreement (.5); revise same (.7);
correspond with Company and D. O’Connor
re Brazil matters (.2); telephone conference
with Company, PJT, AlixPartners, D.
O’Connor, K&E team re special committee
status updates (.5); analyze revised TSA (.5);
correspond with Company, PJT, AlixPartners,
D. O’Connor, K&E team re purchase
agreement, sale issues (.8).
07/11/24 Steve Toth
5.80 Draft correspondence re asset purchase
agreement edits (.2); telephone conference
with Foley, Y. Salloum, K&E team re asset
purchase agreement (.6); correspond with
AlixPartners, D. O’Connor and K&E team re
revised TSA (1.0); analyze and revise TSA
(.3); correspond with PJT re purchaser
finances (.1); analyze and revise TSA (.6);
telephone conference with UCC advisors,
AlixPartners, PJT, Y. Salloum, K&E team re
sale diligence (.4); correspond with Y.
Salloum re bidder qualification (.1);
correspond with N. Warther re prorated taxes
implicating sale process (.1); correspond with
E. Podaras re employee related asset purchase
agreement matters (.3); analyze
correspondence re asset purchase agreement
and labor questions (.3); analyze revised asset
purchase agreement and related
correspondence (1.1); analyze revised TSA
and related correspondence (.7).
07/11/24 Paul Vasiloff
0.50 Review, analyze purchase agreement re
employment issues.
07/11/24 Donatus Wang
1.80 Correspond with Company re sale issues (.8);
review, analyze draft asset purchase
agreement (1.0).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 297 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
50
Date
Name
Hours Description
07/11/24 Nicholas Warther
3.50 Review and revise tax portions of asset
purchase agreement (1.3); correspond with P.
Gunderson, K&E team re same (.9);
conference with BDO, P. Gunderson, K&E
team re same (.8); review and revise tax
portions of TSA (.5).
07/11/24 Cristina Weidner
1.00 Correspond with A. Ziegler, K&E team re
entity structuring.
07/11/24 Spencer A. Winters, P.C.
4.70 Prepare for and participate in telephone
conference with advisors re sale process, case
status (.5); prepare for and participate in
telephone conference with lender advisors re
same (.5); prepare for and participate in
telephone conference with special committee,
Company re same (.5); review and analyze
issues re sale process (1.7); correspond and
telephone conferences with multiple parties re
same (1.5).
07/11/24 Ann-Kathrin Ziegler
1.50 Correspond with C. Weidner, K&E team re
MIM carve out (1.0); review draft asset
purchase agreement re MIM aspects (.5).
07/12/24 Kon Asimacopoulos
1.50 Review, analyze international issues re sale
process.
07/12/24 Cooper Barghols
1.40 Research and summarize applicability of state
transaction notice requirements on proposed
transaction (.6); review and revise
investigation notes re state change of
ownership requirements for Company’s
licensed entities (.8).
07/12/24 Chris Ceresa
2.10 Review, analyze sale related issues (1.1);
correspond with Company, PJT, AlixPartners
teams, Y. Salloum, K&E team re same (1.0).
07/12/24 Bernadette Coppola
2.40 Draft revisions to transition services
agreement (.7); correspond with S. Toth,
K&E team and bidder’s counsel re same (.2);
draft revisions to asset purchase agreement
(.8); correspond with bidder counsel, S. Toth
and K&E team re same (.1); correspond with
PJT re transition services agreement
schedules (.1); correspond with S. Toth and
K&E team re transaction updates and
revisions to documents (.3); correspond with
M. King re revisions to transition services
agreement (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 298 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
51
Date
Name
Hours Description
07/12/24 Anthony M. Del Rio
2.10 Review and revise transaction documents
(1.6); review and analyze regulatory filings
triggered by transaction (.5).
07/12/24 Jaina Desai
3.70 Correspond with B. Matthews, GDC re
escrow account (.2); review, analyze
correspondence re same (.2); correspond with
R. Marston re same (.1); draft correspondence
re same (.2); correspond with R. Marston re
noticing procedures (.1); research, analyze
precedent re sale order (1.7); correspond with
R. Marston, Cole Schotz re same (.2);
telephone conference with AlixPartners re
escrow account (.1); research, analyze
precedent re cure objection summary (.5);
correspond with R. Marston, C. Ceresa re
same (.2); revise sale summary (.2).
07/12/24 Michael Ehret
1.70 Correspond with C. Weidner, K&E team re
contemplated disposal of vents business (.7);
review, revise draft agreements, asset
purchase agreement, TSA (1.0).
07/12/24 Luke Finn
3.40 Telephone conference with PJT, AlixPartners,
S. Toth, K&E team re lenders
discussions (.6); review and revise M&A
counterparty disclosure schedules (1.0);
review, analyze changes between M&A
counterparties APAs (1.0); review, analyze
sale documents (.5); revise same (.3).
07/12/24 Justin M. Garfinkle
1.00 Revise ventilation purchase agreement re IP
issues.
07/12/24 Kate Hardey
0.70 Review, analyze revised disclosure schedules.
07/12/24 Olivia Kaufmann
3.00 Review, analyze state acquisition notification
law (2.5); correspond with C. Barghols and R.
Meintjes re same (.5).
07/12/24 Maggie Kate King
2.50 Correspond with J. Garfinkle, K&E team re
revisions to asset purchase agreement by
M&A counterparty (.4); revise transition
services agreement (2.1).
07/12/24 Sabrina Lieberman
0.10 Correspond with Y. Salloum and K&E team
re NDA summary.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 299 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
52
Date
Name
Hours Description
07/12/24 Brandan Matthews
6.80 Review, analyze issues re purchase agreement
matters (3.9); further review, analyze same
(1.6); conference with Company re cure
schedule (.8); conference with bankers re
lender consent (.5).
07/12/24 Ruan J. Meintjes
1.50 Review and revise M&A counterparty asset
purchase agreement and schedules (1.1);
correspond with S. Toth, K&E team and
opposing counsel re same (.4).
07/12/24 Ruan J. Meintjes
1.60 Research and analyze material state
transaction notification laws applicable to
potential transactions (1.4); prepare summary
of the same (.2).
07/12/24 Trent Nachbar
2.60 Review, analyze issues re asset purchase
agreement and schedules.
07/12/24 Dan O'Connor
4.40 Telephone conference with AlixPartners
team, S. Toth and K&E team re cure costs
(.3); telephone conference with PJT team,
AlixPartners team, S. Toth, K&E team re
lender matters (.5); telephone conference with
PJT team, AlixPartners team, Gibson Dunn
team, Rothschild team, S. Toth, K&E team re
lender matters (.6); telephone conference with
AlixPartners and S. Toth, K&E team re cure
schedule (.5); correspond with M&A
counterparty, counsel re escrow agreement
(.4); review and revise disclosure schedules
(.8); correspond with Foley, BDO and
Company re same (.3); review and revise
M&A Counterparty disclosure schedules (.8);
correspond with L. Finn, T. Nachbar and T.
Petersen re same (.2).
07/12/24 D. Taylor Petersen
2.50 Revise disclosure schedules.
07/12/24 Evangelia Podaras
0.50 Correspond with R. Salins, K&E team re asset
purchase agreement drafts.
07/12/24 Yusuf Salloum
2.00 Conferences with S. Toth, K&E team,
AlixPartners, lenders, PJT teams re sale
transactions (1.4); analyze legal issues re
same (.6).
07/12/24 Scottie Shermetaro
2.30 Telephone conference with N. Shier and B.
Coppola re status of documents for sale of
ventilation business (.5); review and revise
asset purchase agreement (1.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 300 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
53
Date
Name
Hours Description
07/12/24 Noah Shier
1.80 Correspond with Y. Salloum, K&E team re
open sale items (.5); review TSA (1.3).
07/12/24 Paul D. Tanaka, P.C.
1.10 Correspond with S. Toth, K&E team re
purchase agreements and bid drafts (.2);
review and analyze same (.9).
07/12/24 Steve Toth
4.50 Correspond with AlixPartners, D. O’Connor,
K&E team re contracts and cure schedule for
ventilation asset purchase agreement (.3);
telephone conference with AlixPartners, PJT,
Y. Salloum, K&E team re bid analysis (.5);
telephone conference with lender advisors,
AlixPartners, PJT, D. O’Connor, K&E team
re bid analysis (.6); analyze revised asset
purchase agreement (.4); draft correspondence
re same (.3); analyze revised TSA (.2);
correspond with AlixPartners, D. O’Connor,
K&E team re contracts and cures (.2); draft
correspondence re same (.2); analyze
correspondence re finalizing asset purchase
agreement and TSA (1.8).
07/12/24 Donatus Wang
1.20 Correspond with C. Weidner, K&E team,
advisors Company re sale issues.
07/12/24 Cristina Weidner
1.00 Correspond with A. Ziegler, K&E team re
entity structuring.
07/12/24 Spencer A. Winters, P.C.
3.10 Review and analyze issues re sale process
(1.6); correspond and telephone conferences
with multiple parties re same (1.5).
07/13/24 Bernadette Coppola
0.20 Draft revisions to transition services
agreement.
07/13/24 Michael Ehret
1.70 Review, analyze correspondence from
Company re novation issues re sale
structuring (.7), conference with Company,
PwC re same (.8); correspond with C.
Weidner, K&E team re German tax issues
(.2).
07/13/24 Maggie Kate King
1.80 Revise respiratory diagnostics transition
services agreement.
07/13/24 Daniel Lewis, P.C.
0.50 Correspond with B. Coppola and K&E team
re TSA issues.
07/13/24 Brandan Matthews
1.70 Review, analyze issues re M&A counterparty
purchase agreement.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 301 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
54
Date
Name
Hours Description
07/13/24 Ruan J. Meintjes
0.20 Review and analyze M&A counterparty
transition services agreement (.1); revise same
(.1).
07/13/24 Ruan J. Meintjes
0.80 Review and analyze diligence items related to
Section 363 sales (.6); correspond with A. Del
Rio re the same (.2).
07/13/24 Dan O'Connor
1.40 Telephone conference with Company, S.
Toth, K&E team, PJT team, AlixPartners re
intercompany tax matters (.5); telephone
conference with PJT team, AlixPartners, S.
Winters and Y. Salloum re transaction matters
(.5); correspond with Company re insurance
matters (.4).
07/13/24 Yusuf Salloum
1.50 Analyze legal issues re sale transaction (1.2);
correspond with C. Ceresa and K&E team re
same (.3).
07/13/24 Scottie Shermetaro
0.20 Review and revise TSA for sale of respiratory
diagnostics business.
07/13/24 Noah Shier
1.00 Review, draft revisions re TSA.
07/13/24 Paul D. Tanaka, P.C.
0.60 Review and analyze purchase agreement and
bid drafts (.5); correspond with K&E team re
same (.1).
07/13/24 Steve Toth
2.70 Telephone conference with Company, D.
O’Connor, K&E team, PJT and AlixPartners
re bids update (.6); correspond with
Company, PwC, D. O’Connor, K&E team re
intercompany settlement (1.3); analyze
correspondence re asset purchase agreement
and transaction matters (.6); telephone
conference with lender advisors, PJT,
AlixPartners, D. O’Connor, K&E team re sale
updates (.2).
07/13/24 Donatus Wang
1.30 Conference with Company and tax advisors re
sale issues.
07/13/24 Cristina Weidner
3.10 Conference with Company, D. Wang, K&E
team re sale tax structuring and different
proposals.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 302 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
55
Date
Name
Hours Description
07/13/24 Spencer A. Winters, P.C.
2.40 Review and analyze issues re stalking horse
bids (1.1); prepare for and participate in
telephone conference with Company and
advisors re same (.5); prepare for and
participate in telephone conference with
lender advisors re same (.5); correspond and
telephone conferences with multiple parties re
same (.3).
07/13/24 Ann-Kathrin Ziegler
2.50 Review, analyze intercompany summary (.5);
conference with Company, C. Weidner, K&E
team re intercompany structuring (1.0); and
conference with C. Weidner, K&E team, tax
advisors re same (1.0).
07/14/24 Chris Ceresa
1.30 Review, analyze legal issues re potential sale
and purchase agreements (1.0); correspond
with PJT, AlixPartners, Y. Salloum, K&E
team, Company re same (.3).
07/14/24 Jaina Desai
2.40 Revise stalking horse designation extension
notice (1.5); review, analyze correspondence
re same (.4); correspond with Gibson Dunn re
same (.1); correspond with R. Marston re
same (.4).
07/14/24 Luke Finn
0.80 Review, revise M&A counterparty disclosure
schedules.
07/14/24 Trent Nachbar
5.30 Review, analyze legal issues re asset purchase
agreement and schedules (2.2); incorporate
revisions to same (3.1).
07/14/24 Dan O'Connor
1.30 Telephone conference with Company, S.
Toth, K&E team, Company, AlixPartners re
intercompany tax matters (.5); review,
analyze issues re same (.8).
07/14/24 D. Taylor Petersen
0.80 Revise disclosure schedules.
07/14/24 Steve Toth
0.60 Analyze correspondence re tax and diligence
matters as it relates to sale.
07/14/24 Cristina Weidner
2.50 Conferences with A. Ziegler, K&E team, tax
advisors re sale proposals (1.4); correspond
with A. Ziegler, K&E team, tax advisors and
Company re same (1.1).
07/14/24 Ann-Kathrin Ziegler
2.00 Conference with C. Weidner, K&E team, tax
advisors re intercompany structuring (1.0);
conference with Company, C. Weidner, K&E
team, tax advisors re same (1.0).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 303 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
56
Date
Name
Hours Description
07/15/24 Kon Asimacopoulos
1.50 Review, analyze international issues re sales.
07/15/24 Chris Ceresa
3.10 Review, analyze legal issues re potential sale
and purchase agreements (2.4); correspond
with PJT, AlixPartners, S. Toth, K&E team,
Company re same (.7).
07/15/24 Bernadette Coppola
0.10 Correspond with AlixPartners, S. Toth, K&E
team, advisors re transition services
agreement schedules.
07/15/24 Sion Davies
0.20 Correspond with K. Asimacopoulos, K&E
team re filing analysis re potential sales.
07/15/24 Anthony M. Del Rio
2.60 Telephone conference with buyer's counsel re
regulatory filings (.6); review and revise
transaction documents (1.1); review and
analyze filing requirements for same (.9).
07/15/24 Jaina Desai
0.60 Review, analyze correspondence re sale
stream (.2); revise sale stream summary (.4).
07/15/24 Jaina Desai
0.60 Telephone conference with S. Toth re asset
sale (.5); correspond with R. Marston re same
(.1).
07/15/24 Jaina Desai
1.00 Telephone conference with C. Ceresa, R.
Marston re sale stream status, next steps (.5);
correspond with R. Marston re same (.2);
review, analyze correspondence re timeline
updates (.1); correspond with Gibson Dunn re
same (.1); correspond with C. Ceresa re sale
order precedent (.1).
07/15/24 Jaina Desai
0.90 Correspond with R. Marston re stalking horse
declaration (.1); correspond with AlixPartners
re same (.2); review, analyze correspondence
re sale stream (.2); review, analyze sale order
precedent (.3); correspond with J. Foster,
K&E team re same (.1).
07/15/24 Jaina Desai
0.50 Correspond with R. Marston re stalking horse
declaration (.1); correspond with AlixPartners
re same (.2); review, analyze correspondence
re sale stream (.2).
07/15/24 Michael Ehret
1.50 Conference with Company, M&A
counterparty, Deloitte, re transaction (1.0),
review, analyze documents re same (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 304 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
57
Date
Name
Hours Description
07/15/24 Luke Finn
3.80 Revise draft of M&A counterparty disclosure
schedules (1.0); correspond with client re
open diligence questions and additional
requests (.6); review, revise, finalize M&A
counterparty disclosure schedules (1.8);
correspond with M&A counterparty re
same (.4).
07/15/24 Kate Hardey
0.50 Conference with opposing counsel re state
license transfer review.
07/15/24 Olivia Kaufmann
2.30 Correspond with state regulators re notice
requirements (.2); conference with R.
Meintjes re change of ownership research
(.4); participate in regulatory discussion with
bidder counsel (.3); review, analyze bidder
state license summary (.5); conference with
R. Meintjes re same (.3); update bidder state
summary (.6).
07/15/24 Sabrina Lieberman
1.10 Correspond with Y. Salloum, K&E team,
AlixPartners, PJT, Foley re German tax issues
related to sale (.5); correspond with Y.
Salloum, K&E team, AlixPartners, PJT, Foley
re German tax issues related to sale (.6).
07/15/24 Rebecca J. Marston
5.70 Conference with C. Ceresa, J. Desai re sale
work streams (.7); correspond with J. Desai re
same (2.1); correspond with C. Ceresa re tax
planning issue (.1); research same (1.9);
prepare for and conference with counsel to
potential bidder, K&E team, AlixPartners re
potential transaction (.9).
07/15/24 Ruan J. Meintjes
2.30 Review and analyze change of ownership
regulations applicable to ventilation business
(1.9); conference with buyer’s counsel re
same (.4).
07/15/24 Trent Nachbar
3.20 Review, analyze issues re asset purchase
agreement and schedules.
07/15/24 Dan O'Connor
1.70 Telephone conference with M&A
counterparty, Deloitte, N. Warther, K&E
team, Company re respiratory diagnostics tax
matters (.5); telephone conference with PJT
team, Gibson Dunn team, Company,
AlixPartners, S. Winters and S. Toth re
transaction matters (.7); telephone conference
with PJT team, AlixPartners, S. Toth, K&E
team re transaction matters (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 305 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
58
Date
Name
Hours Description
07/15/24 Carolin Paus
4.70 Summarize asset purchase agreement re tax
liabilities (3.8); review, analyze intercompany
issues re same (.9).
07/15/24 Yusuf Salloum
2.30 Prepare for and participate in conferences
with advisors, lenders, S. Toth, K&E team re
sale transaction (1.2); analyze legal issues re
same (1.1).
07/15/24 Steve Toth
3.70 Telephone conference with bidder advisors,
PwC, Company, D. O’Connor, K&E team re
intercompany settlement (.5); correspond with
S. Zablotney re tax issues related to sale (.1);
analyze correspondence re intercompany
issues and TSA (.2); correspond with lender
advisors, Company, D. O’Connor, K&E team,
PJT and AlixPartners teams re bids updates
(.7); telephone conference with Company,
PJT, AlixPartners, D. O’Connor, K&E team
re bid updates (.9); telephone conference with
Foley, D. O’Connor, K&E team, PJT and
AlixPartners re potential sale structure
alternatives (.4); analyze correspondence re
tax and diligence matters (.3); correspond
with D. O’Connor, K&E team re international
tax matters (.6).
07/15/24 Cristina Weidner
1.00 Correspond with A Ziegler, K&E team re
transaction structuring legal issues (.3);
analyze issues re same (.7).
07/15/24 Spencer A. Winters, P.C.
3.40 Review and analyze issues re sale and
marketing process and open legal issues, case
status (1.3); prepare for and participate in
telephone conference with lender advisors re
same (.5); prepare for and participate in
advisor telephone conference with advisors re
same (.5); correspond and telephone
conferences with multiple parties re same
(1.1).
07/15/24 Ann-Kathrin Ziegler
2.00 Conference with Company, potential sale
party, PJT, tax advisor re intercompany
reorganization (.5); draft summary re
potential asset sale re German legal
considerations (.8); review, revise internal
summary re tax indemnities under (.7).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 306 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
59
Date
Name
Hours Description
07/16/24 Cooper Barghols
0.60 Correspond with R. Meintjes, A. Del Rio, B.
King and O. Kaufmann re organizational
materials and strategic process.
07/16/24 Chris Ceresa
3.00 Review, analyze legal issues re potential sale
and purchase agreements (2.2); correspond
with advisors, K&E team, Company re same
(.8).
07/16/24 Bernadette Coppola
0.30 Correspond with S. Toth, K&E team, advisors
and Company re transition services agreement
matters.
07/16/24 Anthony M. Del Rio
1.70 Review and comment on transaction
documents (.6); review and analysis of
licensure requirements (1.1).
07/16/24 Jaina Desai
0.80 Revise stalking horse designation extension
notice (.2); revise, review sale summary (.1);
correspond with R. Marston re same (.2);
draft cure objection summary (.2); correspond
with R. Marston re same, sale order precedent
(.1).
07/16/24 Jaina Desai
4.30 Review, analyze 363 sale order precedent
(3.1); correspond with R. Marston re same
(.2); review, analyze bidding procedures order
(1.0).
07/16/24 Jaina Desai
1.00 Analyze correspondence re sale cure
objections (.3); correspond with objectors re
same (.2); correspond with R. Marston re
same (.1); correspond with AlixPartners re
same (.1); revise cure objection summary (.3).
07/16/24 Justin M. Garfinkle
0.50 Review, analyze registered IP schedules for
RDx sale.
07/16/24 Kate Hardey
1.00 Conference with R. Meintjes, K&E team re
review of state license change of ownership
timing (.7); review, analyze correspondence
from R. Meintjes re state license change of
ownership re potential transaction timing
considerations (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 307 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
60
Date
Name
Hours Description
07/16/24 Olivia Kaufmann
1.90 Conference with K. Hardey, K&E team re
healthcare issues (.5); review, analyze
correspondence from K. Hardey, K&E team
(.2); conference with A. Del Rio re regulator
outreach (.1); correspond with regulator re
license (.1); correspond with A. Del Rio re
same (.2); review, analyze bidder summary
(.2); review, analyze licenses (.3); revise
summary re same (.3).
07/16/24 Rebecca J. Marston
3.80 Correspond with J. Desai re sale objection
parties (2.1); respond to counterparties re
same (.3); review, analyze sale order
precedent (.7); review, analyze sale reply
precedent (.5); correspond with K. Trevett re
sale timeline (.2).
07/16/24 Ruan J. Meintjes
1.40 Review and analyze change of ownership
considerations (.5); comment on bidder’s
counsel’s licensure proposal (.5); coordinate
with K. Hardey, K&E team re same (.4).
07/16/24 Trent Nachbar
2.80 Review, analyze asset purchase agreement
and schedules re corporate and specialist
issues.
07/16/24 Michelle L. Nowicki
3.50 Review, analyze of RDx IP disclosure
schedules and related online IP Office records
(1.1); correspond with S. Shermetaro, K&E
team re same (.2); draft summary of related
issues (1.8); draft trademark ownership
documentation (.4).
07/16/24 Yusuf Salloum
2.00 Analyze legal issues re sale transaction (1.2);
review status re same (.2); correspond with C.
Ceresa, K&E team, advisors re same (.6).
07/16/24 Scottie Shermetaro
0.30 Review and revise disclosure schedules.
07/16/24 Noah Shier
0.50 Correspond with Y. Salloum, K&E team re
TSA (.2); review disclosure schedules (.3).
07/16/24 Paul D. Tanaka, P.C.
1.20 Review and analyze bid drafts and purchase
agreements (.9); correspond with Y. Salloum,
K&E team re same (.3).
07/16/24 Dennis Williams
1.00 Conference with K. Hardey, K&E team re
review of state license change of ownership
timing (.6); review, analyze correspondence
from K. Hardey re state license change of
ownership re potential transaction timing
considerations (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 308 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
61
Date
Name
Hours Description
07/16/24 Spencer A. Winters, P.C.
1.20 Review and analyze bid drafts and purchase
agreements (.9); correspond with Y. Salloum,
K&E team re same (.3).
07/16/24 Ann-Kathrin Ziegler
0.80 Review and revise internal summary re tax
provisions in asset purchase agreements and
internal questions.
07/16/24 Tanzila Zomo
2.00 Prepare draft shell of sale order.
07/17/24 Kon Asimacopoulos
1.50 Review, analyze international issues re
potential sales.
07/17/24 Chris Ceresa
4.50 Review and analyze legal issues re potential
sales (1.6); analyze legal issues re sale order
precedent (.6); correspond with advisors, Y.
Salloum K&E team, Company re sale issues
(.8); telephone conferences with S. Winters,
K&E team, advisors re same (1.1);
correspond with J. Desai re bid procedures
and noticing issues (.4).
07/17/24 Bernadette Coppola
1.30 Correspond with J. Garfinkle and K&E team
re bidder comments to intellectual property
schedules (.2); conference with Deloitte,
AlixPartners, Company, S. Toth and K&E
team re transition services agreement
schedules (1.1).
07/17/24 Anthony M. Del Rio
1.20 Review and analysis of licensure
requirements (.8); review and comment on
transaction documents (.4).
07/17/24 Jaina Desai
0.40 Correspond with R. Marston, C. Ceresa, K.
Chiaghana re updated sale dates (.2);
conference with R. Marston re sale objection
call (.1); correspond with claims objector re
same (.1).
07/17/24 Jaina Desai
0.70 Revise sale objection summary (.2); review,
analyze correspondence re same (.3);
correspond with R. Marston, AlixPartners re
same (.2).
07/17/24 Jaina Desai
4.40 Review, analyze sale order (.8); analyze,
review sale order precedents (1.4); revise sale
order (2.2).
07/17/24 Jaina Desai
1.10 Review, analyze bidding procedures order
(.4); draft correspondence re key dates and
deadlines (.3); revise sale summary (.3);
correspond with R. Marston re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 309 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
62
Date
Name
Hours Description
07/17/24 Jaina Desai
0.80 Review, analyze cash management order,
taxes order for relevant terms impacting sale
order (.3); correspond with C. Ceresa re sale
notice publication (.1); correspond with Omni
re same (.1); revise stalking horse bidder
designation extension notice (.2); correspond
with C. Ceresa re same (.1).
07/17/24 Jaina Desai
0.20 Further revise stalking horse bidder
designation extension notice (.1); correspond
with Cole Schotz, C. Ceresa re same (.1).
07/17/24 Justin M. Garfinkle
1.00 Review, analyze RDx registered IP schedules.
07/17/24 Kate Hardey
0.50 Review, analyze EU conformity statements
(.3); conference with R. Meintjes re same;
review, analyze revised state license summary
(.2).
07/17/24 Olivia Kaufmann
0.70 Review, analyze licenses in disclosure
schedule (.2); revise license summary (.3);
review, analyze licenses (.1); conference with
R. Meintjes re same (.1).
07/17/24 Maggie Kate King
1.00 Revise transition services agreement (.5);
conference with M. Sheridan re deal
workstreams and assignments (.5).
07/17/24 Sabrina Lieberman
0.10 Correspond with Y. Salloum and K&E team
re NDAs.
07/17/24 Savannah Malnar-Cole
0.80 Review and revise clean team agreement.
07/17/24 Ruan J. Meintjes
1.10 Review and analyze vent device listings (.5);
prepare summary of same (.2); revise
transaction schedules (.3); correspond with O.
Kaufmann, K&E team re same (.1).
07/17/24 Michelle L. Nowicki
0.50 Review, analyze RDx documentation and
comments from IP counsel (.1); revise IP
schedules (.2); revise, analyze outstanding
issues (.1); correspond with M. King, K&E
team re RDx IP schedules and issues (.1).
07/17/24 Dan O'Connor
1.00 Telephone conference with PJT team,
Deloitte, Company, AlixPartners, S. Toth and
others re asset purchase agreement matters.
07/17/24 Yusuf Salloum
2.00 Analyze issues re sale transaction (1.3);
correspond with C. Ceresa and K&E team,
Company, advisors re same (.7).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 310 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
63
Date
Name
Hours Description
07/17/24 Noah Shier
2.00 Conference with Y. Salloum, K&E team re
TSA (1.5); review, analyze revised patent and
trademark disclosure schedule (.3); review,
analyze TSA issues (.2).
07/17/24 Steve Toth
1.10 Prepare for and participate in telephone
conference with AlixPartners, Deloitte, D.
O’Connor K&E team re TSA and costs.
07/17/24 Dennis Williams
0.50 Review, analyze EU conformity statements
and conference with R. Meintjes re same (.3);
review, analyze revised state license summary
(.2).
07/17/24 Spencer A. Winters, P.C.
1.60 Prepare for and participate in telephone
conference with Company advisors, C. Ceresa
and K&E team re sale process (.5); telephone
conference with Company advisors re
waterfall issues (.5); review and analyze
issues re sale process, case status (.3);
correspond and telephone conferences with
multiple parties re same (.3).
07/18/24 Marin Boney
0.30 Revise team agreement markup.
07/18/24 Chris Ceresa
2.70 Review, analyze legal issues re potential sale,
purchase agreements, and pleadings (1.4);
correspond with advisors, J. Desai, K&E
team, Company re same (1.3).
07/18/24 Bernadette Coppola
0.20 Analyze statement of work re website
services.
07/18/24 Anthony M. Del Rio
1.10 Review and comment on transaction
documents (.6); review and comment on
outstanding diligence requests (.5).
07/18/24 Jaina Desai
2.00 Revise case timeline (.2); correspond with K.
Trevett re same (.1); revise stalking horse
notice (.2); revise stalking horse declaration
(.2); revise sale summary (.2); correspond
with R. Marston re same (.1); review, analyze
correspondence re sale (.1); correspond with
R. Marston re same (.1); draft sale date
extension notice (.3); correspond with R.
Marston, C. Ceresa re same (.2); correspond
with S. Lieberman re sale stream (.1);
correspond with informal sale objector re
objection deadline (.1); correspond with R.
Marston, C. Ceresa re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 311 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
64
Date
Name
Hours Description
07/18/24 Jaina Desai
1.80 Correspond with Cole Schotz, R. Marston re
sale date extension notice (.2); correspond
with AlixPartners re informal cure objections
(.1); correspond with R. Marston re same (.1);
revise cure objection summary (.2);
correspond with R. Marston re same (.1);
review, analyze correspondence re same (.1);
review, analyze sale presentation (.2);
correspond with S. Lieberman, R. Marston,
PJT re bids and IOIs (.2); correspond with
cure objector re assumption and cure matters
(.1); draft updated key dates and deadlines
extension notice (.4); correspond with R.
Marston re same (.1).
07/18/24 Jaina Desai
0.40 Telephone conference with cure objector, R.
Marston re cure objection (.3); correspond
with R. Marston re same (.1).
07/18/24 Jaina Desai
0.70 Telephone conference with AlixPartners, R.
Marston re cure and sale objections (.5);
correspond with R. Marston re same (.1);
correspond with S. Lieberman re sale process,
objection summary (.1).
07/18/24 Jaina Desai
1.70 Draft sale and cure objection summary (1.3);
correspond with R. Marston re same (.2);
review, analyze correspondence re cure
objections (.2).
07/18/24 Jaina Desai
0.80 Review, analyze objection (.3); draft
extension notice (.2); correspond with R.
Marston re same (.2); correspond with Omni,
Cole Schotz re filed notice (.1).
07/18/24 Luke Finn
1.60 Conference with PJT, advisors re sale (.9);
review, analyze correspondence re regulatory
pathway (.7).
07/18/24 Justin M. Garfinkle
0.70 Review, analyze RDx registered IP schedule
comments.
07/18/24 Olivia Kaufmann
1.00 Review, analyze data room documents for list
of vent products (.4); conference with R.
Meintjes re same (.3); correspond with A. Del
Rio and R. Meintjes re license applications
and deal structure (.3).
07/18/24 Brandan Matthews
0.90 Conference with D. O’Connor, K&E team re
lender materials re sales.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 312 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
65
Date
Name
Hours Description
07/18/24 Ruan J. Meintjes
1.60 Coordinate with client re categorization of
product portfolios (.2); draft summary of
same (.8); correspond with A. Del Rio, K&E
team re transition service agreement questions
(.6).
07/18/24 Dan O'Connor
1.20 Telephone conference with PJT team,
Company, AlixPartners, S. Toth and others re
transaction matters (.5); telephone conference
with S. Winters, K&E team, PJT,
AlixPartners, lender advisors re transaction
matters (.7).
07/18/24 Yusuf Salloum
2.00 Analyze legal issues re sale transactions (1.0);
telephone conferences with S. Winters, K&E
team, and advisors (1.0).
07/18/24 Noah Shier
1.60 Revise disclosure schedules (1.2); review,
analyze software statement of work (.4).
07/18/24 Steve Toth
3.90 Participate in telephone conference with
AlixPartners, S. Winters, K&E team re
waterfall and winddown (.6); participate in
management update telephone conference
with Company, AlixPartners, PJT, S. Winters,
K&E team (.4); participate in telephone
conference with lender advisors, PJT,
AlixPartners, S. Winters, K&E team re sale
(.4); telephone conference with PJT and
AlixPartners re winddown info and lender
diligence preview (.5); draft comments on bid
summary deck (.3); participate in special
committee telephone conference with
Company, PJT, AlixPartners, S. Winters and
K&E team (.6); participate in telephone
conference with lenders, lender advisors, PJT,
AlixPartners, S. Winters, K&E team re bidder
updates (.7); conference with Company,
AlixPartners, S. Winters, K&E team re
intercompany matters (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 313 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
66
Date
Name
Hours Description
07/18/24 Spencer A. Winters, P.C.
4.60 Prepare for and participate in telephone
conference with Company advisors re
waterfall (.5); prepare for and participate in
telephone conference with Company and
advisors re sale process, open legal issues,
case status (.5); prepare for and participate in
weekly telephone conference with lender
advisors re same (.5); prepare for and
participate in special committee conference re
sale process, open legal issues, and case status
(.5); prepare for and participate in telephone
conference with lender principals re same
(.7); prepare for and participate in pre‑call
with Company advisors re same (.2); review
and analyze issues re sale and marketing
process (.8); correspond and telephone
conferences with multiple parties re same (.9).
07/19/24 Cooper Barghols
0.30 Correspond with R. Meintjes, K&E team
and international counsel re deal process and
strategic initiatives.
07/19/24 Anthony M. Del Rio
1.80 Participate in telephone conference with EU
counsel re transaction considerations (.6);
review and analyze open recall impact on
schedules and filing requirements (.7); review
and analyze license materials (.5).
07/19/24 Jaina Desai
0.80 Correspond with informal sale objectors (.5);
correspond with R. Marston re same (.1);
review, analyze extension notice (.2).
07/19/24 Jaina Desai
1.10 Draft correspondence re sale objections (.8);
correspond with R. Marston re same (.2);
analyze correspondence re sale (.1).
07/19/24 Jaina Desai
0.30 Revise sale objection summary (.2);
correspond with C. Ceresa, R. Marston re
same (.1).
07/19/24 Jaina Desai
0.40 Review, analyze correspondence re sale
objections (.2); revise summary re same (.1);
correspond with R. Marston re same (.1).
07/19/24 Luke Finn
1.80 Conference with lender advisors, Company re
sale legal issues (1.0); review, analyze
correspondence from Company re regulatory
transitions (.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 314 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
67
Date
Name
Hours Description
07/19/24 Olivia Kaufmann
1.00 Review, analyze California licensure
application (.4); conference with R. Meintjes
and K&E team re same (.6).
07/19/24 Brandan Matthews
1.40 Conference with S. Toth, Company working
group re lender financial diligence items.
07/19/24 Ruan J. Meintjes
2.60 Review and analyze California department of
health change of ownership filing
requirements (1.5); review and analyze
company application diligence materials (.5);
conference with UK regulatory counsel re
transition services agreements (.6).
07/19/24 Yusuf Salloum
1.50 Analyze legal issues re sale transactions.
07/19/24 Steve Toth
2.20 Participate in telephone conference with
lenders, lender advisors, AlixPartners, PJT, S.
Winters, K&E team re sale process (1.2);
conference with B. Matthews re same (.2);
conference with PJT, AlixPartners, S.
Winters, K&E team re entities and liabilities
and assets (.8).
07/19/24 Spencer A. Winters, P.C.
2.80 Prepare for and participate in telephone
conference with lender advisors re sale
process (1.0); review and analyze issues re
same (.9); correspond and telephone
conferences with multiple parties re same (.9).
07/20/24 Jaina Desai
0.20 Review, analyze correspondence re cure
objections (.1); correspond with cure objector,
R. Marston re same (.1).
07/22/24 Cooper Barghols
0.80 Correspond with bidder team re regulatory
considerations in consummation of proposed
transaction.
07/22/24 Chris Ceresa
1.40 Review, analyze legal issues re sale (.5);
correspond with J. Desai, K&E team re same
(.5); telephone conference with J. Desai, K&E
team re same (.4).
07/22/24 Anthony M. Del Rio
1.00 Conference with bidder and bidder advisors re
transaction structure and transition of
regulatory approvals.
07/22/24 Jaina Desai
0.30 Review, analyze comments re key dates
extension notice (.1); revise same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 315 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
68
Date
Name
Hours Description
07/22/24 Jaina Desai
1.10 Telephone conference with R. Marston re sale
stream updates (.6); further revise extension
notice (.4); correspond with R. Marston re
same (.1).
07/22/24 Jaina Desai
1.30 Correspond with informal sale objectors re
informal cure objections (.2); correspond with
AlixPartners, R. Marston re same (.2);
correspond with C. Ceresa re same (.1); revise
cure objection summary (.2); analyze
restructuring support agreement and DIP CA
for sale milestones (.3); correspond with C.
Ceresa, R. Marston re same (.3).
07/22/24 Jaina Desai
0.60 Telephone conference with R. Marston,
counterparty re informal sale and cure
objection (.2); draft correspondence re same
(.3); review, analyze correspondence re same
(.1).
07/22/24 Jaina Desai
0.60 Draft sale and cure objections summary (.5);
correspond with R. Marston re same (.1).
07/22/24 Luke Finn
4.20 Review, analyze APA disclosure schedules
and new dataroom documents (1.8); draft
initial incremental updates to disclosure
schedules (1.3); prepare for and participate in
conference with bidder, Company, PJT and
AlixPartners re regulatory topics (1.1).
07/22/24 Kate Hardey
1.00 Review, analyze business unit device lists
(.7); conference with R. Meintjes and O.
Kaufmann re same (.3).
07/22/24 Olivia Kaufmann
0.50 Conference with R. Meintjes and K. Hardey
re product lists re sales.
07/22/24 Sabrina Lieberman
0.30 Review, revise NDA summary.
07/22/24 Ruan J. Meintjes
1.60 Participate in telephone conference with
bidder counsel re EU permit transfer strategy
(1.0); correspond with EU counsel re UK
products (.5); correspond with Company re
same (.1).
07/22/24 Trent Nachbar
2.90 Review, analyze legal issues re asset purchase
agreement and schedules.
07/22/24 Dan O'Connor
1.20 Telephone conference with PJT team,
Company, AlixPartners, K. Hardey, K&E
team re regulatory matters (.9); telephone
conference with PJT, AlixPartners, S. Winters
and Y. Salloum re transaction matters (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 316 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
69
Date
Name
Hours Description
07/22/24 Steve Toth
0.20 Participate in telephone conference re bidder
updates with Company, PJT, AlixPartners, S.
Winters, K&E team.
07/22/24 Spencer A. Winters, P.C.
3.30 Prepare for and participate in telephone
conference with advisors re stand‑up costs
(.5); prepare for and participate in telephone
conference with Company and advisors re
sale process (.5); review and analyze issues re
sale process, case status (1.3); correspond and
telephone conferences with multiple parties re
same (1.0).
07/23/24 Chris Ceresa
0.50 Correspond and telephone conference with S.
Winters, K&E team re sale matters.
07/23/24 Bernadette Coppola
0.30 Correspond with S. Toth, K&E team advisors,
re transaction updates and transition services
agreement.
07/23/24 Anthony M. Del Rio
0.60 Review, analyze regulatory status and
registrations of devices.
07/23/24 Jaina Desai
1.20 Telephone conference with R. Marston re sale
(.1); telephone conference with AlixPartners,
R. Marston, K&E team re cure objections
(.5); correspond with R. Marston re same (.1);
revise key dates and deadlines extension
notice (.3); analyze bidding procedures order
(.2).
07/23/24 Jaina Desai
1.00 Telephone conference with AlixPartners, R.
Marston, K&E team re sale objections (.2);
revise cure objection summary (.5); revise
talking points re same (.2); correspond with
R. Marston, C. Ceresa re same (.1).
07/23/24 Jaina Desai
0.30 Conference with R. Marston re sale, auction
matters.
07/23/24 Jaina Desai
0.80 Correspond with informal objectors re
informal objection status, extending objection
deadline.
07/23/24 Jaina Desai
0.10 Correspond with S. Osborne re sale issues.
07/23/24 Jaina Desai
0.40 Review, analyze correspondence re informal
cure objection (.1); correspond with informal
objector re same (.1); revise second extension
notes re key dates and deadlines (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 317 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
70
Date
Name
Hours Description
07/23/24 Jaina Desai
0.60 Correspond with Omni, R. Marston re sale
(.1); revise second notice for deadline
extensions (.2); correspond with C. Ceresa re
same (.1); telephone conference with Omni re
certificate of service (.1); correspond with R.
Marston re same (.1).
07/23/24 Jaina Desai
0.90 Correspond with counterparty re informal sale
and cure objection (.6); revise summary re
same (.3).
07/23/24 Sabrina Lieberman
0.60 Review, analyze NDAs (.4); correspond with
PJT, NDA parties re same (.2).
07/23/24 Noah Shier
0.60 Review, analyze TSA service schedule
update.
07/23/24 Steve Toth
1.30 Conference with C. Ceresa, K&E team re tax
issues re sale (.5); analyze correspondence re
disclosure schedules and regulatory matters
from B. Coppola, K&E team (.4); analyze
correspondence re bid analysis (.4).
07/23/24 Donatus Wang
0.20 Correspond with local counsel and Company
re liquidity planning.
07/23/24 Spencer A. Winters, P.C.
1.50 Review and analyze issues re sale process,
case status (.8); correspond and telephone
conferences with working group re same (.7).
07/23/24 Ann-Kathrin Ziegler
4.50 Review, analyze correspondence with M&A
counterparty re sale (1.0); review, analyze
intercompany summary and legal issues re
same (3.5).
07/24/24 Chris Ceresa
3.20 Review, analyze legal issues re sale (2.1);
correspond and telephone conference with S.
Toth, K&E team re same (1.1).
07/24/24 Bernadette Coppola
0.20 Correspond with AlixPartners, M. O’Brien
and K&E team re transition services
agreement services.
07/24/24 Hannah Crawford
0.30 Correspond with P. Kar, K&E team re
intercompany settlement planning.
07/24/24 Jaina Desai
0.60 Review, analyze revised second sale
milestone extension notice (.2); revise
correspondence re same (.1); correspond with
R. Marston re same (.2); correspond with C.
Ceresa, Cole Schotz re same (.1).
07/24/24 Jaina Desai
0.10 Review, analyze lender presentation re vents
perimeter comparison.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 318 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
71
Date
Name
Hours Description
07/24/24 Jaina Desai
1.40 Telephone conference with C. Ceresa, K&E
team, AlixPartners re cure objection (.4);
correspond with R. Marston re same (.3);
review, analyze correspondence re cure and
sale objections (.3); correspond with informal
cure objectors re same (.3); correspond with
AlixPartners re same (.1).
07/24/24 Jaina Desai
1.60 Review, analyze correspondence re informal
sale and cure objections (.1); correspond with
Y. Salloum, informal cure objector re same
(.2); telephone conference with informal cure
objector re invoices (.1); correspond with
informal cure objector re same (.1); revise
cure objection summary (.3); correspond with
R. Marston re same (.1); telephone conference
with AlixPartners re same (.1); analyze cure
objection summary (.1); correspond with
informal cure objector re informal cure
objection (.2); correspond with AlixPartners,
R. Marston re same (.3).
07/24/24 Jaina Desai
1.00 Review, analyze correspondence re informal
sale and cure objections (.3); correspond with
informal cure objectors re same (.3); revise
cure objection summary (.4).
07/24/24 Jaina Desai
1.40 Correspond with AlixPartners, contract
counterparties, C. Ceresa, K&E team re sale
and cure objections.
07/24/24 Jaina Desai
1.40 Revise sale and cure objection summary (.7);
draft cure objection summary (.5); correspond
with R. Marston, AlixPartners re same (.2).
07/24/24 Luke Finn
3.30 Conference with lenders re bids (.8); review,
analyze dataroom documents (1.1);
correspond with Y. Salloum, K&E team re
sale (.4); review, analyze asset purchase
agreement (1.0).
07/24/24 Sooah Kim
0.50 Review, analyze correspondence from M.
O’Brien, K&E team re TSA and benefits
transition matters.
07/24/24 Sabrina Lieberman
0.20 Review, analyze NDA (.1); review, revise
summary res same (.1).
07/24/24 Rebecca J. Marston
1.00 Correspond with J. Desai re cure objections
(.3); correspond with K&E team, Gibson team
re deadline extensions (.7).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 319 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
72
Date
Name
Hours Description
07/24/24 Jai Mudhar
0.50 Review, analyze correspondence from H.
Crawford, K&E team re intercompany issues
re sale planning.
07/24/24 Maureen D. O'Brien
1.00 Correspond with S. Kim, K&E team re TSA
issues.
07/24/24 Dan O'Connor
0.90 Telephone conference with lender advisors,
PJT, AlixPartners, S. Winters, K&E team re
transaction matters.
07/24/24 Noah Shier
0.30 Review, analyze TSA schedule update.
07/24/24 Steve Toth
5.50 Discuss foreign assets and liabilities with
AlixPartners, S. Winters and K&E team (.9);
participate in telephone conference with
Company, PwC, AlixPartners, BDO, Y.
Salloum, K&E team re intercompany
balances (1.3); conference with Y. Salloum,
K&E team re intercompany settlement,
restructuring, and corporate considerations
(.5); correspond with Y. Salloum, K&E team
re same (.2); correspond with M. O’Brien,
K&E team re TSA employment matters (.2);
conference with AlixPartners, PJT, lender
advisors re same (.9); conference with
AlixPartners, Y. Salloum, K&E team re same
(.6); conference with lenders, lender advisors,
AlixPartners and PJT re winddown and other
costs (.9).
07/24/24 Cristina Weidner
1.00 Review, analyze issues re treatment of
receivables, tax analysis re sales and APAs.
07/24/24 Spencer A. Winters, P.C.
3.80 Review and analyze issues re bids, waterfall
(1.4); telephone conferences with multiple
parties re same (.9); prepare for and
participate in telephone conference with
advisors re waterfall (.5); prepare for and
participate in telephone conference with
lender advisors re same (1.0).
07/25/24 Chris Ceresa
5.10 Review, analyze legal issues re transactions
(3.9); correspond with Y. Salloum, K&E team
re same (.7); telephone conferences with Y.
Salloum, K&E team re same (.5).
07/25/24 Hannah Crawford
0.50 Conference with Company re international
sale considerations.
07/25/24 Anthony M. Del Rio
0.40 Review, analyze filing analysis and related
workplan re health regulatory issues re sales.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 320 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
73
Date
Name
Hours Description
07/25/24 Jaina Desai
3.30 Review, analyze correspondence re cure
objections, sale (1.2); revise summary re
same, summary list re same (1.8); correspond
with R. Marston, K&E team re same (.3).
07/25/24 Jaina Desai
1.80 Correspond with informal cure objectors
(1.1); correspond with R. Marston re purchase
orders, cure objections (.3); correspond with
AlixPartners re same (.2); correspond with C.
Ceresa re same, sale (.1); review, analyze
correspondence re same (.1).
07/25/24 Jaina Desai
1.60 Correspond with D. Hackel re rejection notice
(.1); telephone conference with AlixPartners,
R. Marston, K&E team re cure objections
(.4); correspond with R. Marston re same (.1);
telephone conference with C. Ceresa, R.
Marston re same (.7); telephone conference
with informal cure objector (.1); review,
analyze correspondence re same (.1);
correspond with C. Ceresa, AlixPartners re
cure objector meeting (.1).
07/25/24 Jaina Desai
0.60 Telephone conference with R. Marston re sale
and cure objections (.3); correspond with C.
Ceresa, S. Lieberman, R. Marston re same
(.2); revise sale and cure objection summary
(.1).
07/25/24 Partha Kar
0.50 Correspond with J. Mudhar, K&E team re
sale structure issues.
07/25/24 Sabrina Lieberman
0.30 Review, revise NDA.
07/25/24 Rebecca J. Marston
4.90 Review, analyze cure objections (.8);
correspond with J. Desai re same (.4);
correspond with J. Desai, K&E team re sale
matters (3.7).
07/25/24 Ruan J. Meintjes
0.20 Correspond with S. Toth, K&E team re
outstanding stalking horse asset purchase
agreements.
07/25/24 Jai Mudhar
4.20 Review, analyze intercompany loan issues
(3.5); conference with H. Crawford re same
(.2); correspond with H. Crawford, K&E team
re the same (.5).
07/25/24 Dan O'Connor
0.60 Telephone conference with lender advisors,
PJT, AlixPartners, S. Winters, C. Ceresa and
K&E team re transaction matters.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 321 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
74
Date
Name
Hours Description
07/25/24 Steve Toth
1.90 Participate in update telephone conference
with Company, PJT, AlixPartners, D.
O’Connor and K&E team (.5); participate in
telephone conference re bid and other updates
with lender advisors, PJT, AlixPartners, Y.
Salloum and K&E team (.4); discuss proceeds
waterfall with AlixPartners, PJT, Y. Salloum,
K&E team (.5); discuss status with A.
Clifford (.3); discuss PTO allocation with
AlixPartners and K&E team (.2).
07/25/24 Spencer A. Winters, P.C.
5.90 Prepare for and participate in telephone
conference with Company and advisors re
sale issues (.5); prepare for and participate in
telephone conference with lender advisors re
same (.5); review and revise waterfall analysis
(1.8); review and analyze issues re excluded
entities (1.3); prepare for and participate in
telephone conference with lender advisors re
open sale items (.5); prepare for and
participate in telephone conference with
Company, special committee re issues re
same (.5); draft liquidation analysis summary
(.8).
07/26/24 John G. Caruso
1.00 Review and revise asset purchase agreement.
07/26/24 Chris Ceresa
0.30 Review, analyze transaction issues (.2);
correspond with J. Desai, K&E team re same
(.1).
07/26/24 Hannah Crawford
0.30 Review, analyze correspondence from J.
Mudhar, K&E team re international sale
considerations.
07/26/24 Anthony M. Del Rio
0.50 Review and comment on open transaction
items.
07/26/24 Jaina Desai
2.60 Telephone conference with cure objector,
AlixPartners, C. Ceresa (.3); telephone
conference with C. Ceresa, K&E team re sale
structure analysis (.3); correspond with R.
Marston re same (.1); review, analyze
correspondence re cure objections (.6);
correspond with cure objectors re same (.7);
telephone conference with AlixPartners re
sale stream (.1); correspond with AlixPartners
re cure objections (.3); revise cure objection
summary (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 322 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
75
Date
Name
Hours Description
07/26/24 Jaina Desai
0.60 Correspond with AlixPartners re cure
objections (.2); review, analyze
correspondence re same, sale (.4).
07/26/24 Jaina Desai
0.10 Review, analyze correspondence re sale.
07/26/24 Luke Finn
3.20 Review, analyze transaction correspondence
from D. O’Connor, K&E team (.4); review,
analyze dataroom documents (.7); revise
disclosure schedule draft (2.1).
07/26/24 Partha Kar
0.50 Correspond with H. Crawford, K&E team re
sale structure issues.
07/26/24 Ruan J. Meintjes
0.20 Coordinate with foreign counsel re potential
transition services agreement.
07/26/24 Jai Mudhar
0.40 Conference with C. Ceresa, K&E team re
international entities re sale issues (.2);
correspond with H. Crawford, K&E team re
intercompany issues (.2).
07/26/24 Dan O'Connor
0.80 Telephone conference with PJT, AlixPartners
and S. Toth re asset purchase agreement
matters (.5); review, analyze asset purchase
agreement markup (.2); correspond with PJT
and AlixPartners re same (.1).
07/26/24 Steve Toth
3.20 Discuss tax analysis with D. O’Connor, K&E
team (.7); discuss tax planning with
Company, AlixPartners, D. O’Connor, K&E
team (1.3).; discuss legal entities with PJT,
AlixPartners, S. Winters, K&E team (.7);
discuss legal entities with bidder, bidder
advisors, PJT, AlixPartners, S. Winters, K&E
team (.5).
07/26/24 Spencer A. Winters, P.C.
4.50 Review and analyze issues re tax structuring
of sale, status (1.2); prepare for and
participate in telephone conference with S.
Toth, K&E team re same (1.0); prepare for
and participate in telephone conference with
Company re same (1.0); correspond and
telephone conferences with multiple parties re
same (1.3).
07/26/24 Sara B. Zablotney, P.C.
0.70 Telephone conference with Y. Salloum, K&E
team re RDX sale legal issues.
07/27/24 Rebecca H. Arnall
2.00 Review, analyze purchase agreement re legal
issues re compensation matters (1.1); draft
issue summary (.7); correspond with S. Price
re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 323 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
76
Date
Name
Hours Description
07/27/24 Chris Ceresa
0.60 Review, analyze transaction legal issues.
07/27/24 Bernadette Coppola
0.30 Review, analyze comments to purchase
agreement (.2); correspond with S. Toth,
K&E team re same (.1).
07/27/24 Jaina Desai
1.70 Review, analyze asset purchase agreements
(1.4); draft correspondence re same (.2);
correspond with C. Ceresa re same (.1).
07/27/24 Jaina Desai
0.70 Revise lender presentation re tax
considerations (.5); correspond with C. Ceresa
re same (.1); correspond with N. Warther,
K&E team re same (.1).
07/27/24 Jaina Desai
0.20 Correspond with D. O’Connor, K&E team re
asset purchase agreement (.1); review,
analyze correspondence re same (.1).
07/27/24 Justin M. Garfinkle
2.10 Draft issues summary to RDx purchase
agreement (1.8); review, analyze registered IP
schedules (.3).
07/27/24 Kate Hardey
0.70 Review, analyze APA re legal issues.
07/27/24 Liz Ji
1.20 Review, analyze asset purchase agreement re
legal issues.
07/27/24 Sooah Kim
1.00 Review, analyze purchase agreement (.3);
draft purchase agreement issue summary (.7).
07/27/24 Daniel Lewis, P.C.
0.50 Review, analyze asset purchase agreement
legal issues.
07/27/24 Ruan J. Meintjes
1.40 Review and revise asset purchase agreement
(1.0); draft issue summary of same (.2);
correspond with K. Hardey, K&E team re
same (.2).
07/27/24 Maureen D. O'Brien
0.50 Review, analyze issue summary.
07/27/24 Dan O'Connor
2.50 Review, analyze asset purchase agreement
markup (.6); draft issue summary (1.4);
correspond with S. Toth and K&E team re
same (.5).
07/27/24 Evangelia Podaras
0.70 Review, analyze revised bid asset purchase
agreement (.5); correspond with M. O’Brien,
K&E team re issue summary additions (.2).
07/27/24 Scottie Shermetaro
0.80 Review and revise RDx purchase agreement
re legal issues.
07/27/24 Noah Shier
0.40 Review purchase agreement re legal issues.
07/27/24 Matt Swanson
0.20 Review, analyze purchase agreement re legal
issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 324 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
77
Date
Name
Hours Description
07/27/24 Paul D. Tanaka, P.C.
1.70 Review and analyze draft purchase agreement
(1.3); review and revise issue summary re
same (.2); correspond with S. Toth, K&E
team re same (.2).
07/27/24 Steve Toth
3.70 Analyze revised asset purchase agreement
(2.8); participate in telephone conference with
bidder, bidder counsel, PJT, D. O’Connor,
K&E team (.9).
07/27/24 Paul Vasiloff
0.80 Review, analyze purchase agreement and
draft issues summary.
07/27/24 Nicholas Warther
0.40 Review and revise asset purchase agreement
re legal and tax issues.
07/27/24 Spencer A. Winters, P.C.
0.30 Review and analyze tax presentation re sale.
07/28/24 Rebecca H. Arnall
0.20 Correspond with S. Price re issue summary.
07/28/24 Chris Ceresa
1.20 Review and analyze sale and asset purchase
agreement legal issues (.5); comment on
documents re same (.7).
07/28/24 Bernadette Coppola
0.50 Draft revisions to issue summary (.4);
correspond with D. O’Connor and K&E team
re same (.1).
07/28/24 Anthony M. Del Rio
0.80 Review and comment on open transaction
items.
07/28/24 Jaina Desai
0.20 Review, analyze correspondence from C.
Ceresa, K&E team re sale (.1); correspond
with cure objector re sale key dates and
deadlines (.1).
07/28/24 Jaina Desai
0.40 Revise successful bidder notice.
07/28/24 Jaina Desai
0.30 Review, analyze correspondence re sale (.2);
correspond with S. Lieberman re same (.1).
07/28/24 Michael Ehret
1.00 Review, analyze asset purchase agreement.
07/28/24 Sooah Kim
0.50 Review and revise purchase agreement; revise
purchase agreement issue summary.
07/28/24 Dan O'Connor
2.40 Review and revise issue summary (.8);
correspond with Company, S. Toth and K&E
team re disclosure schedules (.5); telephone
conference with PJT, Company, AlixPartners,
S. Toth, K&E team re transaction matters
(1.1).
07/28/24 D. Taylor Petersen
0.30 Respond to diligence inquiries.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 325 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
78
Date
Name
Hours Description
07/28/24 Steve Toth
2.90 Analyze and revise asset purchase agreement
issue summary (1.8); discuss workstreams
and bidder status with Company, PJT,
AlixPartners, S. Toth and K&E team (1.1).
07/28/24 Nicholas Warther
0.60 Review and revise tax portions of asset
purchase agreement.
07/28/24 Sara B. Zablotney, P.C.
0.90 Telephone conference with N. Warther re
status of sale items (.5); review, revise asset
purchase agreement and issues list (.4).
07/28/24 Ann-Kathrin Ziegler
1.00 Review, analyze tax deck re intercompany
claims clean‑up (.3); review, analyze
questions from H. Crawford, K&E team re
intercompany restructuring (.1); review,
revise draft responses from C. Paus (.6).
07/29/24 Chris Ceresa
2.00 Review and analyze asset purchase agreement
(1.0); comment on documents re same (1.0).
07/29/24 Anthony M. Del Rio
0.60 Telephone conference with EU advisors re
regulatory considerations (.3); review and
comment on transaction documents (.3).
07/29/24 Jaina Desai
1.10 Review, analyze correspondence re sale, cure
objections (.2); correspond with C. Ceresa,
Cole Schotz re same (.3); review, analyze
cure objection summary (.3); correspond with
cure objectors (.3).
07/29/24 Jaina Desai
0.80 Correspond with Cole Schotz re notice of
agenda (.2); revise cure objection summary
(.2); correspond with AlixPartners re same
(.2); correspond with cure objectors re cure
objections (.1); review, analyze precedent re
sale order language (.1).
07/29/24 Jaina Desai
1.10 Review, analyze precedent re sale order
language (.7); correspond with AlixPartners
re cure objection parties (.2); correspond with
C. Ceresa re cure objection deadline extension
(.1); correspond with Q. Wetzel re work in
process summary (.1).
07/29/24 Jaina Desai
1.60 Correspond with R. Marston, C. Ceresa re
cure objection deadline (.1); review, analyze
correspondence re same (.1); review, analyze
correspondence re cure objections (.2); revise
summary re same (.3); draft correspondence
re same (.9).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 326 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
79
Date
Name
Hours Description
07/29/24 Michael Ehret
0.60 Correspond with various party re bid and sale
issues.
07/29/24 Luke Finn
4.60 Review, analyze correspondence from bidder
counsel (.2); review, analyze disclosure
schedule process (.5); review, analyze
disclosure schedules for asset purchase
agreement (3.9).
07/29/24 Justin M. Garfinkle
1.00 Review, analyze registered IP schedules.
07/29/24 Kate Hardey
0.50 Conference with EU counsel re transaction
permits and TSA services.
07/29/24 Partha Kar
0.50 Conference with local counsel re sale.
07/29/24 Ruan J. Meintjes
0.20 Conference with foreign regulatory counsel re
transition services agreement.
07/29/24 Dan O'Connor
5.30 Telephone conference with lender advisors,
AlixPartners, Y. Salloum, K&E team re
transaction matters (.5); telephone conference
with AlixPartners, PJT, Y. Salloum, K&E
team re transaction matters (.3); review and
revise purchase agreement (2.0); review and
revise disclosure schedules (2.5).
07/29/24 Carolin Paus
0.70 Draft summary re intercompany claims and
dividend payments.
07/29/24 Yusuf Salloum
1.00 Analyze issues re sale transaction.
07/29/24 Scottie Shermetaro
0.30 Review, analyze diligence re IP disclosure
schedules.
07/29/24 Steve Toth
3.30 Participate in workstreams discussion with
lender advisors, PJT, AlixPartners, D.
O’Connor and K&E team (.5); discuss tax and
intercompany matters with D. O’Connor,
K&E team (.5); participate in update
telephone conference with lenders, lender
advisors, PJT, AlixPartners, D. O’Connor,
K&E team and Company (.5); participate in
update telephone conference with Company,
PJT, AlixPartners, D. O’Connor, K&E team
(.2); correspond with bidder re asset purchase
agreement issues and questions (.2); analyze
correspondence re TSA, schedules and
diligence (.3); analyze revised asset purchase
agreement (.6); analyze tax steps presentation
(.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 327 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
80
Date
Name
Hours Description
07/29/24 Sarah Ullathorne
0.70 Review, analyze responses to corporate law
questions re sales.
07/29/24 Spencer A. Winters, P.C.
5.00 Prepare for and participate in telephone
conference with Rothschild re open sale items
(.5); prepare for and participate in telephone
conference re tax structure with S. Toth, K&E
team (.5); prepare for and participate in
telephone conference with lender principals re
sale process, tax structure (.5); prepare for and
participate in telephone conference with
Company advisors re sale process, case status
(.5); review and analyze issues re sale
process, case status (1.4); correspond and
telephone conferences with Company, C.
Ceresa, K&E team, advisors re same (1.6).
07/29/24 Ann-Kathrin Ziegler
1.50 Review and revise summary re intercompany
structuring (1.0); conference with C. Paus and
K&E team re same (.5).
07/30/24 Chris Ceresa
1.20 Review and analyze transaction documents
and pleadings (.6); comment on documents re
same (.6).
07/30/24 Bernadette Coppola
0.30 Draft revisions to asset purchase agreement
issue summary (.2); correspond with S. Toth
and K&E team re same (.1).
07/30/24 Anthony M. Del Rio
0.80 Review and comment on transaction
documents.
07/30/24 Jaina Desai
1.70 Telephone conference with C. Ceresa re cure
objection deadline (.1); telephone conference
with C. Ceresa re cure objection updates (.3);
correspond with R. Marston re same (.1);
telephone conference with AlixPartners, A.
Salmen, K&E team re same (.1); telephone
conference with cure objectors re same (.3);
correspond with cure objectors re same (.5);
review, analyze correspondence re same (.3).
07/30/24 Jaina Desai
1.50 Telephone conference with AlixPartners, S.
Lieberman, K&E team re cure objections (.3);
correspond with AlixPartners re same (.2);
correspond with cure objectors re same (.6);
revise cure objection summary (.3); analyze
correspondence re cure objections (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 328 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
81
Date
Name
Hours Description
07/30/24 Jaina Desai
0.70 Analyze, review correspondence re sale (.3);
analyze, review presentation re same (.1);
correspond with R. Marston re same (.3).
07/30/24 Jaina Desai
0.60 Review, analyze correspondence re sale (.1);
correspond with C. Ceresa, R. Marston re
same (.2); correspond with H. Crawford,
K&E team re same (.3).
07/30/24 Michael Ehret
1.00 Conference with Company team re bid (.5);
conference with bidder, Deloitte re tax re sale
(.5).
07/30/24 Luke Finn
7.60 Review, analyze correspondence from S.
Toth, K&E team, Company re sale (.5);
review, analyze asset purchase agreement
(1.8); draft initial draft of corporate issue
summary re asset purchase agreement (3.8);
review, analyze asset purchase agreement
disclosures schedule (1.1); review, analyze
German labor law, collective bargaining issue
(.4).
07/30/24 Justin M. Garfinkle
3.30 Draft issue summary re vents purchase
agreement (.9); review, analyze registered IP
schedules (.8); draft comments to RDx
purchase agreement (1.6).
07/30/24 Kate Hardey
0.80 Review, revise APA.
07/30/24 Sooah Kim
0.50 Review and revise purchase agreement (.3);
draft purchase agreement issue summary (.2).
07/30/24 Daniel Lewis, P.C.
0.50 Review, analyze asset purchase agreement.
07/30/24 Sabrina Lieberman
0.20 Correspond with R. Marston re NDA.
07/30/24 Brandan Matthews
0.10 Review, analyze purchase agreement matters.
07/30/24 Ruan J. Meintjes
1.70 Review and revise asset purchase agreement
(1.3); review and revise asset purchase
agreement (.4).
07/30/24 Trent Nachbar
9.10 Review, analyze, revise asset purchase
agreement and schedules (3.8); further
review, revise APA (3.9); further review,
revise APA schedules (1.4).
07/30/24 Dan O'Connor
5.50 Conference with Company re disclosure
schedules (.8); telephone conference re taxes
with bidder, bidder advisor, AlixPartners, S.
Toth and K&E team (.5); review and revise
asset purchase agreement (2.7); review and
revise disclosure schedules (1.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 329 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
82
Date
Name
Hours Description
07/30/24 Carolin Paus
2.00 Review, analyze slides on proposed
restructuring transaction steps (.7); analyze
intercompany receivables and payables of
German entities (1.3).
07/30/24 Scottie Shermetaro
0.80 Review and revise disclosure schedules (.5);
review and revise asset purchase agreement
issue summary (.3).
07/30/24 Steve Toth
4.70 Participate in telephone conference re tax and
intercompany settlement with AlixPartners,
D. O’Connor, K&E team, Company, bidder,
bidder advisors and PJT (.5); analyze
correspondence from D. O’Connor, K&E
team re schedules and diligence questions
(.6); analyze revised structure presentation
(.2); comment on bidder asset purchase
agreement (2.6); analyze correspondence re
diligence and schedule questions from D.
O’Connor, K&E team (.3); respond to
correspondence re asset purchase agreement
issues from D. O’Connor, K&E team (.2);
analyze attorney notes re foreign transactions
and requirements (.3).
07/30/24 Paul Vasiloff
0.80 Review, analyze purchase agreement (.5);
draft issues summary re same (.3).
07/30/24 Donatus Wang
0.70 Review, analyze presentation on treatment of
intercompany claims (.5); correspond with
local counsel, Company, C. Paus re same (.2).
07/30/24 Nicholas Warther
1.40 Conference with M. Ehret, K&E team and
Company re tax re sale (.6); conference with
Deloitte re tax diligence (.5); review and
revise asset purchase agreement (.3).
07/30/24 Cristina Weidner
1.00 Review, analyze draft structure slides (.3);
conference with A. Ziegler, K&E team re
same (.7).
07/30/24 Spencer A. Winters, P.C.
4.20 Review and analyze issues re marketing
process and case status (1.8); review and
analyze tax structuring issues (.7); correspond
and telephone conferences with multiple
parties re same (1.7).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 330 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
83
Date
Name
Hours Description
07/30/24 Ann-Kathrin Ziegler
3.00 Review, analyze tax presentation re
intercompany structure (1.5); conference with
C. Weidner, K&E team re same (.7); review
and revise correspondence to Company and
German management counsel re same (.8).
07/31/24 Rebecca H. Arnall
3.20 Correspond with S. Kim and S. Price re issue
summary and purchase agreement updates
(.2); revise purchase agreement (1.7); revise
same (.4); correspond with S. Price, K&E
team re same (.1); draft issue summary (.6);
correspond with S. Price re same (.1);
correspond with S. Price, K&E team re same
(.1).
07/31/24 Bernadette Coppola
1.50 Draft revisions to issue summary (.1);
correspond with AlixPartners, S. Toth, K&E
team re transition services agreement (.2);
draft revisions to asset purchase agreement
(.9); correspond with S. Toth and K&E team
re same (.3).
07/31/24 Anthony M. Del Rio
1.40 Review and comment on transaction
documents.
07/31/24 Jaina Desai
0.80 Correspond with R. Marston re sale (.1);
correspond with AlixPartners re cure
objections, sale (.3); correspond with cure
objectors re cure objections (.2); review,
analyze correspondence re same (.2).
07/31/24 Jaina Desai
1.00 Review, analyze correspondence from R.
Marston, K&E team re sale, cure objections
(.2); correspond with cure objectors re cure
objections (.4); telephone conference with
cure objector re same (.2); correspond with R.
Marston re same (.1); correspond with A.
Salmen re sale status (.1).
07/31/24 Jaina Desai
0.40 Telephone conference with S. Toth, K&E
team, PJT re sale tax structure (.3);
correspond with R. Marston, PJT re same (.1).
07/31/24 Jaina Desai
1.00 Correspond with AlixPartners, cure objectors
re cure objections (.2); telephone conference
with C. Ceresa, R. Marston re auction (.5);
telephone conference with informal cure
objector (.1); correspond with AlixPartners re
same (.1); draft correspondence to R.
Marston, K&E team re auction (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 331 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
84
Date
Name
Hours Description
07/31/24 Jaina Desai
2.00 Correspond with R. Marston re auction
matters (.2); correspond with O. Acuna re
same (.1); correspond with C. Ceresa re same
(.2); draft further correspondence to R.
Marston, K&E team re auction (.4); draft
auction summary (.3); analyze, research
auction precedent (.7); correspond with C.
Ceresa re asset purchase agreement (.1).
07/31/24 Jaina Desai
1.50 Analyze, auction precedent re script.
07/31/24 Jaina Desai
1.30 Analyze asset purchase agreement re legal
issues (1.0); draft correspondence to C.
Ceresa re same (.3).
07/31/24 Michael Ehret
2.80 Conference with N. Warther, K&E team re
bidder (.5); conference with bidder re tax
structure (1.0); conference with bidder re
same (.5); review, analyze asset purchase
agreement (.8).
07/31/24 Luke Finn
6.30 Correspond with S. Toth, K&E team re issue
summary (.2); review, revise issue summary
(.8); review, revise, asset purchase agreement
(3.9); further review, revise same (.5);
conference with working group re sale (.9).
07/31/24 Justin M. Garfinkle
1.00 Draft comments to vents purchase agreement
issue summary (.6); review, analyze
registered IP schedules (.4).
07/31/24 Sooah Kim
1.40 Review and revise purchase agreement (1.0);
draft purchase agreement issue summary (.4).
07/31/24 Daniel Lewis, P.C.
0.50 Conference with B. Coppola and K&E team
re APAs.
07/31/24 Sabrina Lieberman
0.40 Conference with KPMG, Company, S.
Zablotney, K&E team re tax issues related to
sale.
07/31/24 Rebecca J. Marston
1.80 Correspond and conference with J. Desai,
K&E team re sale matters.
07/31/24 Brandan Matthews
0.70 Conference with advisors re bids.
07/31/24 Ruan J. Meintjes
1.40 Review and revise asset purchase agreement
(1.2); coordinate with K. Hardey re same (.2).
07/31/24 Jai Mudhar
0.30 Correspond with Y. Salloum and K&E team
re sale.
07/31/24 Trent Nachbar
3.40 Review, analyze asset purchase agreement
and schedules.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 332 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
85
Date
Name
Hours Description
07/31/24 Maureen D. O'Brien
1.00 Review and revise issue summary for two
purchase agreements.
07/31/24 Dan O'Connor
4.10 Telephone conference with PJT, AlixPartners,
S. Winters, S. Toth and K&E team re
transaction matters (.6); telephone conference
with bidder, PJT, AlixPartners and K&E
teams re transaction matters (.3); review and
revise asset purchase agreement (1.0); review
and revise disclosure schedules (1.4); draft
summary of open items for disclosure
schedules (.8).
07/31/24 Evangelia Podaras
1.50 Review, analyze revised vents agreement (.7);
review/revise issue summary (.3); correspond
with M. O’Brien, K&E team re same; review,
analyze revised employee communications
information (.4); correspond with Company re
same (.1).
07/31/24 Yusuf Salloum
1.50 Analyze legal issues re sale transactions.
07/31/24 Scottie Shermetaro
0.40 Review and revise asset purchase agreement.
07/31/24 Noah Shier
0.30 Review, analyze asset purchase agreement
issues list.
07/31/24 Steve Toth
8.80 Discuss bid and process status with PJT,
AlixPartners, D. O’Connor and K&E team
(.7); telephone conference Company, D.
O’Connor, K&E team re tax components of
sales (.7); discuss tax matters with bidder
advisors, bidder, Company, D. O’Connor,
K&E team (.3); discuss asset purchase
agreement concerns with bidder counsel (.2);
participate in telephone conference re tax
matters and structure with bidder advisors,
bidder, PJT, AlixPartners, D. O’ Connor and
K&E team (.3); discuss vents bidder with PJT
(.2); discuss bids with Company and S.
Winters (.4); revise asset purchase agreement
(3.7); revise attorney notes re asset purchase
agreement issues (.4); analyze bidder APAs
(.9); analyze revised asset purchase agreement
(1.0).
07/31/24 Paul Vasiloff
0.90 Provide comments to purchase agreement.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 333 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050104437
48520-10
86
Date
Name
Hours Description
07/31/24 Nicholas Warther
3.70 Review and revise tax portions of asset
purchase agreement (1.4); correspond with P.
Gunderson, K&E team re same (.8);
conference with bidder re tax diligence (.5);
conference with bidder re tax diligence (.5);
conference with Company re same (.5).
07/31/24 Spencer A. Winters, P.C.
4.50 Prepare for and participate in telephone
conference with advisors re open sale issues
(.5); prepare for and participate in telephone
conference with company re same (.5); review
and analyze issues re bidders, next steps (1.6);
correspond and telephone conferences with
multiple parties re same (1.9).
Total
1,499.40
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 334 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104438
Client Matter: 48520-11
In the Matter of Executory Contracts & Unexpired Leases
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 26,620.50
Total legal services rendered
$ 26,620.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 335 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Executory Contracts & Unexpired Leases
Invoice Number:
Matter Number:
1050104438
48520-11
2
Summary of Hours Billed
Name
Hours
Rate
Amount
John G. Caruso
2.20
2,115.00
4,653.00
Chris Ceresa
0.50
1,395.00
697.50
Kenny Chiaghana
4.10
975.00
3,997.50
Jaina Desai
0.30
975.00
292.50
Julia R. Foster
0.50
525.00
262.50
David Hackel
12.40
1,095.00
13,578.00
Joshua Raphael
2.60
1,095.00
2,847.00
Josh Valletta
0.30
975.00
292.50
TOTALS
22.90
$ 26,620.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 336 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Executory Contracts & Unexpired Leases
Invoice Number:
Matter Number:
1050104438
48520-11
3
Description of Legal Services
Date
Name
Hours Description
07/01/24 Chris Ceresa
0.50 Review, analyze legal issues re lease
rejection.
07/01/24 Julia R. Foster
0.50 Research precedent re contract rejection and
assumption-rejection talking points.
07/01/24 David Hackel
3.30 Review, analyze contract rejection procedures
order (.4); draft talking points re same (1.7);
research precedent re same (.2); correspond
with J. Foster re same (.1); review, analyze
precedent and research re same (.9).
07/02/24 David Hackel
2.30 Review, revise contract rejection procedures
order (.7); review, revise talking points re
same (.6); review, analyze precedent, research
re same (.4); correspond with T. Chanroo,
K&E team re same (.2); review, analyze
MWE comments to proposed order (.2);
review, analyze correspondence from C.
Ceresa, K&E team re same, related second
day orders (.2).
07/03/24 Josh Valletta
0.30 Telephone conference with S. Lieberman re
non-consensual 365(d)(4) extensions.
07/08/24 Joshua Raphael
0.80 Review, analyze, revise rejection procedures
order (.3); correspond with C. Ceresa, T.
Chanroo re same (.1); research precedent re
same (.4).
07/10/24 John G. Caruso
1.70 Draft lease term sheet (1.1); review, analyze
existing lease (.6).
07/11/24 John G. Caruso
0.50 Review, analyze issues re revised lease term
sheet.
07/17/24 David Hackel
1.00 Review, analyze issues re contract rejection
procedures and related second day orders (.3);
review, analyze correspondence from C.
Ceresa, K&E team re same (.7).
07/22/24 Jaina Desai
0.10 Correspond with AlixPartners, R. Marston,
K&E team re cure contracts.
07/22/24 David Hackel
2.60 Research re holdover tenant contract issue
(2.4); correspond with J. Raphael re same (.2).
07/22/24 Joshua Raphael
0.60 Research re legal issues re holdover tenant
post lease rejection.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 337 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Executory Contracts & Unexpired Leases
Invoice Number:
Matter Number:
1050104438
48520-11
4
Date
Name
Hours Description
07/23/24 Joshua Raphael
1.20 Further research, analyze rejection of expired
leases with holdover tenant (1.1); correspond
with C. Ceresa re same (.1).
07/25/24 Jaina Desai
0.20 Correspond with D. Hackel re lease rejection
issues.
07/25/24 David Hackel
3.20 Draft, revise rejection notice (1.1); correspond
with C. Ceresa, K&E team re same (.2);
review, analyze precedent, rejection
procedures, related pleadings re same (1.6);
review, analyze issues, precedent re
abandoned property (.3).
07/26/24 Kenny Chiaghana
2.00 Research re treatment of contracts during
chapter 11 in Third Circuit.
07/29/24 Kenny Chiaghana
0.70 Research re executory contracts and admin
claims in Third Circuit.
07/30/24 Kenny Chiaghana
0.90 Research, analyze legal issues re admin
claims re executory contracts.
07/31/24 Kenny Chiaghana
0.50 Legal research re executory contract issues
under Third Circuit caselaw.
Total
22.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 338 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104439
Client Matter: 48520-12
In the Matter of Business Operations
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 35,084.00
Total legal services rendered
$ 35,084.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 339 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050104439
48520-12
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
18.80
1,395.00
26,226.00
Partha Kar
0.50
2,305.00
1,152.50
Olivia Kaufmann
1.50
1,095.00
1,642.50
Sabrina Lieberman
0.50
975.00
487.50
Jai Mudhar
0.50
1,345.00
672.50
Kyle Nolan Trevett
3.80
1,265.00
4,807.00
Donatus Wang
0.10
960.00
96.00
TOTALS
25.70
$ 35,084.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 340 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050104439
48520-12
3
Description of Legal Services
Date
Name
Hours Description
07/01/24 Chris Ceresa
0.30 Review, revise proposed communications
plan materials.
07/01/24 Kyle Nolan Trevett
1.10 Review, revise communications materials re
sale process (.9); correspond with C. Ceresa,
Company re same (.2).
07/01/24 Donatus Wang
0.10 Correspond with Company on cash flow
forecast legal issues.
07/02/24 Chris Ceresa
0.90 Review, analyze final orders for second day
hearing.
07/02/24 Kyle Nolan Trevett
1.30 Review, revise communications materials
(1.1); correspond with C. Ceresa, Company re
same (.2).
07/03/24 Chris Ceresa
1.80 Review, analyze second day hearing orders.
07/03/24 Olivia Kaufmann
1.50 Telephone conference with Company re state
regulatory requirements (.6); conference with
state regulators re notification and application
requirements for licenses (.9).
07/03/24 Jai Mudhar
0.50 Review, analyze issues re account services.
07/03/24 Kyle Nolan Trevett
1.20 Review, revise communications re sale
process (1.1); correspond with C. Ceresa,
Company re same (.1).
07/04/24 Chris Ceresa
0.30 Review, analyze, comment on company
communications.
07/04/24 Partha Kar
0.50 Correspond with Company re Swiss auditor.
07/06/24 Chris Ceresa
0.30 Review, analyze, and comment on company
communications materials.
07/08/24 Chris Ceresa
0.50 Review, analyze company communications
materials and provide comments re same.
07/09/24 Chris Ceresa
0.60 Review, analyze Company communications
materials.
07/10/24 Chris Ceresa
0.40 Review, analyze Company communications
materials.
07/10/24 Chris Ceresa
1.10 Review, analyze business operations issues
(.9); correspond with S. Lieberman, K&E
team re vendor matters (.2).
07/15/24 Chris Ceresa
0.40 Review, analyze business operations issues;
correspond with Company, advisors re same.
07/15/24 Sabrina Lieberman
0.20 Correspond with Company, regulatory
counsel re engagement documents.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 341 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050104439
48520-12
4
Date
Name
Hours Description
07/17/24 Chris Ceresa
0.60 Review, analyze business operations issues
(.3); correspond with Company, advisors re
same (.3).
07/17/24 Chris Ceresa
0.70 Review, revise communication plan (.4);
correspond with Company re same (.3).
07/22/24 Chris Ceresa
1.80 Review, analyze legal issues re company
operations (1.0); correspond with Company,
advisors re same (.8).
07/22/24 Kyle Nolan Trevett
0.20 Telephone conference with C. Ceresa, R.
Marston, Company re communications issues.
07/23/24 Chris Ceresa
1.60 Review, analyze legal issues re company
operations and communications (1.0);
correspond with Company, advisors re same
(.6).
07/24/24 Chris Ceresa
1.20 Review, analyze legal issues re company
operations (1.0); correspond with Company,
advisors re same (.2).
07/24/24 Sabrina Lieberman
0.10 Correspond with Company re legal invoice.
07/25/24 Chris Ceresa
2.10 Review, analyze legal issues re company
operations and vendors (1.7); correspond with
Company, advisors re same (.4).
07/26/24 Chris Ceresa
0.70 Review, analyze legal issues re company
operations and vendors (.3); correspond with
Company, advisors re issues re same (.4).
07/29/24 Chris Ceresa
0.70 Analyze legal issues re company operations
and vendor matters (.5); correspond with
Company, advisors re issues re same (.2).
07/30/24 Chris Ceresa
1.10 Review, analyze legal issues re company
operations and communications (.7);
correspond with Company, advisors re issues
re same (.4).
07/30/24 Sabrina Lieberman
0.20 Correspond with C. Ceresa, K&E team re
foreign counsel issues.
07/31/24 Chris Ceresa
1.70 Review, analyze legal issues re company
operations and communications (1.0);
correspond with Company, advisors re issues
re same (.7).
Total
25.70
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 342 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104440
Client Matter: 48520-13
In the Matter of Claims Administration
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 16,841.00
Total legal services rendered
$ 16,841.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 343 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Claims Administration
Invoice Number:
Matter Number:
1050104440
48520-13
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Tiffani Chanroo
5.60
1,345.00
7,532.00
Kenny Chiaghana
4.60
975.00
4,485.00
Susan D. Golden
1.20
1,600.00
1,920.00
Sarah Osborne
2.20
975.00
2,145.00
Adrian Salmen
0.20
1,265.00
253.00
Kyle Nolan Trevett
0.40
1,265.00
506.00
TOTALS
14.20
$ 16,841.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 344 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Claims Administration
Invoice Number:
Matter Number:
1050104440
48520-13
3
Description of Legal Services
Date
Name
Hours Description
07/01/24 Tiffani Chanroo
0.70 Correspond with K. Chiaghana re bar date
notice (.4); review, revise same (.3).
07/01/24 Kenny Chiaghana
0.90 Analyze, revise bar date publication notice.
07/01/24 Sarah Osborne
0.50 Correspond with D. Hackel, K&E team re
claimant inquiries (.3); review, revise
summary re same (.2).
07/01/24 Kyle Nolan Trevett
0.40 Review, analyze issues re setoff (.3);
correspond with C. Ceresa, Y. Salloum re
same (.1).
07/02/24 Tiffani Chanroo
0.30 Correspond with K. Chiaghana re bar date
notice.
07/02/24 Kenny Chiaghana
0.20 Research re claim setoffs.
07/02/24 Sarah Osborne
0.20 Correspond with D. Hackel, claimant re
potential proof of claim.
07/03/24 Susan D. Golden
0.70 Coordinate proofs and estimates for bid
procedures notice and bar date notice
publications in New York Times.
07/04/24 Kenny Chiaghana
0.50 Analyze, revise bar date order.
07/04/24 Adrian Salmen
0.20 Correspond with T. Chanroo, interested
parties re bar date order.
07/06/24 Tiffani Chanroo
0.50 Review, revise bar date order (.4); correspond
with K. Chiaghana, Omni re service of same
(.1).
07/07/24 Sarah Osborne
0.20 Review, revise proof of claim summary and
creditor correspondence with advisors.
07/09/24 Kenny Chiaghana
1.10 Analyze, revise bar date notices.
07/09/24 Susan D. Golden
0.50 Coordinate with publisher revisions re bar
date and bid procedures notices for New York
Times.
07/09/24 Sarah Osborne
0.20 Correspond with creditor re filing proof of
claim.
07/10/24 Tiffani Chanroo
0.40 Correspond with Omni, Cole Schotz team re
bar date service.
07/11/24 Tiffani Chanroo
2.90 Conference with Omni team, Cole Schotz
team re bar date service (.5); review, analyze
issues re same (1.6); correspond with K.
Chiaghana re same (.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 345 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Claims Administration
Invoice Number:
Matter Number:
1050104440
48520-13
4
Date
Name
Hours Description
07/11/24 Kenny Chiaghana
1.90 Research re bar date package (1.4);
conference with K&E team, T. Chanroo and
Omni team re same (.2); research re bar dater
order (.3).
07/12/24 Tiffani Chanroo
0.80 Correspond with K. Chiaghana, K&E team,
Omni team re bar date service (.4); review,
analyze issues re same (.4).
07/12/24 Sarah Osborne
0.30 Review, revise issues re unsecured creditor
(.1); revise summary re same (.2).
07/15/24 Sarah Osborne
0.60 Correspond with creditor re filing proof of
claim (.4); research re same (.2).
07/19/24 Sarah Osborne
0.20 Revise summary re creditor claims
communications.
Total
14.20
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 346 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104441
Client Matter: 48520-14
In the Matter of Schedules and Statements (SOFAs)
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 70,017.50
Total legal services rendered
$ 70,017.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 347 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Schedules and Statements (SOFAs)
Invoice Number:
Matter Number:
1050104441
48520-14
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
5.30
1,395.00
7,393.50
Tiffani Chanroo
25.30
1,345.00
34,028.50
Kenny Chiaghana
0.90
975.00
877.50
Jaina Desai
3.20
975.00
3,120.00
David Hackel
1.20
1,095.00
1,314.00
Sabrina Lieberman
2.90
975.00
2,827.50
Sarah Osborne
6.00
975.00
5,850.00
Joshua Raphael
2.50
1,095.00
2,737.50
Yusuf Salloum
3.00
1,595.00
4,785.00
Adrian Salmen
4.50
1,265.00
5,692.50
Seth Sanders
1.10
1,265.00
1,391.50
TOTALS
55.90
$ 70,017.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 348 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Schedules and Statements (SOFAs)
Invoice Number:
Matter Number:
1050104441
48520-14
3
Description of Legal Services
Date
Name
Hours Description
07/01/24 David Hackel
0.20 Correspond with T. Chanroo, K&E team re
global notes (.1); review, analyze global notes
(.1).
07/02/24 David Hackel
0.50 Review, analyze global notes, SoFAs,
schedules issues (.3); correspond with J.
Raphael re same (.1); conference with J.
Raphael re same (.1).
07/05/24 Tiffani Chanroo
1.70 Correspond with C. Ceresa, Cole Schotz
team, K&E team re SoFAs, schedules (1.2);
review, analyze SoFAs, schedules (.5).
07/06/24 Tiffani Chanroo
2.20 Review, revise SoFAs and schedules (1.9);
correspond with S. Lieberman, K&E team re
same (.3).
07/06/24 Jaina Desai
2.90 Review, analyze SoFAs and schedules for
accuracy.
07/06/24 Sabrina Lieberman
1.60 Review, revise statements, schedules of
financial affairs.
07/06/24 Sarah Osborne
3.40 Review, analyze issues re debtors’ statements
of financial affairs and schedules of assets and
liabilities (3.2); correspond with T. Chanroo,
K&E team re same (.2).
07/06/24 Joshua Raphael
1.30 Review, analyze SoFAs and schedules.
07/06/24 Adrian Salmen
1.90 Review, analyze SoFAs, schedules.
07/07/24 Tiffani Chanroo
3.20 Review, revise SoFAs and schedules (2.6);
correspond with S. Lieberman, K&E team,
AlixPartners re same (.6).
07/07/24 Kenny Chiaghana
0.90 Analyze, revise schedules and statements.
07/07/24 Jaina Desai
0.30 Review, analyze SoFAs and schedules (.2);
correspond with T. Chanroo, S. Osborne re
same (.1).
07/07/24 Sabrina Lieberman
1.20 Review, analyze schedules and statements re
accuracy.
07/07/24 Sarah Osborne
2.60 Review, analyze statements of financial
affairs and schedules of assets and liabilities
(2.4); correspond with T. Chanroo, K&E team
re same (.2).
07/07/24 Joshua Raphael
1.00 Review, analyze SoFAs and schedules (.7);
correspond with T. Chanroo, C. Ceresa re
same (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 349 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Schedules and Statements (SOFAs)
Invoice Number:
Matter Number:
1050104441
48520-14
4
Date
Name
Hours Description
07/07/24 Yusuf Salloum
1.00 Review, analyze schedules and statements.
07/07/24 Adrian Salmen
0.70 Review, analyze SoFAs, schedules.
07/07/24 Seth Sanders
1.10 Analyze, revise SoFAs, schedules (.9);
correspond with T. Chanroo re same (.2).
07/08/24 Chris Ceresa
4.80 Review, analyze SoFAs (3.1); review, analyze
SOALs re legal issues (1.7).
07/08/24 Tiffani Chanroo
9.60 Review, analyze schedules and statements
(3.9); coordinate the filing re same (3.9);
correspond with C. Ceresa, K&E team re
same (1.8).
07/08/24 Sabrina Lieberman
0.10 Correspond with Y. Salloum and K&E team
re statements and schedules of financial
affairs.
07/08/24 Yusuf Salloum
2.00 Analyze issues re finalizing schedules and
statements.
07/09/24 Chris Ceresa
0.50 Analyze SoFAs, SOALs re legal issues (.4);
correspond with T. Chanroo re same (.1).
07/09/24 Tiffani Chanroo
5.00 Review, analyze 2015.3 report (3.9);
correspond with Alix team, C. Ceresa, K&E
team re same (1.1).
07/10/24 Tiffani Chanroo
2.90 Review, revise 2015.3 report (1.8);
correspond with C. Ceresa, K&E team, Cole
Schotz team, Alix team re same (1.1).
07/10/24 Joshua Raphael
0.20 Review, analyze SoFAs and schedules re
material assets, operations (.1); correspond
with C. Ceresa, K&E team re same (.1).
07/10/24 Adrian Salmen
1.90 Review, analyze precedent 2015.3 reports
(1.1); review, analyze form 2015.3 report (.5);
correspond with C. Ceresa, T. Chanroo, Alix,
Cole Schotz re same (.3).
07/12/24 Tiffani Chanroo
0.70 Correspond with Cole Schotz team, C.
Ceresa, K&E team, AlixPartners re 341
meeting re schedules and statements.
07/17/24 David Hackel
0.50 Review, analyze issues re global notes,
SoFAs and schedules.
Total
55.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 350 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104442
Client Matter: 48520-15
In the Matter of Creditor and Stakeholder Communications
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 12,921.50
Total legal services rendered
$ 12,921.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 351 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Creditor and Stakeholder Communications
Invoice Number:
Matter Number:
1050104442
48520-15
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Julia R. Foster
0.40
525.00
210.00
David Hackel
5.30
1,095.00
5,803.50
Sabrina Lieberman
3.90
975.00
3,802.50
Sarah Osborne
1.30
975.00
1,267.50
Joshua Raphael
0.10
1,095.00
109.50
Josh Sussberg, P.C.
0.20
2,305.00
461.00
Quin Wetzel
1.30
975.00
1,267.50
TOTALS
12.50
$ 12,921.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 352 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Creditor and Stakeholder Communications
Invoice Number:
Matter Number:
1050104442
48520-15
3
Description of Legal Services
Date
Name
Hours Description
07/01/24 David Hackel
0.90 Review, analyze issues re service log,
stakeholder issues (.6); correspond with S.
Osborne, K&E team, Company, advisors re
same (.3).
07/02/24 David Hackel
0.40 Review, analyze issues re service log,
stakeholder issues (.3); correspond with S.
Osborne re same (.1).
07/09/24 Julia R. Foster
0.40 Compile wet ink signed petitions for 341
meeting materials.
07/10/24 Joshua Raphael
0.10 Review, analyze reporting obligations and
correspond with K. Chiaghana re same.
07/11/24 Quin Wetzel
1.30 Review, analyze creditor matrix re
confidentiality (1.1); correspond with S.
Lieberman re same (.2).
07/12/24 Sabrina Lieberman
0.30 Correspond with Q. Wetzel and K&E team re
creditor matrix.
07/12/24 Josh Sussberg, P.C.
0.10 Correspond with creditor re legal issue.
07/17/24 David Hackel
1.40 Review, analyze issues re service log,
stakeholder issues (.8); revise summary re
same (.1); correspond with S. Osborne re
same (.1); conference with S. Osborne re
same (.2); conference with counterparty re
same (.1); correspond with counterparty, PJT
re same (.1).
07/17/24 Sarah Osborne
1.00 Review, analyze creditor communications
(.2); correspond with D. Hackel re same (.4);
correspond with creditor re debtor entity
status (.2); revise summary re same (.2).
07/18/24 David Hackel
0.50 Review, analyze issues re service log,
stakeholder issues (.3); revise summary re
same (.1); correspond with S. Osborne, PJT re
same (.1).
07/19/24 David Hackel
0.50 Review, analyze issues re service log,
stakeholder issues (.3); revise summary re
same (.1); correspond with S. Osborne, Omni
re same (.1).
07/19/24 Sabrina Lieberman
0.40 Conference with Omni re creditor matrix (.2);
correspond with Omni, C. Ceresa, K&E team
re same (.2).
07/20/24 Sabrina Lieberman
0.20 Review, analyze creditor matrix redactions.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 353 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Creditor and Stakeholder Communications
Invoice Number:
Matter Number:
1050104442
48520-15
4
Date
Name
Hours Description
07/22/24 David Hackel
0.40 Review, analyze issues re service log,
stakeholder issues.
07/23/24 David Hackel
0.30 Review, analyze issues re service log,
stakeholder issues.
07/24/24 David Hackel
0.50 Review, analyze issues re service log,
stakeholder issues (.3); correspond with S.
Osborne re same (.1); correspond with S.
Osborne, K&E team, Company, advisors re
same (.1).
07/24/24 Sabrina Lieberman
2.10 Review, revise creditor matrix.
07/24/24 Sarah Osborne
0.30 Review, revise creditor inquiry summary (.2);
correspond with D. Hackel re same (.1).
07/25/24 Sabrina Lieberman
0.50 Review, analyze creditor matrix (.4);
correspond with S. Golden, K&E team re
same (.1).
07/26/24 Josh Sussberg, P.C.
0.10 Correspond with creditor re legal issue.
07/30/24 David Hackel
0.30 Review, analyze issues re service log,
stakeholder issues (.2); correspond with S.
Osborne re same (.1).
07/31/24 David Hackel
0.10 Review, analyze issues re service log,
stakeholder issues.
07/31/24 Sabrina Lieberman
0.40 Conference with creditors re outstanding
creditor issues (.3); correspond with Cole
Schotz re same (.1).
Total
12.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 354 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104443
Client Matter: 48520-16
In the Matter of U.S. Trustee Matters and Communications
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 26,490.50
Total legal services rendered
$ 26,490.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 355 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
U.S. Trustee Matters and Communications
Invoice Number:
Matter Number:
1050104443
48520-16
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
4.50
1,395.00
6,277.50
Tiffani Chanroo
0.30
1,345.00
403.50
Tabitha J. De Paulo
10.90
1,435.00
15,641.50
Jaina Desai
1.00
975.00
975.00
Amy Donahue
0.30
525.00
157.50
Julia R. Foster
0.90
525.00
472.50
Sabrina Lieberman
0.10
975.00
97.50
Rebecca J. Marston
1.20
1,345.00
1,614.00
Quin Wetzel
0.40
975.00
390.00
Tanzila Zomo
1.30
355.00
461.50
TOTALS
20.90
$ 26,490.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 356 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
U.S. Trustee Matters and Communications
Invoice Number:
Matter Number:
1050104443
48520-16
3
Description of Legal Services
Date
Name
Hours Description
07/03/24 Tiffani Chanroo
0.30 Correspond with AlixPartners re reporting
obligations.
07/11/24 Tabitha J. De Paulo
3.80 Review precedent materials and prepare
witness preparation outline for 341 meeting.
07/15/24 Tabitha J. De Paulo
1.40 Review, analyze schedules, global notes and
background materials re 341 meeting.
07/16/24 Chris Ceresa
1.20 Conference with Cole Schotz re preparation
for 341 meeting.
07/16/24 Tabitha J. De Paulo
3.80 Draft witness preparation outline for 341
meeting (2.7); telephone conference with
Company, Cole Schotz re witness preparation
session for 341 meeting (1.1).
07/16/24 Jaina Desai
1.00 Telephone conference with C. Ceresa, K&E
team and AlixPartners re 341 preparation.
07/16/24 Amy Donahue
0.30 Research and pull 341 hearing transcripts for
C. Ceresa.
07/16/24 Julia R. Foster
0.40 Research precedent re 341 meeting
transcripts.
07/16/24 Rebecca J. Marston
1.20 Conference with K&E team, AlixPartners
team re 341 meeting preparation (.8);
correspond with AlixPartners re same (.4).
07/16/24 Tanzila Zomo
0.30 Compile pleadings re 341 meeting.
07/17/24 Chris Ceresa
1.90 Participate in 341 meeting (1.5); prepare for
same (.4).
07/17/24 Tabitha J. De Paulo
1.90 Review, analyze schedules re 341 meeting
(.8); participate in 341 meeting (1.1).
07/17/24 Julia R. Foster
0.20 Correspond with Cole Schotz team re 341
meeting transcript.
07/17/24 Tanzila Zomo
1.00 Open, monitor 341 creditor meeting line.
07/21/24 Chris Ceresa
0.50 Review, analyze draft monthly operating
reports.
07/22/24 Chris Ceresa
0.90 Review, analyze draft monthly operating
reports.
07/22/24 Sabrina Lieberman
0.10 Correspond with U.S. Trustee, Y. Salloum,
K&E team re insurance endorsements.
07/23/24 Quin Wetzel
0.40 Review, analyze docket re monthly operating
reports.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 357 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
U.S. Trustee Matters and Communications
Invoice Number:
Matter Number:
1050104443
48520-16
4
Date
Name
Hours Description
07/25/24 Julia R. Foster
0.30 Correspond re 341 meeting transcript with C.
Ceresa, K&E team.
Total
20.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 358 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104445
Client Matter: 48520-18
In the Matter of Insurance and Surety Matters
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 2,084.50
Total legal services rendered
$ 2,084.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 359 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050104445
48520-18
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Sabrina Lieberman
0.10
975.00
97.50
Adrian Salmen
0.80
1,265.00
1,012.00
Quin Wetzel
1.00
975.00
975.00
TOTALS
1.90
$ 2,084.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 360 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050104445
48520-18
3
Description of Legal Services
Date
Name
Hours Description
07/03/24 Sabrina Lieberman
0.10 Correspond with C. Ceresa re insurance
documents.
07/03/24 Adrian Salmen
0.40 Correspond with T. Chanroo, K&E team,
insurance counsel re second day orders.
07/09/24 Adrian Salmen
0.40 Review, analyze insurance order provisions
(.2); correspond with insurer’s counsel re
same (.2).
07/09/24 Quin Wetzel
1.00 Review, analyze insurance order re
modification, notice requirements (.4);
correspond with A. Salmen re same (.2);
review, analyze insurance reporting
obligations (.3); correspond with K.
Chiaghana re same (.1).
Total
1.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 361 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104446
Client Matter: 48520-19
In the Matter of Utilities
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 4,315.50
Total legal services rendered
$ 4,315.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 362 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Utilities
Invoice Number:
Matter Number:
1050104446
48520-19
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
0.30
1,395.00
418.50
Tiffani Chanroo
2.10
1,345.00
2,824.50
Kenny Chiaghana
1.10
975.00
1,072.50
TOTALS
3.50
$ 4,315.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 363 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Utilities
Invoice Number:
Matter Number:
1050104446
48520-19
3
Description of Legal Services
Date
Name
Hours Description
07/01/24 Chris Ceresa
0.30 Review, analyze objection re utilities (.1);
review settlement agreement (.2).
07/01/24 Tiffani Chanroo
1.20 Correspond with counterparty re utility
objections (.4); review, analyze issues re same
(.8).
07/01/24 Kenny Chiaghana
0.50 Analyze, revise settlement re utilities.
07/02/24 Tiffani Chanroo
0.90 Correspond with counterparty re utilities
objection (.6); review, analyze same (.3).
07/15/24 Kenny Chiaghana
0.10 Correspond with C. Ceresa, K&E
team, AlixPartners team re settlement letter.
07/16/24 Kenny Chiaghana
0.50 Correspond with settlement counterparty, C.
Ceresa and AlixPartners.
Total
3.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 364 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104447
Client Matter: 48520-20
In the Matter of Tax Matters
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 356,554.50
Total legal services rendered
$ 356,554.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 365 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050104447
48520-20
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Jaina Desai
0.90
975.00
877.50
Michael Ehret
43.80
1,895.00
83,001.00
Emanuel Goetz
45.90
750.00
34,425.00
Palmer Gunderson
66.20
995.00
65,869.00
Liz Ji
3.00
1,285.00
3,855.00
Partha Kar
1.00
2,305.00
2,305.00
Sabrina Lieberman
4.30
975.00
4,192.50
James Morgan
2.90
2,445.00
7,090.50
Jai Mudhar
0.40
1,345.00
538.00
Mavnick Nerwal
0.50
2,265.00
1,132.50
Rakesh Patel
2.50
1,665.00
4,162.50
Carolin Paus
3.80
750.00
2,850.00
Steve Toth
1.40
1,820.00
2,548.00
Donatus Wang
1.60
960.00
1,536.00
Nicholas Warther
38.50
1,665.00
64,102.50
Cristina Weidner
4.00
1,665.00
6,660.00
Sara B. Zablotney, P.C.
28.90
2,445.00
70,660.50
Ann-Kathrin Ziegler
0.70
1,070.00
749.00
TOTALS
250.30
$ 356,554.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 366 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050104447
48520-20
3
Description of Legal Services
Date
Name
Hours Description
07/01/24 Michael Ehret
1.20 Telephone conference with M. Goetz re
German tax considerations (.4); review,
analyze issues re same (.8).
07/01/24 Emanuel Goetz
1.00 Telephone conference with M. Ehret, PWC re
German tax considerations.
07/01/24 Palmer Gunderson
2.70 Revise tax disclosures re disclosure statement,
chapter 11 plan, asset purchase agreements
(1.8); draft purchase price allocation
methodology schedule (.9).
07/01/24 Sabrina Lieberman
0.50 Conference with AlixPartners re Hawaiian tax
issue (.1); correspond with C. Ceresa and T.
Chanroo re same (.4).
07/02/24 Palmer Gunderson
1.20 Review, revise asset purchase agreements
(.8); correspond with S. Zablotney, K&E team
re transaction services agreement (.4).
07/02/24 Partha Kar
0.50 Correspond with Company re EY services
and tax matters.
07/02/24 Nicholas Warther
0.50 Review and revise tax portions of asset
purchase agreement.
07/02/24 Sara B. Zablotney, P.C.
2.80 Review, revise asset purchase agreements re
tax issues (.5); review and revise plan and
disclosure statements re tax issues (1.3);
review, analyze issues re German tax entity
(1.0).
07/03/24 Palmer Gunderson
1.30 Correspond with S. Zablotney re tax issues re
asset purchase agreement (.5); review, revise
same (.5); review, analyze tax issues re
transaction services agreement (.2); telephone
conference with S. Lieberman re Internal
Revenue Service company forms (.1).
07/03/24 Sabrina Lieberman
1.80 Conference with Company, AlixPartners, T.
Chanroo re outstanding tax issues (.4);
correspond with N. Warther, K&E team re
same (.2); conference with Hawaiian tax
authority re same (.2); conference with IRS re
same (.2); review, revise replies to tax
authorities (.8).
07/03/24 Nicholas Warther
0.20 Correspond with S. Zablotney, K&E team re
structuring.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 367 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050104447
48520-20
4
Date
Name
Hours Description
07/03/24 Sara B. Zablotney, P.C.
0.60 Correspond with P. Gunderson re tax issues re
asset purchase agreement (.2); review, revise
transaction services agreement re tax matters
(.4).
07/04/24 Michael Ehret
1.20 Review, revise tax presentation (.9);
correspond with N. Warther, PWC re same
(.3).
07/04/24 Sabrina Lieberman
0.30 Revise tax reply forms.
07/04/24 Nicholas Warther
0.50 Review and analyze tax structuring issues.
07/05/24 Michael Ehret
3.70 Review, revise presentation re German tax
considerations (2.4); telephone conference
with N. Warther, PWC re same (.6); review,
analyze issues re tax structuring (.7).
07/05/24 Emanuel Goetz
1.20 Telephone conference with M. Ehret, PWC,
Company re German tax considerations.
07/05/24 Emanuel Goetz
0.50 Review, revise presentation re intercompany
balances, German tax considerations.
07/05/24 Palmer Gunderson
0.20 Review, revise plan and disclosure statement
re tax matters.
07/05/24 Sabrina Lieberman
0.40 Correspond with Company, N. Warther, K&E
team re tax documents.
07/05/24 Donatus Wang
0.60 Review, analyze tax analysis (.4); correspond
with M. Ehret re same (.2).
07/05/24 Nicholas Warther
2.00 Review and analyze German tax structuring
(.7); correspond with K&E team and
Company re same (.8); review and revise plan
(.5).
07/05/24 Cristina Weidner
1.50 Review, analyze tax structure issues.
07/05/24 Sara B. Zablotney, P.C.
0.20 Review, analyze considerations re German
tax issues.
07/05/24 Ann-Kathrin Ziegler
0.50 Review, revise presentation re intercompany
obligations.
07/07/24 Palmer Gunderson
2.40 Review, revise purchaser’s markup of asset
purchase agreement for tax issues.
07/08/24 Michael Ehret
1.50 Review, analyze issues re German tax
structuring (.7); telephone conference with N.
Warther, PWC re same (.6); correspond with
E. Goetz re same (.2).
07/08/24 Emanuel Goetz
0.50 Telephone conference with Company,
Deloitte, PWC re German tax issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 368 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050104447
48520-20
5
Date
Name
Hours Description
07/08/24 Palmer Gunderson
2.90 Correspond with S. Zablotney re asset
purchase agreements and purchase price
allocation schedules re tax issues (1.3); revise
asset purchase agreement re same (1.6).
07/08/24 Sabrina Lieberman
0.20 Correspond with Company, AlixPartners, T.
Chanroo re outstanding tax issues.
07/08/24 Nicholas Warther
1.70 Review and revise tax portions of asset
purchase agreement (.8); teleconference with
Deloitte and Company re tax analysis (.4);
review and revise plan (.5).
07/08/24 Sara B. Zablotney, P.C.
1.00 Review, analyze legal issues re tax allocation
(.6); review, revise asset purchase agreement
re same (.4).
07/08/24 Ann-Kathrin Ziegler
0.20 Review, analyze correspondence from M.
Ehret re intercompany analysis tax matters.
07/09/24 Sabrina Lieberman
0.30 Correspond with Company re outstanding tax
issue (.1); conference with AlixPartners and
T. Chanroo re same (.2).
07/09/24 Jai Mudhar
0.20 Correspond with EY re filing entities.
07/09/24 Cristina Weidner
1.00 Correspond with A. Ziegler, K&E team re
German tax structure.
07/09/24 Sara B. Zablotney, P.C.
0.70 Review, analyze issues re bankruptcy
emergence and timing considerations.
07/09/24 Sara B. Zablotney, P.C.
0.50 Telephone conference with advisors re
German tax structure.
07/10/24 Michael Ehret
6.20 Conference with C. Weidner, K&E team re
international issues, tax, structuring
considerations (1.0); conferences with C.
Weidner, K&E team re same (1.2); review,
analyze draft APAs re structuring and tax
considerations (1.0); review, revise same (.8);
conference with N. Warther, K&E team re tax
matters (1.1); conference with Company,
BDO re same (1.1).
07/10/24 Emanuel Goetz
1.30 Review, revise purchase price allocation re
German tax issues.
07/10/24 Emanuel Goetz
2.90 Review, revise transaction services agreement
and asset purchase agreement re German tax
perspective.
07/10/24 Emanuel Goetz
1.00 Review, analyze issues re German tax
considerations presentation.
07/10/24 Emanuel Goetz
1.20 Telephone conference with M. Ehret, PWC,
Company re German tax issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 369 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050104447
48520-20
6
Date
Name
Hours Description
07/10/24 Palmer Gunderson
2.90 Correspond with Company re purchase price
allocation methodology (.6); telephone
conference with N. Warther re purchase price
allocation methodology (.4); revise asset
purchase agreement schedule for purchase
price allocation methodology (1.1); telephone
conference with N. Warther, Company re
purchase price allocation methodology (.8).
07/10/24 Liz Ji
0.50 Telephone conference with N. Warther, K&E
team re purchase price allocation.
07/10/24 Partha Kar
0.50 Correspond with Company re E&Y and tax
issues.
07/10/24 Sabrina Lieberman
0.10 Correspond with Company, AlixPartners, T.
Chanroo re open tax issues.
07/10/24 Jai Mudhar
0.20 Correspond with P. Kar, Company re E&Y
and tax issues.
07/10/24 Carolin Paus
0.50 Telephone conference C. Weidner, K&E team
re MIM winddown and sale structuring issues.
07/10/24 Nicholas Warther
3.00 Review and revise asset purchase agreement
tax portions (.8); correspond with S. Toth,
K&E team re same (.5); telephone conference
with Company, BDO re same (1.0); review
and analyze purchase price allocation (.7) .
07/10/24 Sara B. Zablotney, P.C.
1.20 Review, revise asset purchase agreement re
tax issues (.9); review, analyze issues re
German tax considerations (.3).
07/11/24 Jaina Desai
0.30 Review, analyze correspondence from C.
Ceresa, K&E team re NOL motion (.1); revise
NOL motion (.2).
07/11/24 Emanuel Goetz
0.80 Research tax consequences re German
intellectual property sale.
07/11/24 Palmer Gunderson
5.00 Telephone conference with purchaser’s
counsel re open tax items in purchase
agreement (.7); review, revise purchase
agreement re same (2.7); correspond with N.
Warther, K&E team re tax issues in purchase
agreement (1.6).
07/11/24 Liz Ji
0.50 Telephone conference with N. Warther, K&E
team re tax structure.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 370 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050104447
48520-20
7
Date
Name
Hours Description
07/11/24 Sara B. Zablotney, P.C.
1.40 Telephone conference with N. Warther re
intercompany and tax matters (.5); review,
revise asset purchase agreement re same (.6);
review, revise transaction services agreement
re same (.3).
07/12/24 Jaina Desai
0.40 Revise NOL exhibit (.2); correspond with T.
Chanroo, Omni re same (.2).
07/12/24 Palmer Gunderson
1.30 Correspond with N. Warther, K&E team re
entity tax classification schedule (.1); review,
analyze tax items in purchase agreement
(1.2).
07/12/24 Sara B. Zablotney, P.C.
1.30 Review, revise purchase agreement re tax and
structure related legal issues.
07/14/24 Michael Ehret
3.50 Review, analyze correspondence from
Company re tax issues (1.4), conference with
C. Weidner, Company, K&E team, PwC re
same (1.1); conference with Company re
same (1.0).
07/14/24 Nicholas Warther
1.70 Review and analyze questions re structuring
(1.1); correspond with P. Gunderson, K&E
team re same (.6).
07/14/24 Sara B. Zablotney, P.C.
0.50 Correspond with N. Warther, K&E team re
tax structuring considerations.
07/15/24 Jaina Desai
0.20 Review, analyze correspondence re tax legal
issues.
07/15/24 Michael Ehret
2.50 Conference with Deloitte, Company, C.
Weidner, K&E team, re intracompany tax
issues (1.0), conference with Company, PwC
re same (1.0), conference with S. Zablotney,
K&E team re international tax issues (.5).
07/15/24 Emanuel Goetz
0.50 Telephone conference with Deloitte,
Company and PWC re methodology of
envisaged intercompany liability resolution.
07/15/24 Emanuel Goetz
0.50 Telephone conference with PWC and M.
Ehret re tax resolution issues.
07/15/24 Palmer Gunderson
1.70 Telephone conference with N. Warther, K&E
team re structure of respiratory sale (.5);
telephone conference with S. Zablotney, K&E
team re sale structure and tax planning (.6);
telephone conference with N. Warther re
transaction structure (.2); review, analyze
issues re tax structure (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 371 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050104447
48520-20
8
Date
Name
Hours Description
07/15/24 Liz Ji
1.00 Telephone conference with N. Warther, K&E
team re respiratory business tax matters re
potential sale (.5); telephone conference with
N. Warther, K&E team re tax structure (.5).
07/15/24 James Morgan
1.20 Telephone conference with N. Warther, K&E
team re sale structure tax matters (.5); review,
analyze issues re tax structure (.7).
07/15/24 Mavnick Nerwal
0.50 Correspond with S. Zablotney re tax
considerations.
07/15/24 Donatus Wang
0.70 Review, analyze summary of allocation of tax
risks under draft asset purchase agreements.
07/15/24 Nicholas Warther
2.50 Conference with Company, M. Ehret, K&E
team re structuring of intercompany
resolution (.9); correspond with M. Ehret,
K&E team re same (1.2); correspond with
Company re same (.4).
07/15/24 Sara B. Zablotney, P.C.
2.80 Review, analyze tax diligence (1.0); telephone
conference with N. Warther, K&E team re
German tax (.5); telephone conference with
N. Warther, K&E team re structure (.5);
review, analyze issues re tax structure (.8).
07/16/24 Michael Ehret
2.70 Correspond with Deloitte re work in process
re tax and structuring items (.7); conference
with BDO, PwC, N. Warther, K&E team,
Company re international tax issues (1.1);
conference with P. Gunderson, K&E team re
German tax issues, correspond with S. Toth re
same (.9).
07/16/24 Emanuel Goetz
2.00 Review, analyze tax structure re
intercompany resolution (1.6); correspond
with M. Ehret re same (.4).
07/16/24 Emanuel Goetz
1.50 Review, analyze resolution issues (1.1);
telephone conference with M. Ehret re same
(.4).
07/16/24 Palmer Gunderson
1.40 Telephone conference with N. Warther,
Company re transaction structure (.8);
telephone conference with N. Warther re
structure slides (.2); review, analyze issues re
transaction structure (.4).
07/16/24 Liz Ji
1.00 Telephone conference with N. Warther, K&E
team re tax structure.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 372 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050104447
48520-20
9
Date
Name
Hours Description
07/16/24 James Morgan
1.20 Conference with R. Patel re transaction
structure (.8); correspond with R. Patel re
German tax considerations (.4).
07/16/24 Rakesh Patel
2.50 Review, analyze legal issues re intercompany
receivables and proposed transaction steps.
07/16/24 Steve Toth
1.40 Analyze correspondence re tax and diligence
matters (.3); participate in teleconference with
Company, AlixPartners, Y. Salloum, K&E
team, and PwC re tax and intercompany
matters (.9); analyze and respond to
correspondence re tax structure considerations
(.2).
07/16/24 Donatus Wang
0.30 Review, analyze tax structuring issues re
sales.
07/16/24 Nicholas Warther
1.50 Conference with Company and advisers re
intercompany modeling (1.0); review and
analyze same (.5).
07/16/24 Cristina Weidner
1.00 Review, analyze tax issues re sale.
07/16/24 Sara B. Zablotney, P.C.
0.80 Telephone conference with N. Warther, K&E
team re transaction status (.5); correspond
with N. Warther re alternative tax structure
(.3).
07/17/24 Michael Ehret
3.70 Review, analyze documents re tax issues
(1.0); conference with Deloitte, Company re
German tax issues (.5); conference with
Company re same (1.0); correspond with
Company re same (.5); correspond with P.
Gunderson, K&E team re international tax
issues (.7).
07/17/24 Emanuel Goetz
3.50 Review, analyze issues re structuring
intercompany resolutions (2.9); telephone
conference with M. Ehret re German tax
issues (.6).
07/17/24 Palmer Gunderson
1.30 Correspond with M. Ehret, K&E team re
German tax issues and transaction planning
(1.1); telephone conference with M. Ehret re
German tax issues (.2).
07/17/24 Sara B. Zablotney, P.C.
1.00 Review and revise tax issues summary (.7);
correspond with N. Warther re transaction
status (.3).
07/18/24 Palmer Gunderson
4.80 Review, analyze issues re tax structure (1.2);
draft structure presentation re restructuring
transactions (3.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 373 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050104447
48520-20
10
Date
Name
Hours Description
07/18/24 Nicholas Warther
0.50 Correspond with M. Ehret, K&E team and
Company re intercompany resolution and tax
issues re same.
07/18/24 Cristina Weidner
0.50 Conference with tax advisor re tax structuring
for transaction (.4); correspond with A.
Ziegler, K&E team re next steps (.1).
07/19/24 Palmer Gunderson
4.30 Review, analyze tax considerations (1.4);
revise tax presentation re same (2.9).
07/19/24 Sabrina Lieberman
0.30 Correspond with Y. Salloum, S. Sanders,
lender advisors re tax memorandum.
07/19/24 Sara B. Zablotney, P.C.
0.50 Correspond with N. Warther, K&E team re
tax structure and open issues.
07/22/24 Michael Ehret
1.70 Conference with Company, PwC re
international tax issues (1.2), correspond with
N. Warther, K&E team re same (.5).
07/22/24 Emanuel Goetz
1.50 Telephone conference M. Ehret, PWC re
valuation (.6); review, analyze respective
documents (.9).
07/22/24 James Morgan
0.50 Conference with R. Patel re UK tax structure.
07/22/24 Nicholas Warther
0.20 Correspond with M. Ehret, K&E team re
German tax structuring.
07/23/24 Michael Ehret
0.70 Conference with S. Zablotney, K&E team re
tax structuring (.4), review, analyze
documents re same (.3).
07/23/24 Emanuel Goetz
2.20 Review, analyze German tax aspects re
valuation.
07/23/24 Emanuel Goetz
0.70 Telephone conference with Deloitte, S.
Zablotney, N. Warther, Y. Salloum and M.
Ehret re tax issues.
07/23/24 Emanuel Goetz
3.00 Draft presentation re German tax
implications.
07/23/24 Palmer Gunderson
4.00 Correspond with N. Warther, K&E team re
steps to address company tax liabilities (.5);
telephone conference with S. Zablotney, K&E
team re resolution of German intercompany
obligations (.5); draft, review, revise structure
slides (3.0).
07/23/24 Carolin Paus
3.30 Analyze intercompany transaction structure re
tax legal issues.
07/23/24 Nicholas Warther
0.50 Correspond with M. Ehret, K&E team re
structuring and next steps.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 374 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050104447
48520-20
11
Date
Name
Hours Description
07/23/24 Sara B. Zablotney, P.C.
0.50 Telephone conference with Y. Salloum, K&E
team re intercompany obligations and tax
matters re same.
07/24/24 Michael Ehret
1.00 Telephone conference with Company re
intercompany tax issues (.8); correspond with
Company, N. Warther re same (.2).
07/24/24 Palmer Gunderson
2.70 Telephone conference with S. Zablotney,
K&E team re global tax issues related to
intercompany obligations (1.0); telephone
conference with Y. Salloum, K&E team re
feasibility of intercompany balances (.5);
telephone conference with N. Warther re
structuring steps to resolve intercompany
balances (.6); correspond with M. Ehret, K&E
team re intercompany balance tax issues (.4);
revise memorandum re resolution of
intercompany balances (.2).
07/24/24 Nicholas Warther
2.20 Conference with Company, PwC, and other
advisers re intercompany settlement (1.0);
correspond with M. Ehret, K&E team re
structure slides (1.2).
07/24/24 Sara B. Zablotney, P.C.
2.00 Telephone conference with P. Gunderson re
structure and tax related items (.8); telephone
conference with N. Warther re tax diligence
(.5); review, analyze issues re same (.7).
07/25/24 Michael Ehret
3.50 Conference with Company re intercompany
tax issues (1.0); review, analyze tax
presentation (2.2); correspond with Y.
Salloum, K&E team re same (.3).
07/25/24 Emanuel Goetz
3.90 Review, revise presentation re German tax
implications.
07/25/24 Palmer Gunderson
3.30 Revise structure presentation re resolution of
intercompany obligations.
07/25/24 Sabrina Lieberman
0.10 Correspond with IRS re open tax questions.
07/25/24 Nicholas Warther
0.70 Conference with Company, P. Gunderson and
K&E team re status and next steps re tax
matters.
07/26/24 Michael Ehret
2.20 Conference with N. Warther, K&E team re
outstanding tax issues (.5); correspond with
N. Warther, K&E team re same (.4); review,
analyze documents re intercompany structure
(.8); conference with N. Warther, K&E team,
Company re tax structuring matters (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 375 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050104447
48520-20
12
Date
Name
Hours Description
07/26/24 Emanuel Goetz
0.30 Telephone conference with M. Ehret re tax
considerations presentation.
07/26/24 Emanuel Goetz
1.90 Telephone conference with M. Ehret re
intercompany payables and receivables (.4);
review, analyze issues re same (1.5).
07/26/24 Palmer Gunderson
0.10 Correspond with N. Warther, K&E team re
structure questions.
07/26/24 Sabrina Lieberman
0.30 Conference with IRS re inquiries (.2);
correspond with A. Salmen, AlixPartners re
same (.1).
07/26/24 Nicholas Warther
5.50 Conference with P. Gunderson, K&E team re
structuring and tax issues (.5); conference
with Company and AlixPartners re same
(2.0); draft, revise presentation re structure
(2.2); correspond with M. Ehret, K&E team re
German tax issues (.8).
07/27/24 Michael Ehret
1.50 Review, analyze tax presentation (.8),
correspond with N. Warther re same (.2),
conference with N. Warther, S. Zablotney re
same (.5).
07/27/24 Emanuel Goetz
1.50 Review, revise presentation re German tax
considerations.
07/27/24 Palmer Gunderson
2.80 Review, revise asset purchase agreement re
tax issues (2.0); correspond with N. Warther,
K&E team re tax issues (.8).
07/27/24 Nicholas Warther
2.10 Review and revise presentation re tax
considerations (.5); correspond with M. Ehret,
K&E team re same (1.1); review and analyze
structuring (.5).
07/27/24 Sara B. Zablotney, P.C.
1.20 Review, revise intercompany plan (.3);
telephone conference with N. Warther, K&E
team re status (.4); review, revise presentation
re same (.5).
07/28/24 Michael Ehret
1.00 Correspond to P. Gunderson re tax issues (.2);
review, analyze documents re same (.6);
correspond with N. Warther, K&E team re
German tax issues (.2).
07/28/24 Emanuel Goetz
1.50 Review, revise RDX asset purchase
agreement re German tax issues.
07/28/24 Nicholas Warther
2.90 Review and revise tax considerations for
lenders (1.6); correspond with M. Ehret, K&E
team re same (.6); Conference with Company,
P. Gunderson, K&E team re same (.7).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 376 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050104447
48520-20
13
Date
Name
Hours Description
07/29/24 Michael Ehret
1.10 Review, analyze correspondence from C.
Paus re tax issues (.2); conference with
Company re same (.4); conference with S.
Winters, K&E team re tax structuring (.5).
07/29/24 Emanuel Goetz
0.80 Review, analyze issues re German tax
considerations.
07/29/24 Palmer Gunderson
6.40 Review, revise structure slides re resolution of
intercompany obligations (3.2); telephone
conference with N. Warther re structure slides
(.3); correspond with N. Warther, K&E team,
Company re structure slides (.6); further
revise structure slides (2.3).
07/29/24 Nicholas Warther
5.70 Conference with lenders re tax considerations
(1.0); review and revise structure presentation
(1.9); review and revise presentation for
lenders re same (.6); conference with P.
Gunderson, K&E team and Company re same
(.7); correspond with M. Ehret, K&E team re
structuring considerations and presentation
(1.5).
07/29/24 Sara B. Zablotney, P.C.
2.30 Telephone conference with Y. Salloum, K&E
team re lender considerations (.5); telephone
conference with N. Warther, K&E team re
structure (.5); review, revise presentation
(1.3).
07/30/24 Michael Ehret
3.00 Review, analyze tax summary (.5);
conference with Company re tax issues (.5);
correspond with P. Gunderson re same (.5);
revise summary re next steps re tax (.5);
conference with Company, PwC re German
tax structuring issues (.5), conference with
Company re tax issues (.5).
07/30/24 Emanuel Goetz
1.30 Review, analyze intercompany settlement.
07/30/24 Emanuel Goetz
1.00 Telephone conference with PWC, M. Ehret re
German tax issues.
07/30/24 Emanuel Goetz
2.00 Review, revise asset purchase agreement re
tax matters.
07/30/24 Emanuel Goetz
1.50 Review, revise tax presentation.
07/30/24 Emanuel Goetz
0.60 Telephone conference with P. Gunderson, M.
Ehret, N. Warther, S. Zablotney re potential
transaction and tax considerations.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 377 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050104447
48520-20
14
Date
Name
Hours Description
07/30/24 Emanuel Goetz
0.90 Telephone conference with M. Ehret, buyer’s
counsel re potential transaction and tax issues
(.6); correspond with M. Ehret re next steps re
same (.3).
07/30/24 Palmer Gunderson
7.50 Revise structure slides (3.9); telephone
conference with Company re sale of
respiratory diagnostics business (.5); draft tax
issues list for revised ventilations business
purchase agreement (1.5); correspond with N.
Warther, K&E team re structure and
resolution of intercompany balances (1.6).
07/30/24 Nicholas Warther
2.30 Review and revise tax structure slides.
07/30/24 Sara B. Zablotney, P.C.
3.70 Telephone conference with N. Warther, K&E
team re structure (1.0); telephone conference
with buyer’s counsel re transaction structure
(1.0); review, analyze structure proposal (.9);
revise presentation (.8).
07/31/24 Michael Ehret
1.90 Correspond with Company re German tax
issues (.2); review, analyze draft asset
purchase agreement (.8); correspond with
Company re same (.2); correspond with N.
Warther, K&E team re tax plan (.2);
conference with Y. Salloum, K&E team re tax
plan (.5).
07/31/24 Emanuel Goetz
0.50 Review, revise tax presentation.
07/31/24 Emanuel Goetz
0.30 Telephone conference with S. Zablotney re
tax issues re divisional sale.
07/31/24 Emanuel Goetz
0.40 Telephone conference with N. Warther, K&E
team, Company re sale of vents division and
legal tax issues re same.
07/31/24 Emanuel Goetz
0.80 Review, analyze asset purchase agreement re
German tax considerations.
07/31/24 Emanuel Goetz
0.90 Telephone conference with N. Warther, K&E
team, Company re structure, intercompany
obligations.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 378 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050104447
48520-20
15
Date
Name
Hours Description
07/31/24 Palmer Gunderson
6.00 Draft structure for sale of ventilation and
respiratory diagnostics businesses (1.3);
review, revise purchase agreement for sale of
respiratory diagnostics business (1.8); review,
revise structure slides re intercompany
balance restructuring (.3); telephone
conference with N. Warther, K&E team re
pre‑closing restructuring steps and tax
implications (1.0); correspond with E. Goetz
re purchase agreement re respiratory
diagnostics business (.5); revise purchase
agreements (1.1).
07/31/24 Nicholas Warther
2.30 Review and revise tax structure presentation
(1.5); conference with BDO tax (.8).
07/31/24 Sara B. Zablotney, P.C.
3.90 Telephone conference with N. Warther, Y.
Salloum re structure with bidders (2.0);
review, revise asset purchase agreement re tax
considerations (1.9).
Total
250.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 379 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104448
Client Matter: 48520-21
In the Matter of Case Administration
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 159,023.00
Total legal services rendered
$ 159,023.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 380 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050104448
48520-21
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Kon Asimacopoulos
12.30
2,305.00
28,351.50
Chris Ceresa
1.10
1,395.00
1,534.50
Tiffani Chanroo
26.30
1,345.00
35,373.50
Kenny Chiaghana
20.80
975.00
20,280.00
Georgia Cooper-Dervan
0.90
1,185.00
1,066.50
Sion Davies
1.90
1,575.00
2,992.50
Jaina Desai
4.10
975.00
3,997.50
Amy Donahue
1.60
525.00
840.00
Julia R. Foster
7.30
525.00
3,832.50
David Hackel
5.20
1,095.00
5,694.00
Partha Kar
0.50
2,305.00
1,152.50
Sabrina Lieberman
13.30
975.00
12,967.50
Georgia Meadow
0.50
355.00
177.50
Jai Mudhar
0.70
1,345.00
941.50
Sarah Osborne
10.10
975.00
9,847.50
Carolin Paus
1.50
750.00
1,125.00
Evangelia Podaras
1.60
1,575.00
2,520.00
Joshua Raphael
0.60
1,095.00
657.00
Yusuf Salloum
2.20
1,595.00
3,509.00
Adrian Salmen
1.60
1,265.00
2,024.00
Seth Sanders
0.70
1,265.00
885.50
Noah Shier
1.00
1,575.00
1,575.00
Noah Spector
3.80
1,185.00
4,503.00
Kyle Nolan Trevett
1.50
1,265.00
1,897.50
Sarah Ullathorne
0.50
1,575.00
787.50
Quin Wetzel
6.90
975.00
6,727.50
Tanzila Zomo
10.60
355.00
3,763.00
TOTALS
139.10
$ 159,023.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 381 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050104448
48520-21
3
Description of Legal Services
Date
Name
Hours Description
07/01/24 Kon Asimacopoulos
1.20 Review, analyze legal issues re international
non-filing Company entities.
07/01/24 Kenny Chiaghana
0.70 Analyze, revise work in process summary
(.5); analyze, revise, summary of case key
dates and deadlines (.2).
07/01/24 Georgia Cooper-Dervan
0.70 Review, analyze legal issues re UK entities.
07/01/24 David Hackel
1.40 Review, analyze issues re chapter 11
post‑petition deck (.3); review, analyze deck,
revisions re case and timeline updates (.8);
correspond with K. Chiaghana, K&E team re
same (.3).
07/01/24 David Hackel
0.70 Review, revise chapter 11 filing and orders
summary (.5); correspond with C. Ceresa,
K&E team re same (.2).
07/01/24 Sabrina Lieberman
0.30 Review and revise work in process summary.
07/01/24 Sabrina Lieberman
2.10 Review and revise talking points for second
day hearing.
07/01/24 Sarah Ullathorne
0.50 Review, analyze international entity issues.
07/02/24 Kon Asimacopoulos
2.20 Review, analyze international entity legal
issues (1.8); correspond with advisors re same
(.4).
07/02/24 Kenny Chiaghana
0.70 Participate in conference with K&E team, C.
Ceresa re case status (.4); analyze, revise
work in process summary (.3).
07/02/24 Kenny Chiaghana
0.70 Analyze, revise various orders re second day
hearing.
07/02/24 Amy Donahue
0.50 Conference with C. Ceresa and K&E team re
work in process.
07/02/24 Julia R. Foster
0.60 Conference with C. Ceresa and K&E team re
work in process.
07/02/24 David Hackel
0.70 Conference with C. Ceresa, K&E team re case
status, next steps.
07/02/24 David Hackel
0.50 Correspond with K. Chiaghana, K&E team re
chapter 11 management presentation (.1);
review, analyze same and related issues (.4).
07/02/24 Sabrina Lieberman
0.60 Conference with C. Ceresa, K&E team re
work in process (.5); review, analyze
correspondence from C. Ceresa, K&E team re
same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 382 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050104448
48520-21
4
Date
Name
Hours Description
07/02/24 Sabrina Lieberman
1.30 Review, revise final orders, talking points re
second day hearing.
07/02/24 Georgia Meadow
0.20 Distribute docket report to C. Ceresa and
K&E team.
07/02/24 Sarah Osborne
0.50 Telephone conference with C. Ceresa, K&E
team re case updates.
07/02/24 Sarah Osborne
5.60 Draft second day hearing talking points (2.9);
revise final orders re second day hearing
(1.1); correspond with T. Chanroo, K&E team
re same (.6); draft summary re same (1.0).
07/02/24 Adrian Salmen
0.60 Conference with C. Ceresa, K&E team re
work in process.
07/02/24 Seth Sanders
0.30 Telephone conference with C. Ceresa, K&E
team re case status.
07/02/24 Seth Sanders
0.40 Telephone conference with AlixPartners re
case timing.
07/02/24 Kyle Nolan Trevett
0.50 Telephone conference with C. Ceresa, K&E
team re work in process.
07/03/24 Kon Asimacopoulos
2.20 Analyze international entity legal issues.
07/03/24 Tiffani Chanroo
6.60 Revise second day motions (3.9); correspond
with C. Ceresa, K&E team re same (1.1);
review, analyze issues re same (1.6).
07/03/24 Kenny Chiaghana
0.20 Analyze, revise summary of case key dates
and deadlines.
07/03/24 Kenny Chiaghana
3.30 Review, revise cash management, insurance,
utilities and bar date orders re second day
hearing (2.9); draft, revise talking points re
same (.4).
07/03/24 Jaina Desai
3.10 Review, revise NOL order (1.4); correspond
with C. Ceresa, T. Chanroo re same (.2);
revise customer programs order (1.3);
correspond with T. Chanroo, C. Ceresa re
same (.2).
07/03/24 Sabrina Lieberman
0.30 Review, analyze correspondence from C.
Ceresa, K&E team re work in process.
07/03/24 Sabrina Lieberman
2.50 Review, revise final orders re second day
hearing.
07/03/24 Georgia Meadow
0.20 Distribute docket report to C. Ceresa and
K&E team.
07/03/24 Sarah Osborne
2.10 Review, revise final orders for second day
hearing (.7); revise same for filing (1.1);
review, revise talking points (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 383 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050104448
48520-21
5
Date
Name
Hours Description
07/03/24 Carolin Paus
1.50 Review and summarize material license
agreements.
07/03/24 Yusuf Salloum
1.20 Review, analyze final orders for first day
pleadings.
07/03/24 Noah Spector
2.20 Analyze and prepare materials for Second
Day hearing.
07/04/24 Kon Asimacopoulos
1.50 Review, analyze international non-filing legal
issues.
07/04/24 Tiffani Chanroo
3.60 Review, revise second day motions (3.3);
correspond with K. Chiaghana, K&E team re
same (.3).
07/04/24 Kenny Chiaghana
0.50 Analyze, revise talking points re second day
hearing.
07/05/24 Kon Asimacopoulos
2.20 Review, analyze international entity legal
issues.
07/05/24 Tiffani Chanroo
3.10 Review, analyze first day order (2.8);
correspond with C. Ceresa, K&E team re
same (.3).
07/05/24 Kenny Chiaghana
0.20 Analyze, revise talking points re second day
hearing.
07/05/24 Jaina Desai
0.30 Revise case timeline.
07/05/24 Sabrina Lieberman
0.10 Review, analyze correspondence from C.
Ceresa, K&E team re work in process.
07/06/24 Sion Davies
0.30 Correspond with Y. Salloum K&E team re
filing analysis.
07/06/24 Sabrina Lieberman
0.30 Review, analyze correspondence from C.
Ceresa, K&E team re work in process.
07/07/24 Tiffani Chanroo
1.80 Review, analyze second day orders (1.4);
correspond with S. Lieberman, K&E team re
same (.4).
07/07/24 Sabrina Lieberman
0.70 Review, revise final orders for second day
hearing.
07/07/24 Noah Spector
1.60 Prepare and revise materials for second day
hearing.
07/08/24 Kon Asimacopoulos
1.50 Review, analyze legal issues re duties,
international considerations.
07/08/24 Chris Ceresa
0.50 Conference with advisors, K&E team re
hearing preparation.
07/08/24 Tiffani Chanroo
1.10 Review, analyze second hearing orders (.8);
correspond with C. Ceresa, K&E team,
Gibson Dunn re same (.3)
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 384 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050104448
48520-21
6
Date
Name
Hours Description
07/08/24 Kenny Chiaghana
0.70 Analyze, revise summary of case key dates
and deadlines.
07/08/24 Kenny Chiaghana
0.50 Draft talking points re second day hearing.
07/08/24 Georgia Cooper-Dervan
0.20 Review, analyze issues re UK NSI analysis.
07/08/24 Amy Donahue
0.20 Review and revise calendar markers for
upcoming hearings.
07/08/24 Julia R. Foster
3.30 Correspond with Y. Salloum and C. Ceresa re
July 9, 2024 hearing logistics (.6); prepare
materials for July 9, 2024 hearing (2.7).
07/08/24 Sabrina Lieberman
0.50 Review, analyze correspondence from Y.
Salloum and K&E team re work in process
(.4); correspond with K. Chiaghana re
summary re same (.1).
07/08/24 Sabrina Lieberman
0.20 Review, revise final order for second day
hearing (.1); correspond with T. Chanroo and
K&E team re same (.1).
07/08/24 Georgia Meadow
0.10 Distribute docket report to C. Ceresa and
K&E team.
07/08/24 Yusuf Salloum
1.00 Review, revise revised first day orders.
07/08/24 Noah Shier
0.30 Correspond with Y. Salloum, K&E team re
work in process.
07/08/24 Kyle Nolan Trevett
0.50 Draft, revise talking points re second day
hearing re privacy issues.
07/09/24 Tiffani Chanroo
0.90 Correspond with J. Foster, CS Cole Schotz
team re petitions (.7); review, analyze
requirements of same (.2).
07/09/24 Sion Davies
1.00 Review, analyze issues re filing analysis.
07/09/24 Julia R. Foster
0.40 Monitor recently filed pleadings.
07/09/24 Sabrina Lieberman
0.20 Review, revise work in process summary (.1);
review, analyze correspondence from C.
Ceresa and K&E team re same (.1).
07/09/24 Tanzila Zomo
3.80 Compile recently filed pleadings (.7); compile
filed schedules of assets and liabilities (2.5);
circulate to C. Ceresa and K&E team re same
(.2); correspond with J. Foster, T. Chanroo re
same (.4).
07/10/24 Kon Asimacopoulos
1.50 Review, analyze legal issues re duties,
international analysis.
07/10/24 Kenny Chiaghana
2.60 Draft summary re reporting obligations re
final orders.
07/10/24 Sion Davies
0.20 Review, analyze issues re filing analysis.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 385 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050104448
48520-21
7
Date
Name
Hours Description
07/10/24 Julia R. Foster
1.50 Review, analyze filed petitions (.8);
correspond with T. Chanroo re wet ink
petition signature pages (.7).
07/10/24 Sabrina Lieberman
0.70 Review, revise work in process summary (.2);
review, analyze correspondence from C.
Ceresa and K&E team re same (.5).
07/10/24 Tanzila Zomo
0.40 Compile recently filed pleadings (.3);
circulate to C. Ceresa, K&E team (.1).
07/11/24 Tiffani Chanroo
0.50 Conference with R. Marston re work in
process.
07/11/24 Tiffani Chanroo
0.90 Review, revise online document folders
(.5); review, analyze recently filed pleadings
(.3); correspond with C. Ceresa, K&E team re
same (.1).
07/11/24 Kenny Chiaghana
2.10 Review, revise summary of obligations re
final orders (1.5); revise summary of work in
process and key dates and deadlines (.3);
conference with K&E team, C. Ceresa re
work in process (.3).
07/11/24 Jaina Desai
0.20 Telephone conference with R. Marston, K&E
team re case status, next steps.
07/11/24 Amy Donahue
0.30 Telephone conference with R. Marston, K&E
team conference meeting re work in process.
07/11/24 Sabrina Lieberman
0.70 Conference with T. Chanroo and K&E team
re work in process (.5); review, analyze
correspondence from C. Ceresa and K&E
team re work in process (.2).
07/11/24 Sarah Osborne
0.50 Telephone conference with T. Chanroo, K&E
team re case updates.
07/11/24 Joshua Raphael
0.30 Conference with T. Chanroo, K&E team re
work in process.
07/11/24 Adrian Salmen
0.50 Conference with C. Ceresa, K&E team re
work in process.
07/11/24 Noah Shier
0.20 Correspond with Y. Salloum, K&E team re
work in process.
07/11/24 Kyle Nolan Trevett
0.20 Telephone conference with C. Ceresa, K&E
team re work in process.
07/11/24 Quin Wetzel
0.40 Telephone conference with T. Chanroo, K&E
team re critical workstreams.
07/11/24 Tanzila Zomo
1.10 Compile first day final orders (.5); compile
recently filed pleadings (.5); circulate to C.
Ceresa, K&E team re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 386 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050104448
48520-21
8
Date
Name
Hours Description
07/12/24 Tiffani Chanroo
4.20 Review, revise first day reporting summary
(3.9); conference with K. Chiaghana re same
(.3).
07/12/24 Kenny Chiaghana
2.20 Analyze, revise summary of obligations re
final orders (2.1); conference with T. Chanroo
re same (.1).
07/12/24 Sabrina Lieberman
0.20 Review, analyze correspondence from C.
Ceresa and K&E team re work in process.
07/12/24 Tanzila Zomo
0.30 Compile recently filed pleadings (.2);
circulate to C. Ceresa, K&E team re same
(.1).
07/13/24 Tiffani Chanroo
1.50 Review, revise first day reporting summary.
07/14/24 Tiffani Chanroo
1.70 Review, revise first day reporting summary.
07/15/24 Tiffani Chanroo
0.40 Review, revise first day reporting summary.
07/15/24 Kenny Chiaghana
1.50 Analyze, revise summary of case key dates
and deadlines.
07/15/24 Julia R. Foster
0.30 Correspond with Cole Schotz re filings.
07/15/24 Sabrina Lieberman
0.40 Review, revise work in process summary (.2);
review, analyze correspondence from C.
Ceresa and K&E team re same (.2).
07/15/24 Noah Shier
0.50 Correspond with Y. Salloum, K&E team re
work in process.
07/15/24 Tanzila Zomo
0.30 Compile recently filed pleadings (.2);
coordinate with J. Foster, K&E team re same
(.1).
07/16/24 Chris Ceresa
0.60 Conference with T. Chanroo, K&E team re
work in process.
07/16/24 Kenny Chiaghana
2.00 Analyze, revise summary of obligations re
first, second day orders (1.0); conference with
K&E team, S. Lieberman re work in process
(.3); analyze, revise summary of work in
process (.7).
07/16/24 Amy Donahue
0.40 Conference with C. Ceresa, K&E team re
work in process.
07/16/24 Julia R. Foster
0.60 Conference with C. Ceresa, K&E team
conference meeting re work in process.
07/16/24 Sabrina Lieberman
0.80 Conference with C. Ceresa, K&E team re
work in process (.4); review, analyze
correspondence from C. Ceresa and K&E
team re same (.4).
07/16/24 Sarah Osborne
0.50 Telephone conference with C. Ceresa, K&E
team re case updates.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 387 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050104448
48520-21
9
Date
Name
Hours Description
07/16/24 Joshua Raphael
0.20 Telephone conference with C. Ceresa, K&E
team re work in process.
07/16/24 Adrian Salmen
0.50 Conference with C. Ceresa, K&E team re
work in process.
07/16/24 Quin Wetzel
3.20 Review, analyze monthly, quarterly reporting
requirements (1.8); draft summary re same
(.7); correspond with C. Ceresa, K. Chiaghana
re same (.3); telephone conference with C.
Ceresa, K&E team re critical workstreams
(.4).
07/16/24 Tanzila Zomo
0.50 Telephone conference with J. Foster, K&E
team re case status updates.
07/17/24 Kenny Chiaghana
0.90 Analyze, revise summary of work in process
and case key dates and deadlines.
07/17/24 David Hackel
0.50 Review, analyze issues re reporting and
disclosure obligations (.3); review, analyze
issues re case update, workstream issues (.2).
07/17/24 Sabrina Lieberman
0.40 Review, revise, work in process summary
(.2); review, analyze correspondence from C.
Ceresa, K&E team re same (.2).
07/17/24 Sarah Osborne
0.30 Review, revise work in process summary (.2);
correspond with K. Chiaghana re same (.1).
07/17/24 Tanzila Zomo
0.40 Compile recently filed pleadings (.3);
circulate to C. Ceresa, K&E team re same
(.1).
07/18/24 Kenny Chiaghana
0.30 Analyze, revise summary of work in process.
07/18/24 Sion Davies
0.20 Correspond with K. Asimacopoulos re foreign
filing analysis.
07/18/24 David Hackel
0.80 Review, analyze issues re case management
and case status, workstream issues (.3);
review, analyze correspondence from C.
Ceresa, K&E team re same (.4); correspond
with C. Ceresa, K&E team re same (.1).
07/18/24 Sabrina Lieberman
0.10 Review, analyze correspondence from C.
Ceresa and K&E team re work in process.
07/19/24 Kenny Chiaghana
0.40 Analyze, revise summary of case key dates
and deadlines.
07/19/24 David Hackel
0.20 Review, analyze issues re case management,
case status, workstream issues.
07/19/24 Tanzila Zomo
0.40 Compile recently filed pleadings (.3);
circulate to C. Ceresa, K&E team re same
(.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 388 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050104448
48520-21
10
Date
Name
Hours Description
07/21/24 Quin Wetzel
0.40 Review, analyze monthly operating report
supplements (.3); correspond with
AlixPartners re same (.1).
07/22/24 Kenny Chiaghana
0.70 Analyze, revise summaries re work in process
and case key dates and deadlines.
07/22/24 David Hackel
0.20 Review, analyze issues re case management
and case status, workstream issues (.1);
correspond with S. Sanders re same (.1).
07/22/24 Sabrina Lieberman
0.20 Correspond with K. Chiaghana re work in
process.
07/22/24 Quin Wetzel
2.90 Review, revise monthly operating reports
(2.6); correspond with AlixPartners, Omni re
same (.3).
07/23/24 Kenny Chiaghana
0.20 Analyze, revise summary of work in process.
07/23/24 Partha Kar
0.50 Conference with local counsel re international
issues.
07/23/24 Sabrina Lieberman
0.10 Review, revise work in process summary.
07/23/24 Tanzila Zomo
1.10 Compile recently filed pleadings (1.0);
circulate to J. Foster, K&E team re same (.1).
07/24/24 Jaina Desai
0.20 Revise work in process summary (.1);
correspond with K. Chiaghana re same (.1).
07/24/24 Jaina Desai
0.30 Telephone conference with C. Ceresa, K&E
team re case status, next steps.
07/24/24 Amy Donahue
0.20 Conference with K&E team re work in
process.
07/24/24 Julia R. Foster
0.30 Conference with C. Ceresa, K&E team re
work in process.
07/24/24 David Hackel
0.20 Conference with C. Ceresa, K&E team re case
status, next steps.
07/24/24 Sabrina Lieberman
0.30 Conference with C. Ceresa, K&E team re
work in process.
07/24/24 Sarah Osborne
0.40 Telephone conference with C. Ceresa, K&E
team re case updates.
07/24/24 Joshua Raphael
0.10 Telephone conference with C. Ceresa, K&E
team re work in process.
07/24/24 Kyle Nolan Trevett
0.30 Telephone conference with C. Ceresa, K&E
team re work in process.
07/24/24 Tanzila Zomo
1.40 Telephone conference with J. Foster, K&E
team re case status updates (.5); compile
recently filed pleadings (.8); circulate same
(.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 389 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050104448
48520-21
11
Date
Name
Hours Description
07/25/24 Evangelia Podaras
1.20 Participate in telephone conference re PTO
(1.0); correspondence re same (.2).
07/26/24 Sabrina Lieberman
0.20 Conference with C. Ceresa re work in
process.
07/26/24 Jai Mudhar
0.30 Conference with A. Chan re local counsel
workstreams.
07/26/24 Evangelia Podaras
0.40 Telephone conference with client re
employment matters (.3); correspondence re
same (.1).
07/27/24 Sion Davies
0.20 Correspond with P. Kar, K&E team re
international filing analysis.
07/28/24 Tanzila Zomo
0.20 Compile recently filed pleadings.
07/29/24 Kenny Chiaghana
0.20 Analyze, revise summary of work in process.
07/29/24 Sabrina Lieberman
0.10 Review revise summary re work in process.
07/29/24 Tanzila Zomo
0.40 Compile recently filed pleadings (.3);
circulate to C. Ceresa, K&E team re same
(.1).
07/30/24 Sarah Osborne
0.20 Review, revise work in process summary.
07/30/24 Tanzila Zomo
0.30 Compile recently filed pleadings, circulate to
C. Ceresa, K&E team.
07/31/24 Kenny Chiaghana
0.20 Analyze, revise summary re work in process,
key dates and deadlines.
07/31/24 Julia R. Foster
0.30 Compile recently filed pleadings.
07/31/24 Jai Mudhar
0.40 Correspond with local counsel re work in
process.
Total
139.10
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 390 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104449
Client Matter: 48520-22
In the Matter of Retention - K&E
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 113,840.00
Total legal services rendered
$ 113,840.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 391 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050104449
48520-22
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
1.70
1,395.00
2,371.50
Michael Y. Chan
5.50
395.00
2,172.50
Kenny Chiaghana
1.10
975.00
1,072.50
Tabitha J. De Paulo
0.50
1,435.00
717.50
Jaina Desai
4.60
975.00
4,485.00
Julia R. Foster
1.50
525.00
787.50
Susan D. Golden
1.00
1,600.00
1,600.00
Sabrina Lieberman
34.70
975.00
33,832.50
Rebecca J. Marston
19.70
1,345.00
26,496.50
Mark McKane, P.C.
1.10
2,065.00
2,271.50
Eric Nyberg
15.50
340.00
5,270.00
Sarah Osborne
4.10
975.00
3,997.50
Joshua Raphael
5.00
1,095.00
5,475.00
Yusuf Salloum
2.80
1,595.00
4,466.00
Adrian Salmen
1.40
1,265.00
1,771.00
Seth Sanders
1.20
1,265.00
1,518.00
Josh Sussberg, P.C.
0.80
2,305.00
1,844.00
Quin Wetzel
3.80
975.00
3,705.00
Spencer A. Winters, P.C.
5.40
1,685.00
9,099.00
Tanzila Zomo
2.50
355.00
887.50
TOTALS
113.90
$ 113,840.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 392 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050104449
48520-22
3
Description of Legal Services
Date
Name
Hours Description
07/01/24 Sabrina Lieberman
0.40 Review, revise budget and staffing
memorandum (.2); correspond with Y.
Salloum, K&E team re conflicts reports (.2).
07/02/24 Tabitha J. De Paulo
0.50 Review and comment on retention
application.
07/02/24 Sabrina Lieberman
0.70 Correspond with Y. Salloum, K&E team re
K&E retention application (.6); review, revise
same (.1).
07/02/24 Rebecca J. Marston
0.70 Correspond and conference with S.
Lieberman, Alix team re parties in interest
list.
07/02/24 Mark McKane, P.C.
0.70 Review K&E application and disclosures (.4);
conference with S. Winters, Y. Salloum re
same (.3).
07/02/24 Eric Nyberg
2.00 Prepare conflicts searching for
creditors/entities, updating lists (1.0); analyze
disclosure of creditors/entities (1.0).
07/02/24 Josh Sussberg, P.C.
0.10 Correspond with Y. Salloum re retention
application issues.
07/03/24 Sabrina Lieberman
0.20 Correspond with C. Ceresa, K&E team re
conflicts reports issues.
07/03/24 Eric Nyberg
2.00 Prepare conflicts searching for
creditors/entities.
07/04/24 Sabrina Lieberman
0.30 Correspond with R. Marston re invoice
review.
07/05/24 Jaina Desai
0.60 Review, analyze, revise K&E fee statement
for privilege and confidentiality.
07/05/24 Sabrina Lieberman
1.30 Review, revise K&E fee statement for
privilege, accuracy (.4); correspond with C.
Ceresa, K&E team re same (.9).
07/06/24 Sabrina Lieberman
0.20 Correspond with R. Marston re K&E
retention schedule.
07/07/24 Sabrina Lieberman
1.10 Review, revise K&E retention application.
07/07/24 Mark McKane, P.C.
0.40 Review and propose revisions to draft K&E
retention declaration.
07/07/24 Yusuf Salloum
0.50 Review, revise K&E retention app.
07/07/24 Josh Sussberg, P.C.
0.70 Review, revise K&E retention application
disclosures (.5); correspond with Y. Salloum
re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 393 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050104449
48520-22
4
Date
Name
Hours Description
07/07/24 Quin Wetzel
1.10 Review, analyze K&E fee statement re
privilege, confidentiality and accuracy.
07/07/24 Spencer A. Winters, P.C.
0.40 Review and analyze issues re K&E fee
application.
07/08/24 Michael Y. Chan
2.50 Draft schedule 2 for K&E retention
declaration.
07/08/24 Sabrina Lieberman
5.00 Conference with Y. Salloum and C. Ceresa re
K&E retention application issues (.1); review
and revise same (3.7); correspond with Y.
Salloum and K&E team re same (1.0);
conference with M. Chan re same (.2).
07/08/24 Eric Nyberg
3.50 Draft schedules 1 and 2 for K&E retention
declaration.
07/08/24 Yusuf Salloum
1.50 Finalize K&E retention application.
07/09/24 Michael Y. Chan
3.00 Draft schedules 1 and 2 for K&E retention
declaration (1.4); review, analyze disclosure
of creditors/entities (1.6).
07/09/24 Jaina Desai
4.00 Review, revise K&E fee statement re
privilege and confidentiality considerations.
07/09/24 Sabrina Lieberman
2.20 Review, revise K&E retention application
(.3); conference with Y. Salloum and K&E
team re same (.7); correspond with Y.
Salloum and K&E team re same (1.2).
07/09/24 Eric Nyberg
3.00 Draft schedules 1 and 2 for declaration ISO
K&E retention (1.5); review,
analyze disclosure of creditors/entities (1.5).
07/09/24 Sarah Osborne
4.10 Review, analyze K&E fee statement for
privilege and confidentiality considerations.
07/09/24 Quin Wetzel
0.50 Review, analyze K&E fee statement re
privilege, confidentiality.
07/10/24 Kenny Chiaghana
1.10 Review, revise K&E fee statement re
privilege and confidentiality considerations.
07/10/24 Sabrina Lieberman
0.70 Review, revise K&E retention summary.
07/10/24 Rebecca J. Marston
0.40 Correspond with S. Lieberman, C. Ceresa re
K&E retention work stream.
07/10/24 Joshua Raphael
2.50 Review, revise K&E fee statement re
privilege and confidentiality.
07/11/24 Sabrina Lieberman
0.10 Correspond with R. Marston and K&E team
re K&E retention schedule.
07/11/24 Joshua Raphael
0.20 Review, analyze K&E fee statement re
privilege and confidentiality.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 394 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050104449
48520-22
5
Date
Name
Hours Description
07/12/24 Sabrina Lieberman
0.20 Correspond with R. Marston and K&E team
re K&E fee statement review.
07/12/24 Joshua Raphael
2.30 Review, analyze K&E fee statement re
privilege, confidentiality.
07/13/24 Tanzila Zomo
2.00 Draft monthly K&E fee statement (1.8);
correspond with R. Marston re same (.2).
07/15/24 Julia R. Foster
0.60 Research precedent re declaration ISO K&E
retention.
07/15/24 Sabrina Lieberman
0.80 Correspond with C. Ceresa and K&E team re
supplemental declaration in support of K&E
retention application.
07/15/24 Rebecca J. Marston
0.20 Correspond with S. Lieberman re
supplemental declaration.
07/15/24 Eric Nyberg
1.00 Prepare conflicts searching for creditors
entities.
07/16/24 Chris Ceresa
0.50 Review, analyze issues re K&E retention
application (.3); correspond with S.
Lieberman and K&E team re same (.2).
07/16/24 Julia R. Foster
0.60 Research precedent re K&E retention orders.
07/16/24 Sabrina Lieberman
5.20 Revise unredacted K&E retention application
(.2); correspond with Y. Salloum and K&E
team re U.S. Trustee questions re K&E
retention application (1.5); draft responses re
same (.3); correspond with PJT re same (.1);
review, revise parties‑in‑interest list (2.5);
revise June monthly K&E fee statement (.6).
07/16/24 Rebecca J. Marston
6.90 Correspond with K&E team re U.S. Trustee
responses to retention application (3.9);
research issues re same (3.0).
07/16/24 Yusuf Salloum
0.80 Analyze issues re K&E retention application.
07/16/24 Quin Wetzel
2.20 Research precedent retention language (2.0);
correspond with R. Marston, S. Lieberman re
same (.2).
07/16/24 Spencer A. Winters, P.C.
0.80 Review and analyze U.S. Trustee questions re
K&E retention.
07/17/24 Susan D. Golden
0.70 Review U.S. Trustee comments to K&E
retention application (.3); correspond with S.
Winters, K&E team re responses to same (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 395 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050104449
48520-22
6
Date
Name
Hours Description
07/17/24 Sabrina Lieberman
2.90 Conference with R. Marston re K&E retention
work in process (.1); correspond with S.
Winters, K&E team re responses to U.S.
Trustee comments to K&E retention
application (1.3); draft same (1.3); correspond
with C. Ceresa and R. Marston re
supplemental disclosures (.2).
07/17/24 Adrian Salmen
1.40 Review, revise K&E fee statement.
07/17/24 Spencer A. Winters, P.C.
1.80 Review and revise responses to U.S. Trustee
questions (.7); research re same (.6);
correspond and telephone conferences with C.
Ceresa and K&E team re same (.5).
07/18/24 Chris Ceresa
0.40 Review, analyze issues re K&E retention
application (.2); correspond with S. Winters
and K&E team re same (.2).
07/18/24 Julia R. Foster
0.30 Review and revise K&E retention order.
07/18/24 Susan D. Golden
0.30 Correspond with S. Lieberman re response to
U.S. Trustee questions to K&E retention
declaration.
07/18/24 Sabrina Lieberman
2.50 Review, revise responses to U.S. Trustee re
K&E retention application (1.2); correspond
with S. Winters, K&E team re responses to
U.S. Trustee re K&E retention application
(1.1); correspond with C. Ceresa and K&E
team re K&E fee statement review (.2).
07/19/24 Sabrina Lieberman
0.60 Correspond with R. Marston, K&E team re
K&E fee statement review (.1); correspond
with S. Winters, K&E team re responses to
U.S. Trustee comments to K&E retention
application (.5).
07/19/24 Spencer A. Winters, P.C.
0.80 Review and revise responses to U.S. Trustee
re K&E retention.
07/20/24 Sabrina Lieberman
0.40 Review, revise K&E monthly fee statement
(.3); draft supplemental declaration in support
of K&E retention (.1).
07/20/24 Sabrina Lieberman
0.10 Correspond with R. Marston re K&E
engagement items.
07/21/24 Sabrina Lieberman
0.30 Correspond with C. Ceresa, K&E team re
K&E fee statement review.
07/22/24 Sabrina Lieberman
1.40 Draft supplemental declaration in support of
K&E retention (.7); correspond with R.
Marston and K&E team re same (.7).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 396 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050104449
48520-22
7
Date
Name
Hours Description
07/22/24 Rebecca J. Marston
5.60 Review and revise invoices for confidentiality
and privilege (2.0); correspond with C.
Ceresa, K&E team re same (.2); correspond
with C. Ceresa, K&E team re U.S. Trustee
comments to K&E retention application (3.4).
07/22/24 Seth Sanders
1.20 Review, revise invoice for privilege and
confidentiality.
07/22/24 Spencer A. Winters, P.C.
0.50 Review and analyze issues re K&E retention.
07/22/24 Tanzila Zomo
0.50 Draft shell re retention declaration.
07/23/24 Sabrina Lieberman
0.70 Revise supplemental declaration in support of
K&E retention (.2); correspond with Y.
Salloum, K&E team re same (.3); conference
with R. Marston re same (.2).
07/23/24 Rebecca J. Marston
2.80 Correspond with C. Ceresa, K&E team re
U.S. Trustee comments to retention
application (1.8); review, analyze precedent re
same (1.0).
07/23/24 Eric Nyberg
4.00 Prepare conflicts searching for creditors
entities (1.5); research re creditors entities
(.5); analyze disclosure of creditors, entities
(.5); draft schedules 1, 2, and 3 to
supplemental declaration (1.5).
07/24/24 Sabrina Lieberman
1.10 Review, revise supplemental declaration in
support of K&E retention (.3); correspond
with S. Winters, K&E team re same (.8).
07/24/24 Rebecca J. Marston
3.10 Correspond with U.S. Trustee, C. Ceresa,
K&E team re retention application issues
(2.4); review and analyze issues re same (.7).
07/25/24 Sabrina Lieberman
0.40 Correspond with C. Husnick, K&E team re
U.S. Trustee comments to K&E retention
application.
07/26/24 Chris Ceresa
0.30 Analyze legal issues re K&E retention order
(.2); correspond with S. Lieberman, K&E
team re same (.1).
07/26/24 Sabrina Lieberman
0.40 Correspond with C. Husnick, K&E team re
U.S. Trustee comments to K&E retention
application.
07/27/24 Sabrina Lieberman
1.10 Review, revise K&E fee statement for
privilege, accuracy and compliance with U.S.
Trustee guidelines.
07/28/24 Sabrina Lieberman
3.10 Review, revise K&E invoice for privilege,
accuracy (2.8); correspond with R. Marston,
K&E team re same (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 397 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050104449
48520-22
8
Date
Name
Hours Description
07/29/24 Chris Ceresa
0.50 Review, analyze comments to K&E retention
order (.3); correspond with R. Marston and
K&E team re same (.2).
07/29/24 Sabrina Lieberman
1.20 Correspond with C. Ceresa re K&E retention
(.2); review, revise K&E invoice for privilege,
accuracy (1.0).
07/29/24 Spencer A. Winters, P.C.
1.10 Review and analyze issues re K&E retention
(.7); correspond and telephone conferences
with C. Ceresa and multiple parties re same
(.4).
07/30/24 Sabrina Lieberman
0.10 Correspond with Y. Salloum, K&E team re
U.S. Trustee comments to retention
application.
Total
113.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 398 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104450
Client Matter: 48520-23
In the Matter of Retention - Non K&E
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 70,134.00
Total legal services rendered
$ 70,134.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 399 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050104450
48520-23
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
9.20
1,395.00
12,834.00
Julia R. Foster
0.50
525.00
262.50
Susan D. Golden
0.70
1,600.00
1,120.00
Sabrina Lieberman
33.90
975.00
33,052.50
Rebecca J. Marston
17.00
1,345.00
22,865.00
TOTALS
61.30
$ 70,134.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 400 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050104450
48520-23
3
Description of Legal Services
Date
Name
Hours Description
07/02/24 Susan D. Golden
0.40 Conference with C. Ceresa re PJT retention
application.
07/02/24 Sabrina Lieberman
2.20 Conference with AlixPartners re retention
application (.1); correspond with C. Ceresa,
R. Marston re professional retention
applications (.7); correspond with
professionals re same (.6); conference with
PJT, S. Winters, K&E team re same (.4);
review, revise professional retention
applications (.4).
07/03/24 Sabrina Lieberman
0.30 Correspond with professional advisors, C.
Ceresa and K&E team re retention
applications.
07/06/24 Chris Ceresa
0.20 Review, analyze non-K&E retention open
items.
07/06/24 Sabrina Lieberman
1.60 Review, revise professional retention
applications (.8); correspond with C. Ceresa,
R. Marston, PJT re same (.2); correspond with
AlixPartners re retention application (.3);
draft summary of key retention related dates,
deadlines (.3).
07/07/24 Sabrina Lieberman
0.30 Correspond with Company, Y. Salloum, K&E
team re professional retention applications.
07/08/24 Sabrina Lieberman
4.10 Conference with AlixPartners re retention
application (.1); conference with Cole Schotz
re same (.1); review and revise professional
retention applications (2.9); correspond with
professional working group re same (.5);
conference with Reed Smith re ordinary
course professional matter (.3); correspond
with C. Ceresa and K&E team re same (.2).
07/09/24 Chris Ceresa
5.60 Review, analyze, comment on all non‑K&E
retention application documents (1.9);
correspond with S. Lieberman, K&E team re
same (1.1); coordinate filing re same (2.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 401 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050104450
48520-23
4
Date
Name
Hours Description
07/09/24 Sabrina Lieberman
9.20 Conference with Y. Salloum and K&E team
re professional retention application issues
(.7); conference with professionals re
retention applications (1.5); review, revise
professional applications (3.3); correspond
with Y. Salloum, K&E team and
professionals re retention applications (3.7).
07/09/24 Rebecca J. Marston
8.00 Review and revise professional retention
applications (3.9); correspond with
professionals, C. Ceresa, K&E team re same
(.6); further review and revise same (3.5).
07/10/24 Chris Ceresa
0.70 Review, analyze legal issues re OCP
retentions.
07/10/24 Sabrina Lieberman
1.20 Conference with Covington re ordinary
course professional list (.2); conference with
C. Ceresa re same (.2); conference with Cole
Schotz re same (.2); draft revised ordinary
course professional notice and exhibits (.5);
correspond with C. Ceresa, R. Marston re
same (.1).
07/10/24 Rebecca J. Marston
0.30 Correspond with S. Lieberman re revised
OCP list.
07/11/24 Sabrina Lieberman
0.80 Correspond with Linklaters, Covington, Reed
Smith, Company, C. Ceresa, K&E team re
ordinary course professional issues (.5);
research precedent re same (.3).
07/12/24 Susan D. Golden
0.30 Correspond with S. Lieberman, C. Ceresa re
OCP declarations.
07/12/24 Sabrina Lieberman
0.40 Correspond with Linklaters re ordinary course
professional declaration of disinterestedness
(.1); correspond with R. Marston and K&E
team re same (.3).
07/15/24 Sabrina Lieberman
0.30 Conference with R. Marston, Linklaters re
ordinary course professional declaration (.2);
correspond with R. Marston and Covington &
Burling re parties‑in‑interest list (.1).
07/15/24 Rebecca J. Marston
0.60 Correspond with S. Lieberman re OCPs, PII
list (.4); prepare for and participate in
telephone conference with OCP re declaration
of disinterestedness (.2).
07/17/24 Chris Ceresa
0.50 Review, analyze issues re retention for non-
K&E professionals.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 402 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050104450
48520-23
5
Date
Name
Hours Description
07/17/24 Sabrina Lieberman
1.70 Revise redacted non‑K&E retention
applications (1.0); correspond with
AlixPartners, PJT and Cole Schotz re same
(.7).
07/18/24 Chris Ceresa
0.40 Review, analyze legal issues re retention for
non-K&E professionals (.3); correspond with
S. Lieberman re same (.1).
07/18/24 Julia R. Foster
0.50 Review and revise AP Services, PJT, Omni
327 and BDO retention orders.
07/18/24 Sabrina Lieberman
1.20 Conference with AlixPartners re U.S. Trustee
comments to AlixPartners retention
application (.1); correspond with non‑K&E
professionals re U.S. Trustee comments to
non‑K&E professional retention applications;
(.7); draft correspondence to U.S. Trustee re
same (.4).
07/20/24 Sabrina Lieberman
0.40 Correspond with C. Ceresa and R. Marston re
legal issues re ordinary course professional
declarations of disinterestedness.
07/21/24 Sabrina Lieberman
0.30 Correspond with AlixPartners, C. Ceresa, R.
Marston re AlixPartners responses to U.S.
Trustee comments to AlixPartners retention
application.
07/22/24 Chris Ceresa
0.80 Review, analyze legal issues re non-K&E
retention matters (.4); correspond with S.
Lieberman and K&E team re same (.4).
07/22/24 Sabrina Lieberman
1.60 Conference with AlixPartners re U.S. Trustee
comments to AlixPartners retention
application (.2); correspond with AlixPartners
re supplemental disclosures (.2); correspond
with ordinary course professionals re
declarations of disinterestedness (.3);
correspond with advisors re parties‑in‑interest
lists (.1); correspond with PJT, C. Ceresa, and
K&E team re PJT responses to U.S. Trustee
comments to PJT retention application (.3);
correspond with BDO re U.S. Trustee
comments to BDO retention application (.2);
correspond with Omni re revised order
authorizing Omni retention as administrative
agent (.1); review and revise same (.2).
07/22/24 Rebecca J. Marston
2.70 Correspond with S. Lieberman re non‑K&E
retention applications (2.1); review and revise
same (.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 403 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050104450
48520-23
6
Date
Name
Hours Description
07/23/24 Chris Ceresa
0.50 Review, analyze legal issues re non-K&E
retention matters (.3); correspond with R.
Marston and K&E team re same (.2).
07/23/24 Sabrina Lieberman
1.80 Correspond with professionals re U.S. Trustee
comments to retention applications (.8);
review, revise order authorizing PJT retention
(.3); correspond with ordinary course
professionals (.3); conference with R.
Marston re same (.2); conference with C.
Ceresa re same (.2).
07/23/24 Rebecca J. Marston
3.60 Correspond with U.S. Trustee, C. Ceresa and
K&E team re retention application issues
(1.7); review and analyze legal issues re same
(1.9).
07/24/24 Sabrina Lieberman
1.50 Conference with professionals re responses to
U.S. Trustee comments (.5); review, revise
order authorizing PJT retention (.3); review,
revise ordinary course professional
declarations of disinterestedness (.4);
correspond with C. Ceresa, R. Marston,
Company re same (.3).
07/25/24 Sabrina Lieberman
1.40 Conference with PJT re retention application
(.1); review and revise same (.3); conference
with R. Marston re same (.1); conference with
AlixPartners re AlixPartners retention
application (.1); review, analyze same (.2);
correspond with Cole Schotz re same (.3);
correspond with Covington re retention issue
(.1); correspond with BDO re retention
application (.2).
07/26/24 Chris Ceresa
0.50 Review, analyze legal issues re non-K&E
retention matters (.3); correspond with S.
Liberman and K&E team re same (.2).
07/26/24 Sabrina Lieberman
2.30 Review, revise Omni and PJT retention orders
(.8); correspond with C. Ceresa, K&E team,
Cole Schotz re same (.5); correspond with
AlixPartners re retention application (.1);
conference with AlixPartners re same (.2);
review and revise same (.4); conference with
Cole Schotz re all professional retention
applications (.2); correspond with BDO re
U.S. Trustee comments to BDO retention
application (.1).
07/27/24 Sabrina Lieberman
0.20 Correspond with AlixPartners re issues re
filed retention documents.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 404 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050104450
48520-23
7
Date
Name
Hours Description
07/28/24 Sabrina Lieberman
0.20 Correspond with Covington re
parties‑in‑interest list.
07/29/24 Sabrina Lieberman
0.10 Conference with ordinary course professional
re declaration of disinterestedness.
07/30/24 Sabrina Lieberman
0.40 Correspond with R. Marston, ordinary course
professionals re declarations of
disinterestedness.
07/30/24 Rebecca J. Marston
1.80 Correspond and conference with S.
Lieberman re OCP, retention matters (.6);
review and revise OCP declarations (1.2).
07/31/24 Sabrina Lieberman
0.40 Correspond with ordinary course
professionals re declarations of
disinterestedness (.1); correspond with R.
Marston re same (.1); review, revise same
(.2).
Total
61.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 405 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104451
Client Matter: 48520-24
In the Matter of Vendor Matters
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 35,625.50
Total legal services rendered
$ 35,625.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 406 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Vendor Matters
Invoice Number:
Matter Number:
1050104451
48520-24
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
0.90
1,395.00
1,255.50
Tiffani Chanroo
6.70
1,345.00
9,011.50
Sabrina Lieberman
15.50
975.00
15,112.50
Sarah Osborne
4.80
975.00
4,680.00
Adrian Salmen
4.40
1,265.00
5,566.00
TOTALS
32.30
$ 35,625.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 407 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Vendor Matters
Invoice Number:
Matter Number:
1050104451
48520-24
3
Description of Legal Services
Date
Name
Hours Description
07/01/24 Tiffani Chanroo
1.80 Correspond with S. Lieberman, K&E team re
vendor issues (1.1); review, analyze legal
issues re same (.7).
07/01/24 Sabrina Lieberman
0.80 Conference with counsel to vendor,
AlixPartners and T. Chanroo re vendor issue
(.1); correspond with T. Chanroo and
AlixPartners re same (.4); review and revise
summary re same (.3).
07/02/24 Tiffani Chanroo
2.50 Correspond with S. Lieberman re vendor
issues (.4); review, analyze issues re same
(.6); conferences with S. Lieberman, vendors
re various issues (1.5).
07/02/24 Sabrina Lieberman
2.40 Conference with T. Chanroo, AlixPartners re
open vendor issues (1.0); conference with T.
Chanroo re same (.1); review and revise
summary re same (.6); conference with
vendors, T. Chanroo re same (.7).
07/03/24 Sabrina Lieberman
0.40 Conference with T. Chanroo, AlixPartners,
vendor counsel re outstanding vendor matters
(.3); review, revise summary re same (.1).
07/05/24 Sabrina Lieberman
0.10 Revise vendor summary.
07/06/24 Sabrina Lieberman
0.20 Review, revise critical vendor form
agreement.
07/08/24 Sabrina Lieberman
0.50 Correspond with vendors re inquiries (.2);
revise summary re same (.1); review, revise
trade agreement (.2).
07/09/24 Adrian Salmen
0.20 Conference with T. Chanroo re vendor
workstream.
07/10/24 Tiffani Chanroo
1.20 Correspond with S. Lieberman re vendor
status (.4); conferences with S. Lieberman,
K&E team re same (.8).
07/10/24 Sabrina Lieberman
2.40 Conference with vendor counsel re vendor
matter (.3); conference with C. Ceresa, K&E
team re same (.7); review, revise vendor
summary (.5); review, analyze
correspondence from Cole Schotz re same
(.2); correspond with AlixPartners re same
(.2); conference with T. Chanroo re same (.5).
07/10/24 Adrian Salmen
1.00 Conference with T. Chanroo, K&E team re
vendor workstream.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 408 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Vendor Matters
Invoice Number:
Matter Number:
1050104451
48520-24
4
Date
Name
Hours Description
07/11/24 Tiffani Chanroo
0.90 Conference with S. Lieberman, K&E team,
Alix team re vendor status (.5); conference
with K&L Gates re vendor matters (.4).
07/11/24 Sabrina Lieberman
1.10 Conference with T. Chanroo and AlixPartners
re outstanding vendor issues (.5); conference
with vendor counsel re same (.2); correspond
with vendor counsel re same (.4).
07/11/24 Adrian Salmen
0.50 Conference with T. Chanroo, K&E team, Alix
re vendor issues.
07/12/24 Sabrina Lieberman
0.40 Conference with vendor re Company assets
(.1); review, revise vendor summary (.2);
correspond with Y. Salloum, K&E Team
AlixPartners re same (.1).
07/15/24 Tiffani Chanroo
0.30 Review, analyze vendor agreement (.2);
correspond with S. Lieberman re same (.1).
07/15/24 Sabrina Lieberman
1.10 Correspond with vendors, C. Ceresa, K&E
team, AlixPartners re outstanding vendor
issues.
07/15/24 Adrian Salmen
0.20 Correspond with S. Lieberman re vendor
outreach.
07/16/24 Sabrina Lieberman
1.00 Conference with vendor counsel re
outstanding vendor matters (.8); correspond
with AlixPartners, K&E team re same (.2).
07/16/24 Adrian Salmen
1.00 Conference with S. Lieberman, vendor
counsel re vendor issues (.8); correspond with
S. Lieberman re same (.2).
07/17/24 Chris Ceresa
0.50 Review, analyze legal issues re vendor
matters (.1); conference with S. Lieberman
and K&E team re same (.4).
07/17/24 Sabrina Lieberman
1.30 Conference with A. Salmen, AlixPartners re
open vendor issues (.2); conference with C.
Ceresa, A. Salmen re same (.7); review, revise
summary re same (.3); correspond with
AlixPartners re same (.1).
07/17/24 Adrian Salmen
0.70 Conference with S. Lieberman, K&E, Alix
teams re vendor issues.
07/18/24 Chris Ceresa
0.40 Review, analyze legal issues re vendor
matters.
07/18/24 Sabrina Lieberman
0.70 Conference with AlixPartners, A. Salmen re
open vendor matters (.2); conference with C.
Ceresa re same (.2); review summary re same
(.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 409 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Vendor Matters
Invoice Number:
Matter Number:
1050104451
48520-24
5
Date
Name
Hours Description
07/18/24 Adrian Salmen
0.40 Conference with S. Lieberman, Alix team re
vendor workstream.
07/19/24 Sabrina Lieberman
0.10 Correspond with vendor counsel re open
vendor issue.
07/23/24 Sabrina Lieberman
0.60 Conference with R. Marston, K&E team,
AlixPartners re open vendor issues (.4);
conference with C. Ceresa re same (.2).
07/23/24 Adrian Salmen
0.20 Conference with S. Lieberman, K&E team,
Alix re vendor issues.
07/24/24 Sabrina Lieberman
0.40 Conference with C. Ceresa, AlixPartners re
open vendor matter (.3); revise summary re
same (.1).
07/25/24 Sabrina Lieberman
1.30 Conference with R. Marston, J. Desai,
AlixPartners re open vendor questions (.5);
conference with vendor re same (.1);
correspond with vendor counsel re same (.2);
review, revise summary re same (.5).
07/26/24 Sabrina Lieberman
0.30 Conference with vendor counsel re open
vendor matter (.2); review, revise summary re
same (.1).
07/26/24 Sarah Osborne
1.60 Correspond with C. Ceresa re demand letter
for payment (.3); research demand letters re
same (1.3).
07/27/24 Sarah Osborne
3.20 Draft demand letter to MSA counterparty.
07/30/24 Sabrina Lieberman
0.40 Conference with A. Salmen, J. Desai,
AlixPartners re open vendor issues.
07/30/24 Adrian Salmen
0.20 Conference with S. Lieberman, K&E team,
Alix re vendor issues.
Total
32.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 410 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104452
Client Matter: 48520-25
In the Matter of Litigation
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 170,730.50
Total legal services rendered
$ 170,730.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 411 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050104452
48520-25
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Stephanie Choi
51.00
355.00
18,105.00
Tabitha J. De Paulo
14.70
1,435.00
21,094.50
Sarah Kimmer
2.00
1,365.00
2,730.00
Angela Leonard
15.20
625.00
9,500.00
Alisa Melekhina
29.70
1,595.00
47,371.50
Noah Spector
60.70
1,185.00
71,929.50
TOTALS
173.30
$ 170,730.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 412 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050104452
48520-25
3
Description of Legal Services
Date
Name
Hours Description
07/01/24 Noah Spector
5.00 Analyze documents of interest for privileged
documents (3.9); further analyze same (.7);
research re same (.4).
07/02/24 Noah Spector
2.30 Analyze documents for privileged material.
07/03/24 Tabitha J. De Paulo
4.80 Review and revise redactions to board
documents (3.9); further review and analyze
same (.5); telephone conference with Cole
Schotz re board minute redactions (.2); revise
redactions and correspondence re same (.2).
07/03/24 Alisa Melekhina
0.80 Strategy telephone conference with T. De
Paulo re discovery work streams and
production staging (.5); strategize re
production process and conference re same
with Litigation Practice Technology team (.3).
07/03/24 Noah Spector
0.70 Analyze documents of interest for privileged
information.
07/07/24 Tabitha J. De Paulo
0.30 Draft, revise hearing preparation outline.
07/08/24 Tabitha J. De Paulo
3.70 Draft, revise M. Schlappig direct examination
outline and prepare for witness preparation
session (1.1); attend witness preparation
session with M. Schlappig (.8); draft, revise
direct examination outline for C. Braley in
support of DIP motion and bid procedures
(1.1); prepare for witness preparation session
with C. Braley (.5); attend witness preparation
session with C. Braley (.2).
07/08/24 Alisa Melekhina
5.20 Review and comment on draft protective
order and notice of entry (3.7); draft summary
re same (.8); conference with T. De Paulo re
same (.4); review federal bankruptcy and civil
rules re protective orders and discovery (.3).
07/08/24 Noah Spector
1.00 Conference with T. De Paulo, witnesses re
witness preparation.
07/09/24 Noah Spector
1.20 Analyze documents of interest for privileged
information.
07/10/24 Tabitha J. De Paulo
0.30 Revise draft protective order.
07/10/24 Alisa Melekhina
0.20 Conference re eDiscovery strategy and review
and production work flows with T. De Paulo
and K&E team.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 413 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050104452
48520-25
4
Date
Name
Hours Description
07/10/24 Noah Spector
4.80 Analyze documents of interest for privileged
information (3.9); further analyze same (.3);
research case law re attorney‑client privilege
(.6).
07/11/24 Noah Spector
4.60 Analyze documents of interest for privileged
information.
07/12/24 Stephanie Choi
7.80 Redact and prepare documents in preparation
for production (3.9); further review, analyze
same (1.1); review, analyze additional
meeting minutes (2.8).
07/13/24 Stephanie Choi
1.70 Redact and prepare newly added documents
in preparation for production (1.0); review,
analyze documents re same (.7).
07/15/24 Stephanie Choi
6.00 Redact documents in preparation for
production (3.9); further redact same (1.1);
review and analyze documents re same (1.0).
07/15/24 Angela Leonard
2.00 Review and analyze Board of Directors
documents (.8); prepare redactions re same
for attorney review (1.2).
07/15/24 Noah Spector
2.90 Analyze documents of interest for privileged
information (2.6); conference with T. De
Paulo, K&E team re same (.3).
07/16/24 Stephanie Choi
5.50 Review, redact and protect additional
documents re committee meetings (3.9);
further review, redact same (1.1); correspond
with T. De Paulo, K&E team re same (.5).
07/16/24 Noah Spector
2.60 Analyze documents of interest for privileged
information (2.0); conference with T. De
Paulo and A. Melekhina re same (.6).
07/17/24 Noah Spector
3.80 Analyze documents of interest for privileged
information (2.6); conference with co‑counsel
re same (.4); conference with U.S. Trustee
(.8).
07/18/24 Tabitha J. De Paulo
0.30 Correspond with A. Melekhina, K&E team re
responses to Company requests.
07/18/24 Sarah Kimmer
2.00 Analyze UCC documents requests (.7); draft
proposed response strategy (.8); conference
with S. Sanders re same (.5).
07/18/24 Angela Leonard
2.00 Review and analyze board of directors
documents (1.0); prepare redactions re same
for attorney review (1.0).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 414 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050104452
48520-25
5
Date
Name
Hours Description
07/18/24 Alisa Melekhina
1.40 Review, analyze privilege designations and
redactions to board of directors meeting
minutes and documents (.4); finalize and
instruct re productions of same (.3);
conference re same with T. De Paulo, N.
Spector, A. Leonard and Cole Schotz (.7).
07/18/24 Noah Spector
4.80 Analyze documents of interest for privileged
information (3.9); conference with K&E team
re same (.4); research re scope of
attorney‑client privilege (.5).
07/19/24 Stephanie Choi
4.50 Draft discovery summary containing Board
documents (3.0); prepare documents for
attorney review (1.5).
07/19/24 Stephanie Choi
3.00 Review, revise redactions to newly edited
board meeting minutes (2.4); correspond with
N. Spector, K&E team re same (.2); review,
revise working folder (.4).
07/19/24 Tabitha J. De Paulo
1.00 Conference with Cole Schotz team re
discovery and privilege issues (.6);
correspond with Cole Schotz re proposed
protective order and discovery issues (.4).
07/19/24 Angela Leonard
2.90 Review and analyze Board of Directors
documents (.9); prepare redactions re same
for attorney review (2.0).
07/19/24 Alisa Melekhina
2.50 Review, analyze privilege designations and
redactions to board of directors
documents(.7), finalize and instruct re
productions of same (.3); advise re same with
T. De Paulo, N. Spector, A. Leonard and Cole
Schotz (.8); review, revise draft Chapter 11
disclosure statement and plan (.5); review,
analyze UCC document requests (.2).
07/19/24 Noah Spector
2.10 Conference with co‑counsel re privilege
review and document requests (.4); review,
analyze documents for production (.6);
analyze documents of interest for privileged
information (1.1).
07/20/24 Stephanie Choi
1.00 Draft discovery summary containing Board
documents and minutes (.6); prepare
documents for attorney review (.4).
07/21/24 Stephanie Choi
2.00 Draft summary re documents reviews in
process.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 415 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050104452
48520-25
6
Date
Name
Hours Description
07/21/24 Angela Leonard
1.50 Review and analyze Board of Directors
documents (.4); prepare redactions re same
for attorney review (1.1).
07/22/24 Stephanie Choi
4.00 Redact newly edited documents in preparation
for production (2.1); review, analyze
redactions (1.1); communicate with T. De
Paulo, K&E team re same (.8).
07/22/24 Angela Leonard
2.60 Review and analyze Board of Directors
documents (1.6); prepare redactions re same
for attorney review (1.0).
07/22/24 Alisa Melekhina
4.80 Review, comment and revise summary of
board redactions and production staging (1.2);
advise re same with T. De Paulo, N. Spector
and paralegal team (.6); review, revise board
minutes redactions and productions (.8);
conference re same with Cole Schotz and N.
Spector (.4); review, analyze MWE draft of
protective order and comments (.9);
summarize and conference re same with T.
De Paulo (.9).
07/22/24 Noah Spector
6.60 Analyze documents of interest for privileged
information (3.9); analyze documents of
interest re same (.2); conference with
co‑counsel, A. Melekhina, K&E team re same
(1.1); revise documents for production (1.4).
07/23/24 Stephanie Choi
2.00 Review, revise file transfer protocol summary
(1.1); conference with T. De Paulo, K&E
team re‑organization of shared network and
file transfer protocol folders (.9).
07/23/24 Tabitha J. De Paulo
1.20 Review and comment on UCC edits to
proposed protective order (.4); revise same for
filing (.3); correspond with A. Melekhina re
same (.2); correspond with A. Melekhina re
discovery issues (.2); review and analyze U.S.
Trustee objection to BDO retention (.1).
07/23/24 Angela Leonard
2.90 Review and analyze Board of Directors
documents (1.2); prepare redactions re same
for attorney review (1.7).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 416 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050104452
48520-25
7
Date
Name
Hours Description
07/23/24 Alisa Melekhina
5.00 Review, comment and revise summary and
file transfer protocol database staging of
board redactions and productions (.8); advise
re same with T. De Paulo, N. Spector and
paralegal team (1.3); revise board minutes and
documents redactions and productions (.7);
conference re same with Cole Schotz and N.
Spector (.5); review, analyze drafts and
updates of protective order and responses and
collections for UCC requests for production
(.9); conference re same with T. De Paulo,
K&E team and Cole Schotz (.8).
07/23/24 Noah Spector
2.80 Analyze documents of interest for privileged
information (1.6); revise documents for
production (1.2).
07/24/24 Stephanie Choi
4.00 Revise redactions for newly edited board
meeting documents (.8); revise additional
board documents within file transfer protocol
(1.0); revise summary to reflect status (.5);
review, revise meeting documents (.8); revise
summary re case status (.2); correspond with
N. Spector, K&E team re same (.7).
07/24/24 Tabitha J. De Paulo
0.30 Review, analyze discovery issues.
07/24/24 Angela Leonard
1.30 Review and analyze Board of Directors
documents (.6); prepare redactions re same
for attorney review (.7).
07/24/24 Noah Spector
3.60 Analyze documents of interest for privileged
information (2.1); conference with S. Choi,
K&E team re same (.6); revise documents for
production (.9).
07/25/24 Stephanie Choi
2.50 Review, revise newly edited board documents
(1.2); correspond with N. Spector, K&E team
re same (.4); update summary to reflect status
(.9).
07/25/24 Noah Spector
1.60 Analyze documents of interest for privileged
information.
07/26/24 Stephanie Choi
3.00 Update summary to reflect status of newly
shared documents (1.6); correspond with A.
Melekhina and K&E team re same (.2);
prepare and redact newly edited board
documents (1.2).
07/26/24 Tabitha J. De Paulo
0.20 Correspond with Cole Schotz re discovery
responses.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 417 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050104452
48520-25
8
Date
Name
Hours Description
07/26/24 Alisa Melekhina
3.40 Review, comment and revise summary and
FTP database staging of board redactions and
productions (.4); advise re same with T. De
Paulo, N. Spector and paralegal team (.4);
revise board minutes and documents
redactions and productions (1.1); conference
re same with Cole Schotz and N. Spector (.9);
review, analyze drafts and updates to
responses and collections for UCC second
requests for production (.6).
07/26/24 Noah Spector
2.60 Analyze documents of interest for privileged
information (1.7); revise documents for
production (.9).
07/28/24 Noah Spector
2.30 Analyze documents of interest for privileged
information.
07/29/24 Stephanie Choi
1.00 Revise board documents and shared portal
(.8); correspond with A. Melekhina, K&E
team re same (.2).
07/29/24 Tabitha J. De Paulo
0.30 Review and respond to correspondence with
Cole Schotz team re discovery issues.
07/29/24 Alisa Melekhina
2.30 Analyze and revise board minutes and
documents redactions and productions (1.1);
conference re same with Cole Schotz and N.
Spector (.9); review, analyze drafts and
updates to responses and collections for UCC
second requests for production (.3).
07/29/24 Noah Spector
1.90 Analyze documents of interest for privileged
information.
07/30/24 Stephanie Choi
1.50 Revise file transfer protocol summary (1.3);
correspond with A. Melekhina, K&E team re
comments and revisions (.2).
07/30/24 Tabitha J. De Paulo
2.20 Review and comment on responses and
objection to UCC discovery responses and
correspondence re same.
07/30/24 Alisa Melekhina
1.30 Review and revise board minutes and
documents redactions and productions (.3);
conference re same with Cole Schotz and N.
Spector (.3); advise re production staging,
finalization, file transfer protocol and
feedback and review with Cole Schotz, N.
Spector and K&E team (.3); review, revise
draft and comments to responses and
objections to UCC document requests (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 418 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050104452
48520-25
9
Date
Name
Hours Description
07/30/24 Noah Spector
2.70 Analyze documents of interest for privileged
information (2.1); review, revise documents
for production (.6).
07/31/24 Stephanie Choi
1.50 Revise documents in file transfer protocol
(.5); review, revise board documents (.9);
revise summary re same (.1).
07/31/24 Tabitha J. De Paulo
0.10 Correspond with A. Melekhina, K&E team re
discovery responses.
07/31/24 Alisa Melekhina
2.80 Review and revise board minutes and
documents redactions and productions (.8);
conference re same with Cole Schotz and N.
Spector (.9); advise re production staging, file
transfer protocol and review with Cole
Schotz, paralegal team and N. Spector (.9);
review, analyze updates to document requests
to lien agents and responses re same (.2).
07/31/24 Noah Spector
0.80 Review, revise documents for production.
Total
173.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 419 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104454
Client Matter: 48520-27
In the Matter of Non-Working Travel
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 5,055.00
Total legal services rendered
$ 5,055.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 420 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Non-Working Travel
Invoice Number:
Matter Number:
1050104454
48520-27
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Spencer A. Winters, P.C.
3.00
1,685.00
5,055.00
TOTALS
3.00
$ 5,055.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 421 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Non-Working Travel
Invoice Number:
Matter Number:
1050104454
48520-27
3
Description of Legal Services
Date
Name
Hours Description
07/08/24 Spencer A. Winters, P.C.
1.50 Travel from Chicago, IL to Philadelphia, PA
re hearing (billed at half time).
07/08/24 Spencer A. Winters, P.C.
1.50 Travel from Philadelphia, PA to Chicago, IL
re hearing (billed at half time).
Total
3.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 422 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104455
Client Matter: 48520-28
In the Matter of Creditors’ Committee Matters
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 108,752.00
Total legal services rendered
$ 108,752.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 423 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Creditors’ Committee Matters
Invoice Number:
Matter Number:
1050104455
48520-28
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
2.60
1,395.00
3,627.00
Kenny Chiaghana
0.90
975.00
877.50
Stephanie Choi
5.00
355.00
1,775.00
Tabitha J. De Paulo
9.90
1,435.00
14,206.50
David Hackel
2.10
1,095.00
2,299.50
Angela Leonard
11.70
625.00
7,312.50
Jennifer Mancini
4.50
1,075.00
4,837.50
Alisa Melekhina
18.30
1,595.00
29,188.50
Dan O'Connor
0.40
1,345.00
538.00
Sarah Osborne
22.90
975.00
22,327.50
Joseph Cermak Profancik
1.60
1,095.00
1,752.00
Joshua Raphael
0.10
1,095.00
109.50
Seth Sanders
14.40
1,265.00
18,216.00
Spencer A. Winters, P.C.
1.00
1,685.00
1,685.00
TOTALS
95.40
$ 108,752.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 424 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Creditors’ Committee Matters
Invoice Number:
Matter Number:
1050104455
48520-28
3
Description of Legal Services
Date
Name
Hours Description
07/01/24 Chris Ceresa
0.90 Review, analyze issues re UCC matters.
07/01/24 Tabitha J. De Paulo
1.40 Conference with UCC counsel re case update
and issues (.5); draft correspondence to UCC
counsel re protective order (.4); correspond
and conference with M. McKane re strategy
(.5).
07/01/24 Angela Leonard
1.50 Review and analyze Board of Directors
materials for production (.5); prepare
redactions re same for attorney review (1.0).
07/01/24 Sarah Osborne
1.00 Research re UCC diligence requests (.8);
correspond with S. Sanders, K&E team re
same (.2).
07/01/24 Joseph Cermak Profancik
0.30 Review, analyze distribution of existing loan
documents (.2); correspond with MWE re
same (.1).
07/01/24 Seth Sanders
2.10 Correspond with MWE, PJT, C. Ceresa, K&E
team re UCC diligence (.9); review, analyze
diligence (1.2).
07/01/24 Spencer A. Winters, P.C.
1.00 Prepare for and participate in telephone
conference with UCC re case overview (.5);
prepare for and participate in weekly advisor
telephone conference re same (.5).
07/02/24 Tabitha J. De Paulo
0.10 Correspond with Klehr team re document
collection and production.
07/02/24 Tabitha J. De Paulo
3.30 Review and revise redactions to board
materials.
07/02/24 Angela Leonard
2.90 Review and analyze Board of Directors
materials for privilege issues (.9); prepare
redactions re same for attorney review (2.0).
07/02/24 Sarah Osborne
1.00 Research re board documents for diligence
requests (.8); correspond with S. Sanders,
K&E team re same (.2).
07/02/24 Seth Sanders
1.20 Correspond with C. Ceresa, K&E team re
preparation of diligence for UCC (.6); review,
analyze diligence re DIP issues (.6).
07/03/24 Tabitha J. De Paulo
0.50 Conference with A. Melekhina re Company
discovery issues re UCC RFPs.
07/03/24 Angela Leonard
2.50 Review and analyze Board of Directors
materials re UCC RPFs (1.5); prepare
redactions re same for attorney review (1.0).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 425 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Creditors’ Committee Matters
Invoice Number:
Matter Number:
1050104455
48520-28
4
Date
Name
Hours Description
07/03/24 Jennifer Mancini
1.50 Redact privileged information from board
minutes.
07/03/24 Sarah Osborne
4.70 Review, revise second day final orders to
incorporate UCC comments (1.3); correspond
with T. Chanroo re same (.3); review, analyze
diligence requests for UCC (2.7); correspond
with S. Sanders, K&E team, AlixPartners re
same (.4).
07/03/24 Seth Sanders
2.40 Telephone conference with S. Osborne re DIP
diligence list (.3); coordinate re board and
special committee meeting diligence (.4);
correspond with PJT, Y. Salloum, K&E team,
AlixPartners re DIP diligence list (.8); revise
diligence summary (.5); telephone conference
with PJT, RBC re valuation (.4).
07/04/24 Angela Leonard
2.00 Review and analyze Board of Directors
materials re UCC RFPs (1.0); prepare
redactions re same for attorney review (1.0).
07/06/24 Sarah Osborne
0.90 Correspond with AlixPartners, S. Sanders,
K&E team re committee diligence requests
(.3); review, analyze diligence requests re
same (.5); correspond with MWE re same
(.1).
07/06/24 Seth Sanders
1.90 Analyze issues re foreign subsidiary equity
pledge (.9); correspond with AlixPartners, Y.
Salloum, K&E team re same (.6); telephone
conferences with Y. Salloum, K&E team re
same (.4).
07/07/24 Angela Leonard
1.80 Review and analyze Board of Directors
materials re UCC RFPs (.4); prepare
redactions re same for attorney review (1.4).
07/07/24 Sarah Osborne
1.30 Correspond with S. Sanders, K&E team, PJT
team re UCC DIP diligence requests (.3);
review, revise diligence documents re same
(.4); analyze issues re same (.2); review,
revise UCC diligence list re same (.4).
07/07/24 Joshua Raphael
0.10 Correspond with S. Sanders, K&E team re
UCC diligence request, perfection
memorandum.
07/07/24 Seth Sanders
1.10 Correspond with MWE, C. Ceresa, K&E team
re UCC DIP diligence requests (.6);
coordinate diligence request responses (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 426 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Creditors’ Committee Matters
Invoice Number:
Matter Number:
1050104455
48520-28
5
Date
Name
Hours Description
07/08/24 Alisa Melekhina
0.50 Review, analyze privilege designations,
attorney list and redactions to board of
directors meeting minutes re UCC RFPs.
07/08/24 Sarah Osborne
3.40 Summarize diligence re UCC diligence
request list (.6); review, revise due diligence
summary re same (.3); correspond with S.
Sanders, K&E team, AlixPartners, PJT teams
re same (.4); draft summary re UCC diligence
requests (2.1).
07/08/24 Joseph Cermak Profancik
1.00 Draft responses to UCC diligence questions
(.5); review and analyze existing loan
documents (.4); correspond with S. Sanders,
K&E team re same (.1).
07/08/24 Seth Sanders
0.80 Correspond with Y. Salloum, AlixPartners re
diligence request (.4); correspond with J.
Profancik, K&E team re DIP diligence
requests (.4).
07/09/24 Jennifer Mancini
1.50 Redact board minutes for privileged
information re UCC RFPs.
07/09/24 Sarah Osborne
0.80 Review, analyze diligence for creditors
committee (.6); correspond with S. Sanders,
K&E team re same (.2).
07/10/24 Tabitha J. De Paulo
0.30 Respond to C. Ceresa and K&E team re
privilege question re board presentation re
UCC RFPs.
07/10/24 Tabitha J. De Paulo
0.50 Review, analyze UCC bylaws; correspond
with UCC, K&E team re same.
07/10/24 Alisa Melekhina
0.30 Review, analyze privilege designations,
redactions and comments to board of directors
meeting minutes re UCC RFPs.
07/11/24 Jennifer Mancini
1.50 Redact board minutes for privileged
information in response to UCC RFPs.
07/11/24 Alisa Melekhina
4.40 Review, analyze privilege designations and
redactions to board of directors meeting
minutes in response to UCC RFPs (3.4);
conference with T. De Paulo and N. Spector
re same (1.0).
07/11/24 Sarah Osborne
0.60 Review, analyze issues re board presentations
for diligence requests (.4); correspond with C.
Ceresa, K&E team re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 427 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Creditors’ Committee Matters
Invoice Number:
Matter Number:
1050104455
48520-28
6
Date
Name
Hours Description
07/12/24 Alisa Melekhina
5.10 Review, analyze privilege designations and
redactions to board of directors meeting
minutes in response to UCC RFPs (3.8);
further review, analyze same (.5); conference
with T. De Paulo and N. Spector re same (.8).
07/15/24 Chris Ceresa
0.40 Review, analyze issues re UCC diligence
requests (.2); correspond with Company, S.
Sanders, K&E team re same (.2).
07/15/24 Alisa Melekhina
2.90 Review, analyze privilege designations and
redactions to board of directors meeting
minutes and materials in connection with
RFPs (1.6); conference with T. De Paulo, N.
Spector and A. Leonard re same (.4); review
and comment on supplemental board
materials and sub committee minutes (.6),
conference re scope and review strategy with
T. De Paulo and N. Spector (.3).
07/15/24 Dan O'Connor
0.40 Telephone conference with PJT team, MWE,
S. Toth, K&E team re UCC advisor matters.
07/16/24 Tabitha J. De Paulo
2.00 Review, analyze and revise redactions to
board materials in response to UCC RFPs.
07/16/24 Angela Leonard
1.00 Review and analyze Board of Directors
materials (.3); prepare redactions re same for
attorney review in response to UCC RFPs
(.7).
07/16/24 Alisa Melekhina
2.00 Review, analyze privilege designations and
redactions to board of directors meeting
minutes and materials in response to UCC
RFPs (1.2); conference with T. De Paulo, N.
Spector, A. Leonard and Cole Schotz re same
(.8).
07/17/24 Chris Ceresa
0.70 Review, analyze issues re UCC diligence
requests (.4); correspond with Company, S.
Sanders, K&E team re same (.3).
07/17/24 Kenny Chiaghana
0.90 Analyze UCC bylaws re confidentiality terms
(.4); research re same (.5).
07/17/24 Stephanie Choi
2.00 Review and finalize redacted documents for
purposes of UCC RFP (1.0); revise additional
board material documents to reflect changes
for attorney review (1.0).
07/17/24 Tabitha J. De Paulo
1.80 Review and analyze UCC document requests
(1.4); conference with C. Ceresa, K&E team
re same (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 428 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Creditors’ Committee Matters
Invoice Number:
Matter Number:
1050104455
48520-28
7
Date
Name
Hours Description
07/17/24 David Hackel
2.10 Review, analyze UCC bylaws re legal issues
(.6); research precedent re same (1.1); draft
summary re same (.4).
07/17/24 Alisa Melekhina
2.20 Review, analyze privilege designations and
redactions to board of directors meeting
minutes and materials in connection with
UCC RFPs (.8); finalize and advise on
productions of same (.6); conference with T.
De Paulo, N. Spector, A. Leonard and Cole
Schotz re same (.8).
07/17/24 Alisa Melekhina
0.90 Review, analyze UCC document requests for
production (.5); conference with T. De Paulo,
K&E team re strategy (.4).
07/17/24 Sarah Osborne
2.10 Review, analyze diligence requests from UCC
(1.4); correspond with S. Sanders re same
(.1); telephone conference with Y. Salloum,
K&E team re same (.4); correspond with T.
De Paulo re same (.2).
07/18/24 Stephanie Choi
3.00 Revise board minute and materials (1.2);
redact same re privilege in connection with
UCC RFPs (.3); correspond with A.
Melekhina, K&E team re same (.4); set up file
transfer protocol transmittal (1.1).
07/19/24 Sarah Osborne
2.60 Telephone conference with Y. Salloum, K&E
team, Cole Schotz team re UCC diligence
requests (.4); review, analyze diligence re
same (1.3); review, revise summary re same
(.9).
07/19/24 Seth Sanders
1.70 Telephone conference with Cole Schotz, C.
Ceresa, K&E team re UCC production (.4);
analyze documents for UCC production (.9);
correspond with S. Osborne, K&E team re
same (.4).
07/24/24 Sarah Osborne
0.30 Review, analyze issues re UCC diligence
requests.
07/26/24 Seth Sanders
0.70 Analyze documents for production re UCC
diligence requests (.5); correspond with T. De
Paulo, Cole Schotz re same (.2).
07/29/24 Sarah Osborne
3.60 Review, analyze issues re UCC diligence
requests (2.2); review, analyze documents and
related documents re same (1.2); correspond
with S. Sanders, K&E team, Cole Schotz
team re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 429 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Creditors’ Committee Matters
Invoice Number:
Matter Number:
1050104455
48520-28
8
Date
Name
Hours Description
07/29/24 Joseph Cermak Profancik
0.30 Review and analyze certified charters re UCC
diligence requests (.2); correspond with S.
Osborne re same (.1).
07/29/24 Seth Sanders
2.50 Analyze documents re UCC production (1.3);
correspond with Cole Schotz, C. Ceresa, K&E
team re same (.6); telephone conferences with
PJT, Cole Schotz re UCC VDR, related issues
(.6).
07/30/24 Chris Ceresa
0.20 Correspond with S. Sanders, K&E team re
UCC items (.1); analyze legal issues re same
(.1).
07/30/24 Sarah Osborne
0.60 Review, analyze issues re board documents
for UCC diligence (.4); correspond with N.
Spector, K&E team re same (.2).
07/31/24 Chris Ceresa
0.40 Correspond with S. Sanders, K&E team re
UCC diligence items (.2); analyze legal issues
re same (.2).
Total
95.40
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 430 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104456
Client Matter: 48520-29
In the Matter of Employee and Labor Matters
For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail)
$ 76,418.50
Total legal services rendered
$ 76,418.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 431 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Employee and Labor Matters
Invoice Number:
Matter Number:
1050104456
48520-29
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Wes Benter
0.50
1,575.00
787.50
Chris Ceresa
7.50
1,395.00
10,462.50
Sooah Kim
0.30
1,095.00
328.50
Rebecca J. Marston
0.50
1,345.00
672.50
Brandan Matthews
0.50
1,345.00
672.50
Maureen D. O'Brien
1.00
2,115.00
2,115.00
Sarah Osborne
7.40
975.00
7,215.00
Carolin Paus
5.70
750.00
4,275.00
Evangelia Podaras
6.70
1,575.00
10,552.50
Joshua Raphael
2.60
1,095.00
2,847.00
Risa Salins
13.80
2,115.00
29,187.00
Yusuf Salloum
1.50
1,595.00
2,392.50
Paul Vasiloff
1.00
1,345.00
1,345.00
Donatus Wang
2.60
960.00
2,496.00
Ann-Kathrin Ziegler
1.00
1,070.00
1,070.00
TOTALS
52.60
$ 76,418.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 432 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Employee and Labor Matters
Invoice Number:
Matter Number:
1050104456
48520-29
3
Description of Legal Services
Date
Name
Hours Description
07/01/24 Evangelia Podaras
0.20 Conference with C. Ceresa, K&E team re
employment matters.
07/01/24 Risa Salins
0.30 Telephone conference with C. Ceresa re
employee matters.
07/02/24 Evangelia Podaras
0.10 Correspond with C. Ceresa, K&E team re
contingency notices.
07/02/24 Paul Vasiloff
0.50 Telephone conference with Y. Salloum, K&E
team re contingency planning.
07/08/24 Maureen D. O'Brien
0.20 Correspond with R. Meintjes, K&E team re
payroll legal issues.
07/08/24 Maureen D. O'Brien
0.80 Correspond with Y. Salloum, K&E team re
COBRA legal issues.
07/08/24 Sarah Osborne
0.60 Draft summary re executive compensation
issues (.5); correspond with C. Ceresa, K&E
team re same (.1).
07/09/24 Chris Ceresa
0.50 Review, analyze potential employment
matters (.3); correspond with E. Podaras,
K&E team re same (.2).
07/09/24 Sarah Osborne
0.30 Review, analyze issues re potential retention
program (.2); correspond with Y. Salloum re
same (.1).
07/09/24 Sarah Osborne
1.10 Review, revise potential retention program
(.2); correspond with Company, Y. Salloum
re same (.1); research precedent re notices for
same (.4); draft same (.3); correspond with Y.
Salloum, Company re same (.1).
07/09/24 Sarah Osborne
0.80 Review, analyze go‑forward obligations
wages motions (.7); correspond with K.
Chiaghana re same (.1).
07/09/24 Evangelia Podaras
1.00 Telephone conference re contingency
employment matters (.5); prepare for same
(.5).
07/09/24 Risa Salins
1.50 Telephone conference with AlixPartners re
employee contingency matters (.5);
conference with E. Podaras, K&E team re
same (.3); review, analyze updates to
employment notices (.7).
07/09/24 Yusuf Salloum
1.50 Analyze legal issues re compensation (1.1);
correspond with S. Osborne and K&E team re
same (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 433 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Employee and Labor Matters
Invoice Number:
Matter Number:
1050104456
48520-29
4
Date
Name
Hours Description
07/10/24 Sarah Osborne
1.10 Review, revise potential compensation
agreement form (.7); review, revise notice re
same (.2); correspond with Y. Salloum,
Company re same (.2).
07/10/24 Carolin Paus
3.70 Research re legal requirements for
employment issues under German law.
07/10/24 Donatus Wang
1.50 Review, analyze employment issues.
07/11/24 Chris Ceresa
0.50 Review, analyze potential employment
contingency matters (.3); correspond with E.
Podaras, K&E team re same (.2).
07/11/24 Sarah Osborne
0.70 Review, revise potential employment
agreement and award notice (.4); correspond
with C. Ceresa, Company re same (.3).
07/11/24 Carolin Paus
2.00 Draft summary re employment issues under
German law.
07/11/24 Joshua Raphael
0.30 Review, analyze issues re PTO (.2);
correspond with K. Trevett, K&E team re
same (.1).
07/11/24 Risa Salins
1.50 Review and provide comments to asset
purchase agreement (1.1); conference with E.
Podaras re same (.2); correspond with E.
Podaras, K&E team re employment
contingency matters (.2).
07/11/24 Donatus Wang
0.80 Review, analyze summary of German
employment issues.
07/11/24 Ann-Kathrin Ziegler
0.50 Review and revise research re German
employment issues (.3); draft correspondence
re labor law (.2).
07/12/24 Sarah Osborne
0.80 Review, revise employee retention program
agreement (.3); correspond with Company re
same (.1); research court orders re same (.4).
07/12/24 Risa Salins
0.30 Provide comments to asset purchase
agreement (.2); discuss with E. Podaras re
same (.1).
07/15/24 Evangelia Podaras
0.20 Review, analyze correspondence from R.
Salins re employment notices.
07/15/24 Risa Salins
1.00 Review, analyze updated employee data for
employment purposes (.8); review, analyze
further correspondence from E. Podaras, K&E
team re transaction (.2).
07/15/24 Donatus Wang
0.30 Correspond with J. Buch re employment
issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 434 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Employee and Labor Matters
Invoice Number:
Matter Number:
1050104456
48520-29
5
Date
Name
Hours Description
07/15/24 Ann-Kathrin Ziegler
0.50 Correspond with D. Wang, K&E team re
German labor law workstream.
07/16/24 Chris Ceresa
0.40 Review, analyze legal issues re employment
contingency plans (.2); correspond with E.
Podaras, K&E team, Company re same (.2).
07/16/24 Rebecca J. Marston
0.50 Conference with C. Ceresa, K&E team,
AlixPartners re contingency employment
notices.
07/16/24 Brandan Matthews
0.50 Conference with Company and PJT re
employment contingency notices.
07/16/24 Sarah Osborne
0.60 Research, analyze precedent re contingency
employment notices and related resolutions.
07/16/24 Evangelia Podaras
0.70 Telephone conference with C. Ceresa, K&E
team and AlixPartners re contingency
employment notices (.5); telephone
conference with K&E team re same (.2).
07/16/24 Joshua Raphael
2.30 Research re paid time off and correspond with
C. Ceresa, K. Trevett re same (1.0); review,
analyze DIP credit agreement re employment
issues (.1); correspond with C. Ceresa, K&E
team re same (.2); draft correspondence re
paid time off and correspond with K. Trevett
re same (.3); correspond with C. Ceresa, K&E
team re same (.3); research re governance
considerations, approvals re employment
issues and correspond with C. Ceresa re same
(.4).
07/16/24 Risa Salins
0.70 Conference with C. Ceresa, K&E team re
employee contingency matters (.3); telephone
conference with AlixPartners re same (.4).
07/17/24 Chris Ceresa
0.60 Review, analyze legal issues re employment
contingency plans (.4); correspond with R.
Salins, K&E team, Company re same (.2).
07/17/24 Evangelia Podaras
0.20 Telephone conference with C. Ceresa, K&E
team re employment contingency issues.
07/17/24 Risa Salins
2.00 Draft updated employment notices (1.5);
correspond with C. Ceresa, K&E team re
same (.5).
07/18/24 Chris Ceresa
0.20 Review, analyze legal issues re employment
contingency plans (.1); correspond with R.
Salins, K&E team, Company re same (.1).
07/18/24 Evangelia Podaras
0.20 Research re state paid time off law (.1);
correspond with AlixPartners re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 435 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Employee and Labor Matters
Invoice Number:
Matter Number:
1050104456
48520-29
6
Date
Name
Hours Description
07/18/24 Risa Salins
0.50 Correspond with E. Podaras, K&E team re
employee matters, communications.
07/22/24 Chris Ceresa
0.50 Review, analyze legal issues re employment
matters (.3); correspond with R. Salins, K&E
team, Company re same (.2).
07/22/24 Evangelia Podaras
0.10 Correspond with C. Ceresa, K&E team re call
with AlixPartners to discuss employment
notices.
07/23/24 Chris Ceresa
1.40 Review, analyze legal issues re employment
matters (1.0); correspond with R. Salins K&E
team, Company re same (.4).
07/23/24 Sooah Kim
0.30 Review, analyze employee benefits related
matters.
07/23/24 Evangelia Podaras
0.70 Conference with Company, C. Ceresa, K&E
re employment notices.
07/23/24 Risa Salins
0.70 Telephone conference with Company re
employee matters (.5); discuss further with C.
Ceresa (.2).
07/24/24 Wes Benter
0.50 Review, analyze federal, California and
Illinois notice requirements.
07/24/24 Chris Ceresa
1.80 Review, analyze legal issues re employment
matters (1.0); correspond with R. Salins, K&E
team, Company re same (.8).
07/24/24 Sarah Osborne
1.40 Draft talking points re employment notices.
07/24/24 Evangelia Podaras
1.80 Prepare for and participate in telephone
conference re comms re employment issues
(.6); correspond with R. Sallins re issues re
same (.5); research re same (.7).
07/24/24 Risa Salins
0.50 Review, analyze employment documents,
communications.
07/25/24 Risa Salins
1.30 Participate in special committee call re
employment matters (.5); telephone
conference with AlixPartners re paid time off
(.5); telephone conference with E. Podaras re
employee matters (.3).
07/26/24 Paul Vasiloff
0.50 Conference with Company re employment
considerations.
07/27/24 Risa Salins
0.50 Review, analyze purchase agreement.
07/29/24 Chris Ceresa
0.80 Review, analyze employment contingency
planning documents (.4); correspond with R.
Salins, Company, K&E team re same (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 436 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Employee and Labor Matters
Invoice Number:
Matter Number:
1050104456
48520-29
7
Date
Name
Hours Description
07/29/24 Evangelia Podaras
1.50 Review, revise employee communications
document (1.1); correspond with C. Ceresa re
same (.2); conference with R. Salins re same
(.2).
07/29/24 Risa Salins
1.70 Consider and provide employment comments
to AlixPartners slides re employment notices
(.5); review and provide comments to draft
employee communications documents (1.0);
discuss same with E. Podaras (.2).
07/30/24 Chris Ceresa
0.40 Review, analyze employment contingency
planning documents (.2); correspond with R.
Salins, Company, K&E team re same (.2).
07/30/24 Risa Salins
0.30 Review, analyze updates to communications
re employment contingency planning.
07/31/24 Chris Ceresa
0.40 Review, analyze contingency planning
documents (.2); correspond with R. Salins,
Company, K&E team re same (.2).
07/31/24 Risa Salins
1.00 Correspond with Company re employment
contingency matters (.1); review, advise re
revised draft of communications re
employment issues (.5); review, revise paid
time off policy (.4).
Total
52.60
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 437 of 914

August 2024
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 438 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105545
Client Matter: 48520-5
In the Matter of Corporate & Governance Matters
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 28,679.00
Total legal services rendered
$ 28,679.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 439 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050105545
48520-5
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
2.70
1,395.00
3,766.50
Erica D. Clark
0.40
1,595.00
638.00
Hannah Crawford
0.30
1,595.00
478.50
Partha Kar
0.50
2,305.00
1,152.50
Sabrina Lieberman
1.70
975.00
1,657.50
Jai Mudhar
1.50
1,345.00
2,017.50
Sarah Osborne
3.10
975.00
3,022.50
Jay M. Ptashek, P.C.
2.00
2,245.00
4,490.00
Steve Toth
1.00
1,820.00
1,820.00
Donatus Wang
0.60
960.00
576.00
Quin Wetzel
6.70
975.00
6,532.50
Spencer A. Winters, P.C.
1.50
1,685.00
2,527.50
TOTALS
22.00
$ 28,679.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 440 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050105545
48520-5
3
Description of Legal Services
Date
Name
Hours Description
08/01/24 Chris Ceresa
0.60 Prepare for and participate in special
committee meeting with S. Winters,
Company, advisors.
08/01/24 Steve Toth
0.50 Participate in special committee conference
with Company, PJT, AlixPartners, S. Winters
and K&E team.
08/01/24 Donatus Wang
0.60 Correspond with Company re liquidity
forecasts for German entities re governance
considerations (.2); telephone conference with
Company and advisors re same (.4).
08/01/24 Quin Wetzel
0.90 Telephone conference with Special
Committee, C. Ceresa and K&E team (.6);
draft minutes re same (.3).
08/01/24 Spencer A. Winters, P.C.
0.50 Prepare for and attend standing special
committee telephone conference with C.
Ceresa and K&E team.
08/05/24 Sarah Osborne
1.90 Draft, review and revise special committee
meeting minutes.
08/05/24 Jay M. Ptashek, P.C.
1.00 Prepare for and attend special committee call
with C. Ceresa, K&E team, Company and
advisors.
08/07/24 Chris Ceresa
0.80 Prepare for and attend special committee
meeting with S. Winters, K&E team,
Company, advisors (.7); review draft minutes
re same (.1).
08/07/24 Steve Toth
0.50 Telephone conference with Company, PJT,
AlixPartners, Y. Salloum, K&E team re
special committee.
08/07/24 Quin Wetzel
2.10 Draft, review and revise minutes re special
committee meeting (1.9); correspond with C.
Ceresa re same (.2).
08/07/24 Spencer A. Winters, P.C.
0.50 Prepare for and attend special committee call
with S. Toth, Company, advisors re sale
process.
08/12/24 Sarah Osborne
1.20 Review, analyze issues re special committee
minutes (.5); correspond with Q. Wetzel,
K&E team re issues re same (.7).
08/13/24 Sabrina Lieberman
0.10 Review, analyze correspondence from C.
Ceresa re Swiss corporate issue.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 441 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050105545
48520-5
4
Date
Name
Hours Description
08/13/24 Quin Wetzel
0.50 Review, analyze international director and
officer structure (.2); correspond with C.
Ceresa, Company re same (.3).
08/15/24 Chris Ceresa
0.60 Prepare for and participate in special
committee meeting with S. Winters,
Company, K&E team and advisors.
08/15/24 Quin Wetzel
1.40 Draft, review, revise minutes for VHC special
committee meeting (.8); correspond with C.
Ceresa re issues same (.6).
08/21/24 Chris Ceresa
0.30 Review, analyze corporate governance issues.
08/23/24 Sabrina Lieberman
0.20 Correspond with C. Ceresa, Swiss local
counsel re Swiss corporate issue.
08/25/24 Sabrina Lieberman
0.50 Correspond with C. Ceresa, K&E team re
Swiss entities.
08/27/24 Sabrina Lieberman
0.20 Correspond with C. Ceresa, T. Chanroo re
Swiss entities corporate issue.
08/28/24 Chris Ceresa
0.40 Prepare for and participate in special
committee conference with Company, S.
Winters, K&E team, and advisors.
08/28/24 Erica D. Clark
0.40 Prepare for and participate in Special
Committee conference with Company, C.
Ceresa, K&E team, and advisors.
08/28/24 Sabrina Lieberman
0.30 Correspond with C. Ceresa, K&E team, local
Swiss counsel re corporate issue.
08/28/24 Jai Mudhar
0.50 Correspond with C. Ceresa, K&E team re
auditor and corporate issues.
08/28/24 Jay M. Ptashek, P.C.
1.00 Prepare for and participate in conference with
Special Committee, Company, and advisors.
08/28/24 Quin Wetzel
1.80 Draft, review, revise minutes re special
committee meeting (1.6); correspond with C.
Ceresa re same (.2).
08/28/24 Spencer A. Winters, P.C.
0.50 Prepare for and participate in conference with
special committee, C. Ceresa, K&E team,
Company, and advisors.
08/29/24 Hannah Crawford
0.30 Correspond with C. Ceresa, K&E team, local
Swiss counsel re corporate audit issue.
08/29/24 Partha Kar
0.50 Telephone conference with J. Mudhar and
Swiss counsel re auditor and corporate issues.
08/29/24 Sabrina Lieberman
0.40 Conference with local Swiss counsel, T.
Chanroo, K&E team re Swiss auditor
corporate issue (.3); correspond with
AlixPartners re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 442 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050105545
48520-5
5
Date
Name
Hours Description
08/29/24 Jai Mudhar
1.00 Telephone conference with P. Kar and Swiss
counsel re auditor and corporate issues (.5);
correspond with same re same (.5).
Total
22.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 443 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105546
Client Matter: 48520-6
In the Matter of Disclosure Statement/Plan/Confirmation
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 51,764.00
Total legal services rendered
$ 51,764.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 444 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050105546
48520-6
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
2.20
1,395.00
3,069.00
Tiffani Chanroo
0.90
1,345.00
1,210.50
Amy Donahue
0.70
525.00
367.50
Julia R. Foster
1.40
525.00
735.00
David Hackel
3.60
1,095.00
3,942.00
Sabrina Lieberman
0.30
975.00
292.50
Sarah Osborne
22.70
975.00
22,132.50
Joshua Raphael
2.20
1,095.00
2,409.00
Seth Sanders
9.00
1,265.00
11,385.00
Kyle Nolan Trevett
0.30
1,265.00
379.50
Quin Wetzel
5.70
975.00
5,557.50
Tanzila Zomo
0.80
355.00
284.00
TOTALS
49.80
$ 51,764.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 445 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050105546
48520-6
3
Description of Legal Services
Date
Name
Hours Description
08/03/24 Sarah Osborne
2.70 Review, analyze RSA terms re plan (.9); draft
summary re same (1.6); correspond with C.
Ceresa, K&E team re same (.2).
08/05/24 Sarah Osborne
6.40 Research re administrative expense plan
requirements (2.8); draft summary re same
(2.1); review, revise same (1.3); correspond
with S. Sanders, K&E team re same (.2).
08/05/24 Seth Sanders
3.00 Research re impaired administrative claims
plans (2.1); revise memo re same (.6);
correspond with S. Osborne re same (.3).
08/05/24 Quin Wetzel
1.50 Research plan precedent (1.3); correspond
with S. Sanders, S. Osborne re same (.2).
08/06/24 Seth Sanders
0.70 Analyze case timeline issues re solicitation
and plan (.4); revise plan (.3).
08/15/24 Seth Sanders
1.50 Review, analyze, revise plan.
08/22/24 Seth Sanders
0.50 Revise plan.
08/23/24 David Hackel
3.40 Research re issues re confirmation brief (.3);
review, analyze confirmation brief precedent
re sale cases (1.2); draft, review, revise
confirmation brief (1.9).
08/25/24 Joshua Raphael
1.90 Review, analyze, revise plan.
08/26/24 David Hackel
0.20 Research, analyze issues re confirmation
brief.
08/26/24 Sarah Osborne
2.40 Review, revise disclosure statement for sale
updates.
08/26/24 Joshua Raphael
0.30 Conference with S. Sanders re plan (.1);
review, revise plan (.2).
08/26/24 Seth Sanders
1.30 Review, analyze, revise plan.
08/27/24 Sabrina Lieberman
0.30 Correspond with Q. Wetzel re declarations in
support of confirmation.
08/27/24 Sarah Osborne
2.10 Review, revise disclosure statement re case
updates.
08/27/24 Seth Sanders
1.00 Analyze, revise plan.
08/27/24 Kyle Nolan Trevett
0.30 Telephone conference with T. Chanroo re
disclosure statement issues.
08/27/24 Quin Wetzel
1.30 Research confirmation declaration precedent
(.5); review, analyze declaration precedent
(.6); correspond with S. Lieberman, J. Foster
re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 446 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050105546
48520-6
4
Date
Name
Hours Description
08/28/24 Amy Donahue
0.70 Prepare draft voting declaration ISO
confirmation.
08/28/24 Julia R. Foster
1.40 Prepare draft Barse declaration ISO
confirmation (.7); prepare draft Schlappig
declaration ISO confirmation (.7).
08/28/24 Sarah Osborne
4.70 Revise draft disclosure statement to include
sale items (2.0); review, analyze precedent re
confirmation orders (.8); draft confirmation
order (1.9).
08/28/24 Seth Sanders
1.00 Revise plan (.8); correspond with J. Raphael
re issues re same (.2).
08/28/24 Quin Wetzel
2.90 Review, revise DS motion, order and timeline
(1.8); review, revise DS exhibits (1.1).
08/28/24 Tanzila Zomo
0.80 Prepare initial shell re confirmation
declaration.
08/29/24 Tiffani Chanroo
0.90 Conference with K. Trevett re DS, DS motion
legal issues (.4): review, analyze materials re
same (.5).
08/29/24 Sarah Osborne
1.20 Draft, review and revise confirmation order.
08/30/24 Sarah Osborne
3.20 Review draft confirmation order (1.1); revise
same (2.1).
08/31/24 Chris Ceresa
2.20 Review, revise plan (1.8); analyze legal issues
re same (.4).
Total
49.80
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 447 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105547
Client Matter: 48520-7
In the Matter of DIP Financing and Cash Collateral
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 89,476.00
Total legal services rendered
$ 89,476.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 448 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050105547
48520-7
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
4.80
1,395.00
6,696.00
Erica D. Clark
15.10
1,595.00
24,084.50
Tabitha J. De Paulo
1.80
1,435.00
2,583.00
Mark McKane, P.C.
1.70
2,065.00
3,510.50
Joseph Cermak Profancik
1.50
1,095.00
1,642.50
Joshua Raphael
2.00
1,095.00
2,190.00
Yusuf Salloum
7.60
1,595.00
12,122.00
Adrian Salmen
2.10
1,265.00
2,656.50
Seth Sanders
0.50
1,265.00
632.50
Noah Spector
3.30
1,185.00
3,910.50
Kyle Nolan Trevett
22.20
1,265.00
28,083.00
Quin Wetzel
1.40
975.00
1,365.00
TOTALS
64.00
$ 89,476.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 449 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050105547
48520-7
3
Description of Legal Services
Date
Name
Hours Description
08/01/24 Chris Ceresa
0.20 Review DIP withdrawal request (.1);
correspond with J. Raphael and K&E team re
issues re same (.1).
08/01/24 Joshua Raphael
0.10 Review, withdrawal DIP notice requests and
correspond with C. Ceresa re same.
08/02/24 Chris Ceresa
0.30 Review, analyze legal issues re financing
status (.2); correspond with Y. Salloum and
K&E team re issues re same (.1).
08/02/24 Joseph Cermak Profancik
0.30 Correspond with lenders' counsel re interest
rate legal issues.
08/02/24 Joshua Raphael
0.20 Prepare DIP officer certificate (.1);
correspond with AlixPartners, C. Ceresa,
K&E team re DIP (.1).
08/02/24 Adrian Salmen
0.40 Conference with AlixPartners re professional
fees re DIP carveout (.3); correspond with R.
Marston re same (.1).
08/03/24 Chris Ceresa
1.20 Review, analyze legal issues re financing
terms and status (.9); correspond with Y.
Salloum and K&E team re issues re same (.3).
08/03/24 Erica D. Clark
8.70 Analyze issues re DIP draw, DIP motion to
compel (3.6); conferences with Y. Salloum
and K&E team re same (.8); comment on
same (4.3).
08/03/24 Tabitha J. De Paulo
0.50 Review, revise correspondence re DIP issues
(.3); telephone conference with Y. Salloum,
K&E team re potential dispute re same (.2).
08/03/24 Mark McKane, P.C.
1.00 Telephone conference with Y. Salloum, K&E
team re DIP issue (.4); prepare for same (.3);
review, revise draft correspondence re same
(.3).
08/03/24 Yusuf Salloum
4.00 Analyze legal issues re DIP funding (2.1);
research re defaults same (1.9).
08/03/24 Adrian Salmen
0.30 Correspond with K. Trevett, K&E team re
DIP financing issues.
08/03/24 Seth Sanders
0.50 Analyze correspondence re DIP proposals
(.3); correspond with Y. Salloum, K&E team
re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 450 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050105547
48520-7
4
Date
Name
Hours Description
08/03/24 Kyle Nolan Trevett
11.00 Review, revise letter re DIP financing issues
(2.2); correspond with Y. Salloum re same
(.3); research, analyze legal issues re motion
to compel (1.2); draft, revise same (3.9);
further draft, revise same (3.4).
08/04/24 Chris Ceresa
1.40 Review, analyze legal issues re financing (.3);
review, comment on draft pleadings re same
(.8); correspond with K. Trevett and K&E
team re same (.3).
08/04/24 Erica D. Clark
6.40 Review, revise motion to compel re DIP (3.7);
analyze, comment on same (2.1); correspond
with Y. Salloum and K&E team re same (.6).
08/04/24 Tabitha J. De Paulo
1.00 Review, revise emergency motion to compel
re DIP.
08/04/24 Yusuf Salloum
3.60 Review, analyze, comment on motion to
compel re DIP (3.2); correspond with E. Clark
and K&E team re same (.4).
08/04/24 Kyle Nolan Trevett
8.80 Review, revise motion to compel re DIP (3.9);
further review, revise same (3.9); correspond
with E. Clark, Y. Salloum re same (.3);
research re same (.7).
08/05/24 Chris Ceresa
0.90 Review, analyze legal issues re compelling
performance re DIP (.3); review, comment on
pleadings re same (.4); correspond with K.
Trevett and K&E team re same (.2).
08/05/24 Tabitha J. De Paulo
0.30 Correspond with J. D’Antonio and N. Spector
re motion to compel re DIP (.1); research re
same (.2).
08/05/24 Mark McKane, P.C.
0.70 Assess draft DIP motion (.5); correspond with
S. Winters re issues re same (.2).
08/05/24 Joshua Raphael
0.50 Review, analyze DIP documents re event of
default terms (.3); correspond with C. Ceresa,
K&E team re same (.2).
08/05/24 Noah Spector
3.30 Research precedent motions to enforce DIP
orders (2.6); draft and revise findings re same
(.7).
08/05/24 Kyle Nolan Trevett
2.20 Review, revise motion to compel re DIP (1.9);
correspond with T. De Paulo, E. Clark re
same (.3).
08/06/24 Joseph Cermak Profancik
0.70 Review and analyze existing security
agreement schedules (.2); review and analyze
intellectual property security agreements (.2);
correspond with Company re same (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 451 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050105547
48520-7
5
Date
Name
Hours Description
08/07/24 Chris Ceresa
0.40 Correspond with E. Clark and K&E team re
DIP financing issues.
08/07/24 Adrian Salmen
0.30 Correspond with J. Raphael, K&E team re
professional fee carveout in connection with
DIP.
08/08/24 Joshua Raphael
0.20 Draft correspondence to S. Winters re DIP
fees.
08/09/24 Chris Ceresa
0.20 Correspond with J. Raphael re variance
reporting items.
08/09/24 Joshua Raphael
0.20 Compile variance report (.1); correspond with
C. Ceresa re same (.1).
08/10/24 Kyle Nolan Trevett
0.20 Correspond with C. Ceresa re motion to
compel (.1); correspond with J. Raphael, Q.
Wetzel re same (.1).
08/10/24 Quin Wetzel
1.40 Review, revise motion to compel re DIP.
08/12/24 Joseph Cermak Profancik
0.50 Correspond with Company re issues re
intercompany note (.2); review and analyze
internal records of same (.3).
08/12/24 Joshua Raphael
0.20 Review, analyze, revise DIP withdrawal
requests (.1); correspond with agent, C.
Ceresa re same (.1).
08/13/24 Joshua Raphael
0.50 Correspond re DIP matters with C. Ceresa,
K&E team.
08/14/24 Joshua Raphael
0.10 Prepare re DIP withdrawal requests.
08/14/24 Adrian Salmen
0.30 Correspond with C. Ceresa, K&E team,
AlixPartners re professional fees in
connection with DIP.
08/20/24 Chris Ceresa
0.20 Review, analyze status of DIP reporting
items.
08/21/24 Adrian Salmen
0.40 Correspond with J. Raphael, K&E team,
AlixPartners, lenders re professional fees in
connection with DIP.
08/28/24 Adrian Salmen
0.40 Correspond with AlixPartners, C. Ceresa and
K&E teams re professional fee DIP carveout.
Total
64.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 452 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105548
Client Matter: 48520-10
In the Matter of Asset Sales/Section 363 Issues: Use, Sale & Disposition of Property
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 2,511,893.00
Total legal services rendered
$ 2,511,893.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 453 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Rebecca H. Arnall
7.30
1,265.00
9,234.50
Cooper Barghols
1.20
975.00
1,170.00
Samantha Bradley
7.00
1,345.00
9,415.00
John G. Caruso
2.70
2,115.00
5,710.50
Chris Ceresa
152.00
1,395.00
212,040.00
Tiffani Chanroo
122.30
1,345.00
164,493.50
Kenny Chiaghana
33.00
975.00
32,175.00
Erica D. Clark
88.30
1,595.00
140,838.50
Bernadette Coppola
21.70
1,575.00
34,177.50
Joseph A. D'Antonio
0.10
1,235.00
123.50
Sion Davies
2.50
1,575.00
3,937.50
Tabitha J. De Paulo
5.80
1,435.00
8,323.00
Anthony M. Del Rio
19.30
1,595.00
30,783.50
Jaina Desai
219.20
975.00
213,720.00
Shareen Dhillon
2.00
1,265.00
2,530.00
Amy Donahue
0.50
525.00
262.50
Luke Finn
175.50
1,345.00
236,047.50
Emma L. Flett
5.40
2,115.00
11,421.00
Julia R. Foster
0.40
525.00
210.00
Justin M. Garfinkle
39.20
1,095.00
42,924.00
David Hackel
0.70
1,095.00
766.50
Kate Hardey
14.30
1,995.00
28,528.50
Olivia Kaufmann
4.70
1,095.00
5,146.50
Sooah Kim
9.20
1,095.00
10,074.00
Maggie Kate King
22.70
1,265.00
28,715.50
Daniel Lewis, P.C.
15.40
1,910.00
29,414.00
Sabrina Lieberman
2.00
975.00
1,950.00
Rebecca J. Marston
67.50
1,345.00
90,787.50
Brandan Matthews
61.50
1,345.00
82,717.50
Ruan J. Meintjes
22.80
1,095.00
24,966.00
Trent Nachbar
29.80
1,265.00
37,697.00
Michelle L. Nowicki
2.70
625.00
1,687.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 454 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
3
Name
Hours
Rate
Amount
Maureen D. O'Brien
6.50
2,115.00
13,747.50
Dan O'Connor
70.30
1,345.00
94,553.50
Sarah Osborne
28.40
975.00
27,690.00
Carolin Paus
3.60
750.00
2,700.00
D. Taylor Petersen
0.70
975.00
682.50
Evangelia Podaras
6.90
1,575.00
10,867.50
Joshua Raphael
53.50
1,095.00
58,582.50
Risa Salins
2.10
2,115.00
4,441.50
Yusuf Salloum
20.00
1,595.00
31,900.00
Anna Schwander
5.40
1,315.00
7,101.00
Scottie Shermetaro
94.10
1,575.00
148,207.50
Barbara M. Siepka
3.80
435.00
1,653.00
Rob Soneson
10.00
625.00
6,250.00
Josh Sussberg, P.C.
0.10
2,305.00
230.50
Matt Swanson
1.40
1,345.00
1,883.00
Paul D. Tanaka, P.C.
5.00
2,115.00
10,575.00
Steve Toth
177.90
1,820.00
323,778.00
Kyle Nolan Trevett
2.80
1,265.00
3,542.00
Paul Vasiloff
4.80
1,345.00
6,456.00
Donatus Wang
3.60
960.00
3,456.00
Spencer A. Winters, P.C.
147.10
1,685.00
247,863.50
Ann-Kathrin Ziegler
3.50
1,070.00
3,745.00
TOTALS
1,810.20
$ 2,511,893.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 455 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
4
Description of Legal Services
Date
Name
Hours Description
08/01/24 Rebecca H. Arnall
0.20 Review, analyze M&A Counterparty purchase
agreement re compensation issues.
08/01/24 Chris Ceresa
2.20 Review and analyze sale and APA legal
issues (.7); comment on transaction docs re
same (1.1); correspond with S. Osborne and
K&E team, Company, advisors re same (.4).
08/01/24 Chris Ceresa
1.20 Review and analyze sale and APA legal
issues (.7); comment on sale order docs re
same (.5).
08/01/24 Bernadette Coppola
1.10 Conference with A. Del Rio and K&E team re
regulatory matters in transition services
agreement (.6); correspond with S.
Shermetaro and K&E team re purchase
agreement and disclosure schedules (.3);
correspond with AlixPartners, S. Toth, and
K&E team re regulatory matters in transition
services agreement (.2).
08/01/24 Sion Davies
0.20 Correspond with various parties re US filing
analysis, sales, related antitrust issues.
08/01/24 Anthony M. Del Rio
1.20 Review and comment on transaction
documents (.7); review and analyze transition
services legal issues (.5).
08/01/24 Jaina Desai
1.60 Telephone conferences with C. Ceresa re
auction open matters (.8); correspond with S.
Osborne, K&E team re various sale and
auction issues (.8).
08/01/24 Jaina Desai
2.40 Telephone conference with AlixPartners re
cure objections (.1); prepare for call re same
(.2); correspond with contract counterparty re
cure objection (.1); telephone conference with
contract counterparty re same (.1); correspond
with various parties re auction logistics (.6);
analyze, review comments re asset purchase
agreement (.2); correspond with S. Osborne re
same (.1); telephone conference with R.
Marston, K&E team, Deloitte re tax sale
structure (1.0).
08/01/24 Jaina Desai
0.20 Correspond with R. Marston re cure schedule
(.1); correspond with AlixPartners re same
(.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 456 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
5
Date
Name
Hours Description
08/01/24 Jaina Desai
4.20 Telephone conference with AlixPartners re
cure schedule (.3); correspond with R.
Marston and AlixPartners re issues re same
(.6); review, analyze bidding procedures order
(.4); review, analyze filed notices (.1); review,
analyze auction notice precedent (.3); draft
auction notice (.6); telephone conference with
third party vendor re auction (.2); correspond
with third party vendor re auction logistics
(.5); review, analyze comments re asset
purchase agreement (.3); correspond with S.
Osborne re same (.2); correspond with
contract counterparties re cure objections (.5);
correspond with AlixPartners re vendor
contracts (.2).
08/01/24 Jaina Desai
0.50 Correspond with R. Marston re auction and
sale hearing, next steps (.3); revise auction
script (.2).
08/01/24 Jaina Desai
1.00 Draft auction notice (.8); correspond with R.
Marston re same (.1); review, analyze
precedent re same (.1).
08/01/24 Jaina Desai
0.40 Correspond with contract counterparties and
AlixPartners re cure objections (.2); revise
cure summary materials (.2).
08/01/24 Amy Donahue
0.50 Research precedent auction hearing
transcripts.
08/01/24 Luke Finn
7.50 Review, analyze ZOLL asset purchase
agreement issues list (1.5); draft consolidated
issues list (1.7); prepare for telephone
conference with S. Toth, K&E team, advisors,
Company re various issues (.5); participate in
same (1.0); review ZOLL disclosure
schedules (1.6); review, analyze ZOLL asset
purchase agreement (1.2).
08/01/24 Justin M. Garfinkle
1.00 Review, analyze registered IP schedules.
08/01/24 Kate Hardey
2.70 Review revisions to Zoll APA and comment
on same (2.2); telephone conference with B.
Coppola, A. Del Rio and R. Meintjes re
revisions to draft TSA (.5)
08/01/24 Daniel Lewis, P.C.
0.30 Correspond with B. Coppola and K&E team
re APAs.
08/01/24 Sabrina Lieberman
0.20 Revise NDA (.1); correspond with PJT,
counterparty re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 457 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
6
Date
Name
Hours Description
08/01/24 Rebecca J. Marston
4.30 Review and revise APA (1.1); correspond
with S. Osborne, K&E team re same (.3);
correspond with J. Desai re various sale work
streams (2.7); correspond with Omni team re
noticing list (.2).
08/01/24 Rebecca J. Marston
1.40 Correspond with C. Ceresa, K&E team,
AlixPartners re cure and sale issues.
08/01/24 Brandan Matthews
2.60 Review, analyze legal issues re APAs.
08/01/24 Ruan J. Meintjes
2.00 Review and revise Zoll asset purchase
agreement (1.1); conference with B. Coppola
re transition services agreement (.5); prepare
summary of transition services changes (.4).
08/01/24 Trent Nachbar
6.60 Review, analyze APA re legal issues (3.9);
review, analyze APA schedules re same (2.7).
08/01/24 Michelle L. Nowicki
2.70 Review, analyze updates to APA schedules
(.6); review, analyze internal trademark
schedules and related IP Office records (.7);
review, revise trademark schedules
accordingly (.8); correspond with M. O’Brien
and K&E team re same (.6).
08/01/24 Maureen D. O'Brien
0.20 Correspond with M. Nowicki, K&E team re
TSA issues.
08/01/24 Maureen D. O'Brien
1.00 Review and revise purchase agreement.
08/01/24 Maureen D. O'Brien
0.80 Review, revise issues lists re APAs.
08/01/24 Dan O'Connor
4.00 Telephone conference with PJT, AlixPartners
and C. Ceresa, K&E re transaction matters
(.4); telephone conference with PJT,
Company, Alix Partners and K&E re
transaction matters (1.8); review and revise
asset purchase agreement (1.8).
08/01/24 Sarah Osborne
3.10 Review, analyze, revise APA markup (2.9);
correspond with C. Ceresa, K&E team re
same (.2).
08/01/24 Evangelia Podaras
1.50 Review, revise APA re employment matters.
08/01/24 Scottie Shermetaro
0.20 Review and revise disclosure schedules.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 458 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
7
Date
Name
Hours Description
08/01/24 Steve Toth
9.30 Revise APA (3.8); telephone conferences
with Company, PJT, AlixPartners, S. Winters,
K&E team, lender advisors re various sale
issues (2.8); analyze legal issues re revised
bidder APA (.5); correspond with advisors,
Company re tax considerations re sale (.1);
analyze revised APAs and update comparison
grid (1.0); analyze and respond to
correspondence re APA and tax matters (.2);
analyze revised APAs (.9).
08/01/24 Spencer A. Winters, P.C.
4.60 Prepare for and attend weekly Company
advisor update telephone conference with S.
Toth, K&E team, advisors (.5); prepare for
and attend weekly lender advisor update
telephone conference with S. Toth, K&E
team, and advisors (.5); prepare for and attend
telephone conference with Company advisors
re sale waterfall issues (.5); prepare for and
attend telephone conference with Company
and advisors re bids (1.0); review and analyze
legal issues re sale process (1.3); correspond
and telephone conferences with multiple
parties re same (.8).
08/02/24 Bernadette Coppola
0.80 Correspond with S. Toth and team re
transition services agreement (.3); draft
revisions to asset purchase agreement (.5).
08/02/24 Sion Davies
0.70 Correspond with M. Ehret, K&E team re tax
issues, sale issues, antitrust Germany issues
(.4); telephone conferences with same re same
(.3).
08/02/24 Anthony M. Del Rio
2.00 Review and analysis of regulatory filing
requirements triggered by various transaction
structures (.8); review and revise transaction
documents (1.2).
08/02/24 Jaina Desai
2.50 Correspond with cure objectors, AlixPartners
re sale objections (.9); telephone conference
with K. Carr re auction logistics (.3);
correspond with C. Ceresa and K&E team re
auction matters (.7); correspond with C. Paus
and K&E team re Germany tax structure
matters (.4); review, analyze bidding
procedures order, cash management order re
legal issues (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 459 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
8
Date
Name
Hours Description
08/02/24 Jaina Desai
4.50 Correspond with PJT Partners, Y. Salloum
and K&E team, AlixPartners, counterparties
re sale legal issues and objections re same
(2.0); further review bidding procedures
documents (.4); revise sale objection
summary based on correspondence (.3); draft,
revise third sale key dates extension notice
(1.1); revise stalking horse selection
documents (.6); review precedent re same
(.1).
08/02/24 Jaina Desai
0.30 Revise, analyze sale order.
08/02/24 Luke Finn
6.60 Review, revise ZOLL asset purchase
agreement (3.9) review, analyze same (.7);
correspond with Company re IMT Medical
PTE transfer (.4); review, analyze dataroom
documents (.8); review, revise disclosure
schedules (.8).
08/02/24 Justin M. Garfinkle
4.50 Review, analyze registered IP schedules (3.0);
draft updates to Vents purchase agreement
(1.5).
08/02/24 Kate Hardey
1.00 Review and revise Zoll Purchase Agreement
(.8); conference with R. Meintjes re same (.2).
08/02/24 Olivia Kaufmann
0.20 Correspondence with A. Del Rio, K. Hardey,
and R. Meintjes regarding license filing
requirements.
08/02/24 Sooah Kim
1.20 Review and revise purchase agreement.
08/02/24 Daniel Lewis, P.C.
0.50 Correspond with Company re IP matters (.2);
review, analyze APA (.3).
08/02/24 Rebecca J. Marston
2.40 Correspond with C. Ceresa, J. Desai re
escrow account (.5); correspond with J. Desai,
K&E team re sale work streams (1.9).
08/02/24 Brandan Matthews
3.00 Review, analyze asset purchase agreement
and disclosure schedules.
08/02/24 Ruan J. Meintjes
3.00 Review and revise bid asset purchase
agreement mark-ups from a regulatory
perspective (2.0); review and analyze
schedules (.5); conference with O. Kaufmann,
K&E team re the same (.5).
08/02/24 Trent Nachbar
7.90 Review, analyze APA (3.9); review, analyze
schedules (3.9); further analyze same (.1).
08/02/24 Maureen D. O'Brien
1.00 Review and revise purchase agreement.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 460 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
9
Date
Name
Hours Description
08/02/24 Dan O'Connor
2.20 Telephone conference with MWE and S. Toth
re transaction matters (.4); review and revise
disclosure schedules (1.3); correspondence
with B. Matthews and T. Nachbar re
transaction matters (.5).
08/02/24 D. Taylor Petersen
0.20 Correspond with D. O’Connor re transaction
legal issues.
08/02/24 Evangelia Podaras
1.50 Review, revise purchase agreement.
08/02/24 Joshua Raphael
0.40 Correspond with S. Toth, K&E team re assets,
liabilities of Vyaire 211 (.1); review, analyze
schedules re same (.3).
08/02/24 Yusuf Salloum
1.00 Review, analyze issues re sale transactions.
08/02/24 Scottie Shermetaro
3.20 Review and revise IP Schedules (.7); review
and revise asset purchase agreement (1.5);
review and revise disclosure schedules (.4);
review and revise RDx TSA (.6).
08/02/24 Steve Toth
2.20 Discuss next tax steps and diligence with D.
O’Connor, K&E team, advisors (.5); discuss
bidder status with UCC counsel (.4); analyze
correspondence re business issues and update
(.3); analyze correspondence re APA
schedules (.4); analyze correspondence re
revised TSA (.2); analyze revised TSAs (.4).
08/02/24 Paul Vasiloff
1.00 Review, revise asset purchase agreement.
08/02/24 Spencer A. Winters, P.C.
3.70 Review and analyze issues re sale process,
case status (1.7); correspond and telephone
conferences with multiple parties re same
(1.5); prepare for and attend telephone
conference with S. Toth and K&E tax team re
sale issues (.5).
08/02/24 Ann-Kathrin Ziegler
1.00 Review, analyze, revise three slide decks re
intercompany claims reconciliation process in
connection with sales.
08/03/24 Bernadette Coppola
0.40 Correspond with S. Toth and K&E team re
revisions to transition services agreement and
asset purchase agreement.
08/03/24 Anthony M. Del Rio
0.70 Review and revise transaction documents.
08/03/24 Jaina Desai
0.30 Correspond with Y. Salloum, K&E team re
sale stream legal issues.
08/03/24 Jaina Desai
0.40 Further revise sale order (.1); correspond with
C. Ceresa, R. Marston re same (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 461 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
10
Date
Name
Hours Description
08/03/24 Jaina Desai
4.00 Review, analyze correspondence re sale order
(.2); review and revise sale order (3.8).
08/03/24 Luke Finn
1.80 Review, analyze ZOLL disclosure schedule
(.6); correspond with opposing counsel re
disclosure schedules (.6); correspond with B.
Coppola, K&E team re purchase agreement
(.6).
08/03/24 Luke Finn
3.10 Revise ZOLL Asset Purchase Agreement
draft (2.8); Correspond with Company, S.
Toth, K&E team re same review (.3).
08/03/24 Justin M. Garfinkle
0.60 Correspond with outside counsel re trademark
issues.
08/03/24 Kate Hardey
0.70 Telephone conference with buyer counsel re
permit transfer process and related issues.
08/03/24 Maggie Kate King
4.00 Review, analyze Zoll Transition Services
Agreement (.8) draft issues list re same (1.2);
review, analyze Trudell Transition Services
Agreement (.9) draft issues re same list (1.1).
08/03/24 Brandan Matthews
3.60 Review, revise React purchase agreement.
08/03/24 Ruan J. Meintjes
1.00 Research and analyze California state
manufacturing licensing matter in connection
with potential sales (.6); correspond with S.
Toth, K&E team re the same (.4).
08/03/24 Dan O'Connor
1.10 Telephone conference with PJT, AlixPartners
and S. Toth, K&E team re transaction matters
(.6); correspondence with B. Matthews and S.
Toth re transaction matters (.5).
08/03/24 Scottie Shermetaro
4.50 Review and revise TSA markups.
08/03/24 Steve Toth
8.00 Analyze revised TSA (.4); correspond with
counsel, D. O’Connor, K&E team, advisors re
issues re same (.2); participate in telephone
conference with Company, PJT, AlixPartners,
and K&E team re bids and auction process
update (.6); further analyze revised TSA (.6);
draft prepare issue list re same (1.2); prepare
correspondence re revised TSA (.4); discuss
bid with bidder's counsel (.2); revise TSAs
and prepare related correspondence (3.4);
analyze bidder markups re legal issues (.4);
prepare comments re same (.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 462 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
11
Date
Name
Hours Description
08/03/24 Spencer A. Winters, P.C.
5.50 Review and analyze tax deck re sale (.5);
review and analyze sale issues (1.8); draft
correspondence to DIP lenders re sales (1.5);
prepare for and participate in telephone
conference with Company, advisors re sale
matters (1.0); correspond and telephone
conferences with multiple parties re same (.7).
08/04/24 Chris Ceresa
1.50 Review and analyze sale and APA legal
issues (.6); review, revise sale documents (.5);
correspond with J. Desai, K&E team,
Company, advisors re same (.4).
08/04/24 Bernadette Coppola
1.00 Conference with S. Toth, K&E team,
Company, advisors, and bidder re negotiation
of transition services agreement.
08/04/24 Anthony M. Del Rio
0.50 Prepare for and telephone conference with
Bidder's counsel re open regulatory and
transactional items.
08/04/24 Jaina Desai
0.20 Analyze, draft correspondence re auction.
08/04/24 Jaina Desai
4.60 Revise auction notice (.6); analyze and
comment on asset purchase agreement
markup (2.1); review, correspond with C.
Ceresa, Y. Salloum re sale stream (.4);
review, analyze bidding procedures order for
auction rules (.5); draft informal memo re
auction rules (.8); analyze comments re sale
order (.2).
08/04/24 Luke Finn
5.80 Revise ZOLL Asset Purchase Agreement to
Company (1.8); review, analyze
correspondence re ZOLL disclosure schedules
(1.8); revise the same (.9); correspond with
ZOLL, Company re same (.5); review and
analyze issues re transition services
agreement (.8).
08/04/24 Justin M. Garfinkle
0.60 Review and analyze registered IP schedule
comments.
08/04/24 Olivia Kaufmann
0.20 Conference with bidder counsel regarding CA
license.
08/04/24 Maggie Kate King
1.40 Telephone conference with S. Toth, K&E
team, Company and purchaser advisors re
various open issues re sale.
08/04/24 Daniel Lewis, P.C.
1.00 Review, analyze TSA issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 463 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
12
Date
Name
Hours Description
08/04/24 Ruan J. Meintjes
0.50 Conference with bidder counsel re California
manufacturing license issue.
08/04/24 Yusuf Salloum
1.50 Review and analyze legal issues re sale
transactions.
08/04/24 Anna Schwander
0.50 Review, analyze German FDI sale issues.
08/04/24 Scottie Shermetaro
3.10 Telephone conference with S. Toth, K&E
team, Company and purchaser advisors re
various open issues re sale (1.4); review and
revise TSA body and schedules (1.5); review
and revise IP disclosure schedules (.2).
08/04/24 Steve Toth
3.90 Analyze correspondence and attorney notes re
TSAs (.4); participate in telephone conference
with bidder, bidder advisors, AlixPartners,
Company and S. Winters, K&E team re TSA
(1.3); discuss tax updates with S. Winters,
K&E team (.4); analyze revised APA and
prepare related correspondence (.9); discuss
bid updates with Company, S. Winters, K&E
team, PJT, and AlixPartners (.6); analyze
correspondence re bids and diligence (.3).
08/04/24 Spencer A. Winters, P.C.
1.50 Review and analyze sale issues, tax issues re
sales (.5); prepare for and attend telephone
conference with S. Toth, K&E team re same
(.5); prepare for and attend telephone with
PJT re same (.5).
08/05/24 Chris Ceresa
3.10 Review and analyze sale and APA legal
issues (1.1); review, revise documents re
same (1.4); correspond with T. Chanroo,
K&E team, Company, advisors re same (.6).
08/05/24 Tiffani Chanroo
2.10 Review, analyze AirLife bid (1.8); correspond
with C. Ceresa, K&E team re same (.3).
08/05/24 Bernadette Coppola
0.40 Correspond with J. Garfinkle and team re
intellectual property schedules (.1);
correspond with S. Shermetaro and team re
bid review (.2); correspond with Company re
assignment of intellectual property (.1).
08/05/24 Sion Davies
0.50 Telephone conference with A. Schwander,
K&E team re German FDI assessment, sale
issues.
08/05/24 Anthony M. Del Rio
2.10 Review and analysis of open transaction and
structure considerations (1.2); review and
revise transaction documents (.9).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 464 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
13
Date
Name
Hours Description
08/05/24 Jaina Desai
3.10 Organize, manage logistics re auction (2.1);
telephone conferences and correspond with R.
Marston, K&E team re same (.7); correspond
with contract counterparties re cure objections
(.2); telephone conference with Omni re
affidavit of service re sale matter (.1).
08/05/24 Jaina Desai
4.00 Telephone conferences with AlixPartners, C.
Ceresa, K&E team, Company re third party
cure objection, sale, and auction matters (1.2);
correspond with R. Marston, K&E team,
AlixPartners re issues re same (2.8).
08/05/24 Jaina Desai
2.90 Correspond with Y. Salloum, S. Toth, K&E
team, AlixPartners, PJT, auction attendees re
sale stream, auction, APA issues, and cure
matters (1.6); revise sale orders (1.3).
08/05/24 Jaina Desai
1.70 Further revise sale orders (1.2); correspond
with AlixPartners, cure objectors re cure
objections (.5).
08/05/24 Jaina Desai
1.10 Review, revise sale orders (.5); correspond
with R. Marston, AlixPartners, third parties re
issues re same (.6).
08/05/24 Luke Finn
10.30 Review, analyze updated ZOLL bid package
(1.6); correspond with S. Zablotney, K&E
team re legal issues re same (1.3); draft ZOLL
Transitional Services summary (.6); review,
analyze correspondence with K&E specialists
re ZOLL APA Issues List (.6); draft, review,
revise same (2.6); draft, review, revise bid
comparison (1.2); telephone conference with
R. Meintjes and K&E team re issues list (.4);
telephone conferences with S. Toth, K&E
team, advisors, Company re sale issues (2.0).
08/05/24 Justin M. Garfinkle
2.10 Review, analyze comments re registered IP
schedules.
08/05/24 Kate Hardey
0.50 Review, analyze purchase agreement bid
drafts.
08/05/24 Sooah Kim
0.20 Analyze employee benefits related matters re
sales.
08/05/24 Daniel Lewis, P.C.
0.80 Review, analyze TSA issues (.3); review,
analyze IP diligence (.3); correspond with M.
King, K&E team re APA issues (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 465 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
14
Date
Name
Hours Description
08/05/24 Rebecca J. Marston
8.20 Conferences with J. Desai, K&E team,
contract counterparties re cure, sale matters
(2.8); correspond with J. Desai, K&E team re
sale, auction (3.5); review, analyze precedent
re auction scripts (1.9).
08/05/24 Brandan Matthews
2.90 Conferences with J. Desai and K&E team re
auction process (.7); conference with
Company re auction process (.5); review,
analyze auction bids (1.7).
08/05/24 Ruan J. Meintjes
1.40 Review and analyze bid drafts re legal health
regulatory issues (.8); prepare summary re
same (.6).
08/05/24 Trent Nachbar
0.50 Review, analyze legal issues re APA and
schedules.
08/05/24 Dan O'Connor
3.90 Review and revise disclosure schedules (.3);
prepare execution version of same (.2);
telephone conference with PJT, Company,
AlixPartners, S. Toth, K&E team re
transaction matters (.5); telephone conference
with Rothschild, Gibson Dunn, S. Toth , K&E
team re transaction matters (1.0); telephone
conference with Company, AlixPartners, PJT,
S. Toth, K&E team re transaction matters (.5);
review, analyze bids and correspondence with
C. Ceresa, K&E team re same (1.0); prepare
issues list for bids (.4).
08/05/24 Carolin Paus
0.70 Review and revise draft slide deck re
elimination of the ICs in connection with sale
process.
08/05/24 D. Taylor Petersen
0.50 Revise disclosure schedules.
08/05/24 Joshua Raphael
3.90 Review, analyze APA proposal re
restructuring legal issues (3.4); correspond
with J. Desai, K&E team re same (.5).
08/05/24 Anna Schwander
3.50 Telephone conference with Company re
German FDI issues re sales (2.1); correspond
with Company re same (1.0); telephone
conference with potential buyer re sale issues
(.4).
08/05/24 Scottie Shermetaro
2.50 Review and revise IP Disclosure Schedules
(2.0); review and revise Zoll APA re IP issues
(.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 466 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
15
Date
Name
Hours Description
08/05/24 Rob Soneson
3.00 Review and analyze intellectual property
search reports (1.2); draft internal schedules
(.9); review, revise same (.9).
08/05/24 Paul D. Tanaka, P.C.
1.10 Review and analyze bid submissions and
related documents (.9); correspond with S.
Toth, K&E team re same (.2).
08/05/24 Steve Toth
7.70 Correspond with AlixPartners and PJT re
liabilities, purchase price issues (.5);
correspond with Company, C. Ceresa and
K&E team, AlixPartners and PJT re bid
comparison issues (.5); review, analyze tax
insurance slides (.4); review, analyze
correspondence re bid documents and issues
(.2); correspond with C. Ceresa, K&E team re
bids and APA issues (.9); participate in
teleconference with lender advisors, PJT,
AlixPartners, and B. Matthews, K&E team re
bids (1.0); teleconferences with Company,
PJT, AlixPartners, S. Winters, K&E team re
bids (.5); analyze bidder APA markup (2.9);
prepare issues lists re same (.6); correspond
with B. Matthews re sale issues (.2).
08/05/24 Spencer A. Winters, P.C.
0.80 Review and analyze sale process issues (.4);
correspond and telephone conferences with
Company, PJT, AlixPartners, S. Toth, K&E
team re same (.4).
08/05/24 Ann-Kathrin Ziegler
1.00 Review revised German tax deck re
intercompany claims re sale process (.7);
correspond with D. Wang and K&E team re
issues re same (.3).
08/06/24 Rebecca H. Arnall
3.20 Draft, revise Zoll APA issue list (2.1);
correspond with S. Price and K&E team re
same (1.1).
08/06/24 John G. Caruso
1.40 Review, analyze, and comment on asset
purchase agreement.
08/06/24 Chris Ceresa
8.20 Review and analyze sale and APA legal
issues (3.9); review, revise sale transaction
documents (2.8); correspond with T. Chanroo,
K&E team, Company, advisors re issues re
same (1.5).
08/06/24 Tiffani Chanroo
6.10 Review, analyze AirLife bid (3.9); correspond
with C. Ceresa, K&E team re legal issues re
same (2.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 467 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
16
Date
Name
Hours Description
08/06/24 Bernadette Coppola
2.90 Draft revisions to asset purchase agreement
issues lists (.6); correspond with J. Garfinkle,
K&E team re same (.1); conference with
bidder, Company, advisors, L. Finn, K&E
team re transition services agreement
schedules (.3); correspond with S. Toth, K&E
team, advisors re bidder transition services
agreement inquiries (.3); correspond with S.
Garfinkle, K&E team, Company re revisions
to disclosure schedules (.3); conference with
D. Lewis re bid package updates (.2);
conference with S. Toth, K&E team, advisors,
and bidder re transaction documents (.7); draft
revisions to transition services agreement
issues list (.4).
08/06/24 Sion Davies
0.20 Correspond with A. Schwander, K&E team re
ex-US filing analysis, sales, related antitrust
issues.
08/06/24 Anthony M. Del Rio
1.00 Review, revise transaction documents re
health regulatory issues.
08/06/24 Jaina Desai
5.50 Draft auction related documents and scripts
(1.1); review and revise same (3.5); review
and analyze precedent re same (.9).
08/06/24 Jaina Desai
3.70 Correspond with D. O'Connor, AlixPartners,
counterparties, U.S. Trustee re sale objection
issues (1.8); correspond with J. Raphael re
asset purchase agreements (.2); review,
analyze cure objections (.4); review, analyze
bidding procedures order (.6); further draft
auction script (.7).
08/06/24 Jaina Desai
3.10 Telephone conferences with R. Martson,
AlixPartners, counterparties re sale objections
and sale issues (1.1); correspond with R.
Marston re same (.1); telephone conference
with S. Toth, K&E team, Goodwin re TSA
considerations (.8); coordinate auction
logistics (1.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 468 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
17
Date
Name
Hours Description
08/06/24 Luke Finn
11.10 Review, analyze ZOLL APA and ZOLL
disclosure schedules (2.5); review, revise
ZOLL APA draft, (3.8); review, analyze
 imtmedical ag (Switzerland) stock purchase
liability (1.8); telephone conferences with
Alix Partners, Cooley, Company re
Transitional Services Agreement, bid
submissions (3.0).
08/06/24 Julia R. Foster
0.20 Correspond with Y. Salloum re auction
matters.
08/06/24 Justin M. Garfinkle
3.70 Draft issues lists to purchase agreements with
multiple bidders (2.5); review, analyze
registered IP schedules (1.2).
08/06/24 Kate Hardey
1.40 Review and revise summary of issue points
for revised bid drafts.
08/06/24 Kate Hardey
0.50 Conference with R. Meintjes, K&E team re
legal issues re revised purchase agreement bid
drafts.
08/06/24 Olivia Kaufmann
0.70 Review, analyze legal issues re APAs (.4);
conference with A. Del Rio, K. Hardey, and
R. Meintjes re same (.3).
08/06/24 Sooah Kim
2.50 Review, analyze each bid purchase agreement
(1.3) draft issues lists (.7); review, analyze
employee benefits related matters re the sale
(.5).
08/06/24 Maggie Kate King
1.80 Draft issues list for Zoll Transition Services
Agreement (.8); review, analyze React
Transition Services Agreement mark up
correspond with tax team re same (.2);
conference with Company and Trudell re
Transition Services Schedules (.5);
conference with Airlife re Transition Services
Agreement (.3).
08/06/24 Daniel Lewis, P.C.
1.00 Review, analyze APA and TSA issues.
08/06/24 Rebecca J. Marston
6.30 Correspond with C. Ceresa, K&E team re
draft APAs, sale matters (3.9); review and
revise sale order (1.3); correspond with J.
Desai re same (1.1).
08/06/24 Brandan Matthews
3.70 Conference with Company and advisors re
bids (1.5); conference with opposing counsel
re Zoll bid (1.0); review and revise purchase
agreements and disclosure schedules (1.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 469 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
18
Date
Name
Hours Description
08/06/24 Ruan J. Meintjes
5.00 Review and analyze submitted bid packages
(3.4); conference with A. Del Rio and K.
Hardey re legal issues re same (.5); draft
issues list re same (1.1).
08/06/24 Trent Nachbar
0.10 Review, analyze APA and schedules.
08/06/24 Maureen D. O'Brien
0.50 Review and revise purchase agreement.
08/06/24 Dan O'Connor
5.00 Telephone conference with Zoll, Cooley,
AlixPartners, M. King K&E team re
transaction matters (1.0); telephone
conference with PJT, AlixPartners, C. Ceresa
K&E re bid comparisons (1.8); telephone
conference with Goodwin team, AlixPartners
and S. Toth K&E re bid submission (.7);
review and revise asset purchase agreement
(1.2); correspondence with S. Toth re same
(.3).
08/06/24 Carolin Paus
0.50 Telephone conference with C. Ceresa and
K&E team re sales processes and tax
structuring issues.
08/06/24 Evangelia Podaras
2.30 Review revised APA bids (1.7); review,
revise issues lists (.6).
08/06/24 Joshua Raphael
11.80 Revise issues list and correspond with C.
Ceresa, K&E team re same (.5); review,
analyze Zoll APA (3.5); correspond with C.
Ceresa, K&E team re same (.1); review,
revise Zoll issues list and APA (3.6); further
revise Zoll APA (.7); correspond with C.
Ceresa, K&E team re same (.8); review,
revise issues list re same (2.5); correspond
with C. Ceresa, K&E team re REACT APA
(.1).
08/06/24 Risa Salins
0.50 Review revised draft of Trudell APA (.3);
analyze employment issues re same (.2).
08/06/24 Yusuf Salloum
1.50 Review, analyze issues re sale transactions.
08/06/24 Anna Schwander
0.30 Telephone conference with German counsel
re sale issues.
08/06/24 Scottie Shermetaro
7.90 Telephone conference with SunMed re TSA
(.7); draft and revise issues list of Zoll TSA
(1.7); draft and revise issues list to Zoll APA
(1.8); review and revise Trudell APA (2.1);
review and revise React TSA (.2); review and
revise IP disclosure schedules (1.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 470 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
19
Date
Name
Hours Description
08/06/24 Matt Swanson
1.00 Review, analyze legal issues re purchase
agreements.
08/06/24 Paul D. Tanaka, P.C.
0.90 Review and analyze Trudell bid submission
and related documents (.6); draft issues list re
same (.2); correspond with Y. Salloum, K&E
team re same (.1).
08/06/24 Steve Toth
11.60 Review, analyze correspondence re bid APA
issues (.5); analyze bidder APA and TSA
legal issues (1.1); prepare correspondence re
APA issues (.1); correspond with
AlixPartners, PJT, Y. Salloum and K&E team
re asset and liabilities perimeters (.6); revise
Vents bid APA comparison (2.0); analyze
correspondence re diligence and bid issues
(.2): correspond with C. Ceresa, K&E team,
bidder advisors re bid APA markup (1.0);
correspond with Company, AlixPartners, PJT,
Y. Salloum K&E team re bid analysis (1.8);
correspond with lender advisors, PJT,
AlixPartners, and S. Winters, K&E team re
bid updates (.7); analyze correspondence re
APA, payable diligence and TSA (.6);
telephone conference with S. Winters, K&E
team and UCC advisors re sale update (.2);
correspond with S. Winters re bid (.2);
analyze bid APA (1.8); telephone conference
with AlixPartners, bidder, bidder advisor, and
S. Winters, K&E team re bid (.8).
08/06/24 Steve Toth
4.10 Analyze correspondence re international
liabilities and diligence and purchaser bid
questions (1.2); analyze bidder proposed
purchase price adjustment (.5); revise bid
comparison grid (1.2); correspond with bidder
counsel re APA (.6); analyze bid comparison
business slide deck (.4); prepare related
correspondence (.2).
08/06/24 Paul Vasiloff
3.00 Draft and revise issues list for four purchase
agreement bids.
08/06/24 Donatus Wang
1.30 Review revised tax structuring materials for
sale of RDx business (.4); prepare and attend
telephone conference with C. Paus and K&E
team re sale processes, tax structuring
considerations (.3); correspond and coordinate
with E. Goetz and C. Paus re same (.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 471 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
20
Date
Name
Hours Description
08/06/24 Spencer A. Winters, P.C.
4.70 Review and analyze sale process, auction
issues (1.4); correspond and telephone
conferences with multiple parties re same
(1.3); prepare for and participate in telephone
conferences with bidders, creditor advisors re
same (2.0).
08/06/24 Ann-Kathrin Ziegler
1.00 Telephone conference with D. Wang and
K&E team re open sale issues (.3); review and
revise intercompany liabilities slide deck (.7).
08/07/24 Rebecca H. Arnall
1.00 Draft revisions to Zoll APA (.8); correspond
with S. Price and K&E team re same (.2).
08/07/24 Chris Ceresa
5.20 Review and analyze sale and APA legal
issues (2.2); review, revise sale documents
(2.2); correspond with T. Chanroo, K&E
team, Company, advisors re same (.8).
08/07/24 Tiffani Chanroo
1.60 Review, revise AirLife bid (.8); analyze
materials re same (.6); correspond with C.
Ceresa re same (.2).
08/07/24 Erica D. Clark
1.20 Analyze issues re sale order, sale process.
08/07/24 Bernadette Coppola
1.40 Draft revisions to asset purchase agreement
issues list (.5); conference with bidder,
Company, advisors, S. Shermetaro, K&E
team re transition services agreement
schedules (.6); draft revisions to purchase
agreement and communicate with S.
Shermetaro and team re same (.3).
08/07/24 Sion Davies
0.50 Analyze issue re ex US filings, sales,
regulatory and antitrust issues.
08/07/24 Anthony M. Del Rio
2.60 Review, revise sale transaction documents
(1.4); review, analyze open regulatory items
re bidder requests (1.2).
08/07/24 Jaina Desai
1.10 Correspond with C. Ceresa, K&E team,
advisors re auction issues.
08/07/24 Jaina Desai
2.00 Correspond with third parties, AlixPartners re
cure objections (.5); draft key dates extension
notice, auction script (1.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 472 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
21
Date
Name
Hours Description
08/07/24 Jaina Desai
1.30 Analyze, bidding procedures documents (.5);
correspond with E. Clark, C. Ceresa re same
(.4); telephone conference with C. Ceresa,
Cooley re sale order (.1); draft
correspondence to C. Ceresa re Cooley call
(.1); correspond with R. Marston re same (.1);
correspond with Cole Schotz re sale extension
notice filing (.1).
08/07/24 Jaina Desai
2.60 Correspond with UCC re sale key dates
extension notice (.1); correspond with third
parties re sale issues and auction logistics (.6);
revise auction related documents (.9);
manage, organize auction logistics (1.0).
08/07/24 Jaina Desai
0.50 Correspond with third parties, AlixPartners re
sale and cure objections.
08/07/24 Luke Finn
10.80 Review, analyze ZOLL APA (1.5); draft
K&E specialist issues lists re ZOLL APA
(.8); review, revise APA and Disclosure
Schedule drafts (3.3); correspond with C.
Ceresa, K&E team re same (.3); review
Company disclosures including updated
employee census, including GDPR concerns
(.8); review, revise ZOLL bid APA (3.3);
distribute same (.3); conference with PJT re
bid comparison issues (.5).
08/07/24 Justin M. Garfinkle
1.00 Review, revise Vents purchase agreement.
08/07/24 Kate Hardey
0.60 Review, analyze revisions to Zoll bid draft
Purchase Agreement.
08/07/24 Sooah Kim
1.30 Review and revise purchase agreement.
08/07/24 Maggie Kate King
0.50 Conference with Zoll re Transition Services.
08/07/24 Daniel Lewis, P.C.
0.50 Correspond with B. Coppola, K&E team re
APA and TSA issues.
08/07/24 Rebecca J. Marston
5.30 Correspond with J. Desai, K&E team re
auction notice, sale order (3.9); review,
analyze issues re same (1.2); correspond with
AlixPartners re notice of assumed and
assigned contracts (.2).
08/07/24 Brandan Matthews
7.10 Conference with Company and advisors re
bids (.5); review and revise purchase
agreement (3.9); review, analyze issues re
same (2.7).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 473 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
22
Date
Name
Hours Description
08/07/24 Ruan J. Meintjes
0.80 Review and revise ZOLL asset purchase
agreement (.5); coordinate with regulatory
team re the same (.3).
08/07/24 Maureen D. O'Brien
0.50 Review and revise purchase agreement.
08/07/24 Dan O'Connor
5.30 Telephone conference with PJT, AlixPartners
and K&E re bid comparisons (.8); telephone
conference with PJT, AlixPartners, Vyaire
and K&E re bid comparisons (.5); telephone
conference with Crowell, Trudell, Deloitte,
K&E re transaction matters (1.5); review and
revise asset purchase agreement (2.2);
correspond with S. Toth re same (.3).
08/07/24 Carolin Paus
0.90 Review, revise updated structure slides re
intercompany and tax issues re sales.
08/07/24 Evangelia Podaras
0.10 Correspond with R. Salins re APA edits.
08/07/24 Evangelia Podaras
1.00 Review, revise bid draft.
08/07/24 Joshua Raphael
4.70 Correspond with C. Ceresa re APA (.1);
review, analyze same (.4); review, analyze
APAs (2.3); review, revise issues lists re same
(1.8); correspond with S. Toth, K&E team re
same (.1).
08/07/24 Yusuf Salloum
2.00 Analyze issues re sale transaction.
08/07/24 Anna Schwander
0.30 Review, analyze correspondence re German
FDI.
08/07/24 Scottie Shermetaro
4.90 Teleconference with B. Coppola re Zoll TSA
alignment (.5); correspond with B. Matthews
re auction bids (.3); review and revise Zoll
APA (1.0); telephone conference with L. Finn
re Zoll APA revisions (.2); review and revise
Zoll APA (1.8); review and revise Trudell
TSA (1.1).
08/07/24 Barbara M. Siepka
3.00 Review, revise IP schedules (2.6); correspond
with R. Soneson and K&E team re same (.4).
08/07/24 Rob Soneson
0.50 Review and analyze intellectual property
search reports (.2); prepare internal schedules
(.1); review, analyze schedules a (.2).
08/07/24 Steve Toth
4.30 Analyze correspondence re APAs and process
issues (.3); analyze bidder APAs (1.6);
review, revise same (1.9) correspond with
bidder counsel re same (.2); analyze revised
TSAs (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 474 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
23
Date
Name
Hours Description
08/07/24 Steve Toth
11.30 Review, comment on bidder APA (3.9);
review, analyze same (1.1); analyze
correspondence re Holdback and PMA (.2);
correspond with Company, PJT, AlixPartners,
and J. Raphael, K&E team re bids (.5);
review, analyze diligence and bid issues (.3);
prepare correspondence re bankruptcy APA
questions (.2); telephone conference with
lender advisors, AlixPartners, PJT, and S.
Winters and K&E team re bids and auction
update (.6); analyze bidder APA and prepare
comments (1.3); revise bidder APA (.8);
analyze correspondence re assumed liabilities
construct and related issues (.5); discuss
auction status with S. Winters (.1); discuss
auction with bidder counsel (.1); telephone
conference with bidder, bidder advisors,
Company, PJT, AlixPartners and Y. Salloum,
K&E team re APA and liabilities issues (1.7).
08/07/24 Paul Vasiloff
0.50 Review, revise purchase agreement.
08/07/24 Spencer A. Winters, P.C.
4.70 Prepare for and attend multiple calls re bid
comparisons, auction (1.5); review and
analyze issues re sale process, vents auction
(1.7); correspond and telephone conferences
with multiple parties re same (1.5).
08/08/24 Rebecca H. Arnall
1.20 Draft updates to Trudell purchase agreement
(1.0); correspond with S. Price, K&E team re
same (.2).
08/08/24 Chris Ceresa
3.60 Review and analyze sale and APA legal
issues (1.2); review, revise sale documents
(2.3); correspond with S. Toth, K&E team,
Company, advisors re same (.1).
08/08/24 Erica D. Clark
5.30 Conference with Company advisors re
auction, sale process (.5); review,
analyze, sale order, materials (3.9); review,
revise same (.9).
08/08/24 Bernadette Coppola
0.20 Correspond with S. Shermetaro, K&E team re
revisions to asset purchase agreement.
08/08/24 Sion Davies
0.20 Analyze issue re ex US filings, sales,
regulatory and antitrust issues.
08/08/24 Anthony M. Del Rio
1.30 Review, revise transaction documents.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 475 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
24
Date
Name
Hours Description
08/08/24 Jaina Desai
2.20 Telephone conference with AlixPartners re
cure objections (.9); correspond with R.
Marston re same (.1); correspond with R.
Marston re sale stream, cure schedule (.2);
revise successful bidder notice (.3); review,
analyze correspondence re cure objections
(.3); correspond with third parties re cure
objections (.4).
08/08/24 Jaina Desai
1.60 Correspond with R. Marston re sale stream,
cure objections (.4); correspond with third
parties, AlixPartners re cure objections (1.2).
08/08/24 Jaina Desai
0.50 Review, analyze correspondence, tracker re
cure objections (.3); correspond with
AlixPartners, third parties re same (.2).
08/08/24 Jaina Desai
0.70 Correspond with AlixPartners re cure
objections (.3); review, analyze
correspondence re bids (.2); correspond with
E. Clark re sale order (.1); correspond with
third parties re cure objections (.1).
08/08/24 Jaina Desai
2.10 Analyze comments to sale order (.2);
correspond with J. Raphael re same (.1);
revise sale order (1.6); correspond with R.
Marston, E. Clark re same (.2).
08/08/24 Luke Finn
2.20 Review variances between ZOLL and React
schedules (1.4); review, analyze React APA
draft (.8).
08/08/24 Julia R. Foster
0.20 Correspond with C. Ceresa re auction
logistics.
08/08/24 Justin M. Garfinkle
1.50 Revise RDx purchase agreement (1.0); review
and analyze legal issues re registered IP
schedules (.5).
08/08/24 Kate Hardey
0.50 Conference and correspond with R. Meintjes,
K&E team, counsel re health re legal issues re
revised Trudell bid draft purchase agreement.
08/08/24 Sooah Kim
0.50 Review and revise purchase agreement.
08/08/24 Maggie Kate King
3.00 Draft issues list for Transition Services
Agreement (2.1); review, analyze same (.9).
08/08/24 Daniel Lewis, P.C.
1.00 Review, analyze APA and TSA issues (.5);
correspond with B. Coppola, K&E team re
same (.5).
08/08/24 Brandan Matthews
3.00 Review, analyze auction and sale matters.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 476 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
25
Date
Name
Hours Description
08/08/24 Ruan J. Meintjes
1.10 Review and revise Trudell asset purchase
agreement (.9); correspond with C. Ceresa,
K&E team re the same (.2).
08/08/24 Trent Nachbar
2.60 Review, analyze APA and schedules.
08/08/24 Maureen D. O'Brien
0.50 Review and revise purchase agreement.
08/08/24 Dan O'Connor
4.60 Review and revise asset purchase agreement
(2.7); correspond with S. Toth and K&E
specialists re same (.3); correspond with
Company re disclosure schedules (.2);
analyze contracts re same (1.4).
08/08/24 Evangelia Podaras
0.50 Review revised bid markup (.4); correspond
with S. Toth and K&E team re same (.1).
08/08/24 Joshua Raphael
0.70 Review, analyze Trudell APA (.4);
correspond with S. Toth, K&E team re same
(.1); correspond with C. Ceresa re issues list
(.2).
08/08/24 Yusuf Salloum
1.00 Analyze issues re sale transaction.
08/08/24 Anna Schwander
0.50 Review, analyze German FDI (.3); correspond
with German counsel re same (.2).
08/08/24 Scottie Shermetaro
1.80 Telephone conference with S. Toth re Trudell
TSA issues list (.1); review and revise Trudell
APA (1.2); draft and revise Trudell TSA
issues list (.5).
08/08/24 Barbara M. Siepka
0.80 Correspond with R. Soneson re trademarks.
08/08/24 Rob Soneson
6.50 Review and analyze intellectual property
search reports (2.4); prepare internal
schedules (1.1); review, revise schedules
(3.0).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 477 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
26
Date
Name
Hours Description
08/08/24 Steve Toth
9.10 Correspond with bidder counsel re APA
issues (.4); analyze correspondence re APA
drafts and diligence matters (.7); review,
revise bidder APAs (3.7); telephone
conference with Company, AlixPartners, PJT,
and C. Ceresa K&E team re sale status (.5);
telephone conference with lender advisors,
PJT, AlixPartners, C. Ceresa, K&E team (.4);
analyze correspondence re lender deal points
(.1) correspond with PJT, AlixPartners, C.
Ceresa K&E team re same (.2); correspond
with S. Shermataro re same (.1); review,
revise attorney notes re bidder documents and
sale issues (.5); revise schedule (.9); review,
revise attorney notes re Vyaire sale
workstreams (.4); discuss tax insurance
updates with Company, C. Ceresa, K&E team
(.5); correspond with S. Winters re bid
protections (.1) review, analyze
correspondence re same (.1); correspond with
B. Matthews re bidder APA (.3); draft
correspondence re same (.2).
08/08/24 Paul Vasiloff
0.30 Review, analyze purchase agreement.
08/08/24 Spencer A. Winters, P.C.
5.80 Review and analyze issues re sale process,
auction (2.2); correspond and telephone
conferences with multiple parties re same
(3.6).
08/09/24 John G. Caruso
0.60 Review and revise the purchase and sale
agreement from Zoll.
08/09/24 Chris Ceresa
9.20 Review and analyze sale and APA legal
issues (3.9); review, revise sale documents
(3.9); correspond with T. Chanroo, K&E
team, Company, advisors re same (1.4).
08/09/24 Tiffani Chanroo
5.00 Review, analyze issues re sale (3.9):
correspond with J. Desai, K&E team re same
(1.1).
08/09/24 Erica D. Clark
2.60 Conference with Company advisors re sale,
auction (.5); analyze correspondences,
materials re same (1.3); review, analyze sale
order (.8).
08/09/24 Jaina Desai
5.00 Telephone conferences with C. Ceresa, K&E
team re auction logistics (1.1); analyze,
coordinate auction logistics (2.0); draft
correspondence re auction logistics (1.9).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 478 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
27
Date
Name
Hours Description
08/09/24 Jaina Desai
4.70 Correspond with T. Chanroo, K&E team re
cure objections, sale stream (1.9); revise sale
order (.4); revise auction notice (.5); analyze
correspondence re sale stream (.2); review,
analyze auction documents (.6); revise
auction script (1.1).
08/09/24 Jaina Desai
1.70 Correspond with Omni, Cole Schotz, C.
Ceresa re filing of auction notice (.8); review,
analyze correspondence re sale stream, bidder
noticing (.2); analyze, research precedent re
U.S. Trustee sale order comments (.7).
08/09/24 Luke Finn
9.60 Review starting APA bid against auction draft
(React Health) (3.5); review, analyze auction
mechanics, notices, and related procedural
documentation and correspondence (1.7);
review Cure Costs schedules and analysis (.8)
review Transition Services Agreements (1.6);
review Airlife bid materials (1.0); telephone
conference with Company Advisors, PJT
Partners re cure issues (1.0).
08/09/24 Justin M. Garfinkle
0.20 Review, analyze registered IP schedules.
08/09/24 Rebecca J. Marston
2.10 Correspond with J. Desai, K&E team re
auction logistics, sale order.
08/09/24 Brandan Matthews
1.50 Conference with Company and advisors re
auction.
08/09/24 Trent Nachbar
0.80 Review, analyze APA and schedules.
08/09/24 Dan O'Connor
4.00 Telephone conference with PJT, AlixPartners
and K&E team re transaction matters (.5);
telephone conference with Vyaire, PJT,
AlixPartners, S. Toth, K&E team re
transaction matters (.6); review and revise
disclosure schedules (1.6); review, analyze
distributor agreements (.4); correspond with
Crowell team re same (.4); correspond with S.
Toth re transaction matters (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 479 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
28
Date
Name
Hours Description
08/09/24 Steve Toth
4.10 Analyze correspondence re bids and diligence
issues (.4); correspond with K&E team, PJT,
and AlixPartners re bid and auction update
(.5); correspond with S. Winters re starting
bid (.1); correspond with AlixPartners, PJT,
and S. Winters, K&E team re budget, auction
matters (.6); correspond with S. Winters re
fiduciary matters (.2); correspond with bidder
counsel re APA (.2); correspond with PJT
with bidder issues (.1); correspond with
Company, PJT, S. Winters, K&E and
AlixPartners re lender updates (.6); revise
APA (.5) review, analyze correspondence re
same (.4); analyze correspondence re starting
bid and related documents (.5).
08/09/24 Spencer A. Winters, P.C.
4.30 Review and analyze issues re auction, sale
process (2.1); correspond and telephone
conferences with multiple parties re same
(2.2).
08/10/24 Rebecca H. Arnall
0.50 Draft, revise issues list re APA.
08/10/24 Chris Ceresa
0.60 Review and analyze sale and APA legal
issues (.2); review, revise documents re same
(.3); correspond with S. Toth, K&E team,
Company, advisors re same (.1).
08/10/24 Tiffani Chanroo
0.90 Review, analyze correspondence re sale
process.
08/10/24 Erica D. Clark
1.10 Review, revise sale order (.6); review, analyze
issues re same (.5).
08/10/24 Bernadette Coppola
0.30 Draft revisions to asset purchase agreement
(.2); correspond with S. Toth, K&E team re
same (.1).
08/10/24 Jaina Desai
3.20 Correspond with Y. Salloum, K&E team,
PJT, Gibson Dunn re sale and auction matters
(1.8); review, analyze comments precedent re
asset purchase agreement schedules (.2);
review, analyze comments, revise auction
script (1.2).
08/10/24 Luke Finn
2.90 Review Schedule 1.6 and React Health
Disclosure Schedules (.6); review bond surety
documents (.3); review, analyze
correspondence re same (.2); review, analyze
updated ZOLL APA draft and React leading
bid APA draft (1.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 480 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
29
Date
Name
Hours Description
08/10/24 Justin M. Garfinkle
0.70 Draft updates to RDx purchase agreement
(.5); review, analyze registered IP schedules
(.2).
08/10/24 Sooah Kim
0.20 Review, analyze employee benefits related
matters in connection with sales.
08/10/24 Daniel Lewis, P.C.
0.50 Correspond with B. Coppola, K&E team re
APA and TSA issues.
08/10/24 Brandan Matthews
1.70 Review, revise leading bidder disclosure
schedules (1.4); and distribute same to K&E
team (.3).
08/10/24 Dan O'Connor
1.20 Telephone conference with S. Toth, K&E
team re APA issues.
08/10/24 Joshua Raphael
0.60 Review, analyze APA documents re sle issues
(.2); correspond with C. Ceresa, AlixPartners
re same (.4).
08/10/24 Yusuf Salloum
1.50 Review, analyze issues re sale transactions.
08/10/24 Scottie Shermetaro
0.40 Review and revise Trudell APA.
08/10/24 Paul D. Tanaka, P.C.
0.40 Review and analyze purchase agreement.
08/10/24 Steve Toth
2.60 Analyze correspondence re schedules and
starting bid (.4); analyze RDx revised APA
(1.4); prepare related correspondence (.4);
analyze revised bidder APA (.4).
08/10/24 Spencer A. Winters, P.C.
0.80 Review and analyze issues re bids (.4);
telephone conference with AlixPartners re
same (.4).
08/11/24 Rebecca H. Arnall
0.70 Draft, revise issue list re APA (.6);
correspond with S. Price, S. Kim and K&E
team re same (.1).
08/11/24 Chris Ceresa
4.40 Review and analyze sale and APA legal
issues (2.4); comment on sale documents re
same (1.7); correspond with T. Chanroo,
K&E team, Company, advisors re same (.3).
08/11/24 Tiffani Chanroo
1.60 Review, analyze correspondence re sale
workstream legal issues.
08/11/24 Erica D. Clark
1.30 Telephone conference with C. Ceresa, K&E
team re sale order (.8); correspond with T.
Chanroo, K&E team re sale order (.2);
Analyze issues re same (.3).
08/11/24 Anthony M. Del Rio
0.40 Review and comment on APA transaction
documents.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 481 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
30
Date
Name
Hours Description
08/11/24 Jaina Desai
5.80 Revise auction script (2.5); correspond with
PJT Partners, C. Ceresa re issues re same
(1.2); review, analyze correspondence re U.S.
Trustee comments to sale order (1.7);
correspond with R. Marston re same (.2);
telephone conference with E. Clark re same
(.2).
08/11/24 Luke Finn
2.00 Telephone conference with advisors,
Company, S. Toth, and K&E team re various
sale issues (1.2); review of Company data
room documents (.5); correspond with buyer
counsels re same (.3).
08/11/24 Justin M. Garfinkle
1.70 Review, analyze registered IP schedules re
legal issues (1.4); review, analyze asset
purchase agreement re legal issues (.3).
08/11/24 Kate Hardey
0.60 Review and comment on opposing counsel
revisions to purchase agreement bid draft.
08/11/24 Sooah Kim
1.00 Review and revise asset purchase agreement
re employment issues (.8); review, analyze
employee benefits related sale documents (.2).
08/11/24 Daniel Lewis, P.C.
0.50 Correspond with B. Coppola, K&E team re
APA and TSA issues.
08/11/24 Brandan Matthews
1.00 Conferences with C. Ceresa, K&E team,
advisors and Company in preparation for
auction.
08/11/24 Ruan J. Meintjes
0.90 Review and analyze Zoll asset purchase
agreement re health regulatory matters (.5);
prepare issues list re same (.2); coordinate
with K. Hardey, K&E team re same (.2).
08/11/24 Maureen D. O'Brien
1.50 Review and revise asset purchase agreement
re employee benefits issues (1.2); correspond
with R. Meintjes re COBRA issues (.3).
08/11/24 Dan O'Connor
1.10 Telephone conference with AlixPartners, PJT,
Y. Salloum, K&E team re Zoll next steps (.6);
telephone call with MWE, AlixPartners, C.
Ceresa, K&E team re sale process update (.5).
08/11/24 Joshua Raphael
0.90 Review, analyze APA markup re restructuring
issues (.5); correspond with C. Ceresa, K&E
team, AlixPartners re same (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 482 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
31
Date
Name
Hours Description
08/11/24 Risa Salins
1.30 Review and provide employment comments
to revised draft of Zoll purchase agreement
(1.0); analyze, comment re employment
contingency matters re same (.3).
08/11/24 Yusuf Salloum
5.00 Multiple telephone conferences with S. Toth,
K&E team, Company, advisors re sale
transaction open issues (2.0); prepare for
auction (1.0); review, revise sale documents
(2.0).
08/11/24 Scottie Shermetaro
1.60 Review and revise IP Disclosure Schedules re
IP issues.
08/11/24 Matt Swanson
0.20 Analyze purchase agreement issues.
08/11/24 Paul D. Tanaka, P.C.
0.60 Review and analyze bid draft asset purchase
agreement re real estate issues (.4);
correspond with Y. Salloum, K&E team re
same (.2).
08/11/24 Steve Toth
1.70 Telephone conference with Company, PJT,
AlixPartners, C. Ceresa and K&E team re bid
and process update (.7); analyze tax
transaction slides re corporate legal issues
(.4); correspond with bidder counsel re
liabilities assumption (.1); telephone
conference with UCC advisors, PJT,
AlixPartners, Y. Salloum and K&E team (.5).
08/11/24 Steve Toth
5.40 Discuss bid updates with PJT, AlixPartners,
Y. Salloum and K&E team (.8); prepare
bidder issues list (.7); analyze tax issues in
APA (.3); draft correspondence re same (.4);
correspond with N. Warther re same (.2);
analyze correspondence re bid comparison
issues (.3); discuss bid issues with PJT,
AlixPartners, Y. Salloum and K&E team (.5)
revise correspondence re same (.3); telephone
conference with N. Warther, K&E team,
Company re tax insurance (.2); telephone
conference with Company, PJT, AlixPartners,
Y. Salloum and K&E team re bid process and
issues (.7) draft correspondence re same (.2);
analyze correspondence re bid issues (.2);
analyze bidder APA (.3); prepare comments
re same (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 483 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
32
Date
Name
Hours Description
08/11/24 Spencer A. Winters, P.C.
3.10 Review and analyze legal issues re bids (1.8);
correspond with S. Toth, K&E team re same
(.5); telephone conference with S. Toth, K&E
team re same (.8).
08/12/24 Rebecca H. Arnall
0.50 Review, analyze issues re APA.
08/12/24 Cooper Barghols
0.80 Review and revise bid purchase agreement
(.3); coordinate with R. Meintjes re same (.5).
08/12/24 John G. Caruso
0.70 Review, analyze legal issues re revised bid
from Zoll.
08/12/24 Chris Ceresa
8.80 Review, analyze legal issues re sale and
auction (3.3); multiple telephone conferences
with Alix, PJT, Y. Salloum, K&E team re sale
issues, auction (3.9); correspond with Alix,
PJT, Y. Salloum, K&E team re same (1.6).
08/12/24 Tiffani Chanroo
10.50 Participate in auction (1.3); conference with
C. Ceresa, K&E team re same (1.4); review,
analyze issues re auction (2.7); review,
analyze U.S. Trustee sale order comments
(2.6); correspond with E. Clark, U.S. Trustee
re same (.6); review, analyze sale declaration
precedent (.7); correspond with J. Desai, K&E
team re same (.4); review, revise
communications materials re sale (.5);
correspond with C. Ceresa, Company re same
(.3).
08/12/24 Erica D. Clark
4.90 Participate in auction, breakout advisor
conferences (2.4); analyze issues re sale order
(.6); comment on same (.2); analyze issues re
sale hearing, objections (1.1); correspond with
C. Ceresa, K&E team re same (.6).
08/12/24 Bernadette Coppola
2.00 Telephone conference with S. Toth, K&E
team, and bidder re transition services
agreement (.4); correspond with S. Toth,
K&E team re transition services agreement
issues list (.1); telephone conference with
bidder, S. Toth, K&E team re transition
services agreement (.4); participate in auction,
advisor conferences (.6); draft revisions to
asset purchase agreement (.2); correspond
with S. Shermetaro, K&E team re bid issues
(.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 484 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
33
Date
Name
Hours Description
08/12/24 Anthony M. Del Rio
1.50 Review and comment on bid issues list (.5);
telephone conference with bidder's counsel re
same (.3); review and comment on transaction
documents (.4); review, analyze auction
materials (.3).
08/12/24 Jaina Desai
16.00 Prepare, coordinate with AlixPartners, PJT
Partners, Company, S. Winters, K&E team to
host auction (3.5); further prepare, coordinate
with AlixPartners, PJT Partners, Company, S.
Winters, K&E team to host auction (3.0);
further prepare, coordinate with AlixPartners,
PJT Partners, Company, S. Winters, K&E
team to host auction (3.0); host auction (3.0);
further host auction (2.5); analyze, draft
correspondence re day two of auction (.5);
telephone conference with PJT Partners, S.
Toth, K&E team re auction bid (.5).
08/12/24 Jaina Desai
0.80 Correspond with cure parties, AlixPartners, T.
Chanroo, K&E team re cure objections (.5);
review, analyze correspondence re same (.1);
review, analyze correspondence re auction
bids (.2).
08/12/24 Luke Finn
6.70 Participate in advisor conference with C.
Ceresa, K&E team re auction (2.1);
correspond with S. Toth, K&E team re Zoll
asset purchase agreement (.8); review, revise
APA and disclosure schedules (3.0);
distribute materials re same to C. Ceresa and
K&E team (.8).
08/12/24 Justin M. Garfinkle
0.70 Review, analyze asset purchase agreement re
legal issues.
08/12/24 Kate Hardey
0.50 Conference with S. Toth and K&E team with
counterparty re TSA matters.
08/12/24 Kate Hardey
0.30 Review, analyze, and comment on Zoll APA
markup.
08/12/24 Olivia Kaufmann
0.20 Telephone conference with A. Del Rio, K.
Hardey, and R. Meintjes re APA legal issues.
08/12/24 Sooah Kim
0.50 Review and revise purchase agreement re
legal issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 485 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
34
Date
Name
Hours Description
08/12/24 Maggie Kate King
3.30 Telephone conference with Zoll bidder
counsel re Transition Services Agreement
(.5); telephone conference with Airlife bidder
counsel re same (.5); participate in auction
(1.3); participate in conferences with C.
Ceresa, K&E team, advisors, Company re
auction (1.0).
08/12/24 Daniel Lewis, P.C.
3.00 Telephone conference with B. Coppola, K&E
team re APA and TSA issues (.3); correspond
with B. Coppola, K&E team re same (.2);
participate in auction (2.0); analyze APA
issues (.5).
08/12/24 Rebecca J. Marston
14.90 Prepare for auction (1.2); host virtual auction
(2.0); conference with J. Desai, K&E team re
sale work streams, auction (3.9); coordinate
auction logistics (3.9); conference with J.
Desai, K&E Team re auction (3.9).
08/12/24 Brandan Matthews
6.10 Review Airlife asset purchase agreement
markup (1.2); conference with Airlife's bidder
counsel re transitional services agreement
(.5); conference with Airlife's bidder counsel
re bid (.5); participate in advisor conferences
re auction (3.9).
08/12/24 Ruan J. Meintjes
0.60 Review and revise Zoll asset purchase
agreement (.3); conference with K. Hardey re
same (.3).
08/12/24 Dan O'Connor
1.90 Review and revise asset purchase agreements.
08/12/24 Joshua Raphael
2.00 Participate in conferences with C. Ceresa,
K&E team, advisors, Company re bidding
issues, sales, and auction.
08/12/24 Risa Salins
0.30 Review and provide comments on draft Zoll
APA re employment issues.
08/12/24 Yusuf Salloum
5.00 Participate in conferences with C. Ceresa,
K&E team, advisors, Company re bidding
issues, sales, and auction (3.5); analyze sale
issues re auction bids (1.5).
08/12/24 Scottie Shermetaro
9.10 Participate in advisor conferences re sale,
bidding, and auction issues (3.9); draft issues
list re of Trudell APA (1.5); review and revise
Zoll APA (3.7).
08/12/24 Matt Swanson
0.20 Analyze purchase agreement legal issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 486 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
35
Date
Name
Hours Description
08/12/24 Paul D. Tanaka, P.C.
0.90 Review, revise bid draft purchase agreement
(.6); correspond with D. O’Connor and K&E
team re same (.3).
08/12/24 Steve Toth
1.20 Telephone conference re topping price with
bidder, bidder advisors, Company, K&E
team, PJT, and Alix (.3); analyze related
correspondence (.3); analyze and revise TSA
(.6).
08/12/24 Steve Toth
8.00 Multiple telephone conferences with bidders,
bidder advisors, PJT, AlixPartners, S. Winters
and K&E team re sale, bidding, and auction
issues (3.8); draft correspondence re same
(.2); analyze revised bidder APA (1.1);
prepare correspondence re same (.5); revise
bidder schedule (.4); analyze revised bidder
APA (1.4); draft correspondence re TSAs and
schedules (.6).
08/12/24 Steve Toth
5.20 Multiple telephone conferences with bidders,
Company, S. Winters, K&E team, PJT and
AlixPartners re bidding, sale, and auction
issues (3.5); correspond with bidders and
bidder advisors re same (1.1); analyze
correspondence re same (.3); analyze bidder
revised APA (.3).
08/12/24 Spencer A. Winters, P.C.
14.30 Analyze bid procedures re auction issues
(2.6); participate in multiple telephone
conferences with C. Ceresa, K&E team,
advisors, bidders, bidder advisors, Company
re auction, bidding, and sale issues (3.9);
further participate in multiple telephone
conference with same re same (3.9); further
participate in multiple telephone conference
with same re same (3.9).
08/13/24 Chris Ceresa
13.50 Review, analyze legal issues re sale and
auction (3.3); participate in multiple
telephone conferences with bidder counsel, S.
Toth, K&E team, advisors, Company re
auction, bidding, and sale issues (3.9); further
participate in multiple telephone conference
with same re same (3.9); further participate in
multiple telephone conference with same re
same (2.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 487 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
36
Date
Name
Hours Description
08/13/24 Tiffani Chanroo
8.80 Participate in multiple telephone conferences
with S. Toth, K&E team, advisors, Company,
bidder advisors re auction, bidding, and sale
issues (3.9); review, analyze legal issues re
same (3.9); review, revise sale order (.6);
review, analyze issues re sale declaration (.4).
08/13/24 Erica D. Clark
2.80 Analyze issues, comments to sale order (.9);
correspond with T. Chanroo, K&E re same
sale objections (.8); telephone conferences
with S. Toth, K&E team, advisors, Company,
bidder advisors re auction, bidding, and sale
issues (1.1).
08/13/24 Bernadette Coppola
1.50 Telephone conferences with S. Toth, K&E
team, advisors, Company, bidder advisors re
auction, bidding, and sale issues (1.3);
correspond with S. Toth, K&E team re
revisions to transaction documents (.2).
08/13/24 Sion Davies
0.20 Correspond with S. Toth and K&E team re
ex-US filing analysis.
08/13/24 Anthony M. Del Rio
0.70 Review, analyze, and comment on transaction
documents.
08/13/24 Jaina Desai
2.00 Telephone conference with AlixPartners re
cure objections (.3); correspond with
AlixPartners re same (.3); review, analyze
correspondence re cure objections (1.0);
correspond with cure parties re cure
objections (.4).
08/13/24 Jaina Desai
5.00 Prepare, coordinate with AlixPartners, PJT
Partners, S. Winters, K&E team to host day 2
of auction (3.1); correspond with same re
same (1.9).
08/13/24 Jaina Desai
5.00 Participate in multiple telephone conferences
with S. Toth, K&E team, advisors, Company,
bidder advisors re auction, bidding, and sale
issues (3.9); further participate in same re
same with same (1.1).
08/13/24 Jaina Desai
5.00 Participate in multiple telephone conferences
with S. Toth, K&E team, advisors, Company,
bidder advisors re auction, bidding, and sale
issues (3.9); correspond with C. Ceresa, K&E
team, advisors, Company, bidders re same
(1.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 488 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
37
Date
Name
Hours Description
08/13/24 Luke Finn
8.30 Telephone conference with Company, bidder
re asset purchase agreement (.7); participate
in multiple telephone conferences with S.
Toth, K&E team, advisors, Company, bidder
advisors re auction, bidding, and sale issues
(3.9); review, revise disclosure schedules and
representations (1.0); correspond with S.
Toth, K&E team re employee benefits matters
(.3); review, analyze engineering milestone
payments with AlixPartners (2.4).
08/13/24 Justin M. Garfinkle
0.80 Draft revisions to Airlife asset purchase
agreement.
08/13/24 Kate Hardey
0.70 Review legal issues re Airlife APA bid draft
(.5); conference with R. Emintjes and K&E
team re same (.2).
08/13/24 Olivia Kaufmann
1.10 Review, analyze APA (.8); telephone
conference with R. Meintjes re same (.3).
08/13/24 Maggie Kate King
3.50 Participate in multiple telephone conferences
with S. Toth, K&E team, advisors, Company,
bidder advisors re auction, bidding, and sale
issues.
08/13/24 Daniel Lewis, P.C.
1.50 Participate in multiple telephone conferences
with S. Toth, K&E team, advisors, Company,
bidder advisors re auction, bidding, and sale
issues (1.0); telephone conference with B.
Coppola, K&E team re bid issues (.3);
correspond with B. Coppola, K&E team re
same (.2).
08/13/24 Rebecca J. Marston
15.40 Participate in multiple telephone conferences
with S. Toth, K&E team, advisors, Company,
bidder advisors re auction, bidding, and sale
issues (3.9); further participate in same with
same re same (3.9) conference with J. Desai,
K&E team re sale work streams, auction
issues (3.9); further conference with J. Desai,
K&E Team re same (3.7).
08/13/24 Brandan Matthews
7.20 Review, analyze Airlife asset purchase
agreement markup (1.1); participate in
multiple telephone conferences with S. Toth,
K&E team, advisors, Company, bidder
advisors re auction, bidding, and sale issues
(3.9); analyze issues re auction, bids (2.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 489 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
38
Date
Name
Hours Description
08/13/24 Ruan J. Meintjes
1.50 Review and revise Airlife bid draft (1.3);
conference with A. Del Rio re the same (.2).
08/13/24 Trent Nachbar
0.30 Review, analyze APA and schedules.
08/13/24 Dan O'Connor
7.20 Participate in multiple telephone conferences
with S. Toth, K&E team, advisors, Company,
bidder advisors re auction, bidding, and sale
issues (3.5); review, analyze issues re auction
bids (1.0); review and revise asset purchase
agreements (.7); review and revise disclosure
schedules (1.5); telephone conference with L.
Finn, C. Ceresa, K&E team re disclosure
schedules (.5).
08/13/24 Joshua Raphael
5.40 Review, analyze precedent re sale reply (.4);
review, analyze objections to sale orders (.5);
participate in auction (1.0); participate in
advisor conferences re auction (.4);
correspond with C. Ceresa, K&E team re
auction, sale items (.1); draft declaration in
support of sale order (.4); correspond with J.
Desai re sale objections (.1); conference with
J. Desai, K&E team re sale objections (.6);
revise sale declarations (1.0); revise notice of
successful bidder (.9).
08/13/24 Yusuf Salloum
1.00 Multiple telephone conferences with S. Toth,
K&E team, advisors, Company, bidder
advisors re auction, bidding, and sale issues.
08/13/24 Scottie Shermetaro
11.10 Multiple telephone conferences re bid
analysis with bidder, bidder advisors,
Company, S. Winters, K&E team,
AlixPartners, and PJT (3.9); further
participate in same with same (3.9); review,
revise Zoll TSA (1.6); review and revise
Airlife Asset Purchase Agreement (1.0);
review and revise Trudell TSA (.7).
08/13/24 Paul D. Tanaka, P.C.
1.10 Review and comment on Airlife bid draft (.8);
correspond with S. Toth, K&E team re same
(.3).
08/13/24 Steve Toth
5.60 Multiple telephone conferences re bid
analysis with bidder, bidder advisors,
Company, S. Winters, K&E team, Alix, and
PJT (3.9); analyze revised bidder APA (.7);
discuss APA tax matters with N. Warther (.3);
correspond with S. Winters, K&E team re
APAs and TSA (.3); revise TSA (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 490 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
39
Date
Name
Hours Description
08/13/24 Steve Toth
4.10 Correspond with S. Winters, K&E team re
TSA issues list (.7); discuss auction issues
with Company, S. Winters, K&E team, Alix,
and PJT (.3); multiple telephone conference re
topping bid with bidder, bidder advisors,
Company, S. Winters, K&E team, Alix, and
PJT (2.6); analyze APA schedules (.1);
analyze correspondence re regulatory and
insurance matters (.3); discuss bid with bidder
counsel and S. Winters (.1).
08/13/24 Donatus Wang
0.20 Telephone conference with C. Paus, K&E
team, Company re open sale structure legal
issues.
08/13/24 Spencer A. Winters, P.C.
12.20 Multiple telephone conferences with S. Toth,
K&E team, advisors, Company, bidder
advisors re auction, bidding, and sale issues
(3.0); further participate in same (3.9);
multiple telephone conferences re bid analysis
with bidder, bidder advisors, Company, S.
Toth, K&E team, AlixPartners, and PJT (3.8);
further participate in same re auction (1.5).
08/14/24 Chris Ceresa
15.70 Review, analyze legal issues re sale and
auction (3.9); further review, analyze legal
issues re same (.6); participate in auction
(3.9); multiple telephone conferences re bid
analysis with bidder, bidder advisors,
Company, S. Toth, K&E team, AlixPartners,
and PJT (3.9); further participate in same
(3.4).
08/14/24 Tiffani Chanroo
6.20 Conference with C. Ceresa, K&E team, PJT,
AlixPartners re same (3.9); review, analyze
issues re same, sale documents (2.3).
08/14/24 Erica D. Clark
1.30 Multiple telephone conferences re bid
analysis with bidder, bidder advisors,
Company, S. Toth, K&E team, AlixPartners,
and PJT (.6); telephone conference with T.
Chanroo, K&E team re sale order (.4);
correspond with T. Chanroo, K&E team re
same (.3)
08/14/24 Bernadette Coppola
2.60 Draft revisions to transition services
agreement.
08/14/24 Bernadette Coppola
0.20 Correspond with D. O'Connor, K&E team re
intellectual property assignment agreement.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 491 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
40
Date
Name
Hours Description
08/14/24 Jaina Desai
8.00 Multiple telephone conferences with S. Toth,
K&E team, advisors, Company, bidder
advisors re auction, bidding, and sale issues
(3.6); further participate in same (3.9);
telephone conference with AlixPartners re
cure objections (.1); correspond with cure
parties re same (.2); correspond with
AlixPartners re same (.2).
08/14/24 Jaina Desai
2.00 Multiple telephone conferences with S. Toth,
K&E team, advisors, Company, bidder
advisors re auction, overbidding, and sale
issues.
08/14/24 Jaina Desai
2.00 Additional telephone conferences with S.
Toth, K&E team, advisors, Company, bidder
advisors re auction, overbidding, and sale
issues.
08/14/24 Jaina Desai
1.10 Review, analyze sale order (.2); correspond
with McDermott, Gibson Dunn re same (.3);
correspond with E. Clark re same (.1);
telephone conference with T. Chanroo, K&E
team re sale objections (.3); revise extension
notice (.2).
08/14/24 Jaina Desai
3.70 Multiple telephone conferences with S. Toth,
K&E team, advisors, PJT, Company, bidder
advisors re auction, overbidding, and sale
issues.
08/14/24 Luke Finn
12.40 Multiple telephone conferences re bid
analysis with bidder, bidder advisors,
Company, S. Toth, K&E team, AlixPartners,
and PJT (3.9); revise disclosure schedules
(2.0); review precedent and update Purchase
Orders language (1.6); analyze and distribute
Employee Benefits Plans materials (1.2);
review, analyze revised bidder disclosure
schedules and APA drafts (1.5); research
Company patents (2.2).
08/14/24 Justin M. Garfinkle
0.60 Analyze disclosure schedules (.4); analyze
registered IP schedules (.2).
08/14/24 Sooah Kim
1.50 Review and revise asset purchase agreement
(1.0); negotiate asset purchase agreement with
opposing counsel (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 492 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
41
Date
Name
Hours Description
08/14/24 Maggie Kate King
2.20 Multiple telephone conferences re bid
analysis with bidder, bidder advisors,
Company, S. Toth, K&E team, AlixPartners,
and PJT (2.0); revise, analyze Asset Purchase
Agreement (.2).
08/14/24 Daniel Lewis, P.C.
1.30 Telephone conference with B. Coppola, K&E
team re bid issues (1.0); correspond with B.
Coppola, K&E team re same (.3).
08/14/24 Rebecca J. Marston
7.20 Multiple telephone conferences re bid
analysis and sale issues with bidder, bidder
advisors, Company, S. Toth, K&E team,
AlixPartners, and PJT (3.9) multiple
telephone conferences with same re same
(3.3).
08/14/24 Brandan Matthews
7.00 Review Airlife asset purchase agreement
markup (.5); multiple telephone conferences
re auction and bid analysis with bidder, bidder
advisors, Company, S. Toth, K&E team,
AlixPartners, and PJT (3.9); multiple
telephone conferences with same re same
(2.6).
08/14/24 Trent Nachbar
3.70 Review, analyze, revise APA and schedules.
08/14/24 Maureen D. O'Brien
0.50 Conference with S. Kim, K&E team re
benefits issues.
08/14/24 Dan O'Connor
7.00 Participate in multiple telephone conferences
re bid analysis and auction with bidder, bidder
advisors, Company, S. Toth, K&E team, Alix,
and PJT (3.9); multiple telephone conferences
with same re same (.6); review and revise
disclosure schedules (2.5).
08/14/24 Joshua Raphael
3.60 Review, revise successful bidder notice (.5);
conference with E. Clark, K&E team re
auction (1.2); revise notice of successful
bidder (.3); correspond with J. Desai, K&E
team re auction (.2); conference with Cole
Schotz re sale (.2); review, analyze Hartford
objection (.2); correspond with Cooley re
successful bidder notice (.2); review, revise
sale declarations (.4); research, analyze
precedent re same (.4).
08/14/24 Joshua Raphael
0.30 Draft correspondence to Cole Schotz, T. de
Paolo re sale declarations.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 493 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
42
Date
Name
Hours Description
08/14/24 Scottie Shermetaro
6.70 Participate in multiple telephone conferences
re auction and bid analysis with bidder, bidder
advisors, Company, S. Toth, K&E team, Alix,
and PJT (3.9); multiple telephone conferences
with same re same (1.6); review and revise
Airlife Asset Purchase Agreement (.3);
review and revise Trudell TSA (.9).
08/14/24 Steve Toth
4.40 Telephone conference re asset carve-out with
Foley, Company, and S. Winters, K&E team
(.2); telephone conference re TSA with PJT
(.1); telephone conference re schedules with
D. O'Connor (.1); analyze revised TSA (.1);
telephone conference with Cooley re
same(.2); telephone conference with S.
Winters, K&E team, PJT, and AlixPartners re
asset carve-out for auction (.2); participate in
advisor conferences re auction issues (1.8);
telephone conference re foreign entities and
carve-out with bidder, bidder advisors,
Company, PJT, Alix, S. Winters and K&E
team (.4); telephone conference re carve-out
with bidders, bidder advisors, Company, S.
Winters, K&E team, PJT and Alix (.9); revise
bid status tracker (.1); revise notes re
documents signatures (.3).
08/14/24 Steve Toth
4.40 Telephone conferences re auction with
Company, PJT, Alix, S. Winters, and K&E
team (1.5); participate in advisor conferences
re auction issues (1.9); correspond with
bidder, bidder advisors, Company, PJT, Alix,
S. Winters, and K&E team re bid updates (.2);
analyze correspondence re bid updates and
issues (.2); correspond with S. Kim re APA
(.1); Correspond with bidder, advisors,
Company, PJT, Alix, S. Winters, and K&E
team re asset carve out (.3); discuss tax
provisions with N. Warther (.2).
08/14/24 Steve Toth
1.90 Telephone conference re signing process with
Cooley, Zoll, S. Winters, and K&E team
(.2); telephone conference with S. Winters,
K&E team re auction (.3); telephone
conference with Crowell re APA and tax
issues (.3); analyze revised APA and prepare
comments (.9); analyze APA for filing (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 494 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
43
Date
Name
Hours Description
08/14/24 Donatus Wang
0.70 Telephone conference with M. Ehret and E.
Goetz re status of Vents and RDx sales
processes and tax structuring.
08/14/24 Spencer A. Winters, P.C.
11.90 Prepare for and participate in auction multiple
telephone conferences re auction and bid
analysis with bidder, bidder advisors,
Company, S. Toth, K&E team, Alix, and PJT
(3.9); further participate in same (3.9); further
participate in same (3.7) analyze legal issues
re same (.4).
08/15/24 Chris Ceresa
5.30 Review and analyze sale and APA legal
issues (2.5); comment on sale documents re
same (2.0); correspond with J. Desai, K&E
team, Company, advisors re same (.8).
08/15/24 Tiffani Chanroo
10.30 Conference with E. Clark, K&E team re sale
and cure objections (.9); telephone
conferences with J. Desai, counterparties re
same (.4); review, analyze issues re same
(3.9); correspond with J. Desai re same (2.8);
review, revise declarations (1.2); correspond
with J. Raphael re same (.4); review, analyze
reservation of rights language (.4); correspond
with J. Raphael, K&E team same (.3).
08/15/24 Kenny Chiaghana
2.00 Participate in conference with T. Chanroo,
K&E team re sale orders (1.3); research re
same (.7).
08/15/24 Erica D. Clark
5.30 Correspond with T. Chanroo, K&E team re
sale order, sale hearing (.8); telephone
conference with Company, Company advisors
re case status, next steps (.5); telephone
conference with Company advisors, AHG
advisors re same (.5); analyze sale objections
(1.4); conference with T. Chanroo, K&E team
re same (1.0); analyze, comment on sale
declarations, (.6); analyze sale documents re
same (.5).
08/15/24 Bernadette Coppola
0.30 Correspond with S. Shermetaro, K&E team re
revisions to transaction agreements.
08/15/24 Anthony M. Del Rio
1.00 Analyze, comment on transaction
considerations (.5); telephone conference with
bidders, Company re entity licensing
considerations (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 495 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
44
Date
Name
Hours Description
08/15/24 Jaina Desai
1.50 Telephone conference with E. Clark, K&E
team re cure objection status (1.2); telephone
conference with T. Chanroo re same (.3).
08/15/24 Jaina Desai
1.50 Revise cure objection summary materials.
08/15/24 Jaina Desai
0.70 Telephone conference with cure party, T.
Chanroo re cure objection (.3); review,
analyze objection re same (.2); correspond
with K. Chiaghana re same (.2).
08/15/24 Jaina Desai
3.90 Correspond with E. Clark, K&E team,
AlixPartners, and cure parties re sale stream,
cure objections (.6); telephone conference
with same re same (.2); review and analyze
open sale objection issues (3.1).
08/15/24 Jaina Desai
3.90 Telephone conference with T. Chanroo re
cure objections (.4); telephone conference
with AlixPartners re same (.5); correspond
with cure parties, AlixPartners, C. Ceresa,
K&E team re sale and cure objections (3.0).
08/15/24 Jaina Desai
0.50 Telephone conference with C. Ceresa, K&E
team re sale status, next steps.
08/15/24 Luke Finn
11.70 Participate in advisor conferences re auction
(3.9); revise disclosure statements, APA (3.6);
correspond with S. Toth, K&E team re
employment provisions (.5); telephone
conference with S. Toth, K&E team re
operating covenant, bids (.7); coordinate with
AlixPartners re new disclosures, assumed
liabilities (3.0).
08/15/24 Justin M. Garfinkle
1.50 Analyze registered IP schedules.
08/15/24 Kate Hardey
0.30 Conference with R. Meintjes re legal issues re
Trudell and Zoll APA bid drafts and related
transaction process.
08/15/24 Sooah Kim
0.30 Review and revise purchase agreement.
08/15/24 Brandan Matthews
0.10 Analyze signature pages for Zoll transaction.
08/15/24 Ruan J. Meintjes
0.70 Telephone conference with Trudell and
licensure counsel (.5); coordinate with A. Del
Rio re the same (.2).
08/15/24 Trent Nachbar
1.20 Review, revise, analyze APA and schedules.
08/15/24 Dan O'Connor
5.30 Analyze auction materials (3.3); review and
revise asset purchase agreements (1.2);
review and revise disclosure schedules (.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 496 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
45
Date
Name
Hours Description
08/15/24 Joshua Raphael
9.90 Revise sale declarations (2.1); multiple
conferences with counterparties re sale
objections (1.0); legal research re sale order
precedent (1.4); correspond with C. Ceresa,
K&E team re same (.4); revise draft APAs
(1.5); revise successful bidder notice (.7);
review, analyze sale order, objections re legal
issues (1.2); conferences with E. Clark, T.
Chanroo, K&E team re sale priority items
(.6); review, revise agenda re sale hearing
(.4); revise, cure objection tracker (.4);
correspond with J. Desai re same (.2).
08/15/24 Anna Schwander
0.30 Review, analyze correspondence re sale
stream.
08/15/24 Scottie Shermetaro
3.50 Review and revise IP disclosure schedules
(2.7); review and revise Zoll TSA (.8).
08/15/24 Steve Toth
7.10 Analyze correspondence re finalizing Zoll
sale documents (.3); telephone conference
with Company, PJT, Alix, and K&E team re
management update (.5); telephone
conference with lender advisors, PJT, Alix, S.
Winters, and K&E team re sale status, next
steps (.5); analyze APA and correspondence
re issues lists (.7); analyze and revise TSAs
(3.0); participate in special committee
telephone conference with Company, PJT,
Alix, S. Winters, and K&E team (.5); analyze
correspondence re transaction documents and
schedules (.7); analyze final APA open points
(.2); analyze correspondence re diligence and
regulatory matters (.4); analyze
correspondence re sale stream update (.3).
08/15/24 Spencer A. Winters, P.C.
4.20 Review and analyze issues re sale hearing,
sales (2.3); telephone conference with
AlixPartners, S. Toth, K&E team, PJT, bidder
party re sale issues (1.5); correspond with S.
Toth, K&E team, PJT, Alix Partners, bidder
party re same (.4).
08/16/24 Chris Ceresa
7.30 Review and analyze sale and APA legal
issues (3.8); comment on sale documents re
same (1.2); correspond with S. Toth, K&E
team, Company, advisors re same (2.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 497 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
46
Date
Name
Hours Description
08/16/24 Tiffani Chanroo
7.00 Conference with C. Ceresa, K&E team, MWE
re same (.5); conference with E. Clark, K&E
team re sale and cure objections (.6); review,
analyze issues re same (3.9); correspond with
J. Desai, K&E team re same (2.0).
08/16/24 Kenny Chiaghana
2.50 Research legal issues re sale orders (2.0);
telephone conferences with various
counterparties re same (.2); telephone
conference re sale objections with E. Clark,
K&E team (.3).
08/16/24 Erica D. Clark
3.40 Telephone conference with C. Ceresa, K&E
team re sale hearing, sale objections, and sale
orders (.7); correspond with C. Ceresa, K&E
team re same (.7); analyze issues re same
(1.1); telephone conference with C. Ceresa,
K&E team, U.S. Trustee re same (.3);
telephone conference with C. Ceresa, K&E
team, Committee re same (.3); analyze,
comment on sale declarations (.3).
08/16/24 Tabitha J. De Paulo
0.80 Review and comment on declarations in
support of sale orders.
08/16/24 Anthony M. Del Rio
2.30 Prepare regulatory filing (1.3); analyze
transaction issues (1.0).
08/16/24 Jaina Desai
4.00 Telephone conference with E. Clark, K&E
team re cure, sale objection status, next steps
(.5); telephone conference with C. Ceresa re
cure objections, auction follow up (.3);
correspond with C. Ceresa, K&E team re
same (.5); telephone conference with S.
Winters, K&E team, UCC (.1); telephone
conference with AlixPartners (.5); revise
extension notice (.4); correspond with
Company re signature packets (.3);
correspond with Cole Schotz re notice filing
(.2); correspond with K. Chiaghana re cure
objections (.3); correspond with third parties,
AlixPartners re cure objections (.9).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 498 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
47
Date
Name
Hours Description
08/16/24 Jaina Desai
3.40 Review, analyze correspondence re sale, cure
objections (1.2); revise cure, sale objection
tracker (.8); review, analyze adequate
assurance materials (.3); correspond with
third parties re same (.3); correspond with
Goodwin re adequate assurance materials,
cure objections (.3); correspond with J.
Raphael re same (.1); correspond with
AlixPartners re sale documents (.1);
correspond with C. Ceresa re same (.1);
correspond with J. Raphael re cure, sale
objections (.2).
08/16/24 Luke Finn
5.30 Telephone conference with S. Toth, K&E
team re Trudell (.6); review Transition
Services Agreement (2.3); correspond with
Company and Cooley regarding court orders
and historic correspondence (1.0); analyze
correspondence re obligations under the Zoll
APA (1.4).
08/16/24 Emma L. Flett
0.50 Analyze correspondence re data privacy
query.
08/16/24 Justin M. Garfinkle
3.10 Review, analyze asset purchase agreement
(1.0); analyze registered IP schedules (2.1).
08/16/24 Olivia Kaufmann
0.30 Telephone conference with state regulator re
license application (.1); correspond with J.
Garfinkle, K&E team re same (.2).
08/16/24 Brandan Matthews
2.20 Review, analyze Zoll transaction issues.
08/16/24 Ruan J. Meintjes
1.30 Participate in telephone conference with
Trudell counsel re California Manufacturing
license (.6); coordinate with Company, S.
Toth, K&E team re the same (.7).
08/16/24 Trent Nachbar
2.70 Review, analyze, revise APA and schedules.
08/16/24 Dan O'Connor
3.80 Telephone conference with PJT, Alix,
Company, S. Toth, K&E team re Trudell
issues list (1.0); review and revise disclosure
schedules (1.5); correspond with Crowell and
Cooley teams re same (.8); telephone
conference with Company re disclosure
schedules (.5).
08/16/24 Sarah Osborne
0.60 Telephone conference with C. Ceresa, K&E
team re sale and cure objections.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 499 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
48
Date
Name
Hours Description
08/16/24 Carolin Paus
0.70 Telephone conference with Company and
Finkenhof re status of Vyaire Medical
GmbH's liquidity planning and the sales
process.
08/16/24 Carolin Paus
0.80 Correspond with D. Wang, K&E team re next
steps re liquidity planning and sale process re
German entities.
08/16/24 Scottie Shermetaro
2.60 Review and revise Trudell Asset Purchase
Agreement (1.2); review and revise IP
disclosure schedules (1.4).
08/16/24 Steve Toth
6.80 Analyze correspondence re diligence and
APA (.2); participate in telephone
conference with Company, S. Winters, K&E
team, Alix and PJT re management update
(.6); prepare correspondence re same (.3);
analyze revised bidder APA (1.0); prepare
issues list (.6); analyze correspondence re
transaction documents (.8); telephone
conference with S. Winters, K&E team re
same (.2); participate in telephone conference
re APA issues with Company, PJT, Alix, S.
Winters and K&E team (1.0); analyze
schedule (.4); prepare updated issues list re
APA (.9); revise, distribute APA tax
provisions (.5); telephone conference with D.
O'Connor re schedules (.1); prepare
correspondence re APA issues (.2).
08/16/24 Donatus Wang
1.30 Prepare and attend update call with Company
and Finkenhof on status of Vents and RDx
sales processes, liquidity forecast for Vyaire
Medical GmbH and tax structuring (.7);
debrief, review and revise call summary and
suggested next steps prepared by C. Paus (.6).
08/16/24 Spencer A. Winters, P.C.
3.50 Review and analyze issues re sale hearing,
sale (1.7); telephone conference with
AlixPartners, PJT, S. Toth, K&E team re
same (1.0); correspond with AlixPartners,
PJT, S. Toth, K&E team re same (.8).
08/16/24 Ann-Kathrin Ziegler
0.50 Review summary of call with Company and
German management counsel re sale process
items.
08/17/24 Tiffani Chanroo
2.90 Review, analyze correspondence re sale (2.3);
correspond with E. Clark, K&E team re same
(.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 500 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
49
Date
Name
Hours Description
08/17/24 Kenny Chiaghana
0.20 Correspond with various sale order
counterparties re open legal issues.
08/17/24 Erica D. Clark
2.10 Review and analyze correspondence re sale
objections, sale materials (1.3); analyze,
comment on sale order, sale declarations (.8).
08/17/24 Jaina Desai
3.80 Revise sale order re vents (.6); correspond
with E. Clark, K&E team re same (.1); revise
sale order re respiratory diagnostics assets
(1.2); correspond with E. Clark, K&E team re
same (.2); correspond with AlixPartners re
same (.2); correspond with UST re same (.1);
review, analyze bidding procedures order (.3);
correspond with C. Ceresa re same (.1);
correspond with J. Raphael re same (.1);
review, analyze correspondence re sale
stream, cure objections (.3); telephone
conference with Omni re service (.1);
correspond with J. Raphael re same (.1);
compile signature packets (.3); correspond
with B. Matthews, K&E team re same (.1).
08/17/24 Luke Finn
3.60 Telephone conference with S. Toth, K&E
team re transition services (2.4);
analyze, distribute IT contracts (1.2).
08/17/24 Justin M. Garfinkle
0.50 Analyze patent schedules re sales.
08/17/24 Brandan Matthews
3.00 Analyze open intellectual property and
transitional services matters.
08/17/24 Trent Nachbar
0.40 Review, analyze APA and schedules re legal
issues.
08/17/24 Joshua Raphael
2.40 Review, revise Braley declaration ISO sales
(1.5); correspond with E. Clark re same (.2);
review, revise Schlappig declaration (.7).
08/17/24 Scottie Shermetaro
2.70 Telephone conference with S. Toth, K&E
team re TSA (.4); review and revise TSA
(1.5); review and revise IP Schedules (.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 501 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
50
Date
Name
Hours Description
08/17/24 Steve Toth
7.90 Analyze correspondence re APA and TSA
issues (.3); telephone conference re APA
issues with Company, S. Winters, K&E, PJT
and Alix (.7); telephone conference re APA
issues with bidder, bidder advisor, Company,
S. Winters, K&E team, PJT and Alix (1.9);
correspond with S. Winters, K&E team re
transaction issues (1.2); revise APA (.7);
telephone conference re TSA with Crowell,
Company, Alix, S. Winters, and K&E
team(1.2); draft correspondence re TSA (.3);
revise TSA (1.2); correspond with Crowell re
APA (.1); revise APA (.1); telephone
conference with Crowell re TSA (.2).
08/18/24 Samantha Bradley
3.50 Prepare SCCs and UK Addendum (1.1);
discuss details of data transfer with S. Toth
and K&E team (.7); draft, revise summary re
same (1.7).
08/18/24 Anthony M. Del Rio
0.30 Review and revise workplan re health
regulatory matters re same.
08/18/24 Jaina Desai
0.50 Correspond with AlixPartners, cure parties re
cure objections.
08/18/24 Luke Finn
2.10 Telephone conference with S. Toth, K&E
team re APA (1.0); telephone conference with
E. Flett, K&E team re GDPR issues (.5);
review and revise Data Transfer Agreement
(.6).
08/18/24 Emma L. Flett
2.20 Analyze correspondence re Company data
transfer agreement (.8); telephone conference
with L. Finn re same (.6); correspond with S.
Bradley re same (.2); review, analyze data
transfer agreement (.6).
08/18/24 Justin M. Garfinkle
0.80 Draft updates to registered IP schedules.
08/18/24 Sabrina Lieberman
0.70 Review, analyze NDA (.2); correspond with
PJT, Y. Salloum, K&E team re same (.3);
conference with PJT, S. Winters, K&E team
re same (.2).
08/18/24 Brandan Matthews
2.00 Telephone conference with S. Toth, K&E
team re sale stream (.5); analyze signing
matters (.5); analyze open intellectual
property matters re Zoll asset purchase
agreement (1.0).
08/18/24 Trent Nachbar
0.50 Analyze legal issues re APA and schedules.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 502 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
51
Date
Name
Hours Description
08/18/24 Yusuf Salloum
0.50 Analyze legal issues re sale transactions.
08/18/24 Scottie Shermetaro
1.00 Correspond with external counsel re IP
Schedule revisions (.2); review and revise IP
Schedules based on comments (.8).
08/18/24 Steve Toth
6.10 Analyze correspondence re revised TSA and
APA issues (.3); participate in all hands
teleconference re APA issues (.8); prepare
related correspondence (.1) and discuss with
S. Winters (.1); revise APA and analyze
related correspondence (1.0); discuss
transaction issues with Company, PJT, Alix,
and K&E team (.4); revise APA (.3); discuss
tax insurance with bidder, bidder advisors,
Marsh, Company, and K&E team (.5); revise
APA and distribute (.7); analyze and respond
to correspondence re TSA and tax (.5);
analyze revised TSA and revise and prepare
related correspondence (1.4).
08/18/24 Spencer A. Winters, P.C.
4.60 Prepare for telephone conference with bidder
re sale (.5); telephone conferences with bidder
re sale (1.0); telephone conference re same
(.5); telephone conference with PJT re bidder
issues (.3); review and analyze issues re sales
process (1.2); telephone conference with S.
Toth, K&E team, PJT re sale (.7); correspond
with S. Toth, K&E team, PJT re same (.4).
08/19/24 Chris Ceresa
3.90 Review, revise sale related agreements and
court filings (3.5); telephone conference with
Company, advisors, S. Toth, K&E team re
same (.4).
08/19/24 Tiffani Chanroo
4.60 Conference with E. Clark, K&E team re sale
process (.6); correspond with J. Desai re sale
issues (1.3); review, revise sale order (.8);
review, analyze issues re sale (1.9).
08/19/24 Kenny Chiaghana
1.20 Correspond with various sale order
counterparties (.8); conference with E. Clark,
K&E team re same (.4).
08/19/24 Erica D. Clark
6.30 Telephone conference with C. Ceresa, K&E
team re sale order, sale objections (2.3);
analyze issues, comment re same (3.6);
prepare and conference with cure party, J.
Desai, K&E team re sale objection (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 503 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
52
Date
Name
Hours Description
08/19/24 Bernadette Coppola
0.30 Correspond with S. Shermetaro, K&E team re
revisions to intellectual property schedules.
08/19/24 Tabitha J. De Paulo
1.20 Review revised declarations in support of
sales.
08/19/24 Anthony M. Del Rio
0.50 Review and comment on regulatory filing
analysis.
08/19/24 Jaina Desai
5.30 Telephone conference with E. Clark, K&E
team re sale, cure objection status, next steps
(.5); correspond with AlixPartners re cure
objections (.5); telephone conference with
AlixPartners re same (.5); correspond with T.
Chanroo, E. Clark re cure and sale objections
(.3); telephone conference with cure objection
parties (.5); review, analyze objections filed
on docket (.7); review, analyze objection
tracker (.6); revise same (.6); review, analyze
correspondence re cure objections (.5);
correspond with cure parties re same (.6).
08/19/24 Jaina Desai
1.30 Correspond with Cooley re sale order
language (.3); correspond with T. Chanroo, E.
Clark re same (.3); revise cure and sale
objection tracker (.7).
08/19/24 Jaina Desai
5.00 Revise sale orders (2.7); draft correspondence
re same (.3); correspond with S. Winters re
same (.1); correspond with AlixPartners re
same (.2); correspond with T. Chanroo re
same (.3); review, analyze sale order
precedent (.3); review, analyze cure
objections (.4); correspond with cure parties
re same (.6); correspond with AlixPartners re
same (.1).
08/19/24 Luke Finn
4.60 Participate in telephone conference re APA,
Zoll HR (1.0); coordinate with Cooley,
Company, S. Toth, K&E team re employment
counsel matters (.9); telephone conference
with T. Noll re sale closing (.4); correspond
with S. Toth re same (.5); coordinate with
Company re census development and data
transfer agreement (1.0); analyze
correspondence with Cooley regarding
international Benefits Plans (.8).
08/19/24 Emma L. Flett
0.50 Analyze correspondence re Company data
transfer agreement (.3); analyze data transfer
agreement (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 504 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
53
Date
Name
Hours Description
08/19/24 Justin M. Garfinkle
3.00 Respond to RDx purchaser re registered IP
questions (.3); review, analyze comments to
IP schedules (.7); draft updates re same (2.0).
08/19/24 Daniel Lewis, P.C.
1.00 Analyze IP disclosures (.5); correspond with
T. Hales and IP counsel re IP disclosures (.5).
08/19/24 Brandan Matthews
1.00 Analyze open intellectual property matters re
Zoll asset purchase agreement.
08/19/24 Ruan J. Meintjes
0.30 Correspond with Company re California
manufacturing license issue.
08/19/24 Trent Nachbar
0.80 Review, analyze legal issues re APA and
schedules.
08/19/24 Dan O'Connor
2.70 Correspond with AlixPartners re financial
statement matters (.4); Correspond with N.
Warther and P. Gunderson re disclosure
schedule matters (.3); review and revise
disclosure schedules (.5); Correspond with M.
Repetto re same (.5); correspondence with S.
Toth, K&E team re Trudell comments to APA
(.5); telephone conference with Company and
L. Finn re HR and APA matters (.5).
08/19/24 Scottie Shermetaro
4.80 Review and revise IP Disclosure Schedules
(4.3); correspond with Company re new
additions and deletions of IP (.5).
08/19/24 Steve Toth
4.30 Telephone conference with S Winters re
transaction update (.1); analyze
correspondence re transaction updates (.4);
telephone conference with PJT, Alix,
Company, S. Winters and K&E team re
management updates (.6); analyze
correspondence re Tax, TSA, and insurance
(.6); telephone conference with D. O’Connor
re Canada contracts (.2); telephone
conference re insurance update with S.
Winters, K&E team and Company (.3)
analyze correspondence re same (.3);
telephone conference re tax matters with N.
Warther (.4); analyze correspondence re
schedules, TSA (.6); analyze revised APA
(.6); draft correspondence re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 505 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
54
Date
Name
Hours Description
08/19/24 Spencer A. Winters, P.C.
4.60 Prepare for call with C. Ceresa, K&E team re
sale hearing prep (.2); telephone conference
with C. Ceresa, K&E team re same (.3);
prepare for weekly call with Company and
advisors (.2); telephone conference with
Company and advisors (.3); telephone
conference with S. Toth, K&E team re tax
and insurance calls (.5); review and analyze
issues re bid, sale hearing (1.8); correspond
with multiple parties re same (1.0); telephone
conference with multiple parties re same (.3).
08/20/24 Chris Ceresa
7.40 Review, revise sale related agreements and
court filings (3.9); telephone conference with
S. Toth, K&E team, Alix, PJT, and Company
re same (1.7); correspond with S. Toth, K&E
team, Alix, PJT, and Company re same (1.8).
08/20/24 Tiffani Chanroo
8.20 Conference with E. Clark re sale objections
(.5); review, analyze issues re same (3.9);
correspond with J. Desai, K&E team re sale
process (3.8).
08/20/24 Kenny Chiaghana
2.50 Correspond with various counterparties re
sale order (1.0); telephone conference with E.
Clark, K&E team re same (.6); research re
same (.9).
08/20/24 Erica D. Clark
6.40 Analyze issues, comment on sale orders,
objection language (3.0); prepare for filing of
same (.9); correspond with J. Desai, K&E
team re same (.9); telephone conference with
J. Desai, K&E team re sale hearing, sale
objections (.8); telephone conference with
Company advisors re cash forecast (.8).
08/20/24 Bernadette Coppola
0.60 Conference with S. Shermetaro and J.
Garfinkle re intellectual property matters re
sale.
08/20/24 Tabitha J. De Paulo
0.30 Review, revise C. Braley declaration in
support of sale.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 506 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
55
Date
Name
Hours Description
08/20/24 Jaina Desai
3.80 Correspond with cure objection parties,
Cooley re sale order language (.5); correspond
with T. Chanroo re same (.3); correspond with
Cole Schotz re affidavits (.2); revise sale
order (.3); analyze, compile documents re
same (.5); correspond with T. Chanroo re
same (.2); correspond with cure and sale
objection parties (.4); correspond with
AlixPartners, E. Clark, K&E team re same
(.4); draft correspondence re sale order (.5);
correspond with Cooley, Gibson Dunn,
McDermott, U.S. Trustee re same (.3);
correspond with T. Chanroo, J. Raphael re
same (.2).
08/20/24 Jaina Desai
3.40 Review, analyze objection summary (.3);
correspond with E. Clark re same (.1); review,
analyze comments re sale orders (.3); review,
analyze bidding procedures order (.4); revise
sale orders (1.4); correspond with E. Clark, T.
Chanroo re same (.2); review, analyze
correspondence re cure objections (.5);
correspond with T. Chanroo re same (.2).
08/20/24 Jaina Desai
4.70 Correspond with Crowell re sale orders (.1);
correspond with Cole Schotz re sale hearing
logistics (.2); correspond with Cooley,
purchaser re same (.1); telephone conference
with C. Ceresa, K&E team re sale stream,
next steps (.5); correspond with cure and sale
objection parties (1.3); revise sale order (.5);
analyze, compile sale documents for filing
(1.5); correspond with C. Ceresa, K&E team,
Cole Schotz re same (.5).
08/20/24 Luke Finn
4.50 Correspond with McDermott team regarding
ZOLL disclosure schedules (.7); draft initial
memo regarding ZOLL interim operating
covenants (2.0); review, analyze potential
issues with sale process re IP assets (.7);
correspond with PJT Partners and Company
re same (1.1).
08/20/24 Justin M. Garfinkle
2.20 Telephone conference with D. Lewis, K&E
team re IP schedules (.6); draft updates to
schedule (1.6).
08/20/24 Kate Hardey
0.20 Confer with R. Meintjes re California license
change of ownership process.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 507 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
56
Date
Name
Hours Description
08/20/24 Kate Hardey
0.50 Review California license application and
related correspondence from Company re
change of ownership in connection with sale
process.
08/20/24 Daniel Lewis, P.C.
0.50 Correspond with S. Toth and K&E team re
disclosures schedules and IP matters.
08/20/24 Brandan Matthews
0.50 Analyze open intellectual property matter re
Zoll asset purchase agreement.
08/20/24 Dan O'Connor
3.60 Correspond with Company re financial
statement matters (.5); revise disclosure
schedules re tax matters (.6); correspond with
N. Warther and P. Gunderson re same (.2);
review and revise APA (1.8); correspond with
S. Toth re same (.5).
08/20/24 Scottie Shermetaro
3.60 Telephone conference with B. Coppola and J.
Garfinkle re IP Schedules (.5); review and
revise IP disclosure schedules (3.1).
08/20/24 Steve Toth
8.00 Analyze correspondence re APA, diligence
and schedules matters (.9); correspond with S.
Winters re APA status(.1); telephone
conference with Company, S. Winters, K&E
team re tax insurance update (.5); telephone
conference with Crowell re APA and bid (.3);
analyze correspondence re APA tax matters
(.3); telephone conference with S. Winters,
K&E team re tax insurance (.3); correspond
with S. Winters, K&E team re insurance and
lender matters (.7); telephone conference with
lender advisors, PJT, Alix, S. Winters, and
K&E team re budget (.8); discuss APA with
N. Warther (.2);analyze and revise APA (.9);
telephone conference with Cooley re
APA(.1); analyze correspondence re
finalizing APAs (.4); analyze APA (.2); draft
correspondence re same (.1); revise, finalize
bid APA (2.2).
08/20/24 Kyle Nolan Trevett
0.30 Review, revise Frejka declaration ISO sales
(.2); correspond with T. De Paulo, E. Frejka
re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 508 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
57
Date
Name
Hours Description
08/20/24 Spencer A. Winters, P.C.
6.50 Review and analyze issues re paydown and
reserve (1.8); review and analyze issues re
finalization of sale (1.9); review and analyze
issues re sale hearing (1.5); correspond with
S. Toth, K&E team, Company re same (.5);
telephone conferences with S. Toth, K&E
team, Company re same (.8).
08/21/24 Cooper Barghols
0.40 Correspond with K. Hardey, A. Del Rio, R.
Meintjes and O. Kaufmann re outstanding
licensure matters re sale process.
08/21/24 Samantha Bradley
0.50 Review, analyze comments on SCCs / DTA.
08/21/24 Chris Ceresa
3.70 Review, revise sale related agreements and
court filings (2.0); telephone conference with
Company, advisors, S. Toth, K&E team re
same (1.0); correspond with S. Toth, K&E
team, Company, advisors re same (.7).
08/21/24 Tiffani Chanroo
6.10 Review, analyze issues re sale (3.9);
correspond with J. Desai, K&E team re same
(2.2).
08/21/24 Kenny Chiaghana
1.50 Correspond with various sale counterparties
(.1); conference with J. Desai, K&E team re
same (.1); correspond with T. Chanroo,
AlixPartners re same (.2); draft supplemental
contract notice (1.1).
08/21/24 Erica D. Clark
7.20 Analyze, comment on declarations ISO sales,
objections (3.9); analyze, comment on sale
order language (1.0); correspond with various
parties re same (1.4); telephone conference
with S. Winters re sale order (.3); telephone
conference with J. Desai, K&E team re sale
objections, sale hearing (.6).
08/21/24 Joseph A. D'Antonio
0.10 Correspond with T. De Paulo re M. Schlappig
declaration issues.
08/21/24 Tabitha J. De Paulo
0.50 Review and comment on Frejka declaration
(.3); revise PJT declaration in support of sale
(.2).
08/21/24 Anthony M. Del Rio
0.50 Review and comment on regulatory filing
analysis.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 509 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
58
Date
Name
Hours Description
08/21/24 Jaina Desai
5.40 Correspond with E. Clark, T. Chanroo re sale
orders (.3); analyze, compile sale orders (.4);
correspond with J. Raphael re same (.1);
correspond with S. Lieberman re cure
objection (.1); telephone conference with E.
Clark, K&E team re sale stream status, next
steps (.5); correspond with J. Raphael, Omni
re noticing, service (.5); correspond with
AlixPartners re revised cure schedule (.3);
telephone conference with AlixPartners re
same (.2); correspond with K&E team, C.
Ceresa re objection party notice (.3);
correspond with K. Chiaghana re sale stream
objections (.3); correspond with cure parties
re objections (1.2); correspond with T.
Chanroo re same (.4); draft correspondence re
same (.4); further revise sale orders (.4).
08/21/24 Jaina Desai
5.10 Correspond with AlixPartners, sale and cure
objection parties re objection (2.5); telephone
conference with AlixPartners re same (.5);
telephone conference with objection parties re
same (.3); revise objection tracker (.5);
review, analyze sale order language (.3);
correspond with objection parties re same
(.2); correspond with T. Chanroo re same (.3);
revise sale order (.5).
08/21/24 Jaina Desai
1.00 Correspond with AlixPartners re cure
objections (.3); correspond with J. Raphael re
sale stream, sale order (.3); review, analyze
sale order language (.2); correspond with T.
Chanroo re same (.2).
08/21/24 Luke Finn
5.30 Review Cooley draft of data transfer
agreement and census matters (.4); execute
data transfer agreement with Company (.4);
review schedules 1.6 of Disclosure Schedules
(1.0); telephone conference with D. Lewis,
K&E team re same (.4); telephone conference
with Company re Zoll APA negotiation
strategy and Zoll integration (.9); Coordinate
with J. Desai, K&E team re sale hearing
preparation (1.1); telephone conference with
Cooley, S. Toth, K&E team re APA, tax
issues(1.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 510 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
59
Date
Name
Hours Description
08/21/24 Emma L. Flett
0.50 Analyze correspondence re data transfer
agreement (.4); telephone conference with S.
Bradley re same (.1).
08/21/24 Justin M. Garfinkle
3.50 Correspond with L. Finn and K&E team re
issues re IP schedules (.9); revise same re
same (2.3) review, analyze legal issues re
disclosure schedules (.3).
08/21/24 Kate Hardey
0.40 Correspond with R. Meintjes, K&E team re
California license transfer process in
connection with sales.
08/21/24 Olivia Kaufmann
0.40 Telephone conference with A. Del Rio, K.
Hardey, R. Meintjes, and C. Barghols
regarding FDA Establishment Registration
and CA license.
08/21/24 Daniel Lewis, P.C.
0.50 Correspond with S. Toth and K&E team re
disclosures schedules and IP matters.
08/21/24 Sabrina Lieberman
0.90 Conference with C. Ceresa, K&E team, Cole
Schotz re sale hearing issues (.4); conference
with Omni, J. Raphael re service of sale
pleadings (.4): correspond with J. Desai re
same (.1).
08/21/24 Brandan Matthews
0.20 Analyze open signing matters.
08/21/24 Ruan J. Meintjes
0.60 Review, analyze regulatory filing
requirements (.3); coordinate with A. Del Rio
re the same (.3).
08/21/24 Dan O'Connor
2.00 Correspond with Crowell team re transaction
status and punch list (.8); review and revise
disclosure schedules (1.2).
08/21/24 Sarah Osborne
3.00 Review, revise agenda for sale hearing (.9);
review, analyze docket filings to correspond
with notices (1.1); telephone conference with
C. Ceresa, K&E team re sales updates (.6);
correspond with Omni, J. Desai, K&E team
regarding AOS (.4).
08/21/24 Scottie Shermetaro
3.90 Review and revise IP Disclosure Schedules.
08/21/24 Steve Toth
2.00 Analyze correspondence re finalizing APA
and schedules (.6); correspond with S.
Winters, K&E team re same (.2); correspond
with S. Winters, K&E team re tax matters
(.2); analyze correspondence re APAs and tax
(.5); telephone conference with Cooley, S.
Winters, K&E team re Zoll APA (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 511 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
60
Date
Name
Hours Description
08/21/24 Kyle Nolan Trevett
2.00 Review, revise Frejka declaration (1.5);
correspond with C. Ceresa, E. Frejka, E.
Clark re same (.5).
08/21/24 Spencer A. Winters, P.C.
2.60 Review and analyze issues re sale hearing,
waterfall (1.3); correspond with S. Toth, K&E
team, PJT, Company re same (.7); telephone
conference with PJT, Company, S. Toth,
K&E team re same (.6).
08/22/24 Samantha Bradley
0.50 Review, revise executed agreement (.3);
correspond with L. Finn re same (.2).
08/22/24 Chris Ceresa
3.90 Review, revise sale related agreements and
court filings (2.1); correspond and telephone
conferences with K&E team, advisors,
Company re same (1.8).
08/22/24 Tiffani Chanroo
10.50 Conference with E. Clark, K&E team, CS
team re sale hearing preparation (2.7); review,
analyze sale issues (3.9); correspond with J.
Desai, K&E team re sale hearing issues (3.9).
08/22/24 Kenny Chiaghana
0.70 Conference with AlixPartners team, J.
Raphael, K&E team re sale hearing.
08/22/24 Kenny Chiaghana
3.00 Analyze, revise supplemental contract notice
(2.2); correspond with various contract parties
re sale hearing (.4); correspond with T.
Chanroo, K&E team re same (.4).
08/22/24 Erica D. Clark
6.90 Analyze issues re sale objections (1.1);
correspond with C. Ceresa, K&E team re
same (.3); conference with Company, DIP
lender advisors re holdback schedule (1.4);
conference with C. Ceresa, K&E Team, Alix
re hearing prep (.8); conferences and
correspond with C. Ceresa, K&E team, Alix
re sale order (1.4); analyze issues, comment
on same (1.9).
08/22/24 Bernadette Coppola
0.40 Conference with S. Toth, Alix Partners, and
team re acquired business perimeter (.3);
correspond with S. Toth and team re
intellectual property schedules (.1).
08/22/24 Anthony M. Del Rio
0.30 Review and comment on regulatory filing
analysis.
08/22/24 Jaina Desai
3.00 Correspond with cure objection parties re
various sale issues (2.3); revise summary
materials re same (.7).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 512 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
61
Date
Name
Hours Description
08/22/24 Jaina Desai
5.10 Correspond with E. Clark re sale orders (.3);
revise sale orders (.4); review, analyze sale
orders (.3); review, analyze restructuring
transaction steps (.3); correspond with C.
Ceresa, G. Palmer, K&E team re same (.2);
correspond with J. Raphael re same (.1);
review, analyze sale order language re cure
objections (.2); further revise sale orders (.4);
telephone conference with C. Ceresa, T.
Chanroo re sale workstream (.3); telephone
conference with T. Chanroo re same (.3);
telephone conference with T. Chanroo re cure
and sale objections (.6); correspond with T.
Chanroo re same (.4); revise objection chart
(.8); review, analyze precedent re objection
summary chart (.5).
08/22/24 Jaina Desai
3.00 Revise sale order (.7); correspond with T.
Chanroo re same (.3); telephone conference
with cure objection parties (.4); correspond
with cure objection parties re same (.6);
correspond with AlixPartners re same (.4);
telephone conference with AlixPartners re
same (.2); analyze, compile documents re sale
order (.4).
08/22/24 Luke Finn
5.30 Correspond with client HR team re census
and data transfer agreement with M&A
counterparty (1.6); draft escrow agreement
instruction letter (.5); telephone conference
with SRS Acquiom escrow agents (.3);
review, analyze asset purchase agreement
language and disclosure schedules for iX5
issues (.7); correspond with B. Coppola, K&E
team re same (.5); conference with C. Ceresa,
K&E team re Asset Purchase Agreement (.4);
attend to correspondence regarding facility
leases (.4); draft bid comparison summary
(.9).
08/22/24 Justin M. Garfinkle
0.70 Analyze, revise IP schedules.
08/22/24 Daniel Lewis, P.C.
1.00 Review, comment on IP schedules to
purchase agreement.
08/22/24 Sabrina Lieberman
0.20 Conference with J. Raphael re notice re sale
documents (.1); correspond with Omni, J.
Raphael re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 513 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
62
Date
Name
Hours Description
08/22/24 Ruan J. Meintjes
0.10 Coordinate with A. Del Rio re change of
ownership licensure filings.
08/22/24 Dan O'Connor
0.70 Telephone conference with Company, C.
Ceresa and AlixPartners re transition / TSA
matters.
08/22/24 Sarah Osborne
1.30 Correspond with Omni re services and
affidavit filings (.2); review, analyze issues re
cures and sale order objections (.8); review,
revise chart re same (.3).
08/22/24 Joshua Raphael
0.10 Correspond C. Ceresa, K&E team re sale
issues.
08/22/24 Scottie Shermetaro
1.70 Telephone conference with E. Clark, K&E
team re M&A counterparty APA
considerations (.3); review and revise IP
Schedules (1.4).
08/22/24 Steve Toth
4.20 Participate in lender update teleconference
with lender advisors, PJT, Alix, C. Ceresa,
and K&E team (1.4); analyze related
correspondence (.3); discuss TSA and asset
perimeter with AlixPartners, E. Clark, and
K&E team (.4); analyze revised APA and
prepare related correspondence (1.2); discuss
APA with M&A counterparty (.1); discuss
bidder transition matters with Company, Alix,
E. Clark, and K&E team (.8).
08/22/24 Spencer A. Winters, P.C.
3.50 Review and analyze issues re sale hearing
(1.8); correspond and telephone conferences
with S. Toth, K&E team, Company, multiple
parties re same (1.7).
08/23/24 Chris Ceresa
4.20 Review, revise sale related agreements and
court filings (2.8); correspond and telephone
conferences with T. Chanroo, K&E team,
advisors, Company re same (1.4).
08/23/24 Tiffani Chanroo
5.90 Review, analyze issues re sale (3.9);
correspond with J. Desai re same (.6); review,
revise sale order (.8); correspond with J.
Raphael, K&E team re same (.6).
08/23/24 Kenny Chiaghana
3.90 Analyze, revise supplemental contract notice
(3.3); correspond with C. Ceresa, K&E team
re same (.2); conference with E. Clark, K&E
team re same (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 514 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
63
Date
Name
Hours Description
08/23/24 Erica D. Clark
4.70 Conferences with S. Winters re sale hearing
(.2); conferences with buyer’s counsel re
same (.2); revise sale order and analyze
related issues (1.4); analyze sale objection
status, correspondences (1.8); conference with
sale team re sale objections, sale hearing (.5);
conference with K&E, PJT re sale hearing
prep (.6).
08/23/24 Bernadette Coppola
0.60 Conference with buyer’s counsel, S.
Shermetaro, and team re intellectual property
schedule (.5); correspond with buyer’s
counsel re same (.1).
08/23/24 Jaina Desai
3.50 Draft sale objection summary chart.
08/23/24 Jaina Desai
3.00 Correspond with sale, cure objection parties
re sale objection and cure matters.
08/23/24 Jaina Desai
2.00 Revise sale orders (.4); correspond with E.
Clark re same (.1); telephone conference with
E. Clark, K&E team re sale status, next steps
(.5); telephone conference with AlixPartners
re cure objections (.3); revise cure objection
tracker (.7).
08/23/24 Luke Finn
6.70 Telephone conference with AlixPartners re
asset purchase agreement (.5); finalize bid
comparison summary (1.5); correspond with
PJT re same (.2); review, analyze interim
operating covenants and shelters (.4); review,
analyze matters re M&A counterparty bid
(.5); review, analyze issues re representations
and warranties (.6); review, analyze
counterparty APA draft (1.8); telephone
conferences with S. Toth, M&A counterparty
re patents (1.2).
08/23/24 Justin M. Garfinkle
0.80 Discuss IP schedules with opposing Vents
counsel (.5); attend to IP schedules (.3).
08/23/24 Kate Hardey
0.20 Conference with R. Meintjes, K&E team re
issues re California license transfer process
related to the sales.
08/23/24 Brandan Matthews
0.50 Provide requested documentation to teams
preparing for transition (.2); attend to open
intellectual property matter regarding M&A
counterparty asset purchase agreement (.3).
08/23/24 Dan O'Connor
0.50 Prepare APA summary for Trudell bid and
emails with L. Finn re same (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 515 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
64
Date
Name
Hours Description
08/23/24 Sarah Osborne
1.30 Draft summary re sale process (1.1);
correspond with J. Raphael re same (.2).
08/23/24 Scottie Shermetaro
3.30 Telephone conference with B. Coppola, J.
Garfinkle and opposing counsel re patent
license (.5); review and revise M&A
counterparty APA, including drafting new
patent license language (1.3); review and
revise disclosure schedules (1.5).
08/23/24 Steve Toth
2.70 Discuss payables with Company and Alix
(.1); discuss APA with buyer’s counsel (.2);
analyze APA matters (.8); analyze revised
APA drafts and prepare comments (1.1);
analyze bid comparison summary and prepare
comments (.5).
08/23/24 Kyle Nolan Trevett
0.50 Telephone conference with T. De Paulo, E.
Frejka re declaration, testimony (.4);
correspond with T. De Paulo, E. Frejka re
same (.1).
08/23/24 Spencer A. Winters, P.C.
1.50 Review and analyze issues re sale hearing,
paydown and wind-down amounts (.8);
correspond and telephone conferences with C.
Ceresa, K&E team, advisors re same (.7).
08/24/24 Chris Ceresa
1.20 Review, revise sale related agreements and
court filings (.7); correspond and telephone
conferences with K&E team, advisors,
Company re same (.5).
08/24/24 Tiffani Chanroo
3.10 Review, analyze issues re sale workstream
(2.7); correspond with J. Raphael, K&E team
re same (.4).
08/24/24 Kenny Chiaghana
5.10 Analyze, revise summary of sale objections re
hearing prep (3.8); correspond with S.
Osborne, K&E team re same (.3); research re
same (1.0).
08/24/24 Erica D. Clark
5.70 Conferences and correspond with various
parties re sale order, sale objections, sale
hearing (.9); analyze issues, comment on
materials re same (4.8).
08/24/24 Jaina Desai
1.50 Review, analyze cure correspondence,
tracker.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 516 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
65
Date
Name
Hours Description
08/24/24 Luke Finn
2.20 Correspond with the C. Ceresa, K&E team re
UCC reservation of rights (.8); revise
disclosure schedules (.7); correspond with
buyer’s counsel regarding updated disclosure
schedules and updated Asset Purchase
Agreement (.7).
08/24/24 Brandan Matthews
0.50 Analyze legal issues, revise APA.
08/24/24 Sarah Osborne
2.00 Review, revise sale objection summary chart
(1.1); review, revise update correspondence to
K&E UK team re sale process (.9).
08/24/24 Steve Toth
0.70 Analyze correspondence re APA and
schedules legal issues.
08/24/24 Spencer A. Winters, P.C.
2.20 Analyze issues re sale hearing (.8); draft
outline of slides re same (.7); review and
analyze issues re same (.7).
08/25/24 Chris Ceresa
1.90 Review, analyze legal issues re sales (1.0);
correspond with S. Winters, K&E team,
advisors, Company re same (.6); draft and
review pleadings and materials re same (.3).
08/25/24 Tiffani Chanroo
1.90 Review, analyze issues re sale work stream
(1.4); correspond with C. Ceresa, K&E team,
contract counterparties re same (.5).
08/25/24 Erica D. Clark
9.30 Conferences and correspond with various
parties re sale order, sale objections, sale
hearing (2.6); analyze legal issues re same
(3.9); further analyze and comment on legal
issues re same (2.8).
08/25/24 Bernadette Coppola
0.10 Conference with buyer's counsel, S.
Shermetaro, and K&E team re intellectual
property transfers.
08/25/24 Luke Finn
1.70 Correspond with B. Coppola, K&E team re
Brazilian and German IP matters and
Disclosure Schedule updates.
08/25/24 Justin M. Garfinkle
1.00 Analyze, revise registered IP schedules.
08/25/24 Daniel Lewis, P.C.
0.20 Correspond with S. Toth and K&E team re IP
issues.
08/25/24 Brandan Matthews
0.10 Review sale signing legal issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 517 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
66
Date
Name
Hours Description
08/25/24 Joshua Raphael
3.00 Revise sale presentation (1.0); review, revise
hearing talking points (.4); correspond with S.
Winters, K&E team, advisors re same (.5);
revise objection cheat sheet and orders (.3);
conferences with E. Clark re orders (.3);
correspond with advisors, lenders re orders
(.1); correspond with purchaser re sale (.1);
review, revise hearing notice (.3).
08/25/24 Scottie Shermetaro
0.20 Review and revise M&A counterparty APA
markup.
08/25/24 Steve Toth
0.50 Analyze and respond to correspondence re IP,
APA and schedules.
08/25/24 Spencer A. Winters, P.C.
6.90 Review and analyze issues re sale hearing,
allocation of proceeds (2.3); correspond and
telephone conferences with multiple parties re
same (2.1); draft talking points re same (2.5).
08/26/24 Chris Ceresa
9.60 Review, analyze legal issues re sales (3.9);
correspond with S. Winters, K&E team,
advisors, company re same (2.2); draft and
review pleadings and materials re same (3.5).
08/26/24 Tiffani Chanroo
5.40 Review, analyze issues re sale workstream
(3.9); correspond with C. Ceresa, K&E team,
contract counterparties re same (1.5).
08/26/24 Kenny Chiaghana
4.00 Analyze, revise summary of sale objections
(2.5); same re sale order (1.5).
08/26/24 Erica D. Clark
6.90 Conferences and correspond with various
parties re sale order, sale hearing (2.4);
conference with UCC counsel and debtor
counsel re DIP paydown, holdback, related
issues (1.4); analyze issues, comment on
materials re same (3.1).
08/26/24 Bernadette Coppola
2.20 Correspond with Company, S. Shermetaro,
K&E team re intellectual property schedules
(.4); conference with buyer, advisors re
transition services agreement schedules (.8);
conference with buyer's counsel re patent
license (.1); draft revisions to patent license
(.4); correspond with buyer's counsel and
team re various issues re same (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 518 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
67
Date
Name
Hours Description
08/26/24 Tabitha J. De Paulo
3.00 Discuss issues re sale orders and paydown
proposals with AlixPartners, S. Winters, and
K&E team (1.1); review, analyze
correspondence with lender and UCC counsel
re same (.7); analyze evidentiary issues for
hearing re same (1.2).
08/26/24 Jaina Desai
1.60 Telephone conference with AlixPartners re
sale and cure objections (.2); review, analyze
correspondence re same (.4); telephone
conference with S. Osborne re same (.1);
correspond with C. Ceresa, K&E team re
same (.2); review, analyze cure objections
tracker, correspondence (.4); review, analyze
objection summary chart (.3).
08/26/24 Luke Finn
5.30 Review and prepare transaction steps
memorandum/schedule (.4); correspond with
Company re same (.5); draft data transfer
agreement for re M&A counterparty bid (.4);
review and prepare final versions of certain
Disclosure Schedule attachment (.7);
telephone conference with client re Surety
Bonds issues (.6); telephone conference with
Company re asset purchase agreement (.6);
correspond with Compnay re iX5 patents and
Brazilian entity sale and Registered IP
Schedules and potential licensing solution
(2.1).
08/26/24 Emma L. Flett
0.50 Analyze correspondence re data transfer
agreement.
08/26/24 Justin M. Garfinkle
0.20 Review, revise disclosure schedules.
08/26/24 Kate Hardey
0.80 Review, analyze correspondence from
Company re product sales issues (.6);
conference with R. Meintjes re same (.2).
08/26/24 Maggie Kate King
1.00 Conference with M&A counterparty re
transition services schedules.
08/26/24 Daniel Lewis, P.C.
0.30 Correspond with S. Toth, K&E team re IP
issues.
08/26/24 Brandan Matthews
1.00 Review, analyze status re sale signing
matters.
08/26/24 Trent Nachbar
1.70 Review, revise APA and schedules.
08/26/24 Dan O'Connor
0.40 Telephone conference with Company,
AlixPartners, J. Raphael, L. Finn and others re
surety bond matters re sales.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 519 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
68
Date
Name
Hours Description
08/26/24 Sarah Osborne
4.50 Prepare for sale hearing (.4); review, revise
ventilation and respiratory diagnostics sale
orders (1.6); compile same for filing (.9);
review, revise notices for sale orders (.3);
correspond with AlixPartners team re updated
cure schedule (.2); draft notice for revised
cure schedule (.9); correspond with
AlixPartners, C. Ceresa, K&E team re cure
amounts (.2).
08/26/24 Scottie Shermetaro
3.30 Telephone conference with client, M&A
counterparty, separation consultants, and M.
King re the TSA services required (1.2);
review and revise APA (2.1).
08/26/24 Steve Toth
1.10 Analyze correspondence re IP and steps
memo (.6); correspond with advisors re A/R,
IP questions (.3); correspond with client re
transition planning (.2).
08/26/24 Spencer A. Winters, P.C.
5.80 Analyze legal issues for sale hearing (1.5);
review and analyze issues re sale, allocation
of proceeds (2.2); correspond and conferences
with Company, advisors, and multiple parties
re same (2.1).
08/27/24 Samantha Bradley
2.50 Review, analyze proposed data sharing
arrangement and discuss Canadian privacy
law requirements and adequacy decision
(1.1); correspond S. Dhillon re same (.3);
review, analyze draft data sharing agreement
(.7); correspond with S. Dhillon re same (.4).
08/27/24 Chris Ceresa
4.80 Review, analyze legal issues re sales (2.7);
correspond with T. Chanroo, K&E team,
advisors, company re same (.9); draft and
review pleadings and materials re same (1.2).
08/27/24 Tiffani Chanroo
6.10 Conferences with C. Ceresa, Company re sale
issues (3.9); Correspond with S. Osborne,
K&E team re sale issues (2.2).
08/27/24 Kenny Chiaghana
3.30 Analyze, revise summary of sale objections
(.4); correspond with S. Osborne re same (.2);
conference with C. Ceresa, K&E team re
same (.4); correspond with various
counterparties re same (.2); analyze, revise
RDx sale order (.5); draft reply ISO sale (1.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 520 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
69
Date
Name
Hours Description
08/27/24 Erica D. Clark
1.90 Conferences and correspond with various
parties re sale order (.8); analyze issues,
comment on, file same (1.1).
08/27/24 Bernadette Coppola
0.60 Correspond with buyers' counsel and team re
license agreement (.3); correspond with
advisors, S. Toth, and team re transition
services agreement schedules (.3).
08/27/24 Anthony M. Del Rio
0.40 Review and comment on vendor supply
questions re sales.
08/27/24 Shareen Dhillon
2.00 Prepare draft of Data Transfer Agreement.
08/27/24 Luke Finn
2.30 Prepare for telephone conference with client
regarding operational issues (.5); attend same
(.6); attend to disclosure issues relating to
certain agreements with company team (.4);
attend to and finalize Data Transfer
Agreement re APA (.8).
08/27/24 Emma L. Flett
1.20 Analyze correspondence re data transfer
agreement (.8); correspond with S Bradley re
same (.4).
08/27/24 Justin M. Garfinkle
0.70 Review legal issues re license of patents re
sales.
08/27/24 Kate Hardey
1.90 Prepare for and participate in telephone
conference with R. Meintjes, K&E team, and
Vyaire team re various transaction, transition,
and diligence matters (1.5); review draft
correspondence re customer device
replacements legal issues (.4).
08/27/24 Olivia Kaufmann
1.60 Conferences with K. Hardey and R. Meintjes
regarding business discussion related to M&A
counterparty unit transfers.
08/27/24 Maggie Kate King
2.00 Telephone conferences with Company, M&A
counterparty re TSA legal issues and open
points.
08/27/24 Ruan J. Meintjes
2.00 Review and analyze product sale options
(1.0); coordinate with K. Hardey re same (.5);
prepare summary of analysis (.5).
08/27/24 Dan O'Connor
1.00 Telephone conference with Company, S. Toth
re interim and transition matters.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 521 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
70
Date
Name
Hours Description
08/27/24 Sarah Osborne
5.60 Telephone conference with C. Ceresa, K&E
team re outstanding cure issues (.5);
correspond with AlixPartners re cure amounts
(.3); correspond with cure parties re same (.2);
review, analyze APA schedules re cure
disputes (2.7); review, analyze APA re cure
consent rights (.8); review, revise sale orders
(.4); compile same (.2); telephone conference
with C. Ceresa, K&E team, AlixPartners,
counterparty re lease and associated cure
costs (.5).
08/27/24 Scottie Shermetaro
3.40 Telephone conferences with M&A
counterparty, B. Coppola, K&E team re TSA
Services (2.3); review and revise IP disclosure
schedules (1.1).
08/27/24 Josh Sussberg, P.C.
0.10 Correspond with advisors re sale issues.
08/27/24 Steve Toth
4.00 Participate in teleconference with Company
and K&E team re operational transition
matters and APA (1.0); analyze
correspondence re APAs and IP (.4);
correspond with B. Coppola re same (.1);
teleconference with Company, Alix, C.
Ceresa, and K&E team re leadership and
structure transition (.6); analyze
correspondence re APA and schedules (.7);
discuss tax and timing with Company, S.
Winters, K&E team (.5); analyze
correspondence re diligence, TSA and IP
matters (.7).
08/27/24 Donatus Wang
0.10 Correspond with Company re updated
liquidity planning for Vyaire Medical GmbH
in connection with sale process.
08/27/24 Spencer A. Winters, P.C.
4.70 Review and analyze issues re sale transition,
sale hearing (2.4); correspond and telephone
conferences with C. Ceresa, K&E team,
Company, advisors re issues re same (2.3).
08/28/24 Chris Ceresa
5.90 Review, analyze legal issues re sales (2.6);
correspond with T. Chanroo and K&E team,
advisors, company re same (.6); draft and
review pleadings and materials re same (2.7).
08/28/24 Kenny Chiaghana
3.10 Analyze, revise sale reply (1.0); same re
summary of sale objections (.5); research re
same (1.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 522 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
71
Date
Name
Hours Description
08/28/24 Erica D. Clark
1.00 Conferences with C. Ceresa, K&E team, Alix
re sale hearing preparation.
08/28/24 Bernadette Coppola
0.50 Correspond with buyer, S. Shermetaro, K&E
team re revisions to license agreement (.3);
correspond with client re transition planning
(.2).
08/28/24 Luke Finn
2.40 Review, analyze matters with Company, B.
Coppola, K&E team, and M&A counterparty
re IP Schedules and licensing of iX5 IP assets
(1.1); review and revise material contract
disputes schedules (.8); review, analyze issues
related to remaining accounts receivable (.5).
08/28/24 Justin M. Garfinkle
0.60 Draft updates to purchase agreement and
patent license.
08/28/24 Sarah Osborne
1.50 Review, analyze cure objections (.7); draft
correspondence to cure parties re same (.6);
review, revise sale objection chart (.2).
08/28/24 Scottie Shermetaro
1.80 Review, analyze issues re TSA Services (.5);
teleconference with M. King and client re
same (.5); review and revise IP disclosure
schedules (.6); correspond with client re same
(.2).
08/28/24 Steve Toth
1.40 Analyze correspondence re APA, IP, and tax
insurance updates (.4); revise APA (.8);
analyze correspondence re contract splitting
and settlement (.2).
08/28/24 Spencer A. Winters, P.C.
5.60 Prepare for witness prep call with C. Braley
(.3); attend same (.5); review and analyze
issues re sale hearing, sale transaction (1.2);
correspond and telephone conferences with
multiple parties re same (1.1); draft
presentation outline (1.0); draft talking points
(1.5).
08/29/24 Chris Ceresa
7.90 Review, analyze legal issues re sales (2.4);
correspond with E. Clark and K&E team,
advisors, company re same (1.6); draft and
review pleadings and materials re same (3.9).
08/29/24 Tiffani Chanroo
5.50 Conference with C. Ceresa, K&E team re sale
prep (2.0); review, analyze issues re same
(3.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 523 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
72
Date
Name
Hours Description
08/29/24 Erica D. Clark
0.70 Conference with C. Ceresa, K&E team, Alix,
PJT, and Company re case status, sale hearing
(.4); conference with Company advisors and
AHG advisors re same (.3).
08/29/24 Bernadette Coppola
1.10 Correspond with L. Finn and team re
revisions to intellectual property schedules
(.2); conference with buyer, Company, and
advisors re updated transition services
agreement schedules (.8); correspond with
client, M. King, K&E team re same (.1).
08/29/24 Luke Finn
5.20 Review, analyze updated Schedule 3.1(a)
draft (.5); review, analyze vendor settlement
matters and update schedules as relates to
interim operating covenants (.4); review,
analyze buyer’s counsel drafts of schedules,
APA (1.2); revise disclosure schedules (1.2);
finalize, compile and distribute proposed final
asset purchase agreement, disclosure
schedules and signature packets to purchaser
(1.0); review, analyze issues re demand letter
and related accounting issues (.5); correspond
with buyer’s counsel and AlixPartners re
same (.4).
08/29/24 Justin M. Garfinkle
0.50 Draft updates to IP schedules.
08/29/24 Dan O'Connor
1.00 Correspond with Company re insurance
matters and APA matters.
08/29/24 Sarah Osborne
2.40 Correspond with AlixPartners re cure
amounts (.3); correspond with cure parties re
objections (.6); correspond with T. Chanroo
re same (.2); review, analyze precedent re sale
objections and sub rosa plans (1.1); review,
revise sale objection summary (.2).
08/29/24 Joshua Raphael
3.80 Telephone conference with T. Paulo, K&E
team, AlixPartners re Sale hearing preparation
(1.6); draft timeline re Sale hearing
presentation (1.3); conference,
correspondence with C. Ceresa, K&E team re
same (.2); review, revise reply in support of
sale (.7).
08/29/24 Scottie Shermetaro
1.10 Review and revise IP disclosure schedules.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 524 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
73
Date
Name
Hours Description
08/29/24 Steve Toth
0.70 Participate in management update telephone
conference with Company, K&E team,
AlixPartners, and PJT (.3); analyze
correspondence re APAs (.4).
08/29/24 Spencer A. Winters, P.C.
8.90 Participate in conference with UCC counsel
(.3); participate in telephone conferences with
lender advisors, Company advisors (1.0);
draft and revise reply brief (2.7); prepare for
and participate in sale prep call with C. Braley
(1.7); review and analyze issues re sale
hearing (1.9); correspond and telephone
conferences with multiple parties re same
(1.3).
08/30/24 Chris Ceresa
7.80 Review, analyze legal issues re sales (3.8);
correspond with S. Winters and K&E team,
advisors, company re same (1.4); draft and
review pleadings and materials re same (2.6).
08/30/24 Tiffani Chanroo
2.00 Review, analyze issues re sale hearing.
08/30/24 Bernadette Coppola
0.20 Conference with Company and advisor team
re intellectual property migration.
08/30/24 Luke Finn
5.50 Correspond with buyer’s counsel and
Company re excluded assets (1.8); review,
analyze correspondence regarding demand
letter (2.1); prepare for final signing
procedures (.8); review, analyze buyer’s
counsel proposed final Asset Purchase
Agreement and signature packet (.8).
08/30/24 Justin M. Garfinkle
0.40 Discuss IP transfers with Company.
08/30/24 David Hackel
0.70 Review, analyze issues re sales and sale
hearing (.4); draft, revise analysis re same
(.3).
08/30/24 Dan O'Connor
0.80 Correspond with M. Vega, S. O'Gorman, S.
Toth and L. Finn re APA matters.
08/30/24 Sarah Osborne
3.10 Draft email summary re sale hearing (.9);
correspond with C. Ceresa, K&E team re
same (.2); compile revised sale orders (.2);
attend sale hearing (1.5); correspond with
cure parties re cure amounts (.3).
08/30/24 Scottie Shermetaro
0.20 Telephone conference with B. Coppola and
Company re required IP assignment
documentation.
08/30/24 Steve Toth
0.30 Analyze correspondence re APAs.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 525 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050105548
48520-10
74
Date
Name
Hours Description
08/30/24 Spencer A. Winters, P.C.
3.60 Prepare for sale hearing presentation and
argument.
08/31/24 Luke Finn
0.70 Correspond with S. Toth, K&E team, buyer
counsel re sale signing legal issues and open
matters.
08/31/24 Spencer A. Winters, P.C.
0.50 Review and analyze sale issues.
Total
1,810.20
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 526 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105550
Client Matter: 48520-11
In the Matter of Executory Contracts & Unexpired Leases
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 23,463.00
Total legal services rendered
$ 23,463.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 527 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Executory Contracts & Unexpired Leases
Invoice Number:
Matter Number:
1050105550
48520-11
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Tiffani Chanroo
9.60
1,345.00
12,912.00
Kenny Chiaghana
0.60
975.00
585.00
Hannah Crawford
1.00
1,595.00
1,595.00
Jai Mudhar
3.70
1,345.00
4,976.50
Joshua Raphael
3.10
1,095.00
3,394.50
TOTALS
18.00
$ 23,463.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 528 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Executory Contracts & Unexpired Leases
Invoice Number:
Matter Number:
1050105550
48520-11
3
Description of Legal Services
Date
Name
Hours Description
08/06/24 Hannah Crawford
0.50 Correspond with J. Mudhar re UK lease (.3);
analyze issues re same (.2)
08/06/24 Jai Mudhar
2.20 Analyze lease legal issues (.8); review, revise
draft summary re same (1.4).
08/07/24 Tiffani Chanroo
2.10 Conference with AlixPartners re contract
counterparty legal issues (.5); review, analyze
materials re same (1.6).
08/07/24 Hannah Crawford
0.50 Correspond with J. Mudhar and P. Kar re UK
lease.
08/07/24 Jai Mudhar
1.50 Review and analyze legal issues re lease
(1.3); correspond with C. Ceresa and K&E
team re same (.2).
08/08/24 Tiffani Chanroo
1.20 Review, analyze issues re contract
counterparty (.7); conference with Q. Wetzel
re same (.3); review, analyze materials re
same (.2).
08/08/24 Joshua Raphael
3.10 Review, analyze non-debtor UK lease issue,
research re same (1.1); draft analysis re same
(1.8); correspond with C. Ceresa re same (.2).
08/21/24 Tiffani Chanroo
0.80 Correspond with K. Chiaghana re
supplemental contract notice (.6); review,
analyze issues re same (.2).
08/23/24 Tiffani Chanroo
4.10 Review, revise supplemental cure notice
(1.8); correspond with K. Chiaghana, K&E
team, Alix team re same (.8); review, analyze
cure schedule (1.5).
08/27/24 Tiffani Chanroo
1.40 Conference with C. Ceresa, Company re
executory contracts (1.0); review, analyze
issues re same (.4).
08/27/24 Kenny Chiaghana
0.60 Research re warehousemen liens.
Total
18.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 529 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105551
Client Matter: 48520-12
In the Matter of Business Operations
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 35,603.00
Total legal services rendered
$ 35,603.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 530 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050105551
48520-12
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
21.10
1,395.00
29,434.50
Tiffani Chanroo
2.30
1,345.00
3,093.50
Hannah Crawford
0.20
1,595.00
319.00
Sabrina Lieberman
0.60
975.00
585.00
Rebecca J. Marston
0.80
1,345.00
1,076.00
Ruan J. Meintjes
1.00
1,095.00
1,095.00
TOTALS
26.00
$ 35,603.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 531 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050105551
48520-12
3
Description of Legal Services
Date
Name
Hours Description
08/05/24 Chris Ceresa
0.90 Review, analyze legal issues re Company
operations (.6); correspond with Company,
advisors re same (.3).
08/05/24 Chris Ceresa
0.90 Review, analyze legal issues re Company
contracts process (.5); correspond with T.
Chanroo, Company, advisors re same (.4).
08/05/24 Tiffani Chanroo
1.10 Review, analyze contract renewal (1.0);
correspond with C. Ceresa, Company re same
(.1).
08/06/24 Chris Ceresa
0.80 Review, analyze legal issues re Company
operations (.6); correspond with Company,
advisors re issues re same (.2).
08/06/24 Chris Ceresa
0.40 Review, analyze legal issues re company
operations (.2); correspond with Company,
advisors re same (.2).
08/07/24 Chris Ceresa
0.60 Review, analyze legal issues re Company
operations and communications (.4);
correspond with Company, advisors re same
(.2).
08/07/24 Rebecca J. Marston
0.80 Correspond with C. Ceresa, Company re
internal communication strategy issues.
08/08/24 Chris Ceresa
1.20 Review, analyze legal issues re company
operations (.9); correspond with Company,
advisors re same (.3).
08/13/24 Chris Ceresa
1.20 Review, analyze contracts re legal issues (.6);
correspond with Company re same (.6).
08/15/24 Chris Ceresa
2.20 Review, revise communications plan and
documents (1.4); correspond with S.
Lieberman, K&E team, Company re issues re
same (.8).
08/19/24 Chris Ceresa
0.30 Review, analyze legal issues re Company's
operations (.2); correspond with S.
Lieberman, K&E team, advisors re same (.1).
08/19/24 Sabrina Lieberman
0.20 Correspond with T. Chanroo, K&E team re
potential claim in Chilean insolvency
proceeding.
08/20/24 Chris Ceresa
0.60 Review, analyze legal issues re Company's
operations (.3); correspond and telephone
conferences with S. Lieberman, K&E team,
advisors re same (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 532 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050105551
48520-12
4
Date
Name
Hours Description
08/20/24 Hannah Crawford
0.20 Correspond with J. Mudhar re Chilean
insolvency proceeding and related issues re
counsel.
08/20/24 Sabrina Lieberman
0.40 Conference with T. Chanroo, AlixPartners re
potential claim in external case (.2);
correspond with C. Ceresa, K&E team,
Company re same (.2).
08/21/24 Chris Ceresa
1.30 Review, analyze legal issues re Company's
operations (.9); correspond and telephone
conferences with Company re same (.4).
08/22/24 Chris Ceresa
4.40 Review, analyze legal issues re Company's
operations and communications (1.3); review
communications plan (2.2); correspond and
telephone conferences with T. Chanroo, K&E
team, advisors re same (.9).
08/23/24 Tiffani Chanroo
1.20 Conferences with Company re consumable
needs (.8); review, analyze issues re same
(.4).
08/26/24 Chris Ceresa
1.10 Review, analyze legal issues re Company
operations and compliance with law (.9);
correspond with Company, T. Chanroo, K&E
team, counterparties, advisors re same (.2).
08/26/24 Ruan J. Meintjes
1.00 Review and analyze product replacement
matter (.7); draft summary of findings and
coordinate with K. Hardey re same (.3).
08/27/24 Chris Ceresa
2.20 Review, analyze legal issues re Company
operations and compliance with law (1.3);
correspond with counterparties, advisors re
same (.9).
08/28/24 Chris Ceresa
2.00 Review, analyze legal issues re Company
operations and compliance with law (.9);
correspond with Company, advisors re same
(1.1).
08/29/24 Chris Ceresa
0.40 Review, analyze legal issues re Company
operations and compliance with law (.2);
correspond with Company and advisors re
same (.2).
08/30/24 Chris Ceresa
0.60 Review, analyze legal issues re Company
operations and compliance with law (.3);
correspond with Company, counterparties,
advisors re same (.3).
Total
26.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 533 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105552
Client Matter: 48520-13
In the Matter of Claims Administration
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 24,729.00
Total legal services rendered
$ 24,729.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 534 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Claims Administration
Invoice Number:
Matter Number:
1050105552
48520-13
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
0.50
1,395.00
697.50
Tiffani Chanroo
4.70
1,345.00
6,321.50
Kenny Chiaghana
7.40
975.00
7,215.00
Sarah Osborne
4.30
975.00
4,192.50
Quin Wetzel
6.10
975.00
5,947.50
Tanzila Zomo
1.00
355.00
355.00
TOTALS
24.00
$ 24,729.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 535 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Claims Administration
Invoice Number:
Matter Number:
1050105552
48520-13
3
Description of Legal Services
Date
Name
Hours Description
08/08/24 Tiffani Chanroo
1.30 Review, analyze issues re supplemental bar
date (1.1); correspond with C. Ceresa, K&E
team re same (.2).
08/08/24 Quin Wetzel
4.40 Research administrative expense priority
(2.1); research storage of property (1.4);
review, analyze material contract (.9).
08/09/24 Chris Ceresa
0.50 Review, analyze claims noticing matters (.3);
correspond with T. Chanroo and K&E team re
same (.2).
08/09/24 Tiffani Chanroo
1.80 Conference with C. Ceresa, K. Chiaghana re
supplemental bar date (.5); conference with
K. Chiaghana, Alix team re additional notice
parties (.5); review, analyze issues re same
(.8).
08/09/24 Kenny Chiaghana
1.20 Draft supplemental bar date motion (.2);
research re same (.2); conference with T.
Chanroo, K&E team re same (.4); correspond
with AlixPartners team re same (.1);
conference with T. Chanroo, AlixPartners
team re same (.2); correspond with R.
Marston re same (.1).
08/09/24 Sarah Osborne
1.50 Research re bar date extensions (1.2);
correspond with D. Hackel re same (.3).
08/09/24 Quin Wetzel
1.70 Review, analyze administrative expense case
law (.3); review, analyze postpetition storage
case law (.4); draft memorandum re same (.9);
correspond with T. Chanroo re same (.1).
08/09/24 Tanzila Zomo
1.00 Prepare initial shell re bar date motion (.6);
draft notice re same (.4).
08/10/24 Kenny Chiaghana
0.20 Analyze, revise supplemental bar date motion.
08/12/24 Kenny Chiaghana
0.30 Analyze, revise supplemental bar date motion.
08/12/24 Sarah Osborne
0.50 Correspond with creditor re claim inquiry
(.2); revise inquiry log re same (.2);
correspond with Omni re same (.1).
08/13/24 Kenny Chiaghana
1.50 Analyze, revise supplemental bar date motion
(1.2); telephone conference with Omni team
re same (.1); correspond with T. Chanroo,
K&E team re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 536 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Claims Administration
Invoice Number:
Matter Number:
1050105552
48520-13
4
Date
Name
Hours Description
08/13/24 Sarah Osborne
0.50 Correspond with T. Chanroo, K&E team re
claim inquiry (.3); correspond with claimant
re same (.2).
08/14/24 Kenny Chiaghana
0.40 Analyze, revise supplemental bar date motion.
08/14/24 Sarah Osborne
0.40 Correspond with D. Hackel, K&E team re
claimant inquiry (.2); correspond with
claimant re same (.2).
08/15/24 Sarah Osborne
0.60 Correspond with claimant re proof of claim
(.2); correspond with C. Ceresa, T. Chanroo,
K&E team re same (.4).
08/16/24 Tiffani Chanroo
0.80 Correspond with S. Lieberman re bar date
extensions.
08/16/24 Sarah Osborne
0.50 Correspond with claimant re proof of claim
(.3); correspond with D. Hackel, K&E team re
same (.2).
08/18/24 Kenny Chiaghana
1.20 Analyze, revise supplemental bar date motion
(.3); research re same (.7); correspond with T.
Chanroo re same (.2).
08/19/24 Tiffani Chanroo
0.80 Correspond with K. Chiaghana re
supplemental bar date motion (.4); review,
analyze issues re same (.4).
08/20/24 Kenny Chiaghana
1.80 Analyze, revise supplemental bar date motion
(1.6); correspond with T. Chanroo re same
(.1); correspond with AlixPartners team re
same (.1).
08/21/24 Sarah Osborne
0.30 Review, analyze claim inquiries.
08/22/24 Kenny Chiaghana
0.80 Analyze, revise supplemental bar date motion.
Total
24.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 537 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105553
Client Matter: 48520-15
In the Matter of Creditor and Stakeholder Communications
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 10,822.00
Total legal services rendered
$ 10,822.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 538 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Creditor and Stakeholder Communications
Invoice Number:
Matter Number:
1050105553
48520-15
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Tiffani Chanroo
1.00
1,345.00
1,345.00
David Hackel
4.00
1,095.00
4,380.00
Sabrina Lieberman
0.40
975.00
390.00
Rebecca J. Marston
0.60
1,345.00
807.00
Sarah Osborne
0.40
975.00
390.00
Quin Wetzel
3.60
975.00
3,510.00
TOTALS
10.00
$ 10,822.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 539 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Creditor and Stakeholder Communications
Invoice Number:
Matter Number:
1050105553
48520-15
3
Description of Legal Services
Date
Name
Hours Description
08/01/24 David Hackel
0.30 Review, analyze issues re service log,
stakeholder issues (.2); correspond with S.
Osborne re same (.1).
08/01/24 Quin Wetzel
1.30 Review, analyze creditor matrix re privilege,
confidentiality (1.1); correspond with C.
Ceresa, R. Marston re same (.2).
08/02/24 David Hackel
0.30 Review, analyze issues re service log,
stakeholder issues (.2); correspond with S.
Osborne re same (.1).
08/02/24 Sabrina Lieberman
0.10 Correspond with creditor re claim.
08/02/24 Rebecca J. Marston
0.60 Review and revise creditor matrix (.4);
correspond with Q. Wetzel, K&E team re
same (.2).
08/02/24 Sarah Osborne
0.40 Correspond with creditors re proof of claims
(.2); review, revise tracker re same (.2).
08/05/24 Tiffani Chanroo
0.50 Conference with C. Ceresa, Omni team re
noticing.
08/05/24 David Hackel
0.20 Review, analyze issues re service log,
stakeholder issues (.1); correspond with S.
Osborne, Omni re same (.1).
08/06/24 David Hackel
0.20 Review, analyze issues re service log,
stakeholder issues.
08/08/24 Tiffani Chanroo
0.50 Conference with C. Ceresa, S. Leiberman re
vendor issues.
08/08/24 David Hackel
0.50 Review, analyze issues re service log,
stakeholder issues, related issues re bar date
(.4); correspond with S. Osborne re same (.1).
08/09/24 David Hackel
0.30 Review, analyze issues re service log,
stakeholder issues, related issues re bar date
(.2); correspond with S. Osborne, K&E team
re same (.1).
08/13/24 David Hackel
0.20 Review, analyze issues re service log,
stakeholder issues (.1); correspond with S.
Osborne re same (.1).
08/14/24 David Hackel
0.60 Review, analyze issues re service log,
stakeholder issues (.3); correspond with S.
Osborne, K&E team re same (.3).
08/15/24 David Hackel
0.30 Review, analyze issues re service log,
stakeholder issues (.2); correspond with S.
Osborne, K&E team re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 540 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Creditor and Stakeholder Communications
Invoice Number:
Matter Number:
1050105553
48520-15
4
Date
Name
Hours Description
08/16/24 David Hackel
0.20 Review, analyze issues re service log,
stakeholder issues (.1); correspond with S.
Osborne, K&E team re same (.1).
08/19/24 David Hackel
0.20 Review, analyze issues re service log,
stakeholder issues (.1); correspond with S.
Osborne, K&E team, PJT re same (.1).
08/20/24 David Hackel
0.10 Review, analyze issues re service log,
stakeholder issues.
08/21/24 David Hackel
0.10 Review, analyze issues re service log,
stakeholder issues.
08/22/24 David Hackel
0.10 Review, analyze issues re service log,
stakeholder issues.
08/22/24 Sabrina Lieberman
0.30 Conference with Omni re service issue.
08/23/24 David Hackel
0.10 Review, analyze issues re service log,
stakeholder issues.
08/23/24 Quin Wetzel
1.90 Review, analyze monthly reports (1.1);
correspond with T. Chanroo, lenders, UCC re
same (.8).
08/24/24 David Hackel
0.10 Correspond with S. Osborne re service log,
stakeholder issues.
08/26/24 Quin Wetzel
0.40 Correspond with lien claimant re claim (.1);
telephone conference with C. Ceresa, lien
claimant re same (.3).
08/29/24 David Hackel
0.10 Review, analyze issues re service log,
stakeholder issues.
08/30/24 David Hackel
0.10 Review, analyze issues re service log,
stakeholder issues.
Total
10.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 541 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105554
Client Matter: 48520-16
In the Matter of U.S. Trustee Matters and Communications
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 10,690.00
Total legal services rendered
$ 10,690.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 542 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
U.S. Trustee Matters and Communications
Invoice Number:
Matter Number:
1050105554
48520-16
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
0.70
1,395.00
976.50
Tiffani Chanroo
2.80
1,345.00
3,766.00
Quin Wetzel
6.10
975.00
5,947.50
TOTALS
9.60
$ 10,690.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 543 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
U.S. Trustee Matters and Communications
Invoice Number:
Matter Number:
1050105554
48520-16
3
Description of Legal Services
Date
Name
Hours Description
08/14/24 Quin Wetzel
0.60 Review, analyze monthly reporting
requirements (.2); correspond with C. Ceresa,
AlixPartners re monthly operating reports
(.4).
08/15/24 Tiffani Chanroo
0.30 Correspond with Q. Wetzel re reporting
obligations.
08/20/24 Tiffani Chanroo
0.30 Correspond with Q. Wetzel re reporting
deadlines.
08/20/24 Quin Wetzel
1.60 Review, analyze monthly operating reports
(.8); correspond with AlixPartners re same
(.8).
08/21/24 Chris Ceresa
0.70 Review, analyze monthly operating reports
and other reporting (.4); correspond with T.
Chanroo, K&E team re same (.3).
08/21/24 Tiffani Chanroo
1.20 Correspond with Q. Wetzel, K&E team re
reporting obligations (.5); review, analyze
issue re same (.7).
08/21/24 Quin Wetzel
2.70 Review, analyze monthly operating reports
(2.1); correspond with T. Chanroo,
AlixPartners re same (.6).
08/22/24 Quin Wetzel
1.20 Correspond with T. Chanroo, C. Ceresa re
monthly operating reports (.9); revise
supplemental disclosure re same (.3).
08/23/24 Tiffani Chanroo
0.60 Correspond with Q. Wetzel re reporting
obligations.
08/26/24 Tiffani Chanroo
0.40 Correspond with Q. Wetzel re reporting
obligations.
Total
9.60
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 544 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105555
Client Matter: 48520-17
In the Matter of Hearings
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 8,686.00
Total legal services rendered
$ 8,686.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 545 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Hearings
Invoice Number:
Matter Number:
1050105555
48520-17
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Tabitha J. De Paulo
3.00
1,435.00
4,305.00
Spencer A. Winters, P.C.
2.60
1,685.00
4,381.00
TOTALS
5.60
$ 8,686.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 546 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Hearings
Invoice Number:
Matter Number:
1050105555
48520-17
3
Description of Legal Services
Date
Name
Hours Description
08/26/24 Tabitha J. De Paulo
0.70 Attend and participate in sale hearing.
08/26/24 Spencer A. Winters, P.C.
0.30 Attend and participate in status conference re
sale hearing.
08/30/24 Tabitha J. De Paulo
2.30 Participate in sale and conduct direct
examination of C. Braley.
08/30/24 Spencer A. Winters, P.C.
2.30 Participate in and attend sale hearing.
Total
5.60
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 547 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105556
Client Matter: 48520-18
In the Matter of Insurance and Surety Matters
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 2,602.50
Total legal services rendered
$ 2,602.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 548 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050105556
48520-18
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Sabrina Lieberman
0.10
975.00
97.50
William T. Pruitt
0.50
1,695.00
847.50
Quin Wetzel
1.70
975.00
1,657.50
TOTALS
2.30
$ 2,602.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 549 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050105556
48520-18
3
Description of Legal Services
Date
Name
Hours Description
08/01/24 Sabrina Lieberman
0.10 Correspond with C. Ceresa and K&E team re
D&O tail issues.
08/01/24 Quin Wetzel
0.80 Review, analyze D&O tail policy terms (.6);
correspond with S. Lieberman, S. Osborne re
same (.2).
08/06/24 Quin Wetzel
0.90 Review, analyze director and officer tail
policy (.8); correspond with C. Ceresa re
same (.1).
08/15/24 William T. Pruitt
0.50 Analyze D&O insurance issues and telephone
conference with Company re same.
Total
2.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 550 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105557
Client Matter: 48520-20
In the Matter of Tax Matters
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 446,939.00
Total legal services rendered
$ 446,939.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 551 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050105557
48520-20
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Michael Ehret
81.10
1,895.00
153,684.50
Emanuel Goetz
38.40
750.00
28,800.00
Palmer Gunderson
72.50
995.00
72,137.50
Sabrina Lieberman
0.30
975.00
292.50
Carolin Paus
1.40
750.00
1,050.00
Jessica H. Sicsu
0.70
1,745.00
1,221.50
Nicholas Warther
65.80
1,665.00
109,557.00
Sara B. Zablotney, P.C.
32.80
2,445.00
80,196.00
TOTALS
293.00
$ 446,939.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 552 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050105557
48520-20
3
Description of Legal Services
Date
Name
Hours Description
08/01/24 Michael Ehret
6.70 Review, revise sale and related documents re
tax issues (.7); correspond with E. Goetz,
K&E team, PJT, Company, re same (2.4);
conferences with E. Goetz, K&E team, PJT,
Company re same (1.0); analyze German tax
issues, tax structuring issues (2.1); analyze
issues re M&A Counterparty tax
considerations (.5).
08/01/24 Emanuel Goetz
1.20 Review, analyze APA from M&A
Counterparty re tax issues (.9); correspond
with M. Ehret re same (.3).
08/01/24 Emanuel Goetz
1.30 Telephone conference with Company and M.
Ehret re tax implications of prospective sale.
08/01/24 Emanuel Goetz
1.50 Telephone conference with Deloitte re
German tax implications of sale of RDx to
M&A Counterparty.
08/01/24 Emanuel Goetz
1.00 Review, analyze M&A Counterparty Rdx
APA re German tax perspective (.8);
correspond with M. Ehret re same (.2).
08/01/24 Emanuel Goetz
0.80 Draft analysis re German tax implications of
RDx sale to M&A Counterparty.
08/01/24 Emanuel Goetz
1.90 Analyze German tax issues re Rdx sale (1.6);
correspond with M. Ehret re same (.3).
08/01/24 Palmer Gunderson
2.30 Correspond with S. Zablotney, K&E team re
ventilations business structuring
considerations and tax planning (.9);
telephone conference with Company, S.
Zablotney, K&E team re German structuring
considerations for ventilations sale (1.1);
review, analyze tax comments in asset
purchase agreement re respiratory diagnostics
business (.3).
08/01/24 Nicholas Warther
2.50 Telephone conference with Deloitte, M.
Ehret, K&E team re German tax analysis (.5);
telephone conference with Company, M.
Ehret, K&E team re same (.5); review and
revise tax portions of APAs (1.0); review and
analyze US tax structuring issues (.5).
08/01/24 Sara B. Zablotney, P.C.
0.40 Review intercompany proposal re sale tax
matters (.2); correspond with P. Gunderson,
K&E team re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 553 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050105557
48520-20
4
Date
Name
Hours Description
08/02/24 Michael Ehret
8.70 Review, revise sale and related documents,
memoranda re tax issues (2.8); correspond
with E. Goetz, K&E team, Deloitte, Company
re same (1.1); conferences with E. Goetz,
K&E team, Deloitte, Company re same (3.0);
conference with Eon, Marsh re tax issues (.5);
analyze German tax issues, tax structuring
issues (.6); analyze issues re M&A
counterparty tax considerations (.7).
08/02/24 Emanuel Goetz
0.50 Telephone conference with M. Ehret re RDx
sale, tax issues.
08/02/24 Emanuel Goetz
5.30 Draft memorandum re German tax
implications to RDx sale (3.9); research re
same (1.1); correspond with M. Ehret re same
(.3).
08/02/24 Palmer Gunderson
5.60 Telephone conference with S. Zablotney,
K&E team re tax issues and sale structure
(.6); review, analyze memorandum re German
tax consequences of sale structure (1.1);
correspond with S. Zablotney, K&E team re
transaction structure and asset purchase
agreements (.4); review and revise asset
purchase agreement re tax issues (3.5).
08/02/24 Nicholas Warther
6.20 Telephone conference with M. Ehret, K&E
team re status and next steps, tax issues (.5);
telephone conference with Deloitte, M. Ehret,
K&E team re tax analysis for sale to M&A
counterparty (.7); correspond with M. Ehret,
K&E team re same (1.3); review and revise
tax structure slides re German analysis (1.1);
review and analyze issues re US tax modeling
(1.2); correspond with BDO re same (.2);
review and revise tax portions of APAs (1.2).
08/02/24 Sara B. Zablotney, P.C.
2.40 Telephone conferences with M. Ehret and
K&E team re structure and insurance
solutions for tax matters (1.0); review Zoll
APA re tax matters (.5); review and comment
on German memorandum re tax and structure
issues (.5); telephone conference with buyer
counsel re structure matters (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 554 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050105557
48520-20
5
Date
Name
Hours Description
08/03/24 Michael Ehret
5.50 Review, revise sale and related documents,
memoranda re tax issues (1.3); correspond
with E. Goetz, K&E team, Deloitte, Marsh,
Company, M&A counterparty re same, tax
issues (1.4); conferences with E. Goetz, K&E
team, Deloitte, Marsh, Company, M&A
counterparty re same (1.5); analyze German
tax issues, tax structuring issues (.6); analyze
issues re M&A counterparty tax
considerations (.7).
08/03/24 Emanuel Goetz
1.00 Revise presentation re German tax issues re
RDx sale.
08/03/24 Emanuel Goetz
1.00 Telephone conference with Marsh, M. Ehret
re RDx sale, tax issues.
08/03/24 Nicholas Warther
3.20 Telephone conference with BDO, M. Ehret,
K&E team re US tax modeling (1.7);
telephone conference with Deloitte and Marsh
re RDX tax planning (1.0); correspond with
M. Ehret, K&E team re same (.5)
08/03/24 Sara B. Zablotney, P.C.
3.20 Attend telephone conference re US tax
analysis with BDO (1.5); review and analyze
TRA tax issues (.4); attend telephone
conference with E. Goetz, K&E team re
insurance issues (1.0); telephone conference
with N. Warther re status re open tax issues
(.3).
08/04/24 Michael Ehret
1.20 Correspond with N. Warther, K&E team re
tax issues, insurance issues (.2); telephone
conference with S. Winters, K&E team re
M&A Counterparty bid and related tax issues
(.7); analyze tax issues re same (.3).
08/04/24 Emanuel Goetz
0.50 Telephone conference with S. Toth, K&E
team re tax and sales issues.
08/04/24 Palmer Gunderson
0.40 Telephone conference with S. Zablotney,
K&E team re tax issues with current sale
proposals.
08/04/24 Nicholas Warther
2.20 Telephone conference with M. Ehret, K&E
team re bids and next steps, related tax issues
(.7); review and analyze tax modeling and
structuring re same (1.5).
08/04/24 Sara B. Zablotney, P.C.
0.30 Telephone conference with P. Gunderson and
K&E team re sale and tax issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 555 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050105557
48520-20
6
Date
Name
Hours Description
08/05/24 Michael Ehret
1.70 Correspond re tax insurance coverage with
Trudell, Deloitte, N. Warther, Company re
same.
08/05/24 Emanuel Goetz
0.50 Analyze tax issues re sales, internal
restructuring.
08/05/24 Palmer Gunderson
0.50 Correspond with S. Zablotney, K&E team re
tax issues in auction bid draft asset purchase
agreements.
08/05/24 Jessica H. Sicsu
0.20 Review, analyze tax insurance matters.
08/05/24 Nicholas Warther
2.20 Correspond with tax insurance broker re
insurance (.6); review and revise tax portions
of APAs (.8); correspond with M. Ehret, K&E
team re same (.3); review and analyze tax
structuring (.5).
08/05/24 Sara B. Zablotney, P.C.
0.30 Correspond with P. Gunderson re timing of
transactions re tax matters.
08/06/24 Emanuel Goetz
1.00 Review, analyze RDx bid APA re German tax
perspective.
08/06/24 Emanuel Goetz
0.70 Review, analyze APA bidder considerations
re German tax perspective.
08/06/24 Emanuel Goetz
1.50 Review, analyze resolution of intercompany
receivables and payables re German tax
implications (1.4); correspond with D. Wang
and C. Paus re same (.1).
08/06/24 Emanuel Goetz
0.50 Review, analyze M&A Counterparty TSA
draft re German tax perspective.
08/06/24 Emanuel Goetz
0.50 Telephone conference with C. Ceresa, K&E
team re sales process and tax structure.
08/06/24 Palmer Gunderson
8.30 Review and revise transaction services
agreement re tax issues (.6); review and revise
issues list re tax and structuring issues redraft
asset purchase agreements (3.9); review,
revise same (2.5); review, analyze transaction
presentation re tax issues (.4); correspond
with P. Gunderson, K&E team re draft asset
purchase agreements (.9).
08/06/24 Carolin Paus
0.90 Conferences re legal issues re tax structure
and intercompany clean up in connection with
sales with E. Goetz and K&E team.
08/06/24 Nicholas Warther
2.00 Review and revise tax portions of APAs (1.2);
correspond with M. Ehret and K&E team re
structuring and tax insurance (.3); review and
analyze structure slides (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 556 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050105557
48520-20
7
Date
Name
Hours Description
08/06/24 Sara B. Zablotney, P.C.
1.00 Review and comment on tax and sales issues
list (.8); correspond with P. Gunderson re
funds flow issues (.2).
08/07/24 Palmer Gunderson
3.60 Review and comment on revised asset
purchase agreement re tax issues (2.8);
correspond with S. Zablotney, K&E team re
APA, tax issues (.8).
08/07/24 Nicholas Warther
0.50 Review and analyze tax structuring re sales.
08/07/24 Sara B. Zablotney, P.C.
1.20 Review and comment on agreements re tax
matters (.8); correspond with N. Warther,
K&E team, advisors re tax issues lists (.4).
08/08/24 Michael Ehret
3.00 Telephone conferences with counsel,
insurance broker, N. Warther, Company re tax
insurance issues (2.0); correspond with same
re same (1.0).
08/08/24 Emanuel Goetz
1.00 Telephone conference with Norton Rose,
Ambridge, Marsh and M. Ehret re tax
insurance, RDx sale.
08/08/24 Emanuel Goetz
0.50 Analyze tax issues re case, sales.
08/08/24 Emanuel Goetz
1.00 Review, analyze NBI-report from Marsh re
insurance coverage, tax issues.
08/08/24 Palmer Gunderson
3.00 Correspond with S. Zablotney, K&E team re
asset purchase agreements, tax issues (1.2);
revise asset purchase agreement re tax issues
(1.8).
08/08/24 Sara B. Zablotney, P.C.
0.50 Telephone conference with P. Gunderson,
K&E team re RDX sale and tax matters.
08/09/24 Michael Ehret
2.70 Telephone conferences Company re tax
insurance issues re tax structuring (.5);
correspond with same, insurance broker, and
AlixPartners re issues re same (2.2).
08/09/24 Palmer Gunderson
2.00 Telephone conference with M&A
counterparty tax counsel re asset purchase
agreement, tax issues (.6); correspond with S.
Zablotney, K&E team re same (.4); review,
revise APA re tax issues (.8); correspond with
S. Zablotney, K&E team re same (.2).
08/09/24 Nicholas Warther
2.50 Telephone conference with Cooley tax re
APA issues (.5); review and revise tax
portions of APAs (1.0); review and analyze
structuring (1.0).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 557 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050105557
48520-20
8
Date
Name
Hours Description
08/09/24 Sara B. Zablotney, P.C.
5.00 Telephone conference with buyer counsel re
bid terms (1.1); review and revise APA re
same (3.3); correspond with P. Gunderson
and K&E team re issues re same (.6).
08/10/24 Palmer Gunderson
2.40 Correspond with S. Zablotney, K&E team re
APA tax issues (.3); review, revise purchase
agreement re tax issues (2.1).
08/10/24 Nicholas Warther
2.70 Review and revise tax portions of Trudell
APA (2.1); correspond with S. Toth, K&E
team, and Company re same (.6).
08/11/24 Michael Ehret
3.00 Correspond with Company, N. Warther, K&E
team, and AlixPartners re issues re sale
structuring and insurance re tax matters.
08/11/24 Emanuel Goetz
0.70 Review, analyze APA from M&A
counterparty re German tax perspective.
08/11/24 Emanuel Goetz
0.80 Review, analyze APA for RDx business re
German tax perspective.
08/11/24 Palmer Gunderson
2.80 Telephone conference with M&A
Counterparty tax counsel re asset purchase
agreement, tax issues (.8); review and revise
restructuring transactions schedule re tax
issues (1.2); correspond with S. Zablotney,
K&E team re tax structuring questions (.4);
review and revise asset purchase agreement
(.4).
08/11/24 Nicholas Warther
4.50 Review and revise tax portions of APA (2.3);
telephone conference with Crowell tax re
same (1.0); telephone conference with
Company re tax insurance (.5); review and
analyze structuring (.7).
08/11/24 Sara B. Zablotney, P.C.
0.50 Telephone conference with P. Gunderson and
K&E team re Trudell APA tax matters.
08/12/24 Michael Ehret
2.20 Telephone conferences Company, N.
Warther, K&E team re tax insurance issues re
tax structuring (.5); correspond with same,
insurance broker, and AlixPartners re issues
re same (1.7).
08/12/24 Emanuel Goetz
0.60 Review, analyze engagement letter,
documents from Marsh re tax issues.
08/12/24 Emanuel Goetz
0.70 Review, analyze insurance coverage, tax
issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 558 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050105557
48520-20
9
Date
Name
Hours Description
08/12/24 Palmer Gunderson
3.00 Correspond with S. Zablotney, K&E team re
tax issues re asset purchase agreements (2.2);
draft schedule of restructuring transaction re
tax issues (.8).
08/12/24 Nicholas Warther
2.50 Telephone conference with M. Ehret and
K&E team re tax insurance issues (.5); review
and revise tax portions of APAs (1.1); review
and analyze structuring (.9).
08/12/24 Sara B. Zablotney, P.C.
0.50 Review, analyze markup to Vents APA re tax
issues.
08/13/24 Michael Ehret
2.20 Correspond with E. Goetz, K&E team re ICs,
tax comments to draft APAs.
08/13/24 Palmer Gunderson
3.30 Correspond with S. Zablotney, K&E team,
Company re asset sale structuring
considerations and tax items in asset purchase
agreements (1.1); revise restructuring
transactions schedule re asset purchase
agreement, tax issues (.8); review and
comment on asset purchase agreement re tax
issues (1.4).
08/13/24 Nicholas Warther
2.20 Review and revise tax portions of APA (1.3);
telephone conference with Company re tax
considerations (.5); correspond with P.
Gunderson and K&E team re same (.4).
08/13/24 Sara B. Zablotney, P.C.
1.10 Review and comment on agreement re tax and
structure matters (.8); correspond with P.
Gunderson re same (.3).
08/14/24 Michael Ehret
2.70 Telephone conferences with counsel,
insurance broker, N. Warther, AlixPartners,
Company re tax insurance issues (2.0);
correspond with same re same (.7).
08/14/24 Palmer Gunderson
1.90 Correspond with S. Zablotney, K&E team re
asset purchase agreement, restructuring
schedule, tax issues (1.2); revise restructuring
transactions schedule re tax issues (.7).
08/14/24 Carolin Paus
0.50 Telephone conference with E. Goetz and
K&E team re planned tax structure issue re
sales.
08/14/24 Jessica H. Sicsu
0.50 Telephone conference with N. Warther re tax
insurance matters.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 559 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050105557
48520-20
10
Date
Name
Hours Description
08/14/24 Nicholas Warther
3.20 Telephone conference with Crowell tax re
purchase agreement (.8); review and analyze
structuring (.8); telephone conference with S.
Toth and K&E team re same and status (.7);
review and revise Trudell purchase agreement
(.9).
08/14/24 Sara B. Zablotney, P.C.
1.00 Telephone conferences with P. Gunderson
and K&E team re Vents sale issues.
08/15/24 Michael Ehret
1.20 Telephone conferences with Company re
questionnaire for tax insurance, PWC
comments re same.
08/15/24 Palmer Gunderson
2.00 Telephone conference with S. Zablotney,
K&E team re resolution of potential tax
liabilities (.5); correspond with S. Zablotney,
K&E team, Company re tax issues in asset
purchase agreements (1.5).
08/15/24 Sabrina Lieberman
0.30 Correspond with N. Warther, K&E team re
tax liability.
08/15/24 Nicholas Warther
1.20 Telephone conference with BDO re
structuring (.5); review and analyze Trudell
APA (.7).
08/15/24 Sara B. Zablotney, P.C.
0.70 Telephone conference with P. Gunderson and
K&E team re tax consequence (.5);
correspond with P. Gunderson and K&E team
re VAT issues (.2).
08/16/24 Michael Ehret
5.20 Conference with Company re insurance issues
(1.3); correspond with N. Warther and K&E
team re insurance policy, comments on APA,
(3.9).
08/16/24 Emanuel Goetz
1.50 Review, analyze tax policies re German tax
issues.
08/16/24 Emanuel Goetz
1.20 Review, analyze M&A Counterparty
comments to APA re German tax perspective.
08/16/24 Emanuel Goetz
0.50 Analyze tax, restructuring issues re Company
sale.
08/16/24 Palmer Gunderson
2.30 Revise asset purchase agreement re tax issues
(1.2); telephone conference with N. Warther,
K&E team re asset purchase agreement, tax
issues (.2); telephone conference with
Company re asset purchase agreement, tax
issues (.5); correspond with N. Warther, K&E
team re asset purchase agreement (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 560 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050105557
48520-20
11
Date
Name
Hours Description
08/16/24 Nicholas Warther
2.80 Telephone conference with Company, P.
Gunderson, K&E team re purchase agreement
and tax insurance (1.0); review and revise tax
portions of APA (.6); correspond with P.
Gunderson, K&E team re same (.5); review
and analyze tax structuring issues (.7).
08/16/24 Sara B. Zablotney, P.C.
2.40 Telephone conferences with Company, N.
Warther re APA tax matters (1.5); review,
revise APA comments re same (.9).
08/17/24 Michael Ehret
1.20 Correspond re APA tax issues, tax insurance,
and open items with S. Toth, and K&E team.
08/17/24 Emanuel Goetz
0.50 Review, analyze M&A Counterparty issues
list re German tax perspective.
08/17/24 Palmer Gunderson
1.50 Telephone conferences with N. Warther,
K&E team, Company re various tax planning
issues re sale transactions.
08/17/24 Nicholas Warther
3.00 Telephone conference with M&A
counterparty advisers re APA tax issues (.7);
telephone conference with Company and P.
Gunderson, K&E team re same (.8); review
and revise tax portions of APA (1.3);
telephone conference with BDO re tax
planning (.2).
08/18/24 Michael Ehret
2.70 Telephone conferences re APA tax issues, tax
insurance, and open items with S. Toth, K&E
team, advisors, and Company.
08/18/24 Palmer Gunderson
3.50 Telephone conference with N. Warther, K&E
team re asset purchase agreement (.5); review,
revise purchase price allocation schedule re
tax issues (.6); correspond with N. Warther,
K&E team re sale structure and tax planning
issues (.6); revise purchase agreement re tax
issues (1.8).
08/18/24 Nicholas Warther
6.00 Telephone conference with Crowell re APA,
tax issues (1.0); review and revise APA re tax
issues (1.8); review and revise purchase price
allocation re tax issues (1.4); telephone
conference with Deloitte and P. Gunderson,
K&E team re tax insurance (1.0); correspond
with P. Gunderson, K&E team and Company
re structuring issues, tax issues (.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 561 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050105557
48520-20
12
Date
Name
Hours Description
08/19/24 Michael Ehret
5.20 Correspond re APA tax issues, tax insurance,
and open items with S. Toth, and K&E team
(3.7); telephone conferences with same and
Company re same (1.5).
08/19/24 Emanuel Goetz
0.50 Review, analyze issues re filing German tax
documents.
08/19/24 Emanuel Goetz
0.80 Review, analyze VAT tax issues re German
tax perspective.
08/19/24 Palmer Gunderson
3.80 Correspond with seller tax counsel re asset
purchase agreement (.5); telephone
conference with N. Warther, K&E team,
Company re tax issues in asset purchase
agreements and tax planning (1.0); research
tax law re Company tax planning (1.3);
correspond with N. Warther, K&E team re tax
diligence and disclosures (.4); review, analyze
asset purchase agreement, related tax issues
(.4); correspond with N. Warther, K&E team
re same (.2).
08/19/24 Nicholas Warther
3.80 Telephone conference with P. Gunderson,
K&E team re tax insurance (1.0); review and
revise tax portions of APA (1.1); correspond
with P. Gunderson, K&E team, Company re
same (.9); telephone conference with
Company re same (.8).
08/19/24 Sara B. Zablotney, P.C.
4.30 Telephone conferences with N. Warther,
K&E team re open items re tax and sale
matters (.8); correspond with N. Warther,
K&E team re tax issues re agreement and
schedules (3.5).
08/20/24 Michael Ehret
6.70 Correspond re APA tax issues, tax insurance,
and open items with S. Toth, and K&E team
(3.9); telephone conferences with same and
Company re same (2.8).
08/20/24 Emanuel Goetz
0.70 Analyze legal issues re tax related insurance.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 562 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050105557
48520-20
13
Date
Name
Hours Description
08/20/24 Palmer Gunderson
6.00 Telephone conference with M&A
counterparty tax counsel re asset purchase
agreement, tax issues (.5); telephone
conference with N. Warther, K&E team and
Company re tax items in asset purchase
agreement (.3); review and comment on
disclosure agreement re tax issues (1.8);
revise purchase price allocation schedule re
tax issues (.4); revise restructuring
transactions schedule re tax issues (.7);
correspond with N. Warther, K&E team re tax
items in asset purchase agreement (1.7);
review, analyze bankruptcy sale orders re tax
structuring considerations (.6).
08/20/24 Nicholas Warther
7.30 Review and revise tax portions of APA (2.8):
telephone conference with S. Zablotney, K&E
team, Company re same, tax issues (.8);
review and analyze structuring, tax issues
(1.3); review and revise sale order language re
tax issues (.4); correspond with Crowell re
APA, tax issues (1.4); review and revise tax
disclosures (.6).
08/20/24 Sara B. Zablotney, P.C.
4.40 Review, analyze agreements re tax issues
(1.5); multiple telephone conferences re
various agreement tax issues with buyer
counsel, Company, N. Warther and K&E
team (1.5); analyze tax year change legal
issues (.8); correspond with N. Warther and S.
Toth re open tax points (.6).
08/21/24 Michael Ehret
4.70 Correspond re APA tax structure issues and
open items with S. Toth, K&E team,
Company, and advisors (3.9); telephone
conferences with same and Company re same
(.8).
08/21/24 Emanuel Goetz
0.40 Review, analyze documentation required re
tax insurance.
08/21/24 Palmer Gunderson
3.50 Research tax law re proposed pre-closing
intercompany restructuring transactions (2.3);
correspond with N. Warther, K&E team re tax
disclosures (.7); review, analyze bankruptcy
sale orders and application of sale proceeds re
tax issues (.5).
08/21/24 Nicholas Warther
0.40 Review and revise APA re tax issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 563 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050105557
48520-20
14
Date
Name
Hours Description
08/22/24 Michael Ehret
1.70 Correspond re APA tax issues and tax
insurance matters with S. Toth, K&E team,
Company, and advisors.
08/22/24 Palmer Gunderson
4.30 Analyze M&A counterparty disclosures re tax
issues (.6); research tax law re proposed pre-
closing intercompany restructuring
transactions (1.7); draft summary re same
(2.0).
08/23/24 Michael Ehret
1.70 Correspond re APA tax structure issues and
open items with E. Goetz, K&E team,
Company, and advisors.
08/23/24 Emanuel Goetz
1.10 Review and comment on Q&A re tax
insurance.
08/23/24 Palmer Gunderson
3.70 Draft, revise summary analysis of tax law re
pre-closing restructuring transactions (3.5);
correspond with N. Warther, K&E team,
Company re tax planning (.2).
08/23/24 Sara B. Zablotney, P.C.
0.20 Correspond with P. Gunderson and K&E
team re R&D tax credit.
08/25/24 Nicholas Warther
1.50 Review and analyze BDO tax modeling re
Vents sale (1.0); correspond with E. Goetz,
K&E team re same (.5).
08/26/24 Michael Ehret
2.00 Correspond re APA tax structure issues and
tax insurance items with E. Goetz, K&E team,
Company, and advisors.
08/26/24 Emanuel Goetz
1.30 Draft analysis re IC receivables and payables,
tax issues (.9); correspond with M. Ehret,
K&E team re same (.4).
08/26/24 Palmer Gunderson
0.30 Correspond with C. Ceresa, K&E team re
restructuring schedule, tax issues.
08/26/24 Nicholas Warther
0.70 Review and analyze tax issues re Vents sale
timing.
08/26/24 Sara B. Zablotney, P.C.
1.40 Review and comment on analysis from BDO
re intercompany and tax matters.
08/27/24 Michael Ehret
0.50 Review comments from E. Clark and C.
Ceresa re tax insurance issues.
08/27/24 Emanuel Goetz
0.20 Revise analysis re IC receivables and
payables, tax issues (.1); correspond with M.
Ehret, K&E team re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 564 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050105557
48520-20
15
Date
Name
Hours Description
08/27/24 Palmer Gunderson
1.30 Review, analyze pre-closing tax planning
materials re Company conference (.4);
telephone conference with Company re
purchase agreement and pre-closing tax
planning (.5); comment on intercompany
restructuring summary re tax issues (.4).
08/27/24 Nicholas Warther
1.70 Review and analyze tax structuring issues
(.5); telephone conference with Company re
same (.7); telephone conference with
Company re purchase price adjustment (.5).
08/27/24 Sara B. Zablotney, P.C.
1.50 Telephone conference re acquired taxes with
Company (.5); telephone conference with N.
Warther and K&E team re timing of Vents
sale (.5) review open issues re tax insurance
matters (.5).
08/28/24 Michael Ehret
3.00 Correspond re APA tax structure issues and
tax insurance items with E. Goetz, K&E team,
Company, and advisors.
08/28/24 Emanuel Goetz
1.10 Analyze tax issues re resolution of
intercompany receivables and payables (.7);
correspond with M. Ehret re German tax
insurance issues (.4).
08/28/24 Emanuel Goetz
2.10 Review, analyze tax issues re insurance (1.7);
correspond with M. Ehret re same (.2);
telephone conference with M. Ehret, Marsh re
same (.2).
08/28/24 Nicholas Warther
0.80 Correspond with E. Goetz, K&E team re tax
insurance.
08/28/24 Sara B. Zablotney, P.C.
0.50 Analyze open issues re tax insurance policy.
08/29/24 Michael Ehret
2.00 Correspond re APA tax structure issues and
tax insurance items with E. Goetz, K&E team,
Company, advisors, and broker.
08/29/24 Emanuel Goetz
0.50 Correspond with Marsh re underwriting of tax
insurance.
08/29/24 Palmer Gunderson
1.20 Draft purchase price allocation principles re
asset sale.
08/29/24 Nicholas Warther
0.20 Correspond with E. Goetz, K&E team re tax
structuring issues.
08/30/24 Michael Ehret
2.00 Correspond re APA tax structure issues and
tax insurance items with E. Goetz, K&E team,
Company, advisors, and broker.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 565 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050105557
48520-20
16
Date
Name
Hours Description
08/31/24 Michael Ehret
1.70 Correspond re tax insurance items with E.
Goetz, K&E team, Company, advisors, and
broker.
Total
293.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 566 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105558
Client Matter: 48520-21
In the Matter of Case Administration
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 67,796.50
Total legal services rendered
$ 67,796.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 567 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050105558
48520-21
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Rebecca H. Arnall
0.20
1,265.00
253.00
Chris Ceresa
3.70
1,395.00
5,161.50
Tiffani Chanroo
7.60
1,345.00
10,222.00
Kenny Chiaghana
5.30
975.00
5,167.50
Erica D. Clark
1.10
1,595.00
1,754.50
Joseph A. D'Antonio
3.70
1,235.00
4,569.50
Amy Donahue
1.80
525.00
945.00
Julia R. Foster
2.40
525.00
1,260.00
David Hackel
1.80
1,095.00
1,971.00
Shaun Patrick Kelly
4.30
495.00
2,128.50
Sabrina Lieberman
2.60
975.00
2,535.00
Rebecca J. Marston
0.50
1,345.00
672.50
Mark McKane, P.C.
1.40
2,065.00
2,891.00
Jai Mudhar
1.70
1,345.00
2,286.50
Sarah Osborne
1.40
975.00
1,365.00
Joshua Raphael
1.20
1,095.00
1,314.00
Adrian Salmen
1.00
1,265.00
1,265.00
Seth Sanders
0.50
1,265.00
632.50
Josh Sussberg, P.C.
0.20
2,305.00
461.00
Matt Swanson
0.20
1,345.00
269.00
Kyle Nolan Trevett
2.50
1,265.00
3,162.50
Nicholas Warther
2.50
1,665.00
4,162.50
Quin Wetzel
0.40
975.00
390.00
Tanzila Zomo
36.50
355.00
12,957.50
TOTALS
84.50
$ 67,796.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 568 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050105558
48520-21
3
Description of Legal Services
Date
Name
Hours Description
08/01/24 Kenny Chiaghana
0.90 Revise analysis re key dates and deadlines
document, work in process document.
08/01/24 Jai Mudhar
0.20 Correspond with C. Ceresa, K&E team re
case status, next steps.
08/01/24 Tanzila Zomo
0.40 Compile pleadings re filing.
08/02/24 Kenny Chiaghana
0.50 Analyze, revise summary of key dates and
deadlines re case status, next steps.
08/02/24 David Hackel
0.30 Review, analyze correspondence re case
update re stalking horse with Y. Salloum,
PJT.
08/02/24 Tanzila Zomo
0.20 Compile pleadings re filing.
08/03/24 Josh Sussberg, P.C.
0.10 Correspond with S. Winters re case status.
08/05/24 Rebecca H. Arnall
0.20 Review updates re bid drafts.
08/05/24 Chris Ceresa
0.50 Telephone conference with T. Chanroo re
work in process and case administrative
issues.
08/05/24 Tiffani Chanroo
2.40 Telephone conference with C. Ceresa re case
status (.5); review, analyze correspondence
from C. Ceresa, K&E team re case status
(1.9).
08/05/24 Joseph A. D'Antonio
3.70 Review documents and draft C. Braley direct
outline re motion to compel DIP Lenders'
compliance with DIP Order.
08/07/24 Chris Ceresa
0.50 Conference with T. Chanroo, K&E team re
work in process and case administration.
08/07/24 Tiffani Chanroo
0.80 Conference with C. Ceresa, K&E team re
work in process (.5): conference with J.
Raphael re case status (.3).
08/07/24 Julia R. Foster
0.50 Participate in conference with D. Hackel,
K&E team re work in process.
08/07/24 David Hackel
0.30 Conference with C. Ceresa, K&E team re case
status, next steps.
08/07/24 Sabrina Lieberman
0.30 Conference with C. Ceresa, K&E team re
work in process.
08/07/24 Rebecca J. Marston
0.50 Conference with C. Ceresa, K&E team re
work in process.
08/07/24 Joshua Raphael
0.40 Conference with C. Ceresa, K&E team re
work in process.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 569 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050105558
48520-21
4
Date
Name
Hours Description
08/07/24 Seth Sanders
0.50 Telephone conference with C. Ceresa, K&E
team re work in process.
08/07/24 Tanzila Zomo
0.80 Telephone conference with J. Foster, K&E
team re case status updates (.5); compile
recently filed pleadings re same (.3).
08/08/24 Tiffani Chanroo
1.50 Conference with C. Ceresa, AlixPartners re
case issues (.5); review, analyze issues re
same (.4); review, revise work in process
tracker (.4); correspond with K. Chiaghana re
same (.2).
08/08/24 Nicholas Warther
2.50 Review and revise tax portions of Trudell
APA (1.2); correspond with S. Toth and K&E
team re same (.3); telephone conferences with
Company, M. Ehret re tax insurance issues
(1.0).
08/09/24 Tanzila Zomo
0.30 Compile pleadings re filings.
08/12/24 Kenny Chiaghana
0.40 Analyze, revise document re work in process
and key dates and deadlines.
08/12/24 Sabrina Lieberman
0.10 Review, revise work in process summary.
08/12/24 Jai Mudhar
0.20 Correspond with C. Ceresa re open case
matters.
08/13/24 Matt Swanson
0.20 Analyze purchase agreement matters.
08/14/24 Julia R. Foster
0.20 Correspond with T. Chanroo re case
deadlines.
08/15/24 Chris Ceresa
1.60 Conference with T. Chanroo, K&E team re
work in process (.5); conference with T.
Chanroo re issues re same (.4); analyze issues
re same (.7).
08/15/24 Tiffani Chanroo
0.90 Conference with C. Ceresa, K&E team re
work in process.
08/15/24 Kenny Chiaghana
0.70 Analyze, revise summary of work in process
(.2); participate in conference with A. Salmen,
K&E team re same (.5).
08/15/24 Erica D. Clark
0.50 Conference with S. Lieberman, K&E team re
case status, work in process.
08/15/24 Julia R. Foster
0.50 Conference with D. Hackel, K&E team re
work in process.
08/15/24 David Hackel
0.50 Conference with C. Ceresa, K&E team re case
status, next steps.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 570 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050105558
48520-21
5
Date
Name
Hours Description
08/15/24 Sabrina Lieberman
1.20 Conference with C. Ceresa, K&E team re
work in process (.5); review, analyze
correspondence from C. Ceresa, K&E team re
same (.7).
08/15/24 Sarah Osborne
0.50 Telephone conference with C. Ceresa, K&E
team re work in process.
08/15/24 Joshua Raphael
0.40 Telephone conference with C. Ceresa, K&E
team re work in process.
08/15/24 Adrian Salmen
0.50 Conference with C. Ceresa, K&E team re
work in process.
08/15/24 Kyle Nolan Trevett
0.50 Telephone conference with C. Ceresa, K&E
team re work in process.
08/15/24 Tanzila Zomo
0.50 Telephone conference with J. Foster, K&E
team re case status updates.
08/16/24 Jai Mudhar
0.20 Correspond with A. Chan re employment
counsel.
08/19/24 Kenny Chiaghana
0.30 Analyze, revise summary of work in process
(.1); participate in conference with S.
Lieberman, K&E team re same (.2).
08/19/24 Sabrina Lieberman
0.10 Review, revise summary re work in process.
08/19/24 Jai Mudhar
0.20 Correspond with C. Ceresa, K&E team re
open legal issues in matter.
08/20/24 Jai Mudhar
0.50 Correspond with counsel re Chilean claim
issue.
08/20/24 Jai Mudhar
0.20 Correspond with counsel re Chilean claim
issue.
08/21/24 Josh Sussberg, P.C.
0.10 Correspond with S. Winters re case status.
08/22/24 Kenny Chiaghana
0.30 Analyze, revise summary of work in process
(.1); participate in conference with C. Ceresa,
K&E team re same (.2).
08/22/24 Erica D. Clark
0.30 Conference with D. Hackel, K&E team re
case status, work in process (.2); correspond
with D. Hackel, K&E team re same (.1).
08/22/24 Amy Donahue
0.50 Participate in conference with E. Clark, K&E
team re work in process (.3); prepare hearing
logistics re upcoming hearing (.2).
08/22/24 David Hackel
0.40 Conference with C. Ceresa, K&E team re case
status, next steps.
08/22/24 Sabrina Lieberman
0.20 Conference with C. Ceresa, K&E team re
work in process.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 571 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050105558
48520-21
6
Date
Name
Hours Description
08/22/24 Sarah Osborne
0.50 Telephone conference with C. Ceresa, K&E
team re work in process.
08/22/24 Joshua Raphael
0.20 Telephone conference with C. Ceresa, K&E
team re work in process.
08/22/24 Adrian Salmen
0.50 Conference with C. Ceresa, K&E team re
work in process.
08/22/24 Kyle Nolan Trevett
0.30 Telephone conference with C. Ceresa, K&E
team re work in process.
08/22/24 Tanzila Zomo
2.20 Telephone conference with C. Ceresa, K&E
team re case status updates (.5); correspond
with A. Donahue re sale hearing logistics (.2);
correspond with T. Chanroo re same (.2);
correspond with Cole Schotz re same (.5);
coordinate logistics re travel to Wilmington
(.3); compile recently filed pleadings re
hearing(.4); circulate pleadings to T. Chanroo,
K&E team re same (.1).
08/23/24 Mark McKane, P.C.
0.20 Confer with T. DePaulo re sale hearing
update.
08/23/24 Tanzila Zomo
0.60 Compile pleadings re filings.
08/23/24 Tanzila Zomo
4.20 Coordinate sale hearing logistics (2.5);
review, revise index re hearing documents
(.7); coordinate hearing registrations (1.0).
08/24/24 Tanzila Zomo
7.30 Prepare documents for sale hearing (3.9);
correspond with C. Ceresa, K. Chiaghana re
same (.9); coordinate printing and delivery of
hearing documents (2.0); correspond with
delivery services re same (.5).
08/25/24 Kenny Chiaghana
1.60 Analyze, revise hearing agenda (.2);
correspond with local counsel, K&E team re
hearing preparations (.1); analyze, revise
summary of sale objections re hearing
preparation (1.3).
08/25/24 Tanzila Zomo
10.20 Coordinate printing and delivery of sale
hearing materials, binders (3.7); prepare
index, materials re same (3.9); correspond
with K. Chiaghana, C. Ceresa re same (1.1);
coordinate hearing lines for all parties (1.5).
08/26/24 Amy Donahue
0.50 Coordinate case logistics and appearances re
upcoming hearing.
08/26/24 Amy Donahue
0.50 Implement and maintain listen-only line for T.
Chanroo, K&E team to attend hearing.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 572 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050105558
48520-21
7
Date
Name
Hours Description
08/26/24 Julia R. Foster
0.50 Coordinate logistics re August 26, 2024 and
August 30, 2024 hearings.
08/26/24 Sabrina Lieberman
0.10 Review, revise summary re work in process.
08/26/24 Mark McKane, P.C.
0.20 Conference with T. De Paulo re contested
distribution issues.
08/26/24 Kyle Nolan Trevett
1.40 Review, revise case timeline (1.3); telephone
conference with C. Ceresa re solicitation
timing issues (.1).
08/26/24 Tanzila Zomo
4.50 Coordinate logistics re sale hearing (2.5);
correspond with C. Ceresa, local counsel re
same (1.0); attend hearing re same (1.0).
08/27/24 Jai Mudhar
0.20 Correspond with C. Ceresa re open case
matters.
08/28/24 Chris Ceresa
0.30 Telephone conference with E. Clark, K&E
team re case status, next steps.
08/28/24 Tiffani Chanroo
2.00 Conference with C. Ceresa, K&E team re
works in process (.5); conference with J.
Raphael, K&E team re sale hearing prep
(1.0); review, analyze issue re cure schedule
(.5).
08/28/24 Kenny Chiaghana
0.60 Analyze, revise summary of work in process
(.3); conference with C. Ceresa, K&E team re
same (.3).
08/28/24 Erica D. Clark
0.30 Conference with C. Ceresa, K&E team re case
status, work in process (.2); correspond with
C. Ceresa, K&E team re same (.1).
08/28/24 Amy Donahue
0.30 Participate in conference with E. Clark, K&E
team re work in process.
08/28/24 Julia R. Foster
0.40 Telephone conference with E. Clark, K&E
team re case updates.
08/28/24 David Hackel
0.30 Conference with C. Ceresa, K&E team re case
status, next steps.
08/28/24 Shaun Patrick Kelly
1.50 Create and alter charts for hearing
presentation.
08/28/24 Sabrina Lieberman
0.40 Conference with E. Clark, K&E team re work
in process (.3); review, revise summary re
same (.1).
08/28/24 Sarah Osborne
0.40 Telephone conference with E. Clark, K&E
team re case updates.
08/28/24 Joshua Raphael
0.20 Telephone conference with C. Ceresa, K&E
team re work in process.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 573 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050105558
48520-21
8
Date
Name
Hours Description
08/28/24 Kyle Nolan Trevett
0.30 Telephone conference with C. Ceresa, K&E
team re work in process.
08/28/24 Quin Wetzel
0.40 Telephone conference with C. Ceresa, K&E
team re case status, next steps.
08/28/24 Tanzila Zomo
0.80 Telephone conference with E. Clark, K&E
team re case status updates (.5); compile
pleadings re filings (.3).
08/29/24 Chris Ceresa
0.80 Telephone conference E. Clark, K&E team,
various parties re case status, next steps.
08/29/24 Julia R. Foster
0.30 Coordinate August 30, 2024 hearing dial-in
logistics.
08/29/24 Shaun Patrick Kelly
1.80 Revise charts and revise hearing presentation.
08/29/24 Mark McKane, P.C.
1.00 Conference with T. DePaulo re remaining
contested sale approval issues (.6); assess and
propose revisions to draft direct examination
(.4).
08/29/24 Tanzila Zomo
4.50 Prepare documents for sale hearing (3.5);
correspond with C. Ceresa, Cole Schotz re
same (.5); coordinate registrations re same
(.5).
08/30/24 Shaun Patrick Kelly
1.00 Review, revise hearing presentation.
08/31/24 Sabrina Lieberman
0.20 Correspond with C. Ceresa, K&E team re
work in process.
Total
84.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 574 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105559
Client Matter: 48520-22
In the Matter of Retention - K&E
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 60,650.00
Total legal services rendered
$ 60,650.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 575 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050105559
48520-22
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
7.00
1,395.00
9,765.00
Michael Y. Chan
2.00
395.00
790.00
Tiffani Chanroo
2.60
1,345.00
3,497.00
Kenny Chiaghana
6.00
975.00
5,850.00
Marta Dudyan
16.00
340.00
5,440.00
Julia R. Foster
0.40
525.00
210.00
Sabrina Lieberman
17.60
975.00
17,160.00
Rebecca J. Marston
3.90
1,345.00
5,245.50
Eric Nyberg
2.00
340.00
680.00
Sarah Osborne
6.50
975.00
6,337.50
Quin Wetzel
2.20
975.00
2,145.00
Spencer A. Winters, P.C.
1.80
1,685.00
3,033.00
Tanzila Zomo
1.40
355.00
497.00
TOTALS
69.40
$ 60,650.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 576 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050105559
48520-22
3
Description of Legal Services
Date
Name
Hours Description
08/01/24 Sabrina Lieberman
0.50 Correspond with Y. Salloum, K&E team re
revised K&E retention order (.3); review,
revise same (.2).
08/01/24 Rebecca J. Marston
1.60 Correspond with Y. Salloum and K&E team
re retention order, certificate of counsel (1.2);
review and revise same (.4).
08/01/24 Spencer A. Winters, P.C.
1.40 Review and analyze issues re K&E retention
(.8); correspond with Y. Salloum and K&E
team re same (.6).
08/02/24 Sabrina Lieberman
0.50 Correspond with Y. Salloum, K&E team,
Cole Schotz re revised K&E retention order.
08/02/24 Rebecca J. Marston
2.30 Correspond with U.S. Trustee, C. Ceresa,
K&E team re K&E retention order (.8);
correspond with Cole Schotz team re same
(.4); review and revise same (1.1).
08/02/24 Spencer A. Winters, P.C.
0.40 Review and analyze issues re K&E retention.
08/05/24 Chris Ceresa
1.30 Review, revise K&E fee statement (1.1);
correspond with K. Chiaghana and K&E team
re same (.2).
08/05/24 Sabrina Lieberman
0.10 Correspond with C. Ceresa, R. Marston re
K&E fee statement.
08/06/24 Sabrina Lieberman
0.30 Correspond with C. Ceresa, K&E team re
K&E fee statement.
08/07/24 Kenny Chiaghana
1.60 Review, revise K&E fee statement re
privilege and confidentiality considerations.
08/07/24 Sabrina Lieberman
0.10 Correspond with K. Chiaghana and K&E
team re review of K&E fee statements.
08/08/24 Chris Ceresa
1.20 Review, revise K&E fee statement (1.0);
correspond with K. Chiaghana and K&E team
re same (.2).
08/09/24 Kenny Chiaghana
1.70 Review, revise K&E fee statement re
privilege and confidentiality considerations.
08/10/24 Kenny Chiaghana
0.40 Review, revise K&E fee statement re
privilege and confidentiality considerations.
08/11/24 Sabrina Lieberman
0.10 Correspond with K. Chiaghana re review of
K&E fee statement.
08/14/24 Sabrina Lieberman
0.10 Correspond with C. Ceresa, K&E team re
monthly fee statement.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 577 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050105559
48520-22
4
Date
Name
Hours Description
08/15/24 Sabrina Lieberman
0.70 Review, revise K&E fee statement re
privilege and accuracy (.4); correspond with
C. Ceresa and K&E team re same (.3).
08/16/24 Sabrina Lieberman
0.50 Conference with C. Ceresa re monthly fee
statement and second supplemental
declaration (.2); correspond with C. Ceresa,
K&E team re same (.3).
08/17/24 Sabrina Lieberman
0.30 Correspond with J. Desai re monthly fee
statement review.
08/19/24 Kenny Chiaghana
0.20 Review, revise K&E monthly statement re
privilege and confidentiality considerations.
08/19/24 Sabrina Lieberman
0.60 Correspond with C. Ceresa, K&E team, PJT
re supplemental declaration in support of
K&E retention.
08/19/24 Tanzila Zomo
1.40 Draft initial shell re second supplemental
declaration.
08/20/24 Chris Ceresa
1.20 Review, revise K&E fee statement (1.0);
correspond with S. Lieberman, K&E team re
same (.2).
08/20/24 Michael Y. Chan
2.00 Analyze issues re supplemental conflicts
disclosure of creditors and certain entities re
K&E retention.
08/20/24 Kenny Chiaghana
0.10 Review, revise K&E monthly statement re
privilege and confidentiality considerations.
08/20/24 Marta Dudyan
4.00 Analyze issues re supplemental conflicts
disclosure of creditors and certain entities re
K&E retention.
08/20/24 Sabrina Lieberman
0.20 Correspond with C. Ceresa, K. Chiaghana re
K&E monthly fee statement.
08/21/24 Chris Ceresa
2.30 Review, revise K&E fee statement (1.8);
correspond with S. Lieberman, K&E team re
same (.5).
08/21/24 Kenny Chiaghana
1.20 Review, revise K&E monthly statement re
privilege and confidentiality considerations.
08/21/24 Marta Dudyan
2.00 Analyze issues re supplemental conflicts
disclosure of creditors and certain entities re
K&E retention.
08/21/24 Sabrina Lieberman
1.50 Review, revise K&E monthly statement (.2);
correspond with C. Ceresa re same (.1);
correspond with C. Ceresa, K&E team re
same (.7); review, analyze disclosure results
(.3); draft second supplemental declaration in
support of K&E retention (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 578 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050105559
48520-22
5
Date
Name
Hours Description
08/22/24 Chris Ceresa
1.00 Review, revise K&E fee statement (.8);
correspond with K. Chiaghana, K&E team re
same (.2).
08/22/24 Sabrina Lieberman
2.20 Conference with T. Chanroo re supplemental
declaration in support of K&E retention (.1);
correspond with T. Chanroo re same (.2);
draft same (.9); review, analyze conflicts
reports (1.0).
08/22/24 Eric Nyberg
0.50 Analyze issues re conflicts, creditor and entity
disclosure re K&E retention.
08/23/24 Marta Dudyan
6.00 Analyze issues re conflicts, creditor and entity
disclosure re K&E retention (3.9); further
review, analyze supplemental disclosures re
creditors, other entities re K&E retention
(2.1).
08/23/24 Sabrina Lieberman
1.70 Correspond with C. Ceresa, K&E team re
K&E monthly fee statement issues.
08/23/24 Eric Nyberg
1.50 Prepare conflicts searches re creditors and
other entities (.5); analyze issues, creditors,
entities re same (1.0).
08/24/24 Sabrina Lieberman
0.30 Review, analyze conflicts reports ISO K&E
retention.
08/25/24 Sarah Osborne
3.10 Review, revise K&E fee statement for
privilege, confidentiality concerns.
08/25/24 Quin Wetzel
2.20 Review, revise K&E monthly statement re
privilege, confidentiality.
08/26/24 Marta Dudyan
4.00 Draft schedules re supplemental declaration re
K&E retention.
08/26/24 Sabrina Lieberman
0.60 Review, revise K&E monthly fee statement
(.3); correspond with C. Ceresa, K&E team re
same (.3).
08/26/24 Sarah Osborne
3.40 Review, revise K&E monthly statement for
privilege, confidentiality considerations.
08/27/24 Kenny Chiaghana
0.80 Review, revise K&E fee statement re
privilege and confidentiality considerations.
08/27/24 Sabrina Lieberman
1.40 Review, revise K&E fee statement for
privilege and accuracy (1.3); correspond with
T. Chanroo, K&E team re disclosure surveys
(.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 579 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050105559
48520-22
6
Date
Name
Hours Description
08/28/24 Sabrina Lieberman
1.40 Review, revise K&E fee statement (1.1);
correspond with C. Ceresa, K&E team re
monthly fee statement (.1); correspond with
Company, C. Ceresa re prepetition fee
statement (.2).
08/29/24 Tiffani Chanroo
0.80 Review, revise K&E monthly fee statement
(.7); correspond with S. Lieberman re same
(.1).
08/29/24 Sabrina Lieberman
3.00 Draft K&E monthly fee statement (2.5);
revise second supplemental declaration ISO
K&E retention (.3); conference with T.
Chanroo re same (.2).
08/30/24 Tiffani Chanroo
1.80 Review, revise supplemental declaration ISO
K&E retention (1.2); correspond with S.
Lieberman re same (.6).
08/30/24 Julia R. Foster
0.40 Research precedent re supplemental
declarations in support of K&E retention.
08/30/24 Sabrina Lieberman
1.10 Review, revise second supplemental
declaration in support of K&E retention (.4);
review, revise first monthly K&E fee
statement (.4); correspond with C. Ceresa,
K&E team, Cole Schotz re same (.3).
08/31/24 Sabrina Lieberman
0.40 Review, revise second supplemental
declaration in support of K&E retention.
Total
69.40
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 580 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105560
Client Matter: 48520-23
In the Matter of Retention - Non K&E
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 17,867.00
Total legal services rendered
$ 17,867.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 581 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050105560
48520-23
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
2.20
1,395.00
3,069.00
Hannah Crawford
0.30
1,595.00
478.50
Sabrina Lieberman
11.10
975.00
10,822.50
Rebecca J. Marston
2.60
1,345.00
3,497.00
TOTALS
16.20
$ 17,867.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 582 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050105560
48520-23
3
Description of Legal Services
Date
Name
Hours Description
08/01/24 Sabrina Lieberman
0.10 Correspond with PJT re fee application issues.
08/01/24 Rebecca J. Marston
0.80 Correspond with C. Ceresa, K&E team re PJT
monthly fee statement (.4); review, analyze
same (.4).
08/02/24 Chris Ceresa
0.50 Review, analyze issues re non‑K&E retention
(.3); correspond with S. Lieberman and K&E
team re same (.2).
08/02/24 Sabrina Lieberman
0.30 Correspond with C. Ceresa, K&E team, Cole
Schotz re PJT fee application (.2); correspond
with R. Marston re declarations of
disinterestedness (.1).
08/04/24 Sabrina Lieberman
0.20 Correspond with C. Ceresa re ordinary course
professional declarations of disinterestedness.
08/05/24 Sabrina Lieberman
1.10 Correspond with BDO, Cole Schotz re revised
retention order (.3); review, revise same (.8).
08/06/24 Sabrina Lieberman
0.20 Conference with Fragomen re ordinary course
professional declaration of disinterestedness.
08/07/24 Sabrina Lieberman
1.20 Conference with BDO re revised retention
order (.1); correspond with Cole Schotz, C.
Ceresa, K&E team re same (.1); review,
analyze ordinary course professional
declarations of disinterestedness (.4);
correspond with ordinary course professionals
re same (.1); conference with Ernst & Young
re same (.2); correspond with BDO, Cole
Schotz, K&E team re revised retention order
(.3).
08/08/24 Chris Ceresa
0.70 Review, analyze issues re non‑K&E retention
(.5); correspond with S. Lieberman and K&E
team re same (.2).
08/08/24 Sabrina Lieberman
5.80 Conference with ordinary course
professionals re declarations of
disinterestedness (.7); conference with R.
Marston re same (.1); correspond with
ordinary course professionals re same (2.7);
conference with Cole Schotz re same (.2);
review, revise same (1.8); correspond with
Cole Schotz re same (.3).
08/08/24 Rebecca J. Marston
1.80 Correspond with S. Lieberman, K&E team re
OCP declarations of disinterestedness (.5);
review and revise same (1.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 583 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050105560
48520-23
4
Date
Name
Hours Description
08/09/24 Sabrina Lieberman
0.20 Correspond with ordinary course
professionals re declarations of
disinterestedness.
08/13/24 Chris Ceresa
0.20 Review, analyze issues re non‑K&E retention.
08/13/24 Sabrina Lieberman
0.50 Correspond with C. Ceresa, R. Marston,
ordinary course professional re declaration
(.2); review, revise same (.2); correspond with
Cole Schotz re same (.1).
08/14/24 Sabrina Lieberman
0.40 Review, revise PJT monthly fee statement
(.3); correspond with C. Ceresa, K&E team re
same (.1).
08/15/24 Sabrina Lieberman
0.30 Correspond with C. Ceresa, PJT, Cole Schotz
re PJT monthly fee application (.2); review,
revise same (.1).
08/19/24 Hannah Crawford
0.30 Correspond with J. Mudhar re local counsel
issues (.2); correspond with Walker Morris re
same (.1).
08/22/24 Sabrina Lieberman
0.20 Review, revise second supplemental
declaration in support of AlixPartners
retention (.1); correspond with C. Ceresa, T.
Chanroo re same (.1).
08/23/24 Sabrina Lieberman
0.20 Correspond with T. Chanroo, Cole Schotz re
AlixPartners second supplemental declaration
in support of retention.
08/30/24 Chris Ceresa
0.30 Review, analyze legal issues re non‑K&E
retention.
08/30/24 Chris Ceresa
0.50 Review, analyze legal issues re non‑KE
retention (.3); correspond with S. Lieberman,
K&E team re same (.2).
08/30/24 Sabrina Lieberman
0.40 Review, analyze PJT monthly fee application
(.2); correspond with C. Ceresa, K&E team,
PJT, Cole Schotz re same (.2).
Total
16.20
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 584 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105561
Client Matter: 48520-24
In the Matter of Vendor Matters
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 3,120.00
Total legal services rendered
$ 3,120.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 585 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Vendor Matters
Invoice Number:
Matter Number:
1050105561
48520-24
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Sabrina Lieberman
3.20
975.00
3,120.00
TOTALS
3.20
$ 3,120.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 586 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Vendor Matters
Invoice Number:
Matter Number:
1050105561
48520-24
3
Description of Legal Services
Date
Name
Hours Description
08/01/24 Sabrina Lieberman
0.10 Conference with vendor counsel re claim
issue.
08/07/24 Sabrina Lieberman
0.20 Conference with vendor counsel re vendor
agreement (.1); correspond with AlixPartners
re same (.1).
08/08/24 Sabrina Lieberman
0.80 Conference with AlixPartners re open vendor
issues (.4); conference with C. Ceresa, T.
Chanroo re same (.4).
08/13/24 Sabrina Lieberman
0.80 Conference with vendor re prepetition claim
(.4); correspond with vendor re prepetition
claim (.2); correspond with C. Ceresa, T.
Chanroo re same (.2).
08/15/24 Sabrina Lieberman
0.60 Conference with AlixPartners re open vendor
matters (.2); correspond with C. Ceresa, T.
Chanroo, AlixPartners re same (.4).
08/16/24 Sabrina Lieberman
0.20 Correspond with C. Ceresa, T. Chanroo,
AlixPartners, vendor counsel re vendor
inquiry.
08/18/24 Sabrina Lieberman
0.10 Correspond with J. Desai, AlixPartners re
vendor matters.
08/22/24 Sabrina Lieberman
0.10 Correspond with vendor counsel re open
issue.
08/26/24 Sabrina Lieberman
0.30 Correspond with T. Chanroo, vendor re claim
extension.
Total
3.20
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 587 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105562
Client Matter: 48520-25
In the Matter of Litigation
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 61,632.50
Total legal services rendered
$ 61,632.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 588 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050105562
48520-25
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Stephanie Choi
2.60
355.00
923.00
Joseph A. D'Antonio
2.30
1,235.00
2,840.50
Tabitha J. De Paulo
29.10
1,435.00
41,758.50
Alisa Melekhina
4.90
1,595.00
7,815.50
Noah Spector
7.00
1,185.00
8,295.00
TOTALS
45.90
$ 61,632.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 589 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050105562
48520-25
3
Description of Legal Services
Date
Name
Hours Description
08/01/24 Stephanie Choi
1.00 Correspond with N. Spector, K&E team re
document production (.5); compile board
meeting materials and agenda for circulation
(.2); revise summary to reflect status of
document requests (.2); correspond with N.
Spector, K&E team re same (.1).
08/01/24 Alisa Melekhina
1.10 Review, analyze board meeting minutes and
materials re redactions and production
requests (.4); correspond with Cole Schotz
and N. Spector re same (.4); correspond with
Cole Schotz, N. Spector, K&E team re
production staging, document requests and
privilege review (.3).
08/01/24 Noah Spector
0.40 Correspond with Cole Schotz re document
production.
08/02/24 Stephanie Choi
0.50 Prepare set of finalized redactions of
additional board materials to FTP (.3);
correspond with N. Spector and K&E team re
same (.2).
08/02/24 Alisa Melekhina
0.80 Review, analyze issues re production staging,
finalization, discovery and privilege review
feedback (.2); correspond with Cole Schotz,
N. Spector, K&E team re same (.2); review,
analyze document request productions to
UCC (.1); review, analyze responses and
objections re same (.2); review, analyze status
updates re meet and confers (.1).
08/05/24 Tabitha J. De Paulo
0.50 Review and revise responses and objections
to UCC’s discovery requests.
08/05/24 Alisa Melekhina
0.50 Review, analyze draft responses and
objections to UCC’s document requests (.3);
review, analyze correspondence with UCC
counsel re discovery meeting (.2).
08/06/24 Stephanie Choi
0.10 Compile newly produced document requests.
08/06/24 Alisa Melekhina
0.80 Review, analyze responses and objections to
UCC document requests and document
production (.5); review, analyze
correspondence with UCC counsel re
discovery and updates (.1); review document
collections from first lien agent re draw
requests (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 590 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050105562
48520-25
4
Date
Name
Hours Description
08/09/24 Alisa Melekhina
0.30 Review, analyze correspondence with UCC
counsel re discovery meeting and updates
(.1); review, analyze investigation custodian
list and related search terms (.2).
08/12/24 Alisa Melekhina
0.40 Review, analyze correspondence with UCC
counsel and Haynes Boone re document
requests and responses (.2); review, analyze
security and inter-company loan agreements
re same (.2).
08/14/24 Alisa Melekhina
0.20 Review, analyze correspondence with UCC
counsel re discovery, search terms and
meeting updates.
08/16/24 Alisa Melekhina
0.40 Review, analyze correspondence with UCC
counsel re discovery, search terms and
meeting updates (.2); review analyze issues re
production links and transmittals (.1);
correspond with N. Spector, K&E team re
same (.1).
08/20/24 Joseph A. D'Antonio
1.80 Review and analyze sale order materials (1.0);
draft M. Schlappig direct outline re same (.8).
08/20/24 Alisa Melekhina
0.20 Review, analyze Cole Schotz UCC meeting
updates, production links and transmittals
(.1); correspond with N. Spector, K&E team
re same (.1).
08/20/24 Noah Spector
2.00 Review and prepare sale hearing materials,
including orders and exhibits for production.
08/21/24 Noah Spector
3.90 Review, analyze sale hearing materials (1.0);
draft and revise materials for sale hearing
(2.9).
08/22/24 Tabitha J. De Paulo
3.20 Prepare for sale hearing witness preparation
sessions (2.3); conference with AlixPartners
re sale hearing preparation (.9).
08/22/24 Noah Spector
0.70 Prepare, analyze materials for sale hearing
(.2); telephone conference with T. De Paulo,
K&E team re same (.5).
08/23/24 Joseph A. D'Antonio
0.50 Conference with T. De Paulo, M. Schlappig,
others re sale hearing witness preparation.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 591 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050105562
48520-25
5
Date
Name
Hours Description
08/23/24 Tabitha J. De Paulo
3.80 Review and revise draft direct examination
for C. Braley (1.2); prepare for witness
preparation session with E. Frejka for sale
hearing (.3); participate in same (.5); prepare
for witness preparation session with M.
Schlappig (.6); participate in same (.7);
correspond with C. Ceresa, K&E team re
same (.2); review, analyze objections to sale
orders (.3).
08/26/24 Tabitha J. De Paulo
2.30 Analyze legal issues re sale hearing.
08/27/24 Tabitha J. De Paulo
3.60 Correspond with C. Ceresa, K&E team re sale
hearing (.1); review, analyze issues re
holdback schedule, financial metrics
(2.3); draft, prepare direct examination
materials for sale hearing (1.2).
08/27/24 Alisa Melekhina
0.20 Review, analyze Cole Schotz UCC updates,
including production links and transmittals
(.1); correspond with N. Spector, K&E team
re same (.1).
08/28/24 Tabitha J. De Paulo
2.80 Telephone conference with C. Braley in
preparation for sale hearing (1.2); review,
analyze materials in preparation for sale
hearing (1.4); telephone conference with
AlixPartners re schedules for same (.2).
08/29/24 Stephanie Choi
1.00 Review, finalize exhibits in preparation for
sale hearing.
08/29/24 Tabitha J. De Paulo
8.00 Draft direct examination for sale hearing
(3.5); compile, prepare demonstratives for
same (.7); draft, analyze issues re mock cross
for sale hearing (2.1); telephone conference
 with C. Braley re preparation for sale hearing
(1.7).
08/30/24 Tabitha J. De Paulo
4.90 Prepare for hearing re sale motion (3.8);
further prepare re same (1.1).
Total
45.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 592 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105564
Client Matter: 48520-27
In the Matter of Non-Working Travel
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 25,073.00
Total legal services rendered
$ 25,073.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 593 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Non-Working Travel
Invoice Number:
Matter Number:
1050105564
48520-27
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
4.00
1,395.00
5,580.00
Tabitha J. De Paulo
8.30
1,435.00
11,910.50
Spencer A. Winters, P.C.
4.50
1,685.00
7,582.50
TOTALS
16.80
$ 25,073.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 594 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Non-Working Travel
Invoice Number:
Matter Number:
1050105564
48520-27
3
Description of Legal Services
Date
Name
Hours Description
08/25/24 Chris Ceresa
1.00 Travel from New York, NY to Wilmington,
DE re sale hearing (billed at half time).
08/25/24 Tabitha J. De Paulo
2.80 Travel from Chicago to Wilmington, DE re
sale hearing (billed at half time).
08/25/24 Spencer A. Winters, P.C.
1.50 Travel from Chicago, IL to Wilmington, DE
re sale hearing (billed at half time).
08/26/24 Chris Ceresa
1.00 Travel from Wilmington, DE to New York,
NY re sale hearing (billed at half time).
08/26/24 Tabitha J. De Paulo
2.50 Travel from Wilmington, DE to Chicago, IL
re sale hearing (billed at half time).
08/26/24 Spencer A. Winters, P.C.
1.50 Travel from Wilmington, DE to Chicago, IL
re sale hearing (billed at half time).
08/29/24 Chris Ceresa
1.00 Travel from New York, NY to Wilmington,
DE re sale hearing (billed at half time).
08/29/24 Spencer A. Winters, P.C.
1.50 Travel from Chicago, IL to Wilmington, DE
re sale hearing (billed at half time).
08/30/24 Chris Ceresa
1.00 Travel from Wilmington, DE to New York,
NY re sale hearing (billed at half time).
08/30/24 Tabitha J. De Paulo
3.00 Travel from Wilmington, DE to Houston, TX
re sale hearing (billed at half time).
Total
16.80
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 595 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105565
Client Matter: 48520-29
In the Matter of Employee and Labor Matters
For legal services rendered through August 31, 2024
(see attached Description of Legal Services for detail)
$ 11,980.50
Total legal services rendered
$ 11,980.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 596 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Employee and Labor Matters
Invoice Number:
Matter Number:
1050105565
48520-29
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Rebecca H. Arnall
0.70
1,265.00
885.50
Chris Ceresa
1.70
1,395.00
2,371.50
Tiffani Chanroo
0.50
1,345.00
672.50
Hannah Crawford
0.50
1,595.00
797.50
Jai Mudhar
1.00
1,345.00
1,345.00
Evangelia Podaras
1.20
1,575.00
1,890.00
Risa Salins
1.90
2,115.00
4,018.50
TOTALS
7.50
$ 11,980.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 597 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Employee and Labor Matters
Invoice Number:
Matter Number:
1050105565
48520-29
3
Description of Legal Services
Date
Name
Hours Description
08/01/24 Evangelia Podaras
0.60 Telephone conference with AlixPartners re
employment contingency planning (.3);
correspond with R. Salins re same (.3).
08/01/24 Risa Salins
0.30 Correspond with R. Sallins, K&E team re
PTO matters.
08/02/24 Rebecca H. Arnall
0.70 Review, revise M&A Counterparty purchase
agreement re compensation issues (.6);
correspond with S. Price re same (.1).
08/02/24 Chris Ceresa
0.30 Review, analyze employment contingency
planning materials (.2); correspond with R.
Salins, K&E team, Company re same (.1).
08/05/24 Chris Ceresa
0.60 Review contingency planning materials (.3);
correspond with R. Salins, K&E team,
Company re same (.3).
08/05/24 Evangelia Podaras
0.30 Telephone conference with C. Ceresa, K&E
team, Company re employment notices.
08/05/24 Risa Salins
0.30 Telephone conference with C. Ceresa re
employee contingency matters.
08/15/24 Hannah Crawford
0.50 Correspond with J. Mudhar, K&E team re UK
employment law counsel.
08/15/24 Jai Mudhar
1.00 Correspond with A. Chan and counsel re
employment matters.
08/28/24 Chris Ceresa
0.30 Review, analyze legal issues re employment
matters.
08/28/24 Evangelia Podaras
0.10 Correspond with C. Ceresa, K&E team re
employment contingency matters.
08/29/24 Chris Ceresa
0.50 Review, analyze legal issues re employment
matters (.2); correspond with E. Podaras re
same (.3)
08/29/24 Tiffani Chanroo
0.50 Conference with C. Ceresa, K&E team re
employment contingency matters.
08/29/24 Evangelia Podaras
0.20 Correspond with C. Ceresa, K&E team re
employment contingency matters.
08/29/24 Risa Salins
1.30 Review, analyze employee data (.5);
telephone conferences with C. Ceresa,
AlixPartners re employment contingency
matters (.8).
Total
7.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 598 of 914

September 2024
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 599 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107349
Client Matter: 48520-5
In the Matter of Corporate & Governance Matters
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail)
$ 46,564.00
Total legal services rendered
$ 46,564.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 600 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050107349
48520-5
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
5.10
1,395.00
7,114.50
Tiffani Chanroo
2.90
1,345.00
3,900.50
Jaina Desai
0.30
975.00
292.50
Luke Finn
0.70
1,345.00
941.50
Partha Kar
0.50
2,305.00
1,152.50
Sabrina Lieberman
1.60
975.00
1,560.00
Jai Mudhar
10.40
1,345.00
13,988.00
Sarah Osborne
0.90
975.00
877.50
Jay M. Ptashek, P.C.
1.00
2,245.00
2,245.00
Joshua Raphael
1.80
1,095.00
1,971.00
Steve Toth
0.70
1,820.00
1,274.00
Donatus Wang
3.80
960.00
3,648.00
Spencer A. Winters, P.C.
1.00
1,685.00
1,685.00
Sara B. Zablotney, P.C.
2.20
2,445.00
5,379.00
Ann-Kathrin Ziegler
0.50
1,070.00
535.00
TOTALS
33.40
$ 46,564.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 601 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050107349
48520-5
3
Description of Legal Services
Date
Name
Hours Description
09/03/24 Jai Mudhar
2.00 Correspond with S. Lieberman, K&E team re
Swiss auditor (.8); review documents from
Swiss counsel (1.2).
09/04/24 Jai Mudhar
1.00 Correspond with Swiss and Dutch Local
Counsel re opt-out (.5); correspond with S.
Lieberman, K&E team re opt-out (.5).
09/04/24 Joshua Raphael
1.40 Draft special committee presentation re plan
(1.1); review, revise special committee
presentation (.2); correspond with C. Ceresa
re same (.1).
09/04/24 Steve Toth
0.70 Discuss intercompany settlement and related
matters with N. Warther, K&E team.
09/05/24 Chris Ceresa
1.60 Attend special committee conference (1.0);
draft minutes re same (.6).
09/05/24 Partha Kar
0.50 Conference with US and Swiss counsel re
auditor issues.
09/05/24 Jai Mudhar
1.20 Correspond with local counsel, S. Lieberman,
K&E team re Swiss Auditor opt-out (1.0);
review, analyze resolution from Dutch
counsel (.2).
09/05/24 Spencer A. Winters, P.C.
0.50 Attend special committee meeting.
09/05/24 Sara B. Zablotney, P.C.
2.20 Attend telephone conference re valuation (.5);
attend follow up telephone conference re
re‑allocation and intercompany (.5); attend
telephone conference re allocation (.5);
correspond with N. Warther, K&E team re
intercompany settlement (.3); review
allocation (.4).
09/06/24 Jaina Desai
0.30 Correspond with Cole Schotz, AlixPartners,
C. Ceresa, K&E team re Swiss audit
conference.
09/06/24 Jai Mudhar
1.00 Review, analyze wind-down considerations
(.7); review, analyze Swiss auditor
considerations (.3).
09/09/24 Tiffani Chanroo
1.30 Conference with S. Lieberman, K&E team,
Grant Thornton re auditor (.5); review,
analyze issues re same (.6); correspond with
S. Lieberman re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 602 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050107349
48520-5
4
Date
Name
Hours Description
09/09/24 Jai Mudhar
1.50 Conference with Swiss Auditor (.5);
correspond with Swiss Counsel and Dutch
Counsel re Swiss and Dutch entities (.5);
correspond with T. Chanroo, K&E team re
Swiss auditor issues and next steps (.3);
correspond with AlixPartners re UK company
options (.2).
09/10/24 Tiffani Chanroo
1.60 Review, analyze correspondence re Swiss
auditor (1.2); correspond with S. Lieberman,
K&E team re same (.4).
09/10/24 Jai Mudhar
2.50 Conference with AlixPartners re UK entity
options (1.0); correspond with AlixPartners re
same (.8); correspond with T. Chanroo, K&E
team regarding Swiss auditor issues (.7).
09/10/24 Jay M. Ptashek, P.C.
0.50 Attend board and advisor calls.
09/11/24 Sabrina Lieberman
0.30 Correspond with J. Mudhar, T. Chanroo re
Swiss auditor resolutions.
09/11/24 Jai Mudhar
1.00 Conference with AlixPartners re UK options
(.5); correspond with AlixPartners re same
(.5).
09/11/24 Jay M. Ptashek, P.C.
0.50 Attend board and advisor calls.
09/12/24 Chris Ceresa
1.50 Conference with S. Winters and special
committee re case matters (.4); draft minutes
re same (.3); conference with J. Mudhar,
K&E team re international corporate
governance points (.8).
09/12/24 Joshua Raphael
0.40 Draft correspondence to Cole Schotz re
foreign entities (.3); correspond with C.
Ceresa re same (.1).
09/13/24 Chris Ceresa
0.40 Telephone conference with D. Wang and
K&E team re German entity corporate
governance issues.
09/13/24 Sarah Osborne
0.90 Review, revise draft correspondence to board
re audit waiver (.5); correspond with S.
Lieberman, local counsel re same (.2); draft
correspondence re same (.2).
09/13/24 Donatus Wang
0.10 Correspond with C. Ceresa, K&E team re tax
issues, novation agreement.
09/13/24 Ann-Kathrin Ziegler
0.50 Conference with D. Wang, K&E team re
German winddown and prepare for
conference.
09/16/24 Jai Mudhar
0.20 Correspond with S. Lieberman, K&E team re
Swiss opt out.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 603 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050107349
48520-5
5
Date
Name
Hours Description
09/17/24 Sabrina Lieberman
0.70 Conference with J. Mudhar re Swiss auditor
documents (.2); correspond with Company re
same (.5).
09/18/24 Chris Ceresa
0.80 Review, analyze open corporate legal issues.
09/18/24 Chris Ceresa
0.40 Telephone conference with Y. Salloum and
Company and special committee re
governance matters.
09/18/24 Sabrina Lieberman
0.30 Correspond with Company, Baker McKenzie,
J. Mudhar, K&E team re Swiss auditor.
09/19/24 Sabrina Lieberman
0.20 Correspond with Company, Baker McKenzie,
C. Ceresa, K&E team re Swiss auditor
documents.
09/23/24 Donatus Wang
3.70 Review, analyze correspondence from C.
Ceresa, K&E team, AlixPartners, Company re
intercompany issues and relevant aspects
under German law (3.0); review, revise
correspondence from C. Paus re same (.7).
09/26/24 Chris Ceresa
0.40 Draft, revise minutes re special committee
conference (.2); correspond with Company
and advisors re issues re special committee
conference (.2).
09/26/24 Luke Finn
0.30 Review, analyze Swiss entity corporate
governance documents.
09/26/24 Spencer A. Winters, P.C.
0.50 Prepare for and attend special committee
meeting.
09/28/24 Luke Finn
0.40 Review, analyze Vyaire Medical Holdings
B.V. executed board and shareholder
resolutions.
09/30/24 Sabrina Lieberman
0.10 Correspond with C. Ceresa, K&E team, Cole
Schotz re international counsel.
Total
33.40
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 604 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107350
Client Matter: 48520-6
In the Matter of Disclosure Statement/Plan/Confirmation
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail)
$ 205,240.50
Total legal services rendered
$ 205,240.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 605 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050107350
48520-6
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
51.10
1,395.00
71,284.50
Tiffani Chanroo
29.20
1,345.00
39,274.00
Jaina Desai
17.30
975.00
16,867.50
Michael Ehret
1.00
1,895.00
1,895.00
Luke Finn
0.40
1,345.00
538.00
Emanuel Goetz
2.50
750.00
1,875.00
Palmer Gunderson
1.20
995.00
1,194.00
David Hackel
1.50
1,095.00
1,642.50
Sabrina Lieberman
1.00
975.00
975.00
Sarah Osborne
2.10
975.00
2,047.50
Joshua Raphael
15.30
1,095.00
16,753.50
Yusuf Salloum
2.40
1,595.00
3,828.00
Seth Sanders
0.50
1,265.00
632.50
Steve Toth
1.40
1,820.00
2,548.00
Nicholas Warther
3.20
1,665.00
5,328.00
Quin Wetzel
11.40
975.00
11,115.00
Spencer A. Winters, P.C.
14.40
1,685.00
24,264.00
Sara B. Zablotney, P.C.
1.30
2,445.00
3,178.50
TOTALS
157.20
$ 205,240.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 606 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050107350
48520-6
3
Description of Legal Services
Date
Name
Hours Description
09/02/24 Tiffani Chanroo
2.20 Review, revise disclosure statement (2.0);
correspond with Q. Wetzel, K&E team re
same (.2).
09/02/24 Sabrina Lieberman
0.10 Correspond with Q. Wetzel re confirmation
declarations.
09/02/24 Joshua Raphael
3.20 Review, revise Plan (2.9); correspond with C.
Ceresa re same (.3).
09/03/24 Chris Ceresa
7.60 Review, analyze plan and DS legal issues
(3.9); review materials and correspondence re
same (2.5); correspond with J. Raphael, K&E
team, advisors re same (1.2).
09/03/24 Chris Ceresa
0.30 Review, revise exclusivity motion.
09/03/24 Tiffani Chanroo
4.60 Review, revise disclosure statement motion,
exhibits (3.9); correspond with Q. Wetzel,
K&E team re same (.7).
09/03/24 Jaina Desai
5.80 Draft voting declaration (1.2); revise
disclosure statement (3.9); correspond with T.
Chanroo, K&E team re same (.7).
09/03/24 Jaina Desai
0.30 Review, analyze voting declaration precedent.
09/03/24 David Hackel
0.30 Analyze issues re confirmation brief (.2);
correspond with K. Chiaghana re same (.1).
09/03/24 Sabrina Lieberman
0.60 Review, revise confirmation declarations.
09/03/24 Joshua Raphael
5.40 Draft correspondence to C. Ceresa, K&E
team, Gibson Dunn re plan and disclosure
statement (.1); review, revise plan (3.0);
correspond with Cole Schotz, S. Sanders,
K&E team re same (.1); research precedent re
same (2.2).
09/03/24 Seth Sanders
0.50 Analyze issues re plan (.3); correspond with J.
Raphael, K&E team re same (.2).
09/03/24 Quin Wetzel
9.10 Research precedent disclosure statement
(2.2); review, analyze precedent releases
(1.3); correspond with T. Chanroo, C. Ceresa
re same (.6); review, revise disclosure
statement (2.2); review, revise disclosure
statement motion (1.2); review, revise
exhibits (1.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 607 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050107350
48520-6
4
Date
Name
Hours Description
09/03/24 Spencer A. Winters, P.C.
3.20 Review and revise draft plan (.8); review and
analyze issues re same (1.3); correspond and
telephone conferences with working group re
same (1.1).
09/04/24 Chris Ceresa
2.30 Review, analyze plan and disclosure
statement legal issues (.8); review, analyze
materials and correspondence re same (.7);
correspond with T. Chanroo, K&E team,
advisors re same (.8).
09/04/24 Chris Ceresa
0.60 Review, revise exclusivity motion.
09/04/24 Tiffani Chanroo
5.40 Conference with C. Ceresa, AlixPartners re
liquidity analysis (.5); conference with Cole
Schotz, C. Ceresa, K&E team re plan,
disclosure statement (.5); review, revise
disclosure statement motion (1.6); review,
analyze issues re same (2.8).
09/04/24 Jaina Desai
4.60 Review, analyze comments re disclosure
statement (.6); correspond with Q. Wetzel, C.
Ceresa re same (.5); revise disclosure
statement (3.5).
09/04/24 Jaina Desai
1.80 Revise disclosure statement.
09/04/24 Luke Finn
0.40 Review, analyze chapter 11 plan documents.
09/04/24 Emanuel Goetz
1.80 Review, analyze chapter 11 plan re tax issues.
09/04/24 Palmer Gunderson
1.20 Review, analyze disclosure statement and
chapter 11 plan.
09/04/24 David Hackel
1.20 Analyze issues, precedent, Company
information re confirmation brief (1.1);
correspond with K. Chiaghana, K&E team re
same (.1).
09/04/24 Sabrina Lieberman
0.30 Review, revise declaration in support of
confirmation.
09/04/24 Joshua Raphael
1.30 Conference with CS, AlixPartners, C. Ceresa,
K&E team re liquidation analysis (.4); review,
revise Plan (.1); correspond, distribute Plan to
professionals (.2); review, revise disclosure
statement (.2); coordinate, correspond with C.
Ceresa, K&E team CS re same, solicitation,
Plan (.4).
09/04/24 Steve Toth
1.40 Review, revise draft plan.
09/04/24 Quin Wetzel
2.10 Review, revise disclosure statement motion
(.8); review, revise disclosure statement
exhibits (1.2); correspond with T. Chanroo re
same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 608 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050107350
48520-6
5
Date
Name
Hours Description
09/04/24 Spencer A. Winters, P.C.
1.50 Review and analyze issues re plan, wind
down (.8); correspond and telephone
conferences with working group re same (.7).
09/05/24 Chris Ceresa
1.60 Review, analyze plan and DS legal issues (.7);
review precedent re same (.6); correspond
with T. Chanroo, K&E team, advisors re same
(.3).
09/05/24 Chris Ceresa
0.70 Review, revise exclusivity motion (.5);
correspond with T. Chanroo, K&E team re
issues re same (.2).
09/05/24 Tiffani Chanroo
3.60 Correspond with C. Ceresa, K&E team re
disclosure statement motion (.7); conference
with Omni team, C. Ceresa, K&E team re
solicitation (.5); review, analyze issue re same
(1.9); review, revise disclosure statement
motion (.5).
09/05/24 Jaina Desai
1.10 Revise disclosure statement motion (1.0);
correspond with T. Chanroo re same (.1).
09/05/24 Joshua Raphael
0.60 Conferences with Omni, Cole Schotz, C.
Ceresa re solicitation (.5); prepare for same
(.1).
09/05/24 Quin Wetzel
0.20 Review, revise disclosure statement motion
and exhibits (.1); correspond with T. Chanroo
re same (.1).
09/05/24 Spencer A. Winters, P.C.
0.80 Review and analyze issues re plan and
winddown.
09/06/24 Chris Ceresa
3.40 Review, analyze plan and disclosure
statement legal issues (1.2); review, analyze
materials and correspondence re same (.9);
correspond with T. Chanroo, K&E team,
advisors re same (1.3).
09/06/24 Tiffani Chanroo
0.70 Conference with C. Ceresa, K&E team,
AlixPartners, Cole Schotz re plan.
09/06/24 Michael Ehret
1.00 Review, revise draft chapter 11 plan (.8);
correspond with N. Warther, E. Goetz re same
(.2).
09/06/24 Emanuel Goetz
0.70 Review, analyze chapter 11 plan.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 609 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050107350
48520-6
6
Date
Name
Hours Description
09/06/24 Joshua Raphael
2.20 Review, analyze key dates and professional
fees study (.3); review, analyze precedent re
same (.5); correspond with C. Ceresa, K&E
team re same (.1); review, analyze case
milestones (.6); correspond with S. Winters,
C. Ceresa re same (.2); telephone conference
with C. Ceresa, Cole Schotz, AlixPartners re
Plan and follow up re same (.5).
09/06/24 Nicholas Warther
1.60 Review and revise tax portions of disclosure
and plan.
09/07/24 Chris Ceresa
1.30 Review, analyze plan and disclosure
statement legal issues (1.0); correspond with
T. Chanroo, K&E team, advisors re same (.3).
09/07/24 Tiffani Chanroo
1.20 Conference with C. Ceresa, K&E team re
plan, disclosure statement (.6); correspond
with Ropes, MWE, C. Ceresa re same (.6).
09/07/24 Joshua Raphael
0.30 Conference with S. Winters, C. Ceresa,
AlixPartners, Cole Schotz re plan and
disclosure statement.
09/07/24 Spencer A. Winters, P.C.
2.30 Review, analyze creditor markups to plan
(1.3); attend telephone conference with C.
Ceresa, K&E team, AlixPartners, Cole Schotz
re same (1.0).
09/09/24 Chris Ceresa
6.20 Review, revise plan (3.1); review, revise
disclosure statement (1.1); review and revise
on disclosure statement motion (1.1);
correspond with J. Raphael, K&E team, Cole
Schotz re issues re same (.9).
09/09/24 Tiffani Chanroo
1.40 Review, analyze disclosure statement timeline
(.5); correspond with Cole Schotz, Omni re
same (.4); review, analyze issues re plan (.5).
09/09/24 Joshua Raphael
0.70 Conference with C. Ceresa, K&E team, GDC
re plan (.3); correspond with C. Ceresa, K&E
team, AlixPartners, Cole Schotz re plan (.4).
09/09/24 Nicholas Warther
1.20 Review and revise tax portions of plan and
disclosure statement.
09/09/24 Spencer A. Winters, P.C.
3.20 Attend call with UCC counsel re plan and
disclosure statement (.3); attend telephone
conference with lender counsel re same (.5);
review and analyze issues re plan, disclosure
statement filing (1.3); telephone conferences
with Y. Salloum, K&E working group re
same (1.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 610 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050107350
48520-6
7
Date
Name
Hours Description
09/09/24 Sara B. Zablotney, P.C.
1.00 Review, analyze plan and disclosure
statement.
09/10/24 Chris Ceresa
3.20 Review, revise plan (1.1); review, comment
on disclosure statement (.7); review and
comment on disclosure statement motion
(1.1); correspond with J. Raphael, K&E team,
Cole Schotz re issues re same (.3).
09/10/24 Chris Ceresa
0.50 Review and revise motion to extend
exclusivity.
09/10/24 Tiffani Chanroo
2.90 Review, analyze correspondence from C.
Ceresa, K&E team re plan.
09/10/24 Joshua Raphael
0.60 Correspond with C. Ceresa re plan opt out
(.2); review, revise plan (.3); review, analyze
tax comments to plan (.1).
09/10/24 Nicholas Warther
0.40 Review and revise plan.
09/10/24 Spencer A. Winters, P.C.
1.20 Review and analyze issues re plan filing (.6);
correspond and telephone conferences with C.
Ceresa, K&E team re same (.6).
09/10/24 Sara B. Zablotney, P.C.
0.20 Conference with C. Ceresa, K&E team re plan
language.
09/11/24 Chris Ceresa
2.40 Review, revise Plan (1.0); review disclosure
statement and DS motion (.4); correspond
with S. Winters, K&E team, Cole Schotz re
issues re Plan, DS, and DS Motion (.7);
correspond with Cole Schotz re filing the
same (.3).
09/11/24 Joshua Raphael
0.30 Review, revise Plan (.2); correspond with C.
Ceresa, T. Chanroo re same (.1).
09/11/24 Spencer A. Winters, P.C.
1.30 Attend standing telephone conferences with
Company, Company advisors (1.0); review
and analyze issues re filing of plan,
Disclosure Statement (.3).
09/12/24 Chris Ceresa
0.70 Review and analyze plan legal issues (.5);
review correspondence with Cole Schotz re
same (.2).
09/12/24 Joshua Raphael
0.60 Review, analyze plan, disclosure statement,
disclosure statement motion (.4); correspond
with C. Ceresa, MWE re same (.2).
09/12/24 Sara B. Zablotney, P.C.
0.10 Attend telephone conference with S. Winters
re plan.
09/16/24 Joshua Raphael
0.10 Correspond with C. Ceresa re Plan.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 611 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050107350
48520-6
8
Date
Name
Hours Description
09/17/24 Chris Ceresa
7.50 Review, analyze legal issues re Plan and
solicitation (3.9); telephone conferences with
Y. Salloum, K&E team, Cole Schotz, counsel
re issues re same (1.9); correspond with Y.
Salloum, K&E team, Cole Schotz, counsel re
issues (1.7).
09/18/24 Chris Ceresa
0.20 Correspond with Cole Schotz re plan and
solicitation issues.
09/18/24 Tiffani Chanroo
7.20 Review, analyze plan (3.9); review, revise
same (3.3).
09/19/24 Chris Ceresa
7.50 Review, analyze legal issues re Plan and
solicitation (3.9); telephone conferences with
Y. Salloum, K&E team, Cole Schotz, counsel
re issues re same (1.9); correspond with Y.
Salloum, K&E team, Cole Schotz, counsel re
issues (1.7).
09/23/24 Chris Ceresa
2.80 Review, analyze plan legal issues (1.4);
review and revise disclosure statement and
plan (1.0); correspond with Cole Schotz re
same (.4).
09/23/24 Jaina Desai
2.00 Review, analyze plan (.8); review, analyze
Plan precedent (.5); draft responses to U.S.
Trustee comments re disclosure statement
(.3); correspond with S. Osborne re same (.2);
review, analyze correspondence from C.
Ceresa, K&E team re same (.2).
09/23/24 Sarah Osborne
2.10 Research precedent re U.S. Trustee objections
to plan and disclosure statement (1.7); review,
revise response summary re same (.4).
09/24/24 Chris Ceresa
0.30 Review, analyze plan legal issues (.1); review
and comment on disclosure statement and
plan (.1); correspond with Cole Schotz team
re same (.1).
09/24/24 Jaina Desai
1.70 Review, analyze plan, disclosure statement re
issues (1.4); draft responses re U.S. Trustee
questions re same (.3).
09/26/24 Chris Ceresa
1.40 Review, analyze plan legal issues (.8); review
and revise disclosure statement and plan (.4);
correspond with Cole Schotz team re same
(.2).
09/26/24 Yusuf Salloum
2.40 Prepare for disclosure statement hearing.
09/26/24 Spencer A. Winters, P.C.
0.40 Review and analyze issues re confirmation
status, open issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 612 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050107350
48520-6
9
Date
Name
Hours Description
09/28/24 Chris Ceresa
0.60 Review, analyze plan legal issues (.3); review
and revise disclosure statement and plan (.2);
correspond with Cole Schotz team re same
(.1).
09/30/24 Spencer A. Winters, P.C.
0.50 Review and analyze issues re disclosure
statement hearing, case status.
Total
157.20
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 613 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107351
Client Matter: 48520-7
In the Matter of DIP Financing and Cash Collateral
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail)
$ 3,815.00
Total legal services rendered
$ 3,815.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 614 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050107351
48520-7
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
1.20
1,395.00
1,674.00
Joshua Raphael
0.80
1,095.00
876.00
Adrian Salmen
1.00
1,265.00
1,265.00
TOTALS
3.00
$ 3,815.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 615 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050107351
48520-7
3
Description of Legal Services
Date
Name
Hours Description
09/04/24 Adrian Salmen
0.40 Correspond with C. Ceresa, K&E team,
AlixPartners re professional fees.
09/05/24 Chris Ceresa
0.50 Review, analyze legal issues re DIP financing
(.4); correspond with Company advisors re
same (.1).
09/05/24 Joshua Raphael
0.20 Correspond with DIP agent, C. Ceresa, K&E
team, AlixPartners re DIP withdrawal request
(.1); review, analyze DIP milestones (.1).
09/07/24 Joshua Raphael
0.10 Draft DIP milestone extension waiver.
09/11/24 Adrian Salmen
0.20 Correspond with C. Ceresa, K&E team re
professional fees.
09/13/24 Chris Ceresa
0.30 Review proposed DIP reporting (.2);
correspond with J. Raphael re same (.1).
09/13/24 Joshua Raphael
0.30 Conference with C. Ceresa, AlixPartners re
updated budget (.1); review, analyze order re
same (.1); draft DIP variance report (.1).
09/16/24 Joshua Raphael
0.10 Review, analyze DIP.
09/18/24 Adrian Salmen
0.20 Correspond with C. Ceresa, K&E team re
professional fees.
09/19/24 Chris Ceresa
0.40 Review, analyze DIP reporting (.3);
correspond with J. Raphael re same (.1).
09/19/24 Joshua Raphael
0.10 Prepare DIP draw requests.
09/25/24 Adrian Salmen
0.20 Correspond with C. Ceresa, AlixPartners re
professional fees.
Total
3.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 616 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107352
Client Matter: 48520-10
In the Matter of Asset Sales/Section 363 Issues: Use, Sale & Disposition of Property
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail)
$ 679,253.50
Total legal services rendered
$ 679,253.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 617 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Hendrik Braun
3.50
1,145.00
4,007.50
Chris Ceresa
10.40
1,395.00
14,508.00
Tiffani Chanroo
3.50
1,345.00
4,707.50
Erica D. Clark
0.20
1,595.00
319.00
Bernadette Coppola
3.00
1,575.00
4,725.00
Hannah Crawford
0.30
1,595.00
478.50
Erin Davey
5.80
975.00
5,655.00
Sion Davies
0.60
1,575.00
945.00
Tabitha J. De Paulo
2.60
1,435.00
3,731.00
Anthony M. Del Rio
1.40
1,595.00
2,233.00
Jaina Desai
4.30
975.00
4,192.50
Michael Ehret
1.20
1,895.00
2,274.00
Luke Finn
99.30
1,345.00
133,558.50
Justin M. Garfinkle
2.40
1,095.00
2,628.00
Emanuel Goetz
1.00
750.00
750.00
Palmer Gunderson
24.10
995.00
23,979.50
David Hackel
1.10
1,095.00
1,204.50
Kate Hardey
9.10
1,995.00
18,154.50
Olivia Kaufmann
0.20
1,095.00
219.00
Sabrina Lieberman
0.20
975.00
195.00
Ruan J. Meintjes
6.70
1,095.00
7,336.50
Jai Mudhar
1.50
1,345.00
2,017.50
Trent Nachbar
15.80
1,265.00
19,987.00
Maureen D. O'Brien
1.50
2,115.00
3,172.50
Dan O'Connor
16.90
1,345.00
22,730.50
Carolin Paus
40.20
750.00
30,150.00
Joshua Raphael
40.20
1,095.00
44,019.00
Yusuf Salloum
29.30
1,595.00
46,733.50
Anna Schwander
18.70
1,315.00
24,590.50
Scottie Shermetaro
10.40
1,575.00
16,380.00
Paul D. Tanaka, P.C.
0.60
2,115.00
1,269.00
Steve Toth
84.30
1,820.00
153,426.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 618 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
3
Name
Hours
Rate
Amount
Sarah Ullathorne
1.80
1,575.00
2,835.00
Paul Vasiloff
3.50
1,345.00
4,707.50
Donatus Wang
10.60
960.00
10,176.00
Nicholas Warther
17.40
1,665.00
28,971.00
Cristina Weidner
5.10
1,665.00
8,491.50
Sara B. Zablotney, P.C.
6.10
2,445.00
14,914.50
Ann-Kathrin Ziegler
8.30
1,070.00
8,881.00
TOTALS
493.10
$ 679,253.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 619 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
4
Description of Legal Services
Date
Name
Hours Description
08/16/24 Joshua Raphael
5.00 Conference with E. Clark, K&E team re sale
process (.6) review, revise sale order and
correspond with E. Clark, K&E team re same
(.2). review, revise declarations in support of
sale orders (2.5); correspond with T. de Paolo,
AlixPartners re same (.1); conference with
UCC, S. Winters, K&E team re sale (.1);
correspond with C. Ceresa re draft APAs (.2);
correspondence with E. Clark, K&E team re
sale order language (.2); review, analyze
comments to sale order and correspond re
same (.4); research sale order language (.4);
correspond with PJT re auction (.1);
correspond with parties in interest re sale
order objections (.2).
08/19/24 Joshua Raphael
2.60 Review, revise sale declarations (.4);
correspond with C. Ceresa, K&E team re sale
orders, declarations, objections, related items
(.4); review, analyze Hartford objection to
sale (.4); correspondence with Hartford re
same (.1); correspond with L. Finn re sale
objection (.1); research, draft sale order
language (.4); review, revise successful bidder
notice (.3); correspond with C. Ceresa, K&E
team, Omni re noticing (.1); correspond with
Covington re sale objection (.2); conference
with E. Clark, K&E team re sale workstream
(.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 620 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
5
Date
Name
Hours Description
08/21/24 Joshua Raphael
6.40 Conference with E. Clark, K&E team re sale
(.6); conference with Cole Schotz, K&E team
re sale hearing (.4); correspond with C.
Ceresa, K&E team re sale orders,
declarations, objections (.5); review, analyze
sale orders (.2); revise sale declarations (.3)
finalize declarations and correspond with
advisors, C. Ceresa, K&E team re same (.2);
review, analyze APAs (.2); review, revise sale
hearing agenda (.7); correspond with E. Clark,
K&E team re same (.1); draft sale hearing
presentation (1.4); review, revise presentation
(1.0); correspond with C. Ceresa re same (.1);
correspond, conference with Omni, C. Ceresa
K&E team re service of sale hearing notice
(.6); correspond with S. Winters, C. Ceresa re
sale hearing presentation (.1).
08/22/24 Joshua Raphael
1.00 Conference with counsel to Hartford (.1);
correspond, conference with Omni, C. Ceresa,
K&E team re service (.1); conference with
AlixPartners, T. Paolo, K&E team re sale
hearing presentation (.8).
08/23/24 Joshua Raphael
4.50 Telephone conference with T. Chanroo, K&E
team re sale workstream (.4); review, revise
sale orders (2.4); correspond with T. Chanroo
re same (.1); review, analyze summary re
sales (.2); correspond with S. Osborne re
same (.2); review, analyze correspondence re
sale, sale objections (.2); revise, sale
objections summary chart (1.0).
08/26/24 Joshua Raphael
4.30 Review, revise sale orders and sale hearing
presentation (1.4); correspond with E. Clark,
K&E team re same (.3); attend status
conference re sale hearing (.4); research re
sale order proceeds, holdback (.7); correspond
with C. Ceresa, K&E team re same, sale
order, RSA, sale Orders (1.1); conference
with Company, D. O'Connor, A&M re surety
bonds (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 621 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
6
Date
Name
Hours Description
08/28/24 Joshua Raphael
9.60 Review, revise sale hearing presentation and
correspond with AlixPartners re same (.7);
draft sale reply (3.9); correspond with C.
Ceresa re same (.1); research re same (.8);
continue drafting reply (.5); review, revise
plan (.1); conference with T. Paulo, K&E
team, AlixPartners re holdback schedule
(1.0); research re sale (.1); draft sale hearing
presentation (.9); continue drafting reply and
research re same (1.5).
08/30/24 Joshua Raphael
4.30 Conferences with AlixPartners, T Paulo, K&E
team re sale hearing (.9); review, revise sale
hearing presentation (.3); review, analyze
timeline re sale hearing presentation (.4);
attend sale hearing and prepare for same (2.7).
09/01/24 Luke Finn
1.40 Review, analyze day-of-signing
communication and administrative matters for
Asset Purchase Agreement.
09/02/24 Sion Davies
0.20 Correspond with German counsel re Germany
FDI filing.
09/02/24 Palmer Gunderson
0.40 Correspond with Company re purchase price
allocation principles.
09/03/24 Chris Ceresa
1.20 Review, analyze sale-related legal issues (.8);
correspond with Y. Salloum, K&E team,
Company re issues re same (.4).
09/03/24 Bernadette Coppola
0.30 Correspond with Company, S. Toth, and K&E
team re entity merger (.1); correspond with
buyer’s counsel, S. Toth, and K&E team re
license terms (.2).
09/03/24 Tabitha J. De Paulo
0.60 Conference with AlixPartners team re
follow‑up requests from BRG re sale.
09/03/24 Anthony M. Del Rio
0.30 Review, analyze regulatory filings.
09/03/24 Jaina Desai
1.00 Conference with C. Ceresa re cure objections
(.1); correspond with T. Chanroo, J. Raphael
re same (.1); correspond with AlixPartners, K.
Chiaghana re same (.2); review, analyze
correspondence re same (.3); review, analyze
objection tracker (.2); correspond with S.
Lieberman re sale workstream (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 622 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
7
Date
Name
Hours Description
09/03/24 Luke Finn
4.40 Review, analyze post-signing communication
and administrative matters for asset purchase
agreement (1.5); review, revise Closing
checklist (.8); review, revise Schedule
attachments (1.2); correspond with Company
and Cooley re various open sale issues (.9).
09/03/24 Justin M. Garfinkle
0.50 Draft list of entities selling intellectual
property.
09/03/24 Emanuel Goetz
1.00 Draft correspondence to German counsel re
German real estate transfer tax implications in
connection with the restructuring transactions.
09/03/24 David Hackel
0.70 Review, analyze issues re sales and sale
hearing (.3); draft, revise analysis re same
(.3); correspond with C. Ceresa, K&E team re
same (.1).
09/03/24 Olivia Kaufmann
0.20 Conference with K. Hardey and R. Meintjes
re license update.
09/03/24 Ruan J. Meintjes
0.30 Correspond with O. Kaufmann, K&E team re
California manufacturer license filings.
09/03/24 Dan O'Connor
2.40 Telephone conference with S. Winters, S.
Toth and C. Ceresa re APA and UCC matters
(.3); review and revise disclosure schedules
(.7); correspond with various parties re APA
and disclosure schedule matters (.6);
correspond with MWE re APA matters (.4);
correspond with Gibson Dunn re APA matters
(.4).
09/03/24 Scottie Shermetaro
0.70 Review and revise IP disclosure schedules.
09/03/24 Paul D. Tanaka, P.C.
0.60 Review and analyze asset purchase agreement
(.4); correspond with L. Finn, K&E team re
same (.2).
09/03/24 Steve Toth
0.90 Discuss update with S. Winters and D.
O’Connor, K&E team (.3); analyze APAs re
closing preparation (.6).
09/04/24 Chris Ceresa
2.60 Review, analyze sale-related legal issues
(2.1); correspond with Y. Salloum, K&E
team, Company, advisors re same (.5).
09/04/24 Tiffani Chanroo
0.50 Conference with C. Ceresa, Cole Schotz,
AlixPartners, Company re cure objections.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 623 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
8
Date
Name
Hours Description
09/04/24 Tiffani Chanroo
2.60 Correspond with counterparties re cures (.3);
review, revise cure objection summary (1.3);
correspond with Cole Schotz team re same
(.2); review, analyze issue re same (.8).
09/04/24 Erica D. Clark
0.20 Analyze cure issues and correspond with C.
Ceresa, K&E team re same.
09/04/24 Tabitha J. De Paulo
2.00 Review, analyze sale motion and related
declarations.
09/04/24 Luke Finn
2.50 Correspond with MWE re final signing sets
(.4); conference with J. Raphael re tax
documentation (.6); review, analyze
correspondence from Cooley re international
issues (.8); review, analyze final RDx Asset
Purchase Agreement (.7).
09/04/24 Justin M. Garfinkle
0.30 Review, analyze IP transfer.
09/04/24 Palmer Gunderson
4.20 Telephone conference with N. Warther, K&E
team re pre‑closing tax planning (.8); revise
purchase price allocations for sale
transactions (1.5); correspond with N.
Warther, K&E team re pre‑closing
restructuring transactions (.6); correspond
with N. Warther re purchase price allocations
for sale transactions (1.3).
09/04/24 Palmer Gunderson
0.40 Review Seller comments on purchase price
allocation for sale transaction.
09/04/24 Joshua Raphael
0.40 Conference with C. Ceresa, K&E team, CS,
AlixPartners, Company re cure reconciliation.
09/04/24 Scottie Shermetaro
0.40 Review and revise IP disclosure schedules.
09/04/24 Steve Toth
1.10 Respond to correspondence from Company,
N. Warther, K&E re internal merger
considerations (.3); analyze and respond to
correspondence from Company and
AlixPartners re APA matters (.4); correspond
with Y. Salloum, K&E team re same (.3);
conference with Crowell re same (.1).
09/04/24 Nicholas Warther
4.00 Telephone conference with Company re
purchase price allocation and closing matters
(1.0); review and analyze same (1.2);
telephone conference with S. Zablotney, K&E
team re documentation for closing (1.0);
review and analyze merger and
documentation (.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 624 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
9
Date
Name
Hours Description
09/04/24 Sara B. Zablotney, P.C.
1.00 Attend telephone conference with N. Warther,
K&E team re closing matters (.5); attend
follow up telephone conference with N.
Warther re allocation (.5).
09/05/24 Chris Ceresa
0.20 Review, analyze sale-related legal issues (.1);
correspond with J. Desai, K&E team re same
(.1).
09/05/24 Tiffani Chanroo
0.40 Correspond with counterparty re cure issues.
09/05/24 Jaina Desai
0.80 Telephone conference with C. Ceresa re sale
workstream transition to Cole Schotz (.2);
correspond with C. Ceresa re same (.1);
correspond with T. Chanroo re same (.1);
correspond with cure parties, T. Chanroo,
K&E team re cure objections (.4).
09/05/24 Luke Finn
1.30 Revise draft of Interim Operating Covenant
memorandum.
09/05/24 Justin M. Garfinkle
0.30 Review, analyze IP transfer.
09/05/24 David Hackel
0.40 Analyze issues re sales.
09/05/24 Dan O'Connor
0.80 Telephone conference with Crowell, Deloitte
S. Zablotney, K&E team re allocation
schedule (.4); correspond with S. Zablotney,
K&E team and Company re same (.4).
09/05/24 Scottie Shermetaro
0.30 Correspond with Company re IP Disclosure
Schedules.
09/05/24 Steve Toth
1.80 Participate in management update
teleconference with Company, S. Winters,
PJT, AlixPartners re sale issues (.3);
correspond with Y. Salloum, K&E team re
APA and closing matters (.6); analyze and
update attorney notes and list re closing
preparation and issues (.9).
09/05/24 Donatus Wang
0.40 Review and analyze update on sales processes
(.2); conference with C. Weidner, K&E team
re same (.2).
09/05/24 Nicholas Warther
0.50 Telephone conference with Deloitte and
Crowell re APA.
09/05/24 Cristina Weidner
0.50 Conference with D. Wang, K&E team re sales
process.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 625 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
10
Date
Name
Hours Description
09/06/24 Jaina Desai
1.40 Correspond with D. O’Connor re sale
workstream (.1); correspond with T. Chanroo,
C. Ceresa re correspondence from cure parties
(.3); draft correspondence to CS re sale
workstream transition (.3); review, analyze
objection summary re cure objection (.4);
correspond with AlixPartners, Cole Schotz re
same (.3).
09/06/24 Luke Finn
0.80 Review, revise closing checklist.
09/06/24 Kate Hardey
0.50 Review, analyze buyer liability (.3);
conference with A. Del Rio re same (.2).
09/06/24 Trent Nachbar
4.50 Draft, revise closing checklist (3.9); review,
analyze same (.6).
09/06/24 Dan O'Connor
0.80 Telephone conference with Crowell, Deloitte
and tax team re allocation schedule (.4);
correspond with N. Warther, K&E tax
team, Company re same (.4).
09/06/24 Anna Schwander
0.80 Review, analyze FDI filing (.4); review,
analyze correspondence re annexes (.4).
09/06/24 Nicholas Warther
0.40 Correspond with Company re purchase price
allocation.
09/06/24 Sara B. Zablotney, P.C.
0.20 Correspond with N. Warther, K&E team re
APA.
09/09/24 Chris Ceresa
0.30 Review, analyze legal issues re international
entities in context of sales.
09/09/24 Bernadette Coppola
0.20 Correspond with Company, S. Toth, K&E
team re sales of intellectual property.
09/09/24 Sion Davies
0.20 Correspond with German counsel re German
FDI.
09/09/24 Jaina Desai
0.50 Review, analyze correspondence from S. Toth
re sale workstream (.3); correspond with T.
Chanroo, K&E team re same (.2).
09/09/24 Luke Finn
1.60 Revise draft of Interim Operating Procedures
memorandum (1.2); conference with
Company re same (.4).
09/09/24 Justin M. Garfinkle
0.50 Review, analyze IP transfers.
09/09/24 Anna Schwander
1.80 Prepare German FDI filing with bidder
counsel.
09/09/24 Scottie Shermetaro
0.10 Review and revise TSA schedules.
09/09/24 Steve Toth
0.60 Analyze Company correspondence re
diligence, TSA, IP and Brazil.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 626 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
11
Date
Name
Hours Description
09/10/24 Sion Davies
0.20 Correspond with German counsel re filing
preparation.
09/10/24 Jaina Desai
0.60 Review, analyze cure objections (.2);
correspond with AlixPartners, Cole Schotz re
same (.4).
09/10/24 Michael Ehret
0.30 Review, analyze correspondence from N.
Warther re purchase price allocation, sales
model post close.
09/10/24 Luke Finn
1.70 Revise sale‑related memorandum to clients
(1.2); review, analyze correspondence with
AlixPartners team re final Asset Purchase
Agreements (.5).
09/10/24 Palmer Gunderson
0.70 Correspond with Company re purchase price
allocation (.5); correspond with N. Warther,
S. Zablotney, Company re sale structure and
timing (.2).
09/10/24 Dan O'Connor
1.60 Correspond with S. Toth, K&E team and
equityholder re FDI filing matters (.6);
correspond with A. Schwander re Germany
FDI filing (1.0).
09/10/24 Anna Schwander
1.30 Prepare German FDI filing.
09/10/24 Steve Toth
2.20 Analyze correspondence re foreign assets and
antitrust data (.2); revise interim operating
covenant memorandum (2.0).
09/10/24 Donatus Wang
0.20 Correspond with C. Ceresa, K&E team re sale
processes.
09/10/24 Nicholas Warther
1.20 Review and analyze purchase price allocation
for buyer.
09/11/24 Bernadette Coppola
0.20 Correspond with advisors re transition
services agreement schedules.
09/11/24 Anthony M. Del Rio
0.30 Review and analysis of inquiry from T.
McDaniel re post-emergence liabilities.
09/11/24 Luke Finn
2.80 Draft Closing Checklist for Asset
Purchase (1.3); review,
analyze correspondence from Company
regarding Interim Operating Covenants (.7);
revise internal administrative matters for
purchase agreement (.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 627 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
12
Date
Name
Hours Description
09/11/24 Palmer Gunderson
1.20 Prepare notes for conference with Company
re purchase price allocation (.3); telephone
conference with Company, N. Warther, K&E
team re purchase price allocation and sale
timing (.9).
09/11/24 Maureen D. O'Brien
1.00 Attend winddown conference with S. Toth,
K&E team (.5); review, analyze guidance and
plan documents (.5).
09/11/24 Dan O'Connor
1.00 Telephone conference with Company, S.
Toth, K&E team re purchase price allocation
and transaction matters.
09/11/24 Anna Schwander
0.80 Correspond with buyer re due diligence (.4);
revise APA (.4).
09/11/24 Scottie Shermetaro
0.10 Correspond with IT consultants re service
level agreements in the TSA.
09/11/24 Steve Toth
2.10 Analyze attorney notes re closing and
international matters (.4); conference with
Company and P. Gunderson, K&E team re
ERP and TSA matters (1.0); participate in
update teleconference with Company and
advisors (.1); discuss closing matters with D.
O’Connor (.2); review, revise attorney notes
re closing matters and related correspondence
(.4).
09/11/24 Paul Vasiloff
3.50 Research re employment issues re sale
transactions.
09/11/24 Nicholas Warther
3.20 Telephone conference with Company, P.
Gunderson, K&E team re purchase price
allocation and sale (1.2); review and analyze
question re US tax modeling (1.6); correspond
with P. Gunderson, K&E team re structuring
(.4).
09/11/24 Sara B. Zablotney, P.C.
1.40 Attend telephone conference with N. Warther,
K&E team re purchase price allocation (1.0);
reinvest comment on summary (.4).
09/12/24 Bernadette Coppola
0.80 Conference with buyer’s counsel and
AlixPartners re transition services agreement
schedules (.4); conference with S. Toth and
AlixPartners re same (.2); review, analyze
comments to transition services agreement
schedules (.1); correspond with S. Toth re
same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 628 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
13
Date
Name
Hours Description
09/12/24 Erin Davey
1.80 Research employment questions in
connection with transactions.
09/12/24 Luke Finn
3.20 Correspond with Company, Cooley re
contract (1.5); review, analyze German entity
matters (1.7).
09/12/24 Justin M. Garfinkle
0.60 Review, analyze issues re IP transfers.
09/12/24 Palmer Gunderson
1.30 Review, analyze Brazil sale offer letter and
(.4); review, analyze structure slides for
restructuring and sales transaction (.4);
correspond with Company re structure slides
and Brazil sale (.5).
09/12/24 Dan O'Connor
2.60 Prepare side letter re asset storage and lease
termination.
09/12/24 Joshua Raphael
0.40 Telephone conference with Cole Schotz, C.
Ceresa, K&E team re UK, international
considerations re sale.
09/12/24 Joshua Raphael
0.30 Revise bid summaries re foreign entities (.2);
correspond with L. Finn, K&E team re
transactions, foreign entities (.1).
09/12/24 Anna Schwander
4.30 Correspond with buyer counsel re German
FDI and due diligence (2.3); review, draft,
and amend draft Annexes (2.0).
09/12/24 Steve Toth
2.60 Participate in weekly advisor update
telephone conference (.5); analyze lease exit
(.2); analyze closing matters (.3); discuss TSA
matters with B. Coppola and AlixPartners
(.3); review, revise equipment letter (.7);
analyze Brazil LOI (.3) discuss business lines
with AlixPartners (.2); prepare related
correspondence (.1).
09/12/24 Nicholas Warther
0.10 Correspond with S. Zablotney, K&E team re
APA.
09/13/24 Chris Ceresa
0.50 Review, analyze legal issues re international
entities in context of sales.
09/13/24 Chris Ceresa
0.70 Review, analyze issues re lease treatment in
sale.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 629 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
14
Date
Name
Hours Description
09/13/24 Luke Finn
2.40 Attend Closing Request conference (.8);
correspond with S. Toth re Closing checklist
(.5); review, analyze correspondence re
Brazilian subsidiary questions and
information sharing (.3); review, analyze
German counsel correspondence re German
entities and German‑held assets (.8).
09/13/24 Palmer Gunderson
2.70 Review and prepare tax comments for
structure slides for restructuring and sale
transactions.
09/13/24 Dan O'Connor
5.80 Review and revise Germany FDI response
summary (1.3); review and revise ultimate
beneficial owner structure summary re same
(1.0); telephone conference with Company,
AlixPartners, S. Toth and re closing matters
(.5); telephone conference with AlixPartners
and S. Toth re lease matters (.4); prepare
closing checklist for APA (2.6).
09/13/24 Carolin Paus
0.50 Conference with J. Raphael re closing.
09/13/24 Joshua Raphael
1.30 Review, analyze disclosure schedules and
correspond with Cole Schotz, C. Paus, K&E
team re foreign assets, entities (.7); telephone
conference with Cole Schotz, C. Ceresa, K&E
team re international considerations, German
entities (.5); correspond with D. Wang, K&E
team re transaction steps (.1).
09/13/24 Anna Schwander
6.80 Finalize of German FDI application (3.9);
finalize German FDI annexes (2.1);
correspond with buyer counsel re same (.8).
09/13/24 Scottie Shermetaro
0.80 Review and revise TSA Schedules.
09/13/24 Steve Toth
1.10 Discuss closing timing with Company,
AlixPartners, D. O’Connor, K&E team (.5);
analyze and respond to correspondence re
asset lines and related issues (.3); analyze
correspondence re diligence and closing
matters (.3).
09/14/24 Luke Finn
0.80 Review, analyze Side Letter re Irvine Asset
Storage correspondence (.3); review and
update Closing checklist (.5).
09/14/24 Maureen D. O'Brien
0.50 Review, analyze safe harbor research.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 630 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
15
Date
Name
Hours Description
09/15/24 Luke Finn
1.10 Review, analyze correspondence from BDO
(.3); review, analyze settlement issue (.4);
review, analyze to Side Letter re Irvine Asset
Storage (.4).
09/15/24 Steve Toth
1.10 Analyze intercompany settlement deck (.5);
analyze diligence and closing matters (.6).
09/16/24 Erin Davey
1.00 Research employment‑related issue re sales.
09/16/24 Luke Finn
5.70 Review assets sale process (.3); attend
conference re product (1.4); review legacy
assets questions from buyer (.4); prepare
drafts and send updates and requests to J.
Mudhar, K&E team (.8); revise Closing
Checklist (1.1); correspond with Company re
lease agreement (.8); attend APA Transaction
Planning conference (.9).
09/16/24 Palmer Gunderson
1.00 Telephone conference with Company, N.
Warther, K&E team re sale transaction
planning steps (.7); telephone conference with
Company and purchaser re purchase price
allocation and sale timer (.3).
09/16/24 Palmer Gunderson
1.20 Update structure slides for sale transactions
(.6); correspond with accounting team re pre-
closing restructuring structure slides (.6).
09/16/24 Kate Hardey
2.20 Review inventory products and related
questions re FDA compliance matters for
Remaining entities (1.7); conference with R.
Meintjes re same (.5).
09/16/24 Ruan J. Meintjes
2.50 Research and analyze post-closing regulatory
obligations (1.9); draft summary of findings
(.3); conference with K Hardey re the same
(.3).
09/16/24 Carolin Paus
4.50 Review, analyze asset purchase agreements.
09/16/24 Yusuf Salloum
1.00 Analyze issues re sale transactions.
09/16/24 Anna Schwander
0.80 Review, analyze FDI filing.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 631 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
16
Date
Name
Hours Description
09/16/24 Steve Toth
5.00 Discuss international closing matters with
Company and AlixPartners (.7); participate in
executive steering committee teleconference
with Company and advisors (.3); participate
in lender advisor update teleconference with
lender advisors, Company, advisors (.1);
participate in advisors update teleconference
with AlixPartners, PJT, Y. Salloum, K&E
team (.2); analyze Brazil LOI (.3); conference
with Company and AlixPartners re same (.7);
analyze and revise closing checklist (1.8);
revise Brazil LOI (.9).
09/16/24 Nicholas Warther
1.50 Telephone conference with Company re APA
workstreams (.5); telephone conference with
buyer re same (1.0).
09/16/24 Sara B. Zablotney, P.C.
0.50 Attend telephone conference with Company,
S. Toth and K&E team re APA.
09/16/24 Sara B. Zablotney, P.C.
0.50 Attend telephone conference with Company,
S. Toth and K&E team re APA.
09/17/24 Chris Ceresa
0.80 Review, analyze open sale closing issues.
09/17/24 Bernadette Coppola
0.20 Correspond with Company and M. King, S.
Toth, K&E team re intellectual property
schedule (.1); correspond with M. King and
K&E team re transition services agreement
schedules (.1).
09/17/24 Hannah Crawford
0.30 Correspond with J. Mudhar re ex-US asset
and equity transfer process.
09/17/24 Anthony M. Del Rio
0.40 Review, analyze regulatory and quality
transition requirements for non-acquired
products.
09/17/24 Michael Ehret
0.10 Correspond with Deloitte, buyer re
transaction.
09/17/24 Luke Finn
5.50 Correspond with foreign local counsel re sale
(2.7); review, analyze deal interim balance
sheet (.5); review, analyze foreign
correspondence re bankruptcy‑specific issue
re sale (1.5); review, analyze LOI (.8).
09/17/24 Justin M. Garfinkle
0.20 Review, analyze registered IP schedule.
09/17/24 Palmer Gunderson
0.10 Correspond with purchasers re company draft
disclosure.
09/17/24 Palmer Gunderson
0.30 Correspond with Company and corporate
teams re Brazil Sale.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 632 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
17
Date
Name
Hours Description
09/17/24 Kate Hardey
3.40 Participate in telephone conference with
Company re FDA product transition matters
(1.0); review, analyze FDA considerations re
product discontinuation (2.1); conference with
R. Meintjes re same (.3).
09/17/24 Ruan J. Meintjes
2.30 Conference with Company re product closure
(1.0); conduct FDA research re ongoing
obligations (1.0); conference with K. Hardey
re the same (.3).
09/17/24 Jai Mudhar
1.50 Correspond with L. Finn re transaction (.5);
correspond with local counsels re transaction
(1.0).
09/17/24 Dan O'Connor
0.50 Correspond with L. Finn re local counsel
matters.
09/17/24 Carolin Paus
1.20 Conference with S. Toth, K&E team re sale.
09/17/24 Carolin Paus
0.50 Draft issues list re sale.
09/17/24 Scottie Shermetaro
0.30 Review and revise TSA Schedules.
09/17/24 Steve Toth
4.80 Participate in steering committee telephone
conference with Company and AlixPartners
(.6); analyze related correspondence (.2);
prepare intercompany novation agreement
(3.0); discuss Brazil LOI with Company and
AlixPartners (.5); revise LOI (.2); analyze
assumed liabilities (.3).
09/17/24 Sarah Ullathorne
1.00 Correspond with Company advisors re
questions on asset and equity transfer.
09/17/24 Donatus Wang
2.00 Analyze structuring of asset sale transactions
and debt assumption contemplated in APA,
(1.2); draft questions on structural aspects
(.5); discuss same with C. Paus and A. Ziegler
(.3).
09/17/24 Ann-Kathrin Ziegler
1.00 Conference with D. Wang, K&E team re
German entities sales process documents and
associated workstreams (.7); review, analyze
correspondence re same (.3).
09/18/24 Chris Ceresa
0.30 Telephone conference with S. Toth, K&E
team, advisors re sale legal issues.
09/18/24 Bernadette Coppola
0.10 Correspond with Company, L. Finn, K&E
team re intellectual property schedules.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 633 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
18
Date
Name
Hours Description
09/18/24 Luke Finn
6.50 Review, analyze correspondence with
Singaporean counsel re asset purchase (.8);
review, analyze correspondence with Turkish
and UAE, counsel (.2); review, analyze
correspondence with Dutch counsel re asset
and equity purchase (1.4); draft update on
Italian asset agreement (.2); review, analyze
correspondence with Cooley re imt medical
(.5); review, analyze correspondence with
Company re IP (.3); attend conference with
prospective buyer (1.0); revise Closing
checklist (.6) review, analyze McDermott
Will & Emery correspondence (.3);
correspond with Cooley re closing checklist
(.4); correspond with Brazilian counsel re
asset purchase (.8).
09/18/24 Palmer Gunderson
0.40 Review accounting team pre-closing
restructuring slides.
09/18/24 Kate Hardey
1.40 Conference with S. Toth re FDA post-market
product considerations (.4); review and revise
FDA notice re same (1.0).
09/18/24 Ruan J. Meintjes
0.60 Conference with S. Toth re closing deadline
and regulatory considerations (.3); coordinate
with K. Hardey re follow-up research (.3).
09/18/24 Dan O'Connor
1.40 Correspondence with Company and A.
Schwander re FDI filings (.5); review and
revise same (.5); telephone conference with
A. Terranova and A. Schwander re FDI
filings (.4).
09/18/24 Yusuf Salloum
2.20 Review, analyze issues re sale closing.
09/18/24 Anna Schwander
1.30 Review, analyze correspondence re FDI.
09/18/24 Scottie Shermetaro
0.60 Review, analyze APA obligations re IP.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 634 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
19
Date
Name
Hours Description
09/18/24 Steve Toth
3.30 Analyze international closing matters (.2);
discuss regulatory considerations with S.
Winters, K&E team (.1); analyze German
counsel correspondence re IP, Germany and
lease matters (.4); analyze correspondence re
Brazil and other intercompany matters (.3);
discuss LOI with bidder, bidder advisor,
working group (1.0); conference with
Company and AlixPartners re same (.3); draft
related correspondence re same (.2); analyze
and respond to correspondence re Dutch
matters (.5); analyze correspondence re
diligence, tax, and international matters (.3).
09/18/24 Donatus Wang
0.30 Review and analyze comments re structuring
of German asset sales.
09/19/24 Erin Davey
3.00 Research employment issues re sale.
09/19/24 Luke Finn
8.30 Review, analyze Company correspondence
regarding intercompany settlement plan and
German tax liability issues (1.1); review,
analyze Company correspondence regarding
Brazilian tax issues and asset transfer
structure (.7); review, analyze Company
correspondence regarding net economic
benefits plans, Dutch tax issues, and Local
Transfer Agreements (1.1); review, analyze
correspondence with Baker and McKenzie
Italy (.5); review, analyze correspondence
with Cooley regarding Checklist (.3); review,
analyze correspondence with Singapore and
Chinese counsel (.9); review, analyze
correspondence regarding confidential sale
(1.0); review, analyze correspondence with
Swiss counsel (1.2); review, analyze Cooley
checklist updates (.4); review, analyze
employee diligence with Company (.8);
review, analyze IP sales correspondence from
Company (.3).
09/19/24 Ruan J. Meintjes
1.00 Coordinate with K. Hardey re FDA regulatory
matters related to product removal (.8);
correspond with Company re California
manufacturing license (.2).
09/19/24 Carolin Paus
0.60 Research re merger clearance.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 635 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
20
Date
Name
Hours Description
09/19/24 Carolin Paus
5.50 Review, analyze correspondence from S.
Toth, AlixPartners, Company re sales (3.4);
review, revise intercompany settlement
agreement (2.1).
09/19/24 Yusuf Salloum
1.00 Review, analyze issues re sale transactions.
09/19/24 Anna Schwander
0.80 Conference with Italian counsel re Italian FDI
filing.
09/19/24 Scottie Shermetaro
0.90 Correspond with Company re IP to be
excluded from Vents sale.
09/19/24 Steve Toth
2.50 Participate in advisor update telephone
conference with Company, AlixPartners, S.
Winters, K&E team (.3); discuss inventory
with AlixPartners (.2); participate in steering
committee teleconference with Company and
working group (.4); analyze and respond to
correspondence re international closing
matters and intercompany issues (1.1);
participate in special committee telephone
conference (.5).
09/20/24 Luke Finn
6.00 Review, analyze correspondence with
international local counsel, Company re
closing (1.4); review, analyze international
Vents IP filings (.1); attend conference re
closing (1.0); review, analyze sale question
(.4); attend conference re the same (.7);
review, analyze international entity wind-
down and Corporate Governance
considerations (.8); review, analyze officers’
certificate (.2); prepare for conference re
closing (.2); participating in conference re
same (.5); review, revise checklist (.3);
review, analyze correspondence re Brazil sale
(.4).
09/20/24 Trent Nachbar
2.20 Review, analyze closing checklist (.9); draft
ancillary documents (1.3).
09/20/24 Yusuf Salloum
2.00 Analyze issue re sale transactions.
09/20/24 Scottie Shermetaro
0.50 Review, analyze revised TSA Schedules.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 636 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
21
Date
Name
Hours Description
09/20/24 Steve Toth
3.80 Participate in daily executive steering
committee teleconference with Company and
AlixPartners (.4); conference with Company
and L. Finn re IP (.1); analyze closing matters
(.2); discuss Brazil transaction with Company
and AlixPartners (.5); discuss closing‑critical
items with AlixPartners, L. Finn, K&E team
(.6); participate in teleconference re closing
checklist with Cooley, L. Finn, K&E team
(.5); analyze foreign correspondence re
closing matters (1.2); analyze and respond to
correspondence re TSA (.3).
09/21/24 Luke Finn
1.70 Correspond with local foreign counsel re sale
(.3); review, analyze Company
correspondence re Brazilian transaction (.9);
review, analyze correspondence regarding
Canadian entity transfer (.1); review, analyze
to Cooley correspondence (.4).
09/21/24 Trent Nachbar
1.70 Review, revise to closing checklist (.7); draft
ancillary documents (1.0).
09/21/24 Steve Toth
2.40 Analyze international matters.
09/22/24 Luke Finn
1.90 Review, analyze Dutch APA (.7); correspond
with S. Toth on the same (.1); correspond
with Dutch local counsel re same (.3) review,
analyze correspondence between Company
and Brazilian local counsel (.3); review,
analyze NDA re potential sale (.5).
09/22/24 Kate Hardey
1.60 Review, revise transaction notice letters for
customers and distributors.
09/22/24 Steve Toth
0.90 Analyze international closing matters (.4);
review, analyze documents re product line
termination (.5).
09/23/24 Luke Finn
3.90 Correspond with international local counsel
(.4); review and analyze Brazilian sale (.8);
review bidder documents (.5); correspond
with Cooley regarding IP matters (.4); review,
analyze intercompany settlement agreement
(.7); correspond with Cooley re checklist (.6);
review, analyze closing documents (.5).
09/23/24 Palmer Gunderson
0.80 Correspond with tax, corporate, and company
teams re pre-closing restructuring steps.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 637 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
22
Date
Name
Hours Description
09/23/24 Carolin Paus
4.20 Review, analyze APAs re German legal issues
(2.4); review, analyze next steps re same (.6);
correspond with A. Ziegler, K&E team re
same (.5); review, analyze tax structuring
considerations under German law (.7).
09/23/24 Yusuf Salloum
3.50 Prepare for transaction closing.
09/23/24 Scottie Shermetaro
0.30 Correspond with Company re IP transfers.
09/23/24 Steve Toth
5.40 Analyze international matters and revise
attorney notes (.4); participate in daily
executive steering committee update
teleconference with AlixPartners, Company,
(.5); analyze correspondence re closing
matters and update attorney notes (.5)
participate in teleconference with lender
advisors, PJT, AlixPartners, Y. Salloum,
K&E team, and Company (.2); revise attorney
notes re closing issues (.3); participate in
advisors update teleconference (.3); revise
attorney notes (.3); analyze structure, tax and
closing issues (1.3); analyze tax and
international matters and related
correspondence (1.3); analyze revisions to
intercompany agreement (.3).
09/23/24 Nicholas Warther
0.50 Review and analyze structuring of
transaction.
09/23/24 Ann-Kathrin Ziegler
1.50 Review, revise sale documentation (1.2);
review, revise correspondence from S. Toth re
same (.3).
09/24/24 Chris Ceresa
1.50 Telephone conference with Y. Salloum, K&E
team, Cole Schotz re open sale legal issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 638 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
23
Date
Name
Hours Description
09/24/24 Luke Finn
6.80 Conference with Cooley re sale (2.0);
conference with prospective purchaser,
Company re Brazilian sale (.8); review,
analyze Net Economic Benefit structure (.4);
review, analyze IP issues (.3); review, analyze
correspondence from local counsel re sale
(.5); review, analyze issues re Brazilian sale
(.2); review, analyze Brazilian Agility
contract question (.3); review, analyze
Intercompany Settlement Agreement (.5);
review, analyze correspondence re sale (.4);
review, analyze correspondence with German
counsel (.3); correspond with Company re
winddown planning (.7); review local counsel
correspondence re buyer export (.4).
09/24/24 Carolin Paus
3.20 Correspond with H. Braun, K&E team re sale
issues (.7); conference with D. Wang, K&E
team re works in process re sale (.9); draft
issues list re same (.5); research individual
asset sales (1.1).
09/24/24 Yusuf Salloum
3.00 Prepare for sale closing.
09/24/24 Scottie Shermetaro
0.30 Correspond with Company re transaction
planning.
09/24/24 Steve Toth
9.90 Analyze international updates (.3); participate
in all‑hands teleconference re transaction
issues (2.0); draft related correspondence (.2);
discuss regulatory and import matters with
Company AlixPartners, K. Hardey, K&E
team (.3); discuss legal issues and funds flow
with Cole Scholtz, AlixPartners, Y. Salloum,
K&E team (.8); discuss Brazil bidder with
Company, PJT, and AlixPartners (.4); analyze
correspondence re potential asset sale (.1);
correspond with AlixPartners, buyer,
Company, and Cole Schotz re lease matters
(.3); revise intercompany agreement (2.8),
discuss same with N. Warther (.8); further
revise same (1.4); prepare related
correspondence (.5).
09/24/24 Donatus Wang
1.10 Conference with A. Ziegler, K&E team re
APA and related documentation.
09/24/24 Nicholas Warther
0.80 Review and analyze structuring and APAs.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 639 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
24
Date
Name
Hours Description
09/24/24 Ann-Kathrin Ziegler
1.00 Conference with D. Wang, K&E team re
German law documentation questions for
sales processes (.5); review and revise
correspondence re same (.5).
09/25/24 Bernadette Coppola
0.20 Correspond with S. Toth and K&E team re
revisions to license agreement and transition
services agreement.
09/25/24 Luke Finn
6.90 Attend conference with S. Toth, K&E team,
advisors re sale process (1.0); review, analyze
correspondence with AlixPartners re asset and
liability breakdown (.7); review, analyze
international asset transfers (1.4); review,
analyze sale issues (.8); correspond with
international counsel re sale process (.7);
review, analyze correspondence from
international local counsel (.4); review and
revise buyer officer certificate (.4); revise deal
checklist (.5); conference with Cooley re
same (1.0).
09/25/24 Trent Nachbar
0.80 Conference with Buyer’s counsel (.5); review,
revise officer’s certificates (.3).
09/25/24 Carolin Paus
1.70 Correspond with Company, A. Ziegler, K&E
team re German entities (.8); correspond with
A. Ziegler, K&E team re APAs and closing
(.9).
09/25/24 Yusuf Salloum
3.40 Prepare for sale closing.
09/25/24 Steve Toth
4.20 Analyze international updates (.1); conference
with AlixPartners and Cole Schotz re landlord
issues (.2); participate in all-hands telephone
conference re closing (1.1); analyze and
prepare correspondence re tax issues re sale
(.4); analyze and respond to correspondence
re A/R (.2); conference with Cooley re
bankruptcy and transaction issues (.4);
participate in telephone conference re closing
checklist with Cooley L. Finn, K&E team
(.5); revise intercompany settlement
agreement (.8); correspond with L. Finn,
K&E team, and Vyaire re Germany closing
matters (.3); analyze closing checklist (.2).
09/25/24 Cristina Weidner
2.40 Review, analyze APA re structuring
points (1.4); conference with various parties
re same (1.0).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 640 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
25
Date
Name
Hours Description
09/25/24 Ann-Kathrin Ziegler
0.80 Review, revise correspondence from C. Paus
(.5); review, analyze correspondence from T.
Zehentbauer re APA (.3).
09/26/24 Chris Ceresa
0.70 Telephone conference with Y. Salloum, K&E
team, Cole Schotz team re open sale legal
issues.
09/26/24 Luke Finn
6.50 Prepare signature packets (1.7); attend
all‑hands conference (1.0); review, analyze
correspondence with India counsel (.3);
review, revise Malaysian Asset
Purchase Agreement (.5); correspond with
Company and Brazilian business
services/Intermed director team re transaction
(.8); review, analyze correspondence with
Singapore counsel (.6); review, analyze
correspondence with international local
counsel (.5); review, analyze Dutch Asset
Purchase (.3); correspond with Cooley re
transaction (.8).
09/26/24 Sabrina Lieberman
0.10 Correspond with C. Ceresa, S. Toth, K&E
team re standstill agreement.
09/26/24 Carolin Paus
7.00 Review and analyze correspondence from A.
Ziegler, K&E team, Company re sale issues
(.8); correspond with German local IP counsel
re IP issues (1.1); draft Asset Sale and
Transfer Agreement (3.8); discuss same with
H. Braun, K&E team (1.3).
09/26/24 Yusuf Salloum
3.20 Review, analyze issues re sale closing.
09/26/24 Steve Toth
2.80 Analyze closing issues (.2); analyze attorney
notes re intercompany agreement (2.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 641 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
26
Date
Name
Hours Description
09/26/24 Steve Toth
5.10 Analyze international matters (.2); discuss
same with L. Finn (.2); participate in all hands
telephone conference re transaction issues
(.6); analyze closing matters, NEB and
distributor model (.3); participate in
teleconference with Company, PJT,
AlixPartners, Y. Salloum, K&E team re sale
update (.6) participate in executive steering
committee conference with Company and
AlixPartners re closing preparation (.3);
analyze intercompany agreement (.6); analyze
international closing documents (.4);
participate in special committee telephone
conference (.1); participate in all‑hands
telephone conference re transaction matters
(.6); participate in telephone conference with
Company, AlixPartners, Y. Salloum, K&E
team re closing issues (.4); correspond with
Y. Salloum, K&E team re inventory (.1);
discuss regulatory matters with AlixPartners,
K. Hardey, K&E team (.7).
09/26/24 Sarah Ullathorne
0.80 Review, analyze draft transfer agreement for
transfer of assets.
09/26/24 Donatus Wang
1.50 Prepare draft APAs.
09/26/24 Ann-Kathrin Ziegler
2.00 Review, analyze responses C. Ceresa, K&E
team re vents sale (.2); correspond with C.
Paus and D. Wang re next steps (.3);
correspond with C. Paus re IP firm (.4);
review, analyze correspondence from C.
Ceresa, K&E team re MIM sale (.4);
correspond with S. Ullathorne, K&E team re
APAs (.7).
09/27/24 Hendrik Braun
3.00 Review, analysis of German sale and transfer
agreements shares and assets.
09/27/24 Hendrik Braun
0.50 Review, analyze APAs re German share
transfers.
09/27/24 Chris Ceresa
0.80 Telephone conference with Y. Salloum, K&E
team, Cole Schotz team re open sale legal
issues.
09/27/24 Bernadette Coppola
0.50 Draft revisions to license agreement (.3);
correspond with buyer’s counsel and M.
King, S. Toth, K&E team re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 642 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
27
Date
Name
Hours Description
09/27/24 Luke Finn
6.50 Attend all‑hands conference (1.0); attend
conference with S. Toth, K&E team re closing
(.7); review, analyze Brazilian deal progress
correspondence (.2); review and revise
executed signature pages (.8); correspond
with local counsel and Company re
intercompany settlement (.6); review, analyze
Dutch Purchase Agreement draft and board
resolutions (.7); correspond with Company re
transactions (.3); compile surety bonds for
buyer (.4); review, analyze intercompany
settlement (.3); review, analyze
correspondence with Organização de
Despachos Feijo (.5) draft Escrow Instruction
Letter (.2); review, analyze updated schedule
of assumed and excluded contracts from
buyer (.4); review Wilmer Hale
correspondence re Brazilian and German
patent issues (.4).
09/27/24 Palmer Gunderson
0.70 Correspond with tax and accounting team re
pre-closing restructuring transactions.
09/27/24 Trent Nachbar
3.40 Revise list of in-scope entities.
09/27/24 Carolin Paus
7.50 Review, analyze issues re SPA (.8);
conference with German local IP counsel re
German IP (.5); review, analyze
correspondence from Company, AlixPartners,
M. Ehret, K&E team re transaction structure
(1.5); draft SPA (3.9); review and revise
APAs (.8).
09/27/24 Yusuf Salloum
3.50 Prepare for sale closings.
09/27/24 Scottie Shermetaro
2.00 Review and revise inter-business license
(1.5); correspond with opposing counsel re
same (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 643 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
28
Date
Name
Hours Description
09/27/24 Steve Toth
4.70 Participate in all‑hands telephone conference
re closing (1.1); analyze closing timing (.5);
discuss same with AlixPartners, Cole Schotz,
Y. Salloum, K&E team (.5); discuss closing
update with Company, AlixPartners, Y.
Salloum, K&E team (.6); prepare related
correspondence (.3); correspond with Cooley
re same (.1); discuss same with AlixPartners,
Cole Schotz, Y. Salloum, K&E team (.5);
prepare related correspondence (.4); analyze
responses (.4); revise intercompany
agreement (.3).
09/27/24 Donatus Wang
3.50 Prepare draft APAs for MIM SPA (1.0);
coordinate notarization of APAs (.5); discuss
related formalities and logistics with C. Paus,
K&E team and Company (.5); prepare APA
signing and notarization requirements (.5);
coordinate KYC check by German notary
(.5); correspond with A. Ziegler, K&E team
on same (.5).
09/27/24 Cristina Weidner
2.20 Review, analyze APA (1.0); review, analyze
SPA (.8); correspond with A. Ziegler, K&E
team re same (.4).
09/27/24 Ann-Kathrin Ziegler
1.50 Review, analyze draft German APA (.6);
review, analyze draft German SPA (.4);
correspond with C. Weidner, K&E team re
APAs (.5).
09/28/24 Luke Finn
2.00 Correspond with local counsel re Singapore
signatures (.5); correspond with Swiss
counsel re Closing (.3); review, analyze
Cooley draft of Dutch Purchase Agreement
(.7); review, analyze signature matrix and
entity review with T. Nachbar (.5).
09/28/24 Palmer Gunderson
1.40 Review and revise purchase price allocation
for sale transactions.
09/28/24 Palmer Gunderson
0.50 Correspond with tax and corporate team re
pre-closing restructuring planning.
09/28/24 Yusuf Salloum
2.00 Analyze issues re sale transaction.
09/28/24 Steve Toth
3.50 Analyze correspondence re closing and
intercompany matters (.7); update attorney
notes (.8); analyze intercompany agreement
(2.0).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 644 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
29
Date
Name
Hours Description
09/28/24 Nicholas Warther
1.50 Telephone conference with BDO and KE
team re structuring of sale (.8); review and
analyze same (.7).
09/29/24 Michael Ehret
0.80 Correspond with S. Toth re vents transaction
(.2); conference with Cooley, buyer, S. Toth
in relation to closing of Vents APA, timing,
open items, next steps (.6).
09/29/24 Luke Finn
2.80 Attend advisor conference re transaction
update (1.1); correspond with local counsel re
sale issues (.2); review and respond to
comments by Swiss counsel on Dutch
Purchase Agreement (.4); review, analyze
transaction conference summary (.2); revise
checklist (.4); review, analyze Cooley updated
draft APA amendment and Schedule 3.11(a)
(.5).
09/29/24 Palmer Gunderson
1.50 Telephone conference with buyer tax counsel
re tax planning (.4); telephone conference
with N. Warther re purchase price allocation
(.2); revise purchase price allocation (.2);
correspond with tax, corporate, and company
teams re restructuring transactions and
purchase price allocation (.7).
09/29/24 Yusuf Salloum
2.00 Prepare for closing.
09/29/24 Scottie Shermetaro
0.20 Correspond with opposing counsel re
inter‑business license.
09/29/24 Steve Toth
6.90 Analyze closing issues update (.3); discuss
closing issues with AlixPartners, Y. Salloum,
K&E team (.9); prepare correspondence to Y.
Salloum, K&E team re issues list (.8);
participate in all hands teleconference re
closing timing and issues (1.3); prepare
related summary correspondence to Y.
Salloum, K&E team (.5); discuss update with
Company, AlixPartners, Y. Salloum, K&E
team (.6); analyze intercompany agreement
and related correspondence (.7); revise
intercompany agreement per Company and
advisor correspondence (1.8).
09/29/24 Nicholas Warther
1.80 Review and revise purchase price allocation
(.6); telephone conference with Deloitte, P.
Gunderson, K&E team re tax analysis (.7);
correspond with P. Gunderson, K&E team re
same (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 645 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
30
Date
Name
Hours Description
09/29/24 Sara B. Zablotney, P.C.
1.70 Attend telephone conference with Y. Salloum,
K&E team re purchase price (.5); attend all
hands status telephone conference re closing
(1.2).
09/30/24 Chris Ceresa
0.80 Telephone conference with Y. Salloum, K&E
team, Cole Schotz team re open legal issues re
sale.
09/30/24 Bernadette Coppola
0.50 Correspond with S. Toth, K&E team,
Company re amendment to asset purchase
agreement.
09/30/24 Anthony M. Del Rio
0.40 Review, analyze questions re transfer of
software and data to buyer.
09/30/24 Luke Finn
4.30 Attend all-hands conference re closing (1.0);
review, analyze Swiss correspondence (.4);
review, analyze Asset Transfers Agreement
update (.3); revise executed signature pages
(.7); revise, analyze Cooley correspondence re
intercompany settlement agreement (.3);
review, analyze Trench Rossi drafts of
Payment Agreement and Assignment
Agreements (.3); review, analyze Cooley
correspondence regarding international entity
asset transfers (.7); review, analyze updated
Italy matters (.2); review, analyze Clinical
Data Platform and Respiratory Knowledge
Portal matters (.4).
09/30/24 Palmer Gunderson
5.30 Correspond with S. Zablotney, K&E tax and
corporate team re pre-closing restructuring
(2.3); correspond with S. Toth, K&E
corporate team re sale transaction planning
(1.4); telephone conference with buyer tax
counsel (.3); correspond with accounting team
re tax allocation for sale transaction (.8);
revise tax allocation for sale transaction (.5).
09/30/24 Sabrina Lieberman
0.10 Correspond with C. Ceresa, A&M re
international counsel.
09/30/24 Trent Nachbar
3.20 Prepare transaction documents for execution.
09/30/24 Carolin Paus
3.80 Draft open issues list (.8); correspond with C.
Ceresa, K&E team, German notary re
required documents / formalities (.9); revise
German asset sale and transfer agreements
(1.1); prepare commercial register
documentation GmbH (1.0).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 646 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050107352
48520-10
31
Date
Name
Hours Description
09/30/24 Joshua Raphael
0.10 Review, analyze DIP, sale orders re
professional fees.
09/30/24 Yusuf Salloum
2.50 Review, analyze sale transactions.
09/30/24 Scottie Shermetaro
2.90 Review and revise amendment to the APA.
09/30/24 Steve Toth
5.60 Analyze APA amendment (.8); analyze
correspondence re schedules, IP and
amendment (.8); participate in all hands
teleconference re closing (.9); prepare related
correspondence (.1); participate in executive
steering committee teleconference with
Company, AlixPartners, Y. Salloum, K&E
team (.2); prepare related correspondence (.2);
participate in lender advisor conference with
AlixPartners, PJT, Y. Salloum, K&E team
(.1); analyze intercompany agreement (2.5).
09/30/24 Donatus Wang
1.60 Review and analyze foreign counsel
correspondence regarding German SPAs and
APAs for asset and shares sales under APAs,
transfer of German IP, KYC checks by
German notary.
09/30/24 Nicholas Warther
1.90 Telephone conference with Cooley tax re tax
elections for sale (.5); correspond with BDO
re same (.8); review and analyze purchase
price allocation (.6).
09/30/24 Sara B. Zablotney, P.C.
0.80 Review and analyze correspondence from S.
Toth, K&E team re closing.
09/30/24 Ann-Kathrin Ziegler
0.50 Correspond with C. Paus and D. Wang re next
steps on German sales documents /
workstreams.
Total
493.10
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 647 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107353
Client Matter: 48520-11
In the Matter of Executory Contracts & Unexpired Leases
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail)
$ 14,052.50
Total legal services rendered
$ 14,052.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 648 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Executory Contracts & Unexpired Leases
Invoice Number:
Matter Number:
1050107353
48520-11
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
1.60
1,395.00
2,232.00
Tiffani Chanroo
3.00
1,345.00
4,035.00
Hannah Crawford
2.30
1,595.00
3,668.50
Tabitha J. De Paulo
0.30
1,435.00
430.50
Jaina Desai
0.60
975.00
585.00
Luke Finn
1.30
1,345.00
1,748.50
Dan O'Connor
0.60
1,345.00
807.00
Steve Toth
0.30
1,820.00
546.00
TOTALS
10.00
$ 14,052.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 649 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Executory Contracts & Unexpired Leases
Invoice Number:
Matter Number:
1050107353
48520-11
3
Description of Legal Services
Date
Name
Hours Description
09/03/24 Chris Ceresa
0.20 Review, revise lease rejection motion.
09/04/24 Chris Ceresa
0.70 Review, revise lease rejection motion.
09/04/24 Tiffani Chanroo
0.80 Correspond with J. Desai re executory
contracts.
09/04/24 Tabitha J. De Paulo
0.30 Review, analyze issue re assumed contracts.
09/04/24 Jaina Desai
0.60 Correspond with K. Chiaghana re cure
objections (.2); correspond with AlixPartners
re same (.2); correspond with cure parties re
same (.2).
09/06/24 Tiffani Chanroo
1.20 Review, analyze executory contracts (.8);
correspond with J. Desai, counterparties re
same (.4).
09/06/24 Luke Finn
0.50 Review, respond to correspondence with Cole
Schotz re contract assignments.
09/08/24 Luke Finn
0.80 Correspond with C. Ceresa, K&E team lease
issues.
09/09/24 Tiffani Chanroo
0.40 Correspond with counterparty re executory
contracts (.1); review, analyze issues re same
(.3).
09/09/24 Hannah Crawford
0.50 Correspond with J. Mudhar re lease liabilities
in UK entity.
09/10/24 Chris Ceresa
0.70 Review and revise motion to extend lease
rejection deadline (.4); correspond with Cole
Schotz re same (.3).
09/10/24 Hannah Crawford
1.00 Correspond with J. Mudhar re UK lease (.3);
conference with AlixPartners re same (.7).
09/11/24 Tiffani Chanroo
0.60 Conference with Cole Schotz team re K+N.
09/11/24 Hannah Crawford
0.50 Conference with AlixPartners re UK lease.
09/13/24 Dan O'Connor
0.60 Telephone conferences with C. Ceresa and S.
Toth re Irvine lease matters.
09/13/24 Steve Toth
0.30 Discuss lease issues with AlixPartners and D.
O’Connor.
09/25/24 Hannah Crawford
0.30 Correspond with AlixPartners re UK Lease.
Total
10.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 650 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107354
Client Matter: 48520-12
In the Matter of Business Operations
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail)
$ 40,634.50
Total legal services rendered
$ 40,634.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 651 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050107354
48520-12
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
7.30
1,395.00
10,183.50
Tiffani Chanroo
2.10
1,345.00
2,824.50
Luke Finn
0.80
1,345.00
1,076.00
Kate Hardey
8.00
1,995.00
15,960.00
Olivia Kaufmann
3.30
1,095.00
3,613.50
Sabrina Lieberman
3.20
975.00
3,120.00
Jai Mudhar
0.20
1,345.00
269.00
Adrian Salmen
0.30
1,265.00
379.50
Steve Toth
1.30
1,820.00
2,366.00
Spencer A. Winters, P.C.
0.50
1,685.00
842.50
TOTALS
27.00
$ 40,634.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 652 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050107354
48520-12
3
Description of Legal Services
Date
Name
Hours Description
09/02/24 Sabrina Lieberman
0.20 Correspond with statutory auditor candidate.
09/02/24 Jai Mudhar
0.20 Correspond with Baker McKenzie re Swiss
entity auditor issue.
09/03/24 Tiffani Chanroo
0.30 Correspond with S. Lieberman, K&E team re
Swiss Auditor.
09/03/24 Sabrina Lieberman
0.20 Correspond with AlixPartners, T. Chanroo,
K&E team re Swiss auditor.
09/04/24 Chris Ceresa
1.80 Review, analyze legal issues re Company
operations and communications (.8);
correspond with T. Chanroo, K&E team,
Company re issues re same (.3); review,
revise communications materials (.7).
09/04/24 Tiffani Chanroo
0.70 Conference with C. Ceresa, Company re
communications (.5); correspond with
Company re same (.2).
09/04/24 Luke Finn
0.80 Review of internal communications materials.
09/04/24 Sabrina Lieberman
0.20 Correspond with J. Mudhar, K&E team re
Swiss auditor.
09/04/24 Spencer A. Winters, P.C.
0.50 Prepare for and attend telephone conference
with AlixPartners re wind-down.
09/05/24 Chris Ceresa
1.70 Review, analyze legal issues re Company
operations and communications (.6);
correspond with T. Chanroo, K&E team,
Company re issues re same (.2); review,
revise communications materials (.9).
09/05/24 Tiffani Chanroo
0.30 Correspond with C. Ceresa, K&E team re
Swiss auditor.
09/05/24 Sabrina Lieberman
0.50 Correspond with T. Chanroo, K&E team re
Swiss auditor.
09/06/24 Chris Ceresa
0.60 Review, analyze legal issues re Company
operations and communications (.3);
correspond with T. Chanroo, K&E team,
Company re issues re same (.1); review,
revise communications materials (.2).
09/06/24 Tiffani Chanroo
0.80 Review, analyze issues re Swiss audit.
09/09/24 Chris Ceresa
1.20 Correspond with Company, Cole Schotz team
re business operations legal issues.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 653 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050107354
48520-12
4
Date
Name
Hours Description
09/09/24 Sabrina Lieberman
0.90 Conference with potential auditor,
AlixPartners, J. Mudhar, K&E team re Swiss
audit (.4); correspond with J. Mudhar, K&E
team re same (.5).
09/10/24 Chris Ceresa
1.10 Correspond with Company, Cole Schotz team
re business operations legal issues.
09/10/24 Sabrina Lieberman
0.40 Correspond with J. Mudhar, K&E team, Cole
Schotz, AlixPartners, prospective auditor,
Baker McKenzie re Swiss audit.
09/11/24 Kate Hardey
0.50 Prepare regulatory questions to EU counsel
(.3); review, analyze US products and FDA
reporting requirements (.2).
09/12/24 Chris Ceresa
0.30 Correspond with Company, Cole Schotz team
re business operations legal issues.
09/12/24 Sabrina Lieberman
0.30 Correspond with C. Ceresa, K&E team re
Swiss auditor.
09/16/24 Sabrina Lieberman
0.50 Correspond with C. Ceresa, local counsel,
Company re Swiss auditor.
09/19/24 Kate Hardey
1.40 Correspond with T. McDaniel re FDA
conference (.2); draft talking points re same
(1.0); conference with O. Kaufmann re review
of device shutdown process (.2).
09/19/24 Olivia Kaufmann
2.60 Research FDA guidance for company that
discontinues doing business (.6); research
precedent regarding same (1.2); conference
with K. Hardey regarding same (.8).
09/20/24 Kate Hardey
2.30 Participate in telephone conference with FDA
re device discontinuation requirements (.9);
conference with Company re same (.5);
review and revise customer FAQ (.6); prepare
customer adverse event notice language (.3).
09/20/24 Olivia Kaufmann
0.50 Attend conference with T. McDaniel, S.
Sridhar, and K. Hardey regarding conference
with FDA.
09/23/24 Chris Ceresa
0.30 Review, analyze legal issues re business
operations.
09/24/24 Kate Hardey
1.30 Conference with Company re product import
matters (1.0); correspond with various parties
re same (.3).
09/24/24 Olivia Kaufmann
0.20 Conference with K. Hardey regarding
regulatory question.
09/25/24 Chris Ceresa
0.30 Review, analyze legal issues re business
operations.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 654 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050107354
48520-12
5
Date
Name
Hours Description
09/26/24 Kate Hardey
1.20 Correspond with Company re various legacy
product regulatory issues.
09/27/24 Kate Hardey
1.30 Review, analyze product import invoices and
analysis of import requirements (1.0);
correspond with Company re same (.3).
09/27/24 Adrian Salmen
0.30 Correspond with insurer counsel, C. Ceresa,
K&E team re business operations.
09/27/24 Steve Toth
1.30 Discuss intercompany matters with Company
and N. Warther, K&E team (.7); analyze and
prepare related correspondence (.6).
Total
27.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 655 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107356
Client Matter: 48520-18
In the Matter of Insurance and Surety Matters
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail)
$ 46,107.00
Total legal services rendered
$ 46,107.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 656 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050107356
48520-18
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Michael Ehret
20.10
1,895.00
38,089.50
Emanuel Goetz
7.90
750.00
5,925.00
Kate Hardey
1.00
1,995.00
1,995.00
Sabrina Lieberman
0.10
975.00
97.50
TOTALS
29.10
$ 46,107.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 657 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050107356
48520-18
3
Description of Legal Services
Date
Name
Hours Description
09/01/24 Michael Ehret
1.00 Correspond with Company re insurance
policy.
09/02/24 Michael Ehret
0.70 Correspond with Company re insurance (.2);
conference discussions with A. Skuratovski,
Marsh re same (.5).
09/03/24 Michael Ehret
0.70 Conference with A. Skuratovski, Marsh re
insurance (.5); conference with E. Goetz re
same (.2).
09/03/24 Emanuel Goetz
0.40 File various documents re German tax
insurance.
09/04/24 Michael Ehret
1.50 Conference with Company and advisors re
insurance policies.
09/05/24 Michael Ehret
1.70 Correspond with Deloitte re Certa insurance
policy (.3); review, analyze documents re
same (.4), attend conference with buyer team,
Deloitte re insurance coverage (1.0).
09/06/24 Michael Ehret
2.20 Review, revise draft insurance policy (1.0);
review, analyze Deloitte comments re same
(1.2).
09/06/24 Emanuel Goetz
3.20 Review, analyze Certa Policy Draft (3.0);
correspond with M. Ehret re same (.2).
09/10/24 Michael Ehret
1.90 Correspond with Deloitte re insurance (.1);
review, analyze documents re insurance
policy (1.0); conference with Deloitte, buyer,
Marsh re insurance policy, comments, next
steps (.5): conference with E. Goetz re
insurance policy (.3).
09/11/24 Michael Ehret
0.70 Review, analyze buyer correspondence re
insurance policy (.1); review, analyze revised
draft (.3); conference with E. Goetz re same
(.2); correspond with AlixPartners re same
(.1).
09/13/24 Michael Ehret
0.40 Correspond with AlixPartners, Marsh in
relation to revised insurance policy.
09/13/24 Emanuel Goetz
0.70 Review, analyze documents re Certa
underwriting process.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 658 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050107356
48520-18
4
Date
Name
Hours Description
09/16/24 Michael Ehret
1.90 Prepare for conference with Certa re
insurance policy (.3); conference with Certa
re same (.9); correspond with E. Goetz re
same (.1); review, analyze correspondence
from N. Warther re purchase price allocation
(.6).
09/16/24 Emanuel Goetz
0.50 Review, analyze internal documents re Certa
underwriting process.
09/16/24 Emanuel Goetz
0.90 Conference with M. Ehret, Certa re tax
insurance.
09/17/24 Michael Ehret
0.50 Correspond with D. O’Connor, Company re
works in process.
09/18/24 Michael Ehret
2.00 Review, revise on revised insurance policy
received from Certa (1.0); conference with E.
Goetz re same (.7), correspond with Company
re same (.3).
09/19/24 Michael Ehret
1.70 Conference with Company re comments on
insurance policy (.4); draft correspondence to
buyer, Deloitte in relation to comments on
revised insurance policy (.2); correspond with
Company, D. O’Connor re status of policy
(.1); correspond with various parties re
insurance policy (.2); conference with E.
Goetz re amendments to insurance policy (.2);
review, analyze BDO steps paper (.3), draft
master agreement re settlement of
intercompany issues (.3).
09/20/24 Michael Ehret
0.50 Correspond with buyer/Deloitte re insurance
policy (.3) conference with E. Goetz re same
(.2).
09/20/24 Sabrina Lieberman
0.10 Correspond with Z. Manning, K&E team re
health plan issue.
09/23/24 Emanuel Goetz
0.90 Conference with M. Ehret, Certa re tax
insurance.
09/24/24 Michael Ehret
1.20 Review, analyze comments of Deloitte on
draft insurance policy (.8); conference with E.
Goetz re same (.3); correspond with A.
Skuratovski, Marsh re to revised draft policy
(.1).
09/24/24 Emanuel Goetz
0.70 Review, analyze tax insurance comments.
09/25/24 Emanuel Goetz
0.60 Review, analyze comments from Marsh on
potential tax insurance by Certa (.3);
correspond with M. Ehret re same (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 659 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050107356
48520-18
5
Date
Name
Hours Description
09/26/24 Michael Ehret
1.50 Review, analyze revised draft insurance
policy, (.8); conference with Deloitte, A.
Skuratovski, Marsh, E. Goetz re Certa
comments (.6); correspond buyer/Deloitte
team re same (.1).
09/30/24 Kate Hardey
1.00 Conference with Marsh re product liability
policies (.6); correspond with Company
advisors re same (.4).
Total
29.10
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 660 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107357
Client Matter: 48520-20
In the Matter of Tax Matters
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail)
$ 107,726.00
Total legal services rendered
$ 107,726.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 661 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050107357
48520-20
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Jaina Desai
0.10
975.00
97.50
Michael Ehret
10.40
1,895.00
19,708.00
Luke Finn
0.40
1,345.00
538.00
Emanuel Goetz
5.90
750.00
4,425.00
Palmer Gunderson
25.60
995.00
25,472.00
Sabrina Lieberman
0.50
975.00
487.50
Alex Stephenson
2.60
1,175.00
3,055.00
Nicholas Warther
23.00
1,665.00
38,295.00
Sara B. Zablotney, P.C.
6.40
2,445.00
15,648.00
TOTALS
74.90
$ 107,726.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 662 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050107357
48520-20
3
Description of Legal Services
Date
Name
Hours Description
09/02/24 Palmer Gunderson
1.10 Correspond with Company re sale and tax
motion (.6); correspond with N. Warther,
K&E team re tax planning (.5).
09/02/24 Nicholas Warther
0.70 Correspond with Company re US tax
reporting items.
09/03/24 Emanuel Goetz
0.30 Revise draft ICO spreadsheet.
09/03/24 Palmer Gunderson
3.80 Review taxes motion re authorization for tax
planning activities (.7); correspond with
Company re tax planning activities (.5);
telephone conference with Company re tax
planning (.5); correspond with Company re
restructuring transactions (1.2); correspond
with BDO, N. Warther, S. Zablotney, K&E
team re tax planning activities (.9).
09/03/24 Nicholas Warther
0.80 Review and analyze structuring.
09/03/24 Sara B. Zablotney, P.C.
2.10 Attend telephone conference re purchase price
allocations and valuations (1.2); follow up re
structuring flexibility (.2); correspond with
AlixPartners, Company, K&E team re PPA
(.3); follow up re intercompany cleanup (.4).
09/04/24 Jaina Desai
0.10 Correspond with P. Gunderson re tax motion.
09/05/24 Nicholas Warther
4.20 Review and analyze purchase price allocation
(.9); telephone conference with Vyaire and
BDO re same and structuring (1.0); telephone
conference with S. Zablotney re same (.5);
review and analyze question re tax modeling
(.9); correspond with S. Zablotney, K&E team
and Company re intercompany resolutions
(.9).
09/06/24 Alex Stephenson
0.20 Discuss consolidated tax issue with N.
Warther.
09/09/24 Sabrina Lieberman
0.30 Correspond with Cole Schotz re IRS
correspondence.
09/09/24 Alex Stephenson
1.40 Research re consolidated loss treatment.
09/10/24 Palmer Gunderson
0.40 Correspond with N. Warther, K&E team re
structure slides and tax notice.
09/10/24 Nicholas Warther
0.40 Review and analyze tax return filing.
09/12/24 Nicholas Warther
0.50 Review and analyze BDO structure slides.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 663 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050107357
48520-20
4
Date
Name
Hours Description
09/13/24 Michael Ehret
2.10 Conference with E. Goetz re transaction
structure (.5); review, analyze BDO tax
memorandum (1.6).
09/13/24 Emanuel Goetz
1.40 Review, analyze slides re BDO tax
memorandum (.9); correspond with M. Ehret
re same (.5).
09/13/24 Palmer Gunderson
0.40 Correspond with working group re structure
slides and tax notice.
09/13/24 Alex Stephenson
1.00 Research re consolidated tax issues (.8);
conference with N. Warther re same (.2).
09/13/24 Nicholas Warther
1.30 Review and analyze structure slides (.4);
correspond with P. Gunderson, K&E team re
same (.3); review and analyze US tax
modeling question (.6).
09/16/24 Michael Ehret
0.10 Correspond with P. Gunderson re tax return
filings.
09/16/24 Emanuel Goetz
0.30 Correspond with M. Ehret the German tax
implications of transactions.
09/16/24 Emanuel Goetz
0.70 Correspond with M. Ehret re buyer notice.
09/16/24 Palmer Gunderson
0.80 Prepare update to company tax disclosure.
09/16/24 Nicholas Warther
0.70 Review and analyze structure slides.
09/16/24 Sara B. Zablotney, P.C.
0.50 Attend telephone conference re intercompany
issues.
09/17/24 Palmer Gunderson
3.30 Correspond with corporate team re novation
steps (.5); review and prepare tax comments
re intercompany settlement agreement (2.8).
09/17/24 Nicholas Warther
0.20 Correspond with P. Gunderson, K&E team re
status and next steps.
09/18/24 Emanuel Goetz
2.20 Review, analyze comments from Certa on the
tax insurance (1.9); review and discuss
outstanding issues with M. Ehret (.3).
09/18/24 Palmer Gunderson
0.40 Correspond with S. Zablotney, K&E tax team
and company re tax diligence update (.1);
correspond with S. Zablotney, K&E tax team
re settlement agreement (.3).
09/18/24 Sara B. Zablotney, P.C.
0.50 Review and revise Novation agreement.
09/19/24 Emanuel Goetz
0.30 Correspond with C. Paus re payment
structure.
09/19/24 Palmer Gunderson
0.70 Correspond with lenders counsel and
Company re tax diligence item (.4);
correspond with accounting team re
restructuring steps (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 664 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050107357
48520-20
5
Date
Name
Hours Description
09/20/24 Sabrina Lieberman
0.20 Correspond with Company, Cole Schotz re
outstanding IRS requests.
09/23/24 Michael Ehret
1.80 Prepare for conference with buyer/Deloitte re
draft insurance policy, open items, (.8);
correspond with Deloitte re comments,
overview re determination of FMV (.3);
correspond with Company re status (.2);
review, analyze Company correspondence re
MIM shares timing (.5).
09/23/24 Palmer Gunderson
0.80 Correspond with Company re master
settlement agreement.
09/23/24 Nicholas Warther
3.00 Review and analyze structure slides (.8);
review and revise intercompany settlement
agreement (1.7); correspond with P.
Gunderson, K&E team and Company re same
(.5).
09/23/24 Sara B. Zablotney, P.C.
1.00 Correspond with N. Warther re intercompany
settlements.
09/24/24 Palmer Gunderson
0.20 Correspond with N. Warther, K&E team re
tax comments on settlement agreement.
09/24/24 Nicholas Warther
3.00 Review and revise intercompany settlement
agreement (2.1); correspond with BDO, P.
Gunderson, K&E team re US tax analysis
(.9).
09/25/24 Michael Ehret
2.20 Discussions with E. Goetz in relation to draft
novation/transfer agreement re intercompany
issues (1.6); review, analyze Marsh
correspondence re Certa insurance (.6).
09/25/24 Emanuel Goetz
0.70 Comment on intercompany settlement
agreement.
09/25/24 Palmer Gunderson
3.20 Analyze tax consequences of intercompany
obligation settlement transactions (2.0);
prepare draft tax treatment for settlement
agreement (1.2).
09/25/24 Nicholas Warther
2.70 Correspond with P. Gunderson, K&E team re
intercompany settlement agreement and
structuring (1.2); review and revise same (.4);
review and revise structure slides (.4);
correspond with P. Gunderson, K&E team re
structuring matters (.7).
09/25/24 Sara B. Zablotney, P.C.
0.90 Research Section 108(3)(6) (.3); review,
analyze correspond re closing (.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 665 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050107357
48520-20
6
Date
Name
Hours Description
09/26/24 Palmer Gunderson
5.40 Review, analyze tax treatment (2.4); review,
analyze BDO comments (3.0).
09/26/24 Nicholas Warther
2.50 Review and revise intercompany settlement
agreement (1.3); review and analyze US tax
consequences of same (.9); correspond with
P. Gunderson, K&E team re same (.3).
09/27/24 Michael Ehret
3.20 Correspond buyer/Deloitte team re comments
on insurance policy, finalization of policy
(.8); review, analyze draft novation agreement
(1.4); conference with Company, S. Toth, P.
Gunderson re various open items (.7);
correspond with C. Paus re open items (.3).
09/27/24 Palmer Gunderson
4.30 Telephone conference with Company re sale
and restructuring transactions (.5); telephone
conference with tax and accounting team re
tax treatment of restructuring transactions and
tax planning for restructuring (1.5); draft tax
comments on revised settlement agreement
(1.2); revise tax treatment language for
settlement agreement (1.1).
09/27/24 Nicholas Warther
1.80 Telephone conference with BDO re US tax
analysis (1.5); review and analyze same (.3).
09/27/24 Sara B. Zablotney, P.C.
0.40 Review, analyze intended tax treatment.
09/28/24 Luke Finn
0.40 Review, analyze Trent Rossi Intermed Tax &
Restructuring correspondence.
09/28/24 Palmer Gunderson
0.80 Telephone conference with S. Zablotney,
K&E tax team and Company (.5); review,
analyze revised settlement agreement (.3).
09/28/24 Sara B. Zablotney, P.C.
0.50 Attend telephone conference with P.
Gunderson, K&E tax team and Company re
intercompany settlements.
09/29/24 Nicholas Warther
0.80 Correspond with Company, P. Gunderson,
K&E team re intercompany settlements.
09/30/24 Michael Ehret
1.00 Review correspondence from Deloitte re
insurance (.5); correspond with A.
Skuratovski, Marsh re novation agreement
(.2); conference with C. Paus re asset transfers
(.3).
09/30/24 Nicholas Warther
0.40 Review and analyze intercompany settlement.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 666 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050107357
48520-20
7
Date
Name
Hours Description
09/30/24 Sara B. Zablotney, P.C.
0.50 Attend telephone conference with N. Warther,
K&E working group re intercompany
settlements.
Total
74.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 667 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107358
Client Matter: 48520-21
In the Matter of Case Administration
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail)
$ 32,923.00
Total legal services rendered
$ 32,923.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 668 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050107358
48520-21
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
4.50
1,395.00
6,277.50
Tiffani Chanroo
7.10
1,345.00
9,549.50
Erica D. Clark
0.40
1,595.00
638.00
Hannah Crawford
1.80
1,595.00
2,871.00
Jaina Desai
0.60
975.00
585.00
Michael Ehret
0.10
1,895.00
189.50
David Hackel
0.70
1,095.00
766.50
Kate Hardey
0.40
1,995.00
798.00
Sabrina Lieberman
3.00
975.00
2,925.00
Jai Mudhar
1.20
1,345.00
1,614.00
Joshua Raphael
2.60
1,095.00
2,847.00
Steve Toth
1.70
1,820.00
3,094.00
Donatus Wang
0.80
960.00
768.00
TOTALS
24.90
$ 32,923.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 669 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050107358
48520-21
3
Description of Legal Services
Date
Name
Hours Description
09/03/24 Tiffani Chanroo
0.60 Conference with C. Ceresa re works in
process, case status.
09/03/24 Erica D. Clark
0.40 Conference with C. Ceresa, K&E team, Cole
Schotz re case status (.3); conference with
PJT re same (.1).
09/03/24 David Hackel
0.10 Review, analyze issues re service log,
stakeholder issues.
09/03/24 Kate Hardey
0.40 Correspond with R. Meintjes and S. Toth re
state license change of ownership
requirements for transaction.
09/03/24 Sabrina Lieberman
0.20 Review, revise works in process summary.
09/04/24 Sabrina Lieberman
1.50 Conference with Cole Schotz, C. Ceresa, T.
Chanroo re works in process (.5); correspond
with C. Schotz, C. Ceresa, K&E team re same
(.3); conference with C. Ceresa re same (.1);
draft correspondence to C. Ceresa, K&E team
re same (.6).
09/04/24 Joshua Raphael
0.40 Conference with C. Ceresa, T. Chanroo, CS re
coordination.
09/05/24 Jaina Desai
0.60 Revise case timeline (.5); correspond with C.
Ceresa, K. Trevett re same (.1).
09/05/24 Sabrina Lieberman
0.20 Correspond with C. Ceresa, K&E team re
works in process.
09/06/24 Tiffani Chanroo
0.50 Conference with Cole Schotz team, C. Ceresa
re works in process.
09/06/24 Hannah Crawford
0.50 Correspond with J. Mudhar re correspondence
to C. Ceresa.
09/06/24 Joshua Raphael
0.50 Telephone conference with C. Ceresa, K&E
team re case status, works in process.
09/09/24 Chris Ceresa
0.20 Telephone conference with J. Raphael and
Cole Schotz team re open case matters.
09/09/24 Joshua Raphael
0.20 Conference with C. Ceresa, Cole Schotz re
works in process.
09/10/24 Chris Ceresa
0.50 Telephone conference with J. Raphael and
Cole Schotz team re open case matters.
09/10/24 Tiffani Chanroo
1.20 Review, analyze reporting obligations (.8);
correspond with Cole Schotz team re same
(.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 670 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050107358
48520-21
4
Date
Name
Hours Description
09/10/24 Joshua Raphael
0.60 Telephone conference with C. Ceresa, Cole
Schotz re matter status.
09/11/24 Chris Ceresa
0.40 Telephone conference with Y. Salloum re
open case items.
09/11/24 Chris Ceresa
0.60 Telephone conference with J. Raphael and
Cole Schotz team re open case matters.
09/11/24 Tiffani Chanroo
1.30 Conference with Cole Schotz team, C. Ceresa
re case status (.6); review, analyze issues re
same (.7).
09/11/24 Joshua Raphael
0.50 Telephone conference with C. Ceresa, K&E
team re open issues.
09/12/24 Chris Ceresa
1.10 Telephone conferences with Y. Salloum, S.
Toth, K&E team, advisors, counsel re open
case issues.
09/12/24 Hannah Crawford
0.80 Conference with J. Mudhar, K&E team, Cole
Schotz re works in process (.5); correspond
with J. Mudhar, K&E team re same (.3).
09/12/24 Sabrina Lieberman
0.80 Conference with Cole Schotz, C. Ceresa,
K&E team re works in process.
09/12/24 Jai Mudhar
0.50 Conference with Cole Schotz on international
workstreams.
09/13/24 Hannah Crawford
0.50 Conference with J. Mudhar, K&E team, Cole
Schotz re works in process.
09/13/24 Sabrina Lieberman
0.20 Conference with S. Osborne re works in
process (.1); correspond with S. Osborne re
same (.1).
09/13/24 Jai Mudhar
0.50 Conference with Cole Schotz, H. Crawford,
K&E team re works in process.
09/13/24 Donatus Wang
0.80 Conference with C. Ceresa, K&E team re
works in process.
09/16/24 Chris Ceresa
0.30 Telephone conference with Cole Schotz team
re open legal matters.
09/17/24 Chris Ceresa
0.40 Telephone conference with Y. Salloum re
case status.
09/17/24 Chris Ceresa
0.40 Telephone conference with Cole Schotz team
re open legal matters.
09/17/24 Tiffani Chanroo
1.70 Conference with C. Ceresa, Cole Schotz team
re works in process (.5); conference with C.
Ceresa re case status, works in process (.6);
review, analyze correspondence from C.
Ceresa re works in process (.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 671 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050107358
48520-21
5
Date
Name
Hours Description
09/17/24 Michael Ehret
0.10 Correspond with Company advisors re
insurance policy (.5); correspond with D.
O’Connor, Company re works in process (.1).
correspond with Deloitte, buyer re transaction
(.1).
09/17/24 Jai Mudhar
0.20 Conference with S. Lieberman re Swiss
auditor issues.
09/17/24 Joshua Raphael
0.40 Conference with C. Ceresa, Cole Schotz re
priority items.
09/18/24 Chris Ceresa
0.20 Telephone conference with Cole Schotz team
re open legal matters.
09/18/24 Tiffani Chanroo
0.40 Conference with C. Ceresa, Cole Schotz team
re case status.
09/19/24 Chris Ceresa
0.40 Telephone conference with Cole Schotz team
re open legal matters.
09/21/24 Sabrina Lieberman
0.10 Review, analyze correspondence from C.
Ceresa, K&E team re works in process.
09/23/24 Tiffani Chanroo
0.10 Review, analyze correspondence from C.
Ceresa re case status.
09/23/24 Steve Toth
0.30 Participate in telephone conference with Cole
Schotz, AlixPartners, and working group re
case matters.
09/25/24 Tiffani Chanroo
0.30 Correspond with D. Hackel re Omni requests.
09/25/24 David Hackel
0.30 Analyze issues re stakeholder log (.2);
correspond with T. Chanroo, K&E team re
same (.1).
09/25/24 Steve Toth
1.10 Conference with Y. Salloum, K&E team,
Cole Schotz, AlixPartners re case updates
(.5); draft related correspondence (.6).
09/26/24 Tiffani Chanroo
1.00 Review, analyze correspondence from C.
Ceresa re case status.
09/26/24 David Hackel
0.30 Analyze issues re stakeholder log (.2);
correspond with S. Osborne re same (.1).
09/26/24 Steve Toth
0.30 Participate in update telephone conference
with PJT, AlixPartners, N. Warther, K&E
team.
Total
24.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 672 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107359
Client Matter: 48520-22
In the Matter of Retention - K&E
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail)
$ 100,920.00
Total legal services rendered
$ 100,920.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 673 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050107359
48520-22
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
27.50
1,395.00
38,362.50
Tiffani Chanroo
8.30
1,345.00
11,163.50
Jaina Desai
6.80
975.00
6,630.00
Julia R. Foster
0.90
525.00
472.50
David Hackel
6.10
1,095.00
6,679.50
Sabrina Lieberman
21.10
975.00
20,572.50
Sarah Osborne
1.40
975.00
1,365.00
Adrian Salmen
5.30
1,265.00
6,704.50
Seth Sanders
4.00
1,265.00
5,060.00
Kyle Nolan Trevett
1.80
1,265.00
2,277.00
Tanzila Zomo
4.60
355.00
1,633.00
TOTALS
87.80
$ 100,920.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 674 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050107359
48520-22
3
Description of Legal Services
Date
Name
Hours Description
09/01/24 Sabrina Lieberman
2.20 Review, revise K&E invoice for privilege,
confidentiality.
09/02/24 Sabrina Lieberman
3.50 Review, revise K&E invoice re privilege,
confidentiality.
09/03/24 Sabrina Lieberman
0.70 Review, revise K&E invoice re privilege,
confidentiality.
09/05/24 Chris Ceresa
0.20 Review, analyze status re K&E fee
application.
09/05/24 Sabrina Lieberman
1.30 Review, revise invoice for privilege and
confidentiality (1.0); correspond with C.
Ceresa, K&E team re same (.3).
09/08/24 Sabrina Lieberman
0.30 Draft correspondence to S. Winters re fee
application (.1); correspond with J. Foster,
K&E team re same (.2).
09/09/24 Sabrina Lieberman
0.20 Correspond with S. Winters, K&E team re fee
application.
09/11/24 Sabrina Lieberman
1.30 Review, revise invoice re privilege and
confidentiality (1.1); correspond with T.
Chanroo, K&E team re same (.2).
09/12/24 Sabrina Lieberman
0.10 Correspond with C. Ceresa re second
supplemental declaration in support of K&E
retention.
09/12/24 Adrian Salmen
2.40 Review, revise K&E invoice for privilege and
confidentiality.
09/13/24 Adrian Salmen
1.60 Review, revise K&E invoice for privilege and
confidentiality.
09/13/24 Seth Sanders
2.10 Review, revise K&E invoice for privilege and
confidentiality.
09/13/24 Kyle Nolan Trevett
0.60 Review, revise K&E invoice re privilege,
confidentiality issues (.5); correspond with S.
Lieberman, K&E team re same (.1).
09/14/24 Kyle Nolan Trevett
0.50 Review, revise invoice re privilege,
confidentiality.
09/16/24 Chris Ceresa
4.40 Review, revise K&E monthly fee statement
entries for confidentiality and privilege issues
(3.9); correspond with S. Lieberman and
K&E team re same (.5).
09/16/24 Tiffani Chanroo
2.00 Review, revise K&E invoice re privilege and
confidentiality considerations.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 675 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050107359
48520-22
4
Date
Name
Hours Description
09/17/24 Chris Ceresa
1.50 Review, revise on K&E monthly fee
statement entries for confidentiality and
privilege issues (1.2); correspond with S.
Lieberman and K&E team re same (.3).
09/18/24 Tiffani Chanroo
0.20 Correspond with S. Lieberman re interim fee
application.
09/18/24 Tanzila Zomo
2.00 Draft initial interim fee application.
09/19/24 Chris Ceresa
2.80 Review, revise K&E monthly fee statement
entries for confidentiality and privilege issues
(2.6); correspond with S. Lieberman and
K&E team re same (.2).
09/19/24 David Hackel
3.90 Review, revise K&E invoice re privilege,
confidentiality.
09/19/24 Sabrina Lieberman
1.40 Review, revise invoice for privilege and
confidentiality (1.1); review, revise interim
fee application (.3).
09/20/24 Chris Ceresa
1.60 Review, revise, comment on K&E monthly
fee statement entries for confidentiality and
privilege issues (1.3); correspond with S.
Lieberman and K&E team re same (.3).
09/20/24 David Hackel
2.20 Review, revise K&E invoice re privilege,
confidentiality.
09/21/24 Tiffani Chanroo
0.50 Review, revise invoice for confidentiality and
privilege considerations.
09/21/24 Sabrina Lieberman
0.70 Review, revise first interim fee application.
09/21/24 Sarah Osborne
1.40 Review, revise K&E invoice for privilege,
confidentiality concerns.
09/22/24 Tiffani Chanroo
1.50 Review, revise invoice for privilege and
confidentiality considerations.
09/22/24 Jaina Desai
5.40 Review, revise invoice re privilege and
confidentially considerations (3.9); further
review, revise invoice re same (1.3);
correspond with S. Lieberman re same (.1);
correspond with K. Trevett re same (.1).
09/23/24 Chris Ceresa
4.70 Review, revise K&E fee statement for
privilege and confidentiality issues (3.9);
correspond with S. Lieberman and K&E team
re same (.8).
09/23/24 Tiffani Chanroo
4.10 Review, revise K&E invoice for
confidentiality and privilege (3.9); correspond
with C. Ceresa, K&E team re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 676 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050107359
48520-22
5
Date
Name
Hours Description
09/23/24 Jaina Desai
1.40 Review, revise invoice re privilege and
confidentially considerations (1.0);
correspond with K. Trevett, K&E team re
same (.4).
09/23/24 Adrian Salmen
1.30 Review, revise K&E invoice re privilege and
confidentiality.
09/23/24 Seth Sanders
1.90 Revise K&E invoice re privilege &
confidentiality.
09/23/24 Kyle Nolan Trevett
0.70 Review, revise invoice re privilege,
confidentiality (.6); correspond with S.
Lieberman, K&E team re same (.1).
09/24/24 Chris Ceresa
1.20 Review, revise K&E fee statement for
privilege and confidentiality issues (1.1);
correspond with S. Lieberman and K&E team
re same (.1).
09/24/24 Julia R. Foster
0.90 Research precedent re K&E interim fee
application.
09/24/24 Sabrina Lieberman
2.90 Review, revise interim fee application.
09/24/24 Tanzila Zomo
2.00 Research re first interim fee application.
09/25/24 Chris Ceresa
0.40 Review, revise K&E fee statement for
privilege and confidentiality issues (.3);
correspond with S. Lieberman and K&E team
re same (.1).
09/25/24 Sabrina Lieberman
2.70 Review, revise interim fee application.
09/25/24 Tanzila Zomo
0.60 Review, revise interim fee application.
09/27/24 Chris Ceresa
2.60 Review, revise K&E fee statement for
privilege and confidentiality issues (2.4);
correspond with S. Lieberman and K&E team
re same (.2).
09/27/24 Sabrina Lieberman
0.10 Correspond with C. Ceresa, AlixPartners re
payment.
09/28/24 Sabrina Lieberman
0.70 Review, revise K&E invoice re privilege,
confidentiality.
09/29/24 Sabrina Lieberman
3.00 Review, revise K&E invoice re privilege and
confidentiality.
09/30/24 Chris Ceresa
8.10 Review, revise K&E fee statement for
privilege and confidentiality issues (3.9);
further review and revise same (3.7);
correspond with S. Lieberman and K&E team
re same (.5).
Total
87.80
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 677 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107360
Client Matter: 48520-23
In the Matter of Retention - Non K&E
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail)
$ 3,108.00
Total legal services rendered
$ 3,108.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 678 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050107360
48520-23
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
1.30
1,395.00
1,813.50
Tiffani Chanroo
0.60
1,345.00
807.00
Sabrina Lieberman
0.50
975.00
487.50
TOTALS
2.40
$ 3,108.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 679 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Retention - Non K&E
Invoice Number:
Matter Number:
1050107360
48520-23
3
Description of Legal Services
Date
Name
Hours Description
09/03/24 Sabrina Lieberman
0.20 Review, analyze correspondence from C.
Ceresa, PJT re fee statements.
09/09/24 Tiffani Chanroo
0.60 Review, analyze BDO monthly fee statement
(.4); correspond with Cole Schotz team re
same (.2).
09/13/24 Chris Ceresa
1.10 Telephone conference with AlixPartners, Cole
Schotz re professional fees planning and
issues.
09/25/24 Chris Ceresa
0.20 Correspond with S. Lieberman re non-K&E
retention filings.
09/25/24 Sabrina Lieberman
0.30 Review, analyze PJT fee application.
Total
2.40
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 680 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107361
Client Matter: 48520-24
In the Matter of Vendor Matters
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail)
$ 6,135.50
Total legal services rendered
$ 6,135.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 681 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Vendor Matters
Invoice Number:
Matter Number:
1050107361
48520-24
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
2.00
1,395.00
2,790.00
Tiffani Chanroo
0.30
1,345.00
403.50
Sabrina Lieberman
0.10
975.00
97.50
Steve Toth
1.10
1,820.00
2,002.00
Spencer A. Winters, P.C.
0.50
1,685.00
842.50
TOTALS
4.00
$ 6,135.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 682 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Vendor Matters
Invoice Number:
Matter Number:
1050107361
48520-24
3
Description of Legal Services
Date
Name
Hours Description
09/03/24 Tiffani Chanroo
0.30 Correspond with K. Chiaghana re possessory
liens.
09/03/24 Sabrina Lieberman
0.10 Conference with vendor counsel re status
update.
09/04/24 Steve Toth
0.60 Correspond with Company, AlixPartners, and
K&E team re vendors.
09/04/24 Spencer A. Winters, P.C.
0.50 Telephone conference with Company,
AlixPartners team re vendors.
09/16/24 Chris Ceresa
0.70 Review, analyze open legal issues with
vendors and counterparties.
09/17/24 Chris Ceresa
1.30 Review, analyze open legal issues with
vendors and counterparties.
09/27/24 Steve Toth
0.50 Correspond with Company, AlixPartners, and
Cole Schotz re vendor issues.
Total
4.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 683 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107362
Client Matter: 48520-25
In the Matter of Litigation
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail)
$ 6,813.00
Total legal services rendered
$ 6,813.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 684 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050107362
48520-25
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
1.30
1,395.00
1,813.50
Tabitha J. De Paulo
0.50
1,435.00
717.50
Alisa Melekhina
0.60
1,595.00
957.00
Maureen D. O'Brien
1.40
2,115.00
2,961.00
Steve Toth
0.20
1,820.00
364.00
TOTALS
4.00
$ 6,813.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 685 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Litigation
Invoice Number:
Matter Number:
1050107362
48520-25
3
Description of Legal Services
Date
Name
Hours Description
09/03/24 Chris Ceresa
0.40 Review, revise removal motion (.2);
correspond with T. Chanroo, K&E team re
issues re same (.2).
09/04/24 Chris Ceresa
0.90 Review, revise removal motion (.5);
correspond with T. Chanroo, K&E team re
issues re same (.4).
09/17/24 Alisa Melekhina
0.10 Review, analyze production links and
transmittals.
09/17/24 Maureen D. O'Brien
1.40 Conference with S. Kim, K&E team
employment matters (.5); review, analyze
research re: same (.5); review plan documents
(.4).
09/18/24 Tabitha J. De Paulo
0.10 Correspond with various parties re discovery
responses.
09/20/24 Tabitha J. De Paulo
0.20 Review and revise responses and objections
to discovery requests.
09/25/24 Tabitha J. De Paulo
0.20 Conference with Company re potential
litigation funding.
09/25/24 Steve Toth
0.20 Discuss litigation with AlixPartners, Y.
Salloum, K&E team Company.
09/27/24 Alisa Melekhina
0.50 Review, analyze objections and responses to
the UCC discovery requests (.2); review,
analyze Cole Schotz and UCC meet and
confer updates (.2); correspond with various
parties on document productions and follow-
up requests (.1).
Total
4.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 686 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107364
Client Matter: 48520-28
In the Matter of Creditors’ Committee Matters
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail)
$ 4,963.00
Total legal services rendered
$ 4,963.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 687 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Creditors’ Committee Matters
Invoice Number:
Matter Number:
1050107364
48520-28
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
2.30
1,395.00
3,208.50
Alisa Melekhina
0.10
1,595.00
159.50
Yusuf Salloum
1.00
1,595.00
1,595.00
TOTALS
3.40
$ 4,963.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 688 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Creditors’ Committee Matters
Invoice Number:
Matter Number:
1050107364
48520-28
3
Description of Legal Services
Date
Name
Hours Description
09/17/24 Chris Ceresa
0.20 Review, analyze UCC requests for production
and interrogatories.
09/17/24 Alisa Melekhina
0.10 Review, analyze Cole Schotz and UCC
updates and correspondence.
09/17/24 Yusuf Salloum
1.00 Review, analyze document and production
requests.
09/18/24 Chris Ceresa
1.80 Review, analyze UCC requests for production
and interrogatories.
09/21/24 Chris Ceresa
0.30 Review, analyze UCC requests for production
and interrogatories.
Total
3.40
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 689 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107365
Client Matter: 48520-29
In the Matter of Employee and Labor Matters
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail)
$ 55,069.00
Total legal services rendered
$ 55,069.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 690 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Employee and Labor Matters
Invoice Number:
Matter Number:
1050107365
48520-29
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Rebecca H. Arnall
1.50
1,265.00
1,897.50
Chris Ceresa
4.20
1,395.00
5,859.00
Jaina Desai
0.50
975.00
487.50
Luke Finn
0.80
1,345.00
1,076.00
Kate Hardey
0.70
1,995.00
1,396.50
Sooah Kim
1.90
1,095.00
2,080.50
Maureen D. O'Brien
4.50
2,115.00
9,517.50
Scott D. Price, P.C.
0.50
2,245.00
1,122.50
Risa Salins
13.00
2,115.00
27,495.00
Paul Vasiloff
2.70
1,345.00
3,631.50
Spencer A. Winters, P.C.
0.30
1,685.00
505.50
TOTALS
30.60
$ 55,069.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 691 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Employee and Labor Matters
Invoice Number:
Matter Number:
1050107365
48520-29
3
Description of Legal Services
Date
Name
Hours Description
09/04/24 Risa Salins
0.30 Correspond with C. Ceresa, K&E team,
AlixPartners re employment matter.
09/10/24 Chris Ceresa
0.30 Correspond with R. Salins and AlixPartners re
employment legal issues.
09/11/24 Chris Ceresa
1.60 Correspond with Company, R. Salins, K&E
team, and AlixPartners re employment legal
issues (.4); telephone conferences with R.
Salins, AlixPartners re issues re same (1.2).
09/11/24 Sooah Kim
0.70 Review, analyze 401(k) plan documents (.3);
conference with Company human resources
team (.4).
09/11/24 Risa Salins
1.00 Review, analyze employment matters
(.4); discuss same with C. Ceresa (.3);
telephone conference with P. Vasiloff re
research re same (.3).
09/12/24 Chris Ceresa
1.20 Telephone conferences with M. O'Brien,
AlixPartners re employment plan issues (1.1);
correspond with M. O’Brien, AlixPartners re
same (.1).
09/12/24 Sooah Kim
1.00 Conference with AlixPartners re
employee‑related issues (.6); review, analyze
401(k) plan documents (.1); conduct research
on safe harbor 401(k) plan requirements (.3).
09/12/24 Maureen D. O'Brien
1.50 Attend conference with C. Ceresa, K&E team
re 401(k) plans (.5); review, analyze plan
documents and applicable law (1.0).
09/12/24 Risa Salins
2.00 Review, analyze updated employee data (.3);
correspond with L. Harmon re same (.2);
review, analyze employment research from P.
Vasiloff and E. Davey (1.2); correspond with
P. Vasiloff re same (.3).
09/13/24 Chris Ceresa
0.50 Review, analyze /employee matter (.3);
correspond from AlixPartners re same (.2).
09/13/24 Risa Salins
1.80 Further review, analyze updated employee
data (.5); review, analyze further employment
matter research (.5); telephone conference
with AlixPartners re employee matters (.5);
correspond with P. Vasiloff re employee
matters, research re same (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 692 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Employee and Labor Matters
Invoice Number:
Matter Number:
1050107365
48520-29
4
Date
Name
Hours Description
09/16/24 Risa Salins
0.80 Conference with P. Vasiloff re employee
matters.
09/16/24 Paul Vasiloff
0.70 Draft updated employment‑related notice.
09/17/24 Luke Finn
0.50 Review, analyze employment issue.
09/17/24 Sooah Kim
0.20 Conduct research on safe harbor plans.
09/17/24 Risa Salins
0.50 Further review, analyze /employee matter
(.3); correspondence from AlixPartners re
same (.2).
09/18/24 Chris Ceresa
0.20 Correspond with R. Salins re open
employment planning issues.
09/18/24 Risa Salins
2.00 Review, analyze updated employee data
under employment statutes (1.5); correspond
with C. Ceresa, AlixPartners re same (.5).
09/19/24 Chris Ceresa
0.20 Correspond with R. Salins re open
employment planning issues.
09/19/24 Risa Salins
2.00 Telephone conference with E. Davey re
employment research (.3); review, analyze
research (.7); review, analyze further updated
employee/offer data (.5); telephone
conference with AlixPartners re employee
matters (.5).
09/20/24 Maureen D. O'Brien
0.50 Review, analyze safe harbor plan issues.
09/20/24 Risa Salins
0.50 Further review, analyze employee
offer/termination data.
09/21/24 Kate Hardey
0.70 Review and revise employee FAQs.
09/22/24 Jaina Desai
0.50 Correspond with Company re employment
issue.
09/22/24 Maureen D. O'Brien
0.50 Review, analyze benefits issues.
09/22/24 Spencer A. Winters, P.C.
0.30 Telephone conferences with AlixPartners, Y.
Salloum re employee issues.
09/23/24 Rebecca H. Arnall
0.80 Correspond with Y. Salloum re outstanding
severance issue.
09/23/24 Maureen D. O'Brien
1.00 Review, analyze benefit plan issues.
09/23/24 Risa Salins
1.00 Correspond with Y. Salloum, K&E team re
employee matters (.3); review and provide
comments to separation agreement (.7).
09/23/24 Paul Vasiloff
1.50 Review and provide comments to separation
agreement.
09/24/24 Rebecca H. Arnall
0.20 Correspond with Y. Salloum re outstanding
severance issue.
09/24/24 Chris Ceresa
0.20 Analyze legal issues re employment matters.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 693 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Employee and Labor Matters
Invoice Number:
Matter Number:
1050107365
48520-29
5
Date
Name
Hours Description
09/24/24 Luke Finn
0.30 Review, analyze employment issue.
09/24/24 Scott D. Price, P.C.
0.50 Review, analyze, discuss severance issues.
09/24/24 Risa Salins
0.30 Revise offer letters.
09/24/24 Paul Vasiloff
0.50 Correspond with Company correspondence re
employment issue.
09/28/24 Rebecca H. Arnall
0.50 Correspond with M. O’Brien re summary
severance plan (.3); review, analyze same
(.2).
09/28/24 Maureen D. O'Brien
1.00 Correspond with R. Arnall re severance plans.
09/29/24 Risa Salins
0.80 Review, analyze updated employee offer data
(.3); telephone conference with AlixPartners
re same (.5).
Total
30.60
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 694 of 914

October 2024
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 695 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108822
Client Matter: 48520-5
In the Matter of Corporate & Governance Matters
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail)
$ 44,407.00
Total legal services rendered
$ 44,407.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 696 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050108822
48520-5
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
2.50
1,395.00
3,487.50
Michael Ehret
0.30
1,895.00
568.50
Luke Finn
0.30
1,345.00
403.50
Emanuel Goetz
0.90
750.00
675.00
Sabrina Lieberman
3.00
975.00
2,925.00
Carolin Paus
10.80
750.00
8,100.00
Donatus Wang
3.30
960.00
3,168.00
Cristina Weidner
11.40
1,665.00
18,981.00
Spencer A. Winters, P.C.
0.50
1,685.00
842.50
Ali Mohammad Zarrabi
4.80
1,095.00
5,256.00
TOTALS
37.80
$ 44,407.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 697 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050108822
48520-5
3
Description of Legal Services
Date
Name
Hours Description
07/10/24 Cristina Weidner
0.50 Attend MIM winddown discussion.
08/06/24 Cristina Weidner
1.50 Telephone conference with A. Ziegler, K&E
team re sale process and tax structure (.3);
correspond with A. Ziegler and K&E team re
same (1.2).
08/16/24 Cristina Weidner
1.00 Attend update telephone conference and
follow up with team.
10/01/24 Carolin Paus
5.60 Coordinate with German notary re required
proof of representation for PoAs (.4); research
issues re shareholder resolutions (1.1); draft
shareholder resolutions for MIM and Vyaire
GmbH (2.9); draft comprehensive workstream
summary (1.2).
10/02/24 Donatus Wang
2.10 Revise draft PoAs for transfer of MIM,
GmbH (1.0); coordinate US notarization of
PoAs (1.1).
10/03/24 Chris Ceresa
0.20 Revise minutes re special committee meeting.
10/03/24 Sabrina Lieberman
0.10 Correspond with H. Crawford, K&E team re
Italian board composition.
10/04/24 Luke Finn
0.30 Prepare Vyaire shareholder resolutions via
DocuSign.
10/04/24 Donatus Wang
0.20 Review, analyze draft shareholder resolution
re approval of asset transfers by MIM and
Vyaire GmbH (.1); revise same (.1).
10/04/24 Cristina Weidner
0.60 Correspond with Company re German
documentation issues.
10/06/24 Chris Ceresa
0.20 Correspond with Company re corporate legal
issues.
10/06/24 Sabrina Lieberman
0.10 Correspond with Company, C. Ceresa re non-
US local counsel.
10/06/24 Cristina Weidner
2.50 Correspond with Company re German
documentation.
10/07/24 Chris Ceresa
0.80 Correspond with Y. Salloum and K&E team
re corporate issues (.3); draft and revise
special committee minutes (.5).
10/07/24 Carolin Paus
5.20 Draft executed versions of shareholder
resolutions (.4); draft share transfer agreement
for transfer of Vyaire medical GmbH (3.9);
coordinate registration of Vyaire Medical Inc.
with German transparency register (.9).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 698 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050108822
48520-5
4
Date
Name
Hours Description
10/08/24 Donatus Wang
1.00 Correspond with Company and German
notary re KYC items, notarization of PoA and
secretary certificates.
10/09/24 Chris Ceresa
0.20 Correspond with Company re corporate
issues.
10/10/24 Chris Ceresa
0.70 Draft minutes re special committee meeting.
10/14/24 Sabrina Lieberman
0.10 Correspond with J. Mudhar, Cole Schotz re
international local counsel invoices.
10/16/24 Sabrina Lieberman
0.20 Conference with C. Ceresa re special
committee meeting.
10/17/24 Sabrina Lieberman
0.70 Draft special committee meeting minutes.
10/20/24 Sabrina Lieberman
0.10 Correspond with Company re Swiss auditor
documents.
10/21/24 Sabrina Lieberman
0.20 Correspond with C. Ceresa re special
committee meeting minutes.
10/22/24 Sabrina Lieberman
0.10 Correspond with Y. Salloum, AlixPartners re
Dutch counsel.
10/23/24 Chris Ceresa
0.20 Correspond with S. Lieberman re issues re
special committee meeting.
10/23/24 Michael Ehret
0.30 Analyze shareholder resolution.
10/23/24 Emanuel Goetz
0.40 Review and revise contemplated shareholders
resolution for Vyaire Medical GmbH.
10/23/24 Cristina Weidner
1.00 Telephone conference with A. Ziegler, K&E
team re shareholder resolution (.8); review,
analyze notes in preparation for same (.2).
10/24/24 Emanuel Goetz
0.50 Review and revise shareholder resolution.
10/24/24 Sabrina Lieberman
0.50 Draft special committee meeting minutes.
10/24/24 Cristina Weidner
1.00 Correspond with A. Ziegler, K&E team re
shareholder resolution and management
representation.
10/30/24 Cristina Weidner
1.00 Review, analyze SPA (.6); correspond with C.
Weidner re same (.4).
10/31/24 Chris Ceresa
0.20 Analyze, review status of corporate items.
10/31/24 Sabrina Lieberman
0.90 Conference with Y. Salloum re shareholder
meeting minutes (.1); draft special committee
meeting minutes (.3); draft shareholder
meeting minutes (.5).
10/31/24 Cristina Weidner
2.30 Draft comments to SPA (1.0); telephone
conference with C. Weidner re set-off
mechanism and intra-group positions (1.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 699 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050108822
48520-5
5
Date
Name
Hours Description
10/31/24 Spencer A. Winters, P.C.
0.50 Prepare for SC meeting (.3); participate in SC
meeting (.2).
10/31/24 Ali Mohammad Zarrabi
4.80 Draft APA amendment, board and
shareholder resolutions re sale of Italian and
Australian subsidiaries (2.8); prepare officer
certificates (1.0); review, analyze checklist re
same (.5); analyze correspondence re same
(.5).
Total
37.80
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 700 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108823
Client Matter: 48520-6
In the Matter of Disclosure Statement/Plan/Confirmation
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail)
$ 63,678.50
Total legal services rendered
$ 63,678.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 701 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050108823
48520-6
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
0.30
1,395.00
418.50
Tiffani Chanroo
8.60
1,345.00
11,567.00
Stephanie Choi
1.20
355.00
426.00
Amy Donahue
2.00
525.00
1,050.00
Palmer Gunderson
3.40
995.00
3,383.00
Sabrina Lieberman
4.60
975.00
4,485.00
Yusuf Salloum
24.70
1,595.00
39,396.50
Nicholas Warther
0.50
1,665.00
832.50
Spencer A. Winters, P.C.
0.90
1,685.00
1,516.50
Tanzila Zomo
1.70
355.00
603.50
TOTALS
47.90
$ 63,678.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 702 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050108823
48520-6
3
Description of Legal Services
Date
Name
Hours Description
10/01/24 Tiffani Chanroo
0.20 Correspond with Company re disclosure
statement.
10/02/24 Tiffani Chanroo
0.90 Review, revise combined hearing notice (.7);
correspond with Cole Schotz team re same
(.2).
10/03/24 Tiffani Chanroo
0.20 Correspond with Cole Schotz team re cover
letter.
10/07/24 Stephanie Choi
0.20 Transfer final set of documents re objections
and responses to UCC's requests.
10/08/24 Chris Ceresa
0.30 Review, revise disclosure statement notices
(.2); correspond with Cole Schotz team re
same (.1).
10/14/24 Stephanie Choi
0.50 Transfer produced documents for UCC.
10/15/24 Stephanie Choi
0.50 Compile and transfer produced documents re
UCC requests and interrogatories.
10/16/24 Yusuf Salloum
1.50 Prepare for confirmation.
10/18/24 Sabrina Lieberman
0.60 Conference with Y. Salloum, K&E team,
AlixPartners, UCC re work in process (.5);
correspond with UCC re same (.1).
10/18/24 Yusuf Salloum
1.00 Prepare for confirmation.
10/21/24 Amy Donahue
1.50 Research and pull plan supplement precedent
for S. Lieberman.
10/21/24 Sabrina Lieberman
0.50 Correspond with Y. Salloum, K&E team,
Cole Schotz re plan supplement.
10/22/24 Sabrina Lieberman
0.20 Telephone conference with P. Gunderson re
plan supplement.
10/22/24 Yusuf Salloum
2.40 Review, analyze issues re confirmation.
10/23/24 Sabrina Lieberman
0.80 Review, revise retained causes of action list
(.5); conference with Y. Salloum re same (.1);
correspond with Cole Schotz, Y. Salloum re
chapter 11 plan (.2).
10/23/24 Yusuf Salloum
2.50 Prepare for confirmation.
10/24/24 Sabrina Lieberman
0.20 Correspond with Y. Salloum, Cole Schotz re
chapter 11 plan.
10/24/24 Sabrina Lieberman
0.80 Review, revise counterproposal to UCC
settlement proposal (.6); correspond with Y.
Salloum, AlixPartners re same (.2).
10/24/24 Yusuf Salloum
2.50 Prepare for plan confirmation.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 703 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050108823
48520-6
4
Date
Name
Hours Description
10/24/24 Spencer A. Winters, P.C.
0.90 Review and analyze issues re UCC settlement
proposal (.4); participate in telephone
conference with special committee re same
(.3); prepare for same (.2).
10/25/24 Palmer Gunderson
2.30 Prepare draft restructuring transactions
memorandum.
10/25/24 Yusuf Salloum
2.30 Prepare for confirmation.
10/26/24 Nicholas Warther
0.50 Review and revise wind-down memorandum.
10/27/24 Palmer Gunderson
0.30 Review, analyze revisions to restructuring
transaction memorandum.
10/27/24 Yusuf Salloum
1.40 Prepare for confirmation.
10/28/24 Palmer Gunderson
0.80 Revise comments on restructuring
transactions memorandum.
10/28/24 Sabrina Lieberman
0.30 Correspond with Y. Salloum, K&E team,
Cole Schotz re plan supplement.
10/28/24 Yusuf Salloum
2.50 Analyze issues re confirmation.
10/29/24 Yusuf Salloum
2.70 Prepare for confirmation hearing.
10/30/24 Tiffani Chanroo
1.00 Conference with S. Lieberman, K&E team re
confirmation brief (.4); review, analyze issues
re same (.6).
10/30/24 Amy Donahue
0.50 Research and pull confirmation brief
precedent for S. Lieberman.
10/30/24 Sabrina Lieberman
0.80 Conference with T. Chanroo, K&E team re
confirmation brief (.5); review, analyze
confirmation brief (.3).
10/30/24 Yusuf Salloum
3.60 Prepare for confirmation.
10/31/24 Tiffani Chanroo
6.30 Review, revise confirmation brief (3.9);
review, analyze materials re same (2.4).
10/31/24 Sabrina Lieberman
0.40 Correspond with T. Chanroo, K&E team re
confirmation brief.
10/31/24 Yusuf Salloum
2.30 Prepare for confirmation hearing.
10/31/24 Tanzila Zomo
1.70 Research confirmation briefs re confirmation
analysis (1.2); research logistics re upcoming
hearings (.5).
Total
47.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 704 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108824
Client Matter: 48520-7
In the Matter of DIP Financing and Cash Collateral
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail)
$ 10,791.00
Total legal services rendered
$ 10,791.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 705 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050108824
48520-7
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
2.60
1,395.00
3,627.00
Sean McClay
3.20
1,575.00
5,040.00
Joshua Raphael
0.90
1,095.00
985.50
Adrian Salmen
0.90
1,265.00
1,138.50
TOTALS
7.60
$ 10,791.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 706 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050108824
48520-7
3
Description of Legal Services
Date
Name
Hours Description
10/02/24 Chris Ceresa
0.20 Review draft DIP reporting (.1); correspond
with J. Raphael re same (.1).
10/04/24 Chris Ceresa
0.20 Review draft DIP reporting (.1); correspond
with J. Raphael re same (.1).
10/08/24 Sean McClay
3.00 Draft forbearance agreement re DIP loan
agreement maturity.
10/09/24 Chris Ceresa
0.20 Review draft DIP reporting (.1); correspond
with J. Raphael re same (.1).
10/09/24 Adrian Salmen
0.30 Correspond with C. Ceresa, K&E team re
professional fees.
10/10/24 Chris Ceresa
0.50 Review, analyze legal issues re DIP
forbearance agreement (.4); correspond with
Y. Salloum and K&E team re same (.1).
10/10/24 Joshua Raphael
0.30 Prepare signature pages re DIP forbearance
agreement (.2); correspond with Y. Han, C.
Ceresa re forbearance agreement (.1).
10/11/24 Chris Ceresa
0.20 Review draft DIP reporting (.1); correspond
with J. Raphael re same (.1).
10/11/24 Chris Ceresa
0.40 Review, analyze legal issues re DIP
forbearance agreement (.3); correspond with
Y. Salloum and K&E team re same (.1).
10/11/24 Joshua Raphael
0.10 Compile, analyze variance report.
10/11/24 Joshua Raphael
0.30 Prepare signature pages for forbearance
agreement (.2); correspond with C. Ceresa,
K&E team, Company re same (.1).
10/14/24 Chris Ceresa
0.20 Correspond with Y. Salloum and K&E team
re DIP forbearance issues.
10/14/24 Sean McClay
0.20 Review, analyze comments to DIP
forbearance agreement.
10/15/24 Chris Ceresa
0.30 Correspond with Y. Salloum and K&E team
re DIP forbearance issues.
10/16/24 Chris Ceresa
0.20 Correspond with Y. Salloum and K&E team
re DIP forbearance issues.
10/16/24 Adrian Salmen
0.30 Correspond with C. Ceresa, K&E team,
lender advisors re professional fees.
10/18/24 Chris Ceresa
0.20 Correspond with Y. Salloum and K&E team
re DIP forbearance issues.
10/18/24 Joshua Raphael
0.20 Prepare DIP variances report (.1); correspond
with AlixPartners re fees (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 707 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050108824
48520-7
4
Date
Name
Hours Description
10/23/24 Adrian Salmen
0.30 Correspond with C. Ceresa, K&E team,
AlixPartners, lender advisors re professional
fees.
Total
7.60
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 708 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108825
Client Matter: 48520-8
In the Matter of Cash Management
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail)
$ 1,170.00
Total legal services rendered
$ 1,170.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 709 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Cash Management
Invoice Number:
Matter Number:
1050108825
48520-8
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Sabrina Lieberman
1.20
975.00
1,170.00
TOTALS
1.20
$ 1,170.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 710 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Cash Management
Invoice Number:
Matter Number:
1050108825
48520-8
3
Description of Legal Services
Date
Name
Hours Description
10/02/24 Sabrina Lieberman
0.20 Correspond with C. Ceresa, JP Morgan re
Indian bank account.
10/03/24 Sabrina Lieberman
0.30 Conference with JP Morgan re India bank
account.
10/04/24 Sabrina Lieberman
0.50 Telephone conference with Cole Schotz re
Indian bank account (.1); telephone
conference with Company re same (.3);
correspond with C. Ceresa, K&E team, Cole
Schotz, Company re same (.1).
10/10/24 Sabrina Lieberman
0.10 Correspond with Company, JP Morgan re
Indian entity.
10/15/24 Sabrina Lieberman
0.10 Correspond with JP Morgan, Company re
India bank account.
Total
1.20
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 711 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108826
Client Matter: 48520-10
In the Matter of Asset Sales/Section 363 Issues: Use, Sale & Disposition of Property
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail)
$ 609,876.00
Total legal services rendered
$ 609,876.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 712 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Hendrik Braun
3.00
1,145.00
3,435.00
Chris Ceresa
1.80
1,395.00
2,511.00
Bernadette Coppola
7.90
1,575.00
12,442.50
Hannah Crawford
0.20
1,595.00
319.00
Anthony M. Del Rio
2.10
1,595.00
3,349.50
Michael Ehret
4.50
1,895.00
8,527.50
Luke Finn
105.80
1,345.00
142,301.00
Justin M. Garfinkle
8.00
1,095.00
8,760.00
Palmer Gunderson
1.20
995.00
1,194.00
Kate Hardey
7.40
1,995.00
14,763.00
Sabrina Lieberman
1.60
975.00
1,560.00
Maximilian Liegl
1.00
1,070.00
1,070.00
Ruan J. Meintjes
5.20
1,095.00
5,694.00
Trent Nachbar
0.20
1,265.00
253.00
Dan O'Connor
23.30
1,345.00
31,338.50
Carolin Paus
25.90
750.00
19,425.00
Yusuf Salloum
36.60
1,595.00
58,377.00
Anna Schwander
1.10
1,315.00
1,446.50
Scottie Shermetaro
17.50
1,575.00
27,562.50
Steve Toth
123.90
1,820.00
225,498.00
Donatus Wang
16.90
960.00
16,224.00
Nicholas Warther
1.00
1,665.00
1,665.00
Cristina Weidner
3.00
1,665.00
4,995.00
Spencer A. Winters, P.C.
5.90
1,685.00
9,941.50
Sara B. Zablotney, P.C.
0.30
2,445.00
733.50
Ali Mohammad Zarrabi
2.80
1,095.00
3,066.00
Ann-Kathrin Ziegler
3.20
1,070.00
3,424.00
TOTALS
411.30
$ 609,876.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 713 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
3
Description of Legal Services
Date
Name
Hours Description
07/10/24 Cristina Weidner
2.00 Attend conferences re sale structuring.
10/01/24 Luke Finn
8.80 Participate in update telephone conferences
with S. Toth, Company re sale stream issues
(1.0); analyze issues re 503(b)(9) estimates
and 510k transfer matters (.6); review and
analyze correspondence re Swiss R&D and
share purchase agreement imtmedical ag
liabilities (2.2); review, analyze collected
signature pages (.5); correspond with Dutch,
Swiss and German co-counsels re sale issues
(1.3); review, analyze Brazilian credits
agreement and payment agreement (.4); draft
bills of sales for various ex-US entities (.8);
draft checklist re same (1.0); review, analyze
draft funds flow (.3); review Trench Rossi
correspondence re sale issues (.5); correspond
with Zoll re sale issues (.2).
10/01/24 Ruan J. Meintjes
0.70 Review and analyze patient health
information matters related to Zoll asset
purchase agreement amendment (.5); draft
summary of analysis re same (.1); coordinate
with A. Del Rio re same (.1).
10/01/24 Dan O'Connor
0.20 Correspond with L. Finn re escrow matters.
10/01/24 Carolin Paus
0.80 Revise asset purchase and transfer agreement.
10/01/24 Scottie Shermetaro
1.20 Review and revise APA amendment re
transferred IP.
10/01/24 Steve Toth
6.00 Analyze correspondence with L. Finn re Zoll
issues (.2); participate in all hands telephone
conference re Zoll issues (.5); analyze
correspondence re closing and tax issues (.8);
participate in exec steerco telephone
conference with Company, AlixPartners, L.
Finn, K&E team (.5); analyze correspondence
and update intercompany agreement (2.6);
analyze correspondence re Brazil matters (.7);
analyze correspondence re transfer
agreements and related closing items (.7).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 714 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
4
Date
Name
Hours Description
10/01/24 Donatus Wang
1.90 Correspond with Company re notarization of
US PoAs and IP and inventory lists for MIM
and Vyaire GmbH (.6); correspond with
AlixPartners re asset lists for MIM and Vyaire
GmbH (.3); telephone conference with S.
Toth, K&E team re same (.2); review and
analyze schedules to ZOLL APA re
intellectual property, consider related
registration requirements (.4); coordinate
German notarization of MIM SPA (.2);
correspond with Cole Schotz re potential
German regulatory requirements (.2).
10/01/24 Nicholas Warther
0.70 Review and revise APA.
10/02/24 Hendrik Braun
1.00 Draft, revise PoAs and notarial statements for
German sale and transfer agreements.
10/02/24 Chris Ceresa
1.10 Correspond with Y. Salloum, Company,
advisors re open sale legal issues (.7); review
and analyze issues re same (.4).
10/02/24 Bernadette Coppola
0.20 Correspond with buyer, S. Toth, K&E team re
license agreement.
10/02/24 Anthony M. Del Rio
0.30 Review and comment on TSA and APA
amendment.
10/02/24 Luke Finn
4.60 Participate in telephone conferences with S.
Toth, K&E team re Zoll (1.0); prepare for
checklist call re same (.5); participate in
checklist telephone conference with various
parties re same (.5); analyze correspondence
re Swiss equity transfer with Baker McKenzie
Zurich and Van Doorne (.7); analyze, draft
first amendment to APA (.6); review, analyze
funds flow (.5); review, analyze
correspondence re bill of sales (.4); draft same
for various entities (.4).
10/02/24 Sabrina Lieberman
0.70 Telephone conference with H. Crawford,
Baker McKenzie, AlixPartners re Italian
entities with respect to sale (.5); correspond
with H. Crawford, K&E team re same (.2).
10/02/24 Maximilian Liegl
1.00 Review, analyze issues re corporate law
aspects of proposed asset and share sales.
10/02/24 Ruan J. Meintjes
0.40 Review and analyze transition services
agreement issues re PHI (.2); coordinate with
A. Del Rio re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 715 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
5
Date
Name
Hours Description
10/02/24 Carolin Paus
1.90 Review and analyze comments to APA (.7);
revise APA, TSA (.9); telephone conference
with S. Toth, K&E team re VAT clause in
APA (.3).
10/02/24 Yusuf Salloum
2.00 Analyze issues re sale closing.
10/02/24 Scottie Shermetaro
2.60 Review and revise first amendment to APA
(1.9); correspond with S. Toth, K&E team re
same (.7).
10/02/24 Steve Toth
14.30 Analyze correspondence re international
closing matters (.3); participate in all hands
telephone conference with various parties re
Zoll closing matters (1.2); analyze
intercompany agreement and closing checklist
(.3); revise intercompany agreement (.9);
revise notes re same (1.2); participate in
advisor update telephone conference with
Cole Schotz, L. Finn, K&E team and
AlixPartners (.7); discuss intercompany
transactions with N. Warther (.2); review,
revise intercompany agreement (1.7); review,
analyze issues re closing timing and business
(.3); discuss closing checklist with Cooley, L.
Finn, K&E team (.9); analyze correspondence
re intercompany issues and Brazil (.3);
review, analyze APA amendment (2.1);
review, revise same (2.2); review, revise
agency agreement (2.0).
10/02/24 Donatus Wang
1.00 Correspond with Company re equipment lists
for and contracts of MIM and Vyaire GmbH
for asset transfer agreement (.3); review
overview of accounts receivable of Vyaire
GmbH from AlixPartners (.2); correspond
with AlixPartners re same (.2); correspond
with German management counsel re status of
sale processes, Zoll closing (.3).
10/03/24 Bernadette Coppola
0.60 Conference with A. Del Rio, K&E team re
healthcare regulatory matters (.3); correspond
with Company, A. Del Rio, K&E team re
additional asset transfers and transition
services (.3).
10/03/24 Anthony M. Del Rio
0.80 Review and comment on TSA and APA open
items.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 716 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
6
Date
Name
Hours Description
10/03/24 Luke Finn
7.10 Participate in telephone conference with S.
Toth, K&E team, various parties re sale
issues, updates (1.0); review,
analyze correspondence re Dutch APA,
international bill of sales, signature matrices,
Germany asset purchase and transfer
agreement (2.3); review, analyze Intermed
and other Brazilian matters with Trench Rossi
(.7); correspond with Company re
directorships, charters and signing authorities
and signature collection (1.8); review, analyze
K&N letter agreement matters (.4); review,
compile materials re Vyaire GmbH and MIM
IP assignments and Swiss equity transfers
(.9).
10/03/24 Kate Hardey
2.10 Telephone conference with A. Del Rio and R.
Meintjes re TSA PHI matters (.6); review and
analyze undisclosed agent agreement (.5);
comment on same (.5); draft correspondence
re same (.4); correspond with Company re
same (.1).
10/03/24 Ruan J. Meintjes
0.80 Review and analyze regulatory considerations
re Azure environment transfer (.5); coordinate
with A. Del Rio re same (.3).
10/03/24 Anna Schwander
0.60 Review, analyze issues re Italian FDI process.
10/03/24 Anna Schwander
0.20 Review, analyze correspondence re German
FDI process.
10/03/24 Scottie Shermetaro
0.20 Correspond with S. Toth, K&E team re
revisions to IP schedules.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 717 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
7
Date
Name
Hours Description
10/03/24 Steve Toth
11.10 Analyze and revise agency agreement (3.8);
revise intercompany agreement (.2);
participate in all hands telephone conference
with L. Finn, K&E team re Zoll closing
matters (1.0); discuss issues with Company,
AlixPartners, PJT, L. Finn, K&E team (1.5);
review, analyze related correspondence (.2);
correspond re Italy matters with H. Crawford
(.5); correspond with Y. Salloum, K&E team
re same (.7); discuss funding matters with
AlixPartners and Y. Salloum (.3); participate
in telephone conference with Company, Y.
Salloum, K&E team, AlixPartners and PJT re
Zoll issues (.8); review, analyze
correspondence re same (.9); revise
intercompany agreement (.8); review, revise
agency agreement (.4).
10/03/24 Donatus Wang
0.50 Participate in update telephone conference
with German management counsel re sales
process (.2); correspond with Company on
notarization of PoAs for German share
transfers (.3).
10/03/24 Spencer A. Winters, P.C.
0.80 Review and analyze issues re Zoll closing.
10/03/24 Ann-Kathrin Ziegler
0.20 Telephone conference with German
management counsel re sales processes.
10/04/24 Chris Ceresa
0.30 Correspond with S. Toth, K&E team re sale
legal items.
10/04/24 Bernadette Coppola
0.30 Correspond with L. Finn, K&E team re bill of
sale (.1); correspond with A. Del Rio and
team re revisions to asset purchase agreement
amendment (.1); correspond with buyer, S.
Toth, K&E team re revisions to license
agreement (.1).
10/04/24 Anthony M. Del Rio
0.70 Review, analyze issues re TSA, APA (.3);
comment on same (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 718 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
8
Date
Name
Hours Description
10/04/24 Luke Finn
6.60 Participate in telephone conference with
various parties re sale updates (1.0); prepare
for check list call (.3); participate in checklist
telephone conference (.4); participate in
"Vyaire Sync" call (.7); coordinate with
AlixPartners, S. Toth, K&E team re Vyaire
GmbH and MIM GmbH matters (1.4);
review, analyze international bill of sales (.5);
telephone conference with Company re same
(.3); analyze AlixPartners correspondence re
inventory and AR schedules (1.6); review,
revise checklist (.4).
10/04/24 Ruan J. Meintjes
0.50 Review and analyze Zoll asset purchase
agreement amendment (.3); coordinate with
A. Del Rio re same (.2).
10/04/24 Trent Nachbar
0.20 Review, analyze bills of sale and assignments.
10/04/24 Yusuf Salloum
3.50 Review, analyze issues re closing sale
transaction.
10/04/24 Scottie Shermetaro
0.40 Review and revise IP disclosure schedules.
10/04/24 Steve Toth
3.40 Participate in all hands telephone conference
with L. Finn, K&E team re Zoll issues (1.0);
participate in exec steerco telephone
conference with Company and AlixPartners
(.3); analyze revised K&E agreement (.1);
analyze closing deliverables and related
correspondence (.6); participate in all hands
telephone conference with L. Finn, K&E team
re closing issues update (.8); discuss
intercompany issues with Company (.1); draft
correspondence re same (.1); correspond with
Company, L. Finn, K&E team and
AlixPartners re funding, related issues (.4).
10/04/24 Donatus Wang
6.10 Revise closing workstreams summary (.1);
correspond with Company re equipment,
inventory and contracts of MIM and Vyaire
GmbH (.3); prepare overview of assets to be
transferred to ZOLL (.8); correspond with S.
Toth, K&E team re same (.1); review, analyze
Zoll comments on draft asset transfer
agreement (.8); revise same (2.0); prepare
schedules on receivables, inventory and
equipment (1.5); correspond with S. Toth,
K&E team and AlixPartners re same (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 719 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
9
Date
Name
Hours Description
10/05/24 Bernadette Coppola
0.60 Telephone conference with B. Fernandez re
patent license (.4); correspond with Company,
S. Toth, K&E team re same (.2).
10/05/24 Hannah Crawford
0.20 Correspond with S. Toth re latest status re
sale transaction.
10/05/24 Luke Finn
2.40 Participate in Company call re sale updates
(.5); review, analyze respiratory knowledge
portal and patent transfers (.6); review,
analyze issues re VM Holdings BV
contingent payment  (.1); review, analyze
correspondence with D. Wang, Van Doorne
re German and Dutch asset purchase
agreements (1.2).
10/05/24 Ruan J. Meintjes
0.30 Review and analyze Zoll asset purchase
agreement amendment.
10/05/24 Yusuf Salloum
1.00 Review, analyze issues re sale closing.
10/05/24 Scottie Shermetaro
0.80 Review and revise APA amendment.
10/05/24 Steve Toth
4.10 Analyze, revise APA amendment and update
attorney notes (1.2); participate in telephone
conference with Company, AlixPartners, S.
Winters and K&E team re Zoll closing
matters (1.2); review, analyze correspondence
re closing matters and APA issues (.7);
correspond with S. Winters, K&E team re
same (.7); participate in all hands telephone
conference with L. Finn, K&E team re Zoll
closing matters (.3).
10/05/24 Spencer A. Winters, P.C.
1.20 Participate in telephone conferences with
AlixPartners, Company, S. Toth, K&E team
re Zoll closing.
10/05/24 Sara B. Zablotney, P.C.
0.30 Review and comment on APA language.
10/06/24 Anthony M. Del Rio
0.30 Review, analyze issues re TSA and
amendment.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 720 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
10
Date
Name
Hours Description
10/06/24 Luke Finn
6.80 Participate in all-hands telephone conference
re sales workstream (.3); review, analyze
issues re intercompany debt novations (.5);
review, analyze Vyaire GmbH asset purchase
agreement (.8); review, analyze
correspondence re same (.8); review, analyze
undisclosed agency agreement (.7); distribute
revised drafts of German and Dutch APAs to
Cooley (.4); review, analyze Cooley
comments to Vyaire B.V. asset purchase
agreement (.6); review, analyze
correspondence with Dutch counsel and
Company re intercompany liabilities (.3);
review, analyze nine bills of sale drafts
received from Cooley (.9); review, analyze
amendment to APA documents (.4) review,
analyze correspondence re same (.4); draft
Brazilian bill of sale documents (.6);
correspond with Trench Rossi re same (.1)
10/06/24 Sabrina Lieberman
0.30 Research precedent re APA amendments.
10/06/24 Carolin Paus
1.20 Review, analyze APA transfer agreement (.5);
draft comments re same (.4); revise
workstream summary (.3).
10/06/24 Yusuf Salloum
3.00 Analyze issues re sale closing.
10/06/24 Steve Toth
3.00 Discuss sale closing issues with Company,
AlixPartners, Y. Salloum and K&E team
(1.0); review, analyze correspondence re same
(.3); correspond with Y. Salloum, K&E team
re creditor updates (.7); review, analyze APA
amendment (.6); review, analyze
correspondence re IP and APA matters (.4).
10/06/24 Donatus Wang
1.00 Review, analyze ZOLL comments on asset
purchase and transfer agreement (.7); revise
same (.3).
10/06/24 Spencer A. Winters, P.C.
0.30 Review and analyze Zoll closing issues.
10/07/24 Bernadette Coppola
0.40 Correspond with Company re patent license
(.2); correspond with buyer's counsel re same
(.1); correspond with S. Toth and K&E team
re amendment to asset purchase agreement
(.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 721 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
11
Date
Name
Hours Description
10/07/24 Luke Finn
9.30 Review Cooley draft of agency agreement
(.4); review, analyze correspondence re
Brazilian entity tax and restructuring (.4);
review, analyze correspondence with
Singapore co-counsel (.2); review, analyze
sale documents re German entities (.8);
correspond with Swiss co-counsel re closing
logistics (.4); review, revise CPAP patent
issues (.3); review, analyze Chinese
enforceability issues (.5); review, analyze
letter agreement (.6); draft German entity
asset purchase agreement documents (.8);
distribute German entity asset purchase
agreement documents (.2); coordinate,
manage checklist call (.4); review and revise
asset purchase agreements for Vyaire Medical
Holdings BV and Vyaire BV entities (1.1);
compile TSA schedules (.9); correspond with
Company, various parties re sale closing
issues (1.3); participate in telephone
conference with various parties re same (1.0).
10/07/24 Carolin Paus
3.90 Review, analyze comments to APAs (1.0);
correspond with C. Weidner, K&E team re
same (.7); analyze, review Zoll APA re
allocation and limitation of liability (1.3);
draft execution version of the asset purchase
and transfer agreement (.4); correspond with
German notary re KYC documents
requirements (.5).
10/07/24 Scottie Shermetaro
0.50 Draft patent schedule for acquired assets.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 722 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
12
Date
Name
Hours Description
10/07/24 Steve Toth
9.90 Analyze correspondence re closing and
international updates (.2); participate in all
hands telephone conference with various
parties re Zoll closing (.8); telephone
conference with AlixPartners, Y. Salloum,
K&E team re sale updates (1.1); participate in
exec steerco telephone conference with
Company, AlixPartners, Y. Salloum, K&E
team (.5); review, analyze amendment to
APA (.8); correspond with Company, PJT, L.
Finn, K&E team and AlixPartners re business
updates (.4); review, revise APA amendment
(.6); participate in special committee
telephone conference with Company, PJT,
Alix, S. Winters, K&E team (.4); analyze and
revise agency agreement (1.6); correspond
with UCC advisors, AlixPartners, Y. Salloum,
K&E team and Cole Schotz re business
updates (.8); review, revise APA amendment
and agency agreement (.3); correspond with
Zoll, Cooley, AlixPartners, Company, Y.
Salloum, K&E team re same (.9); revise
agency agreement (.4); review, analyze Brazil
agreements (.2); review, analyze
correspondence re foreign agreements (.9).
10/07/24 Donatus Wang
1.00 Prepare execution versions of asset sale
approval shareholder resolutions (.4); instruct
C. Paus on preparation of execution version
of Asset Purchase and Transfer Agreement
(.2); correspond with Company and German
notary on notary KYC requests (.4).
10/07/24 Spencer A. Winters, P.C.
1.30 Review and analyze issues re Zoll closing
(.8); prepare for special committee meeting
(.2); participate in same (.3).
10/08/24 Bernadette Coppola
0.30 Correspond with buyer's counsel,
AlixPartners, S. Toth, K&E team re transition
services agreement schedules (.2); correspond
with buyer's counsel, S. Toth and K&E team
re amendment to asset purchase agreement
(.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 723 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
13
Date
Name
Hours Description
10/08/24 Michael Ehret
1.70 Correspond with D. Wang re asset transfer
agreement for MIM IP (.3); correspond with
Company re same (.2); analyze draft overview
re same (.7); correspond with L. Finn, K&E
team re transfer agreement re IP (.5).
10/08/24 Luke Finn
8.10 Participate in all hands telephone conference
re Zoll closing (.8); prepare for same (.2);
prepare checklist re foreign entities call (.6);
participate in same (.4); telephone conference
with S. Toth, K&E team, Company re Italy
and Brazil entities (.5); review, analyze MIM
assets and liabilities (.3) review, analyze
correspondence re Chinese entity (.4); review,
analyze correspondence re Brazilian entity
(.6); revise German IP assignment draft (.4);
prepare schedules of inventory and AR (.8);
review, analyze updated agency agreement
draft (.4); revise signature matrix summary
(.8); research RKP patent (1.2); review,
analyze intercompany settlement agreement
(.7).
10/08/24 Dan O'Connor
1.30 Correspond with Company re IP matters (.3);
correspond with L. Finn re closing matters
(.2); telephone conference with S. Toth, K&E
team, Company, Zoll re Zoll closing (.8).
10/08/24 Yusuf Salloum
3.20 Analyze issues re closing sale transaction.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 724 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
14
Date
Name
Hours Description
10/08/24 Steve Toth
10.50 Participate in telephone conference with L.
Finn, K&E team, Company, Zoll re Zoll
closing (.8);analyze correspondence re same
(.3); participate in exec steerco telephone
conference with Company and AlixPartners
(.4); telephone conference with Cole Schotz
and AlixPartners re sale process updates (.9);
analyze correspondence re intercompany
issues (.1); telephone conference with
Company, AlixPartners, L. Finn, K&E team
re Brazil and Italy matters (.5); review,
analyze issues re same (.3); review, analyze
agency agreement (.3); analyze Brazil
transaction documents (2.1); correspond with
L. Finn, K&E team and Cooley re checklist
(.2); correspond with Company re
intercompany issues (.5); review, revise
intercompany and Brazil documents (1.3);
review, analyze APA amendment (.2);
correspond with AlixPartners and Company
re A/R and funds flow (.7); review, analyze
Brazil sale agreement (.3); telephone
conference with Company re inventory in
transit issues (1.0); review, analyze issues re
same (.3); correspond with Y. Salloum re sale
(.3).
10/08/24 Donatus Wang
1.00 Analyze issues re German legal aspects re
asset purchase and transfer agreement (.6);
telephone conference with C. Paus re same
(.4).
10/09/24 Bernadette Coppola
2.40 Review, analyze issues re patents (.5);
conference with L. Finn re same (1.4); draft
revisions to amendment to asset purchase
agreement (.3); correspond with S. Toth and
K&E team re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 725 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
15
Date
Name
Hours Description
10/09/24 Luke Finn
11.30 Telephone conference with Company, S.
Toth, K&E team re Zoll closing (.8); prepare
for same (.2); telephone conference with S.
Toth, K&E team re same (.5); telephone
conference with UCC advisors, Zoll, S. Toth,
K&E team re same (.7); prepare for same (.6);
review, analyze Zoll drafts of German and
Dutch purchase agreements (1.1); review and
revise Swiss checklist (.3); coordinate signing
processes in Switzerland (.4); review, analyze
correspondence re MIM IP assignment
agreement matters (.5); review, analyze
Chinese VAT and consideration payment
matters (.6); research RKP license (.5);
telephone conference with B. Coppola re
same (1.4); review, analyze issues re Chinese
distribution agreement planning (.4); revise
intercompany settlement agreement (.8);
review, analyze Vyaire BV’s AR and
Inventory schedules (.5); review, analyze
Non-U.S. non-tax assumed payables requests
(.3); revise attachment to schedule 3.11(A)
(.7); revise international bills of sale drafts
(.6); correspond with Feijo re same (.4).
10/09/24 Luke Finn
2.20 Review, analyze updated funds flow from
AlixPartners (.3); review, analyze Brazil and
Intermed restructuring plans (.1); revise
Brazilian bills of sales (.2); revise schedules
re intercompany settlement agreement (.5);
correspond with Company re officers
certificate, bringdown communications (.4);
correspond with various international parties
re sale closing plans (.4); correspond with
Company re updated APAs (.3).
10/09/24 Carolin Paus
3.30 Correspond with C. Weidner re German asset
purchase and transfer agreement (1.2); review
and analyze counterparty comments re
German asset purchase and transfer
agreement (.9); revise German asset purchase
and transfer agreement (1.2).
10/09/24 Yusuf Salloum
3.80 Analyze issues re closing sale transaction.
10/09/24 Steve Toth
1.30 Analyze correspondence re APA amendment,
tax matters and intercompany agreement.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 726 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
16
Date
Name
Hours Description
10/09/24 Steve Toth
8.40 Participate in telephone conference with
various parties re Zoll closing (.8); analyze
correspondence re same (.2); correspond with
AlixPartners, Company, Y. Salloum, K&E
team re sale closing status, next steps (.2);
telephone conference with L. Finn, K&E
team, AlixPartners, Zoll and UCC advisors re
sale closing updates (.7); analyze
intercompany agreement and related
correspondence (.6); analyze correspondence
re Brazil, Italy and China entities (.5); analyze
correspondence re closing and diligence (.3);
review, analyze correspondence re APA
amendment (.4); review, analyze agency
agreements and related correspondence (1.3);
correspond with L. Finn re closing checklist
(.7); review, analyze correspondence re same
(.2); participate in all hands telephone
conference re Zoll closing (1.4); draft
language for TSA schedule (.3); revise non-
US agency agreement (.3); revise US agency
agreement (.4); analyze correspondence re
stipulation (.1).
10/09/24 Donatus Wang
2.10 Review, analyze comments on draft asset
purchase and transfer agreement (.5); revise
same (1.0); analyze, coordinate notarization
of PoAs to German SPAs and secretary
certificates (.6).
10/09/24 Cristina Weidner
1.00 Correspond with D. Wang, K&E team re
APA comments.
10/09/24 Spencer A. Winters, P.C.
0.50 Review, analyze issues re committee motion
re sale and closing status.
10/10/24 Hendrik Braun
0.50 Correspond with S. Toth, K&E team re
German APA issues.
10/10/24 Bernadette Coppola
0.40 Correspond with L. Finn and K&E team re
intellectual property schedules (.2);
conference with S. Toth and S. Shermetaro re
same (.2).
10/10/24 Luke Finn
1.80 Review, analyze schedule 3.11 (.4);
coordinate Company signatures (.8); review,
revise Chinese distribution agreement (.2);
compile Swiss documents (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 727 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
17
Date
Name
Hours Description
10/10/24 Luke Finn
11.90 Telephone conference with S. Toth, K&E
team, AlixPartners, Company, Zoll re Zoll
sale closing (.8); prepare for same (.2);
telephone conference with Cooley re Zoll
checklist (.6); prepare for same (.4);
participate in telephone conferences with
various parties closing requirements (1.6);
review, analyze Swiss contribution
agreements (.4); correspond with Company re
Swiss directors logistics, issues (.3); draft
escrow release letters (.5); review
intercompany settlement schedule updates
(.5); review, analyze updated funds flow and
Vyaire BV AR schedule (.5); review, analyze
agreement executions and other closing
packet preparation matters with Company and
opposing counsel (2.1); analyze
correspondence with Brazilian consultant (.3);
draft, finalize international bills of sale (.8);
draft, finalize international asset purchase
agreements and schedules (1.4); finalize
arrangements for Zurich in person signing
(.5); review, analyze purchaser's signatures
(.6); revise IP schedules to APA amendment
(.4).
10/10/24 Justin M. Garfinkle
0.30 Review, analyze Zoll IP schedules.
10/10/24 Palmer Gunderson
1.00 Telephone conference with N. Warther, K&E
team re settlement agreement (.4); draft
revised language for settlement agreement
(.3); correspond with S. Toth, K&E team re
settlement agreement and sale closing
considerations (.3).
10/10/24 Dan O'Connor
1.30 Prepare escrow release letter (.3); correspond
with Company re escrow release letter (.2);
telephone conferences with Zoll, Company,
L. Finn, K&E team re Zoll closing (.8).
10/10/24 Carolin Paus
0.50 Review and analyze Zoll comments re
German asset purchase and transfer
agreement.
10/10/24 Yusuf Salloum
4.50 Review, analyze issues re closing of sale
transactions.
10/10/24 Scottie Shermetaro
1.50 Review and revise APA amendment and
schedules re assigned IP.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 728 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
18
Date
Name
Hours Description
10/10/24 Steve Toth
3.20 Telephone conference with Cooley re
503(b)(9) considerations (.4); correspond with
Cooley re same (.3); analyze correspondence
re closing matters (1.4); correspond with Zoll,
Company, L. Finn, K&E team re same (.8);
telephone conference with L. Finn re
signature releases (.3).
10/10/24 Steve Toth
5.40 Analyze correspondence re international
updates (.4); telephone conference with
Company, Zoll, L. Finn, K&E team re Zoll
closing (.6); review, analyze international
documents and intercompany agreement (.8);
participate in exec steerco telephone
conference with Company and AlixPartners
(.3); review, analyze APA amendment (.2);
telephone conference with Cole Schotz, Alix
Partners, L. Finn, K&E team re same (.2);
review, analyze closing checklist (.3);
telephone conference with Zoll, L. Finn, K&E
team, Company re Zoll closing (.4);
participate in special committee telephone
conference with Company, AlixPartners, PJT,
Y. Salloum, K&E team (.2); telephone
conference with Zoll, Cooley, AlixPartners,
Company re funds flow (.9); review, analyze
correspondence re intercompany agreement
(.3); correspond with Company re funds flow
issues (.1); correspond with Cooley, L. Finn,
K&E team re closing checklist (.4); review,
analyze correspondence re closing matters
(.3).
10/10/24 Steve Toth
4.00 Participate in telephone conference with
Company and AlixPartners re Brazil matters
(.2); participate in all hands telephone
conference re Zoll closing (.4); revise Brazil
sale document (.3); revise IP schedules (.3);
review, analyze correspondence re closing
matters (2.8).
10/10/24 Donatus Wang
0.20 Correspond with S. Toth, K&E team re asset
purchase and transfer agreement.
10/11/24 Michael Ehret
0.40 Correspond with Company re closing vents.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 729 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
19
Date
Name
Hours Description
10/11/24 Luke Finn
6.50 Review, analyze, coordinate signature
collection (.3); review, coordinate Zurich
signing with Swiss co-counsel (.9); review,
analyze issues re closing process,
communications logistics (1.2); review,
analyze issues re grandfather receivables (.4);
review, analyze, distribute wire instructions
(.3); review, analyze, compile final
documentation re same (.7); review, analyze
immediate post-closing matters (1.6); review,
analyze issues re escrow release matters (.4);
review, analyze Vyaire Medical Holdings BV
authorization issues with opposing counsel
(.2); correspond with Company re post-
closing matters (.5).
10/11/24 Carolin Paus
1.70 Review, revise workstream summary re Zoll
closing (.7); correspond with S. Toth, K&E
team re post-closing workstream issues (.2);
correspond with S. Toth, K&E team re
Trudell closing requirements, documents (.6);
correspond with Company re executed
shareholder resolutions (.2).
10/11/24 Yusuf Salloum
1.00 Analyze issues re closing of sale transaction.
10/11/24 Steve Toth
6.00 Analyze issues re Swiss matters, sale closing
(3.9); analyze correspondence re same (.8);
correspond with Y. Salloum, K&E team re
same (1.1); correspond with Cole Schotz,
AlixPartners, Y. Salloum, K&E team re
corporate matters (.2).
10/11/24 Donatus Wang
0.50 Correspond with Company re closing of
transaction and post-closing matters.
10/12/24 Luke Finn
0.60 Correspond with Singapore, Chinese and
Brazilian counsel (.4); correspond with
opposing counsel re filing (.2).
10/14/24 Luke Finn
1.90 Prepare for telephone conference re RDx (.3);
telephone conference with Company, S. Toth,
K&E team re same (.4); correspond with
Company re post-closing matters re Zoll (.3);
correspond with international local counsels
re post-closing matters re Zoll deal (.4);
correspond with opposing counsel re closing
volume and exchange procedures (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 730 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
20
Date
Name
Hours Description
10/14/24 Dan O'Connor
2.50 Telephone conference with L. Finn re foreign
subsidiary transfers (.4); correspond with L.
Finn re same (.1); review and revise closing
checklist (.5); draft foreign subsidiary transfer
checklist (1.0); correspond with J. Mudhar,
K&E team re ex-US asset and equity transfer
process (.3); correspond with Company re
FDI filings (.2).
10/14/24 Steve Toth
1.80 Participate in executive steerco telephone
conference with Company and AlixPartners
(.4); participate in advisor update telephone
conference with Cole Schotz, AlixPartners, Y.
Salloum, K&E team (.5); analyze
correspondence re closing matters (.9).
10/14/24 Donatus Wang
0.20 Review, analyze apostilled PoA for Breathe
US and secretary certificate for PoA for VMI.
10/15/24 Luke Finn
2.20 Correspond with Company re Brazil sales and
intercompany agreement (.4); draft and
distribute escrow release letter (.5); review
and distribute Swiss agreement (.3); analyze,
coordinate closing set preparation with
opposing counsel (.7); analyze issues re
closing set with Company (.3).
10/15/24 Dan O'Connor
1.10 Correspond with KWM team re Australian
subsidiary equity transfer matters (.4);
correspond with LeeKo team re South Korean
subsidiary equity transfer matters (.4);
correspond with AlixPartners and Company
re closing matters (.3).
10/15/24 Carolin Paus
0.80 Draft correspondence to D. Wang and
Company re required documents re Trudell
closing, VMI registration (.5); revise
workstream summary (.3).
10/15/24 Yusuf Salloum
1.00 Analyze issues re sale transaction.
10/15/24 Steve Toth
1.90 Participate in advisor update telephone
conference with PJT, AlixPartners, Y.
Salloum, K&E team (.1); participate in
telephone conference re tax insurance with
Company, PJT, AlixPartners, Y. Salloum,
K&E team (.4); correspond with Company re
same (.2); analyze correspondence re closing
matters (.3); analyze APA (.9).
10/15/24 Donatus Wang
0.10 Correspond with C. Paus re Trudell closing.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 731 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
21
Date
Name
Hours Description
10/15/24 Spencer A. Winters, P.C.
1.10 Review and analyze issues re RDx closing
(.6); telephone conference with Company, S.
Toth, K&E team re same (.4); prepare for
same (.1).
10/16/24 Luke Finn
2.60 Analyze, coordinate escrow release,
distribution (.4); analyze issues re German
and Italian entities (.2); correspond with
Company re closing volume (.4); analyze
compiled closing volume documents (.7);
review, analyze correspondence re
intercompany settlement agree schedules (.5);
analyze, distribute executed intercompany
documents (.3); coordinate RDx closing
logistics call (.1).
10/16/24 Dan O'Connor
0.40 Correspond with Company re intercompany
settlement matters.
10/16/24 Carolin Paus
0.70 Telephone conference with M. Ehret re
purchase price of MIM, corresponding tax
implications.
10/16/24 Carolin Paus
1.20 Review, analyze KYC documents (.6);
correspond and coordinate with German
notary re same (.2); correspond with S. Toth,
K&E team re Vyaire Medical GmbH (.4).
10/16/24 Yusuf Salloum
2.00 Analyze issues re sale closing.
10/16/24 Steve Toth
5.30 Analyze APA (.4); draft comments re same
(.2); correspond with Company, AlixPartners
re same (.9); draft further comments re same
(3.4); analyze correspondence re same (.3);
correspond with Company re next steps re
same (.1).
10/16/24 Donatus Wang
1.10 Telephone conference with S. Toth, K&E
team re novation (1.0); analyze notarized and
apostilled officer's certificate for PoA of
Breathe US for sale of Vyaire Medical GmbH
(.1).
10/16/24 Ann-Kathrin Ziegler
1.00 Telephone conference with M. Ehret, K&E
team re sale mechanics for VM GmbH (.8);
prepare for same (.2).
10/17/24 Hendrik Braun
1.50 Review, analyze German share purchase and
transfer agreements.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 732 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
22
Date
Name
Hours Description
10/17/24 Michael Ehret
1.40 Correspond with Company re fair market
value determination, MIM disposal, Trudell
transaction (.4); telephone conference with S.
Winters, K&E team, Company re same (1.0).
10/17/24 Luke Finn
1.10 Analyze sale updates (.3); telephone
conference with AlixPartners, D. O’Connor,
K&E team, Company re RDx closing
logistics (.5); prepare for same (.1); analyze
escrow issues (.2).
10/17/24 Dan O'Connor
1.00 Telephone conference with AlixPartners and
Company re closing matters (.5); review and
revise closing checklist (.5).
10/17/24 Yusuf Salloum
2.00 Analyze issues re sale closing, insurance.
10/17/24 Steve Toth
1.80 Correspond re insurance structure (.6);
correspond re TSA matters with AlixPartners,
Y. Salloum, K&E team (.3); prepare related
correspondence (.1); correspond with
Company re APA (.8).
10/17/24 Donatus Wang
0.20 Correspond with Trudell counsel re sale.
10/18/24 Michael Ehret
0.20 Analyze draft SPA, transfer agreement.
10/18/24 Luke Finn
1.20 Correspond with closing counsel re closing
volume matters and intercompany settlement
documents (.8); analyze counsel
correspondence re Brazil wire payment (.2);
analyze counsel correspondence re Swiss
document handover (.2).
10/18/24 Dan O'Connor
0.50 Correspond with Company, S. Toth and Y.
Salloum re engagement of Italy counsel.
10/18/24 Yusuf Salloum
1.50 Analyze issues re sale transaction.
10/18/24 Steve Toth
1.80 Correspond with UCC advisors, AlixPartners,
Cole Schotz, Y. Salloum, K&E team re
transaction updates (.8); correspond with PJT,
Company, Y. Salloum, K&E team re sale
insurance update (1.0).
10/19/24 Luke Finn
1.00 Review, analyze draft of closing volume.
10/19/24 Dan O'Connor
0.40 Telephone conference with Company, M. Y.
Salloum, K&E team re sale tax matters.
10/19/24 Steve Toth
0.40 Correspond with PJT, Company, Y. Salloum,
K&E team re sale insurance update.
10/19/24 Spencer A. Winters, P.C.
0.40 Telephone conference with Company and
advisors re Trudell status update (.3); prepare
for same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 733 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
23
Date
Name
Hours Description
10/21/24 Bernadette Coppola
0.10 Correspond with Company, S. Toth, K&E
team re revisions to purchase agreement.
10/21/24 Luke Finn
2.00 Analyze correspondence with Swiss co-
counsel re close-out and handover (.4); draft
memorandum for Company re VMI
agreement, import and export requirements
(.7); correspond with Cooley re closing
volume matters and intercompany settlement
schedules (.5); analyze final closing volume
(.4).
10/21/24 Justin M. Garfinkle
1.80 Draft comments to Blender purchase
agreement.
10/21/24 Kate Hardey
1.50 Review and revise Blender product purchase
agreement (1.0); conference with R. Meintjes
re same (.5).
10/21/24 Ruan J. Meintjes
1.00 Review and revise Perma Pure asset purchase
agreement (.9); coordinate with K. Hardey re
the same (.1).
10/21/24 Carolin Paus
4.50 Review and analyze feedback from H. Braun
on share purchase agreement and share
transfer agreement (1.4); revise same (1.0);
telephone conference with H. Braun and A.
Ziegler re agenda for call with ASD (.5);
telephone conference with ASD re transfer of
Vyaire Medical GmbH (.5); correspond with
H. Braun, K&E team re draft transfer
agreement (.4); correspond with D. O'Connor,
K&E team re draft share transfer agreement
(.7).
10/21/24 Yusuf Salloum
1.50 Analyze issues re sale transactions closing.
10/21/24 Anna Schwander
0.30 Correspond with H. Braun, K&E team re FDI
Germany clearance.
10/21/24 Steve Toth
0.40 Analyze tax closing matters (.1); correspond
with Y. Salloum, K&E team re same (.3).
10/21/24 Ann-Kathrin Ziegler
1.00 Telephone conference with ASD re German
share transfer agreement (.2); telephone
conference with C. Paus and H. Braun re
same (.1); prepare for same (.2); review and
revise draft correspondence from C. Paus re
follow up to K&E team re Trudell sale
German law transfer (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 734 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
24
Date
Name
Hours Description
10/22/24 Luke Finn
1.40 Analyze issues re Italian entity structure and
tender notifications (.5); analyze co-counsel
contact details for RDx deal (.4); correspond
with Company re Intercompany settlement
agreement and step plan (.5).
10/22/24 Justin M. Garfinkle
0.40 Analyze issues re Blender purchase
agreement.
10/22/24 Kate Hardey
1.20 Review and revise Blender product purchase
agreement.
10/22/24 Carolin Paus
0.70 Correspond with A. Prestel re share transfer
agreement (.3); analyze APA re costs
provision, German notary fees (.4).
10/22/24 Yusuf Salloum
1.60 Analyze issues re sale closing.
10/22/24 Scottie Shermetaro
2.30 Review and revise Blender purchase
agreement.
10/22/24 Steve Toth
4.50 Analyze correspondence with Company and
AlixPartners re TSAs and closing (.4);
correspond with Company and AlixPartners
re cars and insurance for sale (.5); correspond
re tax insurance and related sale matters with
Y. Salloum, K&E team and Company (.5);
correspond re sale insurance update with Y.
Salloum (.3); correspond re TSA matters with
Y. Salloum and AlixPartners (.8); participate
in advisor update telephone conference with
Y. Salloum, K&E team, Cole Schotz and
AlixPartners (.4); analyze issues list re APA
(.4); analyze blenders APA (1.2).
10/23/24 Luke Finn
0.70 Analyze, revise schedule of conveyed IP
assets (.3); correspond with Swiss and Dutch
counsel re document hand over (.2); review,
analyze Brazil wire payments correspondence
(.2).
10/23/24 Dan O'Connor
2.40 Review and revise closing checklist (.6);
telephone conference with Company re same
(.5); review and revise Italy, Australia and
Germany equity transfer documents (1.3).
10/23/24 Carolin Paus
2.30 Review and analyze comments re draft SPA
re MIM (.5); revise SPA to reflect feedback
(.4); revise workstream summary (.3); review
and analyze correspondence re tax insurance
(.6); telephone conference with M. Ehret and
H. Braun re tax insurance (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 735 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
25
Date
Name
Hours Description
10/23/24 Yusuf Salloum
1.50 Prepare for sale closing.
10/23/24 Steve Toth
4.80 Correspond with Company re transaction
issues list (1.0); correspond with Y. Salloum
and K&E team re tax insurance sale matters
(.4); analyze closing matters (.3); participate
in advisors update telephone conference with
Y. Salloum, K&E team, Cole Schotz and
AlixPartners (.9); correspond with Company
and counterparty advisors re issues list (1.6);
revise GmbH resolutions draft (.6).
10/23/24 Nicholas Warther
0.30 Correspond with P. Gunderson, K&E team re
documents for wind-down.
10/23/24 Ann-Kathrin Ziegler
1.00 Telephone conference with C. Weidner, K&E
team re RDX sale insurance and request for
shareholder resolution (.8); prepare for same
(.2).
10/24/24 Bernadette Coppola
0.10 Correspond with S. Shermetaro re purchase
agreement.
10/24/24 Luke Finn
0.70 Analyze, revise disclosure schedule 1.2(p)
(.2); correspond with Swiss co-counsel re
document hand over (.2); distribute final
documents to co-counsels (.3).
10/24/24 Justin M. Garfinkle
1.70 Analyze IP schedules (.2); draft updates to
Blender purchase agreement (1.5).
10/24/24 Dan O'Connor
1.20 Draft summary of ex-US equity transfers
(1.0); correspond with Company re same (.2).
10/24/24 Carolin Paus
0.70 Review and revise shareholders resolution for
VMG.
10/24/24 Carolin Paus
0.50 Correspond with D. O'Connor re required
documents for share transfer (.3); correspond
with Company re required apostilled PoAs
(.2).
10/24/24 Yusuf Salloum
1.40 Prepare for sale closing.
10/24/24 Scottie Shermetaro
1.50 Review and revise asset purchase agreement.
10/24/24 Steve Toth
0.90 Correspond with Company, Y. Salloum and
K&E team re tax update (.1); participate in
advisor update telephone conference with Y.
Salloum and K&E team, Cole Schotz and
AlixPartners (.5); analyze correspondence
from AlixPartners, Company re APAs and
closings (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 736 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
26
Date
Name
Hours Description
10/25/24 Luke Finn
1.20 Analyze correspondence from Brazilian
counsel re Brazilian IP issues (.4); analyze
correspondence from Brazilian counsel re
wire payment (.2); analyze transitional
services agreement (.2); review, analyze
correspondence from Chinese counsel re
Chinese sales (.1); analyze correspondence
with Company and Cooley re Vents ICO
Settlements (.3).
10/25/24 Yusuf Salloum
0.70 Analyze issues re sale closing.
10/25/24 Steve Toth
0.40 Correspond with D. O’Connor, K&E team,
Company re closing and tax structure matters.
10/26/24 Bernadette Coppola
0.20 Draft revisions to asset purchase agreement.
10/26/24 Justin M. Garfinkle
0.50 Analyze Blender asset purchase agreement.
10/26/24 Scottie Shermetaro
1.00 Review and revise Blender purchase
agreement.
10/27/24 Justin M. Garfinkle
0.40 Review, revise Blender purchase agreement.
10/27/24 Scottie Shermetaro
0.20 Review and revise Blender asset purchase
agreement.
10/28/24 Chris Ceresa
0.40 Correspond with Y. Salloum, K&E team and
counsel re open sale issues.
10/28/24 Bernadette Coppola
0.20 Correspond with S. Shermetaro and K&E
team re revisions to asset purchase agreement.
10/28/24 Michael Ehret
0.80 Telephone conference with Company, Y.
Salloum, K&E team re draft memorandum,
intra-group share transfers re MIM, Trudell.
10/28/24 Luke Finn
0.40 Analyze sale issues (.2); review, analyze sale
with Van Doorne (.1); correspond with N.
Warther re sale (.1).
10/28/24 Justin M. Garfinkle
1.40 Analyze issues re Blender purchase
agreement.
10/28/24 Palmer Gunderson
0.20 Correspond with M. Ehret re sale planning.
10/28/24 Dan O'Connor
2.10 Correspond with Company re sale of Vyaire
Medical srl (1.0); correspond with Company
re U.S. offer letters (.3); prepare ancillary
transaction documents (.8).
10/28/24 Scottie Shermetaro
0.60 Review and revise Blender sale APA.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 737 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
27
Date
Name
Hours Description
10/29/24 Bernadette Coppola
1.90 Conference with S. Toth, K&E team,
Company, and buyer re purchase agreement
(.6); draft revisions to purchase agreement
(1.1); correspond with S. Shermetaro and J.
Garfinkle re revisions to purchase agreement
(.2).
10/29/24 Luke Finn
0.30 Correspond with J. Garfinkle re Blender IP
purchase agreement (.1); analyze ZOLL
purchase agreement details(.2).
10/29/24 Justin M. Garfinkle
0.80 Analyze issues re Blender purchase
agreement.
10/29/24 Kate Hardey
1.00 Attend telephone conference with Company
and opposing counsel re Blender purchase
agreement.
10/29/24 Ruan J. Meintjes
0.80 Review and revise purchase agreement (.5);
telephone conference with K. Hardey, K&E
team re same (.3).
10/29/24 Dan O'Connor
1.00 Telephone conference with AlixPartners,
Company re non-debtor transaction matters
(.5); correspond with Company re FDI
notification and quota transfer deed matters
(.5).
10/29/24 Scottie Shermetaro
2.70 Participate in Blender telephone conference
with S. Toth, K&E team, Company and
potential buyer (1.0); review and revise Perma
Pure APA (1.7).
10/29/24 Steve Toth
2.40 Analyze Blender APA (.3); participate in
telephone conference with Y. Salloum, K&E
team and Company re tax updates (.4);
participate in advisor update telephone
conference with Y. Salloum, K&E team,
AlixPartners and Cole Schotz (.5); correspond
with bidder, Company, K. Hardey, K&E team
re Blender APA (.5); correspond with
Company, AlixPartners, D. O’Connor, K&E
team re non-debtor sale updates (.5); analyze
correspondence re payroll, intercompany
balances (.1); correspond with Company re
same (.1).
10/30/24 Luke Finn
0.70 Analyze correspondence with D. O'Connor re
subsidiary corporate governance (.5);
analyze correspondence re final sale
documents (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 738 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
28
Date
Name
Hours Description
10/30/24 Sabrina Lieberman
0.60 Conference with buyer, buyer advisors,
Company, S. Toth, K&E team re transaction
closing.
10/30/24 Ruan J. Meintjes
0.70 Review and revise asset purchase agreement.
10/30/24 Dan O'Connor
4.00 Telephone conference with Trudell, Vyaire,
Deloitte, AlixPartners, S. Toth and K&E
teams re transaction matters (.5); correspond
with AlixPartners re TSA matters (.3);
telephone conference with Company re
foreign corporate governance matters (1.0);
prepare closing punch list re same (.8);
correspond with Company re closing matters
(.5); correspond with Company re transaction
matters (.5); review and revise closing
checklist (.4).
10/30/24 Steve Toth
2.80 Participate in all hands telephone conference
with D. O’Connor, K&E team re Trudell
closing preparation (.5); participate in advisor
telephone conference with Y. Salloum and
K&E team, Cole Schotz and AlixPartners
(.6); analyze Blender APA (1.6); correspond
with B. Coppola re closing matters (.1).
10/30/24 Ali Mohammad Zarrabi
2.80 Review, analyze VDR and other sale related
documents (1.0); prepare APA amendment,
officer certificates (1.1); analyze
correspondence re same (.7).
10/31/24 Bernadette Coppola
0.20 Correspond with S. Toth and K&E team re
termination of transition services agreement
services (.1); correspond with S. Shermetaro
and K&E team re purchase agreement
analysis (.1).
10/31/24 Luke Finn
0.40 Analyze filing matters for closing volume
with L. Jenkins.
10/31/24 Justin M. Garfinkle
0.70 Research assignability of Company lists.
10/31/24 Kate Hardey
1.60 Review and revise purchase agreement
regulatory provisions.
10/31/24 Dan O'Connor
3.90 Review and revise closing checklist (1.0);
review and revise closing punch list (.5);
review, analyze funds flow (.6); correspond
with Company re equity transfer matters (.3);
review and revise equity transfer agreements
(1.1); prepare related resolutions for Italy and
Australia (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 739 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050108826
48520-10
29
Date
Name
Hours Description
10/31/24 Carolin Paus
1.20 Review and analyze comments re sale of
MIM (.3); revise same (.2); conference with
C. Weidner and M. Ehret re maturity date of
purchase price claim and potential set-off (.4);
revise draft re same (.3).
10/31/24 Yusuf Salloum
1.40 Analyze issues re sale closing.
10/31/24 Scottie Shermetaro
2.00 Review and revise Perma Pure APA (1.1);
conduct diligence re sale of customer lists for
legacy products (.9).
10/31/24 Steve Toth
4.10 Telephone conference with Y. Salloum, K&E
team re sale updates (.9); participate in
advisor telephone conference with Y Salloum
and K&E team, AlixPartners and Cole Schotz
(.6); telephone conference with D. O’Connor
re Trudell issues (.2); correspond with Cole
Schotz re Blender APA bankruptcy issues
(.3); revise Blender APA (2.1).
10/31/24 Spencer A. Winters, P.C.
0.30 Review and analyze issues re sale closing and
settlement.
Total
411.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 740 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108827
Client Matter: 48520-11
In the Matter of Executory Contracts & Unexpired Leases
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail)
$ 635.50
Total legal services rendered
$ 635.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 741 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Executory Contracts & Unexpired Leases
Invoice Number:
Matter Number:
1050108827
48520-11
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Sabrina Lieberman
0.10
975.00
97.50
Dan O'Connor
0.40
1,345.00
538.00
TOTALS
0.50
$ 635.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 742 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Executory Contracts & Unexpired Leases
Invoice Number:
Matter Number:
1050108827
48520-11
3
Description of Legal Services
Date
Name
Hours Description
10/04/24 Dan O'Connor
0.40 Correspond with Company and AlixPartners
re cure costs.
10/10/24 Sabrina Lieberman
0.10 Correspond with C. Ceresa, Cole Schotz,
contract counterparty re assumption and
assignment of contract.
Total
0.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 743 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108828
Client Matter: 48520-12
In the Matter of Business Operations
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail)
$ 30,992.50
Total legal services rendered
$ 30,992.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 744 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050108828
48520-12
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
0.30
1,395.00
418.50
Hannah Crawford
14.30
1,595.00
22,808.50
Kate Hardey
2.50
1,995.00
4,987.50
Sabrina Lieberman
0.80
975.00
780.00
Cristina Weidner
1.20
1,665.00
1,998.00
TOTALS
19.10
$ 30,992.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 745 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050108828
48520-12
3
Description of Legal Services
Date
Name
Hours Description
06/12/24 Cristina Weidner
1.20 Telephone conference with A. Ziegler, K&E
team re liquidity planning for Germany.
10/01/24 Hannah Crawford
0.20 Review, analyze issues re Italy bankruptcy
counsel.
10/01/24 Kate Hardey
1.00 Prepare for telephone conference with FDA re
product imports (.1); telephone conference
with FDA re same (.4); review and revise
summary presentation re same (.5).
10/02/24 Hannah Crawford
1.80 Review, analyze issues re Italian operations
(1.5); correspond with S. Lieberman re same
(.3).
10/02/24 Kate Hardey
1.00 Review and comment on FDA meeting
minutes (.3); review, analyze draft
undisclosed agent agreement (.2); review,
analyze correspondence with Company re
same (.4); correspond with Company re same
(.1).
10/03/24 Hannah Crawford
5.70 Telephone conference with S. Davies (.5);
review, analyze issues re Italian law
considerations (2.0); review, analyze issues re
antitrust analysis (.5); correspond with
Company re court summons (.5); correspond
with Company re RDx entity (.5); review,
analyze issues re audit of financial statements
(.3); correspond with S. Schwander re FDI
filing (.5); correspond with S. Lieberman re
Italian operations (.4); telephone conference
with S. Toth re Italian operations (.5).
10/04/24 Hannah Crawford
0.50 Correspond with A. Schwander re FDI filing.
10/07/24 Hannah Crawford
1.50 Correspond with S. Ullathorne and P. Kar re
annual accounts overdue letter (.5);
correspond with Company re filing accounts
(.5); correspond with Company re position
(.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 746 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050108828
48520-12
4
Date
Name
Hours Description
10/08/24 Hannah Crawford
2.80 Telephone conference with Company re
foreign entity issue (.5); telephone conference
with Company re Basingstoke (.5);
correspond with S. Winters, K&E team re
Vyaire Medical Products Limited (.5);
correspond with Company re same (.5); draft
notice (.5); correspond with Company re
Singapore entity (.3).
10/08/24 Kate Hardey
0.50 Review and revise FDA meeting minutes (.3);
correspond with Company re same (.2).
10/11/24 Chris Ceresa
0.30 Review, analyze legal issues re Korean
counsel.
10/17/24 Sabrina Lieberman
0.10 Correspond with Y. Salloum and C. Ceresa re
ordinary course professional list.
10/18/24 Hannah Crawford
0.60 Correspond with Company re Italian counsel
(.2); correspond with D. O’Connor re Italian
counsel (.2); correspond with S. Toth and D.
O’Connor re Italian counsel (.2).
10/21/24 Sabrina Lieberman
0.70 Conference with Cole Schotz re Korean
counsel (.1); correspond with Y. Salloum, C.
Ceresa, Cole Schotz, AlixPartners re same
(.6).
10/22/24 Hannah Crawford
0.40 Correspond with Y. Salloum and D.
O’Connor re tender notifications (.2);
correspond with Legance re Italian counsel
assistance (.2).
10/23/24 Hannah Crawford
0.60 Correspond with L. Finn re Italy tender
notifications (.2); correspond with Y. Salloum
re same (.2); correspond with Company re
Italian counsel (.2).
10/24/24 Hannah Crawford
0.20 Correspond with Legance re engagement
letter for Italian counsel.
Total
19.10
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 747 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108830
Client Matter: 48520-18
In the Matter of Insurance and Surety Matters
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail)
$ 36,987.50
Total legal services rendered
$ 36,987.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 748 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050108830
48520-18
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Michael Ehret
17.80
1,895.00
33,731.00
Emanuel Goetz
0.50
750.00
375.00
William T. Pruitt
1.70
1,695.00
2,881.50
TOTALS
20.00
$ 36,987.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 749 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050108830
48520-18
3
Description of Legal Services
Date
Name
Hours Description
10/01/24 Michael Ehret
0.50 Review, analyze insurance coverage status
(.3); correspond with S. Toth re same, status
(.2).
10/07/24 Michael Ehret
0.30 Analyze insurance policy, next steps (.1);
correspond with Company re same (.2).
10/08/24 Michael Ehret
0.30 Correspond with Company re insurance
policy, status.
10/09/24 Michael Ehret
0.70 Correspond with Deloitte, TML re insurance
update.
10/10/24 Michael Ehret
1.50 Correspond with Company re insurance
negotiation (.5); prepare for same (.8);
analyze correspondence from Deloitte re
insurance (.2).
10/13/24 Michael Ehret
1.50 Telephone conference with Marsh re
insurance policy comments, fair market value
representation and transfer of MIM (1.0);
follow up telephone conference with Marsh re
same (.5).
10/14/24 Michael Ehret
2.20 Telephone conference with Company re
insurance coverage status, fair market value
determination, next steps (1.1); correspond
with Company re same (.5); analyze
correspondence re Trudell, insurance status
(.6).
10/15/24 Michael Ehret
1.30 Telephone conference with S. Winters, K&E
team, PJT, Company re insurance policy, fair
market value determination.
10/16/24 William T. Pruitt
0.40 Analyze issues re director appointment and
related D&O insurance issues (.2); correspond
with C. Ceresa re same (.2).
10/18/24 Michael Ehret
0.60 Telephone conference with E. Goetz, K&E
team re insurance updates.
10/22/24 Michael Ehret
1.80 Telephone conference with Company, Y.
Salloum, K&E team re fair market value
determinations re MIM transfer,
representation letter re insurance, next steps
(.5); correspond with E. Goetz re same,
memorandum (.2); telephone conference with
E. Goetz re same (.3); follow up telephone
conference with Company, Y. Salloum, K&E
team re Trudell, next steps (.8).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 750 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050108830
48520-18
4
Date
Name
Hours Description
10/22/24 Emanuel Goetz
0.50 Telephone conference with M. Ehret, K&E
team, Company re representation letter re
insurance coverage, next steps.
10/22/24 William T. Pruitt
0.30 Analyze issues re scope of coverage for
certain individuals under D&O policy (.1);
review policies re same (.1); correspond with
Y. Salloum re same (.1).
10/23/24 Michael Ehret
0.80 Telephone conference with C. Weidner, K&E
team re tax issues re insurance.
10/23/24 William T. Pruitt
0.60 Analyze issues re scope of coverage under
D&O policies for insured persons (.3); review
D&O insurance policies re same (.2);
correspond with Marsh and Y. Salloum re
same (.1).
10/24/24 Michael Ehret
2.60 Telephone conference with Y. Salloum, K&E
team, Company re insurance coverage,
representation letter (1.0); draft agenda,
representation letter, shareholders resolution
(1.6).
10/28/24 Michael Ehret
0.40 Correspond with PwC re draft memorandum,
insurance policy.
10/29/24 Michael Ehret
1.10 Telephone conference with Company, Y.
Salloum, K&E team re insurance policy,
Trudell (.6); revise draft insurance policy (.5).
10/31/24 Michael Ehret
2.20 Telephone conference with Marsh re
insurance, MIM memorandum (.8);
correspond with Company re same, next steps
(.2); draft comments re insurance policy (1.2).
10/31/24 William T. Pruitt
0.40 Analyze insurance and indemnification issues
(.3); correspond with Y. Salloum re same (.1).
Total
20.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 751 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108831
Client Matter: 48520-20
In the Matter of Tax Matters
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail)
$ 150,356.00
Total legal services rendered
$ 150,356.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 752 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050108831
48520-20
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Hannah Crawford
0.60
1,595.00
957.00
Michael Ehret
33.60
1,895.00
63,672.00
Emanuel Goetz
14.80
750.00
11,100.00
Palmer Gunderson
33.10
995.00
32,934.50
Sabrina Lieberman
0.20
975.00
195.00
Nicholas Warther
14.70
1,665.00
24,475.50
Cristina Weidner
2.00
1,665.00
3,330.00
Sara B. Zablotney, P.C.
5.60
2,445.00
13,692.00
TOTALS
104.60
$ 150,356.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 753 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050108831
48520-20
3
Description of Legal Services
Date
Name
Hours Description
06/25/24 Cristina Weidner
2.00 Telephone conference with M. Ehret, K&E
team re German tax structuring.
10/01/24 Michael Ehret
0.20 Correspond with S. Toth, K&E team,
Company advisors re novation agreement,
comments.
10/01/24 Palmer Gunderson
2.90 Telephone conference with Company re tax
planning for transfer of subsidiaries (.8);
prepare tax comments on amendment to
purchase agreement (1.5); correspond with N.
Warther, K&E team re tax planning for
transferred subsidiaries (.6).
10/01/24 Sabrina Lieberman
0.10 Correspond with Cole Schotz re IRS
correspondence.
10/01/24 Nicholas Warther
1.10 Telephone conference with BDO, S. Toth,
K&E team re tax analysis of Zoll transaction
(.6); correspond with S. Toth, K&E team re
same (.5).
10/01/24 Sara B. Zablotney, P.C.
1.20 Review, analyze Zoll structure information
(.3); telephone conference with S. Toth, K&E
team re same (.5) correspond with S. Toth,
K&E team re intercompany issues (.4).
10/02/24 Michael Ehret
1.10 Correspond with Company re FMV
determination for disposal of shares, novation
settlement agreement (.6); analyze
correspondence re German tax implications
upon set-off (.5).
10/02/24 Palmer Gunderson
4.50 Prepare tax comments to purchase agreement
amendment (1.8); revise purchase price
allocation for sale transaction (.5); revise
intended tax treatment language for settlement
agreement (.4); correspond M. Ehret, K&E
team re settlement agreement (.7); analyze
regulations and compliance rules for tax
election (1.1).
10/02/24 Nicholas Warther
1.00 Review and analyze tax portions of
intercompany settlement agreement (.4);
review and revise Zoll APA (.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 754 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050108831
48520-20
4
Date
Name
Hours Description
10/03/24 Palmer Gunderson
1.60 Telephone conference with N. Warther, K&E
team re settlement agreement (.4); review,
analyze comments to settlement agreement
(.3); correspond with N. Warther, K&E team
re tax treatment of settlement agreement (.6);
correspond with Company, N. Warther, K&E
team re revised purchase price allocation (.3).
10/03/24 Sara B. Zablotney, P.C.
0.70 Correspond with N. Warther, K&E team re
intercompany issues (.6); correspond with N.
Warther, K&E team re intended tax treatment
(.1).
10/04/24 Michael Ehret
1.70 Draft VAT clause (.5); correspond with C.
Paus re same (.3); telephone conference with
C. Paus re same (.2); correspond with S.
Zablotney, K&E team re BDO US comments,
issues (.4); correspond with S. Zablotney,
K&E team re novation and set-off agreement
(.3).
10/04/24 Palmer Gunderson
1.10 Finalize, revise purchase price allocation with
tax and company (.2); prepare tax forms for
tax elections (.9).
10/04/24 Sara B. Zablotney, P.C.
0.60 Correspond with N. Warther, K&E team re
financial statements (.3); review, analyze PPA
(.3).
10/05/24 Palmer Gunderson
2.40 Correspond with N. Warther, K&E team re
tax planning for sale transaction (.4); prepare
tax forms for sale transaction (1.6);
correspond with N. Warther, K&E team re
settlement agreement (.4).
10/05/24 Nicholas Warther
0.80 Review and revise agency agreement (.6);
correspond with P. Gunderson, K&E team re
same (.2).
10/06/24 Nicholas Warther
1.00 Review and analyze tax portions of agency
agreement.
10/07/24 Nicholas Warther
0.60 Review and revise tax portions of agency
agreement.
10/08/24 Palmer Gunderson
0.80 Analyze and prepare tax comments on
settlement agreement.
10/08/24 Nicholas Warther
0.30 Correspond with P. Gunderson, K&E team re
tax structuring.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 755 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050108831
48520-20
5
Date
Name
Hours Description
10/09/24 Michael Ehret
1.50 Telephone conference with Company re tax
return filing, novation settlement agreement
(1.0); draft overview re fair market value
determination (.5).
10/09/24 Palmer Gunderson
4.40 Correspond with N. Warther, K&E team re
company tax diligence items (.3); analyze and
prepare tax comments on updated settlement
agreement (2.1); telephone conference with
N. Warther, K&E team re restructuring
transactions and tax treatment of settlement
agreement (.2); draft correspondence re tax
treatment and structure of settlement
agreement (1.8).
10/09/24 Nicholas Warther
1.40 Review and revise intercompany settlement
(.8); correspond with P. Gunderson, K&E
team re same (.6).
10/10/24 Michael Ehret
3.20 Correspond with C. Paus, K&E team re VAT
clause updates, open tax items re sale, APA
(2.0); correspond with Company re same, tax
analysis, tax exposure calculation (1.2).
10/10/24 Palmer Gunderson
0.80 Review, analyze draft tax forms for tax
election.
10/10/24 Nicholas Warther
2.70 Review and revise intercompany settlement
agreement (1.4); correspond with Company re
same (.6); review and analyze 338 elections
(.7).
10/10/24 Sara B. Zablotney, P.C.
0.40 Participate in telephone conference with S.
Toth, K&E team re intercompany issues.
10/11/24 Michael Ehret
2.80 Telephone conference with Deloitte, TML re
technical arguments re insurance coverage
(1.0); draft correspondence to Deloitte re
same (.5); telephone conference with
Company re same, next steps (1.0); telephone
conference with Deloitte re same (.3).
10/14/24 Emanuel Goetz
0.60 Review, analyze envisaged tax insurance.
10/16/24 Michael Ehret
2.50 Telephone conference with Company re off-
setting receivables, tax implications and fair
market value determinations (.5); telephone
conference with E. Goetz re Trudell
transaction, tax issues, next steps (.8); draft
presentation re same (.9); correspond with
Company, E. Goetz, K&E team re same (.3).
10/16/24 Emanuel Goetz
0.80 Telephone conference with M. Ehret, K&E
team re tax implications re Trudell.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 756 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050108831
48520-20
6
Date
Name
Hours Description
10/16/24 Palmer Gunderson
1.50 Analyze tax consequences of settlement of
intercompany obligations for sale transaction.
10/17/24 Hannah Crawford
0.30 Telephone conference with AlixPartners re
Basingstoke taxes.
10/17/24 Hannah Crawford
0.30 Correspond with S. Toth and AlixPartners re
tax issue.
10/17/24 Emanuel Goetz
0.80 Review and revise set off analysis re Vyaire
GmbH.
10/17/24 Palmer Gunderson
1.90 Analyze and prepare tax comments on
purchase agreement (1.1); correspond with N.
Warther, K&E team re tax planning for sale
transaction (.8).
10/17/24 Nicholas Warther
0.30 Review and analyze issues re Brazil
intercompany.
10/17/24 Sara B. Zablotney, P.C.
0.50 Telephone conference with M. Ehret, K&E
team re tax insurance.
10/18/24 Michael Ehret
3.50 Telephone conference with Company re MIM
transfer, fair market value determination
(1.0); correspond with Company re same
(1.0); telephone conference with Deloitte re
open tax items (.8); correspond with Deloitte
re same (.2); analyze Deloitte correspondence
re same (.5).
10/18/24 Emanuel Goetz
0.60 Telephone conference with M. Ehret, K&E
team, Company re insurance for Vyaire
Medical GmbH.
10/18/24 Emanuel Goetz
0.80 Telephone conference with M. Ehret and
Deloitte re open topics re tax insurance for
Vyaire Medical GmbH.
10/18/24 Emanuel Goetz
0.30 Review and revise tax insurance for VMG.
10/18/24 Palmer Gunderson
1.00 Correspond with E. Goetz, K&E team re tax
planning for sale transaction.
10/18/24 Sara B. Zablotney, P.C.
0.80 Analyze Brazil receivable (.4); correspond
with P. Gunderson, K&E team re same (.1);
analyze Brazil cancellation (.3).
10/19/24 Michael Ehret
2.70 Telephone conference with Y. Salloum, K&E
team, Company re insurance, tax structure,
next steps (.5); analyze Marsh correspondence
re same (.3); telephone conference with
Marsh re same (.7); telephone conference
with Trudell, Deloitte, Marsh re alternative
structures (1.0); correspond with Company re
same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 757 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050108831
48520-20
7
Date
Name
Hours Description
10/19/24 Palmer Gunderson
0.30 Correspond with N. Warther, S. Zablotney
and BDO re tax planning for sale transaction.
10/19/24 Sara B. Zablotney, P.C.
0.20 Correspond with P. Gunderson, K&E team re
Brazil agreement.
10/20/24 Palmer Gunderson
1.10 Review, analyze purchase agreement (.9);
correspond with N. Warther and S. Zablotney
re tax issues in purchase agreement (.2).
10/20/24 Sabrina Lieberman
0.10 Correspond with Cole Schotz re open tax
items.
10/21/24 Palmer Gunderson
0.50 Correspond with N. Warther, S. Zablotney,
and BDO re tax planning for sale transaction.
10/21/24 Sara B. Zablotney, P.C.
0.20 Correspond with N. Warther, K&E team re
Brazil sale transaction.
10/22/24 Michael Ehret
0.70 Telephone conference with Company re
German tax implications.
10/22/24 Emanuel Goetz
1.20 Telephone conference with Company, S.
Toth, K&E team re tax issues re insurance
(.9); telephone conference with M. Ehret re
same (.3).
10/22/24 Emanuel Goetz
0.30 Analyze issues, strategy re MIM valuation.
10/22/24 Palmer Gunderson
1.50 Review and analyze tax issues in plan
supplement (.9); telephone conference with S.
Liberman re plan supplement (.2); correspond
with N. Warther and S. Zablotney re same
(.4).
10/22/24 Nicholas Warther
0.60 Correspond with P. Gunderson, K&E team re
wind-down documentation.
10/23/24 Michael Ehret
1.60 Telephone conference with PwC, Company,
E. Goetz re MIM transfer (.4); telephone
conference with Y. Salloum, K&E team,
Company re next steps, tax implications (.5);
correspond with S. Toth, K&E team re same
(.7).
10/23/24 Emanuel Goetz
0.80 Telephone conference with M. Ehret, K&E
team re next steps for receiving tax insurance.
10/23/24 Emanuel Goetz
0.40 Telephone conference with C. Paus, K&E
team re German implications of share transfer
in MIM.
10/23/24 Palmer Gunderson
3.10 Review and prepare tax comments on
purchase agreement (2.9); correspond with N.
Warther and S. Zablotney re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 758 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050108831
48520-20
8
Date
Name
Hours Description
10/24/24 Emanuel Goetz
0.50 Analyze spreadsheet re valuation of MIM
Medizinische Monitoring und Instrumente
GmbH.
10/24/24 Nicholas Warther
1.30 Review and analyze tax structuring and
documentation (.8); correspond with Y.
Salloum, K&E team re same (.5).
10/25/24 Michael Ehret
1.20 Telephone conference with PwC re MIM
transfer analysis, shareholder update, tax
implications (.7); correspond with various
parties re shareholder resolution, agenda (.5).
10/25/24 Emanuel Goetz
2.50 Draft summary of German tax implications re
MIM sale.
10/27/24 Michael Ehret
2.80 Review, analyze draft memorandum re MIM
transfer, German tax implications (2.5);
correspond with Company, E. Goetz re same
(.3).
10/28/24 Michael Ehret
3.00 Analyze structure memorandum re MIM,
purchase price determination (.9); telephone
conference with PwC re tax structuring
considerations, shareholder meeting (.4); draft
and revise tax memorandum (1.7).
10/28/24 Emanuel Goetz
1.50 Review and revise draft summary of German
tax implications re MIM transfer.
10/28/24 Palmer Gunderson
2.10 Telephone conference with N. Warther, S.
Zablotney, BDO, Company re wind down tax
planning (1.0); correspond with N. Warther,
K&E team re tax planning for sale transaction
(.2); revise tax comments on purchase
agreement (.5); telephone conference with N.
Warther and S. Zablotney re wind down tax
planning (.4).
10/28/24 Nicholas Warther
2.10 Telephone conference with BDO re tax
analysis (1.0); review and analyze structuring
(1.1).
10/28/24 Sara B. Zablotney, P.C.
1.00 Telephone conference re wind down with N.
Warther, K&E team (.5); telephone
conference with Company re same, BDO (.5).
10/29/24 Michael Ehret
1.50 Telephone conference with E. Goetz, K&E
team, Company re tax implications re MIM
transfer (.5); analyze, draft memorandum re
MIM transfer (.8); correspond with Company
re same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 759 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050108831
48520-20
9
Date
Name
Hours Description
10/29/24 Emanuel Goetz
0.50 Telephone conference with Company, Y.
Salloum, K&E team re tax implications re
MIM transfer.
10/29/24 Emanuel Goetz
1.20 Review and revise tax insurance draft for
Vyaire Medical GmbH.
10/29/24 Emanuel Goetz
1.00 Review and revise summary draft re German
tax implications summary re MIM transfer.
10/29/24 Emanuel Goetz
1.00 Draft summary re German tax implications
summary re MIM transfer.
10/29/24 Palmer Gunderson
1.60 Research and prepare summary of tax
treatment of worthless stock deductions in
context of ownership change rules (.6);
telephone conference with S. Zablotney, N.
Warther, Company and BDO re wind-down
tax planning (.8); prepare for same (.2).
10/29/24 Nicholas Warther
0.80 Telephone conference with P. Gunderson,
BDO, Company re wind-down tax
structuring.
10/30/24 Michael Ehret
1.50 Analyze intra-group share transfer
memorandum (.6); correspond with Company
re same (.5); correspond with Marsh re
memorandum re MIM transfer (.4).
10/31/24 Michael Ehret
2.10 Telephone conference with Company re
reconciliation numbers (.6); correspond with
Company, Y. Salloum, K&E team re same
(.4); review, revise draft SPA re MIM transfer
(.6); telephone conference with C. Paus, K&E
team re purchase price clause, set-off (.5).
10/31/24 Nicholas Warther
0.70 Review and revise tax portions of Blender
APA.
Total
104.60
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 760 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108832
Client Matter: 48520-21
In the Matter of Case Administration
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail)
$ 12,220.50
Total legal services rendered
$ 12,220.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 761 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050108832
48520-21
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
0.20
1,395.00
279.00
Tiffani Chanroo
0.50
1,345.00
672.50
Hannah Crawford
0.20
1,595.00
319.00
Sabrina Lieberman
6.30
975.00
6,142.50
Josh Sussberg, P.C.
0.10
2,305.00
230.50
Steve Toth
1.60
1,820.00
2,912.00
Cristina Weidner
1.00
1,665.00
1,665.00
TOTALS
9.90
$ 12,220.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 762 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050108832
48520-21
3
Description of Legal Services
Date
Name
Hours Description
08/14/24 Cristina Weidner
1.00 Attend telephone conference re current status,
correspondence.
10/01/24 Tiffani Chanroo
0.50 Correspond with J. Foster, K&E team re
cancelled hearing (.1); review, analyze
correspondence re case status (.4).
10/04/24 Steve Toth
0.50 Discuss open bankruptcy issues and case
status with Cole Schotz, Y. Salloum, K&E
team and AlixPartners.
10/11/24 Josh Sussberg, P.C.
0.10 Correspond with S. Winters re case status.
10/17/24 Sabrina Lieberman
0.30 Conference with Y. Salloum, K&E team,
AlixPartners re work in process.
10/17/24 Steve Toth
0.60 Correspond with Cole Schotz, AlixPartners,
Y. Salloum, K&E team re case updates.
10/18/24 Sabrina Lieberman
0.40 Conference with Y. Salloum, K&E team,
AlixPartners re work in process.
10/18/24 Steve Toth
0.50 Correspond with Cole Schotz, Y. Salloum,
K&E team re case update.
10/21/24 Sabrina Lieberman
0.70 Conference with Y. Salloum, Cole Schotz,
AlixPartners re work in process.
10/22/24 Sabrina Lieberman
1.10 Conference with Y. Salloum, AlixPartners,
Cole Schotz re work in process.
10/23/24 Sabrina Lieberman
0.70 Conference with Y. Salloum, S. Toth,
AlixPartners, Cole Schotz re work in process.
10/24/24 Hannah Crawford
0.20 Correspond with Legance re case status.
10/24/24 Sabrina Lieberman
0.50 Conference with Y. Salloum, K&E team,
AlixPartners re work in process.
10/25/24 Sabrina Lieberman
0.80 Conference with Y. Salloum, Cole Schotz,
AlixPartners re work in process (.6); draft
weekly internal memorandum (.2).
10/28/24 Sabrina Lieberman
0.10 Conference with Y. Salloum, AlixPartners re
work in process.
10/29/24 Sabrina Lieberman
0.70 Conference with Y. Salloum, Cole Schotz,
AlixPartners re work in process (.6);
correspond with Y. Salloum, K&E team re
same (.1).
10/30/24 Sabrina Lieberman
0.40 Correspond with Y. Salloum, K&E team re
work in process.
10/31/24 Chris Ceresa
0.20 Correspond with Company re operations.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 763 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050108832
48520-21
4
Date
Name
Hours Description
10/31/24 Sabrina Lieberman
0.60 Conference with Y. Salloum, Cole Schotz,
AlixPartners re work in process.
Total
9.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 764 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108833
Client Matter: 48520-22
In the Matter of Retention - K&E
For legal services rendered through October 31, 2024
(see attached Description of Legal Services for detail)
$ 52,661.50
Total legal services rendered
$ 52,661.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 765 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050108833
48520-22
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
9.40
1,395.00
13,113.00
Tiffani Chanroo
14.60
1,345.00
19,637.00
Susan D. Golden
0.50
1,600.00
800.00
Sabrina Lieberman
17.70
975.00
17,257.50
Josh Sussberg, P.C.
0.10
2,305.00
230.50
Spencer A. Winters, P.C.
0.50
1,685.00
842.50
Tanzila Zomo
2.20
355.00
781.00
TOTALS
45.00
$ 52,661.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 766 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050108833
48520-22
3
Description of Legal Services
Date
Name
Hours Description
10/01/24 Chris Ceresa
2.80 Review, revise K&E fee statement for
privilege and confidentiality issues (2.5);
correspond with S. Lieberman and K&E team
re same (.3).
10/01/24 Sabrina Lieberman
0.50 Review, revise supplemental declaration in
support of K&E retention.
10/02/24 Sabrina Lieberman
0.20 Review, revise second supplemental
declaration in support of K&E retention.
10/03/24 Chris Ceresa
2.60 Review, revise K&E fee statement for
privilege and confidentiality issues (2.4);
correspond with S. Lieberman and K&E team
re same (.2).
10/03/24 Tiffani Chanroo
0.80 Review, revise monthly fee statement re
privilege, confidentiality.
10/03/24 Sabrina Lieberman
2.10 Review, revise July monthly fee statement
(.6); review, revise declaration in support of
K&E retention (1.5).
10/03/24 Spencer A. Winters, P.C.
0.50 Review, revise K&E fee application.
10/04/24 Chris Ceresa
1.90 Review, revise K&E fee statement for
privilege and confidentiality issues (1.7);
correspond with S. Lieberman and K&E team
re same (.2).
10/04/24 Tiffani Chanroo
1.40 Review, revise interim fee statement re
privilege, confidentiality.
10/07/24 Sabrina Lieberman
0.10 Correspond with C. Ceresa, K&E team re
K&E fee application.
10/09/24 Chris Ceresa
0.80 Correspond with S. Lieberman and K&E team
re K&E fee statement issues.
10/09/24 Tanzila Zomo
2.20 Review, revise fee statement re
confidentiality issues (1.9); correspond with
S. Lieberman re same (.3).
10/10/24 Tiffani Chanroo
0.60 Review, analyze K&E interim fee application.
10/10/24 Sabrina Lieberman
0.20 Correspond with C. Ceresa, T. Chanroo re
interim fee application.
10/11/24 Tiffani Chanroo
0.20 Review, analyze correspondence from S.
Lieberman re K&E fee application.
10/11/24 Sabrina Lieberman
0.50 Conference with C. Ceresa, K&E team re
interim fee application.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 767 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050108833
48520-22
4
Date
Name
Hours Description
10/13/24 Sabrina Lieberman
2.80 Review, revise invoice re confidentiality and
privilege considerations.
10/14/24 Sabrina Lieberman
2.50 Review, revise invoice re privilege,
confidentiality.
10/21/24 Chris Ceresa
0.10 Correspond with Y. Salloum and S.
Lieberman re K&E retention items.
10/21/24 Chris Ceresa
0.20 Correspond with S. Lieberman, K&E team re
K&E retention legal issues.
10/22/24 Sabrina Lieberman
0.80 Review, revise September invoice re
privilege, confidentiality.
10/22/24 Josh Sussberg, P.C.
0.10 Correspond with S. Winters re fee auditor.
10/24/24 Tiffani Chanroo
4.90 Review, revise K&E invoice for privilege and
confidentiality.
10/25/24 Sabrina Lieberman
3.20 Review, revise September invoice re
privilege, confidentiality (2.7); correspond
with S. Toth, K&E team re same (.5).
10/28/24 Tiffani Chanroo
0.20 Correspond with S. Lieberman re interim fee
application.
10/28/24 Susan D. Golden
0.50 Conference with fee examiner, Cole Schotz,
Y. Salloum re fee examiner appointment and
fee examiner expectations (.3); correspond
with C. Ceresa, K&E team re interim fee
application (.2).
10/28/24 Sabrina Lieberman
0.20 Correspond with Y. Salloum, K&E team re
interim fee application.
10/29/24 Chris Ceresa
0.20 Correspond with S. Lieberman, K&E team re
K&E retention.
10/29/24 Tiffani Chanroo
0.10 Correspond with S. Lieberman re interim fee
application.
10/30/24 Tiffani Chanroo
4.20 Review, analyze interim fee application (3.9);
correspond with S. Lieberman re same (.3).
10/31/24 Chris Ceresa
0.80 Correspond with S. Lieberman, K&E team re
K&E retention.
10/31/24 Tiffani Chanroo
2.20 Review, revise interim fee application (1.9);
correspond with S. Lieberman re same (.3).
10/31/24 Sabrina Lieberman
4.60 Conference with S. Winters, Y. Salloum,
AlixPartners re K&E fee application (.5);
correspond with U.S. Trustee re same (.1);
review, revise certification of counsel (.2);
correspond with C. Ceresa, AlixPartners, Cole
Schotz re same (.2); review, revise interim fee
application (3.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 768 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050108833
48520-22
5
Total
45.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 769 of 914

November 1, 2024 – November 14, 2024

Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 770 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 18, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050109733
Client Matter: 48520-5
In the Matter of Corporate & Governance Matters
For legal services rendered through November 14, 2024
(see attached Description of Legal Services for detail)
$ 16,930.00
Total legal services rendered
$ 16,930.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 771 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050109733
48520-5
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
0.40
1,395.00
558.00
Michael Ehret
1.80
1,895.00
3,411.00
Emanuel Goetz
6.30
750.00
4,725.00
Sabrina Lieberman
0.90
975.00
877.50
Dan O'Connor
0.80
1,345.00
1,076.00
Carolin Paus
4.20
750.00
3,150.00
Steve Toth
1.10
1,820.00
2,002.00
Donatus Wang
0.30
960.00
288.00
Spencer A. Winters, P.C.
0.50
1,685.00
842.50
TOTALS
16.30
$ 16,930.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 772 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050109733
48520-5
3
Description of Legal Services
Date
Name
Hours Description
11/04/24 Emanuel Goetz
1.50 Revise documents for shareholder meeting.
11/04/24 Emanuel Goetz
0.50 Revise agenda for shareholder meeting.
11/04/24 Emanuel Goetz
0.70 Revise documents for shareholders meeting.
11/04/24 Emanuel Goetz
0.30 Review, analyze issues re statutory liability.
11/04/24 Emanuel Goetz
0.50 Revise documentation for shareholders
meeting.
11/05/24 Michael Ehret
0.70 Correspond with Alix re documentation for
shareholders meeting (.3); telephone
conference with Company re shareholders
meeting (.4).
11/05/24 Steve Toth
0.30 Correspond with Y. Salloum, K&E team and
Company re shareholder meeting.
11/06/24 Chris Ceresa
0.30 Correspond with S. Lieberman and Company
re corporate governance items.
11/06/24 Michael Ehret
1.10 Correspond with Alix, Marsh re shareholders
meeting of Medical GmbH (.3); attend
shareholders meeting of Medical GmbH
(.5); review analyze minutes for shareholders
meeting (.3).
11/06/24 Emanuel Goetz
1.90 Review, revise documents for shareholders
meeting.
11/06/24 Sabrina Lieberman
0.10 Correspond with C. Ceresa, Company,
AlixPartners re board meetings.
11/06/24 Carolin Paus
1.90 Review, analyze issues re German
transparency register (1.1); correspond with
D. O'Connor, K&E team re board
composition issue (.4); conference with
German notary re same (.4).
11/06/24 Steve Toth
0.80 Participate in telephone conference with Y.
Salloum and K&E team, PwC and Company
re shareholder meeting and insurance matters
(.5); analyze Germany shareholder meeting
minutes (.3).
11/07/24 Sabrina Lieberman
0.50 Review, revise shareholder meeting minutes
(.1); draft special committee meeting minutes
(.4).
11/07/24 Carolin Paus
1.60 Correspond with D. O’Connor re board
composition (.7); draft shareholder resolution
(.9).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 773 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Corporate & Governance Matters
Invoice Number:
Matter Number:
1050109733
48520-5
4
Date
Name
Hours Description
11/08/24 Dan O'Connor
0.80 Correspond with Company re board
composition issues.
11/08/24 Donatus Wang
0.30 Conference with C. Paus re board
composition.
11/11/24 Emanuel Goetz
0.30 Correspond with Company re settlement
agreement.
11/11/24 Emanuel Goetz
0.60 Review, analyze issues re STA.
11/11/24 Carolin Paus
0.30 Correspond with Company re governance
requirements.
11/12/24 Carolin Paus
0.40 Execute shareholder resolution.
11/13/24 Chris Ceresa
0.10 Correspond with Company, S. Lieberman,
K&E team re corporate governance matters.
11/14/24 Sabrina Lieberman
0.30 Draft special committee meeting minutes.
11/14/24 Spencer A. Winters, P.C.
0.50 Prepare for SC meeting (.1); attend special
committee meeting (.4).
Total
16.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 774 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 18, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050109734
Client Matter: 48520-6
In the Matter of Disclosure Statement/Plan/Confirmation
For legal services rendered through November 14, 2024
(see attached Description of Legal Services for detail)
$ 202,401.00
Total legal services rendered
$ 202,401.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 775 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050109734
48520-6
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Tiffani Chanroo
36.70
1,345.00
49,361.50
Sabrina Lieberman
35.50
975.00
34,612.50
Yusuf Salloum
43.90
1,595.00
70,020.50
Seth Sanders
29.70
1,265.00
37,570.50
Steve Toth
0.90
1,820.00
1,638.00
Spencer A. Winters, P.C.
4.30
1,685.00
7,245.50
Tanzila Zomo
5.50
355.00
1,952.50
TOTALS
156.50
$ 202,401.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 776 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050109734
48520-6
3
Description of Legal Services
Date
Name
Hours Description
11/01/24 Tiffani Chanroo
1.00 Review, revise confirmation brief.
11/01/24 Sabrina Lieberman
2.20 Review, revise confirmation brief.
11/01/24 Yusuf Salloum
2.00 Prepare for confirmation.
11/01/24 Seth Sanders
4.90 Draft, revise plan (2.8); research issues re
same (1.3); telephone conferences with Y.
Salloum re same (.3); correspond with Y.
Salloum re same (.5).
11/02/24 Sabrina Lieberman
0.60 Review, revise confirmation brief.
11/03/24 Tiffani Chanroo
4.40 Review, revise confirmation brief (3.9);
correspond with S. Lieberman re same (.5).
11/03/24 Seth Sanders
1.30 Telephone conference with Y. Salloum, CS,
advisors re committee settlement (.4); further
revise plan (.7); correspond with Y. Salloum
re same (.2).
11/04/24 Tiffani Chanroo
3.20 Review, revise confirmation brief (3.1);
correspond with S. Lieberman re same (.1).
11/04/24 Sabrina Lieberman
4.40 Review, revise confirmation brief.
11/04/24 Yusuf Salloum
2.40 Prepare for confirmation.
11/04/24 Seth Sanders
1.20 Correspond with Cole Schotz, Y. Salloum re
UCC investigation, settlement (.5); telephone
conferences with Cole Schotz, Y. Salloum re
same (.4); revise plan (.3).
11/05/24 Tiffani Chanroo
3.80 Review, revise confirmation brief (3.6);
correspond with S. Lieberman re same (.2).
11/05/24 Sabrina Lieberman
1.10 Conference with T. Chanroo re confirmation
brief (.1); review, revise same (1.0).
11/05/24 Yusuf Salloum
1.90 Review, analyze confirmation issues.
11/06/24 Sabrina Lieberman
1.20 Conference with Y. Salloum, AlixPartners,
Cole Schotz re UCC comments to plan.
11/06/24 Spencer A. Winters, P.C.
0.30 Review and analyze confirmation issues (.2);
telephone conference with Y. Salloum re
same (.1).
11/07/24 Tiffani Chanroo
4.00 Review, analyze confirmation brief (3.0);
conference with Y. Salloum, S. Lieberman,
Cole Schotz re same (.9); correspond withS.
Lieberman re same (.1).
11/07/24 Sabrina Lieberman
1.00 Conference with Y. Salloum, T. Chanroo,
Cole Schotz re confirmation brief (.9);
correspond with T. Chanroo re same (.1).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 777 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050109734
48520-6
4
Date
Name
Hours Description
11/07/24 Yusuf Salloum
3.40 Prepare for confirmation.
11/07/24 Seth Sanders
5.20 Telephone conferences with Y. Salloum, Cole
Schotz teams re plan amendments and
AlixPartners declaration (1.4); correspond
with Cole Schotz re same (.4); analyze, revise
plan (1.1); correspond with STB re amended
plan (.1); revise Braley declaration (2.2).
11/07/24 Steve Toth
0.30 Discuss confirmation order and related
matters with S. Sanders, K&E team, CS and
AlixPartners.
11/07/24 Spencer A. Winters, P.C.
0.90 Review and analyze confirmation issues (.4);
attend special committee telephone
conference re same (.4); prepare for same (.1).
11/08/24 Tiffani Chanroo
1.20 Correspond with S. Lieberman re escrow
agreement (.2); review, analyze confirmation
issues (1.0).
11/08/24 Sabrina Lieberman
3.20 Conference with Y. Salloum, S. Sanders, Cole
Schotz re plan and confirmation brief (.5);
review revise confirmation brief (2.7).
11/08/24 Sabrina Lieberman
0.50 Review, revise professional fee escrow
account (.3); correspond with Y. Salloum, T.
Chanroo re same (.2).
11/08/24 Yusuf Salloum
5.90 Prepare for confirmation hearing (3.5);
analyze materials re same (2.4).
11/08/24 Seth Sanders
4.40 Revise Braley declaration (1.8); correspond
with CS re same (.1); analyze injunction
provision in plan (.6); correspond and
conference with Y. Salloum re same (.4);
revise brief (1.4); correspond with Y. Salloum
re same (.1).
11/08/24 Spencer A. Winters, P.C.
0.20 Review and analyze confirmation issues (.1);
telephone conference with Y. Salloum re
same (.1).
11/09/24 Tiffani Chanroo
1.00 Review, revise confirmation brief (.9);
correspond with S. Lieberman re same (.1).
11/09/24 Sabrina Lieberman
4.20 Conference with Y. Salloum re confirmation
brief (.1); correspond with Y. Salloum, T.
Chanroo re same (.3); review, revise same
(3.8).
11/09/24 Yusuf Salloum
6.30 Review, revise confirmation documents (3.6);
research re same (2.7).
11/10/24 Tiffani Chanroo
3.40 Review, revise confirmation brief.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 778 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050109734
48520-6
5
Date
Name
Hours Description
11/10/24 Sabrina Lieberman
2.70 Review, revise confirmation brief (2.3);
conference with Y. Salloum re same (.4).
11/10/24 Yusuf Salloum
5.70 Review, revise confirmation documents (3.4);
research re same (2.3).
11/10/24 Seth Sanders
3.00 Revise Braley declaration (1.8); conference
with Y. Salloum re same (.3); correspond with
CS team, S. Winters, K&E team re same (.4);
analyze special committee presentation re
same (.5).
11/10/24 Spencer A. Winters, P.C.
0.30 Review, analyze confirmation brief.
11/11/24 Tiffani Chanroo
8.40 Review, analyze brief (3.9); review, analyze
outstanding confirmation issues (3.9);
conference with Y. Salloum, K&E team, CS
team re confirmation (.6).
11/11/24 Sabrina Lieberman
7.00 Conference with Cole Schotz, AlixPartners,
Y. Salloum, K&E team re confirmation
documents (.9); conference with AlixPartners
re wind-down budget (.1); conference with Y.
Salloum re same (.1); review, revise
confirmation documents (5.9).
11/11/24 Sabrina Lieberman
0.70 Correspond with T. Chanroo re professional
fee escrow account.
11/11/24 Yusuf Salloum
6.80 Review, revise confirmation documents (3.8);
research re same (3.0).
11/11/24 Seth Sanders
5.30 Telephone conferences with AlixPartners, CS,
Y. Salloum, K&E team re confirmation order
and related documents (1.2); revise plan,
confirmation declaration, confirmation order
(3.1); correspond with Y. Salloum, K&E team
re same (.3); analyze confirmation talking
points (.4); correspond with S. Lieberman re
same (.3).
11/11/24 Steve Toth
0.60 Telephone conference with S. Lieberman,
K&E team, Alix and CS re confirmation and
related matters.
11/11/24 Spencer A. Winters, P.C.
1.90 Review and revise chapter 11 plan (.8);
review, analyze Braley declaration (.3);
review and analyze confirmation issues (.3);
correspond with Y. Salloum K&E team re
same (.5).
11/11/24 Tanzila Zomo
3.40 Research re confirmation order precedent
(1.5); research re escrow agreements (1.9).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 779 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050109734
48520-6
6
Date
Name
Hours Description
11/12/24 Tiffani Chanroo
3.60 Review, revise confirmation order (1.1);
correspond with Cole Schotz team re same
(.1); correspond with S. Lieberman re
professional fee escrow (.8); review, analyze
issues re same (.4); review, analyze
outstanding issues re plan confirmation (1.2).
11/12/24 Sabrina Lieberman
2.50 Conference with Cole Schotz, AlixPartners,
Y. Salloum, K&E team re confirmation
hearing (.2); draft confirmation hearing
talking points (2.3).
11/12/24 Sabrina Lieberman
0.50 Correspond with T. Chanroo, Company,
Citibank re professional fee escrow account.
11/12/24 Yusuf Salloum
3.80 Review materials to prepare for confirmation.
11/12/24 Seth Sanders
1.00 Revise confirmation talking points (.3);
correspond with S. Lieberman re same (.2);
revise draft case analysis (.4); correspond
with S. Lieberman re same (.1).
11/12/24 Tanzila Zomo
1.30 Research re confirmation hearing talking
points.
11/13/24 Tiffani Chanroo
2.30 Correspond with S. Lieberman re professional
fee escrow (.4); review, analyze materials re
same (1.9).
11/13/24 Sabrina Lieberman
2.00 Review, revise confirmation hearing talking
points.
11/13/24 Sabrina Lieberman
1.40 Correspond with T. Chanroo, Y. Salloum,
AlixPartners, Company, Citibank re
professional fee escrow account.
11/13/24 Yusuf Salloum
5.70 Prepare for confirmation hearing (3.4); review
materials re same (2.3).
11/13/24 Seth Sanders
2.90 Telephone conferences with AlixPartners, CS,
Y. Salloum re confirmation preparation (1.4);
prepare hearing talking points (1.1);
correspond with S. Winters, Y. Salloum re
same (.2); telephone conference with Omni re
confirmation hearing (.2).
11/13/24 Spencer A. Winters, P.C.
0.70 Draft talking points re confirmation hearing.
11/13/24 Tanzila Zomo
0.30 Research re certificates of formation.
11/14/24 Tiffani Chanroo
0.40 Correspond with S. Lieberman, K&E team re
plan confirmation.
11/14/24 Sabrina Lieberman
0.30 Correspond with T. Chanroo, AlixPartners re
professional fee escrow account.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 780 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Disclosure Statement/Plan/Confirmation
Invoice Number:
Matter Number:
1050109734
48520-6
7
Date
Name
Hours Description
11/14/24 Seth Sanders
0.50 Analyze issues re winddown mechanics (.3);
correspond with W. Pruitt, Y. Salloum re
same (.2).
11/14/24 Tanzila Zomo
0.50 Coordinate listen-only line re confirmation
hearing.
Total
156.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 781 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 18, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050109735
Client Matter: 48520-7
In the Matter of DIP Financing and Cash Collateral
For legal services rendered through November 14, 2024
(see attached Description of Legal Services for detail)
$ 97.50
Total legal services rendered
$ 97.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 782 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050109735
48520-7
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Sabrina Lieberman
0.10
975.00
97.50
TOTALS
0.10
$ 97.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 783 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
DIP Financing and Cash Collateral
Invoice Number:
Matter Number:
1050109735
48520-7
3
Description of Legal Services
Date
Name
Hours Description
11/13/24 Sabrina Lieberman
0.10 Correspond with S. Sanders re DIP.
Total
0.10
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 784 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 18, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050109737
Client Matter: 48520-10
In the Matter of Asset Sales/Section 363 Issues: Use, Sale & Disposition of Property
For legal services rendered through November 14, 2024
(see attached Description of Legal Services for detail)
$ 258,573.00
Total legal services rendered
$ 258,573.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 785 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050109737
48520-10
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Hendrik Braun
3.40
1,145.00
3,893.00
Bernadette Coppola
0.60
1,575.00
945.00
Hannah Crawford
0.80
1,595.00
1,276.00
Michael Ehret
6.30
1,895.00
11,938.50
Luke Finn
5.80
1,345.00
7,801.00
Justin M. Garfinkle
2.30
1,095.00
2,518.50
Emanuel Goetz
3.30
750.00
2,475.00
Palmer Gunderson
4.00
995.00
3,980.00
Kate Hardey
0.40
1,995.00
798.00
Sabrina Lieberman
5.60
975.00
5,460.00
Dan O'Connor
46.90
1,345.00
63,080.50
Carolin Paus
24.70
750.00
18,525.00
Yusuf Salloum
23.90
1,595.00
38,120.50
Scottie Shermetaro
3.20
1,575.00
5,040.00
Steve Toth
33.50
1,820.00
60,970.00
Donatus Wang
1.30
960.00
1,248.00
Nicholas Warther
0.40
1,665.00
666.00
Cristina Weidner
2.40
1,665.00
3,996.00
Ali Mohammad Zarrabi
23.60
1,095.00
25,842.00
TOTALS
192.40
$ 258,573.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 786 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050109737
48520-10
3
Description of Legal Services
Date
Name
Hours Description
11/01/24 Bernadette Coppola
0.20 Correspond with client, S. Toth and K&E
team re transition services agreement
services.
11/01/24 Luke Finn
0.30 Correspond with Company re intercompany
settlement and transitional services
agreement.
11/01/24 Palmer Gunderson
2.10 Research application of tax allocation rules
for sale transaction (1.3); correspond with N.
Warther and S. Zablotney re revisions to
transition services agreement (.3); review and
revise tax comments on purchase agreement
(.5).
11/01/24 Sabrina Lieberman
0.60 Conference with buyer, buyer counsel, S.
Toth, K&E team re transaction progress.
11/01/24 Dan O'Connor
4.60 Telephone conference with Company, buyer,
AlixPartners, S. Toth and K&E team re
closing matters (.5); telephone conference
with Company re executive steerco matters
(.5); review and revise TSA (.6); correspond
with Company and N. Warther re purchase
price matters (.4); correspond with
AlixPartners re 503(b)(9) and cure cost
matters (.3); review, analyze closing checklist
(.6); draft closing summary (.7); correspond
with A. Zarrabi re transaction matters (.4);
review and revise W-9s (.6).
11/01/24 Yusuf Salloum
3.50 Review, analyze sale transaction issues.
11/01/24 Steve Toth
1.40 Participate in all hands telephone conference
re transaction closing (.6); analyze closing
checklist (.3); review, analyze issues re tax
matters, allocation and intercompany issues
(.5).
11/01/24 Ali Mohammad Zarrabi
3.40 Review, analyze APA (.4); draft shell
disclosure schedules (.6); review, analyze
share transfer agreement (.8); review, analyze
issues re sale transactions (1.6).
11/02/24 Steve Toth
1.10 Discuss insurance update with Y. Salloum,
K&E team and Vyaire (.5); review, analyze
issues re same (.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 787 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050109737
48520-10
4
Date
Name
Hours Description
11/03/24 Bernadette Coppola
0.10 Correspond with D. O'Connor and K&E team
re disclosure schedules.
11/03/24 Dan O'Connor
3.10 Correspond with buyer team and advisors re
Italian closing matters (.8); review and revise
POA and quota transfer deeds for same (.8);
analyze foreign subsidiary resignation matters
(.4); correspond with Company re Australian
sale matters (.5); review, analyze closing
checklist (.6).
11/04/24 Michael Ehret
1.10 Draft overview for settlement agreement (.3);
telephone conference with Company, E.
Goetz re settlement agreement (.4);
correspond with Alix, Marsh, CS re sale (.4).
11/04/24 Luke Finn
0.60 Review, analyze issues re patents (.2); review,
analyze sale agreement and first amendment
thereto (.4).
11/04/24 Justin M. Garfinkle
0.40 Review, analyze patent issues.
11/04/24 Emanuel Goetz
0.30 Review, analyze tax issues re German
transaction.
11/04/24 Emanuel Goetz
0.40 Discuss tax issues re German transaction with
M. Ehret.
11/04/24 Emanuel Goetz
1.00 Review and revise SPA.
11/04/24 Palmer Gunderson
1.30 Revise tax comments to purchase agreement
(.7); prepare draft allocation schedule for sale
transaction (.6).
11/04/24 Sabrina Lieberman
0.60 Conference with buyer, buyer counsel, S.
Toth, K&E team re transaction progress.
11/04/24 Dan O'Connor
3.60 Conference with Company, buyer team,
AlixPartners, S. Toth, K&E team re closing
matters (.5); telephone conference with
advisors re Italy purchase agreement matters
(.5); telephone conference with Crowell re
transaction matters (.4); telephone conference
with Company re transaction matters (.6);
review and revise bills of sale and assignment
and assumption agreements (1.0); correspond
with A. Zarrabi re same (.3); review and
revise officer certificate (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 788 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050109737
48520-10
5
Date
Name
Hours Description
11/04/24 Carolin Paus
2.20 Review, analyze German notarization issues
(1.4); conference with M. Ehret and E. Goetz
re share purchase agreement re shares in MIM
(.6); correspond with D. O'Connor and K&E
team re closing (.2).
11/04/24 Yusuf Salloum
3.90 Analyze issues re sale transaction.
11/04/24 Scottie Shermetaro
0.20 Review, analyze purchased asset list and
relevant IP license agreements.
11/04/24 Steve Toth
3.60 Participate in all hands telephone conference
re transaction closing (.6); review, analyze
issues re same (.2); participate in advisors
telephone conference with Y. Salloum, K&E
team, CS and AlixPartners re same (.7);
discuss Italy PoA with D. O'Connor (.1);
analyze IP questions issues (.3); review,
analyze issues re Brazil IP matters (.6);
review, analyze APA issues (1.1).
11/04/24 Ali Mohammad Zarrabi
4.30 Draft secretary certificate (.3); review;
analyze APA (.4); review, analyze Perma
Pure schedules (.2); review; analyze bills of
sale (.3); attend meeting with Trudell re same
(.4); attend meeting re Italy transaction (.5);
review, analyze issues re transaction closing
(2.2).
11/05/24 Bernadette Coppola
0.30 Correspond with S. Shermetaro, K&E team re
asset purchase agreement.
11/05/24 Luke Finn
2.50 Review, analyze issues re license agreement
(.3); review, analyze issues re Malaysia bank
(.2); correspond with Company re
intercompany agreement schedules (.4);
review, analyze intercompany agreement
schedules (.3); correspond with buyer counsel
re intercompany agreement schedules (.2);
review, analyze Korean debt issue (.3);
review, analyze documentation re IP
assignment (.8).
11/05/24 Justin M. Garfinkle
1.00 Draft summary of rights under respective
purchase agreements.
11/05/24 Kate Hardey
0.40 Review, analyze draft disclosure schedules.
11/05/24 Sabrina Lieberman
0.60 Conference with buyer, buyer counsel, S.
Toth, K&E team re transaction progress.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 789 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050109737
48520-10
6
Date
Name
Hours Description
11/05/24 Dan O'Connor
3.10 Conference with Company, buyer team,
AlixPartners, S. Toth and other K&E team re
closing matters (.5); telephone conference
with Company and S. Toth re non-debtor
matters (.5); correspond with Company, S.
Shermetaro, K&E team re seller name matters
(.8); review, analyze closing checklist (.5);
correspond with Crowell team re employee
issues and assigned contracts (.5); correspond
with C. Paus re German transaction matters
(.3).
11/05/24 Carolin Paus
3.40 Conference with German notary re transfer of
Vyaire Medical GmbH (.6); draft sub-PoA for
notarization (.8); research re UBO
requirements for the transfer of shares (1.0);
correspond with Company re required UBO
(1.0).
11/05/24 Yusuf Salloum
4.80 Analyze issues re German structuring (3.0);
analyze issues re sale transaction (1.8).
11/05/24 Scottie Shermetaro
2.10 Telephone conference with A. Zarrabi re
disclosure schedules (.2); attend telephone
conference with Company re scope of IP
rights in acquisition (.5); review and revise
disclosure schedules (1.4).
11/05/24 Steve Toth
3.00 Participate in all hands telephone conference
re closing (.5); discuss funds flow, purchase
price and related matters with D. O'Connor,
AlixPartners and Company (.5); participate in
advisor telephone conference with Y.
Salloum, K&E team, AlixPartners and CS re
sale issues (.9); analyze issues re closing
matters (.3); discuss APA and related matters
with D. O'Connor (.2); correspond with
Company, Y. Salloum, K&E team re IP issues
re transaction (.6).
11/05/24 Donatus Wang
0.50 Review, analyze issues re share transfers (.2);
correspond with C. Paus re status of closing
workstreams (.3).
11/05/24 Ali Mohammad Zarrabi
1.40 Review, analyze schedules (.2); revise China
subsidiary bill of sale (.4); review, analyze
issues re sale transactions (.8).
11/06/24 Michael Ehret
0.70 Review, analyze comments re draft MIM SPA
(.4); review, revise draft SPA (.3).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 790 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050109737
48520-10
7
Date
Name
Hours Description
11/06/24 Luke Finn
0.40 Review, analyze i tax issues re sale.
11/06/24 Justin M. Garfinkle
0.50 Review, analyze seller name issue.
11/06/24 Emanuel Goetz
0.30 Review and revise SPA.
11/06/24 Sabrina Lieberman
0.60 Conference with buyer, buyer counsel, S.
Toth, K&E team re transaction progress.
11/06/24 Dan O'Connor
3.70 Conference with Company, buyer,
AlixPartners, S. Toth and other K&E team re
closing matters (.5); telephone conference
with Company re transaction matters (.8);
review, analyze funds flow issues (.5);
review, analyze closing materials (1.4);
correspond with A. Zarrabi re closing matters
(.5).
11/06/24 Carolin Paus
2.10 Draft sub-PoA for notarization (.7);
conference with German notary re same (.5);
correspond with Company re KYC
documentation (.5); revise SPA (.4).
11/06/24 Yusuf Salloum
3.60 Review, analyze German issues re sale
closing.
11/06/24 Scottie Shermetaro
0.50 Review, analyze diligence materials.
11/06/24 Steve Toth
1.50 Review, analyze closing matters (.2);
participate in all hands telephone conference
re closing work in process (.6); discuss buyer
issues with Company (.7).
11/06/24 Donatus Wang
0.30 Correspond with C. Paus re German SPAs.
11/06/24 Ali Mohammad Zarrabi
1.80 Review, analyze transaction documents (1.2);
conference with S. Toth, K&E team re closing
(.6).
11/07/24 Hendrik Braun
0.20 Review, analyze issues re SPA and share
transfers.
11/07/24 Hannah Crawford
0.80 Correspond with D. O’Connor re ex-US asset
and equity transfer process.
11/07/24 Luke Finn
0.60 Review, analyze issues re TSA schedules (.4);
correspond with Company re bidder escrow
(.2).
11/07/24 Sabrina Lieberman
0.40 Conference with buyer, buyer counsel, S.
Toth, K&E team re transaction progress.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 791 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050109737
48520-10
8
Date
Name
Hours Description
11/07/24 Dan O'Connor
5.40 Conference with Company, buyer team,
AlixPartners, S. Toth, K&E team re closing
matters (.5); telephone conference with
AlixPartners team, Company, other advisors
re Italy counsel onboarding (.7); prepare
amendment to APA (2.5); correspond with S.
Toth re same (.5); prepare cover amendment
to amendment to APA (.7); review, revise
closing checklist (.5).
11/07/24 Carolin Paus
0.80 Conference with M. Ehret re required closing
documents and settlement agreement.
11/07/24 Yusuf Salloum
3.40 Review, analyze issues re sale closing.
11/07/24 Steve Toth
3.80 Participate in all hands telephone conference
re closing (.5); correspond with K&E team
and AlixPartners re closing matters (.4);
analyze and revise APA amendment (1.1);
discuss same with D. O'Connor (.4); review,
analyze issues re Brazil and tax matters re
transactions (.2); correspond s with Company
and AlixPartners re transaction issues (.7);
analyze issues re bill of sale (.5).
11/07/24 Ali Mohammad Zarrabi
0.50 Telephone conference with buyer re closing
matters.
11/08/24 Hendrik Braun
0.80 Review, analyze issues re share transfers.
11/08/24 Michael Ehret
1.20 Review, analyze draft rep letter, draft SPA,
draft transfer agreement (.8); correspond with
Company re same (.4).
11/08/24 Luke Finn
0.20 Review, analyze employee issue re sale.
11/08/24 Justin M. Garfinkle
0.40 Review, analyze patent license agreement
obligations.
11/08/24 Emanuel Goetz
0.80 Revise support letters.
11/08/24 Palmer Gunderson
0.60 Correspond with N. Warther and Company re
purchase price allocation for sale transaction.
11/08/24 Sabrina Lieberman
0.50 Conference with buyer, buyer counsel, S.
Toth, K&E team re transaction progress.
11/08/24 Dan O'Connor
3.30 Conference with Company, buyer team,
AlixPartners, S. Toth, K&E team re closing
matters (.5); telephone conference with
Company re executive steerco matters (.5);
review and revise amendment to APA (1.8);
review, analyze closing checklist (.5).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 792 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050109737
48520-10
9
Date
Name
Hours Description
11/08/24 Carolin Paus
2.20 Correspond with H. Braun re requirements for
change in management (.4); draft officers'
certificate (.8); draft change‑in‑management
application with German commercial register
(.5); correspond with Company re same (.5).
11/08/24 Scottie Shermetaro
0.40 Review, analyze IP license issues related to
unacquired patents.
11/08/24 Steve Toth
2.50 Analyze correspondence from foreign counsel
re international closings (.3); participate in all
hands telephone conference re closing
checklist (.6); review, analyze issues re same
(.2); participate in advisor telephone
conference with Y. Salloum, K&E team, CS
and AlixPartners (.4); discuss closing matters
with Company and AlixPartners (.8); review,
analyze issues re same (.2).
11/08/24 Nicholas Warther
0.40 Review and analyze purchase price allocation.
11/08/24 Cristina Weidner
2.40 Comment on settlement agreement and
related SPA.
11/08/24 Ali Mohammad Zarrabi
0.50 Attend conference with buyer re closing.
11/09/24 Dan O'Connor
1.50 Conference with Company, buyer team,
AlixPartners, S. Toth and K&E team re
closing matters (.5); review and revise bills of
sale for US and foreign asset transfers (1.0).
11/09/24 Carolin Paus
2.70 Draft settlement agreement.
11/09/24 Steve Toth
0.40 Correspond with Crowell, D. O'Connor and
K&E team re closing deliverables.
11/10/24 Michael Ehret
0.90 Correspond with C. Paus, E. Goetz re closing.
11/10/24 Sabrina Lieberman
0.50 Conference with buyer, buyer counsel and
advisors, AlixPartners, S. Toth, K&E team re
closing work in process.
11/10/24 Dan O'Connor
3.90 Conference with Company, buyer team,
AlixPartners, S. Toth and other K&E team
members re closing matters (.5); telephone
conference with AlixPartners re transaction
matters (.5); correspond with AlixPartners,
other advisors re transaction matters (.9);
telephone conference with advisors re closing
checklist matters (.5); review, revise closing
checklist (1.5).
11/10/24 Carolin Paus
1.00 Review, revise settlement agreement (.6);
review, analyze issues re same (.4).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 793 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050109737
48520-10
10
Date
Name
Hours Description
11/10/24 Steve Toth
0.50 Participate in all hands telephone conference
re Trudell closing.
11/11/24 Hendrik Braun
0.50 Review, analyze issues re German
transactions.
11/11/24 Michael Ehret
1.40 Correspond with C. Weidner, C. Paus re
amendments to set-off and waiver agreement
(.4); review, revise set-off and waiver
agreement (.6); correspond with E. Goetz re
closing (.4).
11/11/24 Luke Finn
0.90 Review, analyze second amendment to asset
purchase agreement (.5); conference with
Company re closing issues (.4).
11/11/24 Sabrina Lieberman
1.40 Conference with buyer, buyer counsel, S.
Toth, K&E team re transaction progress.
11/11/24 Dan O'Connor
6.30 Conferences with Company, buyer team,
AlixPartners, S. Toth, K&E team re closing
matters (1.0); telephone conference with
Company advisors re closing matters (.8);
telephone conferences with Company,
AlixPartners team and S. Toth re transaction
matters (.5); correspond with H. Joo re South
Korea closing matters (.4); correspond with
C. Paus re closing matters (3.6).
11/11/24 Carolin Paus
6.20 Conference with C. Weider re settlement
agreement (.6); revise settlement agreement
(1.2); review, analyze issue re SPA (.7);
review, analyze issue re notarization of share
transfer agreement (1.5); conference with M.
Ehret and E. Goetz re tax and governance
issues (1.0); correspond with H. Braun re SPA
(.6); correspond with S. Toth and K&E team
re same (.6).
11/11/24 Yusuf Salloum
2.30 Prepare for closing.
11/11/24 Steve Toth
0.60 Analyze APA (.4); revise same (.2).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 794 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050109737
48520-10
11
Date
Name
Hours Description
11/11/24 Steve Toth
6.00 Analyze issues re Brazil matters (.2);
participate in all hands telephone conference
re closing (.6); analyze and draft
correspondence to foreign counsel re foreign
transfer documents (.5); discuss insurance and
funds flow with Company, AlixPartners, D.
O'Connor and K&E team (.4); discuss
Blender transaction with Company and
AlixPartners (.4); participate in second all
hand telephone conference re transaction
issues (.7); review, analyze issues re APA,
closing and related APA documents and
drafts (2.2); conference with D. O'Connor,
K&E team, AlixPartners and Company re
revised APA (.5); conference with D.
O'Connor and Crowell re same (.5).
11/11/24 Donatus Wang
0.30 Review, analyze issues re intercompany
receivables agreement (.1); review, analyze
issues re closing (.2).
11/11/24 Ali Mohammad Zarrabi
2.30 Review, analyze outstanding issues re
transaction.
11/12/24 Hendrik Braun
1.40 Review, analyze draft notarial deed and draft
share transfer agreement.
11/12/24 Michael Ehret
1.00 Correspond with Company advisors re
transfer agreement (.3); correspond with Alix,
Marsh re payment of premium, emails,
organization of closing steps (.7).
11/12/24 Luke Finn
0.30 Review, analyze issues re TSA.
11/12/24 Emanuel Goetz
0.40 Conference with Company, M. Ehret re post-
closing issues.  ds MIM-Transfer.
11/12/24 Emanuel Goetz
0.10 Conference with M. Ehret re post-closing
issues.
11/12/24 Sabrina Lieberman
0.40 Conference with buyer, buyer counsel, S.
Toth, K&E team re transaction progress.
11/12/24 Dan O'Connor
5.90 Conference with Company, buyer,
AlixPartners, S. Toth, K&E team re closing
matters (.5); telephone conference with
advisor re non-debtor assets (.5); attend
closing telephone conference (.4); review,
analyze closing matters (3.9); correspond with
S. Toth, K&E team re same (.6).
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 795 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Invoice Number:
Matter Number:
1050109737
48520-10
12
Date
Name
Hours Description
11/12/24 Carolin Paus
4.10 Conference with H. Braun and M. Ehret re
share purchase documentation (2.1);
telephone conference with advisor re same
(.5) telephone conference with German notary
re share transfer issues (.9); correspond with
M. Ehret and Company re settlement
agreement (.6).
11/12/24 Yusuf Salloum
2.40 Close sale transactions.
11/12/24 Steve Toth
7.30 Analyze issues re closing matters (2.7);
correspond with AlixPartners and Y. Salloum
re closing (.1); participate in all hands
telephone conference re Trudell closing (.4);
analyze revised closing documents (1.3);
analyze issues re Brazil matters (.6); analyze
issues re final closing matters (.9); correspond
with D. O'Connor and Crowell re closing
matters and schedule (.4); finalize closing
matters and documents (.8); close transaction
with all hands telephone conference (.1).
11/12/24 Donatus Wang
0.20 Review, analyze issues re share transfer.
11/12/24 Ali Mohammad Zarrabi
2.70 Review, analyze APA (.4); prepare disclosure
schedules (.6); review, analyze issues re
closing (1.7).
11/13/24 Hendrik Braun
0.50 Review, analyze issues re closing re German
transactions.
11/13/24 Dan O'Connor
2.50 Review, analyze post‑closing issues (1.9);
correspond with CS, S. Toth, K&E team re
same (.6).
11/13/24 Steve Toth
1.80 Analyze APA (.6); review, analyze issues re
closing documents (.3); review, analyze issues
re potential transactions (.3); correspond with
D. O'Connor and AlixPartners re TSA issues
(.4); correspond with D. O’Connor, K&E
team and AlixPartners re same (.2).
11/13/24 Ali Mohammad Zarrabi
6.70 Review and revise APA and disclosure
schedules (1.2); correspond with various
parties re Blender APA and treatment of
ZOLL/Trudell equipment in Brazil (2.1);
review, analyze issues re sale transactions
(3.4).
Total
192.40
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 796 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 18, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050109738
Client Matter: 48520-12
In the Matter of Business Operations
For legal services rendered through November 14, 2024
(see attached Description of Legal Services for detail)
$ 97.50
Total legal services rendered
$ 97.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 797 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050109738
48520-12
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Sabrina Lieberman
0.10
975.00
97.50
TOTALS
0.10
$ 97.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 798 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Business Operations
Invoice Number:
Matter Number:
1050109738
48520-12
3
Description of Legal Services
Date
Name
Hours Description
11/07/24 Sabrina Lieberman
0.10 Conference with vendor re outstanding issue.
Total
0.10
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 799 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 18, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050109739
Client Matter: 48520-17
In the Matter of Hearings
For legal services rendered through November 14, 2024
(see attached Description of Legal Services for detail)
$ 8,212.50
Total legal services rendered
$ 8,212.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 800 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Hearings
Invoice Number:
Matter Number:
1050109739
48520-17
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Tiffani Chanroo
0.50
1,345.00
672.50
Amy Donahue
0.50
525.00
262.50
Yusuf Salloum
3.40
1,595.00
5,423.00
Seth Sanders
0.80
1,265.00
1,012.00
Spencer A. Winters, P.C.
0.50
1,685.00
842.50
TOTALS
5.70
$ 8,212.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 801 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Hearings
Invoice Number:
Matter Number:
1050109739
48520-17
3
Description of Legal Services
Date
Name
Hours Description
11/14/24 Tiffani Chanroo
0.50 Telephonically attend confirmation hearing.
11/14/24 Amy Donahue
0.50 Assist attorneys to monitor lines
re confirmation hearing.
11/14/24 Yusuf Salloum
3.40 Attend confirmation hearing (.4); prepare for
same (3.0).
11/14/24 Seth Sanders
0.80 Telephonically attend confirmation hearing
(.5); prepare for same (.3).
11/14/24 Spencer A. Winters, P.C.
0.50 Attend confirmation hearing (.4); prepare for
same (.1).
Total
5.70
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 802 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 18, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050109740
Client Matter: 48520-18
In the Matter of Insurance and Surety Matters
For legal services rendered through November 14, 2024
(see attached Description of Legal Services for detail)
$ 23,065.00
Total legal services rendered
$ 23,065.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 803 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050109740
48520-18
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Michael Ehret
7.60
1,895.00
14,402.00
Emanuel Goetz
7.40
750.00
5,550.00
Palmer Gunderson
0.20
995.00
199.00
Dan O'Connor
0.50
1,345.00
672.50
William T. Pruitt
0.80
1,695.00
1,356.00
Seth Sanders
0.70
1,265.00
885.50
TOTALS
17.20
$ 23,065.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 804 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050109740
48520-18
3
Description of Legal Services
Date
Name
Hours Description
11/01/24 Palmer Gunderson
0.20 Correspond with M. Ehret re insurance
policy.
11/02/24 William T. Pruitt
0.30 Review company indemnification provisions
and D&O insurance policy (.2); correspond
with Y. Salloum and S. Sanders re same (.1).
11/05/24 Michael Ehret
1.80 Correspond with Alix, Marsh re insurance
policy (.4); telephone conference with
Deloitte re comments on insurance policy
(.3); correspond with Marsh re final insurance
policy (.4); review, analyze issues re
insurance policy (.7).
11/05/24 Emanuel Goetz
0.80 Review, revise insurance policy.
11/05/24 Emanuel Goetz
0.30 Review, analyze insurance issue.
11/05/24 Emanuel Goetz
0.70 Conference with M. Ehret re insurance policy.
11/06/24 Michael Ehret
1.90 Review, analyze revised insurance policy (.6);
correspond with E. Goetz re same
(.3); review, analyze insurance policy (.6);
correspond with various parties re finalization
of insurance policy (.2); correspond with E.
Goetz, K&E team, Company re insurance
premium (.2).
11/06/24 Emanuel Goetz
0.80 Review and revise insurance policy draft.
11/06/24 Emanuel Goetz
0.50 Review, analyze issues re tax insurance.
11/07/24 Michael Ehret
1.30 Review revised draft policy (.6); correspond
with Alix, Marsh re status (.4); correspond
with E. Goetz, re documentation finalization
documents, closing preparation (.3).
11/07/24 Emanuel Goetz
0.30 Review, analyze issues re tax insurance.
11/07/24 Emanuel Goetz
1.60 Revise insurance representation letter and
support letters.
11/08/24 Emanuel Goetz
0.20 Conference with M. Ehret re insurance.
11/11/24 Michael Ehret
1.10 Telephone conference with Company re to
funding of insurance premium (.5);
correspond with various parties re preparation
of rep letters for insurance policy (.6).
11/11/24 Emanuel Goetz
0.40 Draft representation letter re tax insurance.
11/11/24 Emanuel Goetz
1.00 Review, analyze issues re tax insurance.
11/11/24 Emanuel Goetz
0.60 Telephone conference with S. Toth, K&E
team, AlixPartners re tax insurance.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 805 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Insurance and Surety Matters
Invoice Number:
Matter Number:
1050109740
48520-18
4
Date
Name
Hours Description
11/11/24 Dan O'Connor
0.50 Correspond with Y. Salloum and M. Ehret re
insurance policy matters.
11/12/24 Michael Ehret
0.60 Conference with Company re set-off, amounts
(.2); correspond with E. Goetz, buyer,
Deloitte re insurance policy (.4).
11/12/24 William T. Pruitt
0.50 Analyze D&O tail coverage (.4); telephone
conference with S. Sanders re same (.1).
11/13/24 Michael Ehret
0.90 Correspond with E. Goetz re insurance
premium (.4); correspond with Marsh,
Company re status of insurance issues (.5).
11/13/24 Emanuel Goetz
0.20 Correspond with Marsh re tax insurance.
11/13/24 Seth Sanders
0.70 Analyze issues re wind down, D&O tail (.3);
telephone conference with W. Pruitt re same
(.1); correspond with Y. Salloum, K&E team
re same (.3).
Total
17.20
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 806 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 18, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050109741
Client Matter: 48520-20
In the Matter of Tax Matters
For legal services rendered through November 14, 2024
(see attached Description of Legal Services for detail)
$ 64,547.50
Total legal services rendered
$ 64,547.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 807 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050109741
48520-20
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Michael Ehret
30.50
1,895.00
57,797.50
Emanuel Goetz
9.00
750.00
6,750.00
TOTALS
39.50
$ 64,547.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 808 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050109741
48520-20
3
Description of Legal Services
Date
Name
Hours Description
11/01/24 Michael Ehret
2.70 Telephone conference with Certa, Clifford
Chance, Alix re negotiation of insurance
policy, implications, structuring
considerations (.4); prepare for same (.3);
correspond with Alix, Marsh, re same (.1);
review, analyze draft policy (.4); correspond
with Trudell, Deloitte re to insurance policy
(.3); correspond with Company ire exhibits to
settlement agreement (.5); correspond with
Alix, Marsh re figures, overview (.4); review,
analyze tax issues (.3).
11/02/24 Michael Ehret
1.20 Review analyze revised tax insurance policy
issues (.4); draft responses for same (.2);
attendance telephone conference with
Company, S. Toth re same (.3); review,
analyze tax issues (.3).
11/03/24 Michael Ehret
1.30 Telephone conference with Trudell, Deloitte
re tax matters related to insurance policy (.3);
correspond with Alix, Marsh re same (.4);
review, analyze tax issues (.6).
11/04/24 Michael Ehret
4.80 Correspond with E. Goetz, Company re tax
issues related to intercompany transactions
(.4); review analyze tax materials, schedule of
intercompany transactions (.4); telephone
conference with Company, E. Goetz re
intercompany transactions (.5); review, revise
draft overview of same (.6); review, analyze
tax issues (2.9).
11/04/24 Emanuel Goetz
0.50 Conference with Company and M. Ehret re
intercompany settlement re tax issues.
11/04/24 Emanuel Goetz
1.00 Review, analyze intercompany settlement
agreement re tax issues.
11/04/24 Emanuel Goetz
0.90 Conference with Company, M. Ehret re tax
issues re intercompany settlement.
11/04/24 Emanuel Goetz
0.50 Conference with M. Ehret and Company re
intercompany settlement re tax issues.
11/05/24 Michael Ehret
3.40 Review, analyze tax issues re intercompany
settlement.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 809 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Tax Matters
Invoice Number:
Matter Number:
1050109741
48520-20
4
Date
Name
Hours Description
11/06/24 Michael Ehret
4.10 Telephone conference with Company re
intercompany transactions (.4); correspond
with E. Goetz re closing preparations (.3);
review, analyze tax issues re same (3.4).
11/06/24 Emanuel Goetz
0.30 Conference with Company and M. Ehret re
MIM-transfer.
11/06/24 Emanuel Goetz
0.40 Discuss MIM transfer with C. Paus.
11/07/24 Michael Ehret
1.60 Review, analyze tax issues re intercompany
settlement.
11/07/24 Emanuel Goetz
0.30 Correspond with M. Ehret re MIM transfer
and tax insurance.
11/07/24 Emanuel Goetz
0.60 Review, analyze issues re MIM transfer and
tax insurance.
11/08/24 Michael Ehret
1.70 Review, analyze tax issues re intercompany
settlement.
11/10/24 Michael Ehret
1.90 Review, analyze tax issues re intercompany
settlement.
11/10/24 Emanuel Goetz
0.50 Review and revise settlement agreement re
tax issues.
11/11/24 Michael Ehret
3.30 Correspond with Alix, Marsh re intercompany
tax issues (.4); review, analyze tax issues re
same (2.9).
11/11/24 Emanuel Goetz
0.20 Conference with M. Ehret re intercompany
issues.
11/11/24 Emanuel Goetz
0.30 Review, analyze transfer documents.
11/11/24 Emanuel Goetz
0.90 Conference with M. Ehret re intercompany
settlement tax issues.
11/11/24 Emanuel Goetz
0.40 Conference with M. Ehret re intercompany
settlement tax issues.
11/11/24 Emanuel Goetz
1.40 Revise intercompany settlement agreement
(.9); correspond with M. Ehret re tax issues
(.5).
11/12/24 Michael Ehret
3.70 Review, analyze tax issues re intercompany
settlement.
11/12/24 Emanuel Goetz
0.50 Revise STA.
11/12/24 Emanuel Goetz
0.30 Review, analyze tax issues re intercompany
settlement.
11/13/24 Michael Ehret
0.80 Review, analyze tax issues re intercompany
settlement.
Total
39.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 810 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 18, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050109742
Client Matter: 48520-21
In the Matter of Case Administration
For legal services rendered through November 14, 2024
(see attached Description of Legal Services for detail)
$ 6,549.00
Total legal services rendered
$ 6,549.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 811 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050109742
48520-21
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
1.20
1,395.00
1,674.00
Sabrina Lieberman
5.00
975.00
4,875.00
TOTALS
6.20
$ 6,549.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 812 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Case Administration
Invoice Number:
Matter Number:
1050109742
48520-21
3
Description of Legal Services
Date
Name
Hours Description
11/04/24 Sabrina Lieberman
0.60 Conference with Y. Salloum, Cole Schotz,
AlixPartners re work in process.
11/05/24 Sabrina Lieberman
1.10 Conference with Y. Salloum, Cole Schotz,
AlixPartners re work in process.
11/06/24 Sabrina Lieberman
0.40 Conference with Y. Salloum, Cole Schotz,
AlixPartners re work in process.
11/08/24 Sabrina Lieberman
1.00 Conference with Y. Salloum, Cole Schotz,
AlixPartners re work in process.
11/11/24 Sabrina Lieberman
0.20 Conference with Y. Salloum, Cole Schotz,
AlixPartners re work in process.
11/12/24 Sabrina Lieberman
0.80 Draft internal memorandum re sales and
confirmation.
11/13/24 Sabrina Lieberman
0.50 Review, revise internal memorandum re sales
and confirmation.
11/14/24 Chris Ceresa
1.20 Review, analyze issues re work in process.
11/14/24 Sabrina Lieberman
0.40 Draft internal memorandum re sales and
confirmation.
Total
6.20
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 813 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 18, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050109743
Client Matter: 48520-22
In the Matter of Retention - K&E
For legal services rendered through November 14, 2024
(see attached Description of Legal Services for detail)
$ 38,594.50
Total legal services rendered
$ 38,594.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 814 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050109743
48520-22
2
Summary of Hours Billed
Name
Hours
Rate
Amount
Chris Ceresa
0.30
1,395.00
418.50
Tiffani Chanroo
13.20
1,345.00
17,754.00
Susan D. Golden
5.80
1,600.00
9,280.00
Sabrina Lieberman
11.10
975.00
10,822.50
Tanzila Zomo
0.90
355.00
319.50
TOTALS
31.30
$ 38,594.50
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 815 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050109743
48520-22
3
Description of Legal Services
Date
Name
Hours Description
11/01/24 Tiffani Chanroo
2.40 Correspond with Y. Salloum re interim fee
application (.2); review, revise September
invoice for confidentiality and privilege (2.2).
11/01/24 Sabrina Lieberman
1.00 Review, revise September invoice for
confidentiality and privilege (.7); review,
revise interim fee application (.3).
11/02/24 Sabrina Lieberman
0.70 Review, revise interim fee application.
11/03/24 Tiffani Chanroo
1.20 Review, revise interim fee application.
11/03/24 Sabrina Lieberman
1.70 Review, revise September invoice for
confidentiality and privilege (.2); review,
revise interim fee application (1.5).
11/04/24 Chris Ceresa
0.30 Correspond with S. Lieberman and K&E team
re open items re K&E retention.
11/04/24 Sabrina Lieberman
1.00 Correspond with Y. Salloum re supplemental
declarations (.1); correspond with T. Chanroo,
K&E team re interim fee application (.1);
review, revise interim fee application (.8).
11/05/24 Tiffani Chanroo
1.40 Review, revise interim fee application (1.3);
correspond with S. Lieberman re same (.1).
11/05/24 Susan D. Golden
1.20 Review and revise K&E first interim fee
application (1.1); correspond with S.
Lieberman re same (.1).
11/05/24 Sabrina Lieberman
1.30 Conference with T. Chanroo, K&E team re
K&E interim fee application (.1); review,
revise same (1.2).
11/06/24 Tiffani Chanroo
1.20 Review, revise interim fee application (1.1);
correspond with S. Lieberman re same (.1).
11/06/24 Susan D. Golden
0.70 Review revised interim fee application (.5);
correspond with S. Lieberman re same (.2).
11/06/24 Sabrina Lieberman
0.70 Correspond with S. Winters, K&E team re fee
application (.5); review, revise same (.2).
11/07/24 Tiffani Chanroo
0.40 Correspond with S. Lieberman, K&E team re
interim fee application.
11/07/24 Susan D. Golden
0.60 Correspond with S. Lieberman re additional
comments to K&E first interim fee
application.
11/07/24 Sabrina Lieberman
0.50 Correspond with S. Winters, K&E team re
interim fee application.
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 816 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Retention - K&E
Invoice Number:
Matter Number:
1050109743
48520-22
4
Date
Name
Hours Description
11/08/24 Susan D. Golden
3.30 Review, analyze September invoice for
privilege and confidentiality.
11/08/24 Sabrina Lieberman
1.20 Review, revise fee application (.2);
correspond with S. Golden, K&E team re
same (.8); correspond with T. Chanroo re
interim fee application (.2).
11/08/24 Tanzila Zomo
0.90 Draft K&E fee application.
11/11/24 Tiffani Chanroo
0.20 Correspond with S. Lieberman re interim fee
application.
11/12/24 Tiffani Chanroo
3.40 Review, revise interim fee application (3.1);
correspond with S. Lieberman re same (.3).
11/12/24 Sabrina Lieberman
0.90 Review, revise interim fee application (.5);
correspond with T. Chanroo re same (.4).
11/13/24 Tiffani Chanroo
2.40 Correspond with Y. Salloum, K&E team re
interim fee application (.4); review, analyze
issues re same (1.8); correspond with Y.
Salloum re same (.2).
11/13/24 Sabrina Lieberman
1.80 Review, revise interim fee application.
11/14/24 Tiffani Chanroo
0.60 Correspond with S. Lieberman re September
fee application.
11/14/24 Sabrina Lieberman
0.30 Correspond with T. Chanroo, K&E team re
fee application.
Total
31.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 817 of 914

Exhibit J

Detailed Description of Expenses and Disbursements
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 818 of 914

June 9, 2024 – June 30, 2024
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 819 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
August 29, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050102712
Client Matter: 48520-26
In the Matter of Expenses
For expenses incurred through June 30, 2024
(see attached Description of Expenses for detail)
$ 25,041.09
Total expenses incurred
$ 25,041.09
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 820 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
2
Description of Expenses
Description
Amount
Standard Copies or Prints
357.30
Color Copies or Prints
454.30
Local Transportation
62.79
Travel Expense
1,344.44
Airfare
2,133.93
Transportation to/from airport
386.99
Travel Meals
37.98
Other Court Costs and Fees
10,350.90
Working Meals/K&E Only
978.89
Outside Retrieval Service
2,074.20
Computer Database Research
77.00
Westlaw Research
893.17
Overtime Transportation
386.74
Overtime Meals - Attorney
117.63
Rental Expenses
5,142.16
Overnight Delivery - Hard
242.67
Total
$ 25,041.09
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 821 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
3
Description of Expenses
Standard Copies or Prints
Date
Description
Amount
06/09/24
Standard Copies or Prints
23.10
06/09/24
Standard Copies or Prints
6.30
06/09/24
Standard Copies or Prints
2.20
06/09/24
Standard Copies or Prints
35.10
06/09/24
Standard Copies or Prints
3.60
06/09/24
Standard Copies or Prints
3.40
06/10/24
Standard Copies or Prints
81.90
06/10/24
Standard Copies or Prints
27.40
06/10/24
Standard Copies or Prints
1.20
06/10/24
Standard Copies or Prints
16.80
06/10/24
Standard Copies or Prints
29.50
06/10/24
Standard Copies or Prints
32.60
06/10/24
Standard Copies or Prints
0.90
06/10/24
Standard Copies or Prints
7.40
06/11/24
Standard Copies or Prints
1.40
06/11/24
Standard Copies or Prints
0.10
06/11/24
Standard Copies or Prints
1.00
06/12/24
Standard Copies or Prints
0.30
06/13/24
Standard Copies or Prints
1.40
06/13/24
Standard Copies or Prints
4.80
06/13/24
Standard Copies or Prints
2.00
06/18/24
Standard Copies or Prints
2.10
06/18/24
Standard Copies or Prints
0.70
06/18/24
Standard Copies or Prints
1.30
06/18/24
Standard Copies or Prints
14.80
06/20/24
Standard Copies or Prints
11.20
06/20/24
Standard Copies or Prints
2.00
06/20/24
Standard Copies or Prints
7.90
06/23/24
Standard Copies or Prints
9.10
06/25/24
Standard Copies or Prints
2.40
06/25/24
Standard Copies or Prints
3.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 822 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
4
06/25/24
Standard Copies or Prints
9.00
06/26/24
Standard Copies or Prints
6.60
06/27/24
Standard Copies or Prints
4.70
06/27/24
Standard Copies or Prints
0.10
Total
357.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 823 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
5
Color Copies or Prints
Date
Description
Amount
06/09/24
Color Copies or Prints
67.65
06/10/24
Color Copies or Prints
118.80
06/10/24
Color Copies or Prints
7.15
06/11/24
Color Copies or Prints
6.05
06/11/24
Color Copies or Prints
0.55
06/12/24
Color Copies or Prints
0.55
06/12/24
Color Copies or Prints
0.55
06/13/24
Color Copies or Prints
66.00
06/18/24
Color Copies or Prints
17.60
06/20/24
Color Copies or Prints
71.50
06/25/24
Color Copies or Prints
60.50
06/25/24
Color Copies or Prints
31.90
06/27/24
Color Copies or Prints
5.50
Total
454.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 824 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
6
Local Transportation
Date
Description
Amount
06/09/24
Tiffani Chanroo - Taxi, transportation in connection with case
filing 06/09/2024
14.08
06/10/24
Tiffani Chanroo -Taxi, transportation in connection with case
filing 06/10/2024
15.71
06/10/24
Tiffani Chanroo - Taxi, transportation in connection with case
filing 06/10/2024
14.69
06/10/24
Tiffani Chanroo - Taxi, transportation - in connection with case
filing 06/10/2024
18.31
Total
62.79
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 825 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
7
Travel Expense
Date
Description
Amount
06/10/24
Julia R. Foster - Lodging, Wilmington, DE, First Day Hearing
257.64
06/10/24
Tiffani Chanroo - Lodging, DE Dupont, First Day Hearing
548.90
06/10/24
Yusuf Salloum - Lodging, Wilmington, DE, First Day Hearing
537.90
Total
1,344.44
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 826 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
8
Airfare
Date
Description
Amount
06/10/24
Julia R. Foster - Agency Fee
58.00
06/10/24
Julia R. Foster – Airfare (Coach) from Philadelphia to Wilmington,
DE, First Day Hearing
805.75
06/10/24
Sabrina Lieberman – Rail, New York to Wilmington, First Day
Hearing
205.20
06/10/24
Sabrina Lieberman - Agency Fee
58.00
06/10/24
Tiffani Chanroo – Rail, New York to Wilmington, First Day
Hearing
205.20
06/10/24
Tiffani Chanroo - Agency Fee
58.00
06/10/24
Yusuf Salloum - Agency Fee
58.00
06/10/24
Yusuf Salloum - Rail, NY to Wilmington, First Day Hearing
162.90
06/11/24
Tiffani Chanroo - Agency Fee
58.00
06/11/24
Tiffani Chanroo - Rail, Wilmington to New York, First Day
Hearing
205.20
06/11/24
Yusuf Salloum - Agency Fee
58.00
06/11/24
Yusuf Salloum – Airfare (Coach), Chicago to Wilmington, First
Day Hearing
201.68
Total
2,133.93
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 827 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
9
Transportation to/from airport
Date
Description
Amount
06/11/24
Julia R. Foster - Transportation from airport to residence
06/11/2024
135.88
06/20/24
Jaina Desai – Transportation from hotel to airport 6/20/2024
114.06
06/20/24
Jaina Desai – Transportation from airport to residence 6/20/2024
137.05
Total
386.99
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 828 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
10
Travel Meals
Date
Description
Amount
06/10/24
Julia R. Foster – Travel Meals, Wilmington Dinner
28.23
06/11/24
Julia R. Foster – Travel Meals, Wilmington Breakfast
9.75
Total
37.98
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 829 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
11
Other Court Costs and Fees
Date
Description
Amount
06/17/24
Miller Advertising Agency Inc - Publication of notice in New York
Times (Business)
10,350.90
Total
10,350.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 830 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
12
Working Meals/K&E Only
Date
Description
Amount
06/09/24
Sabrina Lieberman – NY Dinner, working meal (Sabrina
Lieberman, Chris Ceresa, Tiffani Chanroo, Rebecca J. Marston,
Kyle Nolan Trevett, Seth Sanders, David Hackel, Sarah Osborne,
Jaina Desai, Quin Wetzel, Kenny Chiaghana) 06/09/2024
355.29
06/09/24
Sabrina Lieberman – NY Dinner, working meal (Sabrina
Lieberman, Chris Ceresa, Tiffani Chanroo, Rebecca J. Marston,
Kyle Nolan Trevett, Seth Sanders, David Hackel, Sarah Osborne,
Jaina Desai, Quin Wetzel, Kenny Chiaghana) 06/09/2024
558.39
06/26/24
Carolin Paus – Germany Dinner, working meal (Carolin Paus, Paul
Paefgen) 06/26/2024
25.21
06/27/24
Nicholas Warther – CH Dinner, working meal 06/27/2024
40.00
Total
978.89
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 831 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
13
Outside Retrieval Service
Date
Description
Amount
06/10/24
CSC - Status/information search.
2,074.20
Total
2,074.20
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 832 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
14
Computer Database Research
Date
Description
Amount
06/14/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 05/2024 by Jaina Desai
54.00
06/14/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 05/2024 by Joshua Raphael
23.00
Total
77.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 833 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
15
Westlaw Research
Date
Description
Amount
06/17/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Opperman, Chase M. on
6/17/2024
141.05
06/18/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Opperman, Chase M. on
6/18/2024
508.70
06/26/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Chiaghana, Kenechi on
6/26/2024
23.35
06/28/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Welch, Melinda on 6/28/2024
23.35
06/28/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Burton, Brenda on 6/28/2024
196.72
Total
893.17
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 834 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
16
Overtime Transportation
Date
Description
Amount
06/09/24
David Hackel – Taxi, overtime transportation from NY office to
residence.
19.81
06/10/24
David Hackel – Taxi, overtime transportation to NY office from
residence.
41.98
06/10/24
David Hackel – Taxi, overtime transportation from NY office to
residence.
23.72
06/10/24
Sabrina Lieberman – Taxi, overtime transportation from NY office
to hotel
18.40
06/11/24
Donatus Wang – Taxi, overtime transportation.
19.12
06/13/24
Sabrina Lieberman – Taxi, overtime transportation from CH office
to residence
31.79
06/18/24
Sabrina Lieberman – Taxi, overtime transportation from CH office
to residence.
33.77
06/23/24
Sabrina Lieberman – Taxi, overtime transportation from CH office
to residence
13.88
06/23/24
Sabrina Lieberman – Taxi, overtime transportation from residence
to CH office.
10.66
06/25/24
Sabrina Lieberman - Taxi, overtime transportation from CH office
to residence
26.25
06/25/24
Donatus Wang - Taxi, overtime transportation.
20.06
06/26/24
Sabrina Lieberman - Taxi, overtime transportation from CH office
to residence.
24.68
06/26/24
Scottie Shermetaro - Taxi, overtime transportation from CH office
to residence.
43.70
06/27/24
Nicholas Warther - Taxi, overtime transportation from CH office
to residence.
58.92
Total
386.74
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 835 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
17
Overtime Meals - Attorney
Date
Description
Amount
06/16/24
Han Yoonie 6/11/2024 OT Meal
35.46
06/23/24
Sabrina Lieberman - Sabrina Lieberman, Overtime Meals -
Attorney, Chicago, IL Overtime meal in office. Sabrina Lieberman
06/23/2024
13.17
06/23/24
Sabrina Lieberman - Sabrina Lieberman, Overtime Meals -
Attorney, Chicago, IL Overtime meal in office. Sabrina Lieberman
06/23/2024
2.53
06/25/24
Sabrina Lieberman - Sabrina Lieberman, Overtime Meals -
Attorney, Chicago, IL Overtime meal in office. Sabrina Lieberman
06/25/2024
26.47
06/26/24
Scottie Shermetaro - Scottie Shermetaro, Overtime Meals -
Attorney, Chicago Document review. Scottie Shermetaro
06/26/2024
40.00
Total
117.63
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 836 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
18
Rental Expenses
Date
Description
Amount
06/14/24
Aquipt Holdings LLC - Rental Expenses
4,325.60
06/14/24
Aquipt Holdings LLC - Rental Expenses
816.56
Total
5,142.16
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 837 of 914

Legal Services for the Period Ending June 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050102712
48520-26
19
Overnight Delivery - Hard
Date
Description
Amount
06/17/24
FEDERAL EXPRESS - 776794772737
242.67
Total
242.67
TOTAL EXPENSES
$ 25,041.09
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 838 of 914

July 2024
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 839 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 2, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050104453
Client Matter: 48520-26
In the Matter of Expenses
For expenses incurred through July 31, 2024
(see attached Description of Expenses for detail)
$ 33,951.83
Total expenses incurred
$ 33,951.83
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 840 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
2
Description of Expenses
Description
Amount
Standard Copies or Prints
91.10
Color Copies or Prints
623.15
Local Transportation
51.98
Travel Expense
806.90
Airfare
1,161.36
Transportation to/from airport
1,517.95
Travel Meals
89.52
Other Court Costs and Fees
21,857.76
Working Meals/K&E Only
40.00
Outside Retrieval Service
283.36
Computer Database Research
1,634.62
Westlaw Research
4,591.34
LexisNexis Research
684.41
Overtime Transportation
70.87
Overtime Meals - Attorney
337.61
Computer Database Research - Soft
109.90
Total
$ 33,951.83
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 841 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
3
Description of Expenses
Standard Copies or Prints
Date
Description
Amount
07/01/24
Standard Copies or Prints
1.10
07/02/24
Standard Copies or Prints
1.40
07/02/24
Standard Copies or Prints
2.00
07/03/24
Standard Copies or Prints
0.60
07/03/24
Standard Copies or Prints
0.40
07/03/24
Standard Copies or Prints
4.80
07/08/24
Standard Copies or Prints
9.00
07/09/24
Standard Copies or Prints
3.60
07/09/24
Standard Copies or Prints
5.20
07/10/24
Standard Copies or Prints
1.60
07/10/24
Standard Copies or Prints
1.60
07/10/24
Standard Copies or Prints
0.50
07/11/24
Standard Copies or Prints
26.00
07/11/24
Standard Copies or Prints
0.60
07/15/24
Standard Copies or Prints
1.60
07/16/24
Standard Copies or Prints
6.90
07/16/24
Standard Copies or Prints
2.40
07/16/24
Standard Copies or Prints
2.60
07/16/24
Standard Copies or Prints
0.20
07/17/24
Standard Copies or Prints
3.10
07/17/24
Standard Copies or Prints
0.20
07/18/24
Standard Copies or Prints
0.20
07/23/24
Standard Copies or Prints
1.20
07/23/24
Standard Copies or Prints
0.10
07/24/24
Standard Copies or Prints
2.40
07/25/24
Standard Copies or Prints
2.60
07/26/24
Standard Copies or Prints
1.60
07/29/24
Standard Copies or Prints
0.10
07/30/24
Standard Copies or Prints
3.50
07/31/24
Standard Copies or Prints
2.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 842 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
4
07/31/24
Standard Copies or Prints
2.00
Total
91.10
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 843 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
5
Color Copies or Prints
Date
Description
Amount
07/01/24
Color Copies or Prints
5.50
07/02/24
Color Copies or Prints
66.00
07/09/24
Color Copies or Prints
2.75
07/10/24
Color Copies or Prints
10.45
07/11/24
Color Copies or Prints
0.55
07/11/24
Color Copies or Prints
1.10
07/11/24
Color Copies or Prints
31.35
07/16/24
Color Copies or Prints
79.20
07/16/24
Color Copies or Prints
1.10
07/17/24
Color Copies or Prints
193.60
07/17/24
Color Copies or Prints
1.10
07/23/24
Color Copies or Prints
2.75
07/24/24
Color Copies or Prints
92.40
07/26/24
Color Copies or Prints
1.65
07/29/24
Color Copies or Prints
3.30
07/30/24
Color Copies or Prints
59.95
07/31/24
Color Copies or Prints
17.60
07/31/24
Color Copies or Prints
52.80
Total
623.15
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 844 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
6
Local Transportation
Date
Description
Amount
07/11/24
Nicholas Warther - overtime transportation.
51.98
Total
51.98
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 845 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
7
Travel Expense
Date
Description
Amount
07/08/24
Julia R. Foster - hotel for Second Day Hearing
317.90
07/08/24
Yusuf Salloum - hotel for Second Day Hearing
489.00
Total
806.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 846 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
8
Airfare
Date
Description
Amount
07/02/24
Julia R. Foster – agency expense related to airfare to hearing.
58.00
07/02/24
Julia R. Foster ‑ airfare to hearing.
579.78
07/02/24
Spencer A. Winters, P.C. ‑ airfare to hearing
465.58
07/02/24
Spencer A. Winters, P.C. ‑ agency expense related to airfare to
hearing.
58.00
Total
1,161.36
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 847 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
9
Transportation to/from airport
Date
Description
Amount
06/14/24
BOSTON COACH CORPORATION - 06/10/2024 JULIA
FOSTER Pick Up at 333 W Wolf Point Plz CHICAGO IL 60654
and Drop Off at ORD OHare International Airport Chicago/United
Airlines/1776
143.28
06/14/24
Julia Foster – Transport from airport in Philadelphia to hotel in
Wilmington, DE.
198.00
06/30/24
Julia Foster – Transport from airport in Chicago to home in
Chicago.
134.61
07/09/24
Julia R. Foster ‑ Transport from airport to hotel on July 8, 2024.
136.29
07/12/24
Julia R. Foster ‑ Transport from hotel to airport on July 8, 2024.
197.00
07/17/24
Spencer A. Winters - Transport from airport to hotel on July 8,
2024
181.75
07/31/24
Julia R. Foster – Transport from airport to home on July 9, 2024.
134.61
07/31/24
Julia R. Foster ‑ Transport from home to airport on July 8, 2024.
130.61
07/31/24
Spencer A. Winters - Transport from airport to home on July 8,
2024.
132.90
07/31/24
Tabitha De Paulo – Transport from residence to airport on July 8,
2024
128.90
Total
1,517.95
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 848 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
10
Travel Meals
Date
Description
Amount
07/08/24
Julia R. Foster - Julia R. Foster, Hotel - Travel Meals, Wilmington,
DE Traveled to Delaware for Vyaire hearing (lunch) 07/08/2024
16.52
07/08/24
Julia R. Foster - Julia R. Foster, Hotel - Travel Meals, Wilmington,
DE Traveled to Delaware for Vyaire hearing (dinner) 07/08/2024
50.00
07/09/24
Julia R. Foster - Julia R. Foster, Hotel - Travel Meals, Wilmington,
DE Traveled to Delaware for Vyaire hearing Julia R. Foster
07/09/2024
23.00
Total
89.52
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 849 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
11
Other Court Costs and Fees
Date
Description
Amount
07/11/24
Miller Advertising Agency Inc - Publication of Vyaire Bar Date
Notice in the New York Times (Business)
9,564.76
07/15/24
Miller Advertising Agency Inc - Publication of Vyaire Bid
Procedures / Sale Notice in the New York Times (National edition)
12,293.00
Total
21,857.76
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 850 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
12
Working Meals/K&E Only
Date
Description
Amount
07/30/24
Nicholas Warther - Nicholas Warther, Working Meal/K and E
Only, Chicago Dinner at the office. Nicholas Warther 07/30/2024
40.00
Total
40.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 851 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
13
Outside Retrieval Service
Date
Description
Amount
07/31/24
Clarivate Analytics (Compumark) Inc - Saegis excluded charge for
July.
283.36
Total
283.36
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 852 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
14
Computer Database Research
Date
Description
Amount
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Graham Wendorff
60.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Abigail Schinderle
85.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Rebecca Marston
20.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Jaina Desai
346.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Sarah Osborne
333.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Tiffani Chanroo
20.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Robert Orren
44.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Jaina Desai
185.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Kyle Trevett
60.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Julia Foster
20.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by
5.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Joshua Raphael
66.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by David Hackel
28.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Quin Wetzel
60.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Sabrina Lieberman
175.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Kenny Chiaghana
60.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Rachel Lehmann
5.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Seth Sanders
15.00
07/18/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 06/2024 by Kenny Chiaghana
40.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 853 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
15
07/22/24
Schweitzer Fachinformationen oHG - Beck-online 06/2024, 1x
7.62
Total
1,634.62
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 854 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
16
Westlaw Research
Date
Description
Amount
06/14/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Meintjes, Ruan on 6/14/2024
114.34
06/15/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Trevett, Kyle on 6/15/2024
23.35
06/17/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Hackel, David on 6/17/2024
209.95
06/18/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Debbie, John on 6/18/2024
210.17
06/18/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Meintjes, Ruan on 6/18/2024
45.73
06/19/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Hackel, David on 6/19/2024
419.90
06/19/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Meintjes, Ruan on 6/19/2024
91.47
06/20/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Osborne, Sarah on 6/20/2024
46.66
06/20/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Meintjes, Ruan on 6/20/2024
137.21
06/20/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Hackel, David on 6/20/2024
163.30
06/20/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Raphael, Joshua on 6/20/2024
69.99
06/21/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Meintjes, Ruan on 6/21/2024
22.87
06/23/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Lieberman, Sabrina on
6/23/2024
23.35
06/24/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Meintjes, Ruan on 6/24/2024
22.87
06/24/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Kaufmann, Olivia on 6/24/2024
16.65
06/26/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Lieberman, Sabrina on
6/26/2024
23.35
06/26/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Kaufmann, Olivia on 6/26/2024
63.31
06/26/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Meintjes, Ruan on 6/26/2024
91.47
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 855 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
17
07/02/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Lieberman, Sabrina on 7/2/2024
169.37
07/02/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Kaufmann, Olivia on 7/2/2024
17.99
07/03/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Lieberman, Sabrina on 7/3/2024
100.91
07/03/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Spector, Noah on 7/3/2024
414.05
07/05/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Spector, Noah on 7/5/2024
406.44
07/08/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Salmen, Adrian on 7/8/2024
75.68
07/08/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Osborne, Sarah on 7/8/2024
201.61
07/09/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Spector, Noah on 7/9/2024
515.43
07/12/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Meintjes, Ruan on 7/12/2024
24.70
07/12/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Kaufmann, Olivia on 7/12/2024
43.19
07/15/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Osborne, Sarah on 7/15/2024
25.20
07/16/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Raphael, Joshua on 7/16/2024
25.20
07/22/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Raphael, Joshua on 7/22/2024
93.59
07/22/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Hackel, David on 7/22/2024
252.01
07/23/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Raphael, Joshua on 7/23/2024
68.39
07/25/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Lieberman, Sabrina on
7/25/2024
202.83
07/25/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Raphael, Joshua on 7/25/2024
83.18
07/25/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Osborne, Sarah on 7/25/2024
50.40
07/26/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Desai, Jaina Maheshkumar on
7/26/2024
25.23
Total
4,591.34
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 856 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
18
LexisNexis Research
Date
Description
Amount
06/20/24
RELX Inc DBA LexisNexis - LexisNexis Research on 6/20/2024
by Joshua Raphael
155.14
07/02/24
RELX Inc DBA LexisNexis - LexisNexis Research on 7/2/2024 by
Sabrina Lieberman
249.46
07/03/24
RELX Inc DBA LexisNexis - LexisNexis Research on 7/3/2024 by
Seth Sanders
51.78
07/08/24
RELX Inc DBA LexisNexis - LexisNexis Research on 7/8/2024 by
Sarah Osborne
51.72
07/16/24
RELX Inc DBA LexisNexis - LexisNexis Research on 7/16/2024
by Joshua Raphael
51.72
07/22/24
RELX Inc DBA LexisNexis - LexisNexis Research on 7/22/2024
by Joshua Raphael
51.72
07/23/24
RELX Inc DBA LexisNexis - LexisNexis Research on 7/23/2024
by Joshua Raphael
72.87
Total
684.41
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 857 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
19
Overtime Transportation
Date
Description
Amount
06/10/24
Rebecca J. Marston - Rebecca J. Marston, Taxi, Overtime Lyft
from office to hotel in NY.
12.93
07/31/24
Nicholas Warther - Nicholas Warther, Taxi, Uber ride home from
office. 07/31/2024
57.94
Total
70.87
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 858 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
20
Overtime Meals - Attorney
Date
Description
Amount
07/07/24
Jaina Desai - overtime meal
40.00
07/08/24
Scottie Shermetaro - overtime meal
40.00
07/08/24
Sabrina Lieberman - overtime meal
25.91
07/09/24
Sabrina Lieberman - overtime meal
18.45
07/10/24
Scottie Shermetaro - overtime meal
40.00
07/10/24
Bernadette Coppola - overtime meal
36.69
07/14/24
GRUBHUB HOLDINGS INC - Matthews Brandan 7/11/2024 OT
Meal
41.44
07/14/24
Matthews Brandan – overtime meal
32.09
07/17/24
Jaina Desai - overtime meal
40.00
07/30/24
Steve Toth, Overtime Meals - Attorney, Chicago OT Meal
11.47
07/31/24
Steve Toth, Overtime Meals - Attorney, Chicago OT Meal
11.56
Total
337.61
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 859 of 914

Legal Services for the Period Ending July 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050104453
48520-26
21
Computer Database Research - Soft
Date
Description
Amount
06/28/24
Domain Tools searches
30.00
07/01/24
PACER Usage for 07/2024
48.30
07/01/24
PACER Usage for 07/2024
25.40
07/01/24
PACER Usage for 07/2024
6.20
Total
109.90
TOTAL EXPENSES
$ 33,951.83
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 860 of 914

August 2024
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 861 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 9, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050105563
Client Matter: 48520-26
In the Matter of Expenses
For expenses incurred through August 31, 2024
(see attached Description of Expenses for detail)
$ 6,007.31
Total expenses incurred
$ 6,007.31
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 862 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050105563
48520-26
2
Description of Expenses
Description
Amount
Standard Copies or Prints
19.30
Color Copies or Prints
84.15
Local Transportation
740.33
Travel Expense
1,810.60
Airfare
1,508.00
Travel Meals
242.15
Court Reporter Fee/Deposition
72.90
Working Meals/K&E Only
27.30
Computer Database Research
229.00
Overtime Transportation
665.04
Overtime Meals - Attorney
608.54
Total
$ 6,007.31
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 863 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050105563
48520-26
3
Description of Expenses
Standard Copies or Prints
Date
Description
Amount
08/12/24
Standard Copies or Prints
13.90
08/23/24
Standard Copies or Prints
2.00
08/28/24
Standard Copies or Prints
3.00
08/28/24
Standard Copies or Prints
0.40
Total
19.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 864 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050105563
48520-26
4
Color Copies or Prints
Date
Description
Amount
08/12/24
Color Copies or Prints
14.85
08/13/24
Color Copies or Prints
3.30
08/28/24
Color Copies or Prints
66.00
Total
84.15
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 865 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050105563
48520-26
5
Local Transportation
Date
Description
Amount
08/25/24
Chris Ceresa, Taxi from home to train station to attend sale
hearing.
52.30
08/25/24
Tanzila Zomo - Taxi from train station to hotel to attend
sale hearing.
13.72
08/25/24
Tanzila Zomo - Taxi from home to train station to attend sale
hearing.
82.76
08/26/24
Chris Ceresa, Taxi from train station to home returning from sale
hearing.
30.50
08/26/24
Chris Ceresa, Taxi from local counsel office to train station
returning from sale hearing.
22.44
08/26/24
Tanzila Zomo - Taxi from train station to home returning from sale
hearing.
74.49
08/29/24
Chris Ceresa, Taxi, from home to train station to attend sale
hearing.
63.34
08/29/24
Tanzila Zomo, Taxi, from home to train station to attend
rescheduled sale hearing.
69.23
08/29/24
Tanzila Zomo, Taxi, from train station to hotel to attend
rescheduled sale hearing.
21.06
08/30/24
Chris Ceresa, Taxi from train station to local counsel office to
attend rescheduled sale hearing.
212.99
08/30/24
Chris Ceresa, Taxi from train station to home returning from
rescheduled sale hearing
41.20
08/30/24
Tanzila Zomo, Taxi, from local counsel office to train station
returning from rescheduled sale hearing.
20.28
08/30/24
Tanzila Zomo, Taxi, from train station to home returning from
rescheduled sale hearing
36.02
Total
740.33
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 866 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050105563
48520-26
6
Travel Expense
Date
Description
Amount
08/25/24
Chris Ceresa, Lodging, Wilmington, DE, Attend sale hearing
08/25/2024
438.90
08/26/24
Tanzila Zomo – Lodging, Wilmington, DE to attend sale hearing.
559.90
08/29/24
Chris Ceresa, Lodging, Wilmington, DE, Attend rescheduled sale
hearing 08/29/2024
405.90
08/29/24
Tanzila Zomo, Lodging, Wilmington, DE, Attend rescheduled sale
hearing 08/29/2024
405.90
Total
1,810.60
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 867 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050105563
48520-26
7
Airfare
Date
Description
Amount
08/22/24
Chris Ceresa, Rail, New York, NY to Wilmington, DE, to attend
sale hearing.
207.00
08/22/24
Chris Ceresa, Rail, Wilmington, DE to New York, NY, to return
from sale hearing.
167.00
08/22/24
Tanzila Zomo – train, New York, NY to Wilmington, DE to attend
and return from sale hearing.
276.00
08/25/24
Chris Ceresa, Rail, Wilmington, DE to New York, NY, to return
from sale hearing (modified train schedule).
(120.00)
08/25/24
Chris Ceresa, Rail, Wilmington, DE to New York, NY, to return
from sale hearing (modified train schedule).
48.00
08/28/24
Chris Ceresa, Rail, New York, NY to Wilmington, DE, to attend
rescheduled sale hearing.
135.00
08/28/24
Chris Ceresa, Rail, Wilmington, DE to New York, NY, to return
from rescheduled sale hearing.
210.00
08/28/24
Tanzila Zomo, Rail, New York, NY to Wilmington, DE, to attend
rescheduled sale hearing.
135.00
08/28/24
Tanzila Zomo, Rail, New York, NY to Wilmington, DE, to attend
rescheduled sale hearing (modified train schedule).
(4.00)
08/29/24
Chris Ceresa, Rail, New York, NY to Wilmington, DE, to attend
rescheduled sale hearing (modified train schedule).
(4.00)
08/29/24
Tanzila Zomo, Rail, Wilmington, DE to New York, NY, to return
from rescheduled sale hearing.
246.00
08/29/24
Tanzila Zomo, Rail, Wilmington, DE to New York, NY, to return
from rescheduled sale hearing (modified train schedule).
36.00
08/30/24
Chris Ceresa, Rail, Wilmington, DE to New York, NY, to return
from rescheduled sale hearing (modified train schedule).
106.00
08/30/24
Tanzila Zomo, Rail, Wilmington, DE to New York, NY, to return
from rescheduled sale hearing (modified train schedule).
70.00
Total
1,508.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 868 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050105563
48520-26
8
Travel Meals
Date
Description
Amount
08/25/24
Chris Ceresa, Travel Meals (dinner), New York, NY - Attend sale
hearing.
39.85
08/26/24
Chris Ceresa, Travel Meals (breakfast), Wilmington, DE - Attend
sale hearing.
10.70
08/26/24
Chris Ceresa, Travel Meals (dinner), New York, NY - Attend sale
hearing.
5.33
08/26/24
Tanzila Zomo - Travel Meals (breakfast), Wilmington, DE -
Attend sale hearing
9.48
08/26/24
Tanzila Zomo - Travel Meals (dinner), New York, NY - Attend
sale hearing.
23.20
08/26/24
Tanzila Zomo - Travel Meals (lunch), Wilmington, DE - Attend
sale hearing.
8.87
08/29/24
Chris Ceresa, Travel Meals (lunch), New York, NY - Attend
rescheduled sale hearing.
28.80
08/29/24
Chris Ceresa, Travel Meals (dinner), New York, NY - Attend
rescheduled sale hearing.
49.64
08/29/24
Tanzila Zomo, Travel Meals (dinner), New York, NY - Attend
rescheduled sale hearing.
55.60
08/30/24
Chris Ceresa, Travel Meals (breakfast), Wilmington, DE - Attend
rescheduled sale hearing.
10.68
Total
242.15
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 869 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050105563
48520-26
9
Court Reporter Fee/Deposition
Date
Description
Amount
08/19/24
RELIABLE WILMINGTON - Transcript order for Vyaire
72.90
Total
72.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 870 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050105563
48520-26
10
Working Meals/K&E Only
Date
Description
Amount
08/07/24
Steve Toth - Working Meal/K&E Only, Chicago Overtime Meal.
14.12
08/13/24
Steve Toth - Working Meal/K&E Only, Chicago Overtime Meal.
13.18
Total
27.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 871 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050105563
48520-26
11
Computer Database Research
Date
Description
Amount
08/09/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 07/2024 by Sabrina Lieberman
92.00
08/09/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 07/2024 by Jaina Desai
71.00
08/09/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 07/2024 by David Hackel
66.00
Total
229.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 872 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050105563
48520-26
12
Overtime Transportation
Date
Description
Amount
08/01/24
Jaina Desai - Taxi, Overtime Lyft from office to home.
18.05
08/01/24
Steve Toth - Taxi, overtime transportation from office to home.
32.26
08/01/24
Steve Toth - Taxi, overtime transportation from office to home.
35.69
08/06/24
Scottie Shermetaro - Taxi, overtime from office to home.
35.61
08/06/24
Jaina Desai - Taxi, Overtime Lyft from office to home.
20.73
08/06/24
Steve Toth - Taxi, overtime transportation from office to home.
21.77
08/07/24
Brandan Matthews - Taxi, overtime transportation from office to
home.
56.61
08/08/24
Steve Toth - Taxi, overtime transportation from office to home.
38.35
08/09/24
Jaina Desai - Taxi, overtime Lyft from office to home.
19.29
08/12/24
Jaina Desai - Taxi, overtime Lyft from office to home.
15.22
08/12/24
Rebecca J. Marston - Taxi, overtime Uber home from office to
home.
25.46
08/12/24
Brandan Matthews - Taxi, Uber from office to home.
63.16
08/13/24
Jaina Desai - Taxi, overtime Lyft from office to home.
16.10
08/13/24
Scottie Shermetaro - Taxi, overtime from office to home.
39.99
08/13/24
Steve Toth - Taxi, overtime transportation from office to home.
32.55
08/13/24
Rebecca J. Marston - Taxi, overtime transportation from office to
home.
17.87
08/14/24
Scottie Shermetaro - Taxi, from office to home.
22.60
08/14/24
Jaina Desai - Taxi, overtime Lyft from home to office prior to 7
a.m.
13.99
08/14/24
Steve Toth - Taxi, overtime transportation from office to home.
36.26
08/14/24
Steve Toth - Taxi, overtime transportation from office to home.
33.69
08/14/24
Jaina Desai - Taxi, overtime Lyft home from office to home.
16.93
08/27/24
Scottie Shermetaro - Taxi, overtime from office to home.
28.15
08/28/24
Quin Wetzel - Taxi, overtime from office to home.
24.71
Total
665.04
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 873 of 914

Legal Services for the Period Ending August 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050105563
48520-26
13
Overtime Meals - Attorney
Date
Description
Amount
08/01/24
Steve Toth - Overtime Meals - Attorney, Chicago OT Meal
13.59
08/01/24
Jaina Desai - Overtime Meals - Attorney, Chicago, IL Overtime
dinner
40.00
08/06/24
Steve Toth, Overtime Meals - Attorney, Chicago OT Meal
11.47
08/06/24
Scottie Shermetaro - Overtime Meals - Attorney, Chicago.
40.00
08/06/24
Jaina Desai - Overtime Meals - Attorney, Chicago, IL.
40.00
08/09/24
Jaina Desai - Overtime Meals - Attorney, Chicago, IL.
39.98
08/10/24
Donatus Wang - Overtime Meal (7/10/24) – Attorney, Munich.
16.26
08/10/24
Carolin Paus - Overtime Meal (7/15/24) – Attorney, Munich.
17.73
08/11/24
Matthews Brandan - Overtime meal (8/7/24) - Attorney, Chicago.
38.58
08/12/24
R. Marston and J. Desai - Overtime meals (2) – Attorneys (2),
Chicago, IL.
76.14
08/13/24
Scottie Shermetaro – Overtime meals – Attorney, Chicago, IL.
40.00
08/13/24
R. Marston and J. Desai - Overtime meals (2) – Attorneys (2),
Chicago, IL.
75.47
08/14/24
Scottie Shermetaro - Overtime meals - Attorney, Chicago, IL.
40.00
08/14/24
Jaina Desai - Overtime meals - Attorney, Chicago, IL.
40.00
08/27/24
Scottie Shermetaro - Overtime meals - Attorney, Chicago.
39.32
08/28/24
Quin Wetzel - Overtime meals - Attorney, Chicago, IL.
40.00
Total
608.54
TOTAL EXPENSES
$ 6,007.31
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 874 of 914

September 2024
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 875 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
October 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107363
Client Matter: 48520-26
In the Matter of Expenses
For expenses incurred through September 30, 2024
(see attached Description of Expenses for detail)
$ 7,859.33
Total expenses incurred
$ 7,859.33
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 876 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050107363
48520-26
2
Description of Expenses
Description
Amount
Standard Copies or Prints
51.20
Color Copies or Prints
304.70
Local Transportation
212.99
Airfare
1,097.62
Transportation to/from airport
1,239.88
Outside Printing Services
1,771.48
Computer Database Research
1,129.00
Westlaw Research
331.15
LexisNexis Research
1,348.49
Overtime Transportation
275.54
Overtime Meals - Attorney
86.38
Computer Database Research - Soft
10.90
Total
$ 7,859.33
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 877 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050107363
48520-26
3
Description of Expenses
Standard Copies or Prints
Date
Description
Amount
08/01/24
Standard Copies or Prints
0.60
08/01/24
Standard Copies or Prints
0.10
08/05/24
Standard Copies or Prints
1.20
08/08/24
Standard Copies or Prints
9.90
08/12/24
Standard Copies or Prints
0.40
08/13/24
Standard Copies or Prints
0.80
08/14/24
Standard Copies or Prints
0.30
08/14/24
Standard Copies or Prints
0.20
08/15/24
Standard Copies or Prints
0.20
08/22/24
Standard Copies or Prints
0.40
08/23/24
Standard Copies or Prints
0.50
08/26/24
Standard Copies or Prints
0.50
08/28/24
Standard Copies or Prints
0.20
08/28/24
Standard Copies or Prints
0.40
08/29/24
Standard Copies or Prints
0.50
09/03/24
Standard Copies or Prints
0.30
09/04/24
Standard Copies or Prints
0.20
09/04/24
Standard Copies or Prints
0.10
09/05/24
Standard Copies or Prints
6.20
09/11/24
Standard Copies or Prints
0.20
09/11/24
Standard Copies or Prints
1.80
09/12/24
Standard Copies or Prints
0.80
09/13/24
Standard Copies or Prints
0.30
09/13/24
Standard Copies or Prints
1.20
09/17/24
Standard Copies or Prints
0.80
09/18/24
Standard Copies or Prints
6.30
09/18/24
Standard Copies or Prints
0.90
09/23/24
Standard Copies or Prints
0.70
09/23/24
Standard Copies or Prints
0.30
09/23/24
Standard Copies or Prints
2.70
09/24/24
Standard Copies or Prints
1.60
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 878 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050107363
48520-26
4
09/24/24
Standard Copies or Prints
0.90
09/25/24
Standard Copies or Prints
5.30
09/25/24
Standard Copies or Prints
0.70
09/25/24
Standard Copies or Prints
0.50
09/26/24
Standard Copies or Prints
0.70
09/26/24
Standard Copies or Prints
1.90
09/27/24
Standard Copies or Prints
0.40
09/30/24
Standard Copies or Prints
0.20
Total
51.20
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 879 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050107363
48520-26
5
Color Copies or Prints
Date
Description
Amount
08/01/24
Color Copies or Prints
0.55
08/01/24
Color Copies or Prints
25.85
08/03/24
Color Copies or Prints
9.90
08/13/24
Color Copies or Prints
1.10
08/13/24
Color Copies or Prints
11.55
08/13/24
Color Copies or Prints
2.20
08/22/24
Color Copies or Prints
15.95
08/28/24
Color Copies or Prints
22.00
08/28/24
Color Copies or Prints
17.60
09/05/24
Color Copies or Prints
23.10
09/06/24
Color Copies or Prints
21.45
09/11/24
Color Copies or Prints
22.55
09/12/24
Color Copies or Prints
0.55
09/12/24
Color Copies or Prints
20.90
09/13/24
Color Copies or Prints
20.35
09/13/24
Color Copies or Prints
17.60
09/18/24
Color Copies or Prints
1.10
09/23/24
Color Copies or Prints
1.65
09/24/24
Color Copies or Prints
24.20
09/24/24
Color Copies or Prints
22.00
09/24/24
Color Copies or Prints
4.95
09/25/24
Color Copies or Prints
5.50
09/25/24
Color Copies or Prints
3.85
09/26/24
Color Copies or Prints
1.10
09/26/24
Color Copies or Prints
0.55
09/30/24
Color Copies or Prints
6.60
Total
304.70
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 880 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050107363
48520-26
6
Local Transportation
Date
Description
Amount
09/06/24
Chris Ceresa – transportation for hearing
212.99
Total
212.99
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 881 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050107363
48520-26
7
Airfare
Date
Description
Amount
08/20/24
Spencer A. Winters, P.C. - airfare (coach) to hearing
678.94
08/29/24
Spencer A. Winters, P.C. - airfare (coach) to hearing
418.68
Total
1,097.62
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 882 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050107363
48520-26
8
Transportation to/from airport
Date
Description
Amount
08/31/24
Tabitha DePaulo – transportation from airport to residence
132.90
09/05/24
Tabitha De Paulo – transportation from airport to hotel
181.75
09/05/24
Spencer Winters – transportation from airport to residence
137.05
09/05/24
Spencer Winters – transportation from airport to hotel
225.93
09/05/24
Tabitha De Paulo – transportation from airport to hotel
206.75
09/05/24
Spencer Winters transport from local office to airport
181.75
09/05/24
Spencer Winters – transportation from hotel to airport
173.75
Total
1,239.88
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 883 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050107363
48520-26
9
Outside Printing Services
Date
Description
Amount
06/12/24
RELIABLE WILMINGTON - Outside printing for Vyaire
1,523.08
06/12/24
RELIABLE WILMINGTON - Outside printing for Vyaire
248.40
Total
1,771.48
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 884 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050107363
48520-26
10
Computer Database Research
Date
Description
Amount
08/09/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 07/2024 by Joshua Raphael
167.00
08/09/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 07/2024 by David Hackel
99.00
08/09/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 07/2024 by Sarah Osborne
837.00
08/09/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 07/2024 by Rebecca Marston
26.00
Total
1,129.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 885 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050107363
48520-26
11
Westlaw Research
Date
Description
Amount
08/08/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Wetzel, Quin on 8/8/2024
28.57
08/08/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Raphael, Joshua on 8/8/2024
8.58
08/11/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Marston, Rebecca on 8/11/2024
28.57
08/12/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Chanroo, Tiffani on 8/12/2024
37.12
08/26/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Raphael, Joshua on 8/26/2024
57.08
08/27/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Raphael, Joshua on 8/27/2024
114.15
08/28/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges by Raphael, Joshua on 8/28/2024
57.08
Total
331.15
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 886 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050107363
48520-26
12
LexisNexis Research
Date
Description
Amount
08/04/24
RELX Inc DBA LexisNexis - LexisNexis Research on 8/4/2024 by
Nicholas Warther
192.50
08/08/24
RELX Inc DBA LexisNexis - LexisNexis Research on 8/8/2024 by
Joshua Raphael
335.46
08/20/24
RELX Inc DBA LexisNexis - LexisNexis Research on 8/20/2024
by Palmer Gunderson
57.77
08/22/24
RELX Inc DBA LexisNexis - LexisNexis Research on 8/22/2024
by Palmer Gunderson
308.04
08/26/24
RELX Inc DBA LexisNexis - LexisNexis Research on 8/26/2024
by Joshua Raphael
155.15
08/27/24
RELX Inc DBA LexisNexis - LexisNexis Research on 8/27/2024
by Palmer Gunderson
144.42
08/28/24
RELX Inc DBA LexisNexis - LexisNexis Research on 8/28/2024
by Joshua Raphael
155.15
Total
1,348.49
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 887 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050107363
48520-26
13
Overtime Transportation
Date
Description
Amount
09/03/24
Quin Wetzel - overtime transportation
19.56
09/05/24
Nicholas Warther - overtime transportation
68.03
09/23/24
Steve Toth - overtime transportation
33.00
09/24/24
Steve Toth - overtime transportation (evening)
19.92
09/24/24
Steve Toth - overtime transportation (morning)
24.60
09/25/24
Steve Toth - overtime transportation (evening)
26.48
09/25/24
Steve Toth - overtime transportation (morning)
27.14
09/26/24
Steve Toth - overtime transportation (evening)
21.13
09/26/24
Steve Toth - overtime transportation (morning)
35.68
Total
275.54
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 888 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050107363
48520-26
14
Overtime Meals - Attorney
Date
Description
Amount
08/06/24
Alma Chan – overtime meal
20.00
09/03/24
Quin Wetzel - overtime meal
20.00
09/19/24
Nicholas Warther - Nicholas Warther - overtime meal
20.00
09/24/24
Steve Toth - overtime meal
14.91
09/26/24
Steve Toth - overtime meal
11.47
Total
86.38
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 889 of 914

Legal Services for the Period Ending September 30, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050107363
48520-26
15
Computer Database Research - Soft
Date
Description
Amount
06/01/24
PACER Usage for 06/2024
0.70
08/01/24
PACER Usage for 08/2024
10.20
Total
10.90
TOTAL EXPENSES
$ 7,859.33
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 890 of 914

October 2024
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 891 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 6, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050108836
Client Matter: 48520-26
In the Matter of Expenses
For expenses incurred through October 31, 2024
(see attached Description of Expenses for detail)
$ 3,957.43
Total expenses incurred
$ 3,957.43
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 892 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050108836
48520-26
2
Description of Expenses
Description
Amount
Standard Copies or Prints
16.30
Color Copies or Prints
50.60
Local Transportation
254.13
Travel Expense
360.80
Airfare
1,556.62
Transportation to/from airport
324.35
Travel Meals
178.00
Outside Retrieval Service
1.83
Computer Database Research
23.76
Westlaw Research
729.90
LexisNexis Research
131.05
Overtime Transportation
234.22
Overtime Meals - Attorney
95.87
Total
$ 3,957.43
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 893 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050108836
48520-26
3
Description of Expenses
Standard Copies or Prints
Date
Description
Amount
10/01/24
Standard Copies or Prints
0.10
10/02/24
Standard Copies or Prints
0.20
10/02/24
Standard Copies or Prints
0.40
10/08/24
Standard Copies or Prints
0.10
10/09/24
Standard Copies or Prints
0.40
10/10/24
Standard Copies or Prints
0.10
10/22/24
Standard Copies or Prints
0.50
10/23/24
Standard Copies or Prints
8.30
10/24/24
Standard Copies or Prints
0.10
10/29/24
Standard Copies or Prints
0.40
10/31/24
Standard Copies or Prints
5.70
Total
16.30
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 894 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050108836
48520-26
4
Color Copies or Prints
Date
Description
Amount
10/02/24
Color Copies or Prints
9.90
10/03/24
Color Copies or Prints
1.10
10/08/24
Color Copies or Prints
2.20
10/09/24
Color Copies or Prints
12.10
10/16/24
Color Copies or Prints
3.30
10/23/24
Color Copies or Prints
7.70
10/28/24
Color Copies or Prints
12.10
10/29/24
Color Copies or Prints
2.20
Total
50.60
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 895 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050108836
48520-26
5
Local Transportation
Date
Description
Amount
08/29/24
Spencer A. Winters, P.C., Taxi, home from hearing 08/29/2024
87.04
09/13/24
VITAL TRANSPORTATION SERVICES INC - Zomo Tanzila -
home from hearing 08/30/2024
122.36
10/03/24
Hannah Crawford - Taxi home from working late 10/03/2024
44.73
Total
254.13
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 896 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050108836
48520-26
6
Travel Expense
Date
Description
Amount
08/26/24
Tabitha J. De Paulo, Lodging, Wilmington, DE, Travel to
Wilmington, DE. 08/26/2024
174.90
08/30/24
Tabitha J. De Paulo - Lodging, Wilmington, DE, Travel to
Wilmington, DE. 08/30/2024
185.90
Total
360.80
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 897 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050108836
48520-26
7
Airfare
Date
Description
Amount
08/21/24
Tabitha J. De Paulo, Airfare (coach), from Chicago, IL to
Philadelphia, PA, 08/25/2024
678.94
08/26/24
Tabitha J. De Paulo - Airfare (coach), from Philadelphia, PA to
Chicago, IL, 08/27/2024
320.08
08/27/24
Tabitha J. De Paulo - Airfare (flight change), from Philadelphia,
PA to Chicago, IL, 08/27/2024
103.60
08/28/24
Tabitha J. De Paulo - Airfare (coach), round trip, Chicago,
IL/Philadelphia, PA, 08/28/2024-08/29/2024
454.00
Total
1,556.62
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 898 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050108836
48520-26
8
Transportation to/from airport
Date
Description
Amount
09/26/24
SUNNY'S WORLDWIDE - 09/18/2024 WINTERS SPENCER
Pick Up at PHL Airport and Drop Off at Hotel
143.00
09/26/24
SUNNY'S WORLDWIDE - 09/19/2024 WINTERS SPENCER
Pick Up at Hotel and Drop Off at PHL Airport
181.35
Total
324.35
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 899 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050108836
48520-26
9
Travel Meals
Date
Description
Amount
08/25/24
Tabitha J. De Paulo, Travel Meals, Chicago, Illinois Travel to
Wilmington, Delaware. 08/25/2024
20.00
08/25/24
Spencer A. Winters, P.C. - Travel Meals, PHL hearing 08/25/2024
20.00
08/26/24
Spencer A. Winters, P.C. - Travel Meals with Tabitha J. De Paulo,
PHL hearing 08/26/2024
40.00
08/26/24
Tabitha J. De Paulo, Travel Meals, Wilmington, Delaware Travel
to Wilmington, Delaware. 08/26/2024
18.00
08/28/24
Tabitha J. De Paulo - Travel Meals, Chicago, Illinois Travel to
Wilmington, Delaware 08/28/2024
20.00
08/29/24
Tabitha J. De Paulo - Travel Meals, Wilmington, Delaware Travel
to Wilmington, Delaware 08/29/2024
20.00
08/29/24
Spencer A. Winters, P.C. - Travel Meals, Chicago hearing
08/29/2024
20.00
08/30/24
Tabitha J. De Paulo - Travel Meals, Philadelphia, Pennsylvania
Travel to Wilmington, Delaware 08/30/2024
20.00
Total
178.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 900 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050108836
48520-26
10
Outside Retrieval Service
Date
Description
Amount
10/02/24
BUNDESANZEIGER VERLAG - Document Retrieval Service.
1.83
Total
1.83
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 901 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050108836
48520-26
11
Computer Database Research
Date
Description
Amount
09/30/24
RELX Inc DBA LexisNexis - Courtlink Usage for 09/2024
3.76
10/22/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 09/2024
20.00
Total
23.76
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 902 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050108836
48520-26
12
Westlaw Research
Date
Description
Amount
09/03/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges on 9/3/2024
24.76
09/12/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges on 9/12/2024
265.37
09/16/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges on 9/16/2024
278.73
09/19/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges on 9/19/2024
112.09
10/04/24
THOMSON REUTERS - WEST PUBLISHING CORP -
WESTLAW Research Charges, 10/4/2024
48.95
Total
729.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 903 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050108836
48520-26
13
LexisNexis Research
Date
Description
Amount
09/13/24
RELX Inc DBA LexisNexis - LexisNexis Research on 9/13/2024
28.88
09/25/24
RELX Inc DBA LexisNexis - LexisNexis Research on 9/25/2024
102.17
Total
131.05
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 904 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050108836
48520-26
14
Overtime Transportation
Date
Description
Amount
09/23/24
Donatus Wang - Taxi, Overtime Transportation 09/23/2024
20.21
10/03/24
Steve Toth - Taxi, Overtime Transportation 10/03/2024
32.72
10/08/24
Steve Toth - Taxi, Overtime Transportation 10/08/2024
32.41
10/09/24
Steve Toth - Taxi, Overtime Transportation 10/09/2024
38.44
10/10/24
Steve Toth - Taxi, Overtime Transportation 10/10/2024
39.29
10/10/24
Scottie Shermetaro - Taxi, Overtime Transportation 10/10/2024
18.85
10/23/24
Steve Toth - Taxi, Overtime Transportation 10/23/2024
25.49
10/31/24
Sabrina Lieberman - Taxi, Overtime Transportation 10/31/2024
26.81
Total
234.22
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 905 of 914

Legal Services for the Period Ending October 31, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050108836
48520-26
15
Overtime Meals - Attorney
Date
Description
Amount
10/02/24
Steve Toth - Overtime Meals - Attorney, Chicago 10/02/2024
11.56
10/09/24
Steve Toth - Overtime Meals - Attorney, Chicago 10/09/2024
8.12
10/10/24
Carolin Paus – Overtime Meals – Attorney, München, Germany
19/09/2024
16.89
10/10/24
Carolin Paus – Overtime Meals – Attorney, München, Germany
16/09/2024
20.00
10/10/24
Steve Toth - Overtime Meals - Attorney, Chicago 10/10/2024
9.74
10/21/24
Paul Paefgen - Overtime Meals - Attorney, München, Germany
10/21/2024
18.00
10/23/24
Steve Toth - Overtime Meals - Attorney, Chicago 10/23/2024
11.56
Total
95.87
TOTAL EXPENSES
$ 3,957.43
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 906 of 914

November 1, 2024 – November 14, 2024
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 907 of 914

601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
December 18, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050109744
Client Matter: 48520-26
In the Matter of Expenses
For expenses incurred through November 14, 2024
(see attached Description of Expenses for detail)
$ 538.32
Total expenses incurred
$ 538.32
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 908 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050109744
48520-26
2
Description of Expenses
Description
Amount
Standard Copies or Prints
8.90
Color Copies or Prints
55.55
Computer Database Research
337.00
Overtime Transportation
117.15
Overtime Meals - Attorney
19.72
Total
$ 538.32
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 909 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050109744
48520-26
3
Description of Expenses
Standard Copies or Prints
Date
Description
Amount
11/04/24
Standard Copies or Prints
0.60
11/04/24
Standard Copies or Prints
3.20
11/04/24
Standard Copies or Prints
0.50
11/05/24
Standard Copies or Prints
4.40
11/05/24
Standard Copies or Prints
0.10
11/06/24
Standard Copies or Prints
0.10
Total
8.90
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 910 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050109744
48520-26
4
Color Copies or Prints
Date
Description
Amount
11/04/24
Color Copies or Prints
18.70
11/05/24
Color Copies or Prints
31.35
11/05/24
Color Copies or Prints
0.55
11/06/24
Color Copies or Prints
1.10
11/07/24
Color Copies or Prints
2.75
11/13/24
Color Copies or Prints
1.10
Total
55.55
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 911 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050109744
48520-26
5
Computer Database Research
Date
Description
Amount
09/03/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 08/2024 by Joshua Raphael
8.00
09/03/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 08/2024 by Rebecca Marston
99.00
09/03/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 08/2024 by Kenny Chiaghana
20.00
09/03/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 08/2024 by Jaina Desai
55.00
11/13/24
RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets
Usage for 10/2024 by Sabrina Lieberman
155.00
Total
337.00
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 912 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050109744
48520-26
6
Overtime Transportation
Date
Description
Amount
11/05/24
Steve Toth - overtime transportation
34.21
11/05/24
Sabrina Lieberman - overtime transportation
24.42
11/07/24
Steve Toth - overtime transportation
30.62
11/12/24
Sabrina Lieberman - overtime transportation
27.90
Total
117.15
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 913 of 914

Legal Services for the Period Ending November 14, 2024
Vyaire Medical Inc.
Expenses
Invoice Number:
Matter Number:
1050109744
48520-26
7
Overtime Meals - Attorney
Date
Description
Amount
11/10/24
Carolin Paus – overtime meal
19.72
Total
19.72
TOTAL EXPENSES
$ 538.32
Case 24-11217-BLS    Doc 882-2    Filed 12/23/24    Page 914 of 914

File and source

File

gov.uscourts.deb.193283.882.2.pdf

Size

22,113,296 bytes

SHA-256

dafebd329b21b85a24950410d686c52819f681d6d5366bdb59603bc2793fa89c

Our copy

gov.uscourts.deb.193283.882.2.pdf

Original

PACER (login required)